
<html lang="en"     class="pb-page"  data-request-id="2b0e83b5-01e6-4e80-97e7-cf8820172e32"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;article:article:10.1021/acs.jmedchem.0c01664;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network" /></meta><meta name="dc.Creator" content="Jan  Skácel" /></meta><meta name="dc.Creator" content="Barbara S.  Slusher" /></meta><meta name="dc.Creator" content="Takashi  Tsukamoto" /></meta><meta name="dc.Description" content="Ceramides are composed of a sphingosine and a single fatty acid connected by an amide linkage. As one of the major classes of biologically active lipids, ceramides and their upstream and downstream..." /></meta><meta name="Description" content="Ceramides are composed of a sphingosine and a single fatty acid connected by an amide linkage. As one of the major classes of biologically active lipids, ceramides and their upstream and downstream..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 4, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01664" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01664" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01664" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01664" /></link>
        
    
    

<title>Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01664" /></meta><meta property="og:title" content="Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0039.jpeg" /></meta><meta property="og:description" content="Ceramides are composed of a sphingosine and a single fatty acid connected by an amide linkage. As one of the major classes of biologically active lipids, ceramides and their upstream and downstream metabolites have been implicated in several pathological conditions including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation. Consequently, tremendous efforts have been devoted to deciphering the dynamics of metabolic pathways involved in ceramide biosynthesis. Given that several distinct enzymes can produce ceramide, different enzyme targets have been pursued depending on the underlying disease mechanism. The main objective of this review is to provide a comprehensive overview of small molecule inhibitors reported to date for each of these ceramide-producing enzymes from a medicinal chemistry perspective." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01664"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01664">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01664&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01664&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01664&amp;href=/doi/10.1021/acs.jmedchem.0c01664" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 279-297</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01627" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c01704" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jan Skácel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan Skácel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Sk%C3%A1cel">Jan Skácel</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara S. Slusher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara S. Slusher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara+S.++Slusher">Barbara S. Slusher</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9814-4157" title="Orcid link">http://orcid.org/0000-0001-9814-4157</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Takashi Tsukamoto</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takashi Tsukamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21205, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (410) 614-0982. Fax: (410) 614-0659. Email: <a href="/cdn-cgi/l/email-protection#d3a7a7a0a6b8b2bebca7bc93b9bbbebafdb6b7a6"><span class="__cf_email__" data-cfemail="8df9f9fef8e6ece0e2f9e2cde7e5e0e4a3e8e9f8">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takashi++Tsukamoto">Takashi Tsukamoto</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0216-7520" title="Orcid link">http://orcid.org/0000-0002-0216-7520</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01664&amp;href=/doi/10.1021%2Facs.jmedchem.0c01664" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 279–297</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 September 2020</li><li><span class="item_label"><b>Published</b> online</span>4 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01664" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01664</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D279%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJan%2BSk%25C3%25A1cel%252C%2BBarbara%2BS.%2BSlusher%252C%2BTakashi%2BTsukamoto%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01664%26title%3DSmall%2BMolecule%2BInhibitors%2BTargeting%2BBiosynthesis%2Bof%2BCeramide%252C%2Bthe%2BCentral%2BHub%2Bof%2Bthe%2BSphingolipid%2BNetwork%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D297%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01664"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1265</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01664" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Skácel&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;S. Slusher&quot;},{&quot;first_name&quot;:&quot;Takashi&quot;,&quot;last_name&quot;:&quot;Tsukamoto&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;279-297&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01664&quot;},&quot;abstract&quot;:&quot;Ceramides are composed of a sphingosine and a single fatty acid connected by an amide linkage. As one of the major classes of biologically active lipids, ceramides and their upstream and downstream metabolites have been implicated in several pathological conditions including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation. Consequently, tremendous efforts have been devoted to deciphering the dynamics of metabolic pathways involved in ceramide biosynthesis. Given that several distinct enzymes can produce ceramide, different enzyme targets have been pursued depending on the underlying disease mechanism. The main objective of this review is to provide a comprehensive overview of small molecule inhibitors reported to date for each of these ceramide-producing enzymes from a medicinal chemistry perspective.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01664&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01664" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01664&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01664" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01664&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01664" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01664&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01664&amp;href=/doi/10.1021/acs.jmedchem.0c01664" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01664" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01664" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01664%26sid%3Dliteratum%253Aachs%26pmid%3D33395289%26genre%3Darticle%26aulast%3DSk%25C3%25A1cel%26date%3D2021%26atitle%3DSmall%2BMolecule%2BInhibitors%2BTargeting%2BBiosynthesis%2Bof%2BCeramide%252C%2Bthe%2BCentral%2BHub%2Bof%2Bthe%2BSphingolipid%2BNetwork%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D279%26epage%3D297%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Ceramides are composed of a sphingosine and a single fatty acid connected by an amide linkage. As one of the major classes of biologically active lipids, ceramides and their upstream and downstream metabolites have been implicated in several pathological conditions including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation. Consequently, tremendous efforts have been devoted to deciphering the dynamics of metabolic pathways involved in ceramide biosynthesis. Given that several distinct enzymes can produce ceramide, different enzyme targets have been pursued depending on the underlying disease mechanism. The main objective of this review is to provide a comprehensive overview of small molecule inhibitors reported to date for each of these ceramide-producing enzymes from a medicinal chemistry perspective.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingolipids belong to a class of non-glycerol-based lipids built on a sphingosine backbone. Sphingosine derivatives acylated at the amino group with fatty acids of different chain length and degree of unsaturation are termed ceramides. Because of the structural variation in the fatty acid component, ceramides can occur in several structurally different forms. For instance, ceramide formed from sphingosine (d18:1) and oleic acid (18:1(9Z)) containing a total of 18 carbons and a C8–C9 Z-double bond is referred to as Cer(d18:1/18:1(9Z)).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cumulative evidence suggests that different ceramides, in terms of the fatty acid composition, may play distinct and tissue-specific physiological roles under various biological contexts.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Ceramides are known to be synthesized through three major pathways, namely, the de novo biosynthesis pathway, the salvage pathway, and sphingomyelin hydrolysis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Because of their pathophysiological implications in diseases, some of the enzymes involved in these pathways have been extensively studied as therapeutic targets including ceramide synthase, dihydroceramide desaturase, and sphingomyelinase, each of which catalyzes the final step in the de novo biosynthesis pathway, the salvage pathway, and sphingomyelin hydrolysis, respectively. Other ceramide-producing enzymes include glucocerebrosidase, galactocerebrosidase, and ceramide-1-phosphate phosphatase. With the increasing interest in ceramide biosynthesis as therapeutic targets, there are a number of well-written review articles detailing the biological and physiological aspects of these ceramide-producing enzymes.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16">(5−16)</a> There are also review articles on small molecule inhibitors of these enzymes,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21">(17−21)</a> though they are relatively limited in scope and lack detailed insights from a medicinal chemistry perspective. This Perspective provides a comprehensive and in-depth overview of small molecule inhibitors reported to date for each of these ceramide-producing enzymes including the latest development in this field with greater potential for therapeutic application.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ceramide biosynthesis pathways (adapted from ref <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>). Various biosynthetic routes to ceramide are depicted for Cer(d18:1/18:1(9Z)). De novo pathway, salvage pathway, and sphingomyelin hydrolysis are highlighted in purple, orange, and cyan, respectively. Other sources of ceramide include glucocerebrosidase (gray), galactocerebrosidase (green), and ceramide-1-phosphate phosphatase (beige).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Dihydroceramide Desaturase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">De novo synthesis of ceramide begins with decarboxylative condensation of <span class="smallcaps smallerCapital">l</span>-serine and palmitoyl-CoA catalyzed by serine C-palmitoyltransferase. The resulting product, 3-dehydrosphinganine, is converted into sphinganine by 3-dehydrosphinganine reductase. Ceramide synthase catalyzes the acylation of sphinganine with fatty-acyl-CoAs of varying chain length to yield dihydroceramides. In the final step of the de novo biosynthesis pathway, dihydroceramide desaturase converts dihydroceramides into ceramides. While dihydroceramide desaturase 1 (DES1) encoded by DEGS1 in human displays only desaturase activity, its closest paralog, dihydroceramide desaturase 2 (DES2) encoded by DEGS2, exhibits both desaturase and hydroxylase activities. DEGS1 deficiency has recently been reported to lead to an imbalance between saturated/unsaturated sphingolipids and cause leukodystrophy and peripheral hypomyelination,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> highlighting the clinical significance of DES1. DES1 has been also implicated as a therapeutic target in various diseases including cancer,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Alzheimer’s disease,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and diabetes.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Along with these findings, a number of structurally diverse DES1 inhibitors have been reported in the literature.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">GT11 (<b>1</b>) is one of the first DES1 inhibitors described in the literature (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It is a ceramide derivative in which the C4–C5 double bond of the sphingosine component is replaced by a cyclopropene moiety. The design of this molecule was based on early reports on the activity of sterculic acid as a potent inhibitor of the Δ9-stearoyl-CoA desaturase.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> As expected from its structure, kinetics studies using rat liver microsomes revealed that GT11 (<b>1</b>) inhibits DES1 in a competitive manner with respect to <i>N</i>-octanoylsphinganine with a <i>K</i><sub>i</sub> value of 6 μM.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Interestingly, GT11 (<b>1</b>) was found to inhibit dihydroceramide desaturase activity in primary cultured cerebellar neurons with an approximately 250-fold greater inhibitory potency, presumably due to a local subcellular enrichment of the inhibitor in the endoplasmic reticulum, the main site of action of the enzyme.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> It should be noted, however, that GT11 (<b>1</b>) was also reported to display greater potency when HGC27 cell lysates were used as a source of the enzyme with an IC<sub>50</sub> value of 52 nM and a <i>K</i><sub>i</sub> value of 22 nM.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of ceramide-based DES1 inhibitors GT11 (<b>1</b>), XM462 (<b>2</b>), and compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">XM462 (<b>2</b>) is a mechanism-based DES1 inhibitor in which the C5 methylene group of the sphinganine component is replaced by a sulfur atom (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> It inhibits desaturase activity in rat liver microsomes with an IC<sub>50</sub> value of 8.2 μM. The rationale for incorporating a sulfur atom into the sphinganine component is based on the previous reports on the activity of some thia fatty acids as fatty acyl-CoA desaturase inhibitors.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> XM462 (<b>2</b>) was found to be a mixed-type inhibitor with <i>K</i><sub>iapp</sub> and α values of 2 μM and 0.83, respectively. Although the precise mechanism of inhibition was not investigated, the ceramide analog is anticipated to bind to the enzyme active site, where its C4 hydrogen is removed as a radical to afford the carbon radical intermediate in equilibrium with the sulfur radical species. The inhibition may then arise from coordination of the intermediate(s) to the enzyme active site.</div><div class="NLM_p">There are several other ceramide analogs reported as DES1 inhibitors including those derived from GT11 (<b>1</b>)<a onclick="showRef(event, 'ref28 ref34'); return false;" href="javascript:void(0);" class="ref ref28 ref34">(28,34)</a> and XM462 (<b>2</b>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Most notably, ceramide analog <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) containing a C6–C7 double bond was found to act as a potent DES1 inhibitor with an IC<sub>50</sub> value of 155 nM when HGC27 cell lysates were used as a source of the enzyme.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Contrary to expectations based on its structural similarity to DES1 substrates, compound <b>3</b> showed a noncompetitive type of inhibition.</div><div class="NLM_p">Fenretinide (<b>4</b>), also known as <i>N</i>-(4-hydroxyphenyl)retinamide (4-HPR), is a synthetic retinoid derivative originally developed as a chemotherapeutic agent because of its ability to attenuate cancer cell growth with relatively low toxicity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Fenretinide (<b>4</b>) was first recognized as a DES1 inhibitor when it was found to increase dihydroceramides in a dose dependent manner in SMS-KCNR cells.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Subsequently, DES1 was confirmed as the primary target for fenretinide (<b>4</b>) using rat liver microsomes with an IC<sub>50</sub> value of 2.32 μM.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In 20 min incubation experiments, fenretinide (<b>4</b>) acted as a competitive inhibitor with a <i>K</i><sub>i</sub> value of 8.28 μM. In addition to fenretinide (<b>4</b>), its known metabolites were evaluated for their ability to inhibit desaturase activity. Among them, 4-oxo-<i>N</i>-(4-hydroxyphenyl)retinamide <b>5</b> (4-oxo-4-HPR, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) showed the highest inhibitory potency with an IC<sub>50</sub> value of 1.68 μM. <i>N</i>-(4-Methoxyphenyl)retinamide <b>6</b> (4-MPR) and 4-oxo-<i>N</i>-(4-methoxyphenyl)retinamide <b>7</b> (4-oxo-4-MPR) had minimal effects on DES1 activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), demonstrating the essential role played by the phenolic moiety in the potent inhibitory activity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of retinoid-based DES1 inhibitors <b>4</b>–<b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SKI II (<b>8</b>) is an orally available dual inhibitor of sphingosine kinases 1 (SK1) and 2 (SK2) with <i>K</i><sub>i</sub> values of 16 μM and 7.9 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> It was later discovered that SKI II (<b>8</b>) also inhibits DES1.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Unlike fenretinide (<b>4</b>), SKI II (<b>8</b>) was found to act as a noncompetitive inhibitor of DES1 in HGC-27 cell lysates with a <i>K</i><sub>i</sub> value of 0.3 μM despite that they share the 4-aminophenol moiety. On the basis of these findings, it is speculated that SKI II (<b>8</b>) targets the upstream enzyme, cytochrome b5 reductase (Cb5R), which plays an essential role in the desaturation process by regenerating ferrocytochrome b5. Compounds <b>9</b> and <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), analogs of SKI II (<b>8</b>), were also reported as inhibitors of desaturase activity in Jurkat cells with varying degrees of inhibitory potency and selectivity for SK1 and SK2,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> which should, together with other SKI II (<b>8</b>) analogs devoid of desaturase inhibitory activity, serve as useful probes to understand the biology of SK1, SK2, and DES1.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of SKI II (<b>8</b>) and its derivatives <b>9</b> and <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, a series of DES1 inhibitors containing a 4-acylaminophenol or 6-acylamino-3-pyridinol scaffold were disclosed in a patent application (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Compounds <b>11</b> and <b>12</b> were reported to potently inhibit DES1 activity in Jurkat cells with an IC<sub>50</sub> value of 1 nM, while fenretinide (<b>4</b>), used as a control, exhibited an IC<sub>50</sub> value of 100–250 nM under the same assay conditions. The impact of converting a phenol to a 3-pyridinol moiety was most profound for compound <b>13</b>, which exhibited >20-fold improvement in potency over the corresponding phenol derivative <b>14</b> possessing the same acyl group. At present, only limited pharmacological data are available for these highly potent DES1 inhibitors. It remains to be seen whether these compounds have the potential to be developed into viable therapeutic agents.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of DES1 inhibitors <b>11</b>–<b>14</b> containing a 6-acylamino-3-pyridinol or 4-acylaminophenol scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">There are other non-ceramide analogs reported as DES1 inhibitors including resveratrol, celecoxib, curcumin, and Δ9-tetrahydrocannabinol (THC).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Their utility as DES1 inhibitors, however, remains questionable given their rather weak inhibitory activity against DES1 coupled with the fact that they act on other targets more potently and/or display polypharmacological behaviors.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Ceramide Synthase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ceramide synthase (CerS) catalyzes the acylation of sphingoid bases with fatty-acyl-CoAs of varying chain length.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As mentioned earlier, CerS can recognize sphinganine as a substrate and produce dihydroceramides, penultimate intermediates of the de novo biosynthesis pathway. CerS can also directly produce ceramides when sphingosine is used as a substrate via the salvage pathway, reutilizing sphingosine formed as a result of degradation of higher order sphingolipids. CerS is encoded by six distinct genes (CerS1–6), each of which shows preference for a particular range of Acyl-CoA substrates (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref10 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref10 ref44 ref45">(10,44,45)</a> For instance, CerS1, which is primarily expressed in the brain, has a high substrate preference for stearoyl-CoA. Indeed, C18-ceramide was reported to be the most abundant ceramide in the rat brain, representing nearly half of the total ceramide amount.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Given the distinct substrate specificity and tissue distribution shown by each of the six isoforms, it is not surprising that the clinical and pathological significance of CerS varies among them.<a onclick="showRef(event, 'ref9 ref10 ref47'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref47">(9,10,47)</a> Therefore, the therapeutic potential of CerS inhibition highly depends on the ability to target a specific isoform of CerS. Until recently, though, there had been no isoform-selective CerS inhibitors, hindering efforts to develop CerS-targeting therapeutic agents.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Acyl-CoA substrate preference of CerS isoforms.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fumonisin B1 (<b>15</b>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), a mycotoxin produced by <i>Fusarium moniliforme</i>, is one of the first reported CerS inhibitors.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In rat liver microsomes, fumonisin B1 (<b>15</b>) was found to inhibit conversion of [<sup>3</sup>H]sphingosine to [<sup>3</sup>H]ceramide with an IC<sub>50</sub> value of 0.1 μM. It is postulated that the two tricarballylic acid side chains of fumonisin B1 (<b>15</b>) play a crucial role in interacting with the acyl-CoA binding site while its amino group mimics that of sphinganine/sphingosine.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Inhibition kinetics studies using mouse brain microsomes indicated that fumonisin B1 (<b>15</b>) is a competitive inhibitor with respect to sphinganine while it displayed a mixed-type inhibition with respect to stearoyl-CoA.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Although speculative, it is conceivable that a fraction of fumonisin B1 (<b>15</b>) was hydrolyzed in brain microsomes to form aminopentol (<b>16</b>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), which is known to serve as a CerS substrate by making the fatty acyl-CoA binding site accessible to an acyl donor.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This may explain the observed mixed-type inhibition with respect to stearoyl-CoA by fumonisin B1 (<b>15</b>). It should also be noted that the resulting <i>N</i>-acyl derivatives of aminopentol likely serve as CerS inhibitors as seen with <i>N</i>-palmitoyl and <i>N</i>-nervonoyl derivatives of aminopentol.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of fumonisin B1 (<b>15</b>) and aminopentol (<b>16</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fumonisin B1 (<b>15</b>) has been widely used to study effects of CerS inhibition on the sphingolipid metabolism and cell viability.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Fumonisin B1 (<b>15</b>) is cytotoxic to various mammalian cell lines, at least in part due to its lack of isoform selectivity.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This has hindered efforts to assess the therapeutic potential of selectively targeting each isoform.</div><div class="NLM_p">FTY720 (<b>17</b>), also known as fingolimod, is a sphingosine-like molecule approved by FDA for the treatment of the relapsing form of multiple sclerosis (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). After enantiospecific monophosphorylation, the resulting metabolite <b>18</b> acts as a functional antagonist of sphingosine-1-phosphate (S1P) receptors <i>in vivo</i>. Interestingly, FTY720 (<b>17</b>) itself was found to inhibit N-acylation of dihydrosphingosine with docosanoyl-CoA with an IC<sub>50</sub> value of 6.4 μM in the human pulmonary artery endothelial cell (HPAEC) lysate.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> It appears to act as a competitive inhibitor with respect to dihydrosphingosine with a <i>K</i><sub>i</sub> value of 2.15 μM for CerS2 when C22-CoA was used as an acyl donor. A different research group, however, reported more complex inhibition kinetics of FTY720 (<b>17</b>) using homogenates prepared from HEK cells overexpressing CerS4, namely, noncompetitive and uncompetitive inhibition toward C18-CoA and sphinganine, respectively.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Yet another group showed that FTY720 (<b>17</b>) is competitive with respect to fluorescent NBD-sphinganine and noncompetitive with respect to C16:0-CoA.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of FTY720 (<b>17</b>) and its derivatives <b>18</b>–<b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The (<i>R</i>)- and (<i>S</i>)-enantiomers of 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol (AAL) are derivatives of FTY720 (<b>17</b>) in which the benzylic carbon was replaced by an ether oxygen and one of the two prochiral hydroxymethyl groups is replaced by a methyl group (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> It was reported that (<i>R</i>)-AAL (<b>19</b>) but not (<i>S</i>)-AAL (<b>20</b>) is phosphorylated by recombinant mouse sphingosine kinase 1a.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This finding is consistent with the enantiospecificity of sphingosine kinases displayed toward FTY720 (<b>17</b>). Interestingly, the nonphosphorylatable enantiomer (<i>S</i>)-AAL (<b>20</b>) was subsequently found to inhibit C16:0 CerS activity of HEK293 lysates (∼50% inhibition at 10 μM) in a competitive manner with respect to NBD-sphinganine.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> None of the three additional analogs <b>21</b>–<b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) showed substantial CerS inhibitory activity at 10 μM, suggesting that both the amino group and the long carbon chain of (<i>S</i>)-AAL (<b>20</b>) are essential for the potent inhibitory activity.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Investigation on the isoform selectivity of (<i>S</i>)-AAL (<b>20</b>) revealed that it inhibits CerS1 potently (>90% inhibition at 10 μM) and, to a lesser extent, CerS5 and CerS6 (nearly 50% inhibition at 10 μM).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Although benzyloxy analog <b>24</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) was found to be a somewhat weaker CerS1 inhibitor (76% inhibition at 10 μM), it showed no inhibitory activity toward CerS2 and CerS4–6, representing one of the first isoform-selective CerS inhibitors. It should be noted that (<i>S</i>)-AAL (<b>20</b>) and compound <b>24</b> (at 10 μM) have CerS1 inhibitory activity–cytotoxicity ratios of 0.2 and 3.6, respectively. The results suggest the possibility of differentiating CerS1 inhibitory activity from cytotoxicity, an important step forward for the future therapeutic development of CerS inhibitors.</div><div class="NLM_p">In another study, <i>N</i>-alkyl and <i>N</i>-acyl derivatives <b>25</b>–<b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) were profiled for their effects on ceramide synthase activity of cell lysates and live cells by measuring the levels of C14–C24 ceramides or dihydroceramides.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> For instance, compounds <b>25</b> inhibited C16-, C18-, and C24-dihyroceramide synthesis with IC<sub>50</sub> values of 25.7, 50.7, and 60.6 μM, respectively, in a microsomal fraction of HCT-116 cells. Subsequent experiments using a cell lysate of CerS2, CerS4, or CerS6 overexpressing HT-116 cells indicated that compound <b>25</b> preferentially inhibits CerS2 and CerS4.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of CerS inhibitors <b>25</b>–<b>29</b> derived from FTY720 (<b>17</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">More recently, P053 (<b>29</b>), a dichloro analog of <b>24</b>, was reported as a potent and selective inhibitor of CerS1 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> P053 (<b>29</b>) inhibited human and murine CerS1 (hCerS1 and mCerS1) with IC<sub>50</sub> values of 0.54 and 0.46 μM, respectively, while it showed substantially lower inhibitory potency against hCerS2, mCerS2, hCerS4, mCerS5, and hCerS6 (IC<sub>50</sub> = 7–30 μM). The inhibition of CerS1 by P053 (<b>29</b>) appears to be noncompetitive with respect to either sphinganine or C18 fatty acyl-CoA. Consistent with its <i>in vitro</i> isoform selectivity, P053 (<b>29</b>) selectively reduced C18 ceramide and other C18 sphingolipids in HEK293 cell culture. P053 (<b>29</b>) is orally available in mice and reduced C18 ceramide levels in skeletal muscles of mice on a high-fat diet, leading to the enhancement of fatty acid oxidation and reduction in overall adiposity. These findings demonstrate the therapeutic potential of CerS1 inhibition for the treatment of obesity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  Sphingomyelinase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingomyelin, the most abundant form of sphingolipids, is a non-glycerol-based phospholipid in which the primary alcohol of ceramide is linked to choline through a phosphodiester bond.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> Sphingomyelin is synthesized from ceramide by sphingomyelin synthase in the Golgi apparatus. Because of varying chain length (C14 to C26) of the fatty acid moiety of the ceramide molecule, sphingomyelin occurs in a number of structurally different forms. Upon synthesis, sphingomyelin is exported to other membrane systems. Indeed, sphingomyelin constitutes a significant fraction of the total lipid composition of the plasma and lysosomal membranes.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Membrane sphingomyelin can be hydrolyzed back to ceramide via hydrolysis of the phosphodiester catalyzed by sphingomyelinase, thereby serving as a reservoir for ceramide.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Sphingomyelinase can be divided into three evolutionarily unrelated classes based on their pH optima: acid sphingomyelinase (aSMase), neutral sphingomyelinase (nSMase), and alkaline sphingomyelinase. No potent inhibitors have been reported for alkaline sphingomyelinase to date, and thus this topic will not be covered in this review. On the other hand, tremendous efforts have been made to identify potent inhibitors of aSMase and nSMase, in part driven by the therapeutic potential of targeting these enzymes for the treatment of various diseases, including cancer, neurodegenerative diseases, major depression disorder, pulmonary inflammation, atherosclerosis, and viral infections.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">4.1.  Acid Sphingomyelinase</h3><div class="NLM_p">Two forms of aSMase, both encoded by the SPMD1 gene, have been known to exist as a result of two distinct post-translational trafficking pathways within the ER-Golgi network.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Lysosomal aSMase is transported to the endolysosomal compartment and anchored to the inner lysosomal membrane. Secretory aSMase is transported to the outer leaflet of the plasma membrane and secreted into the extracellular space under certain conditions.</div><div class="NLM_p">Clinical significance of aSMase has been well recognized as some forms of Niemann–Pick disease, a lysosomal storage disorder, were found to be caused by loss-of-function mutations in the SMPD1 gene.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Upregulation of aSMase has also been implicated in a number of diseases including several neurodegenerative disorders where excess ceramide is believed to play a pathogenic role.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> As described later, these findings have spurred efforts to develop aSMase inhibitors as therapeutic agents.</div><div class="NLM_p">Several crystal structures have been reported for mammalian aSMase.<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66−68)</a> Two distinct conformations were observed in the crystal structures of murine aSMase depending on the folding and positioning of the membrane-interacting N-terminal saposin domain.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> A closed globular conformation (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>) is believed to be predominant in the absence of membranes and render the enzyme inactive (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A), while an open conformation (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FIB">5FIB</a>) is expected to establish an interface with the catalytic domain essential for activity (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B). The active site carries a binuclear zinc complex, playing a central role in the catalytic process at the core of the active site. A hydrophobic track that extends from the edge of the active site to the saposin domain is predicted to accommodate the fatty acid chains of sphingomyelin. aSMase is positively charged at acidic lysosomal pH and is tightly associated with lysosomal membrane surfaces, presumably through the positively charged residues in the saposin domain. This formed the mechanistic basis for indirect inhibition of aSMase by cationic amphiphilic molecules, which constitute one of the two major classes of aSMase inhibitors, the other being those directly interacting with the enzyme.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structures of (A) the closed form (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>) and (B) the open form (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FIB">5FIB</a>) of murine aSMase.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The saposin domain is shown in blue, and the active site zinc ions are shown as gray spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AY-9944 (<b>30</b>) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), originally reported as an inhibitor of cholesterol biosynthesis,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> was later found to recapitulate the pathological features similar to those found in Niemann–Pick disease in rats.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Furthermore, it was found that aSMase activity was significantly reduced in the tissues of rats treated with AY-9944 (<b>30</b>), although it failed to inhibit aSMase activity in a cell-free system.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Tricyclic antidepressants, imipramine (<b>31</b>) and desipramine (<b>32</b>) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), were also reported to decrease aSMase activity in murine neuroblastoma and human fibroblast cell cultures.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Interestingly, iminodibenzyl (<b>33</b>) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) containing the same tricyclic core but devoid of the side chain showed no effect on aSMase activity, indicating the essential role of the cationic amphiphilic characteristics of these molecules. Additional cationic amphiphilic drugs were subsequently found to reduce aSMase activity in cell cultures.<a onclick="showRef(event, 'ref73 ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75 ref76">(73−76)</a> It is postulated that these molecules accumulate in lysosomes as positively charged species and compete for the aSMase binding site at the inner lysosomal membrane, resulting in a detachment and proteolytic degradation of the enzyme.<a onclick="showRef(event, 'ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref76 ref77 ref78">(76−78)</a> These indirect aSMase inhibitors are now collectively referred to as functional inhibitors of acid sphingomyelinase (FIASMAs).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> It should be noted that many FIASMAs are FDA approved for clinical use. For instance, the clinical benefit of amitriptyline (<b>34</b>) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) was investigated in patients with cystic fibrosis, in which ceramide is known to accumulate in bronchial epithelial cells.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> While FIASMAs offer a unique mechanism to indirectly reduce aSMase activity, their safety profile remains to be seen given that many of these molecules act on various CNS targets.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of representative functional inhibitors of aSMase (FIASMAs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Screening of tropical plant extracts and microbial secondary metabolites using a crude preparation of aSMase from the bovine brain led to the discovery of some xanthone-based molecules as aSMase inhibitors (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> α-Mangostin (<b>35</b>), cowanol (<b>36</b>), and cowanin (<b>37</b>) inhibited aSMase with IC<sub>50</sub> values of 14.1, 10.9, and 19.2 μM, respectively. These inhibitors differ structurally from FIASMAs in that they lack a basic nitrogen atom necessary for amphiphilic properties. Indeed, all of the three compounds inhibited aSMase in a competitive manner with respect to sphingomyelin, suggesting direct interaction with the enzyme. α-Mangostin analog <b>38</b> containing saturated side chains retained the inhibitory activity (IC<sub>50</sub> = 10.9 μM), while diacetyl analog <b>39</b> showed no inhibitory activity, highlighting the important role played by the two phenolic OH groups of α-mangostin (<b>35</b>) and its derivatives.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of xanthone-based aSMase inhibitors <b>35</b>–<b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using the γ-pyrone fragment of the xanthone-based inhibitors discussed above as the branching point of origin, a collection of 500 γ-pyrones spanning three hierarchy levels in the branch were assembled for screening.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Two potent compounds <b>40</b> and <b>41</b> containing a benzopyran scaffold (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) were identified as potent inhibitors of aSMase prepared from rat brain homogenates with IC<sub>50</sub> values of 3.1 and 9.5 μM, respectively. These compounds displayed no inhibitory activity toward nSMase at concentrations up to 50 μM.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of γ-pyrone-based aSMase inhibitors <b>40</b> and <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Epicatechin-3-<i>O</i>-gallate (<b>42</b>) (ECg, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) was reported to inhibit secretory SMase, a secreted form of aSMase.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Further investigation identified a synthetic catechin, 3′-<i>O</i>-methylepigallocatechin-3-<i>O</i>-gallate (<b>43</b>) (EGCg-3′-O-Me, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), as a low micromolar inhibitor of secretory SMase from rat plasma with an IC<sub>50</sub> value of 1.7 μM. Secretory SMase was found to be activated by oxidation and inactivated by reduction. Thus, these compounds are believed to act as reducing agents toward the enzyme to achieve its inhibition. Indeed, EGCg-3′-O-Me displayed noncompetitive inhibition when C6 NBD sphingomyelin was used as a substrate, indicating the presence of an allosteric site targeted by the epicatechin-based compounds.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of catechin-based secretory SMase inhibitors <b>42</b> and <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Weak aSMase inhibitory activity observed for phosphatidylinositol-4,5-bisphosphate (PtdIns4,5P2) against aSMase<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> prompted exploration of other phosphatidylinositol derivatives including PtdIns3,5P2 (<b>44</b>) (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> PtdIns3,5P2 (<b>44</b>) potently inhibited a recombinant human aSMase (>90% inhibition at 5 μM) in a micellar assay system. It displayed a noncompetitive mode of inhibition with a <i>K</i><sub>i</sub> value of 0.53 μM and showed no inhibitory activity against rat brain microsomal nSMase at concentrations of up to 50 μM. Subsequently, racemic sulfonate derivatives <b>45</b>–<b>49</b> with alkyl groups of varying length (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) were synthesized in an attempt to remove the polar phosphate moiety of PtdIns3,5P2 (<b>44</b>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Compound <b>49</b> containing a dodecyl group was found to be most potent against aSMase prepared from rat brain homogenates with an IC<sub>50</sub> value of 0.90 μM, comparable to that of PtdIns3,5P2 (<b>44</b>) (IC<sub>50</sub> = 0.93 μM). Unlike PtdIns3,5P2 (<b>44</b>), however, compound <b>49</b> acted as a competitive inhibitor with a <i>K</i><sub>i</sub> value of 0.42 μM, suggesting a mode of binding distinct from that of PtdIns3,5P2 (<b>44</b>) despite common structural features shared by the two molecules.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of inositol-4,5-bisphosphate-based aSMase inhibitors <b>44</b>–<b>49</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">α-Aminobisphosphonate <b>50</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) was identified as a potent aSMase inhibitor (IC<sub>50</sub> = 0.04 μM) through screening of a bisphosphonate compound library using rat brain homogenates as a source of the enzyme.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Additional compounds were synthesized in order to gain further insight into the SAR of bisphosphonate derivatives. Among them, compounds <b>51</b>–<b>53</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>) exhibited IC<sub>50</sub> values below 100 nM. None of these compounds inhibited nSMase of rat brain homogenates.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of bisphosphonate-based aSMase inhibitors <b>50</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cocrystal structure of murine aSMase with compound <b>51</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>) shows that one of the two phosphonate groups in the inhibitor interacts with both zinc atoms in the active site (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Compound <b>51</b> appears to act as a transition state analog inhibitor by mimicking the intermediate formed by a nucleophilic attack of a water molecule to the phosphodiester of sphingomyelin. Surprisingly, the nine-carbon chain of compound <b>51</b> does not seem to bind to the hydrophobic track of aSMase, a putative binding site for the alkyl chains of sphingomyelin.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Crystal structure of the murine aSMase active site in complex with compound <b>51</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Key residues are shown as a green stick model, zinc ions are shown as gray spheres, and compound <b>51</b> is shown as a cyan stick model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">α-Substituted serinol derivatives <b>54</b>–<b>57</b> were reported as aSMase inhibitors in a patent application (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The most potent compound <b>57</b> containing a 1-nonyl-1<i>H</i>-1,2,3-triazol-4-yl group inhibited aSMase with an IC<sub>50</sub> value of 1.14 μM in a biochemical assay. It is conceivable that the two primary hydroxyl groups of these compounds serve as alternatives to the highly polar phosphonate moieties of <b>50</b>–<b>53</b>. Indeed, compound <b>57</b> was found to be orally available in mice and distributed to the brain. Furthermore, compound <b>57</b> was found to normalize the enhanced brain aSMase activity in APP/PS1 mice to that of wild type.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of serinol-based aSMase inhibitors <b>54</b>–<b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By use of a pharmacophore model developed from the previously reported xanthone-based aSMase inhibitors, hydroxamate-containing compound <b>58</b> (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) was identified as a submicromolar competitive inhibitor of human aSMase from the supernatants of Huh7 cell lysates with an IC<sub>50</sub> value of 0.48 μM.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Compound <b>58</b> was also found to dose-dependently reduce generation of ceramide and LPS-induced inflammation in human NIH3T3 cells. Subsequent efforts guided by molecular docking led to the discovery of compound <b>59</b> devoid of a flexible alkyl chain (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Compound <b>59</b> inhibited aSMase from the supernatants of Huh7 cell lysates with an IC<sub>50</sub> value of 0.32 μM. In Sprague-Dawley rats, compound <b>59</b> showed good CNS permeability and reduced aSMase activity in cerebral cortex and hippocampus following intraperitoneal injection. Neither <b>58</b> nor <b>59</b> inhibited nSMase at concentrations up to 100 μM.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of hydroxamate-based aSMase inhibitors <b>58</b> and <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.2.  Neutral Sphingomyelinase</h3><div class="NLM_p">As indicated by its name, the catalytic phosphodiesterase activity of nSMase is optimal at neutral pH. In mammals, four distinct genes, SMPD2–5, have been identified to date, encoding nSMase1–3<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a> and mitochondria-associated nSMase,<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> respectively. nSMase1–3 show little sequence homology while substantial sequence homology (50.6% similarity) exists between nSMase2 and mitochondria-associated nSMase.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93,94)</a> These isoforms differ in tissue distribution and subcellular localization, suggesting distinct physiological and pathogenic roles.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">Similar to aSMase, the therapeutic utility of nSMase inhibition has gained increasing attention as another strategy to regulate ceramide levels in various disease conditions. Most efforts have focused on nSMase2, which is the most extensively studied isoform in terms of its potential as a therapeutic target in a number of disease areas.</div><div class="NLM_p">nSMase2 contains a hydrophobic N-terminal domain (NTD) and a C-terminal catalytic domain (CAT). The NTD is a lipid-binding domain that interacts with phosphatidylserine (PS), which is required for its full enzymatic activity. The CAT is interrupted by a large insertion (175–339), and the crystal structure of the human nSMase2 CAT devoid of the insertion (residues 117–651 Δ175–339) was recently determined at 1.85 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG">5UVG</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The structure reveals a deoxyribonuclease I (DNase I)-like fold as expected from the structural and catalytic similarity between the two enzymes (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>A). Its active site contains conserved residues within DNase I-like superfamily involved in Mg<sup>2+</sup> binding and catalysis. The hydrophobic track stretching from the active site is believed to be the binding site for the alkyl chains of sphingomyelin. In this structure, however, an evolutionarily conserved motif termed “DK switch” is positioned such that it obstructs the active site entrance (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>B) and places the conserved Asp430 away from the active site. This observation suggests that “DK switch” adopts different conformations to regulate the enzymatic activity. It was subsequently postulated that PS binding triggers conformational change of “DK switch”, resulting in the formation of the active enzyme.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> These structural insights should serve as a guide for facilitating the rational design of nSMase inhibitors.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Crystal structure of human nSMase2 CAT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG">5UVG</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> (A) Ca<sup>2+</sup> shown as a gray sphere occupies the position of the primary Mg<sup>2+</sup> ion required for the Mg<sup>2+</sup>-dependent activity of nSMase2. DK switch is shown in blue, and the conserved Asp430 is shown as a purple stick model. (B) Close-up view of the substrate binding site. DK switch shown in blue obstructs the entrance to the hydrophobic track stretching from the active site (painted in yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scyphostatin (<b>60</b>), isolated from <i>Trichopeziza mollissima</i>, represents the first low-micromolar inhibitor of nSMase.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>, it bears some structural resemblance to ceramide in that they both contain the <i>N</i>-acylamino alcohol scaffold.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Scyphostatin (<b>60</b>) is a far more potent nSMase inhibitor than other naturally occurring compounds previously reported<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100,101)</a> with an IC<sub>50</sub> value of 1.0 μM using rat brain microsomes as an enzyme source.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> It showed 50-fold selectivity over aSMase and no inhibitory activity against <i>Staphylococcus aureus</i> and <i>Bacillus cereus</i> SMases.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> In preliminary kinetics studies, scyphostatin (<b>60</b>) displayed mixed-type inhibition with respect to sphingomyelin. The presence of the epoxide moiety suggests the possibility of covalent bond formation between the inhibitor and the enzyme though the precise mechanism of inhibition has not yet been elucidated.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of scyphostatin <b>60</b> and its derivatives <b>61</b>–<b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequent to the discovery of scyphostatin (<b>60</b>), several analogs have been evaluated as nSMase inhibitors (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>). Compound <b>61</b> containing a spiroexpoxide moiety exhibited 80% inhibition of nSMase activity in rat brain microsomes following 90 min preincubation at 200 μM.<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103,104)</a> It was found that inhibition by compound <b>61</b> was time dependent, suggestive of a covalent modification of the enzyme.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Compounds <b>62</b> and <b>63</b> displayed substantially lower inhibitory activity compared to <b>61</b>, demonstrating the crucial role played by the primary hydroxyl group in the enzyme inhibition.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Because of its structural similarity to scyphostatin (<b>60</b>) and compound <b>61</b>, manumycin A (<b>64</b>) was evaluated for its ability to inhibit nSMase using a partially purified enzyme from rat brain microsomes.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Manumycin A (<b>64</b>) was, indeed, found to inhibit nSMase in a time-dependent manner (34% inhibition without preincubation and 79% inhibition following 60 min preincubation at 100 μM). Its truncated analog <b>65</b> displayed enhanced inhibitory activity (90% inhibition without preincubation and 98% inhibition following 60 min preincubation at 100 μM), while analog <b>66</b> (racemic) containing a saturated acyl group showed weaker activity (10% inhibition without preincubation and 88% inhibition following 60 min preincubation at 100 μM). Although these analogs were not directly (head-to-head) compared to scyphostatin, it appears that none of them exceeded the inhibitory potency achieved by scyphostatin (<b>60</b>).</div><div class="NLM_p">Alutenusin (<b>67</b>) (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), originally isolated from <i>Alternaria</i> sp., was identified as an nSMase inhibitor through microbial screening.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Alutenusin (<b>67</b>) containing a biphenyl scaffold is one of the first nSMase inhibitors structurally distinct from sphingolipids and was found to inhibit nSMase from rat brain microsomes with a <i>K</i><sub>i</sub> value of 20 μM. As expected from its non-sphingolipid-like structure, alutenusin (<b>67</b>) displayed a noncompetitive inhibition with respect to sphingomyelin. Furthermore, it showed no inhibitory activity against aSMase from rat brain microsomes at concentrations up to 950 μM.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structure of alutenusin (<b>67</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hydroquinones <b>68</b>–<b>70</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>), isolated from <i>Acremonium murorum</i>, were reported to inhibit nSMase of rat brain microsomes with IC<sub>50</sub> values of 7.2 μg/mL (34 μM), 3.6 μg/mL (17 μM), and 3.2 μg/mL (16 μM), respectively.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Compound <b>71</b> (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>), the corresponding quinolone derivative of <b>69</b>, was also found to potently inhibit nSMase of rat brain microsomes with a IC<sub>50</sub> value of 0.8 μg/mL (4.2 μM).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Another hydroquinone-based compound, ubiquinol (<b>72</b>) (CoQ<sub>10</sub>H<sub>2</sub>, <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>), was reported to inhibit Mg<sup>2+</sup>-dependent nSMase of pig liver plasma membranes (>90% inhibition at 100 μM following 15 min preincubation) in a noncompetitive manner with respect to sphingomyelin.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Subsequent studies releveled that inhibition by ubiquinol (<b>72</b>) is time-dependent, displaying a greater degree of potency when preincubated for 60 min.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Furthermore, CoQ<sub>6</sub>H<sub>2</sub> (<b>73</b>) (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) was found to have the optimal isoprenoid side chain length for nSMase inhibition among several homologs.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures of benzoquinol- and benzoquinone-based nSMase inhibitors <b>68</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an attempt to mimic the phosphodiester moiety of sphingomyelin, some phosphorus-based compounds have also been examined as nSMase inhibitors. After some early efforts resulting in identification of weak nSMase inhibitors,<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> compound <b>74</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) was found to inhibit nSMase of bovine brain microsomes with an IC<sub>50</sub> value of 3.3 μM.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> It should be noted that the stereochemistry of <b>74</b> is opposite that of sphingomyelin at both of the two chiral centers. Surprisingly, compound <b>75</b> possessing the same stereochemistry as sphingomyelin (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) showed much weaker inhibitory potency (IC<sub>50</sub> = 181 μM). These findings indicate that compound <b>74</b> does not act as a substrate-based inhibitor despite its structural similarity to sphingomyelin. Indeed, compound <b>74</b> displayed noncompetitive inhibition with respect to sphingomyelin with a <i>K</i><sub>i</sub> value of 1.6 μM. Consistent with its mode of inhibition, compound <b>74</b> showed no inhibitory effect on SMase from <i>B. cereus</i> even though it shares common structural and mechanistic features in the catalytic domain with mammalian nSMase.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of phosphonate-based nSMase inhibitors <b>74</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Some sphingomyelin analogs possessing a carbamate moiety as a replacement for the phosphodiester group were identified as low-micromolar nSMase inhibitors (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> By use of rat brain microsomes as the enzyme source, carbamates <b>76</b> and <b>77</b> were found to inhibit nSMase with IC<sub>50</sub> values of 2.8 and 1.8 μM, respectively. SAR studies indicate that only a narrow range of acyl groups are tolerated at the amino group. Both <i>N</i>-acetyl and <i>N</i>-stearoyl derivatives <b>78</b> and <b>79</b> showed no inhibitory activity at concentrations up to 100 μM.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of carbamate-based nSMase inhibitors <b>76</b>–<b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ceramide derivatives <b>80</b> and <b>81</b> containing a thiourea moiety (<a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) were reported to inhibit nSMase semipurified from bovine brain microsomes with low micromolar potency in a time-dependent manner (∼90% inhibition after 60 min preincubation).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Compounds <b>80</b> and <b>81</b> displayed competitive inhibition with respect to sphingomyelin with <i>K</i><sub>i</sub> values of 1.7 and 2.5 μM, respectively, suggesting direct binding of these ceramide derivatives to the active site of the enzyme. Assuming that the primary hydroxyl group of these inhibitors corresponds to that of ceramide, the stereochemistry of the amino-attached (<i>R</i>)-chiral carbon appears opposite to that of ceramide. The corresponding (<i>S</i>)-derivatives of <b>80</b> and <b>81</b>, however, were not explored in this report.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structures of thiourea-based nSMase inhibitors <b>80</b> and <b>81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ceramide derivatives containing a lactone moiety in their sphingosine component were found to inhibit nSMase from rat brain microsomes (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Compounds <b>82</b> and <b>83</b>, the so-called sphingolactones, achieved nearly 50% and 90% inhibition following 15 min of preincubation at 350 μM. It is speculated that the time-dependent inhibition resulted from irreversible covalent binding of the lactone carbonyl moiety to the enzyme.</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of γ-lactone-based nSMase inhibitors <b>82</b> and <b>83</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Aminoguanidine derivatives C11AG (<b>84</b>) and <b>85</b> (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>) were reported to inhibit nSMase activity of rat brain microsomes with IC<sub>50</sub> values of 8.2 and 5 μM, respectively.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Although C11AG (<b>84</b>) is less potent than compound <b>85</b>, it displayed superior antiviral potency against HSV-1 in Rita cells with a favorable therapeutic index. C11AG (<b>84</b>) showed 30-fold selectivity over aSMase and no inhibitory activity toward other phospholipases including phospholipase A2, phospholipase D, and phosphatidylcholine-specific phospholipase C. In subsequent studies, C11AG (<b>84</b>) was found to suppress LPS-stimulated sphingomyelin degradation and ceramide synthesis in RAW cells, resulting in suppression of NF-κB liberation.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Another aminoguanidine derivative, ES048 (<b>86</b>) (<a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>), was reported to inhibit nSMase activity in mouse splenocytes though it exhibited a U-shaped dose–response curve with the maximal effect (∼80% inhibition) at 1 μM.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> It showed no inhibitory effects on either aSMase from mouse splenocytes or recombinant human aSMase.</div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structures of aminoguanidine-based nSMase inhibitors <b>84</b>–<b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Some N-dialkylated amino acids were reported as low micromolar nSMase inhibitors (<a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a></a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Among the compounds tested, serine and alanine derivatives <b>87</b> and <b>88</b> were most potent with IC<sub>50</sub> values of 1.8 and 2.8 μM, respectively, using U937 cell lysate as a source of the enzyme. Preliminary SAR studies indicated that the carboxyl group and the propenyl (-C═CH-CH<sub>2</sub>-) linkers are essential for the potent inhibitory activity.</div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of α-amino acid-based nSMase inhibitors <b>87</b> and <b>88</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">GW4869 (<b>89</b>) (<a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a></a>) was identified by a high throughput assay using a partially purified and delipidated rat brain nSMase.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> GW4869 (<b>89</b>) is a noncompetitive inhibitor with respect to sphingomyelin with an IC<sub>50</sub> value of 1 μM. GW4869 (<b>89</b>) showed no inhibitory activity against human aSMase. Interestingly, PS, a known endogenous activator of nSMase,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> was found to reduce the inhibitory potency of GW4869 (<b>89</b>). The two substances, however, were unlikely to compete for the same binding site since a PS-independent <i>B. cereus</i> SMase was also inhibited by GW4869 (<b>89</b>) with similar potency. GW4869 (<b>89</b>) significantly inhibited TNF-induced sphingomyelin hydrolysis in a dose-dependent manner in MCF7 cells, while it showed no effects on the de novo ceramide biosynthetic pathway.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Since its discovery, GW4869 (<b>89</b>) has been by far the most widely used prototype nSMase2 inhibitor for studying the physiological and pathological roles of nSMase. Indeed, as an <i>in vivo</i> probe molecule, GW4869 (<b>89</b>) has demonstrated the therapeutic utility of nSMase2 inhibition in a variety of animal disease models, including Alzheimer’s disease,<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a> traumatic brain injury,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> lung injury,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> metabolic disease,<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> heart failure,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> and cancer.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> Despite its proven track record as a tool compound, systematic structural optimization efforts on GW4869 (<b>89</b>) has not yet been reported, presumably due to its high lipophilic core scaffold contributing to poor aqueous solubility.</div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures of GW4869 (<b>89</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Various 4<i>H</i>-1,2,4-triazole-3(2<i>H</i>)-thione derivatives were reported as low micromolar nSMase inhibitors (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>). Compounds <b>90</b> and <b>91</b> inhibited mouse nSMase with IC<sub>50</sub> values of 2.5 and 2.4 μM, respectively.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> The same group also reported a series of 3,4-dihydropyrimidine-2(1<i>H</i>)-thione derivatives including <b>92</b> and <b>93</b> (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>) as nSMase inhibitors with IC<sub>50</sub> values of 0.9 and 0.86 μM, respectively. More recently, cambinol (<b>94</b>) (<a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a></a>), a 2-thioxo-2,3-dihydropyrimidin-4(1<i>H</i>)-one derivative originally reported as a SIRT1/2 inhibitor,<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> was identified as a nSMase2 inhibitor from screening assays using the recombinant human enzyme.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Cambinol (<b>94</b>) displayed uncompetitive inhibition with respect to sphingomyelin with a <i>K</i><sub>i</sub> value of 7 μM. It also inhibited nSMase activity of <i>B. cereus</i> and rat brain homogenate with IC<sub>50</sub> values of 5 and 6 μM, respectively. Furthermore, cambinol was found to block TNF-α induced increase in ceramide levels in the rat primary neurons. It should be noted that inhibitors <b>90</b>–<b>94</b> possess the cyclic thiourea moiety as the common structural feature. In particular, it is conceivable that the pyrimidine-based core rings of compounds <b>92</b>–<b>94</b> play a similar role in binding to the enzyme. Cambinol (<b>94</b>) was independently identified as a tau propagation inhibitor from cell-based functional assays.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Molecular docking and molecular dynamic simulation studies using recently published crystal structure of nSMase2 CAT<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> indicate that it binds to nSMase2 at the DK switch and inhibits the enzyme by directing Asp430 away from the active site.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Structures of nSMase inhibitors <b>90</b>–<b>94</b> containing a 1,2,4-triazole-3-thione or pyrimidine-2-thione ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2,6-Dimethoxy-4-(5-phenyl-4-thiophen-2-yl-1<i>H</i>-imidazol-2-yl)phenol (<b>95</b>) (DPTIP, <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>) was identified as a potent inhibitor of human nSMase2 through a high throughput screening of >365 000 compounds from the Molecular Libraries Small Molecule Repository (MLSMR) and the NCGC Pharmaceutical Collection (NPC).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> DPTIP (<b>95</b>) inhibited a human recombinant nSMase2 with an IC<sub>50</sub> value of 30 nM in a noncompetitive manner with respect to sphingomyelin. DPTIP (<b>95</b>) inhibited release of extracellular vesicles from the rat primary astrocyte cultures in a dose dependent manner. Furthermore, DPTIP (<b>95</b>) attenuated IL-1β-induced astrocyte-derived extracellular vesicle (ADEV) release in GFAP-GFP mice following intraperitoneal administration. Subsequent medicinal chemistry efforts identified 4-(1<i>H</i>-imidazol-2-yl)-2,6-dimethoxyphenol as a key pharmacophore essential for the potent nSMase2 inhibition, and several derivatives containing this pharmacophore exhibited inhibitory potency comparable to that of DPTIP, including compounds <b>96</b>–<b>99</b> (<a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a></a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures of nSMase inhibitors <b>95</b>–<b>99</b> based on the 4-(1<i>H</i>-imidazol-2-yl)-2,6-dialkoxyphenol scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>100</b> containing an imidazo[1,2-<i>b</i>]pyridazine ring is another inhibitor identified from screening efforts using a human recombinant nSMase2.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a> Preliminary SAR studies revealed that the imidazo[1,2-<i>b</i>]pyridazin-8-amine scaffold is essential for the potent inhibition as compounds possessing other 6,5-fused ring scaffolds failed to show any inhibitory activity. On the other hand, modifications of the pyrrolidine ring of <b>100</b> led to the discovery of phenyl (<i>R</i>)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-<i>b</i>]pyridazin-8-yl)pyrrolidin-3-yl)carbamate (<b>101</b>) (PDDC) with improved potency (IC<sub>50</sub> = 0.3 μM).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> It displayed a noncompetitive inhibition with respect to sphingomyelin with a <i>K</i><sub>i</sub> value of 0.3 μM. Consistent with its noncompetitive mode of inhibition, PDDC (<b>101</b>) showed no inhibitory activity against aSMase and two other phosphodiesterases (PDE3A and PDE4D2). It was found to be metabolically stable and orally available in mice with excellent CNS permeability. As seen with DPTIP, but by oral administration, PDDC (<b>101</b>) inhibited ADEV release in a dose dependent manner in GFAP-GFP mice.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> It was also reported to reverse cognitive impairment in 5XFAD mice following intraperitoneal administration.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Subsequently, extensive structure–activity relationship (SAR) studies were conducted using PDDC as a molecular template, providing additional potent nSMase2 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a></a>) within this structural series including compounds <b>102</b> (IC<sub>50</sub> = 0.1 μM) and <b>103</b> (IC<sub>50</sub> = 0.07 μM).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><figure id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0033.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of nSMase inhibitors <b>100</b>–<b>103</b> containing an imidazo[1,2-<i>b</i>]pyridazine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Targeting both nSMase2 and acetylcholinesterase (AChE) may lead to a new therapeutic approach to Alzheimer’s disease since it could not only suppress exosome biogenesis but also enhance cholinergic synaptic plasticity. To this end, a ∼70-compound library largely comprising phenserine analogs and other known AChE inhibitors was screened for nSMase2 inhibitory activity.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> One hit from the screening, compound <b>104</b> (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>), was validated as a weak inhibitor of nSMase2 (60% inhibition at 50 μM). Subsequent hit-to-lead optimization led to the discovery of compounds <b>105</b> and <b>106</b> (<a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a></a>) displaying nearly 100-fold more potent inhibitory activity. As anticipated from their phensvenine-like structures,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> compounds <b>105</b> and <b>106</b> were also found to inhibit AChE with IC<sub>50</sub> values of 7 and 1.7 μM, respectively. Both compounds displayed an uncompetitive mechanism of inhibition with respect to sphingomyelin. Consistent with these findings, molecular docking analysis using a crystal structure of the nSMase2 CAT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG">5UVG</a>) indicates that both compounds bind to nSMase2 at the DK-switch and stabilize its inactive conformation<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> in a manner similar to what was proposed for cambinol (<b>94</b>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Both compounds were reported to suppress the release of tau-bearing extracellular vesicles (EVs) in cell-based assays, and compound <b>106</b> significantly reduced IL1β-induced release of tau-carrying exosomes in tau P301S (PS19 line) mice.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><figure id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0034.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures of phensvenine-based nSMase inhibitors <b>104</b>–<b>106</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4.3.  Bacterial Sphingomyelinase</h3><div class="NLM_p">There are two different types of bacterial SMase depending on the phosphodiester cleaving site.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Like human SMase, sphingomyelinase C (SMaseC) catalyzes the hydrolysis of the phosphoester linkage between ceramide and phosphocholine. Sphingomyelinase D, on the other hand, hydrolyzes the other phosphoester bond, resulting in the release of ceramide-1-phosohate and choline. Given the primary focus of this review article on ceramide-producing enzymes, only SMaseC inhibitors will be discussed herein. SMaseC can be found in many species of bacteria, including <i>S. aureus</i>, <i>B. cereus</i>, <i>Clostridium perfringens</i>, and <i>Leptospira interrogans</i>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It appears that SMaseC is evolutionally related to mammalian neutral sphingomyelinases as they share a number of conserved residues in the catalytic region and adopt the same fold as DNase I, another metal-dependent phosphodiesterase. Indeed, mammalian nSMase1 and nSMase2 were cloned based on their sequence homology to bacterial SMaseC.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> SMaseC, however, differs from the mammalian homologs in that it is a secretory protein that can target the host cell plasma membrane. For instance, increase in ceramide caused by SMaseC is known to alter the physical properties of the host cell plasma membrane and, possibly, contribute to the pathogenesis of some infectious diseases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In fact, antibodies against SMaseC, but not those against phosphatidylcholine and phosphatidylinositol-specific phospholipases C, were found to protect mice from a lethal dose of <i>B. cereus</i>,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> underscoring the potential therapeutic utility of SMaseC inhibitors.</div><div class="NLM_p">Prior to the elucidation of human nSMase2 crystal structure,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> a number of crystal structures have been solved for SMaseC.<a onclick="showRef(event, 'ref142 ref143 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref142 ref143 ref144 ref145">(142−145)</a> The first crystal structure of SMaseC was determined for <i>Listeria ivanovii</i> SMaseC (SmcL) at 1.9 Å resolution (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZWX">1ZWX</a>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Like human nSMase2, SmcL adopts a DNase I-like protein fold and possesses a number of key residues in the active site conserved among bacterial SMases and eukaryotic nSMases (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>A), suggesting a common catalytic mechanism for binding and hydrolysis of sphingomyelin. The structure also revealed a large hydrophobic β-hairpin and hydrophobic loop surrounding the active site. In the absence of identifiable membrane-spanning regions, these segments unique to bacterial SMases are thought to play an important role in mediating protein–host membrane interactions to guide the phosphodiester moiety of sphingomyelin into the active site (<a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a></a>B). It should be noted that, unlike the human nSMase2 CAT structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG">5UVG</a>) discussed earlier, the DK switch in this structure forms a short α-helix that directs the conserved Asp160 residue into the active site, conceivably representing the active conformation of the enzyme.</div><figure id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0035.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. (A) Overall structure of SmcL (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZWX">1ZWX</a>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> The hydrophobic β-hairpin and the hydrophobic loop are shown in green and red, respectively. Phosphate ion shown as an orange/red stick model is likely located in the position occupied by the phosphate moiety of sphingomyelin in the enzyme–substrate complex. DK switch shown in blue forms a short α-helix and directs the conserved Asp160 residue shown as a purple stick model into the active site. (B) Schematic diagram of SmcL-catalyzed hydrolysis of sphingomyelin into ceramide on the outer leaflet of the plasma membrane (adapted from ref <a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As could be expected from the close evolutionary relationship between the two classes of enzymes, some mammalian nSMase inhibitors, including GW4869 (<b>89</b>) and cambinol (<b>94</b>), were also found to inhibit <i>B. cereus</i> SMaseC as described earlier.<a onclick="showRef(event, 'ref122 ref133'); return false;" href="javascript:void(0);" class="ref ref122 ref133">(122,133)</a> Conversely, it is conceivable that some of the SMaseC inhibitors described below act as mammalian nSMase inhibitors.</div><div class="NLM_p">Phosphonate-based sphingomyelin analogs <b>107</b> and <b>108</b> (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>) were explored as transition-state analog inhibitors of sphingomyelinase.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a> Compounds <b>107</b> and <b>108</b>, however, showed rather weak inhibitory potency against <i>B. cereus</i> SMaseC with IC<sub>50</sub> values of 120 μM and 78 μM, respectively.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Phosphoramidate <b>109</b><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and difluoromethylene phosphonate <b>110</b><a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>) also exhibited low inhibitory potency against <i>B. cereus</i> SMaseC with IC<sub>50</sub> values of 53 and 57 μM, respectively. The weak inhibitory activity of these compounds can be at least partially attributed to the lack of the double bond corresponding to the C4–C5 double bond of sphingomyelin. Despite the presence of the C4–C5 double bond, however, the inhibitory activity of thiophosphate derivative <b>111</b> (<a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a></a>) was reported to be even weaker than other phosphorus-based compounds.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> It was found, however, that compound <b>111</b> can be recognized as a substrate by <i>B. cereus</i> SMaseC, releasing 1-thiosphingosine. Since the free thiol group can be captured by various labeling reagents as generated, compound <b>111</b> may serve as a useful substrate to continuously monitor SMaseC activity.</div><figure id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0036.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structures of phosphorus-based SMaseC inhibitors <b>107</b>–<b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the inspection of the <i>B. cereus</i> SMaseC crystal structures,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> sphingomyelin analog <b>112</b> containing a bipyridyl moiety (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>) was designed to interact with the active site Mg<sup>2+</sup> ion, predicted to play a critical role in the catalytic process.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Compound <b>112</b> inhibited <i>B. cereus</i> SMaseC with an IC<sub>50</sub> value of 1.2 μM. It displayed a competitive inhibition with respect to sphingomyelin with a <i>K</i><sub>i</sub> value of 5.2 μM, indicating that the inhibitor competes with the substrate at the active site of the enzyme as designed. Compound <b>113</b> (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>), a regioisomer of <b>112</b> with a bipyridyl moiety linked to the C3 secondary hydroxyl group, showed only weak inhibitory activity (20% inhibition at 100 μM). Docking simulation analyses suggest that the bipyridyl moiety of compound <b>112</b> is optimally positioned to participate in the coordination with the active site Mg<sup>2+</sup> ion while that of compound <b>113</b> is oriented away from the active site.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Subsequent structural optimization efforts led to the discovery of two submicromolar inhibitors <b>114</b> and <b>115</b> (<a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a></a>).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Compound <b>114</b>, devoid of an acyl group, inhibited <i>B. cereus</i> SMaseC with an IC<sub>50</sub> value of 0.9 μM. Compound <b>115</b> has a phenyl group replacing the alkenyl chain extending from the C3 position and inhibited <i>B. cereus</i> SMaseC with an IC<sub>50</sub> value of 0.8 μM. Like compound <b>112</b>, the two inhibitors displayed a competitive inhibition with respect to sphingomyelin with <i>K</i><sub>i</sub> values of 2.8 and 1.3 μM, respectively. Intraperitoneal injection of compound <b>115</b> in mice decreased the lethality of the <i>B. cereus</i> treatment in a dose-dependent manner, demonstrating for the first time <i>in vivo</i> efficacy of a small molecule SMaseC inhibitor.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0037.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Structures of SMaseC inhibitors <b>112</b>–<b>115</b> containing a bipyridyl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">5.  Other Ceramide-Producing Enzymes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to the enzymes involved in the three major ceramide biosynthesis pathways described above, glucocerebrosidase, galactocerebrosidase, and ceramide-1-phosphate phosphatase are known to produce ceramide from distinct substrates (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Ceramide-1-phoshate can be hydrolyzed by phosphatidate phosphohydrolase,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> presumably owing to its overall structural similarity to phosphatidate. Although definitive evidence for the existence of monophosphatase specific to ceramide-1-phosphate remains to be seen, it has been implicated that ceramide-1-phosphate phosphatase activities detected in brain synaptosomes<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> and liver plasma membrane fractions<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> are distinct from that of phosphatidate phosphatase. Such enzyme, if identified, could serve as another therapeutic target aimed at regulating ceramide biosynthesis. Glucocerebrosidase and galactocerebrosidase are lysosomal glycoside hydrolases that cleave glucosylceramide and galactosylceramide, respectively, resulting in the generation of ceramide (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The physiological and pathological significance of ceramide produced by these enzymes has not yet been extensively studied. However, accumulation of glucosylceramide due to inherited deficiency of glucocerebrosidase is linked to a rare genetic lysosomal storage disorder, Gaucher disease.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> On the other hand, Krabbe disease, another genetic lysosomal storage disorder, is known to be caused by a deficiency in galactocerebrosidase, which leads to the accumulation of galactosylceramide.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Mutations in these enzymes commonly result in protein misfolding and subsequent premature degradation in the ER. To this end, interests in developing inhibitors of these enzymes have been predominantly driven by the goal of identifying molecular chaperones capable of stabilizing the native conformation of the mutant enzymes and increasing translocation of functional enzymes to the lysosomes. For instance, ambroxol (<b>116</b>) (<a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a></a>) was reported to act as a mixed-type inhibitor of human recombinant glucocerebrosidase at the neutral pH found in the ER and to display no inhibitory activity at the acidic pH of lysosomes.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> This pH dependent inhibitory action makes ambroxol (<b>116</b>) an ideal pharmacological chaperone for mutant glucocerebrosidases. Indeed, treatment with ambroxol (<b>116</b>) resulted in the increase of glucocerebrosidase activity and protein levels in N370S/N370S GD-1 fibroblast cell line.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> It should be noted that there have been active research efforts to develop pharmacological chaperones for lysosomal enzymes as new therapeutic options for various types of genetic lysosomal storage disorders including Gaucher and Krabbe diseases. Excellent review articles focused on the medicinal chemistry aspects of these efforts have been published in recent years.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a></div><figure id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0038.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structure of a pH-dependent glucocerebrosidase inhibitor, ambroxol <b>116</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">6.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The intricate metabolic network surrounding ceramide reflects the dynamic role played by ceramide at the core of sphingolipid metabolism pathways in both physiological and pathological conditions. The fact that several distinct enzymes can each produce ceramide has provided potentially important therapeutic opportunities by inhibiting specific ceramide-producing enzymes depending on the disease of interest. As described in this review article, tremendous efforts have been devoted to identifying small molecule inhibitors of these enzymes. Upon review of the structural evolution of these inhibitors, one notable trend appears to be a departure from lipid-like scaffolds originating from the structures of substrates. This movement has been most likely driven by a strong desire to identify more drug-like inhibitors that can serve not only as biological probe molecules but also as lead molecules for future therapeutic development. In particular, DES1 inhibitor SKI II (<b>8</b>), CerS1 inhibitor P053 (<b>29</b>),<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> aSMase inhibitor <b>59</b>,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and nSMase2 inhibitors DPTIP (<b>95</b>),<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> PDDC (<b>101</b>),<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> and <b>106</b><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> represent promising leads for further optimization as these compounds displayed not only submicromolar inhibitory potency but also desirable <i>in vivo</i> pharmacokinetics and promising <i>in vivo</i> profile as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Inhibitors of Ceramide Biosynthesis</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">target, *additional known target</th><th class="colsep0 rowsep0" align="center">pharmacokinetics</th><th class="colsep0 rowsep0" align="center">preliminary <i>in viv</i>o findings</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SKI II (<b>8</b>)<a onclick="showRef(event, 'ref39 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref41">(39,41)</a></td><td class="colsep0 rowsep0" align="left">DES1 (<i>K</i><sub>i</sub> = 0.3 μM in HGC-27 cell lysates), *SK1/SK2</td><td class="colsep0 rowsep0" align="left">Orally available in mice</td><td class="colsep0 rowsep0" align="left">Showed a significant inhibition of tumor growth in mice bearing JC tumors following oral admin.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P053 (<b>29</b>)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td><td class="colsep0 rowsep0" align="left">CerS1 (IC<sub>50</sub> = 0.54 μM against human CerS1)</td><td class="colsep0 rowsep0" align="left">Orally available in mice</td><td class="colsep0 rowsep0" align="left">Increased fatty acid oxidation in skeletal muscle and reduced overall adiposity in mice fed a high-fat diet following oral admin.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td><td class="colsep0 rowsep0" align="left">aSMase (IC<sub>50</sub> = 0.32 μM in Huh7 cell lysates)</td><td class="colsep0 rowsep0" align="left">Distributed to the brain in rats (ip admin)</td><td class="colsep0 rowsep0" align="left">Improved depression-like behaviors of rats, reduced the cortical and hippocampal aSMase activity, and restored neurogenesis in the brain following ip admin.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPTIP (<b>95</b>)<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></td><td class="colsep0 rowsep0" align="left">nSMase2 (IC<sub>50</sub> = 0.03 μM against human nSMase2)</td><td class="colsep0 rowsep0" align="left">Distributed to the brain in rats (ip admin)</td><td class="colsep0 rowsep0" align="left">Attenuated IL-1β-induced ADEV release in in GFAP-GFP mice following ip admin.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDDC (<b>101</b>)<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a></td><td class="colsep0 rowsep0" align="left">nSMase2 (IC<sub>50</sub> = 0.3 μM against human nSMase2)</td><td class="colsep0 rowsep0" align="left">Distributed to the brain in rats (oral admin)</td><td class="colsep0 rowsep0" align="left">Attenuated IL-1β-induced ADEV release in GFAP-GFP mice following oral admin and reversed cognitive impairment in 5XFAD mice following ip admin.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td><td class="colsep0 rowsep0" align="left">nSMase2 (IC<sub>50</sub> = 0.5 μM against human nSMase2), *AChE</td><td class="colsep0 rowsep0" align="left">Distributed to the brain (sc admin)</td><td class="colsep0 rowsep0" align="left">Diminished IL1β-induced brain EV release in tau P301S (line PS19) mice following sc admin.</td></tr></tbody></table></div></div><div class="NLM_p">Despite the growing interest in ceramide-producing enzymes as therapeutic targets, exploration of structure-based drug design has been limited to aSMase<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and <i>B. cereus</i> SMaseC.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Further progress in structural biology is crucial for successful development of structure-based drug design strategies for inhibitors of other ceramide-producing enzymes. While the recent elucidation of the crystal structure of human nSMase2 catalytic domain<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> is an important breakthrough, the full-length structure of nSMase2 would be highly desirable given that many nSMase inhibitors do not appear to bind to the active site.</div><div class="NLM_p last">Finally, recent advancement in the field of sphingolipidomics<a onclick="showRef(event, 'ref161 ref162'); return false;" href="javascript:void(0);" class="ref ref161 ref162">(161,162)</a> is highly encouraging and relevant to inhibitors of ceramide-producing enzymes given that the use of reliable biomarkers is becoming increasingly important in successful translation of experimental drugs into clinical development.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Application of the most advanced sphingolipidomics analysis techniques in clinical studies should provide in-depth information on the metabolic consequence(s) of inhibiting specific ceramide producing enzymes, enabling informed decision making at various stages of clinical development. It is certainly a very exciting time to explore therapeutics for many disease areas by targeting ceramide biosynthesis.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01664" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takashi Tsukamoto</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Department of Neurology, 
     and , Johns Hopkins University, Baltimore, Maryland 21205, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0216-7520" title="Orcid link">http://orcid.org/0000-0002-0216-7520</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#85f1f1f6f0eee4e8eaf1eac5efede8ecabe0e1f0"><span class="__cf_email__" data-cfemail="631717101608020e0c170c23090b0e0a4d060716">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Skácel</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Department of Neurology, 
     and , Johns Hopkins University, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara S. Slusher</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Department of Neurology, 
     and , Johns Hopkins University, Baltimore, Maryland 21205, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9814-4157" title="Orcid link">http://orcid.org/0000-0001-9814-4157</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Jan Skácel</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=BIO-d7e3021-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jan Skácel</b> received his Ph.D. in Medicinal Chemistry from the University of Chemistry and Technology, Prague. As a Ph.D. student, he worked at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences under the direction of Dr. Zlatko Janeba. His doctoral research was mainly focused on the design and synthesis of novel PNP and HG(X)PRT inhibitors. Currently, Dr. Skácel is a postdoctoral fellow at Johns Hopkins University, where he explores the design and synthesis of novel nSMase2 inhibitors under the direction of Prof. Takashi Tsukamoto.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Barbara S. Slusher</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=BIO-d7e3026-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Barbara S. Slusher</b> is Professor of Neurology, Pharmacology, Neuroscience, Psychiatry, Medicine, and Oncology and the Director of Johns Hopkins Drug Discovery at Johns Hopkins School of Medicine. Prior to joining Johns Hopkins in September 2009, she spent 18 years in the pharmaceutical industry. She has extensive experience in drug discovery spanning through phase I/IIa clinical development. She is an inventor of over 80 issued patents and applications and an author of over 250 scientific articles. She serves on the board or as a scientific consultant to multiple biotechnology companies and cofounded the first International Academic Drug Discovery Consortium.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Takashi Tsukamoto</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=BIO-d7e3031-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Takashi Tsukamoto</b> is Associate Professor of Neurology at Johns Hopkins University and the Director of Medicinal Chemistry at Johns Hopkins Drug Discovery. He received his Ph.D. in Chemistry from Tokyo Institute of Technology and pursued his postdoctoral studies at the University of Michigan. Prior to joining Johns Hopkins in 2009, Dr. Tsukamoto has held a variety of research positions in the pharmaceutical industry. During the course of his career, he has served as a lead medicinal chemist in a number of drug discovery projects, exploring new therapeutics for neurological disorders and cancer. He is the lead inventor of the cytidine deaminase inhibitor cedazuridine and its combination with decitabine, which received FDA approval as Inqovi in 2020.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors of this manuscript have been supported by NIH Grants P30MH075673 (B.S.S) and R01AG059799 (B.S.S. and T.T.) and a Tau Pipeline Enabling Program Grant T-PEP-18-579974C jointly funded by the Alzheimer’s Association and Rainwater Charitable Foundation (to B.S.S). The authors are also grateful for the support provided by the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">CerS</td><td class="NLM_def"><p class="first last">ceramide synthase</p></td></tr><tr><td class="NLM_term">DES1</td><td class="NLM_def"><p class="first last">dihydroceramide desaturase 1</p></td></tr><tr><td class="NLM_term">FIASMAs</td><td class="NLM_def"><p class="first last">functional inhibitors of acid sphingomyelinase</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">phosphatidylserine</p></td></tr><tr><td class="NLM_term">SMase</td><td class="NLM_def"><p class="first last">sphingomyelinase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 163 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raetz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spener, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Meer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanNieuwenhze, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witztum, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span> <span> </span><span class="NLM_article-title">A comprehensive classification system for lipids</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1194/jlr.E400004-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.E400004-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15722563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFaqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=839-861&author=E.+Fahyauthor=S.+Subramaniamauthor=H.+A.+Brownauthor=C.+K.+Glassauthor=A.+H.+Merrillauthor=R.+C.+Murphyauthor=C.+R.+Raetzauthor=D.+W.+Russellauthor=Y.+Seyamaauthor=W.+Shawauthor=T.+Shimizuauthor=F.+Spenerauthor=G.+van+Meerauthor=M.+S.+VanNieuwenhzeauthor=S.+H.+Whiteauthor=J.+L.+Witztumauthor=E.+A.+Dennis&title=A+comprehensive+classification+system+for+lipids&doi=10.1194%2Fjlr.E400004-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive classification system for lipids</span></div><div class="casAuthors">Fahy, Eoin; Subramaniam, Shankar; Brown, H. Alex; Glass, Christopher K.; Merrill, Alfred H., Jr.; Murphy, Robert C.; Raetz, Christian R. H.; Russell, David W.; Seyama, Yousuke; Shaw, Walter; Shimizu, Takao; Spener, Friedrich; van Meer, Gerrit; VanNieuwenhze, Michael S.; White, Stephen H.; Witztum, Joseph L.; Dennis, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">839-861</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Lipids are produced, transported, and recognized by the concerted actions of numerous enzymes, binding proteins, and receptors.  A comprehensive anal. of lipid mols., "lipidomics," in the context of genomics and proteomics is crucial to understanding cellular physiol. and pathol.; consequently, lipid biol. has become a major research target of the postgenomic revolution and systems biol.  To facilitate international communication about lipids, a comprehensive classification of lipids with a common platform that is compatible with informatics requirements has been developed to deal with the massive amts. of data that will be generated by the lipid community.  As an initial step in this development, the authors divide lipids into 8 categories (fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides) contg. distinct classes and subclasses of mols., devise a common manner of representing the chem. structures of individual lipids and their derivs., and provide a 12 digit identifier for each unique lipid mol.  The lipid classification scheme is chem. based and driven by the distinct hydrophobic and hydrophilic elements that compose the lipid.  This structured vocabulary will facilitate the systematization of lipid biol. and enable the cataloging of lipids and their properties in a way that is compatible with other macromol. databases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmvzCdGOvWmLVg90H21EOLACvtfcHk0lh2zDAJXVeQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFaqtLY%253D&md5=1ca24f3b244e28edc6509cd08057072f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1194%2Fjlr.E400004-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.E400004-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DE.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DRaetz%26aufirst%3DC.%2BR.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26aulast%3DSeyama%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DW.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSpener%26aufirst%3DF.%26aulast%3Dvan%2BMeer%26aufirst%3DG.%26aulast%3DVanNieuwenhze%26aufirst%3DM.%2BS.%26aulast%3DWhite%26aufirst%3DS.%2BH.%26aulast%3DWitztum%26aufirst%3DJ.%2BL.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DA%2520comprehensive%2520classification%2520system%2520for%2520lipids%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2005%26volume%3D46%26spage%3D839%26epage%3D861%26doi%3D10.1194%2Fjlr.E400004-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, B. W.</span></span> <span> </span><span class="NLM_article-title">The long and the short of ceramides</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">9922</span>– <span class="NLM_lpage">9923</span>, <span class="refDoi"> DOI: 10.1074/jbc.H118.003522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.H118.003522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29934368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFynurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=9922-9923&author=B.+W.+Wattenberg&title=The+long+and+the+short+of+ceramides&doi=10.1074%2Fjbc.H118.003522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The long and the short of ceramides</span></div><div class="casAuthors">Wattenberg, Binks W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">9922-9923</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A brief review with refs. and commentary on recent research by Tidhar et al. (ibid. 2018, 293, 9912-9921).  The sphingolipid ceramide is not only a precursor of more complex sphingolipids, but also a potent signaling mol.  Specific ceramide species have distinct cellular functions, and each ceramide synthase therefore has particular roles in cells and organisms.  Tidhar and colleagues, utilizing two ceramide synthases differing widely in fatty acid specificity, have identified a short amino acid sequence that is crit. for this specificity.  This work represents a crucial first step in the understanding of both the enzymol. and the biol. driving the diverse functions of ceramide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbP5ndY1ilrVg90H21EOLACvtfcHk0lgcIDdY8A6J2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFynurfL&md5=c19b5a7b4eccf6565d37dbd201c83ef7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.H118.003522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.H118.003522%26sid%3Dliteratum%253Aachs%26aulast%3DWattenberg%26aufirst%3DB.%2BW.%26atitle%3DThe%2520long%2520and%2520the%2520short%2520of%2520ceramides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D9922%26epage%3D9923%26doi%3D10.1074%2Fjbc.H118.003522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gault, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">An overview of sphingolipid metabolism: From synthesis to breakdown</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>688</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-6741-1_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-1-4419-6741-1_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20919643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=2010&pages=1-23&author=C.+R.+Gaultauthor=L.+M.+Obeidauthor=Y.+A.+Hannun&title=An+overview+of+sphingolipid+metabolism%3A+From+synthesis+to+breakdown&doi=10.1007%2F978-1-4419-6741-1_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of sphingolipid metabolism: from synthesis to breakdown</span></div><div class="casAuthors">Gault, Christopher R.; Obeid, Lina M.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">688</span>
        (<span class="NLM_cas:issue">Sphingolipids as Signaling and Regulatory Molecules</span>),
    <span class="NLM_cas:pages">1-23</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Sphingolipids constitute a class of lipids defined by their eighteen carbon amino-alc. backbones which are synthesized in the ER from nonsphingolipid precursors.  Modification of this basic structure is what gives rise to the vast family of sphingolipids that play significant roles in membrane biol. and provide many bioactive metabolites that regulate cell function.  Despite the diversity of structure and function of sphingolipids, their creation and destruction are governed by common synthetic and catabolic pathways.  In this regard, sphingolipid metab. can be imagined as an array of interconnected networks that diverge from a single common entry point and converge into a single common breakdown pathway.  In their simplest forms, sphingosine, phytosphingosine and dihydrosphingosine serve as the backbones upon which further complexity is achieved.  For example, phosphorylation of the C1 hydroxyl group yields the final breakdown products and/or the important signaling mols. sphingosine-1-phosphate, phytosphingosine-1-phosphate and dihydrosphingosine-1-phosphate, resp.  On the other hand, acylation of sphingosine, phytosphingosine, or dihydrosphingosine with one of several possible acyl CoA mols. through the action of distinct ceramide synthases produces the mols. defined as ceramide, phytoceramide, or dihydroceramide.  Ceramide, due to the differing acyl CoAs that can be used to produce it, is tech. a class of mols. rather than a single mol. and therefore may have different biol. functions depending on the acyl chain it is composed of.  At the apex of complexity is the group of lipids known as glycosphingolipids (GSL) which contain dozens of different sphingolipid species differing by both the order and type of sugar residues attached to their headgroups.  Since these mols. are produced from ceramide precursors, they too may have differences in their acyl chain compn., revealing an addnl. layer of variation.  The glycosphingolipids are divided broadly into two categories: glucosphingolipids and galactosphingolipids.  The glucosphingolipids depend initially on the enzyme glucosylceramide synthase (GCS) which attaches glucose as the first residue to the C1 hydroxyl position.  Galactosphingolipids, on the other hand, are generated from galactosylceramide synthase (GalCerS), an evolutionarily dissimilar enzyme from GCS.  Glycosphingolipids are further divided based upon further modification by various glycosyltransferases which increases the potential variation in lipid species by several fold.  Far more abundant are the sphingomyelin species which are produced in parallel with glycosphingolipids, however they are defined by a phosphocholine headgroup rather than the addn. of sugar residues.  Although sphingomyelin species all share a common headgroup, they too are produced from a variety of ceramide species and therefore can have differing acyl chains attached to their C-2 amino groups.  Whether or not the differing acyl chain lengths in SMs dictate unique functions or important biophys. distinctions has not yet been established.  Understanding the function of all the existing glycosphingolipids and sphingomyelin species will be a major undertaking in the future since the tools to study and measure these species are only beginning to be developed (see Fig 1 for an illustrated depiction of the various sphingolipid structures).  The simple sphingolipids serve both as the precursors and the breakdown products of the more complex ones.  Importantly, in recent decades, these simple sphingolipids have gained attention for having significant signaling and regulatory roles within cells.  In addn., many tools have emerged to measure the levels of simple sphingolipids and therefore have become the focus of even more intense study in recent years.  With this thought in mind, this chapter will pay tribute to the complex sphingolipids, but focus on the regulation of simple sphingolipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-glJUw4HtHrVg90H21EOLACvtfcHk0lgcIDdY8A6J2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtg%253D%253D&md5=512ae1d4d9d2f9f2f231e0e189a2b3a0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6741-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-6741-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DAn%2520overview%2520of%2520sphingolipid%2520metabolism%253A%2520From%2520synthesis%2520to%2520breakdown%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2010%26volume%3D688%26spage%3D1%26epage%3D23%26doi%3D10.1007%2F978-1-4419-6741-1_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases: Roles in cell physiology and signaling</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>688</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-6741-1_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-1-4419-6741-1_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20919646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=2010&pages=60-71&author=J.+Stibanauthor=R.+Tidharauthor=A.+H.+Futerman&title=Ceramide+synthases%3A+Roles+in+cell+physiology+and+signaling&doi=10.1007%2F978-1-4419-6741-1_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases: roles in cell physiology and signaling</span></div><div class="casAuthors">Stiban, Johnny; Tidhar, Rotem; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">688</span>
        (<span class="NLM_cas:issue">Sphingolipids as Signaling and Regulatory Molecules</span>),
    <span class="NLM_cas:pages">60-71</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ceramide synthases (CerS) are integral membrane proteins of the endoplasmic reticulum.  Six mammalian CerS have been described, with each utilizing fatty acyl CoAs of relatively defined chain lengths for N-acylation of the sphingoid long chain base.  In this chapter, we review the main functional features of the CerS proteins, discuss their fatty acid specificity, kinetics, tissue distribution and mode of inhibition, as well as possible posttranslational modifications.  We then address the reason that mammals contain six distinct CerS, whereas most other enzymes in the sphingolipid biosynthetic pathway only occur in one or two isoforms.  Finally, we discuss the putative roles of CerS and the ceramide derived from the CerS, in signaling pathways and in development of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQW55vCLljy7Vg90H21EOLACvtfcHk0lgcIDdY8A6J2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtQ%253D%253D&md5=1c06bdac2417d993aeaaab15efabe5e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6741-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-6741-1_4%26sid%3Dliteratum%253Aachs%26aulast%3DStiban%26aufirst%3DJ.%26aulast%3DTidhar%26aufirst%3DR.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthases%253A%2520Roles%2520in%2520cell%2520physiology%2520and%2520signaling%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2010%26volume%3D688%26spage%3D60%26epage%3D71%26doi%3D10.1007%2F978-1-4419-6741-1_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnick, R. N.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthesis and metabolism as a target for cancer therapy</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2003.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.canlet.2003.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15013522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=169-180&author=C.+P.+Reynoldsauthor=B.+J.+Maurerauthor=R.+N.+Kolesnick&title=Ceramide+synthesis+and+metabolism+as+a+target+for+cancer+therapy&doi=10.1016%2Fj.canlet.2003.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthesis and metabolism as a target for cancer therapy</span></div><div class="casAuthors">Reynolds, C. Patrick; Maurer, Barry J.; Kolesnick, Richard N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-180</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sphingolipids, which include ceramides and sphingosine, are essential structural components of cell membranes that also have messenger functions that regulate the proliferation, survival, and death of cells.  Exogenous application of ceramide is cytotoxic, and exposure of cells to radiation or chemotherapy is assocd. with increased ceramide levels due to enhanced de novo synthesis, catabolism of sphingomyelin, or both.  Ceramide can be metabolized to less toxic forms by glycosylation, acylation, or by catabolism to sphingosine, which is then phosphorylated to the anti-apoptotic sphingosine 1-phosphate.  Glucosylceramide synthase overexpression has been shown to enhance resistance to doxorubicin, suggesting that inhibition of ceramide metab. or catabolism might enhance cancer chemotherapy.  Several anticancer agents, including the cytotoxic retinoid, fenretinide (4-HPR), have been shown to act, at least in part, by increasing tumor cell ceramide via de novo synthesis.  Combinations of 4-HPR and modulators of ceramide action and/or metab. demonstrated increased anti-tumor activity in pre-clin. models with minimal toxicity for non-malignant cells, and were effective in a p53-independent manner against tumor cell lines resistant to std. cytotoxic agents.  Phase I trials of ceramide metab. inhibitors in combination with 4-HPR and with other cytotoxic agents are in development.  Thus, pharmacol. manipulation of sphingolipid metab. to enhance tumor cell ceramide is being realized and offers a novel approach to cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzYTneIHg6rVg90H21EOLACvtfcHk0lgNLjyMpP1SBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7c%253D&md5=417e52b2c2723e022ca5fc8478f349bc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMaurer%26aufirst%3DB.%2BJ.%26aulast%3DKolesnick%26aufirst%3DR.%2BN.%26atitle%3DCeramide%2520synthesis%2520and%2520metabolism%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D169%26epage%3D180%26doi%3D10.1016%2Fj.canlet.2003.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Sphingolipids and their metabolism in physiology and disease</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/nrm.2017.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fnrm.2017.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29165427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=175-191&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Sphingolipids+and+their+metabolism+in+physiology+and+disease&doi=10.1038%2Fnrm.2017.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids and their metabolism in physiology and disease</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-191</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many functions, which rivals, if not exceeds, that of the genome or proteome.  These results highlight crit. roles for bioactive sphingolipids in most, if not all, major cell biol. responses, including all major cell signalling pathways, and they link sphingolipid metab. to key human diseases.  Nevertheless, the fairly nascent field of bioactive sphingolipids still faces challenges in its biochem. and mol. underpinnings, including defining the mol. mechanisms of pathway and enzyme regulation, the study of lipid-protein interactions and the development of cellular probes, suitable biomarkers and therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9A-uh9uFPrVg90H21EOLACvtfcHk0lgNLjyMpP1SBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKqt7fE&md5=81409d71ab1c29c9dea5f060105032be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.107%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingolipids%2520and%2520their%2520metabolism%2520in%2520physiology%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D19%26spage%3D175%26epage%3D191%26doi%3D10.1038%2Fnrm.2017.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Cuenca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbarroja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Puig, A.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1851</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2014.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbalip.2014.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslags7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1851&publication_year=2015&pages=40-50&author=S.+Rodriguez-Cuencaauthor=N.+Barbarrojaauthor=A.+Vidal-Puig&title=Dihydroceramide+desaturase+1%2C+the+gatekeeper+of+ceramide+induced+lipotoxicity&doi=10.1016%2Fj.bbalip.2014.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity</span></div><div class="casAuthors">Rodriguez-Cuenca, S.; Barbarroja, N.; Vidal-Puig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1851</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The pathogenic relevance of sphingolipid metab. is increasingly being recognized.  Here we elaborate on a new player within the sphingolipid field: the degs1 enzyme, a recently discovered enzyme that catalyzes the final step in the de novo biosynthesis of ceramides controlling the step from dihydroceramides to ceramides.  Here, we describe its function and dysregulation by factors such as oxidative stress, hypoxia and inflammation and provide evidence indicating that dihydroceramides constitute a biol. active mol. from the sphingolipid family with certain differential characteristics with respect to its delta-4 unsatd. counterparts, the ceramides.  Finally we present pathophysiol. scenarios characterised by specific increases in dihydroceramide that challenge the concept that "all ceramides species are the same".  This article is part of a Special Issue entitled Linking transcription to physiol. in lipodomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTKHI742MCMbVg90H21EOLACvtfcHk0lgNLjyMpP1SBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslags7zL&md5=c11c540ed2c8b854bdba4c41645435ec</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2014.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2014.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Cuenca%26aufirst%3DS.%26aulast%3DBarbarroja%26aufirst%3DN.%26aulast%3DVidal-Puig%26aufirst%3DA.%26atitle%3DDihydroceramide%2520desaturase%25201%252C%2520the%2520gatekeeper%2520of%2520ceramide%2520induced%2520lipotoxicity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2015%26volume%3D1851%26spage%3D40%26epage%3D50%26doi%3D10.1016%2Fj.bbalip.2014.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Olaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliostro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidoni, R.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.plipres.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22200621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFCktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=82-94&author=G.+Fabriasauthor=J.+Munoz-Olayaauthor=F.+Cingolaniauthor=P.+Signorelliauthor=J.+Casasauthor=V.+Gagliostroauthor=R.+Ghidoni&title=Dihydroceramide+desaturase+and+dihydrosphingolipids%3A+Debutant+players+in+the+sphingolipid+arena&doi=10.1016%2Fj.plipres.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena</span></div><div class="casAuthors">Fabrias, Gemma; Munoz-Olaya, Jose; Cingolani, Francesca; Signorelli, Paola; Casas, Josefina; Gagliostro, Vincenzo; Ghidoni, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">82-94</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are a wide family of lipids that share common sphingoid backbones, including (2S,3R)-2-amino-4-octadecane-1,3-diol (dihydrosphingosine) and (2S,3R,4E)-2-amino-4-octadecene-1,3-diol (sphingosine).  The metab. and biol. functions of sphingolipids derived from sphingosine have been the subject of many reviews.  In contrast, dihydrosphingolipids have received poor attention, mainly due to their supposed lack of biol. activity.  However, the reported biol. effects of active site directed dihydroceramide desaturase inhibitors and the involvement of dihydrosphingolipids in the response of cells to known therapeutic agents support that dihydrosphingolipids are not inert but are in fact biol. active and underscore the importance of elucidating further the metabolic pathways and cell signaling networks involved in the biol. activities of dihydrosphingolipids.  Dihydroceramide desaturase is the enzyme involved in the conversion of dihydroceramide into ceramide and it is crucial in the regulation of the balance between sphingolipids and dihydrosphingolipids.  Furthermore, given the enzyme requirement for O2 and the NAD(P)H cofactor, the cellular redox balance and dihydroceramide desaturase activity may reciprocally influence each other.  In this review both dihydroceramide desaturase and the biol. functions of dihydrosphingolipids are addressed and perspectives on this field are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPYnW2t819bVg90H21EOLACvtfcHk0lgNLjyMpP1SBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFCktro%253D&md5=6c9bbd0a1bcca73de0ca72ffe3859749</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DMunoz-Olaya%26aufirst%3DJ.%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DGagliostro%26aufirst%3DV.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DDihydroceramide%2520desaturase%2520and%2520dihydrosphingolipids%253A%2520Debutant%2520players%2520in%2520the%2520sphingolipid%2520arena%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2012%26volume%3D51%26spage%3D82%26epage%3D94%26doi%3D10.1016%2Fj.plipres.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases as potential targets for therapeutic intervention in human diseases</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1841</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2013.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbalip.2013.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24021978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFelu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1841&publication_year=2014&pages=671-681&author=J.+W.+Parkauthor=W.+J.+Parkauthor=A.+H.+Futerman&title=Ceramide+synthases+as+potential+targets+for+therapeutic+intervention+in+human+diseases&doi=10.1016%2Fj.bbalip.2013.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases as potential targets for therapeutic intervention in human diseases</span></div><div class="casAuthors">Park, Joo-Won; Park, Woo-Jae; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1841</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">671-681</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Ceramide is located at a key hub in the sphingolipid metabolic pathway and also acts as an important cellular signaling mol.  Ceramide contains one acyl chain which is attached to a sphingoid long chain base via an amide bond, with the acyl chain varying in length and degree of satn.  The identification of a family of six mammalian ceramide synthases (CerS) that synthesize ceramide with distinct acyl chains, has led to significant advances in our understanding of ceramide biol., including further delineation of the role of ceramide in various pathophysiologies in both mice and humans.  Since ceramides, and the complex sphingolipids generated from ceramide, are implicated in disease, the CerS might potentially be novel targets for therapeutic intervention in the diseases in which the ceramide acyl chain length is altered.  This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9INu_SVNk4bVg90H21EOLACvtfcHk0lgnNJKzpXIIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFelu7nF&md5=bf04d53475052497d59daeaf6456b71e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2013.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DW.%2BJ.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthases%2520as%2520potential%2520targets%2520for%2520therapeutic%2520intervention%2520in%2520human%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2014%26volume%3D1841%26spage%3D671%26epage%3D681%26doi%3D10.1016%2Fj.bbalip.2013.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases in biomedical research</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26248326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=25-32&author=F.+Cingolaniauthor=A.+H.+Futermanauthor=J.+Casas&title=Ceramide+synthases+in+biomedical+research&doi=10.1016%2Fj.chemphyslip.2015.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases in biomedical research</span></div><div class="casAuthors">Cingolani, Francesca; Futerman, Anthony H.; Casas, Josefina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipid metab. consists of multiple metabolic pathways that converge upon ceramide, one of the key mols. among sphingolipids (SLs).  In mammals, ceramide synthesis occurs via N-acylation of sphingoid backbones, dihydrosphingosine (dhSo) or sphingosine (So).  The reaction is catalyzed by ceramide synthases (CerS), a family of enzymes with six different isoforms, with each showing specificity towards a restricted group of acyl-CoAs, thus producing ceramides (Cer) and dihydroceramides (dhCer) with different fatty acid chain lengths.  A large body of evidence documents the role of both So and dhSo as bioactive mols., as well as the involvement of dhCer and Cer in physiol. and pathol. processes.  In particular, the fatty acid compn. of Cer has different effects in cell biol. and in the onset and progression of different diseases.  Therefore, modulation of CerS activity represents an attractive target in biomedical research and in finding new treatment modalities.  In this review, functional, structural and biochem. features of CerS and examine CerS inhibitors that are currently available are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzE6aQ4E0Av7Vg90H21EOLACvtfcHk0lgnNJKzpXIIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7%252FM&md5=edabfc593072a31c147a42e7727b022b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DCasas%26aufirst%3DJ.%26atitle%3DCeramide%2520synthases%2520in%2520biomedical%2520research%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D25%26epage%3D32%26doi%3D10.1016%2Fj.chemphyslip.2015.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassbender, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span> <span> </span><span class="NLM_article-title">A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1111/jnc.13145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fjnc.13145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25925550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVClurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2015&pages=183-192&author=E.+Gulbinsauthor=S.+Walterauthor=K.+A.+Beckerauthor=R.+Halmerauthor=Y.+Liuauthor=M.+Reichelauthor=M.+J.+Edwardsauthor=C.+P.+Mullerauthor=K.+Fassbenderauthor=J.+Kornhuber&title=A+central+role+for+the+acid+sphingomyelinase%2Fceramide+system+in+neurogenesis+and+major+depression&doi=10.1111%2Fjnc.13145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression</span></div><div class="casAuthors">Gulbins, Erich; Walter, Silke; Becker, Katrin Anne; Halmer, Ramona; Liu, Yang; Reichel, Martin; Edwards, Michael J.; Mueller, Christian P.; Fassbender, Klaus; Kornhuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-192</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Major depressive disorder is a severe and chronic illness with high lifetime prevalence and a high incidence of suicide as the cause of death for patients with this diagnosis.  Major depressive disorder is often treated with anti-depressants.  Although these drugs have been used for many years, their exact mode of action is still unknown.  It has been suggested that many anti-depressants act by increasing the concns. of serotonergic transmitters in the synaptic space.  However, recent studies have examd. the effects of anti-depressants on neurogenesis in the hippocampus, the restoration of hippocampal neuronal networks that may be affected by major depression, and the regulation of the hypothalamic-pituitary-adrenal axis by immature neurons in the hippocampus.  Here, we present and discuss a novel hypothesis suggesting that these events are regulated by the concns. of sphingolipids, in particular ceramide, in the hippocampus.  These concepts suggest that the acid sphingomyelinase/ceramide system plays a central role in the pathogenesis of major depression and may be a novel target for anti-depressants.  Major depressive disorder is a severe and chronic illness with high lifetime prevalence and high incidence of suicide.  Major depression is caused in part by an imbalance between factors that pos. and neg. control neurogenesis.  Anti-depressants inhibit the acid sphingomyelinase/ceramide system and thereby reduce the sum of neg. factors restoring neurogenesis, neuronal survival, and improved mood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SAzDGaleDrVg90H21EOLACvtfcHk0lgnNJKzpXIIaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVClurk%253D&md5=0a65fa53a7d0435413525f2d3b1fe385</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13145%26sid%3Dliteratum%253Aachs%26aulast%3DGulbins%26aufirst%3DE.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%2BA.%26aulast%3DHalmer%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DM.%2BJ.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DFassbender%26aufirst%3DK.%26aulast%3DKornhuber%26aufirst%3DJ.%26atitle%3DA%2520central%2520role%2520for%2520the%2520acid%2520sphingomyelinase%252Fceramide%2520system%2520in%2520neurogenesis%2520and%2520major%2520depression%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D134%26spage%3D183%26epage%3D192%26doi%3D10.1111%2Fjnc.13145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J. S.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutic target for aging and age-related neurodegenerative diseases: The role of acid sphingomyelinase</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1038/s12276-020-0399-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs12276-020-0399-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=32203096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltFSjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2020&pages=380-389&author=M.+H.+Parkauthor=H.+K.+Jinauthor=J.+S.+Bae&title=Potential+therapeutic+target+for+aging+and+age-related+neurodegenerative+diseases%3A+The+role+of+acid+sphingomyelinase&doi=10.1038%2Fs12276-020-0399-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase</span></div><div class="casAuthors">Park, Min Hee; Jin, Hee Kyung; Bae, Jae-sung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-389</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">2092-6413</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Aging, which is assocd. with age-related changes in physiol. processes, is the most significant risk factor for the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.  Accumulating evidence has indicated that sphingolipids are significant regulators that are assocd. with pathogenesis in aging and several age-related neurodegenerative diseases.  In particular, abnormal levels of acid sphingomyelinase (ASM), one of the significant sphingolipid-metabolizing enzymes, have been found in the blood and some tissues under various neuropathol. conditions.  Moreover, recent studies have reported the importance of ASM as a crit. mediator that contributes to pathologies in aging and age-related neurodegenerative diseases.  In this review, we describe the pathophysiol. processes that are regulated by ASM, focusing on the age-related neurodegenerative environment.  Furthermore, we discuss novel insights into how new therapeutics targeting ASM may potentially lead to effective strategies to combat aging and age-related neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg2mYJ_v9RRrVg90H21EOLACvtfcHk0lj3NnHRofEJgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltFSjsbY%253D&md5=936db712241902b938c08be197aa1674</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs12276-020-0399-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-020-0399-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BH.%26aulast%3DJin%26aufirst%3DH.%2BK.%26aulast%3DBae%26aufirst%3DJ.%2BS.%26atitle%3DPotential%2520therapeutic%2520target%2520for%2520aging%2520and%2520age-related%2520neurodegenerative%2520diseases%253A%2520The%2520role%2520of%2520acid%2520sphingomyelinase%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2020%26volume%3D52%26spage%3D380%26epage%3D389%26doi%3D10.1038%2Fs12276-020-0399-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhle, C.</span></span> <span> </span><span class="NLM_article-title">Secretory sphingomyelinase in health and disease</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1515%2Fhsz-2015-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25803076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotFWltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2015&pages=707-736&author=J.+Kornhuberauthor=C.+Rheinauthor=C.+P.+Mullerauthor=C.+Muhle&title=Secretory+sphingomyelinase+in+health+and+disease&doi=10.1515%2Fhsz-2015-0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Secretory sphingomyelinase in health and disease</span></div><div class="casAuthors">Kornhuber, Johannes; Rhein, Cosima; Mueller, Christian P.; Muehle, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">707-736</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Acid sphingomyelinase (ASM), a key enzyme in sphingolipid metab., hydrolyzes sphingomyelin to ceramide and phosphorylcholine.  In mammals, the expression of a single gene, SMPD1, results in two forms of the enzyme that differ in several characteristics.  Lysosomal ASM (L-ASM) is located within the lysosome, requires no addnl. Zn2+ ions for activation and is glycosylated mainly with high-mannose oligosaccharides.  By contrast, the secretory ASM (S-ASM) is located extracellularly, requires Zn2+ ions for activation, has a complex glycosylation pattern and has a longer in vivo half-life.  In this review, we summarize current knowledge regarding the physiol. and pathophysiol. of S-ASM, including its sources and distribution, mol. and cellular mechanisms of generation and regulation and relevant in vitro and in vivo studies.  Polymorphisms or mutations of SMPD1 lead to decreased S-ASM activity, as detected in patients with Niemann-Pick disease B. Thus, lower serum/plasma activities of S-ASM are trait markers.  No genetic causes of increased S-ASM activity have been identified.  Instead, elevated activity is the result of enhanced release (e.g., induced by lipopolysaccharide and cytokine stimulation) or increased enzyme activation (e.g., induced by oxidative stress).  Increased S-ASM activity in serum or plasma is a state marker of a wide range of diseases.  In particular, high S-ASM activity occurs in inflammation of the endothelium and liver.  Several studies have demonstrated a correlation between S-ASM activity and mortality induced by severe inflammatory diseases.  Serial measurements of S-ASM reveal prolonged activation and, therefore, the measurement of this enzyme may also provide information on past inflammatory processes.  Thus, S-ASM may be both a promising clin. chem. marker and a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKjnkkVp2Ie7Vg90H21EOLACvtfcHk0lj3NnHRofEJgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotFWltbY%253D&md5=6ea99e68268b51b1296ac0ced8ce228e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0109%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DRhein%26aufirst%3DC.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DMuhle%26aufirst%3DC.%26atitle%3DSecretory%2520sphingomyelinase%2520in%2520health%2520and%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2015%26volume%3D396%26spage%3D707%26epage%3D736%26doi%3D10.1515%2Fhsz-2015-0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The neutral sphingomyelinase family: Identifying biochemical connections</span>. <i>Adv. Enzyme Regul.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.advenzreg.2010.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.advenzreg.2010.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21035485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=51-58&author=C.+J.+Clarkeauthor=B.+X.+Wuauthor=Y.+A.+Hannun&title=The+neutral+sphingomyelinase+family%3A+Identifying+biochemical+connections&doi=10.1016%2Fj.advenzreg.2010.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The neutral sphingomyelinase family: Identifying biochemical connections</span></div><div class="casAuthors">Clarke, Christopher J.; Wu, Bill X.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzyme Regulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">AEZRA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-2571</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Neutral sphingomyelinases (N-SMases) are considered to be key mediators of stress-induced ceramide prodn.  The extended family of N-SMases is a subset of the DNase I superfamily and comprises members from bacteria, yeast, and mammals.  In recent years, the identification and cloning of mammalian N-SMase family members has led to significant advances in understanding their physiol. roles and regulation.  However, there is still limited information on their regulation at the biochem. and mol. level.  Here, the authors summarize current knowledge about the biochem. regulation of eukaryotic N-SMases and identify the major areas where knowledge is lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5mouhaPiOrVg90H21EOLACvtfcHk0lj3NnHRofEJgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OjsLY%253D&md5=4022f5a93bcc3435fe79d7fe275ea899</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.advenzreg.2010.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.advenzreg.2010.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520neutral%2520sphingomyelinase%2520family%253A%2520Identifying%2520biochemical%2520connections%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2011%26volume%3D51%26spage%3D51%26epage%3D58%26doi%3D10.1016%2Fj.advenzreg.2010.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamseddine, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.jbior.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25465297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGit7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=24-41&author=A.+A.+Shamseddineauthor=M.+V.+Airolaauthor=Y.+A.+Hannun&title=Roles+and+regulation+of+neutral+sphingomyelinase-2+in+cellular+and+pathological+processes&doi=10.1016%2Fj.jbior.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes</span></div><div class="casAuthors">Shamseddine, Achraf A.; Airola, Michael V.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Our understanding of the functions of ceramide signaling has advanced tremendously over the past decade.  In this review, we focus on the roles and regulation of neutral sphingomyelinase 2 (nSMase2), an enzyme that generates the bioactive lipid ceramide through the hydrolysis of the membrane lipid sphingomyelin.  A large body of work has now implicated nSMase2 in a diverse set of cellular functions, physiol. processes, and disease pathologies.  We discuss different aspects of this enzyme's regulation from transcriptional, post-translational, and biochem.  Furthermore, we highlight nSMase2 involvement in cellular processes including inflammatory signaling, exosome generation, cell growth, and apoptosis, which in turn play important roles in pathologies such as cancer metastasis, Alzheimer's disease, and other organ systems disorders.  Lastly, we examine avenues where targeted nSMase2-inhibition may be clin. beneficial in disease scenarios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEdx4XHmhwrVg90H21EOLACvtfcHk0lj3NnHRofEJgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGit7rM&md5=cb69e74eebfb7a4fb6f6c3cda13195b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DShamseddine%26aufirst%3DA.%2BA.%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DRoles%2520and%2520regulation%2520of%2520neutral%2520sphingomyelinase-2%2520in%2520cellular%2520and%2520pathological%2520processes%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2015%26volume%3D57%26spage%3D24%26epage%3D41%26doi%3D10.1016%2Fj.jbior.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monturiol-Gross, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naylor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alape-Giron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flieger, A.</span></span> <span> </span><span class="NLM_article-title">Bacterial sphingomyelinases and phospholipases as virulence factors</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00082-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1128%2FMMBR.00082-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27307578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Kqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=597-628&author=M.+Flores-Diazauthor=L.+Monturiol-Grossauthor=C.+Naylorauthor=A.+Alape-Gironauthor=A.+Flieger&title=Bacterial+sphingomyelinases+and+phospholipases+as+virulence+factors&doi=10.1128%2FMMBR.00082-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial sphingomyelinases and phospholipases as virulence factors</span></div><div class="casAuthors">Flores-Diaz, Marietta; Monturiol-Gross, Laura; Naylor, Claire; Alape-Giron, Alberto; Flieger, Antje</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-628</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bacterial sphingomyelinases and phospholipases are a heterogeneous group of esterases which are usually surface assocd. or secreted by a wide variety of Gram-pos. and Gram-neg. bacteria.  These enzymes hydrolyze sphingomyelin and glycerophospholipids, resp., generating products identical to the ones produced by eukaryotic enzymes which play crucial roles in distinct physiol. processes, including membrane dynamics, cellular signaling, migration, growth, and death.  Several bacterial sphingomyelinases and phospholipases are essential for virulence of extracellular, facultative, or obligate intracellular pathogens, as these enzymes contribute to phagosomal escape or phagosomal maturation avoidance, favoring tissue colonization, infection establishment and progression, or immune response evasion.  This work presents a classification proposal for bacterial sphingomyelinases and phospholipases that considers not only their enzymic activities but also their structural aspects.  An overview of the main physiopathol. activities is provided for each enzyme type, as are examples in which inactivation of a sphingomyelinase- or a phospholipase-encoding gene impairs the virulence of a pathogen.  The identification of sphingomyelinases and phospholipases important for bacterial pathogenesis and the development of inhibitors for these enzymes could generate candidate vaccines and therapeutic agents, which will diminish the impacts of the assocd. human and animal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9SXAh1gTjk7Vg90H21EOLACvtfcHk0lhDYUDqT1r-9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Kqtr0%253D&md5=fd357e334eb85c92dffc048522500394</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00082-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00082-15%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Diaz%26aufirst%3DM.%26aulast%3DMonturiol-Gross%26aufirst%3DL.%26aulast%3DNaylor%26aufirst%3DC.%26aulast%3DAlape-Giron%26aufirst%3DA.%26aulast%3DFlieger%26aufirst%3DA.%26atitle%3DBacterial%2520sphingomyelinases%2520and%2520phospholipases%2520as%2520virulence%2520factors%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2016%26volume%3D80%26spage%3D597%26epage%3D628%26doi%3D10.1128%2FMMBR.00082-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of sphingolipid metabolism enzymes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">1957</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbamem.2006.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17049336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=1957-1977&author=A.+Delgadoauthor=J.+Casasauthor=A.+Llebariaauthor=J.+L.+Abadauthor=G.+Fabrias&title=Inhibitors+of+sphingolipid+metabolism+enzymes&doi=10.1016%2Fj.bbamem.2006.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of sphingolipid metabolism enzymes</span></div><div class="casAuthors">Delgado, Antonio; Casas, Josefina; Llebaria, Amadeu; Abad, Jose Luis; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1957-1977</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are a family of lipids that play essential roles both as structural cell membrane components and in cell signaling.  The cellular contents of the various sphingolipid species are controlled by enzymes involved in their metabolic pathways.  In this context, the discovery of small chem. entities able to modify these enzyme activities in a potent and selective way should offer new pharmacol. tools and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGkDZBpzjGhbVg90H21EOLACvtfcHk0lhDYUDqT1r-9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt7zO&md5=2c784651c0fb01c8f19d5d177a02823a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520sphingolipid%2520metabolism%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2006%26volume%3D1758%26spage%3D1957%26epage%3D1977%26doi%3D10.1016%2Fj.bbamem.2006.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of acid sphingomyelinase</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1159/000315100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000315100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20501999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=1-8&author=C.+Arenz&title=Small+molecule+inhibitors+of+acid+sphingomyelinase&doi=10.1159%2F000315100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Acid Sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Despite of the importance of the acid sphingomyelinase for sphingomyelin homeostasis and sphingolipid signaling, potent and selective inhibitors for this enzyme are rare.  An increasing set of data on the inhibition of acid sphingomyelinase in different disease models using indirect inhibitors has been generated and strongly implies acid sphingomyelinase as an emerging drug target.  Very recently, some new and promising inhibitors from different substance classes have been developed.  In this review, previous and current developments in the field are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0JWqu52OurVg90H21EOLACvtfcHk0lhDYUDqT1r-9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsr8%253D&md5=fab358f1d275fe86618fbc76a23fc8c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1159%2F000315100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315100%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520acid%2520sphingomyelinase%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D1%26epage%3D8%26doi%3D10.1159%2F000315100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhabak, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Novel drugs targeting sphingolipid metabolism</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1007/978-3-7091-1368-4_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-3-7091-1368-4_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2013&pages=187-196&author=K.+P.+Bhabakauthor=C.+Arenz&title=Novel+drugs+targeting+sphingolipid+metabolism&doi=10.1007%2F978-3-7091-1368-4_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel drugs targeting sphingolipid metabolism</span></div><div class="casAuthors">Bhabak, Krishna P.; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">Sphingolipids: Basic Science and Drug Development</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  While the evidence for an involvement of sphingolipids (SLs) in a variety of diseases is rapidly increasing, the development of sphingolipid-related drugs is still in its infancy.  In fact, the recently FDA-approved fingolimod or FTY-720 (see chapter by J. Pfeilschifter for more information) is the first drug on the market to interfere with sphingolipid signaling.  The reasons for this lagging are manifold and within this chapter we try to name some of them.  Ceramide is in the center of sphingolipid metab.  We describe the most important and most recent inhibitors for enzymes controlling cellular ceramide levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorRSYJ5zERArVg90H21EOLACvtfcHk0lgVXipXp5g9kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL7K&md5=2b2704689d2ed3555c83d36dc7faa504</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1368-4_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1368-4_10%26sid%3Dliteratum%253Aachs%26aulast%3DBhabak%26aufirst%3DK.%2BP.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DNovel%2520drugs%2520targeting%2520sphingolipid%2520metabolism%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D215%26spage%3D187%26epage%3D196%26doi%3D10.1007%2F978-3-7091-1368-4_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luberto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26200918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=45-59&author=M.+Adadaauthor=C.+Lubertoauthor=D.+Canals&title=Inhibitors+of+the+sphingomyelin+cycle%3A+Sphingomyelin+synthases+and+sphingomyelinases&doi=10.1016%2Fj.chemphyslip.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases</span></div><div class="casAuthors">Adada, Mohamad; Luberto, Chiara; Canals, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-59</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Sphingolipids are a class of bioactive lipids, which are key modulators of an increasing no. of physiol. and pathophysiol. processes that include cell cycle, apoptosis, angiogenesis, stress and inflammatory responses.  Sphingomyelin is an important structural component of biol. membranes, and one of the end-points in the synthesis of sphingolipids.  Mainly synthesized in the Golgi app., sphingomyelin is transported to all other biol. membranes.  Upon stimulation, sphingomyelin can be hydrolyzed to ceramide by 5 different sphingomyelinases.  The diversity and cellular topol. of ceramide allow it to exert multiple biologies.  Furthermore, ceramide can be metabolized to many other bioactive sphingolipids.  Ceramide, coming from sphingomyelin or other complex sphingolipids, can be hydrolyzed to sphingosine, which can easily change cellular localization.  In turn, sphingosine can be recycled to ceramide and to sphingomyelin in the endoplasmic reticulum, completing the sphingomyelin cycle.  Our understanding of the roles of various sphingolipids in the regulation of different cellular processes has come from studying the enzymes that regulate these sphingolipids, and their manipulation.  The use of pharmacol. inhibitors has been crit. for their study, as well as being promising bullets for disease treatment.  Some of these diseases involving the sphingomyelin cycle include cancer, inflammation, atherosclerosis, diabetes and some rare diseases such as Niemann-Pick disease.  This review will focus on the enzymes involved in the sphingomyelin cycle, their history, and their involvement in pathophysiol. processes.  Finally, it will describe in details all the small mols. that are being used to inhibit these enzymes and their use in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjd9O5ncoqb7Vg90H21EOLACvtfcHk0lgVXipXp5g9kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsr3O&md5=031be24b5bc303721852894ba81b6bc7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DAdada%26aufirst%3DM.%26aulast%3DLuberto%26aufirst%3DC.%26aulast%3DCanals%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520the%2520sphingomyelin%2520cycle%253A%2520Sphingomyelin%2520synthases%2520and%2520sphingomyelinases%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D45%26epage%3D59%26doi%3D10.1016%2Fj.chemphyslip.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casasampere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26248324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=33-44&author=M.+Casasampereauthor=Y.+F.+Ordonezauthor=A.+Pouauthor=J.+Casas&title=Inhibitors+of+dihydroceramide+desaturase+1%3A+Therapeutic+agents+and+pharmacological+tools+to+decipher+the+role+of+dihydroceramides+in+cell+biology&doi=10.1016%2Fj.chemphyslip.2015.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology</span></div><div class="casAuthors">Casasampere, Mireia; Ordonez, Yadira F.; Pou, Ana; Casas, Josefina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Dihydroceramide desaturase (Des1) is the last enzyme in the de novo synthesis of ceramides (Cer).  It catalyzes the insertion of a double bond into dihydroceramides (dhCer) to convert them to Cer, both of which are further metabolized to more complex (dihydro) sphingolipids.  For many years dhCer have received poor attention, mainly due to their supposed lack of biol. activity.  It was not until about ten years ago that the concept that dhCer might have regulatory roles in biol. emerged for the first time.  Since then, multiple publications have established that dhCer are implicated in a wide spectrum of biol. processes.  Physiol. and pathophysiol. functions of dhCer have been recently reviewed.  In this review we will focus on the biochem. features of Des1 and on its inhibition by different compds. with presumably different modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrccXfvOQjNArVg90H21EOLACvtfcHk0lgVXipXp5g9kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jM&md5=86eb5e2a77b2a53336b0fbec272e13dd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DCasasampere%26aufirst%3DM.%26aulast%3DOrdonez%26aufirst%3DY.%2BF.%26aulast%3DPou%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520dihydroceramide%2520desaturase%25201%253A%2520Therapeutic%2520agents%2520and%2520pharmacological%2520tools%2520to%2520decipher%2520the%2520role%2520of%2520dihydroceramides%2520in%2520cell%2520biology%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D33%26epage%3D44%26doi%3D10.1016%2Fj.chemphyslip.2015.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haag, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korenke, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suriyanarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbracht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, I.</span></span> <span> </span><span class="NLM_article-title">Degs1-associated aberrant sphingolipid metabolism impairs nervous system function in humans</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1229</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1172/JCI124159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1172%2FJCI124159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30620338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BB3cnptFersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=1229-1239&author=G.+Karsaiauthor=F.+Kraftauthor=N.+Haagauthor=G.+C.+Korenkeauthor=B.+Hanischauthor=A.+Othmanauthor=S.+Suriyanarayananauthor=R.+Steinerauthor=C.+Knoppauthor=M.+Mullauthor=M.+Bergmannauthor=J.+M.+Schroderauthor=J.+Weisauthor=M.+Elbrachtauthor=M.+Begemannauthor=T.+Hornemannauthor=I.+Kurth&title=Degs1-associated+aberrant+sphingolipid+metabolism+impairs+nervous+system+function+in+humans&doi=10.1172%2FJCI124159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans</span></div><div class="casAuthors">Karsai Gergely; Othman Alaa; Suriyanarayanan Saranya; Steiner Regula; Hornemann Thorsten; Karsai Gergely; Othman Alaa; Suriyanarayanan Saranya; Steiner Regula; Hornemann Thorsten; Kraft Florian; Haag Natja; Hanisch Benjamin; Knopp Cordula; Elbracht Miriam; Begemann Matthias; Kurth Ingo; Korenke G Christoph; Mull Michael; Bergmann Markus; Schroder J Michael; Weis Joachim</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1229-1239</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Sphingolipids are important components of cellular membranes and functionally associated with fundamental processes such as cell differentiation, neuronal signaling, and myelin sheath formation.  Defects in the synthesis or degradation of sphingolipids leads to various neurological pathologies; however, the entire spectrum of sphingolipid metabolism disorders remains elusive.  METHODS:  A combined approach of genomics and lipidomics was applied to identify and characterize a human sphingolipid metabolism disorder.  RESULTS:  By whole-exome sequencing in a patient with a multisystem neurological disorder of both the central and peripheral nervous systems, we identified a homozygous p.Ala280Val variant in DEGS1, which catalyzes the last step in the ceramide synthesis pathway.  The blood sphingolipid profile in the patient showed a significant increase in dihydro sphingolipid species that was further recapitulated in patient-derived fibroblasts, in CRISPR/Cas9-derived DEGS1-knockout cells, and by pharmacological inhibition of DEGS1.  The enzymatic activity in patient fibroblasts was reduced by 80% compared with wild-type cells, which was in line with a reduced expression of mutant DEGS1 protein.  Moreover, an atypical and potentially neurotoxic sphingosine isomer was identified in patient plasma and in cells expressing mutant DEGS1.  CONCLUSION:  We report DEGS1 dysfunction as the cause of a sphingolipid disorder with hypomyelination and degeneration of both the central and peripheral nervous systems.  TRIAL REGISTRATION:  Not applicable.  FUNDING:  Seventh Framework Program of the European Commission, Swiss National Foundation, Rare Disease Initiative Zurich.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBHJFurk9wJGyYR5VtavbzfW6udTcc2eYxCbzO1p1yW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnptFersA%253D%253D&md5=dae3c2a4d6f1705470b3047eb0454118</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1172%2FJCI124159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI124159%26sid%3Dliteratum%253Aachs%26aulast%3DKarsai%26aufirst%3DG.%26aulast%3DKraft%26aufirst%3DF.%26aulast%3DHaag%26aufirst%3DN.%26aulast%3DKorenke%26aufirst%3DG.%2BC.%26aulast%3DHanisch%26aufirst%3DB.%26aulast%3DOthman%26aufirst%3DA.%26aulast%3DSuriyanarayanan%26aufirst%3DS.%26aulast%3DSteiner%26aufirst%3DR.%26aulast%3DKnopp%26aufirst%3DC.%26aulast%3DMull%26aufirst%3DM.%26aulast%3DBergmann%26aufirst%3DM.%26aulast%3DSchroder%26aufirst%3DJ.%2BM.%26aulast%3DWeis%26aufirst%3DJ.%26aulast%3DElbracht%26aufirst%3DM.%26aulast%3DBegemann%26aufirst%3DM.%26aulast%3DHornemann%26aufirst%3DT.%26aulast%3DKurth%26aufirst%3DI.%26atitle%3DDegs1-associated%2520aberrant%2520sphingolipid%2520metabolism%2520impairs%2520nervous%2520system%2520function%2520in%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D1229%26epage%3D1239%26doi%3D10.1172%2FJCI124159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Breen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudz, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Buren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, D.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=23267130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=77-84&author=P.+Breenauthor=N.+Josephauthor=K.+Thompsonauthor=J.+M.+Kravekaauthor=T.+I.+Gudzauthor=L.+Liauthor=M.+Rahmaniyanauthor=J.+Bielawskiauthor=J.+S.+Pierceauthor=W.+van+Burenauthor=G.+Bhattiauthor=D.+Separovic&title=Dihydroceramide+desaturase+knockdown+impacts+sphingolipids+and+apoptosis+after+photodamage+in+human+head+and+neck+squamous+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells</span></div><div class="casAuthors">Breen, Paul; Joseph, Nicholas; Thompson, Kyle; Kraveka, Jacqueline M.; Gudz, Tatyana I.; Li, Li; Rahmaniyan, Mehrdad; Bielawski, Jacek; Pierce, Jason S.; Van Buren, Eric; Bhatti, Gaurav; Separovic, Duska</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Dihydroceramide desaturase 1 (DES) is the enzyme responsible for converting dihydroceramide into ceramide in the de novo sphingolipid biosynthesis pathway.  Dihydroceramide can inhibit ceramide channel formation to interfere with apoptosis.  We have shown that following ceramide synthase knockdown, photodynamic therapy (PDT), a cancer treatment modality, is assocd. with decreased levels of ceramides and dihydroceramides in cells that are resistant to apoptosis.  Aim: Here we investigated the effect of DES knockdown on the sphingolipid profile and apoptosis in human head and neck squamous carcinoma cells after PDT with the silicon phthalocyanine Pc 4.  Materials and Methods: Following siRNA transfection and PDT treatment, quant. real-time polymerase chain reaction for quantification of DES mRNA, immunoblotting for protein expression, mass spectrometry for sphingolipid anal., spectrofluorometry for caspase 3-like (DEVDase) activity, flow cytometry for apoptosis detection, and trypan blue assay for cell viability evaluation, were performed.  Results: Down-regulation of DES led to a substantial increase in levels of dihydroceramides without affecting ceramide levels.  PDT-induced accumulation of individual dihydroceramides and global ceramides was increased by DES knockdown.  Concomitantly, mitochondrial depolarization, DEVDase activation, late-apoptosis and cell death were attenuated by DES knockdown.  Early apoptosis, however, was enhanced.  Conclusion: Our findings support the following: (i) dihydroceramide reduces pro-apoptotic effects of ceramide; (ii) cells adapt to DES knockdown to become more sensitive to ceramide and early-apoptosis; (iii) DES is a potential mol. target for regulating apoptotic resistance to PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzL-HvZqc6wbVg90H21EOLACvtfcHk0lgbxqk9wzinzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSjs70%253D&md5=e0a825a2750a2794b561c7a8aab6d5da</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreen%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DGudz%26aufirst%3DT.%2BI.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DJ.%2BS.%26aulast%3Dvan%2BBuren%26aufirst%3DW.%26aulast%3DBhatti%26aufirst%3DG.%26aulast%3DSeparovic%26aufirst%3DD.%26atitle%3DDihydroceramide%2520desaturase%2520knockdown%2520impacts%2520sphingolipids%2520and%2520apoptosis%2520after%2520photodamage%2520in%2520human%2520head%2520and%2520neck%2520squamous%2520carcinoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2013%26volume%3D33%26spage%3D77%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez-Gutierrez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito-Cuesta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandosell, F.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase 1 inhibitors reduce amyloid-beta levels in primary neurons from an Alzheimer’s disease transgenic model</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">49</span>, <span class="refDoi"> DOI: 10.1007/s11095-017-2312-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs11095-017-2312-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29411122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BC1MvosVSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2018&pages=49&author=L.+Ordonez-Gutierrezauthor=I.+Benito-Cuestaauthor=J.+L.+Abadauthor=J.+Casasauthor=G.+Fabriasauthor=F.+Wandosell&title=Dihydroceramide+desaturase+1+inhibitors+reduce+amyloid-beta+levels+in+primary+neurons+from+an+Alzheimer%E2%80%99s+disease+transgenic+model&doi=10.1007%2Fs11095-017-2312-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model</span></div><div class="casAuthors">Ordonez-Gutierrez Lara; Benito-Cuesta Irene; Wandosell Francisco; Ordonez-Gutierrez Lara; Wandosell Francisco; Abad Jose Luis; Casas Josefina; Fabrias Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The induction of autophagy has recently been explored as a promising therapeutic strategy to combat Alzheimer's disease.  Among many other factors, there is evidence that ceramides/dihydroceramides act as mediators of autophagy, although the exact mechanisms underlying such effects are poorly understood.  Here, we describe how two dihydroceramide desaturase inhibitors (XM461 and XM462) trigger autophagy and reduce amyloid secretion by neurons.  METHODS:  Neurons isolated from wild-type and APP/PS1 transgenic mice were exposed to the two dihydroceramide desaturase inhibitors to assess their effect on these cell's protein and lipid profiles.  RESULTS:  Both dihydroceramide desaturase inhibitors increased the autophagic vesicles in wild-type neurons, reflected as an increase in LC3-II, and this was correlated with the accumulation of dihydroceramides and dihydrosphingomyelins.  Exposing APP/PS1 transgenic neurons to these inhibitors also produced a 50% reduction in amyloid secretion and/or production.  The lipidomic defects triggered by these dihydroceramide desaturase inhibitors were correlated with a loss of S6K activity, witnessed by the changes in S6 phosphorylation, which strongly suggested a reduction of mTORC1 activity.  CONCLUSIONS:  The data obtained strongly suggest that dihydroceramide desaturase 1 activity may modulate autophagy and mTORC1 activity in neurons, inhibiting amyloid secretion and S6K activity.  As such, it is tantalizing to propose that dihydroceramide desaturase 1 may be an important therapeutic target to combat amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvOg7QsHOnSyO2kE7krGOBfW6udTcc2eYxCbzO1p1yW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvosVSktA%253D%253D&md5=a44eaee90592293c72828628954ac4ae</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs11095-017-2312-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-017-2312-2%26sid%3Dliteratum%253Aachs%26aulast%3DOrdonez-Gutierrez%26aufirst%3DL.%26aulast%3DBenito-Cuesta%26aufirst%3DI.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DWandosell%26aufirst%3DF.%26atitle%3DDihydroceramide%2520desaturase%25201%2520inhibitors%2520reduce%2520amyloid-beta%2520levels%2520in%2520primary%2520neurons%2520from%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520model%26jtitle%3DPharm.%2520Res.%26date%3D2018%26volume%3D35%26spage%3D49%26doi%3D10.1007%2Fs11095-017-2312-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaurasia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippetts, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayoral Monibas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschek, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaddai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previs, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, S. A.</span></span> <span> </span><span class="NLM_article-title">Targeting a ceramide double bond improves insulin resistance and hepatic steatosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1126/science.aav3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1126%2Fscience.aav3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31273070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOhsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2019&pages=386-392&author=B.+Chaurasiaauthor=T.+S.+Tippettsauthor=R.+Mayoral+Monibasauthor=J.+Liuauthor=Y.+Liauthor=L.+Wangauthor=J.+L.+Wilkersonauthor=C.+R.+Sweeneyauthor=R.+F.+Pereiraauthor=D.+H.+Sumidaauthor=J.+A.+Maschekauthor=J.+E.+Coxauthor=V.+Kaddaiauthor=G.+I.+Lancasterauthor=M.+M.+Siddiqueauthor=A.+Possauthor=M.+Pearsonauthor=S.+Satapatiauthor=H.+Zhouauthor=D.+G.+McLarenauthor=S.+F.+Previsauthor=Y.+Chenauthor=Y.+Qianauthor=A.+Petrovauthor=M.+Wuauthor=X.+Shenauthor=J.+Yaoauthor=C.+N.+Nunesauthor=A.+D.+Howardauthor=L.+Wangauthor=M.+D.+Erionauthor=J.+Rutterauthor=W.+L.+Hollandauthor=D.+E.+Kelleyauthor=S.+A.+Summers&title=Targeting+a+ceramide+double+bond+improves+insulin+resistance+and+hepatic+steatosis&doi=10.1126%2Fscience.aav3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a ceramide double bond improves insulin resistance and hepatic steatosis</span></div><div class="casAuthors">Chaurasia, Bhagirath; Tippetts, Trevor S.; Mayoral Monibas, Rafael; Liu, Jinqi; Li, Ying; Wang, Liping; Wilkerson, Joseph L.; Sweeney, C. Rufus; Pereira, Renato Felipe; Sumida, Doris Hissako; Maschek, J. Alan; Cox, James E.; Kaddai, Vincent; Lancaster, Graeme Iain; Siddique, Monowarul Mobin; Poss, Annelise; Pearson, Mackenzie; Satapati, Santhosh; Zhou, Heather; McLaren, David G.; Previs, Stephen F.; Chen, Ying; Qian, Ying; Petrov, Aleksandr; Wu, Margaret; Shen, Xiaolan; Yao, Jun; Nunes, Christian N.; Howard, Andrew D.; Wang, Liangsu; Erion, Mark D.; Rutter, Jared; Holland, William L.; Kelley, David E.; Summers, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6451</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Excess calorie intake can ultimately lead to a metabolic syndrome that interferes with fat or lipid metab.  There are many different types of lipids, and it has been widely debated which are the true culprits underlying metabolic disorders.  Chaurasia et al. report that ceramides are the major contributor to insulin resistance and fatty liver disease (see the Perspective by Kusminski and Scherer).  This appears to be caused by the enzyme dihydroceramide desaturase 1 (DES1), which is normally involved in ceramide prodn. by inserting a double bond into the backbone of the mol.  In mice fed a high-fat diet, deletion of DES1 improved glucose and lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8xoYIoe7g07Vg90H21EOLACvtfcHk0liMbRVjy26V-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOhsLnE&md5=fa1ffeaff6c37554fb9e1550c32d6218</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.aav3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aav3722%26sid%3Dliteratum%253Aachs%26aulast%3DChaurasia%26aufirst%3DB.%26aulast%3DTippetts%26aufirst%3DT.%2BS.%26aulast%3DMayoral%2BMonibas%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DSweeney%26aufirst%3DC.%2BR.%26aulast%3DPereira%26aufirst%3DR.%2BF.%26aulast%3DSumida%26aufirst%3DD.%2BH.%26aulast%3DMaschek%26aufirst%3DJ.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BE.%26aulast%3DKaddai%26aufirst%3DV.%26aulast%3DLancaster%26aufirst%3DG.%2BI.%26aulast%3DSiddique%26aufirst%3DM.%2BM.%26aulast%3DPoss%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DSatapati%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DPrevis%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DC.%2BN.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DRutter%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DSummers%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520a%2520ceramide%2520double%2520bond%2520improves%2520insulin%2520resistance%2520and%2520hepatic%2520steatosis%26jtitle%3DScience%26date%3D2019%26volume%3D365%26spage%3D386%26epage%3D392%26doi%3D10.1126%2Fscience.aav3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1960</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1002/1521-3773(20010518)40:10<1960::AID-ANIE1960>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1960-1962&author=G.+Triolaauthor=G.+Fabriasauthor=A.+Llebaria&title=Synthesis+of+a+cyclopropene+analogue+of+ceramide%2C+a+potent+inhibitor+of+dihydroceramide+desaturase&doi=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Llebaria, Amadeu</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1960-1962</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review, with 23 refs., describes the synthesis of cyclopropene ceramide analog erythro-1, and inhibition expts. that show that erythro-1 is a potent inhibitor of dihydroceramide desaturase.  The introduction of a cyclopropene unit to replace the double bond in the ceramide structure has resulted in the first potent inhibitor of dihydroceramide desaturase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8eFQcfKc3e7Vg90H21EOLACvtfcHk0liMbRVjy26V-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFyqtbk%253D&md5=074d121dda360e732c35714558a52ac1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010518%252940%253A10%253C1960%253A%253AAID-ANIE1960%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DLlebaria%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520cyclopropene%2520analogue%2520of%2520ceramide%252C%2520a%2520potent%2520inhibitor%2520of%2520dihydroceramide%2520desaturase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D1960%26epage%3D1962%26doi%3D10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenstone, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogerty, A. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the desaturation of stearic to oleic acid by cyclopropene fatty acids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1038/2141244a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2F2141244a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=6066117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaF2sXksVWntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1967&pages=1244-1245&author=A.+R.+Johnsonauthor=J.+A.+Pearsonauthor=F.+S.+Shenstoneauthor=A.+C.+Fogerty&title=Inhibition+of+the+desaturation+of+stearic+to+oleic+acid+by+cyclopropene+fatty+acids&doi=10.1038%2F2141244a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the desaturation of stearic to oleic acid by cyclopropene fatty acids</span></div><div class="casAuthors">Johnson, Alan Rhodes; Pearson, Judith A.; Shenstone, F. S.; Fogerty, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">5094</span>),
    <span class="NLM_cas:pages">1244-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">During the incubation of liver prepns. malvalic acid (2.5 and 10 micromoles) and sterculic acid (2.4 and 9.6 micromoles) inhibited the desatn. of stearic acid (I) to oleic acid (II), being most pronounced in the esterified fatty acids and being dependent upon the concn. of the cyclopropene fatty acid.  Methyl sterculate fed to hens at 2.8 and 13.9 mg./kg./day for 3 months reduced the conversion of I to II in liver prepns. from these hens to 12 and 3%, resp., compared with 68% conversion in a control prepn., and reduced the amt. of II in the egg yolk to 48.3 and 30.5% of the total fatty acids compared with 51.8% in the controls.  The high I:II ratio in egg yolk and the consequent hardening of the yolk in methyl sterculate-fed hens can be attributed to inhibition of the hepatic desaturase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBNbLHSHyU7Vg90H21EOLACvtfcHk0liMbRVjy26V-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXksVWntLY%253D&md5=d77bb312ed8715aa1e2d15d22f7d01f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F2141244a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F2141244a0%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DPearson%26aufirst%3DJ.%2BA.%26aulast%3DShenstone%26aufirst%3DF.%2BS.%26aulast%3DFogerty%26aufirst%3DA.%2BC.%26atitle%3DInhibition%2520of%2520the%2520desaturation%2520of%2520stearic%2520to%2520oleic%2520acid%2520by%2520cyclopropene%2520fatty%2520acids%26jtitle%3DNature%26date%3D1967%26volume%3D214%26spage%3D1244%26epage%3D1245%26doi%3D10.1038%2F2141244a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9924</span>– <span class="NLM_lpage">9932</span>, <span class="refDoi"> DOI: 10.1021/jo030141u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030141u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9924-9932&author=G.+Triolaauthor=G.+Fabriasauthor=J.+Casasauthor=A.+Llebaria&title=Synthesis+of+cyclopropene+analogues+of+ceramide+and+their+effect+on+dihydroceramide+desaturase&doi=10.1021%2Fjo030141u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclopropene Analogues of Ceramide and Their Effect on Dihydroceramide Desaturase</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Casas, Josefina; Llebaria, Amadeu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9924-9932</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of several analogs of the N-[(1S,2R)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11), the first reported inhibitor of dihydroceramide desaturase, as well as their effects on this enzyme, are described.  Modifications of the parent structure include variations on the cyclopropene ring, the N-acyl chain length, the configuration of the stereocenters, and the hydroxyl group at C1.  The key intermediates for the synthesis are the products resulting from the addn. of suitable organolithium compds. to either Garner's aldehyde or its enantiomer.  The final products are obtained by TMSTf-induced cleavage of the protecting groups and N-acylation, both under specific conditions.  An alternative method for N-Boc deprotection is also reported that allows us to obtain the cyclopropene analog of sphingosine, which can be transformed into GT11 upon acylation.  The procedure consists of the conversion of the Garner aldehyde addn. products into the bicyclic dihydrooxazolo[3,4,0]oxazol-3-ones by transesterification in basic medium of the tert-Bu group with the hydroxyl function at C3.  Mild cleavage of the N,O-isopropylidene cyclic acetal affords the oxazolidin-2-one, which gives the sphingosine analog upon sapon.  Furthermore, the oxazolidin-2-one compd. is also the key intermediate in the synthesis of the terminal deoxy, methoxy, and fluoro derivs.  Detn. of dihydroceramide desaturase activity in vitro showed that GT11 was a competitive inhibitor (Ki = 6 μM) and that its analogs with N-hexanoyl and N-decanoyl moieties inhibited the enzyme with similar potencies (IC50 = 13 and 31 μM, resp.).  No decrease in dihydroceramide desaturase activity was obsd. with any of the other compds. tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCMQkmCf6D7Vg90H21EOLACvtfcHk0lhPiG63kJnwMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOkurk%253D&md5=c728d11084c5ec16999d51c9e1f6f0d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo030141u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030141u%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520cyclopropene%2520analogues%2520of%2520ceramide%2520and%2520their%2520effect%2520on%2520dihydroceramide%2520desaturase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9924%26epage%3D9932%26doi%3D10.1021%2Fjo030141u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragusin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhausen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broere, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Echten-Deckert, G.</span></span> <span> </span><span class="NLM_article-title">Specificity of the dihydroceramide desaturase inhibitor n-[(1r,2s)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanami de (gt11) in primary cultured cerebellar neurons</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1124/mol.104.003681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fmol.104.003681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15371559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1671-1678&author=G.+Triolaauthor=G.+Fabriasauthor=M.+Dragusinauthor=L.+Niederhausenauthor=R.+Broereauthor=A.+Llebariaauthor=G.+van+Echten-Deckert&title=Specificity+of+the+dihydroceramide+desaturase+inhibitor+n-%5B%281r%2C2s%29-2-hydroxy-1-hydroxymethyl-2-%282-tridecyl-1-cyclopropenyl%29ethyl%5Doctanami+de+%28gt11%29+in+primary+cultured+cerebellar+neurons&doi=10.1124%2Fmol.104.003681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl] octanamide (GT11) in primary cultured cerebellar neurons</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Dragusin, Mihaela; Niederhausen, Lars; Broere, Roland; Llebaria, Amadeu; van Echten-Deckert, Gerhild</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1678</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydroceramide deaturase catalyzes the conversion of the innocuous precursor dihydroceramide into a highly bioactive product ceramide.  We studied the effect of GT11, the first inhibitor of this enzyme, in primary cultured cerebellar neurons.  Although deaturase was efficiently inhibited (IC50 of 23 nM), the compd. lost its specificity at higher concns.  From 5 μM upward, GT11 also decreased de novo sphingolipid biosynthesis.  Studies with two differentially labeled radioactive analogs of GT11 support that the inhibitor itself and not a downstream metabolic product, interferes with sphingolipid biosynthesis.  It is interesting that serine palmitoyltransferase activity decreased in the presence of high concns. of GT11 in intact cells, but not when added directly into cell homogenates.  However, suppression of enzyme transcription could not be detected.  But at high concns. GT11 provoked an accumulation of sphingosine-1-phosphate and esp. of dihydrosphingosine-1-phosphate, suggesting a decreased activity of sphingosine-1-phosphate lyase.  Enzyme activity measurements indeed supported this assumption.  Thus, at higher concns., GT11 interferes with lyase activity, inducing an accumulation of sphingoid base phosphates that, in turn, down-regulate serine palmitoyltransferase activity.  At low concns., however, GT11 is the first specific inhibitor of dihydroceramide deaturase described so far.  Considering the proapoptotic and proinflammatory effect of ceramide, GT11 could also turn out to be a novel cell-protective agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6eiC3ZeIUKbVg90H21EOLACvtfcHk0lhPiG63kJnwMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jL&md5=5ec69cb057f96da478cf1c3a7d0a6b44</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.003681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.003681%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DDragusin%26aufirst%3DM.%26aulast%3DNiederhausen%26aufirst%3DL.%26aulast%3DBroere%26aufirst%3DR.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3Dvan%2BEchten-Deckert%26aufirst%3DG.%26atitle%3DSpecificity%2520of%2520the%2520dihydroceramide%2520desaturase%2520inhibitor%2520n-%255B%25281r%252C2s%2529-2-hydroxy-1-hydroxymethyl-2-%25282-tridecyl-1-cyclopropenyl%2529ethyl%255Doctanami%2520de%2520%2528gt11%2529%2520in%2520primary%2520cultured%2520cerebellar%2520neurons%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1671%26epage%3D1678%26doi%3D10.1124%2Fmol.104.003681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span> <span> </span><span class="NLM_article-title">From the configurational preference of dihydroceramide desaturase-1 towards delta(6)-unsaturated substrates to the discovery of a new inhibitor</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4394</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1039/C6CC08268H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2FC6CC08268H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28379228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1enu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=4394-4397&author=A.+Pouauthor=J.+L.+Abadauthor=Y.+F.+Ordonezauthor=M.+Garridoauthor=J.+Casasauthor=G.+Fabriasauthor=A.+Delgado&title=From+the+configurational+preference+of+dihydroceramide+desaturase-1+towards+delta%286%29-unsaturated+substrates+to+the+discovery+of+a+new+inhibitor&doi=10.1039%2FC6CC08268H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">From the configurational preference of dihydroceramide desaturase-1 towards Δ6-unsaturated substrates to the discovery of a new inhibitor</span></div><div class="casAuthors">Pou, Ana; Abad, Jose-Luis; Ordonez, Yadira F.; Garrido, Maria; Casas, Josefina; Fabrias, Gemma; Delgado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4394-4397</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dihydroceramide desaturase 1 (Des1) catalyzes the last step of ceramide synthesis de novo, thus regulating the physiol. relevant balance between dihydrosphingolipids and sphingolipids.  Here we report on the configurational preference of Des1 towards isomeric Δ6-unsatd. dihydroceramide analogs and the discovery of a potent Des1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJVfgy1KwErVg90H21EOLACvtfcHk0lgY712COHMHTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1enu7s%253D&md5=c0047f508f55ee177b0d4e92de4ce12e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC6CC08268H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC08268H%26sid%3Dliteratum%253Aachs%26aulast%3DPou%26aufirst%3DA.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DOrdonez%26aufirst%3DY.%2BF.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DA.%26atitle%3DFrom%2520the%2520configurational%2520preference%2520of%2520dihydroceramide%2520desaturase-1%2520towards%2520delta%25286%2529-unsaturated%2520substrates%2520to%2520the%2520discovery%2520of%2520a%2520new%2520inhibitor%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D4394%26epage%3D4397%26doi%3D10.1039%2FC6CC08268H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Olaya, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matabosch, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egido-Gabas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fcmdc.200700325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=18236489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=946-953&author=J.+M.+Munoz-Olayaauthor=X.+Mataboschauthor=C.+Bediaauthor=M.+Egido-Gabasauthor=J.+Casasauthor=A.+Llebariaauthor=A.+Delgadoauthor=G.+Fabrias&title=Synthesis+and+biological+activity+of+a+novel+inhibitor+of+dihydroceramide+desaturase&doi=10.1002%2Fcmdc.200700325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase</span></div><div class="casAuthors">Munoz-Olaya, Jose M.; Matabosch, Xavier; Bedia, Carmen; Egido-Gabas, Meritxell; Casas, Josefina; Llebaria, Amadeu; Delgado, Antonio; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">946-953</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel mechanism-based dihydroceramide desaturase inhibitor (XM462) in which the substrate C5 methylene group is replaced by a sulfur atom is reported.  Dihydroceramide desaturase inhibition occurred both in vitro and in cultured cells with IC50 values of 8.2 and 0.78 μM, at a substrate concn. of 10 μM.  In vitro expts. showed that XM462 produced a mixed-type inhibition (Ki = 2 μM, α = 0.83).  LC-MS analyses showed that accumulation of endogenous dihydroceramides occurred in cells upon treatment with XM462 in serum-free medium, whereas ceramides built up in controls.  In addn., XM462 was found to be metabolised to its 1-glucosyl and 1-phosphocholine derivs., and to the products of N-deacylation and reacylation with palmitoyl and stearoyl groups.  In Jurkat A3 cells cultured in serum-free medium, viability, as the percentage of trypan blue unstained cells in total cells, was reduced upon XM462 treatment (5 μM, 24 h), but not in controls.  The interest of this compd. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo98D7t9TGb7Vg90H21EOLACvtfcHk0lgY712COHMHTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVWmtL8%253D&md5=4cbc9db99062a5146e255ddf3daedf35</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700325%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Olaya%26aufirst%3DJ.%2BM.%26aulast%3DMatabosch%26aufirst%3DX.%26aulast%3DBedia%26aufirst%3DC.%26aulast%3DEgido-Gabas%26aufirst%3DM.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520inhibitor%2520of%2520dihydroceramide%2520desaturase%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D946%26epage%3D953%26doi%3D10.1002%2Fcmdc.200700325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buist, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallmann, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymerson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigel, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, P.</span></span> <span> </span><span class="NLM_article-title">Use of sulfur as an oxidant detector</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)80115-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0040-4039%2800%2980115-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVens7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1988&pages=435-438&author=P.+H.+Buistauthor=H.+G.+Dallmannauthor=R.+R.+Rymersonauthor=P.+M.+Seigelauthor=P.+Skala&title=Use+of+sulfur+as+an+oxidant+detector&doi=10.1016%2FS0040-4039%2800%2980115-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Use of sulfur as an oxidant detector</span></div><div class="casAuthors">Buist, Peter H.; Dallmann, H. Garry; Rymerson, Robert R.; Seigel, Peter M.; Skala, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The oxidn. of a no. of Me thiastearates has been examd. as a function of sulfur position using the yeast, Saccharomyces cerevisiae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqBUsRmHzz0LVg90H21EOLACvtfcHk0lgY712COHMHTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVens7w%253D&md5=3a3533c4db1d4d6943d206008cab7d85</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2980115-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252980115-X%26sid%3Dliteratum%253Aachs%26aulast%3DBuist%26aufirst%3DP.%2BH.%26aulast%3DDallmann%26aufirst%3DH.%2BG.%26aulast%3DRymerson%26aufirst%3DR.%2BR.%26aulast%3DSeigel%26aufirst%3DP.%2BM.%26aulast%3DSkala%26aufirst%3DP.%26atitle%3DUse%2520of%2520sulfur%2520as%2520an%2520oxidant%2520detector%26jtitle%3DTetrahedron%2520Lett.%26date%3D1988%26volume%3D29%26spage%3D435%26epage%3D438%26doi%3D10.1016%2FS0040-4039%2800%2980115-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hovik, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spydevold, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, J.</span></span> <span> </span><span class="NLM_article-title">Thia fatty acids as substrates and inhibitors of stearoyl-coa desaturase</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1349</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(97)00135-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0005-2760%2897%2900135-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9434139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1349&publication_year=1997&pages=251-256&author=K.+E.+Hovikauthor=O.+S.+Spydevoldauthor=J.+Bremer&title=Thia+fatty+acids+as+substrates+and+inhibitors+of+stearoyl-coa+desaturase&doi=10.1016%2FS0005-2760%2897%2900135-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Thia fatty acids as inhibitors and substrates of Δ9 desaturation of stearic acid</span></div><div class="casAuthors">Hovik, Kjerstin E.; Spydevold, Oystein S.; Bremer, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-256</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thia fatty acids are fatty acid analogs, where sulfur atoms substitute methylene groups in the carbon chain.  In 7800 C1 Morris hepatoma cells and in hepatocytes 9-thia and 10-thia stearic acid are strong inhibitors of Δ9 desaturase, while 3,9-dithia stearic acid and 3,10-dithia stearic acid are much weaker inhibitors.  No effect on the Δ9 desaturase can be obsd. with 3-thia stearic acid.  In microsomes, an equimolar concn. of 9-thia stearoyl-CoA inhibits the Δ9 desatn. of [1-14C]stearoyl-CoA approx. 75, while 3,9-dithia stearoyl-CoA and 3,10-dithia stearoyl-CoA again are weak inhibitors. 3-Thia stearoyl-CoA has no effect on the desatn. of [1-14C]stearoyl-CoA. [2-14C]3-Thia stearoyl-CoA is Δ9 desatd. to [2-14C]thia oleic acid.  This desatn. is inhibited by unlabeled stearoyl-CoA, which therefore is the preferred substrate.  These results show that a sulfur atom in the 3 position reduces the affinity of the CoA ester for the enzyme, but permits desatn.  A sulfur in the 9 or 10 position does not affect binding to the enzyme.  The 9-thia and 10-thia stearoyl-CoA, which cannot be desatd., therefore are strong inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosH_UDeCVc_rVg90H21EOLACvtfcHk0lgY712COHMHTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGjtLs%253D&md5=bd0dee3cdb118617e698e6ed71aa6e90</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2897%2900135-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252897%252900135-5%26sid%3Dliteratum%253Aachs%26aulast%3DHovik%26aufirst%3DK.%2BE.%26aulast%3DSpydevold%26aufirst%3DO.%2BS.%26aulast%3DBremer%26aufirst%3DJ.%26atitle%3DThia%2520fatty%2520acids%2520as%2520substrates%2520and%2520inhibitors%2520of%2520stearoyl-coa%2520desaturase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1997%26volume%3D1349%26spage%3D251%26epage%3D256%26doi%3D10.1016%2FS0005-2760%2897%2900135-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Analogs of the dihydroceramide desaturase inhibitor gt11 modified at the amide function: Synthesis and biological activities</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3707</span>– <span class="NLM_lpage">3712</span>, <span class="refDoi"> DOI: 10.1039/b510198k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2Fb510198k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16211106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOiur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3707-3712&author=C.+Bediaauthor=G.+Triolaauthor=J.+Casasauthor=A.+Llebariaauthor=G.+Fabrias&title=Analogs+of+the+dihydroceramide+desaturase+inhibitor+gt11+modified+at+the+amide+function%3A+Synthesis+and+biological+activities&doi=10.1039%2Fb510198k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of the dihydro-ceramide desaturase inhibitor GT11 modified at the amide function: synthesis and biological activities</span></div><div class="casAuthors">Bedia, Carmen; Triola, Gemma; Casas, Josefina; Llebaria, Amadeu; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3707-3712</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dihydro-ceramide desaturase is the last enzyme in the biosynthesis of ceramide de novo.  The cyclopropene-contg. sphingolipid GT11 I is a competitive inhibitor of dihydro-ceramide desaturase.  The biol. effects of chem. modification of the GT11 amide linkage are reported in this article.  Either N-Me substitution or replacement of the amide α-carbonyl methylene by oxygen result in inactive compds.  In contrast, both urea and thiourea analogs of GT11, as well as three α-keto-amides, did inhibit the desatn. of N-octanoyl-sphinganine to N-octanoyl-sphingosine, although with significantly lower potency than GT11.  Furthermore, the α-keto-amides inhibit the acidic ceramidase with similar potencies (IC50 52-83 μM).  Inhibition of the neutral/alk. ceramidase by these compds. requires around 20-fold higher concns.  Structure-activity relationships and the biol. interest of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMMlfjxVHbFrVg90H21EOLACvtfcHk0lg590trzoEfmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOiur%252FI&md5=847ac0c814d5b2bffef9db92d8444ee8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fb510198k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb510198k%26sid%3Dliteratum%253Aachs%26aulast%3DBedia%26aufirst%3DC.%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DAnalogs%2520of%2520the%2520dihydroceramide%2520desaturase%2520inhibitor%2520gt11%2520modified%2520at%2520the%2520amide%2520function%253A%2520Synthesis%2520and%2520biological%2520activities%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D3707%26epage%3D3712%26doi%3D10.1039%2Fb510198k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simbari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">3-deoxy-3,4-dehydro analogs of xm462. Preparation and activity on sphingolipid metabolism and cell fate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3173</span>– <span class="NLM_lpage">3179</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmc.2012.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22537678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3173-3179&author=L.+Camachoauthor=F.+Simbariauthor=M.+Garridoauthor=J.+L.+Abadauthor=J.+Casasauthor=A.+Delgadoauthor=G.+Fabrias&title=3-deoxy-3%2C4-dehydro+analogs+of+xm462.+Preparation+and+activity+on+sphingolipid+metabolism+and+cell+fate&doi=10.1016%2Fj.bmc.2012.03.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate</span></div><div class="casAuthors">Camacho, Luz; Simbari, Fabio; Garrido, Maria; Abad, Jose Luis; Casas, Josefina; Delgado, Antonio; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3173-3179</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three analogs of the dihydroceramide deaturase inhibitor XM462 are reported.  The compds. inhibit both dihydroceramide deaturase and acid ceramidase, but with different potencies depending on the N-acyl moiety.  Other enzymes of sphingolipid metab., such as neutral ceramidase, acid sphingomyelinase, acid glucosylceramide hydrolase, sphingomyelin synthase and glucosylceramide synthase, are not affected.  The effect on the sphingolipidome of the two best inhibitors, namely (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)octanamide (RBM2-1B) and (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)pivalamide (RBM2-1D), is in accordance with the results obtained in the enzyme assays.  These two compds. reduce cell viability in A549 and HCT116 cell lines with similar potencies and both induced apoptotic cell death to similar levels than C8-Cer in HCT116 cells.  The possible therapeutic implications of the activities of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwahFbtXayrVg90H21EOLACvtfcHk0lg590trzoEfmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWqtbk%253D&md5=b6d0f5f9b140e173d5903934c7c4ac33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%26aufirst%3DL.%26aulast%3DSimbari%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3D3-deoxy-3%252C4-dehydro%2520analogs%2520of%2520xm462.%2520Preparation%2520and%2520activity%2520on%2520sphingolipid%2520metabolism%2520and%2520cell%2520fate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3173%26epage%3D3179%26doi%3D10.1016%2Fj.bmc.2012.03.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becci, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gander, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=421218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE1MXktlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1979&pages=1339-1346&author=R.+C.+Moonauthor=H.+J.+Thompsonauthor=P.+J.+Becciauthor=C.+J.+Grubbsauthor=R.+J.+Ganderauthor=D.+L.+Newtonauthor=J.+M.+Smithauthor=S.+L.+Phillipsauthor=W.+R.+Hendersonauthor=L.+T.+Mullenauthor=C.+C.+Brownauthor=M.+B.+Sporn&title=N-%284-hydroxyphenyl%29retinamide%2C+a+new+retinoid+for+prevention+of+breast+cancer+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat</span></div><div class="casAuthors">Moon, Richard C.; Thompson, Henry J.; Becci, Peter J.; Grubbs, Clinton J.; Gander, Robert J.; Newton, Dianne L.; Smith, Joseph M.; Phillips, Sandra L.; Henderson, William R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1339-46</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The synthesis of a new retinoid N-(4-hydroxyphenyl)-all-trans-retinamide (I)  [65646-68-6] is described.  I was more potent that retinyl acetate in reversing keratinization caused by retinoid deficiency in tracheal organ culture.  I was markedly less toxic than retinyl acetate when fed orally to rats over 2-wk or 6-mo periods.  I was an effective agent for inhibition of the development of breast cancer induced in rats by N-nitroso-N-methylurea, although it was not as potent as retinyl acetate in this regard.  However, the lesser toxicity of I makes it a superior agent for prevention of breast cancer.  High-pressure liq. chromatog. analyses of liver and breast exts. from rats treated for 6 mo with retinoids show the pharmacokinetic basis for the superiority of I; this retinoid and its metabolites were found in high concns. in breast tissue, without any measurable accumulation in the liver or evident liver toxicity.  In contrast, chronic feeding of retinyl acetate caused marked deposition of retinyl esters in the liver and severe hepatotoxicity.  Whole mounts of rat mammary glands, made after chronic feeding of I showed that it had a marked antiproliferative effect on mammary epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos8Iznf_bvpLVg90H21EOLACvtfcHk0lg590trzoEfmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktlaku7c%253D&md5=3e4d0463a75c7f17f2ce0927e2f2d668</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DR.%2BC.%26aulast%3DThompson%26aufirst%3DH.%2BJ.%26aulast%3DBecci%26aufirst%3DP.%2BJ.%26aulast%3DGrubbs%26aufirst%3DC.%2BJ.%26aulast%3DGander%26aufirst%3DR.%2BJ.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DPhillips%26aufirst%3DS.%2BL.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26aulast%3DMullen%26aufirst%3DL.%2BT.%26aulast%3DBrown%26aufirst%3DC.%2BC.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DN-%25284-hydroxyphenyl%2529retinamide%252C%2520a%2520new%2520retinoid%2520for%2520prevention%2520of%2520breast%2520cancer%2520in%2520the%2520rat%26jtitle%3DCancer%2520Res.%26date%3D1979%26volume%3D39%26spage%3D1339%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span> <span> </span><span class="NLM_article-title">Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">16718</span>– <span class="NLM_lpage">16728</span>, <span class="refDoi"> DOI: 10.1074/jbc.M700647200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M700647200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17283068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1agsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16718-16728&author=J.+M.+Kravekaauthor=L.+Liauthor=Z.+M.+Szulcauthor=J.+Bielawskiauthor=B.+Ogretmenauthor=Y.+A.+Hannunauthor=L.+M.+Obeidauthor=A.+Bielawska&title=Involvement+of+dihydroceramide+desaturase+in+cell+cycle+progression+in+human+neuroblastoma+cells&doi=10.1074%2Fjbc.M700647200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma Cells</span></div><div class="casAuthors">Kraveka, Jacqueline M.; Li, Li; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim; Hannun, Yusuf A.; Obeid, Lina M.; Bielawska, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16718-16728</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The role of dihydroceramide desaturase as a key enzyme in the de novo pathway of ceramide generation was investigated in human neuroblastoma cells (SMS-KCNR).  A novel assay using water-sol. analogs of dihydroceramide, dihydroceramidoids (D-erythro-dhCCPS analogs), was used to measure desaturase activity in situ.  Conversion of D-erythro-2-N-[12'-(1''-pyridinium)-dodecanoyl]-4,5-dihydrosphingosine bromide (C12-dhCCPS) to its 4,5-desatd. counterpart, D-erythro-2-N-[12'-(1''-pyridinium)dodecanoyl]sphingosine bromide (C12-CCPS), was detd. by liq. chromatog./mass spectrometry anal.  The validity of the assay was confirmed using C8-cyclopropenylceramide, a competitive inhibitor of dihydroceramide desaturase.  A human homolog (DEGS-1) of the Drosophila melanogaster des-1 gene was recently identified and reported to have desaturase activity.  Transfection of SMS-KCNR cells with small interfering RNA to DEGS-1 significantly blocked the conversion of C12-dhCCPS to C12-CCPS.  The assocd. accumulation of endogenous dihydroceramides confirmed DEGS-1 as the main active dihydroceramide desaturase in these cells.  The partial loss of DEGS-1 inhibited cell growth, with cell cycle arrest at G0/G1.  This was accompanied by a significant decrease in the amt. of phosphorylated retinoblastoma protein.  This hypophosphorylation was inhibited by tautomycin and not by okadaic acid, suggesting the involvement of protein phosphatase 1.  Addnl., we found that treatment of SMS-KCNR cells with fenretinide inhibited desaturase activity in a dose-dependent manner.  An increase in dihydroceramides (but not ceramides) paralleled this process as measured by liq. chromatog./mass spectrometry.  There were no effects on the mRNA or protein levels of DEGS-1, suggesting that fenretinide acts at the post-translational level as an inhibitor of this enzyme.  Tautomycin was also able to block the hypophosphorylation of the retinoblastoma protein obsd. upon fenretinide treatment.  These findings suggest a novel biol. function for dihydroceramides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpESfa0p4qfN7Vg90H21EOLACvtfcHk0li4iBjM-4gvDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1agsr8%253D&md5=56f06a2c01172fcd71b0f2d78beeb053</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M700647200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M700647200%26sid%3Dliteratum%253Aachs%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSzulc%26aufirst%3DZ.%2BM.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DBielawska%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520dihydroceramide%2520desaturase%2520in%2520cell%2520cycle%2520progression%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D16718%26epage%3D16728%26doi%3D10.1074%2Fjbc.M700647200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curley, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span> <span> </span><span class="NLM_article-title">Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">24754</span>– <span class="NLM_lpage">24764</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.250779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M111.250779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21543327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFGmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=24754-24764&author=M.+Rahmaniyanauthor=R.+W.+Curleyauthor=L.+M.+Obeidauthor=Y.+A.+Hannunauthor=J.+M.+Kraveka&title=Identification+of+dihydroceramide+desaturase+as+a+direct+in+vitro+target+for+fenretinide&doi=10.1074%2Fjbc.M111.250779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide</span></div><div class="casAuthors">Rahmaniyan, Mehrdad; Curley, Robert W., Jr.; Obeid, Lina M.; Hannun, Yusuf A.; Kraveka, Jacqueline M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">24754-24764</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide.  We previously demonstrated that fenretinide (4-HPR) inhibited DES activity in SMS-KCNR neuroblastoma cells.  In this study, we investigated whether 4-HPR acted directly on the enzyme in vitro.  N-C8:0-D-erythro-dihydroceramide (C8-dhCer) was used as a substrate to study the conversion of dihydroceramide into ceramide in vitro using rat liver microsomes, and the formation of tritiated water after the addn. of the tritiated substrate was detected and used to measure DES activity.  NADH served as a cofactor.  The apparent Km for C8-dhCer and NADH were 1.92 ± 0.36 μM and 43.4 ± 6.47 μM, resp.; and the Vmax was 3.16 ± 0.24 and 4.11 ± 0.18 nmol/min/g protein.  Next, the effects of 4-HPR and its metabolites on DES activity were investigated. 4-HPR was found to inhibit DES in a dose-dependent manner.  At 20 min, the inhibition was competitive; however, longer incubation times demonstrated the inhibition to be irreversible.  Among the major metabolites of 4-HPR, 4-oxo-N-(4-hydroxyphenyl)retinamide (4-oxo-4-HPR) showed the highest inhibitory effect with substrate concn. of 0.5 μM, with an IC50 of 1.68 μM as compared with an IC50 of 2.32 μM for 4-HPR.  N-(4-Methoxyphenyl)retinamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl)retinamide (4-oxo-4-MPR) had minimal effects on DES activity.  A known competitive inhibitor of DES, C8-cyclopropenylceramide was used as a pos. control.  These studies define for the first time a direct in vitro target for 4-HPR and suggest that inhibitors of DES may be used as therapeutic interventions to regulate ceramide desatn. and consequent function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIlNxfyqhQbVg90H21EOLACvtfcHk0li4iBjM-4gvDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFGmsLw%253D&md5=e9cddef915d8b9e976ca654317631256</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.250779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.250779%26sid%3Dliteratum%253Aachs%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DCurley%26aufirst%3DR.%2BW.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520dihydroceramide%2520desaturase%2520as%2520a%2520direct%2520in%2520vitro%2520target%2520for%2520fenretinide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D24754%26epage%3D24764%26doi%3D10.1074%2Fjbc.M111.250779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase inhibitors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.101345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fjpet.106.101345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16632640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=596-603&author=K.+J.+Frenchauthor=J.+J.+Upsonauthor=S.+N.+Kellerauthor=Y.+Zhuangauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+inhibitors&doi=10.1124%2Fjpet.106.101345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase inhibitors</span></div><div class="casAuthors">French, Kevin J.; Upson, John J.; Keller, Staci N.; Zhuang, Yan; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine kinase (SK) is an oncogenic sphingolipid-metabolizing enzyme that catalyzes the formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) at the expense of proapoptotic ceramide.  Thus, SK is an attractive target for cancer therapy because blockage of S1P formation leads to inhibition of proliferation, as well as the induction of apoptosis in cancer cells.  We have recently identified novel SK inhibitors with nanomolar to low micromolar potencies toward recombinant human SK.  This study describes the continuing anal. of these inhibitors through in vitro and in vivo expts.  All three structurally diverse SK inhibitors tested showed antitumor activity in mice without exhibiting toxicity.  Blood and tumor inhibitor concns. exceeded in vitro potency levels.  Cell signaling analyses in vitro revealed mixed inhibition of mitogen-activated protein kinase kinase and Akt phosphorylation by the SK inhibitors.  Importantly, 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) is orally bioavailable, detected in the blood for at least 8 h, and showed a significant inhibition of tumor growth in mice.  These compds. are the first examples of nonlipid selective inhibitors of SK with in vivo antitumor activity and provide leads for further development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOz-4ODWl8HbVg90H21EOLACvtfcHk0li4iBjM-4gvDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D&md5=625e4f9f3c438f2ee00f9039ffb76690</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101345%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D596%26epage%3D603%26doi%3D10.1124%2Fjpet.106.101345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e44543</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0044543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0044543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22970244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOltLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=P.+Gaoauthor=Y.+K.+Petersonauthor=R.+A.+Smithauthor=C.+D.+Smith&title=Characterization+of+isoenzyme-selective+inhibitors+of+human+sphingosine+kinases&doi=10.1371%2Fjournal.pone.0044543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span></div><div class="casAuthors">Gao, Peng; Peterson, Yuri K.; Smith, Ryan A.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e44543</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Sphingosine kinases (SKs) are promising new therapeutic targets for cancer because they regulate the balance between pro-apoptotic ceramides and mitogenic sphingosine-1-phosphate.  The functions of the two SK isoenzymes, SK1 and SK2, are not redundant, with genetic ablation of SK2 having more pronounced anticancer effects than removal of SK1.  Although several small mol. inhibitors of SKs have been described in the literature, detailed characterization of their mol. and cellular pharmacol., particularly their activities against human SK1 and SK2, have not been completed.  Computational modeling of the putative active sites of SK1 and SK2 suggests structural differences that might allow isoenzyme-selective inhibitors.  Therefore, we characterized several SK-inhibitory compds. which revealed differential inhibitory effects on SK1 and SK2 as follows: SKI-II and ABC294735 are SK1/2-dual inhibitors; CB5468139 is a SK1-selective inhibitor; and ABC294640 is a SK2-selective inhibitor.  We examd. the effects of the SK inhibitors on several biochem. and phenotypic processes in A498 kidney adenocarcinoma cells.  The SK2-selective inhibitor ABC294640 demonstrated the most pronounced effects on SK1 and SK2 mRNA expression, decrease of S1P levels, elevation of ceramide levels, cell cycle arrest, and inhibition of proliferation, migration and invasion.  ABC294640 also down-regulated the expression or activation of several signaling proteins, including STAT3, AKT, ERK, p21, p53 and FAK.  These effects were equiv. or superior to responses to the SK1/2-dual inhibitors.  Overall, these results suggest that inhibition of SK2 results in stronger anticancer effects than does inhibition of SK1 or both SK1 and SK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7FPd4N4yAUbVg90H21EOLACvtfcHk0lioc8LkpUA4LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOltLjF&md5=d0eeac2da418c330f5e63fc866a77003</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044543%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCharacterization%2520of%2520isoenzyme-selective%2520inhibitors%2520of%2520human%2520sphingosine%2520kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0044543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casasampere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanllehi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor ski ii</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1720</span>, <span class="refDoi"> DOI: 10.1194/jlr.M049759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.M049759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24875537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1agsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1711-1720&author=F.+Cingolaniauthor=M.+Casasampereauthor=P.+Sanllehiauthor=J.+Casasauthor=J.+Bujonsauthor=G.+Fabrias&title=Inhibition+of+dihydroceramide+desaturase+activity+by+the+sphingosine+kinase+inhibitor+ski+ii&doi=10.1194%2Fjlr.M049759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II</span></div><div class="casAuthors">Cingolani, Francesca; Casasampere, Mireia; Sanllehi, Pol; Casas, Josefina; Bujons, Jordi; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1711-1720</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Sphingosine kinase inhibitor (SKI) II has been reported as a dual inhibitor of sphingosine kinases (SKs) 1 and 2 and has been extensively used to prove the involvement of SKs and sphingosine-1-phosphate (S1P) in cellular processes.  Dihydroceramide desaturase (Des1), the last enzyme in the de novo synthesis of ceramide (Cer), regulates the balance between dihydroceramides (dhCers) and Cers.  Both SKs and Des1 have interest as therapeutic targets.  Here we show that SKI II is a noncompetitive inhibitor (Ki = 0.3 μM) of Des1 activity with effect also in intact cells without modifying Des1 protein levels.  Mol. modeling studies support that the SKI II-induced decrease in Des1 activity could result from inhibition of NADH-cytochrome b5 reductase.  SKI II, but not the SK1-specific inhibitor PF-543, provoked a remarkable accumulation of dhCers and their metabolites, while both SKI II and PF-543 reduced S1P to almost undetectable levels.  SKI II, but not PF543, reduced cell proliferation with accumulation of cells in the G0/G1 phase.  SKI II, but not PF543, induced autophagy.  These overall findings should be taken into account when using SKI II as a pharmacol. tool, as some of the effects attributed to decreased S1P may actually be caused by augmented dhCers and/or their metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNQtrJS2ry7Vg90H21EOLACvtfcHk0lioc8LkpUA4LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1agsrnE&md5=b0c80a9893c7616875c436364d56a108</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M049759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M049759%26sid%3Dliteratum%253Aachs%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DCasasampere%26aufirst%3DM.%26aulast%3DSanllehi%26aufirst%3DP.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DBujons%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520dihydroceramide%2520desaturase%2520activity%2520by%2520the%2520sphingosine%2520kinase%2520inhibitor%2520ski%2520ii%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1711%26epage%3D1720%26doi%3D10.1194%2Fjlr.M049759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullino, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebello, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creek, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span> <span> </span><span class="NLM_article-title">From sphingosine kinase to dihydroceramide desaturase: A structure-activity relationship (sar) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl)thiazol-2-yl)amino)phenol (ski-ii)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">984</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01439</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01439" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=965-984&author=L.+Aurelioauthor=C.+V.+Scullinoauthor=M.+R.+Pitmanauthor=A.+Sextonauthor=V.+Oliverauthor=L.+Daviesauthor=R.+J.+Rebelloauthor=L.+Furicauthor=D.+J.+Creekauthor=S.+M.+Pitsonauthor=B.+L.+Flynn&title=From+sphingosine+kinase+to+dihydroceramide+desaturase%3A+A+structure-activity+relationship+%28sar%29+study+of+the+enzyme+inhibitory+and+anticancer+activity+of+4-%28%284-%284-chlorophenyl%29thiazol-2-yl%29amino%29phenol+%28ski-ii%29&doi=10.1021%2Facs.jmedchem.5b01439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)</span></div><div class="casAuthors">Aurelio, Luigi; Scullino, Carmen V.; Pitman, Melissa R.; Sexton, Anna; Oliver, Victoria; Davies, Lorena; Rebello, Richard J.; Furic, Luc; Creek, Darren J.; Pitson, Stuart M.; Flynn, Bernard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">965-984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sphingosine kinase (SK) inhibitor, SKI-II, has been employed extensively in biol. investigations of the role of SK1 and SK2 in disease and has demonstrated impressive anticancer activity in vitro and in vivo.  However, interpretations of results using this pharmacol. agent are complicated by several factors: poor SK1/2 selectivity, addnl. activity as an inducer of SK1-degrdn., and off-target effects, including its recently identified capacity to inhibit dihydroceramide desaturase-1 (Des1).  In this study, we have delineated the structure-activity relationship (SAR) for these different targets and correlated them to that required for anticancer activity and detd. that Des1 inhibition is primarily responsible for the antiproliferative effects of SKI-II and its analogs.  In the course of these efforts, a series of novel SK1, SK2, and Des1 inhibitors have been generated, including compds. with significantly greater anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5l2c1kugWFLVg90H21EOLACvtfcHk0lioc8LkpUA4LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlCltw%253D%253D&md5=53212d9b590fac3eff62b4fbff069f4e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01439%26sid%3Dliteratum%253Aachs%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DScullino%26aufirst%3DC.%2BV.%26aulast%3DPitman%26aufirst%3DM.%2BR.%26aulast%3DSexton%26aufirst%3DA.%26aulast%3DOliver%26aufirst%3DV.%26aulast%3DDavies%26aufirst%3DL.%26aulast%3DRebello%26aufirst%3DR.%2BJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26atitle%3DFrom%2520sphingosine%2520kinase%2520to%2520dihydroceramide%2520desaturase%253A%2520A%2520structure-activity%2520relationship%2520%2528sar%2529%2520study%2520of%2520the%2520enzyme%2520inhibitory%2520and%2520anticancer%2520activity%2520of%25204-%2528%25284-%25284-chlorophenyl%2529thiazol-2-yl%2529amino%2529phenol%2520%2528ski-ii%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D965%26epage%3D984%26doi%3D10.1021%2Facs.jmedchem.5b01439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span>; <span class="NLM_string-name">Mccall, J. M.</span>; <span class="NLM_string-name">Blitzer, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Dihydroceramide Desaturase for Treating Disease</span>. PCT Int. Appl. <span class="NLM_patent">WO 2018112077</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=D.+L.+Romero&author=J.+M.+Mccall&author=J.+Blitzer&title=Inhibitors+of+Dihydroceramide+Desaturase+for+Treating+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DD.%2BL.%26atitle%3DInhibitors%2520of%2520Dihydroceramide%2520Desaturase%2520for%2520Treating%2520Disease%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases at the centre of sphingolipid metabolism and biology</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1042/BJ20111626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1042%2FBJ20111626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22248339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=789-802&author=T.+D.+Mullenauthor=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Ceramide+synthases+at+the+centre+of+sphingolipid+metabolism+and+biology&doi=10.1042%2FBJ20111626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases at the center of sphingolipid metabolism and biology</span></div><div class="casAuthors">Mullen, Thomas D.; Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipid metab. in metazoan cells consists of a complex interconnected web of numerous enzymes, metabolites, and modes of regulation.  At the center of sphingolipid metab. reside ceramide synthases (CerSs), a group of enzymes that catalyze the formation of ceramides from sphingoid base and acyl-CoA substrates.  From a metabolic perspective, these enzymes occupy a unique niche in that they simultaneously regulate de novo sphingolipid synthesis and the recycling of free sphingosine produced from the degrdn. of pre-formed sphingolipids (salvage pathway).  Six mammalian CerSs (CerS1-CerS6) have been identified.  Unique characteristics have been described for each of these enzymes, but perhaps the most notable is the ability of individual CerS isoforms to produce ceramides with characteristic acyl-chain distributions.  Through this control of acyl-chain length and perhaps in a compartment-specific manner, CerSs appear to regulate multiple aspects of sphingolipid-mediated cell and organismal biol.  Here, the authors discuss the function of CerSs as crit. regulators of sphingolipid metab., highlight their unique characteristics, and explore the emerging roles of CerSs in regulating programmed cell death, cancer, and many other aspects of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragKGT5uAgn7Vg90H21EOLACvtfcHk0lj-qA3gu5471Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKktw%253D%253D&md5=56ec959e19c18947244ec20afeeb0b4c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1042%2FBJ20111626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111626%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DT.%2BD.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DCeramide%2520synthases%2520at%2520the%2520centre%2520of%2520sphingolipid%2520metabolism%2520and%2520biology%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26spage%3D789%26epage%3D802%26doi%3D10.1042%2FBJ20111626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Mammalian ceramide synthases</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1002/iub.319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fiub.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20222015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=347-356&author=M.+Levyauthor=A.+H.+Futerman&title=Mammalian+ceramide+synthases&doi=10.1002%2Fiub.319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian ceramide synthases</span></div><div class="casAuthors">Levy, Michal; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Inc.</span>)
        </div><div class="casAbstract">A review.  In mammals, ceramide, a key intermediate in sphingolipid metab. and an important signaling mol., is synthesized by a family of 6 ceramide synthases (CerSs), each of which synthesizes ceramides with distinct acyl chain lengths.  There are a no. of common biochem. features between the CerSs, such as their catalytic mechanism, and their structure and intracellular localization.  Different CerSs also display marked differences in their biol. properties, with each of them playing distinct roles in processes as diverse as cancer and tumor suppression, in response to chemotherapeutic drugs, in apoptosis, and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB06J4X10_O7Vg90H21EOLACvtfcHk0lj-qA3gu5471Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFegtbw%253D&md5=1796685b5383eed06d1e51949aa22950</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fiub.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.319%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DMammalian%2520ceramide%2520synthases%26jtitle%3DIUBMB%2520Life%26date%3D2010%26volume%3D62%26spage%3D347%26epage%3D356%26doi%3D10.1002%2Fiub.319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Car, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zendzian-Piotrowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedorowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawicka, D.</span></span> <span> </span><span class="NLM_article-title">Ceramide profiles in the brain of rats with diabetes induced by streptozotocin</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1943</span>– <span class="NLM_lpage">1952</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08575.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1742-4658.2012.08575.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22429392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1eqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=1943-1952&author=H.+Carauthor=M.+Zendzian-Piotrowskaauthor=S.+Prokopiukauthor=A.+Fiedorowiczauthor=A.+Sadowskaauthor=K.+Kurekauthor=D.+Sawicka&title=Ceramide+profiles+in+the+brain+of+rats+with+diabetes+induced+by+streptozotocin&doi=10.1111%2Fj.1742-4658.2012.08575.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide profiles in the brain of rats with diabetes induced by streptozotocin</span></div><div class="casAuthors">Car, Halina; Zendzian-Piotrowska, Malgorzata; Prokopiuk, Slawomir; Fiedorowicz, Anna; Sadowska, Anna; Kurek, Krzysztof; Sawicka, Diana</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1943-1952</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diabetes is assocd. with disturbances of brain activity and cognitive impairment.  We hypothesize that ceramides may constitute an important contribution to diabetes-linked neuro-dysfunction.  In our study we used rats injected with streptozotocin (STZ) as a model of severe hyperglycemia.  Using the gas-liq. chromatog. technique we found a significant increase of ceramide content in brains and a decrease in plasma of diabetic rats.  The inhibitor of serine palmitoyltransferase, myriocin, reduced ceramide generation in hyperglycemic brains, although injected alone it exerted a paradoxical effect of ceramide upregulation.  Myriocin had no impact on ceramide concn. in the plasma of either control or diabetic rats.  The level of ceramide satd. fatty acids was elevated whereas the level of ceramide poly-unsatd. fatty acids was downregulated in brains of all exptl. groups.  The concn. of ceramide mono-unsatd. fatty acids remained unchanged.  The pattern of individual ceramide species was altered depending on treatment.  We noted an STZ-evoked increase of brain ceramide C16:0, C18:0 and C20:0 and a strong decline in ceramide C18:2 fatty acid levels.  Some changes of brain ceramide pattern were modified by myriocin.  We found a decreased amt. of total ceramide-ω-6 fatty acids in STZ-treated rat brains and no changes in ceramide-ω-3 concn.  We conclude that ceramides may be important mediators of diabetes-accompanied brain dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9DrBq0XVqrVg90H21EOLACvtfcHk0lj-qA3gu5471Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1eqtbo%253D&md5=95ccd80497b5d390ab35496a08bd73ac</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08575.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08575.x%26sid%3Dliteratum%253Aachs%26aulast%3DCar%26aufirst%3DH.%26aulast%3DZendzian-Piotrowska%26aufirst%3DM.%26aulast%3DProkopiuk%26aufirst%3DS.%26aulast%3DFiedorowicz%26aufirst%3DA.%26aulast%3DSadowska%26aufirst%3DA.%26aulast%3DKurek%26aufirst%3DK.%26aulast%3DSawicka%26aufirst%3DD.%26atitle%3DCeramide%2520profiles%2520in%2520the%2520brain%2520of%2520rats%2520with%2520diabetes%2520induced%2520by%2520streptozotocin%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D1943%26epage%3D1952%26doi%3D10.1111%2Fj.1742-4658.2012.08575.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brachtendorf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Hindi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosch, S.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases in cancer therapy and chemoresistance</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2019.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.plipres.2019.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30953657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFOjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2019&pages=160-185&author=S.+Brachtendorfauthor=K.+El-Hindiauthor=S.+Grosch&title=Ceramide+synthases+in+cancer+therapy+and+chemoresistance&doi=10.1016%2Fj.plipres.2019.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases in cancer therapy and chemoresistance</span></div><div class="casAuthors">Brachtendorf, Sebastian; El-Hindi, Khadija; Groesch, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160-185</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance is one major reason for failure of cancer therapy.  In the past 10 years, evidence emerged showing that ceramides of specific chain length, generated by six different ceramide synthases (CerS), are deregulated in different cancer types thereby influencing chemosensitivity.  In this review we sum up the cellular mechanisms regulated by CerS and the resp. ceramides of specific chain length contributing to chemoresistance and how we can interfere with these mechanisms to overcome drug resistance by targeting CerS.  We compile an overview of the different cellular effects influenced by CerS in dependency of the used drug and cancer type.  Finally, the potential of CerS as new drug targets in chemotherapy or as biomarkers for the prediction of therapeutic response rates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgt5Cm1eB87Vg90H21EOLACvtfcHk0liv9bO-v1jZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFOjsL0%253D&md5=28dfbbdcf07bf6271a39f7cce94418ad</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2019.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2019.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DBrachtendorf%26aufirst%3DS.%26aulast%3DEl-Hindi%26aufirst%3DK.%26aulast%3DGrosch%26aufirst%3DS.%26atitle%3DCeramide%2520synthases%2520in%2520cancer%2520therapy%2520and%2520chemoresistance%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2019%26volume%3D74%26spage%3D160%26epage%3D185%26doi%3D10.1016%2Fj.plipres.2019.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norred, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with fusarium moniliforme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">14486</span>– <span class="NLM_lpage">14490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2998712-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1860857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlt12luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=14486-14490&author=E.+Wangauthor=W.+P.+Norredauthor=C.+W.+Baconauthor=R.+T.+Rileyauthor=A.+H.+Merrill&title=Inhibition+of+sphingolipid+biosynthesis+by+fumonisins.+Implications+for+diseases+associated+with+fusarium+moniliforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sphingolipid biosynthesis by fumonisins.  Implications for diseases associated with Fusarium moniliforme</span></div><div class="casAuthors">Wang, Elaine; Norred, William P.; Bacon, Charles W.; Riley, Ronald T.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14486-90</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Incubation of rat hepatocytes with fumonisins inhibited incorporation of [14C]serine into the sphingosine moiety of cellular sphingolipids with an IC50 of 0.1 μM for fumonisin B1 (I).  In contrast, I increased the amt. of the biosynthetic intermediate sphinganine, which suggests that fumonisins inhibit the conversion of [14C]sphinganine to N-acyl-[14C]sphinganines, a step that is thought to precede introduction of the 4,5-trans double bond of sphingosine (1986).  In agreement with this mechanism, I inhibited the activity of sphingosine N-acyltransferase (ceramide synthase) in rat liver microsomes with 50% inhibition at approx. 0.1 μM and reduced the conversion of [3H]sphingosine to [3H]ceramide by intact hepatocytes.  As far as the authors are aware, this is the 1st discovery of a naturally occurring inhibitor of this step of sphingolipid metab.  These findings suggest that disruption of the de novo pathway of sphingolipid biosynthesis may be a crit. event in the diseases that have been assocd. with consumption of fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriD3wO0JGdirVg90H21EOLACvtfcHk0liv9bO-v1jZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt12luro%253D&md5=cc1b3ed76f6c11b4be62b94aebfdbdfd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2998712-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252998712-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DE.%26aulast%3DNorred%26aufirst%3DW.%2BP.%26aulast%3DBacon%26aufirst%3DC.%2BW.%26aulast%3DRiley%26aufirst%3DR.%2BT.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520sphingolipid%2520biosynthesis%2520by%2520fumonisins.%2520Implications%2520for%2520diseases%2520associated%2520with%2520fusarium%2520moniliforme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D14486%26epage%3D14490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. T.</span></span> <span> </span><span class="NLM_article-title">Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins</span>. <i>Environ. Health Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1289/ehp.01109s2283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1289%2Fehp.01109s2283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11359697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVOgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=283-289&issue=Suppl.+2&author=A.+H.+Merrillauthor=M.+C.+Sullardsauthor=E.+Wangauthor=K.+A.+Vossauthor=R.+T.+Riley&title=Sphingolipid+metabolism%3A+Roles+in+signal+transduction+and+disruption+by+fumonisins&doi=10.1289%2Fehp.01109s2283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins</span></div><div class="casAuthors">Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine; Voss, Kenneth A.; Riley, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives Supplements</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">EHPSEO</span>;
        ISSN:<span class="NLM_cas:issn">1078-0475</span>.
    
            (<span class="NLM_cas:orgname">National Institute of Environmental Health Sciences</span>)
        </div><div class="casAbstract">A review and discussion with 59 refs.  Sphingolipids have important roles in membrane and lipoprotein structure and in cell regulation as second messengers for growth factors, differentiation factors, cytokines, and a growing list of agonists.  Bioactive sphingolipids are formed both by the turnover of complex sphingolipids and as intermediates of sphingolipid biosynthesis.  Usually, the amts. are highly regulated; however, by inhibiting ceramide synthase, fumonisins block the biosynthesis of complex sphingolipids and cause sphinganine (and sometimes sphingosine) to accumulate.  Where the mechanism has been studied most thoroughly, the accumulation of sphingoid bases is a primary cause of the toxicity of fumonisin B (FB).  Nonetheless, the full effects of fumonisins probably involve many biochem. events.  The elevations in sphingoid bases also affect the amts. of other lipids, including the 1-phosphates and N-acetyl derivs. of sphinganine.  Furthermore, the aminopentol backbone of FB1 (AP1) is both an inhibitor and a substrate for ceramide synthase, and the resultant N-palmitoyl-AP1 (PAP1) is an even more potent inhibitor of ceramide synthase (presumably as a product analog).  PAP1 is 10 times more toxic than FB1 or AP1 for HT-29 cells in culture, and hence may play a role in the toxicity of nixtamalized fumonisins.  All these processes - the effects of fumonisins on sphingolipid metab., the pathways altered by perturbation of sphingolipid metab., and the complex cellular behaviors regulated by sphingolipids - must be borne in mind when evaluating the pathol. effects of fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUIifa-AOFYbVg90H21EOLACvtfcHk0liv9bO-v1jZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVOgt70%253D&md5=ca4e749da342361f74b36648fe05e288</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1289%2Fehp.01109s2283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.01109s2283%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DVoss%26aufirst%3DK.%2BA.%26aulast%3DRiley%26aufirst%3DR.%2BT.%26atitle%3DSphingolipid%2520metabolism%253A%2520Roles%2520in%2520signal%2520transduction%2520and%2520disruption%2520by%2520fumonisins%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2001%26volume%3D109%26issue%3DSuppl.%25202%26spage%3D283%26epage%3D289%26doi%3D10.1289%2Fehp.01109s2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Echten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Fumonisin b1 inhibits sphingosine (sphinganine) n-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">27299</span>– <span class="NLM_lpage">27306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2819%2974249-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8262970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXis1enurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=27299-27306&author=A.+H.+Merrillauthor=G.+van+Echtenauthor=E.+Wangauthor=K.+Sandhoff&title=Fumonisin+b1+inhibits+sphingosine+%28sphinganine%29+n-acyltransferase+and+de+novo+sphingolipid+biosynthesis+in+cultured+neurons+in+situ"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ</span></div><div class="casAuthors">Merrill, Alfred H., Jr.; van Echten, Gerhild; Wang, Elaine; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27299-306</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The current study utilized mouse cerebellar neurons in culture to evaluate the distribution of newly synthesized ceramides among different complex sphingolipids.  Fumonisin B1 inhibited ceramide synthase in mouse brain microsomes with a competitive-like kinetic behavior with respect to both sphinganine and stearoyl-CoA.  Fumonisin B1 inhibited sphingolipid biosynthesis in cultured cerebellar neurons in situ as reflected by accumulation of free sphinganine, a redn. in the mass of total sphingolipids, redns. in the incorporation of [14C]serine into glucosylceramide, lactosylceramide, sphingomyelin, and gangliosides (GM1, GD3, GD1a, GD1b, GT1b, and GQ1b), and inhibition of the incorporation of [14C]galactose and [3H]sphinganine into complex sphingolipids.  Dose-response studies revealed that the labeling of sphingomyelin (IC50 of 0.7 μM) was more sensitive to inhibition by fumonisin B1 than was glycolipid formation (IC50 of ∼7 μM) in these cells.  A similar effect was seen when β-fluoroalanine was added to inhibit the activity of serine palmitoyltransferase, the first enzyme of the pathway.  The inhibition of complex sphingolipid synthesis was reversible, and nearly normal labeling profiles were obtained 48 h after removing the mycotoxin.  These studies establish that fumonisin B1 inhibits de novo sphingolipid biosynthesis by neuronal cells and, moreover, that limiting ceramide synthesis differentially affects the formation of sphingomyelin vs. glycosphingolipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouHI-ry4l6y7Vg90H21EOLACvtfcHk0lhaIZsuQxyClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1enurk%253D&md5=69e734d2e3b09551ae3cf78b22f7a606</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2974249-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252974249-5%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3Dvan%2BEchten%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DFumonisin%2520b1%2520inhibits%2520sphingosine%2520%2528sphinganine%2529%2520n-acyltransferase%2520and%2520de%2520novo%2520sphingolipid%2520biosynthesis%2520in%2520cultured%2520neurons%2520in%2520situ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D27299%26epage%3D27306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humpf, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vales, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of n-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, ap1, and a new category of ceramide synthase inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">19060</span>– <span class="NLM_lpage">19064</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.30.19060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.273.30.19060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9668088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=19060-19064&author=H.+U.+Humpfauthor=E.+M.+Schmelzauthor=F.+I.+Meredithauthor=H.+Vesperauthor=T.+R.+Valesauthor=E.+Wangauthor=D.+S.+Menaldinoauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Acylation+of+naturally+occurring+and+synthetic+1-deoxysphinganines+by+ceramide+synthase.+Formation+of+n-palmitoyl-aminopentol+produces+a+toxic+metabolite+of+hydrolyzed+fumonisin%2C+ap1%2C+and+a+new+category+of+ceramide+synthase+inhibitor&doi=10.1074%2Fjbc.273.30.19060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase</span></div><div class="casAuthors">Humpf, Hans-Ulrich; Schmelz, Eva-Maria; Meredith, Filmore I.; Vesper, Hubert; Vales, Teresa R.; Wang, Elaine; Menaldino, David S.; Liotta, Dennis C.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">19060-19064</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fumonisin B1 (FB1) is the predominant member of a family of mycotoxins produced by Fusarium moniliforme (Sheldon) and related fungi.  Certain foods also contain the aminopentol backbone (AP1) that is formed upon base hydrolysis of the ester-linked tricarballylic acids of FB1.  Both FB1 and, to a lesser extent, AP1 inhibit ceramide synthase due to structural similarities between fumonisins (as 1-deoxy-analogs of sphinganine) and sphingoid bases.  To explore these structure-function relationships further, erythro- and threo-2-amino, 3-hydroxy-(and 3,5-dihydroxy-) octadecanes were prepd. by highly stereoselective syntheses.  All of these analogs inhibit the acylation of sphingoid bases by ceramide synthase, and are themselves acylated with Vmax/Km of 40-125 for the erythro-isomers (compared with approx. 250 for D-erythro-sphinganine) and 4-6 for the threo-isomers.  Ceramide synthase also acylates AP1 (but not FB1, under the conditions tested) to N-palmitoyl-AP1 (PAP1) with a Vmax/Km of approx. 1.  The toxicity of the PAP1 was evaluated using HT29 cells, a human colonic cell line.  PAP1 was at least 10 times more toxic than FB1 or AP1 and caused sphinganine accumulation as an inhibitor of ceramide synthase.  These studies demonstrate that: the 1-hydroxyl group is not required for sphingoid bases to be acylated; both erythro- and threo-isomers are acylated with the highest apparent Vmax/Km for the erythro-analogs; and AP1 is acylated to PAP1, a new category of ceramide synthase inhibitor as well as a toxic metabolite that may play a role in the diseases caused by fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kGeiahYbB7Vg90H21EOLACvtfcHk0lhaIZsuQxyClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGrtLw%253D&md5=76349ef60303310823373e34e7fb268c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.30.19060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.30.19060%26sid%3Dliteratum%253Aachs%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DSchmelz%26aufirst%3DE.%2BM.%26aulast%3DMeredith%26aufirst%3DF.%2BI.%26aulast%3DVesper%26aufirst%3DH.%26aulast%3DVales%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DAcylation%2520of%2520naturally%2520occurring%2520and%2520synthetic%25201-deoxysphinganines%2520by%2520ceramide%2520synthase.%2520Formation%2520of%2520n-palmitoyl-aminopentol%2520produces%2520a%2520toxic%2520metabolite%2520of%2520hydrolyzed%2520fumonisin%252C%2520ap1%252C%2520and%2520a%2520new%2520category%2520of%2520ceramide%2520synthase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D19060%26epage%3D19064%26doi%3D10.1074%2Fjbc.273.30.19060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seiferlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpf, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Hydrolyzed fumonisins hfb1 and hfb2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic n-acyl-metabolites</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1120</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1002/mnfr.200700118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fmnfr.200700118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17729221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOnu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1120-1130&author=M.+Seiferleinauthor=H.+U.+Humpfauthor=K.+A.+Vossauthor=M.+C.+Sullardsauthor=J.+C.+Allegoodauthor=E.+Wangauthor=A.+H.+Merrill&title=Hydrolyzed+fumonisins+hfb1+and+hfb2+are+acylated+in+vitro+and+in+vivo+by+ceramide+synthase+to+form+cytotoxic+n-acyl-metabolites&doi=10.1002%2Fmnfr.200700118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites</span></div><div class="casAuthors">Seiferlein, Michaela; Humpf, Hans-Ulrich; Voss, Kenneth A.; Sullards, M. Cameron; Allegood, Jeremy C.; Wang, Elaine; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1120-1130</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Fumonisins B1 and B2 (FB1 and FB2) are the most abundant members of the fumonisins - mycotoxins that are produced by Fusarium verticillioides and are natural inhibitors of ceramide synthase.  Their hydrolyzed forms, HFB1 and HFB2 (also called AP1 and AP2) are found in some foods, and they are not only inhibitors of ceramide synthase but also undergo acylation by this enzyme.  This study characterized the conversion of HFB1 and HFB2 by ceramide synthase to their resp. N-acylated metabolites using rat liver microsomes and palmitoyl-CoA or nervonoyl-CoA as cosubstrates, and examd. animals that had been dosed with hydrolyzed fumonisins to ascertain if acylation occurs in vivo.  Using an HPLC-MS/MS method that allowed the sensitive and selective detection of the acylation products, both HFB1 and HFB2 were found to be metabolized in vitro to nervonoyl- or palmitoyl-HFB1 and -HFB2 (i.e. C24:1-HFB1/2 and C16-HFB1/2, resp.).  The apparent vmax was considerably higher for formation of C24:1HFB1 (157 pmol/min/mg protein) than for formation of C16HFB1 (8.7 pmol/min/mg protein).  The acylation products also inhibited ceramide synthase and significantly reduced the no. of viable cells in an in vitro [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)] assay using a human colonic cell line (HT29).  Furthermore, HPLC-MS/MS anal. of tissues from rats given i.p. doses of HFB1 confirmed that formation of N-acyl-HFB1 occurs in vivo to produce metabolites with fatty acids of various chain lengths.  The contribution of acylated HFB1 and HFB2 metabolites to fumonisin toxicity in vivo warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaapec0eBA5rVg90H21EOLACvtfcHk0lhaIZsuQxyClA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOnu73L&md5=ea6b2934a8e0b9dc9d6f97294a233f5e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.200700118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.200700118%26sid%3Dliteratum%253Aachs%26aulast%3DSeiferlein%26aufirst%3DM.%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DVoss%26aufirst%3DK.%2BA.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DHydrolyzed%2520fumonisins%2520hfb1%2520and%2520hfb2%2520are%2520acylated%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520ceramide%2520synthase%2520to%2520form%2520cytotoxic%2520n-acyl-metabolites%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2007%26volume%3D51%26spage%3D1120%26epage%3D1130%26doi%3D10.1002%2Fmnfr.200700118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of fumonisin b1-induced toxicities and its applications in the mechanism-based interventions</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2019.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.toxicon.2019.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31173793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFOru7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2019&pages=1-5&author=X.+Liuauthor=L.+Fanauthor=S.+Yinauthor=H.+Chenauthor=H.+Hu&title=Molecular+mechanisms+of+fumonisin+b1-induced+toxicities+and+its+applications+in+the+mechanism-based+interventions&doi=10.1016%2Fj.toxicon.2019.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of fumonisin B1-induced toxicities and its applications in the mechanism-based interventions</span></div><div class="casAuthors">Liu, Xiaoyi; Fan, Lihong; Yin, Shutao; Chen, Hui; Hu, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fumonisin B1 (FB1), the most toxic member of fumonisins, is one of the most common mycotoxins contaminating feed and food.  It has been shown to produce pleiotropic toxicities in animals including neurotoxicity, hepatotoxicity and nephrotoxicity, and with highly potential impact on human health.  Proposed mechanisms include disruption of sphingolipid metab., induction of oxidative stress, activation of endoplasmic reticulum (ER) stress and MAPKs, modulation of autophagy and alteration of DNA methylation.  These mechanistic findings provide the theor. basis for effectively managing FB1-induced adverse health effects.  In this review, we will summarize the present understanding of the mol. basis underlying FB1-mediated toxicities, discuss the feasibility of developing mechanism-based approach to prevent FB1-induced toxicities, and suggest the issues that need to be addressed in the future in the field of FB1 toxicity-related studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXzP9N8LZflrVg90H21EOLACvtfcHk0lgkprUsbv_AJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFOru7bE&md5=e197f334b855b06b4102341641cbbaaf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2019.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2019.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DH.%26atitle%3DMolecular%2520mechanisms%2520of%2520fumonisin%2520b1-induced%2520toxicities%2520and%2520its%2520applications%2520in%2520the%2520mechanism-based%2520interventions%26jtitle%3DToxicon%26date%3D2019%26volume%3D167%26spage%3D1%26epage%3D5%26doi%3D10.1016%2Fj.toxicon.2019.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorshkova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skobeleva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzapoiazova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, V.</span></span> <span> </span><span class="NLM_article-title">Fty720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5477</span>, <span class="refDoi"> DOI: 10.1074/jbc.M805186200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M805186200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19119142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFSntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=5467-5477&author=E.+V.+Berdyshevauthor=I.+Gorshkovaauthor=A.+Skobelevaauthor=R.+Bittmanauthor=X.+Luauthor=S.+M.+Dudekauthor=T.+Mirzapoiazovaauthor=J.+G.+Garciaauthor=V.+Natarajan&title=Fty720+inhibits+ceramide+synthases+and+up-regulates+dihydrosphingosine+1-phosphate+formation+in+human+lung+endothelial+cells&doi=10.1074%2Fjbc.M805186200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells</span></div><div class="casAuthors">Berdyshev, Evgeny V.; Gorshkova, Irina; Skobeleva, Anastasia; Bittman, Robert; Lu, Xuequan; Dudek, Steven M.; Mirzapoiazova, Tamara; Garcia, Joe G. N.; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5467-5477</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Novel immunomodulatory mol. FTY720 is a synthetic analog of myriocin, but unlike myriocin FTY720 does not inhibit serine palmitoyltransferase.  Although many of the effects of FTY720 are ascribed to its phosphorylation and subsequent sphingosine 1-phosphate (S1P)-like action through S1P1,3-5 receptors, studies on modulation of intracellular balance of signaling sphingolipids by FTY720 are limited.  In this study, we used stable isotope pulse labeling of human pulmonary artery endothelial cells with L-[U-13C, 15N]serine as well as in vitro enzymic assays and liq. chromatog.-tandem mass spectrometry methodol. to characterize FTY720 interference with sphingolipid de novo biosynthesis.  In human pulmonary artery endothelial cells, FTY720 inhibited ceramide synthases, resulting in decreased cellular levels of dihydroceramides, ceramides, sphingosine, and S1P but increased levels of dihydrosphingosine and dihydrosphingosine 1-phosphate (DHS1P).  The FTY720-induced modulation of sphingolipid de novo biosynthesis was similar to that of fumonisin B1, a classical inhibitor of ceramide synthases, but differed in the efficiency to inhibit biosynthesis of short-chain vs. long-chain ceramides.  In vitro kinetic studies revealed that FTY720 is a competitive inhibitor of ceramide synthase 2 toward dihydrosphingosine with an apparent Ki of 2.15 μM.  FTY720-induced up-regulation of DHS1P level was mediated by sphingosine kinase (SphK) 1, but not SphK2, as confirmed by expts. using SphK1/2 silencing with small interfering RNA.  Our data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids.  These findings open a novel direction for therapeutic applications of FTY720 that focuses on inhibition of ceramide biosynthesis, ceramide-dependent signaling, and the up-regulation of DHS1P generation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbph9U9yevJ7Vg90H21EOLACvtfcHk0lgkprUsbv_AJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFSntb0%253D&md5=49f070c74097290e88bf6691d731f921</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M805186200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M805186200%26sid%3Dliteratum%253Aachs%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DGorshkova%26aufirst%3DI.%26aulast%3DSkobeleva%26aufirst%3DA.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDudek%26aufirst%3DS.%2BM.%26aulast%3DMirzapoiazova%26aufirst%3DT.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DFty720%2520inhibits%2520ceramide%2520synthases%2520and%2520up-regulates%2520dihydrosphingosine%25201-phosphate%2520formation%2520in%2520human%2520lung%2520endothelial%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D5467%26epage%3D5477%26doi%3D10.1074%2Fjbc.M805186200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laviad, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthesis is modulated by the sphingosine analog fty720 via a mixture of uncompetitive and noncompetitive inhibition in an acyl-coa chain length-dependent manner</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">16090</span>– <span class="NLM_lpage">16098</span>, <span class="refDoi"> DOI: 10.1074/jbc.M807438200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M807438200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19357080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16090-16098&author=S.+Lahiriauthor=H.+Parkauthor=E.+L.+Laviadauthor=X.+Luauthor=R.+Bittmanauthor=A.+H.+Futerman&title=Ceramide+synthesis+is+modulated+by+the+sphingosine+analog+fty720+via+a+mixture+of+uncompetitive+and+noncompetitive+inhibition+in+an+acyl-coa+chain+length-dependent+manner&doi=10.1074%2Fjbc.M807438200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-dependent Manner</span></div><div class="casAuthors">Lahiri, Sujoy; Park, Hyejung; Laviad, Elad L.; Lu, Xuequan; Bittman, Robert; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16090-16098</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">FTY720, a sphingosine analog, is in clin. trials as an immunomodulator.  The biol. effects of FTY720 are believed to occur after its metab. to FTY720 phosphate.  However, very little is known about whether FTY720 can interact with and modulate the activity of other enzymes of sphingolipid metab.  We examd. the ability of FTY720 to modulate de novo ceramide synthesis.  In mammals, ceramide is synthesized by a family of six ceramide synthases, each of which utilizes a restricted subset of acyl-CoAs.  We show that FTY720 inhibits ceramide synthase activity in vitro by noncompetitive inhibition toward acyl-CoA and uncompetitive inhibition toward sphinganine; surprisingly, the efficacy of inhibition depends on the acyl-CoA chain length.  In cultured cells, FTY720 has a more complex effect, with ceramide synthesis inhibited at high (500 nM to 5 μM) but not low (<200 nM) sphinganine concns., consistent with FTY720 acting as an uncompetitive inhibitor toward sphinganine.  Finally, electrospray ionization-tandem mass spectrometry demonstrated, unexpectedly, elevated levels of ceramide, sphingomyelin, and hexosylceramides after incubation with FTY720.  Our data suggest a novel mechanism by which FTY720 might mediate some of its biol. effects, which may be of mechanistic significance for understanding its mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmh_8JR-P59bVg90H21EOLACvtfcHk0lgkprUsbv_AJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjsLc%253D&md5=d99d9cd44e82a228b028f501d15aa1c0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M807438200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M807438200%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLaviad%26aufirst%3DE.%2BL.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthesis%2520is%2520modulated%2520by%2520the%2520sphingosine%2520analog%2520fty720%2520via%2520a%2520mixture%2520of%2520uncompetitive%2520and%2520noncompetitive%2520inhibition%2520in%2520an%2520acyl-coa%2520chain%2520length-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16090%26epage%3D16098%26doi%3D10.1074%2Fjbc.M807438200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span> <span> </span><span class="NLM_article-title">A fluorescent assay for ceramide synthase activity</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1194/jlr.D025627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.D025627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22661289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1701-1707&author=H.+J.+Kimauthor=Q.+Qiaoauthor=H.+D.+Toopauthor=J.+C.+Morrisauthor=A.+S.+Don&title=A+fluorescent+assay+for+ceramide+synthase+activity&doi=10.1194%2Fjlr.D025627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescent assay for ceramide synthase activity</span></div><div class="casAuthors">Kim, Hyun Joon; Qiao, Qiao; Toop, Hamish D.; Morris, Jonathan C.; Don, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1701-1707</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">The sphingolipids are a diverse family of lipids with important roles in membrane compartmentalization, intracellular signaling, and cell-cell recognition.  The central sphingolipid metabolite is ceramide, formed by the transfer of a variable length fatty acid from CoA to a sphingoid base, generally sphingosine or dihydrosphingosine (sphinganine) in mammals.  This reaction is catalyzed by a family of 6 ceramide synthases (CerS1-6).  CerS activity is usually assayed using either radioactive substrates or LC-MS/MS.  Here, the authors describe a CerS assay with fluorescent, NBD-labeled sphinganine as substrate.  The assay is readily able to detect endogenous CerS activity when using amts. of cell or tissue homogenate protein that are lower than those reported for the radioactive assay, and the Km was essentially the same for NBD-sphinganine and unlabeled sphinganine, indicating that NBD-sphinganine is a good substrate for these enzymes.  Using this assay, the authors confirmed that the new clin. immunosuppressant, FTY 720, was a competitive inhibitor of CerS activity, and showed that inhibition required the compd.'s lipid tail and amine headgroup.  In summary, the authors describe a fluorescent assay for CerS activity that circumvents the need to use radioactive substrates, while being more accessible and inexpensive than LC-MS based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_c-FbSPLksbVg90H21EOLACvtfcHk0lgY-p7eU3q6xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSqtLnF&md5=9817ad606b3839b0d039982e4d418e1c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1194%2Fjlr.D025627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.D025627%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDon%26aufirst%3DA.%2BS.%26atitle%3DA%2520fluorescent%2520assay%2520for%2520ceramide%2520synthase%2520activity%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D1701%26epage%3D1707%26doi%3D10.1194%2Fjlr.D025627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieschl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">The immune modulator fty720 targets sphingosine 1-phosphate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">21453</span>– <span class="NLM_lpage">21457</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+fty720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lgY-p7eU3q6xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520fty720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of analogs of aal(s) for use as ceramide synthase 1 inhibitors</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">11593</span>– <span class="NLM_lpage">11596</span>, <span class="refDoi"> DOI: 10.1039/C5OB01931A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2FC5OB01931A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26535908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCms73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=11593-11596&author=H.+D.+Toopauthor=A.+S.+Donauthor=J.+C.+Morris&title=Synthesis+and+biological+evaluation+of+analogs+of+aal%28s%29+for+use+as+ceramide+synthase+1+inhibitors&doi=10.1039%2FC5OB01931A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of analogs of AAL(S) for use as ceramide synthase 1 inhibitors</span></div><div class="casAuthors">Toop, Hamish D.; Don, Anthony S.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">11593-11596</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A convergent synthesis to access hydrophobic tail analogs and head group modifications of AAL(S) I is described.  The analogs synthesized were evaluated for their ability to inhibit ceramide synthase 1 and for their cytotoxicity in K562 cells.  Our results have identified inhibitors which are non-cytotoxic yet maintain CerS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBaCpRopafurVg90H21EOLACvtfcHk0lgY-p7eU3q6xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCms73O&md5=b202a76af3e1c25480596d1457238aad</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC5OB01931A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01931A%26sid%3Dliteratum%253Aachs%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520analogs%2520of%2520aal%2528s%2529%2520for%2520use%2520as%2520ceramide%2520synthase%25201%2520inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D11593%26epage%3D11596%26doi%3D10.1039%2FC5OB01931A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiffmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birod, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiros, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivkovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of specific ceramide synthases</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2011.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.biochi.2011.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21945810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFGjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=558-565&author=S.+Schiffmannauthor=D.+Hartmannauthor=S.+Fuchsauthor=K.+Birodauthor=N.+Ferreirosauthor=Y.+Schreiberauthor=A.+Zivkovicauthor=G.+Geisslingerauthor=S.+Groschauthor=H.+Stark&title=Inhibitors+of+specific+ceramide+synthases&doi=10.1016%2Fj.biochi.2011.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of specific ceramide synthases</span></div><div class="casAuthors">Schiffmann, Susanne; Hartmann, Daniela; Fuchs, Sina; Birod, Kerstin; Ferreiros, Nerea; Schreiber, Yannick; Zivkovic, Aleksandra; Geisslinger, Gerd; Groesch, Sabine; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-565</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Ceramide synthases (CerSs) are key enzymes in the biosynthesis of ceramides and display a group of at least six different isoenzymes (CerS1-6).  Ceramides itself are bioactive mols.  Ceramides with different N-acyl side chains (C14:0-Cer - C26:0-Cer) possess distinct roles in cell signaling.  Therefore, the selective inhibition of specific CerSs which are responsible for the formation of a specific ceramide holds promise for a no. of new clin. treatment strategies, e.g., cancer.  Here, we identified four of hitherto unknown functional inhibitors of CerSs derived from the FTY720 (Fingolimod) lead structure and showed their inhibitory effectiveness by two in vitro CerS activity assays.  Addnl., we tested the substances in two cell lines (HCT-116 and HeLa) with different ceramide patterns.  In summary, the in vitro activity assays revealed out that ST1058 and ST1074 preferentially inhibit CerS2 and CerS4, while ST1072 inhibits most potently CerS4 and CerS6.  Importantly, ST1060 inhibits predominately CerS2.  First structure-activity relationships and the potential biol. impact of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIGghUZw85hLVg90H21EOLACvtfcHk0lg2M0__QEcEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFGjtA%253D%253D&md5=af3943b0158723198aee511587440c2e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2011.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2011.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffmann%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DBirod%26aufirst%3DK.%26aulast%3DFerreiros%26aufirst%3DN.%26aulast%3DSchreiber%26aufirst%3DY.%26aulast%3DZivkovic%26aufirst%3DA.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DGrosch%26aufirst%3DS.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520specific%2520ceramide%2520synthases%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D558%26epage%3D565%26doi%3D10.1016%2Fj.biochi.2011.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiveash, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindaraju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwen, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couttas, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoehn, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz-Peiffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3165</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05613-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs41467-018-05613-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30131496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BB3c3gsVOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3165&author=N.+Turnerauthor=X.+Y.+Limauthor=H.+D.+Toopauthor=B.+Osborneauthor=A.+E.+Brandonauthor=E.+N.+Taylorauthor=C.+E.+Fiveashauthor=H.+Govindarajuauthor=J.+D.+Teoauthor=H.+P.+McEwenauthor=T.+A.+Couttasauthor=S.+M.+Butlerauthor=A.+Dasauthor=G.+M.+Kowalskiauthor=C.+R.+Bruceauthor=K.+L.+Hoehnauthor=T.+Fathauthor=C.+Schmitz-Peifferauthor=G.+J.+Cooneyauthor=M.+K.+Montgomeryauthor=J.+C.+Morrisauthor=A.+S.+Don&title=A+selective+inhibitor+of+ceramide+synthase+1+reveals+a+novel+role+in+fat+metabolism&doi=10.1038%2Fs41467-018-05613-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism</span></div><div class="casAuthors">Turner Nigel; Osborne Brenna; Fiveash Corrine E; Govindaraju Hemna; Das Abhirup; Fath Thomas; Montgomery Magdalene K; Lim Xin Ying; Lim Xin Ying; Teo Jonathan D; McEwen Holly P; Couttas Timothy A; Don Anthony S; Toop Hamish D; Taylor Elysha N; Butler Stephen M; Morris Jonathan C; Brandon Amanda E; Cooney Gregory J; Kowalski Greg M; Bruce Clinton R; Hoehn Kyle L; Fath Thomas; Schmitz-Peiffer Carsten; Don Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology.  Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue.  C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans.  We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency.  Lipidomic profiling shows that P053 is highly selective for CerS1.  Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance.  Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR03VZRArx4bCCEBeYuoi7AfW6udTcc2eYynPB4g9sj3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3gsVOitQ%253D%253D&md5=63ddf6f40e9a100f077917167d27517f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05613-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05613-7%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DX.%2BY.%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DBrandon%26aufirst%3DA.%2BE.%26aulast%3DTaylor%26aufirst%3DE.%2BN.%26aulast%3DFiveash%26aufirst%3DC.%2BE.%26aulast%3DGovindaraju%26aufirst%3DH.%26aulast%3DTeo%26aufirst%3DJ.%2BD.%26aulast%3DMcEwen%26aufirst%3DH.%2BP.%26aulast%3DCouttas%26aufirst%3DT.%2BA.%26aulast%3DButler%26aufirst%3DS.%2BM.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DKowalski%26aufirst%3DG.%2BM.%26aulast%3DBruce%26aufirst%3DC.%2BR.%26aulast%3DHoehn%26aufirst%3DK.%2BL.%26aulast%3DFath%26aufirst%3DT.%26aulast%3DSchmitz-Peiffer%26aufirst%3DC.%26aulast%3DCooney%26aufirst%3DG.%2BJ.%26aulast%3DMontgomery%26aufirst%3DM.%2BK.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDon%26aufirst%3DA.%2BS.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520ceramide%2520synthase%25201%2520reveals%2520a%2520novel%2520role%2520in%2520fat%2520metabolism%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3165%26doi%3D10.1038%2Fs41467-018-05613-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanani, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, B.</span></span> <span> </span><span class="NLM_article-title">The many faces (and phases) of ceramide and sphingomyelin i - single lipids</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1007/s12551-017-0297-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12551-017-0297-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28815463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGktLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=589-600&author=M.+L.+Fananiauthor=B.+Maggio&title=The+many+faces+%28and+phases%29+of+ceramide+and+sphingomyelin+i+-+single+lipids&doi=10.1007%2Fs12551-017-0297-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces (and phases) of ceramide and sphingomyelin I - single lipids</span></div><div class="casAuthors">Fanani, Maria Laura; Maggio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">589-600</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ceramides, the simplest kind of two-chained sphingolipids, contain a single hydroxyl group in position 1 of the sphingoid base.  Sphingomyelins further contain a phosphocholine group at the OH of position 1 of ceramide.  Ceramides and sphingomyelins show a variety of species depending on the fatty acyl chain length, hydroxylation, and unsatn.  Because of the relatively high transition temp. of sphingomyelin compared to lecithin and, particularly, of ceramides with 16:0-18:0 satd. chains, a widespread idea on their functional importance refers to formation of rather solid domains enriched in sphingomyelin and ceramide.  Frequently, and esp. in the cell biol. field, these are generally (and erroneously) assumed to occur irresp. on the type of N-acyl chain in these lipids.  This is because most studies indicating such condensed ordered domains employed sphingolipids with acyl chains with 16 carbons while scarce attention has been focused on the influence of the N-acyl chain on their surface properties.  However, abundant evidence has shown that variations of the N-acyl chain length in ceramides and sphingomyelins markedly affect their phase state, interfacial elasticity, surface topog., electrostatics and miscibility and that, even the usually conceived "condensed" sphingolipids and many of their mixts., may exhibit liq.-like expanded states.  This review is a summarized overview of our work and of related others on some facts regarding membranes composed of single mol. species of ceramide and sphingomyelin.  A second part is dedicated to discuss the miscibility properties between species of sphingolipids that differ in N-acyl and oligosaccharide chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6x7s45I54GrVg90H21EOLACvtfcHk0lg2M0__QEcEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGktLfN&md5=84be6833a8b26a97c1d44f38b532e185</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs12551-017-0297-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-017-0297-z%26sid%3Dliteratum%253Aachs%26aulast%3DFanani%26aufirst%3DM.%2BL.%26aulast%3DMaggio%26aufirst%3DB.%26atitle%3DThe%2520many%2520faces%2520%2528and%2520phases%2529%2520of%2520ceramide%2520and%2520sphingomyelin%2520i%2520-%2520single%2520lipids%26jtitle%3DBiophys.%2520Rev.%26date%3D2017%26volume%3D9%26spage%3D589%26epage%3D600%26doi%3D10.1007%2Fs12551-017-0297-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanani, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, B.</span></span> <span> </span><span class="NLM_article-title">The many faces (and phases) of ceramide and sphingomyelin ii - binary mixtures</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1007/s12551-017-0298-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12551-017-0298-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28823080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKnu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=601-616&author=M.+L.+Fananiauthor=B.+Maggio&title=The+many+faces+%28and+phases%29+of+ceramide+and+sphingomyelin+ii+-+binary+mixtures&doi=10.1007%2Fs12551-017-0298-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces (and phases) of ceramide and sphingomyelin II - binary mixtures</span></div><div class="casAuthors">Fanani, Maria Laura; Maggio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-616</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A rather widespread idea on the functional importance of sphingolipids in cell membranes refers to the occurrence of ordered domains enriched in sphingomyelin and ceramide that are largely assumed to exist irresp. of the type of N-acyl chain in the sphingolipid.  Ceramides and sphingomyelins are the simplest kind of two-chained sphingolipids and show a variety of species, depending on the fatty acyl chain length, hydroxylation, and unsatn.  Abundant evidences have shown that variations of the N-acyl chain length in ceramides and sphingomyelins markedly affect their phase state, interfacial elasticity, surface topog., electrostatics, and miscibility, and that even the usually conceived "condensed" sphingolipids and many of their mixts. may exhibit liq.-like expanded states.  Their lateral miscibility properties are subtlety regulated by those chem. differences.  Even between ceramides with different acyl chain length, their partial miscibility is responsible for a rich two-dimensional structural variety that impacts on the membrane properties at the mesoscale level.  In this review, we will discuss the miscibility properties of ceramide, sphingomyelin, and glycosphingolipids that differ in their N-acyl or oligosaccharide chains.  This work is a second part that accompanies a previous overview of the properties of membranes formed by pure ceramides or sphingomyelins, which is also included in this Special Issue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAAaFL6j0n7Vg90H21EOLACvtfcHk0liwipS8zRumKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKnu73K&md5=adf7ac565f4ed4e7c490e9d3e19a9bc2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs12551-017-0298-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-017-0298-y%26sid%3Dliteratum%253Aachs%26aulast%3DFanani%26aufirst%3DM.%2BL.%26aulast%3DMaggio%26aufirst%3DB.%26atitle%3DThe%2520many%2520faces%2520%2528and%2520phases%2529%2520of%2520ceramide%2520and%2520sphingomyelin%2520ii%2520-%2520binary%2520mixtures%26jtitle%3DBiophys.%2520Rev.%26date%3D2017%26volume%3D9%26spage%3D601%26epage%3D616%26doi%3D10.1007%2Fs12551-017-0298-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Meer, G.</span></span> <span> </span><span class="NLM_article-title">Lipid traffic in animal cells</span>. <i>Annu. Rev. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1146/annurev.cb.05.110189.001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1146%2Fannurev.cb.05.110189.001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2688705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3cXjtlOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1989&pages=247-275&author=G.+van%0AMeer&title=Lipid+traffic+in+animal+cells&doi=10.1146%2Fannurev.cb.05.110189.001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid traffic in animal cells</span></div><div class="casAuthors">Van Meer, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell Biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-75</span>CODEN:
                <span class="NLM_cas:coden">ARCBE2</span>;
        ISSN:<span class="NLM_cas:issn">0743-4634</span>.
    </div><div class="casAbstract">A review, with ∼130 refs., of lipid traffic in animal cells, sites of lipid sorting events for generating the distribution in different organelles, and mechanisms of lipid sorting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeLUW76FBt4rVg90H21EOLACvtfcHk0liwipS8zRumKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtlOhuw%253D%253D&md5=da040ac35b58f53164f9ce140b4c5f6b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cb.05.110189.001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cb.05.110189.001335%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeer%26aufirst%3DG.%26atitle%3DLipid%2520traffic%2520in%2520animal%2520cells%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Biol.%26date%3D1989%26volume%3D5%26spage%3D247%26epage%3D275%26doi%3D10.1146%2Fannurev.cb.05.110189.001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goni, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, A.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelinases: Enzymology and membrane activity</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(02)03482-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0014-5793%2802%2903482-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12401200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVOjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2002&pages=38-46&author=F.+M.+Goniauthor=A.+Alonso&title=Sphingomyelinases%3A+Enzymology+and+membrane+activity&doi=10.1016%2FS0014-5793%2802%2903482-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelinases: enzymology and membrane activity</span></div><div class="casAuthors">Goni, Felix M.; Alonso, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 112 refs., of sphingomyelinase properties, catalytic mechanism, and membrane interactions.  Six types of sphingomyelinases are considered, namely acidic, secretory, Mg2+-dependent neutral, Mg2+-independent neutral, alk., and bacterial enzymes with both phospholipase C and sphingomyelinase activity.  Sphingomyelinase assay methods and specific inhibitors are also reviewed.  Kinetic and mechanistic studies are summarized, and a kinetic model and a general-base catalytic mechanism are proposed.  Sphingomyelinase-membrane interactions are considered from the point of view of the influence of lipids on enzyme activity.  Moreover, the effects of sphingomyelinase activity on membrane architecture (increased membrane permeability, membrane aggregation, and fusion) are described.  Finally, a no. of open questions on the above topics are enunciated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB1kb-CrYn6rVg90H21EOLACvtfcHk0liwipS8zRumKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVOjtLo%253D&md5=0486ffeff663dd86a0001893a1454608</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2802%2903482-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252802%252903482-8%26sid%3Dliteratum%253Aachs%26aulast%3DGoni%26aufirst%3DF.%2BM.%26aulast%3DAlonso%26aufirst%3DA.%26atitle%3DSphingomyelinases%253A%2520Enzymology%2520and%2520membrane%2520activity%26jtitle%3DFEBS%2520Lett.%26date%3D2002%26volume%3D531%26spage%3D38%26epage%3D46%26doi%3D10.1016%2FS0014-5793%2802%2903482-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desnick, R. J.</span></span> <span> </span><span class="NLM_article-title">Types a and b niemann-pick disease</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ymgme.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28164782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1ersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2017&pages=27-33&author=E.+H.+Schuchmanauthor=R.+J.+Desnick&title=Types+a+and+b+niemann-pick+disease&doi=10.1016%2Fj.ymgme.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Types A and B Niemann-Pick disease</span></div><div class="casAuthors">Schuchman, Edward H.; Desnick, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-33</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The eponym Niemann-Pick disease (NPD) refers to a group of patients who present with varying degrees of lipid storage and foam cell infiltration in tissues, as well as overlapping clin. features including hepatosplenomegaly, pulmonary insufficiency and/or central nervous system (CNS) involvement.  Due to the pioneering work of Roscoe Brady and co-workers, we now know that there are two distinct metabolic abnormalities that account for NPD.  The first is due to the deficient activity of the enzyme acid sphingomyelinase (ASM; "types A & B" NPD), and the second is due to defective function in cholesterol transport ("type C" NPD).  Herein only types A and B NPD will be discussed.  Type A NPD patients exhibit hepatosplenomegaly in infancy and profound CNS involvement.  They rarely survive beyond 2-3 years of age.  Type B patients also have hepatosplenomegaly and pathol. alterations of their lungs, but there are usually no CNS signs.  The age of onset and rate of disease progression varies greatly among type B patients, and they frequently live into adulthood.  Intermediate patients also have been reported with mild to moderate neurol. findings.  All patients with types A and B NPD have mutations in the gene encoding ASM (SMPD1), and thus the disease is more accurately referred to as ASM deficiency (ASMD).  Herein we will review the clin., pathol., biochem., and genetic findings in types A and B NPD, and emphasize the seminal contributions of Dr. Brady to this disease.  We will also discuss the current status of therapy for this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUy0fwGlQM7Vg90H21EOLACvtfcHk0liwipS8zRumKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1ersbY%253D&md5=444d00f998e4c82d08a243514a41ac56</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26aulast%3DDesnick%26aufirst%3DR.%2BJ.%26atitle%3DTypes%2520a%2520and%2520b%2520niemann-pick%2520disease%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2017%26volume%3D120%26spage%3D27%26epage%3D33%26doi%3D10.1016%2Fj.ymgme.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of mammalian acid sphingomyelinase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12196</span>, <span class="refDoi"> DOI: 10.1038/ncomms12196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fncomms12196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27435900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12196&author=A.+Gorelikauthor=K.+Illesauthor=L.+X.+Heinzauthor=G.+Superti-Furgaauthor=B.+Nagar&title=Crystal+structure+of+mammalian+acid+sphingomyelinase&doi=10.1038%2Fncomms12196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of mammalian acid sphingomyelinase</span></div><div class="casAuthors">Gorelik, Alexei; Illes, Katalin; Heinz, Leonhard X.; Superti-Furga, Giulio; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12196</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASMase, ASM, SMPD1) converts sphingomyelin into ceramide, modulating membrane properties and signal transduction.  Inactivating mutations in ASMase cause Niemann-Pick disease, and its inhibition is also beneficial in models of depression and cancer.  To gain a better understanding of this crit. therapeutic target, we detd. crystal structures of mammalian ASMase in various conformations.  The catalytic domain adopts a calcineurin-like fold with two zinc ions and a hydrophobic track leading to the active site.  Strikingly, the membrane interacting saposin domain assumes either a closed globular conformation independent from the catalytic domain, or an open conformation, which establishes an interface with the catalytic domain essential for activity.  Structural mapping of Niemann-Pick mutations reveals that most of them likely destabilize the protein's fold.  This study sheds light on the mol. mechanism of ASMase function, and provides a platform for the rational development of ASMase inhibitors and therapeutic use of recombinant ASMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGridMh3_0b9ArVg90H21EOLACvtfcHk0lgJfYMbqNTGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVelt70%253D&md5=5f2284adc9619117853e2b0c2a06c635</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fncomms12196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12196%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DHeinz%26aufirst%3DL.%2BX.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520mammalian%2520acid%2520sphingomyelinase%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12196%26doi%3D10.1038%2Fncomms12196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prive, G. G.</span></span> <span> </span><span class="NLM_article-title">Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">3026</span>– <span class="NLM_lpage">3042</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2016.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.jmb.2016.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27349982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyntLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2016&pages=3026-3042&author=Z.+J.+Xiongauthor=J.+Huangauthor=G.+Podaauthor=R.+Pomesauthor=G.+G.+Prive&title=Structure+of+human+acid+sphingomyelinase+reveals+the+role+of+the+saposin+domain+in+activating+substrate+hydrolysis&doi=10.1016%2Fj.jmb.2016.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis</span></div><div class="casAuthors">Xiong, Zi-Jian; Huang, Jingjing; Poda, Gennady; Pomes, Regis; Prive, Gilbert G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3026-3042</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (I) is a lysosomal phosphodiesterase that catalyzes the hydrolysis of sphingomyelin to produce ceramide and phosphocholine.  While other lysosomal sphingolipid hydrolases require a saposin activator protein for full activity, the I polypeptide incorporates a built-in N-terminal saposin domain and does not require an external activator protein.  Here, the authors report the crystal structure of human I and describe the organization of the 3 main regions of the enzyme: the N-terminal saposin domain, the proline-rich connector, and the catalytic domain.  The saposin domain was tightly assocd. along an edge of the large, bowl-shaped catalytic domain and adopted an open form that exposed a hydrophobic concave surface ∼30 Å from the catalytic center.  The calcd. electrostatic potential of the enzyme was electropos. at the acidic pH of the lysosome, consistent with the strict requirement for the presence of acidic lipids in target membranes.  Mol. docking studies indicated that sphingomyelin binds with the ceramide-phosphate group positioned at the binuclear Zn center and mol. dynamics simulations indicated that the intrinsic flexibility of the saposin domain was important for monomer-dimer exchange and for membrane interactions.  Overall, I uses a combination of electrostatic and hydrophobic interactions to cause local disruptions of target bilayers in order to bring the lipid headgroup to the catalytic center in a membrane-bound reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoll53c_B4LEbVg90H21EOLACvtfcHk0lgJfYMbqNTGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyntLbF&md5=852a00d567e604849f7ca517f261ea97</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2016.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2016.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DPoda%26aufirst%3DG.%26aulast%3DPomes%26aufirst%3DR.%26aulast%3DPrive%26aufirst%3DG.%2BG.%26atitle%3DStructure%2520of%2520human%2520acid%2520sphingomyelinase%2520reveals%2520the%2520role%2520of%2520the%2520saposin%2520domain%2520in%2520activating%2520substrate%2520hydrolysis%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D428%26spage%3D3026%26epage%3D3042%26doi%3D10.1016%2Fj.jmb.2016.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R. R.</span></span> <span> </span><span class="NLM_article-title">Human acid sphingomyelinase structures provide insight to molecular basis of niemann-pick disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13082</span>, <span class="refDoi"> DOI: 10.1038/ncomms13082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fncomms13082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27725636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GnurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13082&author=Y.+F.+Zhouauthor=M.+C.+Metcalfauthor=S.+C.+Garmanauthor=T.+Edmundsauthor=H.+Qiuauthor=R.+R.+Wei&title=Human+acid+sphingomyelinase+structures+provide+insight+to+molecular+basis+of+niemann-pick+disease&doi=10.1038%2Fncomms13082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease</span></div><div class="casAuthors">Zhou, Yan-Feng; Metcalf, Matthew C.; Garman, Scott C.; Edmunds, Tim; Qiu, Huawei; Wei, Ronnie R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13082</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and phosphocholine, essential components of myelin in neurons.  Genetic alterations in ASM lead to ASM deficiency (ASMD) and have been linked to Niemann-Pick disease types A and B.  Olipudase alfa, a recombinant form of human ASM, is being developed as enzyme replacement therapy to treat the non-neurol. manifestations of ASMD.  Here we present the human ASM holoenzyme and product bound structures encompassing all of the functional domains.  The catalytic domain has a metallophosphatase fold, and two zinc ions and one reaction product phosphocholine are identified in a histidine-rich active site.  The structures reveal the underlying catalytic mechanism, in which two zinc ions activate a water mol. for nucleophilic attack of the phosphodiester bond.  Docking of sphingomyelin provides a model that allows insight into the selectivity of the enzyme and how the ASM domains collaborate to complete hydrolysis.  Mapping of known mutations provides a basic understanding on correlations between enzyme dysfunction and phenotypes obsd. in ASMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0JJXSvWY4rVg90H21EOLACvtfcHk0lgJfYMbqNTGkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GnurjP&md5=4128c3df4585ba86a2eee9adf2a602d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fncomms13082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13082%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BF.%26aulast%3DMetcalf%26aufirst%3DM.%2BC.%26aulast%3DGarman%26aufirst%3DS.%2BC.%26aulast%3DEdmunds%26aufirst%3DT.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DR.%2BR.%26atitle%3DHuman%2520acid%2520sphingomyelinase%2520structures%2520provide%2520insight%2520to%2520molecular%2520basis%2520of%2520niemann-pick%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13082%26doi%3D10.1038%2Fncomms13082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span> <span> </span><span class="NLM_article-title">Changes in brain hydrolytic enzyme activities in rats treated with cholesterol biosynthesis inhibitor, ay9944</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(75)90685-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0006-8993%2875%2990685-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=48406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE2MXlt1KqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1975&pages=97-114&author=M.+Igarashiauthor=K.+Suzukiauthor=S.+M.+Chenauthor=K.+Suzuki&title=Changes+in+brain+hydrolytic+enzyme+activities+in+rats+treated+with+cholesterol+biosynthesis+inhibitor%2C+ay9944&doi=10.1016%2F0006-8993%2875%2990685-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in brain hydrolytic enzyme activities in rats treated with the cholesterol biosynthesis inhibitor, AY9944</span></div><div class="casAuthors">Igarashi, Masahiro; Suzuki, Kinuko; Chen, Shih M.; Suzuki, Kunihiko</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-114</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">In 5-day-old rats, AY9944 (I) [366-93-8] (30 mg/kg, for 30 days, i.p.) increased the activities of 13 brain hydrolytic enzymes reaching a peak in 15-25 day-old rats and corresponding to the max. appearance of neuronal inclusions and degenerating oligodendroglia.  Despite the continued administration of I and a high tissue concn. of 7-dehydrocholesterol [434-16-2] most enzyme activities declined after 25 days to steady levels somewhat higher than the controls.  In 5-, 15-, 25-, and 35-day-old rats which received injections for 10 days, enzyme activities reached a peak at the end of the injections and then rapidly returned to normal within 10 days thereafter, corresponding to the appearance and disappearance of the abnormal inclusions.  However 7-dehydrocholesterol continued to increase for 10 days after drug administration was discontinued.  I had no direct effect on any of the enzymes in vitro.  Apparently, lysosomal activation occurred concomitantly with the formation of I-induced abnormal neuronal inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU-gx72Lj7_7Vg90H21EOLACvtfcHk0ljM2bNlxao8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlt1KqsLw%253D&md5=4fb403e7a542e9df2ea87a7f7fc4b5b2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2875%2990685-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252875%252990685-X%26sid%3Dliteratum%253Aachs%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%2BM.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DChanges%2520in%2520brain%2520hydrolytic%2520enzyme%2520activities%2520in%2520rats%2520treated%2520with%2520cholesterol%2520biosynthesis%2520inhibitor%252C%2520ay9944%26jtitle%3DBrain%2520Res.%26date%3D1975%26volume%3D90%26spage%3D97%26epage%3D114%26doi%3D10.1016%2F0006-8993%2875%2990685-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, M.</span></span> <span> </span><span class="NLM_article-title">Niemann-pick disease-like inclusions caused by a hypocholesteremic agent</span>. <i>Invest. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=62729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADyaE2s%252FltVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1976&pages=1022-1027&author=M.+Sakuragawa&title=Niemann-pick+disease-like+inclusions+caused+by+a+hypocholesteremic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Niemann-Pick disease-like inclusions caused by a hypocholesteremic agent</span></div><div class="casAuthors">Sakuragawa M</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1022-7</span>
        ISSN:<span class="NLM_cas:issn">0020-9988</span>.
    </div><div class="casAbstract">AY9944, an inhibitor of cholesterol biosynthesis, was injected into albino rats and the ocular tissue was studied by light and electron microscopy.  Abundant lamellar inclusion bodies accumulated in various cells of the eye, especially in the ganglion cells of the retina and glial cells of the optic nerve.  Prolonged administration of this drug resulted in degeneration of retinal ganglion cells and oligodendroglial cells of the optic nerve.  Micro-organelles of the inclusion body-laden cells were otherwise normal in their appearance.  The electron microscopic appearance of these inclusion bodies and their distribution in the ocular tissues closely resembled those of Niemann-Pick diseasees.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_s-GqsofmyDAyhZbj3lKdfW6udTcc2ebX3nq3sC7biLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2s%252FltVygtA%253D%253D&md5=9fd6d4719692781a78d401bde0456b80</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakuragawa%26aufirst%3DM.%26atitle%3DNiemann-pick%2520disease-like%2520inclusions%2520caused%2520by%2520a%2520hypocholesteremic%2520agent%26jtitle%3DInvest.%2520Ophthalmol.%26date%3D1976%26volume%3D15%26spage%3D1022%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentchev, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barranger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. O.</span></span> <span> </span><span class="NLM_article-title">Niemann-pick disease experimental model: Sphingomyelinase reduction induced by ay-9944</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1126/science.66749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1126%2Fscience.66749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=66749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE2sXhs1yqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1977&pages=317-319&author=N.+Sakuragawaauthor=M.+Sakuragawauthor=T.+Kuwabaraauthor=P.+G.+Pentchevauthor=J.+A.+Barrangerauthor=R.+O.+Brady&title=Niemann-pick+disease+experimental+model%3A+Sphingomyelinase+reduction+induced+by+ay-9944&doi=10.1126%2Fscience.66749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Niemann-pick disease experimental model:  sphingomyelinase reduction induced by AY-9944</span></div><div class="casAuthors">Sakuragawa, Norio; Sakuragawa, Machiko; Kuwabara, Toichiro; Pentchev, Peter G.; Barranger, John A.; Brady, Roscoe O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4287</span>),
    <span class="NLM_cas:pages">317-19</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Organs of rats treated with the drug AY-9944 (trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride), causing symptoms similar to those in Niemann-Pick disease, for 5 days showed a redn. in sphingomyelinase activity.  This redn. may be due to impaired enzyme synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlu-9NFLoDRbVg90H21EOLACvtfcHk0ljM2bNlxao8eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhs1yqtb4%253D&md5=9fee57b589110d543b8ce7ad8cef7910</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.66749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.66749%26sid%3Dliteratum%253Aachs%26aulast%3DSakuragawa%26aufirst%3DN.%26aulast%3DSakuragaw%26aufirst%3DM.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DPentchev%26aufirst%3DP.%2BG.%26aulast%3DBarranger%26aufirst%3DJ.%2BA.%26aulast%3DBrady%26aufirst%3DR.%2BO.%26atitle%3DNiemann-pick%2520disease%2520experimental%2520model%253A%2520Sphingomyelinase%2520reduction%2520induced%2520by%2520ay-9944%26jtitle%3DScience%26date%3D1977%26volume%3D196%26spage%3D317%26epage%3D319%26doi%3D10.1126%2Fscience.66749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albouz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauw, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berwald-Netter, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, N.</span></span> <span> </span><span class="NLM_article-title">Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures</span>. <i>Biomedicine</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000155973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=6285997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL38XksV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1981&pages=218-220&author=S.+Albouzauthor=J.+J.+Hauwauthor=Y.+Berwald-Netterauthor=J.+M.+Boutryauthor=R.+Bourdonauthor=N.+Baumann&title=Tricyclic+antidepressants+induce+sphingomyelinase+deficiency+in+fibroblast+and+neuroblastoma+cell+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures</span></div><div class="casAuthors">Albouz, S.; Hauw, J. J.; Berwald-Netter, Y.; Boutry, J. M.; Bourdon, R.; Baumann, N.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine Express</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">218-20</span>CODEN:
                <span class="NLM_cas:coden">BMEXBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-0885</span>.
    </div><div class="casAbstract">Tricyclic antidepressants (imipramine (I)  [50-49-7] and desipramine  [50-47-5]) gave rise to an important decrease of sphingomyelinase  [9031-54-3] activity in murine neuroblastoma and human fibroblast cell cultures.  It occurred within 1 to 2 h at a final concn. of 1 or 2 × 10-5 M in cell culture medium.  Other lysosomal enzymes such as acid lipase, arylsulfatases A and B and hexosaminidases were not modified.  Low level of sphingomyelinase activity may be related to the amphiphilic characteristics of the drugs; iminodibenzyl  [494-19-9] which has the same tricyclic core but is devoid of the side chain necessary for amphiphilic properties had no effect.  As iminodibenzyl has no therapeutic action, amphiphilicity may be requisite to antidepressant properties of tricyclic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDg6WWOf2N7Vg90H21EOLACvtfcHk0liW8Ycq0flRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksV2gsLk%253D&md5=7adddf6acea3f0042968fb7e0535f4f2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1159%2F000155973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000155973%26sid%3Dliteratum%253Aachs%26aulast%3DAlbouz%26aufirst%3DS.%26aulast%3DHauw%26aufirst%3DJ.%2BJ.%26aulast%3DBerwald-Netter%26aufirst%3DY.%26aulast%3DBoutry%26aufirst%3DJ.%2BM.%26aulast%3DBourdon%26aufirst%3DR.%26aulast%3DBaumann%26aufirst%3DN.%26atitle%3DTricyclic%2520antidepressants%2520induce%2520sphingomyelinase%2520deficiency%2520in%2520fibroblast%2520and%2520neuroblastoma%2520cell%2520cultures%26jtitle%3DBiomedicine%26date%3D1981%26volume%3D35%26spage%3D218%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoyoshi, E.</span></span> <span> </span><span class="NLM_article-title">Reduction of acid sphingomyelinase activity in human fibroblasts induced by ay-9944 and other cationic amphiphilic drugs</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a135438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1093%2Foxfordjournals.jbchem.a135438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2419314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL28XmtFylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1985&pages=1669-1679&author=Y.+Yoshidaauthor=K.+Arimotoauthor=M.+Satoauthor=N.+Sakuragawaauthor=M.+Arimaauthor=E.+Satoyoshi&title=Reduction+of+acid+sphingomyelinase+activity+in+human+fibroblasts+induced+by+ay-9944+and+other+cationic+amphiphilic+drugs&doi=10.1093%2Foxfordjournals.jbchem.a135438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs</span></div><div class="casAuthors">Yoshida, Yutaka; Arimoto, Kiyoshi; Sato, Mitsuru; Sakuragawa, Norio; Arima, Masataka; Satoyoshi, Eijiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-79</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">AY-9944 (I)  [366-93-8], a cationic amphiphilic drug, caused a rapid, irreversible and concn.-dependent redn. of acid sphingomyelinase(EC 3.1.4.12)  [9031-54-3] activity in normal human fibroblasts without changing the activities of other lysosomal hydrolases tested.  Examns. of activities against synthetic substrates and of the pH dependency of sphingomyelinase in the drug-treated cells also suggested that the redn. of activity was specific to acid sphingomyelinase.  Such a specific redn. was also found with 12 other cationic amphiphilic drugs, most of which are inducers of exptl. phospholipidosis in animals and/or cultured cells.  These results strongly suggest that acid sphingomyelinase is involved in the process of drug-induced lipidosis.  The redn. of acid sphingomyelinase seemed not to be due to direct inhibition by these drugs, a specific loss of the enzyme into the culture medium, the presence of inhibitor in the drug-treated cells, or impaired synthesis of the enzyme.  There was no indication that changes in the catalytic properties of the enzyme or changes in its requirement for detergents for activity occurred in the cell.  AY-9944 and other cationic amphiphilic drugs may cause redn. of acid sphingomyelinase activity by inducing an increased rate of degrdn. of the enzyme or by causing an irreversible inactivation via some undetected factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFaESClCA37Vg90H21EOLACvtfcHk0liW8Ycq0flRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmtFylsg%253D%253D&md5=3b1553ca4af524b30386b8df3058b383</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a135438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a135438%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DArimoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSakuragawa%26aufirst%3DN.%26aulast%3DArima%26aufirst%3DM.%26aulast%3DSatoyoshi%26aufirst%3DE.%26atitle%3DReduction%2520of%2520acid%2520sphingomyelinase%2520activity%2520in%2520human%2520fibroblasts%2520induced%2520by%2520ay-9944%2520and%2520other%2520cationic%2520amphiphilic%2520drugs%26jtitle%3DJ.%2520Biochem.%26date%3D1985%26volume%3D98%26spage%3D1669%26epage%3D1679%26doi%3D10.1093%2Foxfordjournals.jbchem.a135438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albouz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spezzatti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, N.</span></span> <span> </span><span class="NLM_article-title">Calmodulin antagonist w-7 inhibits lysosomal sphingomyelinase activity in c6 glioma cells</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1989.tb09221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1471-4159.1989.tb09221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2540282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Ggtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1989&pages=1645-1647&author=M.+Massonauthor=S.+Albouzauthor=J.+M.+Boutryauthor=B.+Spezzattiauthor=M.+Castagnaauthor=N.+Baumann&title=Calmodulin+antagonist+w-7+inhibits+lysosomal+sphingomyelinase+activity+in+c6+glioma+cells&doi=10.1111%2Fj.1471-4159.1989.tb09221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Calmodulin antagonist W-7 inhibits lysosomal sphingomyelinase activity in C6 glioma cells</span></div><div class="casAuthors">Masson, Martial; Albouz, Samia; Boutry, Jeanne Marie; Spezzatti, Bettina; Castagna, Monique; Baumann, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1645-7</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) is known to be a potent calmodulin antagonist and inhibitor of calmodulin-dependent protein kinases.  W-7 and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) are inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.  In C6 glioma cells, W-7 and not H-7 inhibited concn.-dependently acid sphingomyelinase, a result indicating the modulation of this lysosomal enzyme by a calmodulin-dependent system.  Other lysosomal enzymes, such as β-glucosidase, α-galactosidase, and arylsulfatase A, were unaffected by W-7 and H-7, a finding indicating a selective effect of W-7 on sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25n7icNK5eLVg90H21EOLACvtfcHk0liW8Ycq0flRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Ggtbk%253D&md5=51d17ba23978b7f029131927d30c75ba</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1989.tb09221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1989.tb09221.x%26sid%3Dliteratum%253Aachs%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DAlbouz%26aufirst%3DS.%26aulast%3DBoutry%26aufirst%3DJ.%2BM.%26aulast%3DSpezzatti%26aufirst%3DB.%26aulast%3DCastagna%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DN.%26atitle%3DCalmodulin%2520antagonist%2520w-7%2520inhibits%2520lysosomal%2520sphingomyelinase%2520activity%2520in%2520c6%2520glioma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1989%26volume%3D52%26spage%3D1645%26epage%3D1647%26doi%3D10.1111%2Fj.1471-4159.1989.tb09221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaffrezou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gau, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, G.</span></span> <span> </span><span class="NLM_article-title">Reversal of multidrug resistance by calcium channel blocker sr33557 without photoaffinity labeling of p-glycoprotein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">19858</span>– <span class="NLM_lpage">19864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2955070-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1918089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlvFOrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=19858-19864&author=J.+P.+Jaffrezouauthor=J.+M.+Herbertauthor=T.+Levadeauthor=M.+N.+Gauauthor=P.+Chatelainauthor=G.+Laurent&title=Reversal+of+multidrug+resistance+by+calcium+channel+blocker+sr33557+without+photoaffinity+labeling+of+p-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein</span></div><div class="casAuthors">Jaffrezou, Jean Pierre; Herbert, Jean Marc; Levade, Thierry; Gau, Marie Noelle; Chatelain, Pierre; Laurent, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">19858</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The altered pharmacol. of drugs in multidrug-resistant cells (decreased accumulation and retention) appears to be mediated by a high mol. wt. integral membrane protein, called P-glycoprotein (P-gp).  Agents known to reverse this pleiotropic drug resistance (chemosensitizers) have been shown to interact with P-gp; and as such, the inhibition of photoaffinity labeling by P-gp probes (such as [3H]azidonine) has been proposed as a basis for mass screening of chemosensitizers.  In this study, direct evidence is provided that a novel calcium channel blocker SR33557 (I), which was 4.5 times more potent in sensitizing P388/ADR cells to doxorubicin as compared to verapamil while inducing a similar increase in uptake and decrease in efflux of [14C]doxorubicin, did not compete for the [3H]azidonine-binding site on P-gp, whereas verapamil did.  Moreover, SR33557, which is inherently photoactivable, did not photolabel P-gp, but a 65-kDa protein did appear to be an acceptor; and this binding was displaced by diltiazem and nifedipine, but not by verapamil.  Finally, the implication for the participation of a sphingomyelin/sphingosine cycle (as a potential lipid second messenger system) in the chemosensitization of P388/ADR cells was investigated.  SR33557 (30 μM) induced a 72% inhibition in acid lysosomal sphingomyelinase activity, a 5-fold increase in sphingosine levels, and a 75% inhibition in intracellular protein kinase C activity.  Although no direct link is established between these observations and P-gp activity, further studies on a possible sphingosine-mediated regulation of P-gp may yield information on the involvement of this second messenger system in the action of SR33557.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSPeBr0m_ybVg90H21EOLACvtfcHk0lgN8fTXxwnT3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlvFOrtbk%253D&md5=d3f93d3a455f364a59585e4195de8dc6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2955070-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252955070-5%26sid%3Dliteratum%253Aachs%26aulast%3DJaffrezou%26aufirst%3DJ.%2BP.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DGau%26aufirst%3DM.%2BN.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DLaurent%26aufirst%3DG.%26atitle%3DReversal%2520of%2520multidrug%2520resistance%2520by%2520calcium%2520channel%2520blocker%2520sr33557%2520without%2520photoaffinity%2520labeling%2520of%2520p-glycoprotein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D19858%26epage%3D19864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terfloth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltfang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span> <span> </span><span class="NLM_article-title">Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1021/jm070524a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070524a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlejsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=219-237&author=J.+Kornhuberauthor=P.+Tripalauthor=M.+Reichelauthor=L.+Terflothauthor=S.+Bleichauthor=J.+Wiltfangauthor=E.+Gulbins&title=Identification+of+new+functional+inhibitors+of+acid+sphingomyelinase+using+a+structure-property-activity+relation+model&doi=10.1021%2Fjm070524a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure-Property-Activity Relation Model</span></div><div class="casAuthors">Kornhuber, Johannes; Tripal, Philipp; Reichel, Martin; Terfloth, Lothar; Bleich, Stefan; Wiltfang, Jens; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-237</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some org. weak bases induce a detachment from inner lysosomal membranes and subsequent inactivation of acid sphingomyelinase (ASM) and thus work as functional ASM inhibitors.  The aim of the present investigation was to develop a structure-property-activity relation (SPAR) model in order to specify the structural and physicochem. characteristics of probes capable of functionally inhibiting ASM.  High pKa and high log P values are necessary but not sufficient preconditions for functional inhibition of ASM.  The exptl. data supported the requirement of an addnl. factor, which is necessary for functional inhibition of ASM.  This factor k is related to the steric hindrance of the most basic nitrogen atom and presumably modulates the free presentation of a protonated nitrogen atom at the inner lysosomal surface.  During the course of the study, the authors characterized 26 new functional ASM inhibitors, including doxepine 63, fluoxetine 104, maprotiline 109, nortriptyline 114, paroxetine 118, sertraline 124, suloctidil 125, and terfenadine 127.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3zAdkl_bqSbVg90H21EOLACvtfcHk0lgN8fTXxwnT3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlejsbnP&md5=93b672e37d8574bf09ee8dadb865039a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm070524a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070524a%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DTerfloth%26aufirst%3DL.%26aulast%3DBleich%26aufirst%3DS.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520new%2520functional%2520inhibitors%2520of%2520acid%2520sphingomyelinase%2520using%2520a%2520structure-property-activity%2520relation%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D219%26epage%3D237%26doi%3D10.1021%2Fjm070524a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>559</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00033-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0014-5793%2804%2900033-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=14960314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252Fnt1SksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=559&publication_year=2004&pages=96-98&author=M.+Kolzerauthor=N.+Werthauthor=K.+Sandhoff&title=Interactions+of+acid+sphingomyelinase+and+lipid+bilayers+in+the+presence+of+the+tricyclic+antidepressant+desipramine&doi=10.1016%2FS0014-5793%2804%2900033-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine</span></div><div class="casAuthors">Kolzer Melanie; Werth Norbert; Sandhoff Konrad</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">559</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">96-8</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The tricyclic antidepressant desipramine causes a decrease in cellular acid sphingomyelinase (A-SMase, EC 3.1.4.12) activity when added to culture medium of human fibroblasts.  This effect can be prevented by incubation of the cells with the protease inhibitor leupeptin, which suggests that desipramine induces proteolytic degradation of the lysosomal enzyme.  By using surface plasmon resonance (SPR, Biacore) we were able to monitor the interactions of A-SMase and substrate-containing lipid bilayers immobilized on the surface of a Pioneer trade mark L1 sensor chip.  SPR binding curves show that the enzyme hardly dissociates from the lipid surface at acidic pH values.  On the other hand, a drop in binding signals (resonance units, RU) of approximately 50% occurred after injection of 20 mM desipramine.  Our findings indicate that desipramine interferes with the binding of A-SMase to the lipid bilayers and thereby displaces the enzyme from its membrane-bound substrate.  The application of control substances suggests a key role for the cationic moiety of desipramine.  We hypothesize that the displacement of the glycoprotein A-SMase from the inner membranes of late endosomes and lysosomes by desipramine renders it susceptible to proteolytic cleavage by lysosomal proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSvh2pXInD65agfuraLLzSfW6udTcc2eZbEhKTKfq6orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252Fnt1SksQ%253D%253D&md5=e327b94a0fc7ad8edf303c99dc2d245b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900033-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900033-X%26sid%3Dliteratum%253Aachs%26aulast%3DKolzer%26aufirst%3DM.%26aulast%3DWerth%26aufirst%3DN.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DInteractions%2520of%2520acid%2520sphingomyelinase%2520and%2520lipid%2520bilayers%2520in%2520the%2520presence%2520of%2520the%2520tricyclic%2520antidepressant%2520desipramine%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D559%26spage%3D96%26epage%3D98%26doi%3D10.1016%2FS0014-5793%2804%2900033-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muehlbacher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groemer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span> <span> </span><span class="NLM_article-title">Functional inhibitors of acid sphingomyelinase (fiasmas): A novel pharmacological group of drugs with broad clinical applications</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1159/000315101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000315101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20502000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=9-20&author=J.+Kornhuberauthor=P.+Tripalauthor=M.+Reichelauthor=C.+Muhleauthor=C.+Rheinauthor=M.+Muehlbacherauthor=T.+W.+Groemerauthor=E.+Gulbins&title=Functional+inhibitors+of+acid+sphingomyelinase+%28fiasmas%29%3A+A+novel+pharmacological+group+of+drugs+with+broad+clinical+applications&doi=10.1159%2F000315101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications</span></div><div class="casAuthors">Kornhuber, Johannes; Tripal, Philipp; Reichel, Martin; Muehle, Christiane; Rhein, Cosima; Muehlbacher, Markus; Groemer, Teja W.; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Acid sphingomyelinase (ASM) is an important lipid-metabolizing enzyme cleaving sphingomyelin to ceramide, mainly within lysosomes.  Acid ceramidase (AC) further degrades ceramide to sphingosine which can then be phosphorylated to sphingosine-1-phosphate.  Ceramide and its metabolite sphingosine-1-phosphate have been shown to antagonistically regulate apoptosis, cellular differentiation, proliferation and cell migration.  Inhibitors of ASM or AC therefore hold promise for a no. of new clin. therapies, e.g. for Alzheimer's disease and major depression on the one hand and cancer on the other.  Inhibitors of ASM have been known for a long time.  Cationic amphiphilic substances induce the detachment of ASM protein from inner lysosomal membranes with its consecutive inactivation, thereby working as functional inhibitors of ASM.  We recently exptl. identified a large no. of hitherto unknown functional inhibitors of ASM and detd. specific physicochem. properties of such cationic amphiphilic substances that functionally inhibit ASM.  We propose the acronym "FIASMA" (Functional Inhibitor of Acid SphingoMyelinAse) for members of this large group of compds. with a broad range of new clin. indications.  FIASMAs differ markedly with respect to mol. structure and current clin. indication.  Most of the available FIASMAs are licensed for medical use in humans, are minimally toxic and may therefore be applied for disease states assocd. with increased activity of ASM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLKnWFqe8RjbVg90H21EOLACvtfcHk0li9EIl4UgYPvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsrw%253D&md5=5d2be89bb837b472ea4c9182b85ddc3c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1159%2F000315101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315101%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DMuhle%26aufirst%3DC.%26aulast%3DRhein%26aufirst%3DC.%26aulast%3DMuehlbacher%26aufirst%3DM.%26aulast%3DGroemer%26aufirst%3DT.%2BW.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DFunctional%2520inhibitors%2520of%2520acid%2520sphingomyelinase%2520%2528fiasmas%2529%253A%2520A%2520novel%2520pharmacological%2520group%2520of%2520drugs%2520with%2520broad%2520clinical%2520applications%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D9%26epage%3D20%26doi%3D10.1159%2F000315101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Icheva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deppisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graepler-Mainka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riethmueller, J.</span></span> <span> </span><span class="NLM_article-title">Long-term pulmonal therapy of cystic fibrosis-patients with amitriptyline</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1159/000445648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000445648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27395380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ynur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=565-572&author=C.+Adamsauthor=V.+Ichevaauthor=C.+Deppischauthor=J.+Lauerauthor=G.+Herrmannauthor=U.+Graepler-Mainkaauthor=S.+Heyderauthor=E.+Gulbinsauthor=J.+Riethmueller&title=Long-term+pulmonal+therapy+of+cystic+fibrosis-patients+with+amitriptyline&doi=10.1159%2F000445648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline</span></div><div class="casAuthors">Adams, Constantin; Icheva, Vanya; Deppisch, Caroline; Lauer, Josefine; Herrmann, Gloria; Graepler-Mainka, Ute; Heyder, Susanne; Gulbins, Erich; Riethmueller, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">565-572</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Several recent clin. studies revealed an accumulation of ceramide in bronchial epithelial cells of patients with cystic fibrosis (CF).  Degrdn. of ceramide concns. in lungs of CF patients employing the functional acid sphingomyelinase inhibitor amitriptyline revealed a benefit in lung function, wt. and exacerbation rates.  Methods: To test for a beneficial effect of amitriptyline in vivo, we performed two phase II randomized, double-blind, placebo-controlled studies.  CF patients were treated with 25 mg amitriptyline twice daily, i.e. a total dose of 50 mg/d.  After those two studies part of the patients used amitriptyline in an off-lable-use for routine treatment.  These patients were obsd. after one, two and three years after continuous use of amitriptyline and were matched with those patients who were not treated.  These patients were used as a control group.  Results: After one year of treatment, forced expiratory vol. in 1 s predicted (FEV1) increased significantly by 7.6±7.0%, p=<0.001, and wt. increased by 2.1±2.3kg, p=<0.001 in the amitriptyline population (n=20), whereas FEV1 decreased significantly in the control group by 1.8±3.3%, p=0.010, and wt. increased by 1.1±2.7kg, p=0.010 (n=14).  After two years of treatment, FEV1 increased significantly by 5.6±10.3%, p=0.009, and wt. increased by 3.6±2.9kg, p=<0.001 in the amitriptyline population (n=12).  In contrast, FEV1 decreased in the control group by 2.1±3.7%, p=0.051 and wt. increased by only 0.4±2.9kg, p=0.31 (n=10).  After three years of treatment, FEV1 increased significantly by 7.7±8%, p=0.050, and wt. increased by 7.3±3.8kg, p=0.016, in the amitriptyline population (n=5), whereas FEV1 decreased in the control group by 1.0±1.3%, p=0.075 and wt. increased by 0.4±1.5kg, p=0.29 (n=5).  Conclusion: Amitriptyline significantly increases FEV1, reduces ceramide in lung cells and increases wt. of CF patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj_G6lhBCRt7Vg90H21EOLACvtfcHk0li9EIl4UgYPvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ynur7O&md5=8a016e35665ad4de3cefef1d16b6135a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1159%2F000445648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000445648%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DIcheva%26aufirst%3DV.%26aulast%3DDeppisch%26aufirst%3DC.%26aulast%3DLauer%26aufirst%3DJ.%26aulast%3DHerrmann%26aufirst%3DG.%26aulast%3DGraepler-Mainka%26aufirst%3DU.%26aulast%3DHeyder%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26aulast%3DRiethmueller%26aufirst%3DJ.%26atitle%3DLong-term%2520pulmonal%2520therapy%2520of%2520cystic%2520fibrosis-patients%2520with%2520amitriptyline%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2016%26volume%3D39%26spage%3D565%26epage%3D572%26doi%3D10.1159%2F000445648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acidic sphingomyelinase by xanthone compounds isolated from garcinia speciosa</span>. <i>J. Enzyme Inhib.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1080/14756360009030346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1080%2F14756360009030346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10938539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1ygs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=129-138&author=C.+Okudairaauthor=Y.+Ikedaauthor=S.+Kondoauthor=S.+Furuyaauthor=Y.+Hirabayashiauthor=T.+Koyanoauthor=Y.+Saitoauthor=K.+Umezawa&title=Inhibition+of+acidic+sphingomyelinase+by+xanthone+compounds+isolated+from+garcinia+speciosa&doi=10.1080%2F14756360009030346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acidic sphingomyelinase by xanthone compounds isolated from Garcinia speciosa</span></div><div class="casAuthors">Okudaira, Chiyono; Ikeda, Yoko; Kondo, Shinichi; Furuya, Shigeki; Hirabayashi, Yoshio; Koyano, Takashi; Saito, Yoshio; Umezawa, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Sphingomyelinase is considered to be involved in the regulation of apoptosis and cell growth.  In the course of our screening for acidic sphingomyelinase inhibitors we isolated three xanthone compds., α-mangostin, cowanin, and cowanol, from the bark of Garcinia speciosa.  These compds. competitively inhibited bovine brain-derived acidic sphingomyelinase with IC50 values of 14.1, 19.2, and 10.9 μM, resp. and inhibited the acidic sphingomyelinase more effectively than the neutral sphingomyelinase of bovine brain.  α-Mangostin inhibited the acidic sphingomyelinase in the most selective manner.  α-Mangostin was chem. modified and its structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqEPtlHF_D7Vg90H21EOLACvtfcHk0li9EIl4UgYPvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1ygs7Y%253D&md5=7b550de425e3085911abca36aa50418e</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1080%2F14756360009030346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360009030346%26sid%3Dliteratum%253Aachs%26aulast%3DOkudaira%26aufirst%3DC.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DHirabayashi%26aufirst%3DY.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DUmezawa%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520acidic%2520sphingomyelinase%2520by%2520xanthone%2520compounds%2520isolated%2520from%2520garcinia%2520speciosa%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D2000%26volume%3D15%26spage%3D129%26epage%3D138%26doi%3D10.1080%2F14756360009030346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chammaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yektaoglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyrones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3666</span>– <span class="NLM_lpage">3670</span>, <span class="refDoi"> DOI: 10.1002/anie.200906555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200906555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFWisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3666-3670&author=S.+Wetzelauthor=W.+Wilkauthor=S.+Chammaaauthor=B.+Sperlauthor=A.+G.+Rothauthor=A.+Yektaogluauthor=S.+Rennerauthor=T.+Bergauthor=C.+Arenzauthor=A.+Giannisauthor=T.+I.+Opreaauthor=D.+Rauhauthor=M.+Kaiserauthor=H.+Waldmann&title=A+scaffold-tree-merging+strategy+for+prospective+bioactivity+annotation+of+gamma-pyrones&doi=10.1002%2Fanie.200906555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Scaffold-Tree-Merging Strategy for Prospective Bioactivity Annotation of γ-Pyrones</span></div><div class="casAuthors">Wetzel, Stefan; Wilk, Wolfram; Chammaa, Samy; Sperl, Bianca; Roth, Anke G.; Yektaoglu, Aybike; Renner, Steffen; Berg, Thorsten; Arenz, Christoph; Giannis, Athanassios; Oprea, Tudor I.; Rauh, Daniel; Kaiser, Markus; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3666-3670, S3666/1-S3666/115</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Natural products (NPs) can be regarded as biol. relevant compd. classes selected during evolution and endowed with structural parameters required for binding to proteins.  They are a rich source of small-mol. modulators of protein function.  However, their use is often hampered by their limited accessibility and a lack of knowledge about their biol. targets.  Synthetically accessible NP-inspired and NP-derived compd. collections may offer an attractive possibility to overcome these limitations if their bioactivity could be annotated prospectively.  Cheminformatic methods can provide crucial clues and crit. insight to guide compd.-development programs.  Accordingly, several chemoinformatic approaches have been described for the anal. of NP structure and properties in the context of bioactive-compd. development and to chart NP chem. space.  We recently introduced a hierarchical, chem.-based classification and arrangement of natural products in a natural product scaffold tree to inspire the synthesis of NP-derived compd. collections.  Brachiation along lines of biol. relevance, i.e., movement along the branches of the NP tree from complex to simpler structures, enables the identification of structurally simpler scaffolds with retained, yet varying bioactivity.  In the light of these findings, we hypothesized that the correlation of NP scaffolds not annotated for bioactivity with scaffolds of related yet non-natural small mols. with known bioactivity and targets could identify potential proteins targeted by natural product inspired and derived compd. collections.  We envisaged that merging of trees not annotated for bioactivity (e.g. the NP scaffold tree) with trees annotated for bioactivity would generate novel merged trees from which bioactivity could be assigned prospectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZAsXs8diPP7Vg90H21EOLACvtfcHk0lhAvcNejxrSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFWisrc%253D&md5=dc65ee32bbfa712223b6c670fd84a09d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906555%26sid%3Dliteratum%253Aachs%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DWilk%26aufirst%3DW.%26aulast%3DChammaa%26aufirst%3DS.%26aulast%3DSperl%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DYektaoglu%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGiannis%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DA%2520scaffold-tree-merging%2520strategy%2520for%2520prospective%2520bioactivity%2520annotation%2520of%2520gamma-pyrones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D3666%26epage%3D3670%26doi%3D10.1002%2Fanie.200906555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuzaki, H.</span></span> <span> </span><span class="NLM_article-title">Strong inhibition of secretory sphingomyelinase by catechins, particularly by (−)-epicatechin 3-o-gallate and (−)-3′-o-methylepigallocatechin 3-o-gallate</span>. <i>J. Nutr. Sci. Vitaminol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.3177/jnsv.62.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3177%2Fjnsv.62.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27264097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWhsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=123-129&author=K.+Kobayashiauthor=Y.+Ishizakiauthor=S.+Kojoauthor=H.+Kikuzaki&title=Strong+inhibition+of+secretory+sphingomyelinase+by+catechins%2C+particularly+by+%28%E2%88%92%29-epicatechin+3-o-gallate+and+%28%E2%88%92%29-3%E2%80%B2-o-methylepigallocatechin+3-o-gallate&doi=10.3177%2Fjnsv.62.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Strong inhibition of secretory sphingomyelinase by catechins, particularly by (-)-epicatechin 3-O-gallate and (-)-3'-O-methylepigallocatechin 3-O-Gallate</span></div><div class="casAuthors">Kobayashi, Keiko; Ishizaki, Yuki; Kojo, Shosuke; Kikuzaki, Hiroe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Science and Vitaminology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-129</span>CODEN:
                <span class="NLM_cas:coden">JNSVA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-4800</span>.
    
            (<span class="NLM_cas:orgname">Center for Academic Publications Japan</span>)
        </div><div class="casAbstract">Sphingomyelinases (SMases) are key enzymes involved in many diseases which are caused by oxidative stress, such as atherosclerosis, diabetes mellitus, nonalcoholic fatty liver disease, and Alzheimer's disease.  SMases hydrolyze sphingomyelin to generate ceramide, a well-known pro-apoptotic lipid.  SMases are classified into five types based on pH optimum, subcellular localization, and cation dependence.  Previously, we demonstrated that elevation of secretory sphingomyelinase (sSMase) activity increased the plasma ceramide concn. under oxidative stress induced by diabetes and atherosclerosis in murine models.  These results suggest that sSMase inhibitors can prevent the progress of these diseases.  The present study demonstrated that sSMase activity was activated by oxidn. and inhibited by redn.  Furthermore, we examd. whether catechins inhibited the sSMase activity in a physiol. plasma concn.  Among catechins, (-)-epicatechin 3-O-gallate (ECg) exhibited strong inhibitory effect on sSMase (IC50=25.7 μM).  This effect was attenuated by methylation at the 3''- or 4''-position.  On the other hand, (-)-epigallocatechin 3-O-gallate (EGCg) and (-)-catechin 3-O-gallate (Cg) exhibited weaker inhibitory activity than ECg, and (-)-epicatechin and (-)-epigallocatechin did not affect sSMase activity.  Addnl., one synthetic catechin, (-)-3'-O-methylepigallocatechin 3-O-gallate (EGCg-3'-O-Me), showed the strongest inhibitory effect (IC50=1.7 μm) on sSMase.  This phenomenon was not obsd. for (-)-4'-O-methylepigallocatechin 3-O-gallate.  These results suggest that the redn. potential, the presence of the galloyl residue at the C-3 position, and the steric requirement to interact with sSMase protein are important for effective inhibition of sSMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41MMdqZIgFbVg90H21EOLACvtfcHk0lhAvcNejxrSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWhsL3O&md5=9d8ae02b23f399641f9657d23d1c0fb8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3177%2Fjnsv.62.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3177%252Fjnsv.62.123%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DIshizaki%26aufirst%3DY.%26aulast%3DKojo%26aufirst%3DS.%26aulast%3DKikuzaki%26aufirst%3DH.%26atitle%3DStrong%2520inhibition%2520of%2520secretory%2520sphingomyelinase%2520by%2520catechins%252C%2520particularly%2520by%2520%2528%25E2%2588%2592%2529-epicatechin%25203-o-gallate%2520and%2520%2528%25E2%2588%2592%2529-3%25E2%2580%25B2-o-methylepigallocatechin%25203-o-gallate%26jtitle%3DJ.%2520Nutr.%2520Sci.%2520Vitaminol.%26date%3D2016%26volume%3D62%26spage%3D123%26epage%3D129%26doi%3D10.3177%2Fjnsv.62.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintern, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrkorn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schram, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Acid sphingomyelinase from human urine: Purification and characterization</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>922</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(87)90055-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2887%2990055-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2825797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1cXht1OhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=922&publication_year=1987&pages=323-336&author=L.+E.+Quinternauthor=G.+Weitzauthor=H.+Nehrkornauthor=J.+M.+Tagerauthor=A.+W.+Schramauthor=K.+Sandhoff&title=Acid+sphingomyelinase+from+human+urine%3A+Purification+and+characterization&doi=10.1016%2F0005-2760%2887%2990055-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Acid sphingomyelinase from human urine:  purification and characterization</span></div><div class="casAuthors">Quintern, Lothar E.; Weitz, Gaby; Nehrkorn, Heidi; Tager, Joseph M.; Schram, Andre W.; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">922</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-36</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    </div><div class="casAbstract">Acid sphingomyelinase (EC 3.1.4.12) (I) was purified from human urine in the presence of 0.1% Nonidet P-40.  I activity could be enriched 23,000-fold by sequential chromatog. on octyl-Sepharose, concanavalin A-Sepharose, Blue Sepharose and DEAE-cellulose.  The last purifn. step yielded an enzyme prepn. with a specific activity of ∼2.5 mmol sphingomyelin (SM) cleaved/h/mg protein and with a yield of ∼3%.  Purified I appeared to be homogeneous in SDS-PAGE with a mol. wt. of 70,000.  In the presence of 0.08% Na taurodeoxycholate, the I prepn. showed phosphodiesterase activity toward SM, phosphatidylcholine (PC), and phosphatidylglycerol (PG).  These activities copurified during the entire purifn. procedure, indicating that I hydrolyzes not only SM, but also possesses a phospholipase C activity in hydrolyzing PC and PG.  The addn. of 100 μM tripalmitoylglycerol to the assay system (which contains 100 μM SM) instead of detergent, stimulated the reaction ∼20-fold compared to an assay which did not contain detergents, thus offering a very sensitive and efficient system for the assay of I in a system free of detergents.  SM degrdn. was strongly inhibited by phosphatidylinositol 4',5'-bisphosphate, adenosine 3',5'-diphosphate and adenine-9β-D-arabinofuranoside 5'-monophosphate (50% inhibition at inhibitor concns. of 1-5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3L30YWQA9-rVg90H21EOLACvtfcHk0lhAvcNejxrSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXht1OhtLc%253D&md5=0506a42a176fc98245cfd8258ea5df09</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2887%2990055-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252887%252990055-5%26sid%3Dliteratum%253Aachs%26aulast%3DQuintern%26aufirst%3DL.%2BE.%26aulast%3DWeitz%26aufirst%3DG.%26aulast%3DNehrkorn%26aufirst%3DH.%26aulast%3DTager%26aufirst%3DJ.%2BM.%26aulast%3DSchram%26aufirst%3DA.%2BW.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DAcid%2520sphingomyelinase%2520from%2520human%2520urine%253A%2520Purification%2520and%2520characterization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1987%26volume%3D922%26spage%3D323%26epage%3D336%26doi%3D10.1016%2F0005-2760%2887%2990055-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlinz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingenstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3,5-bisphosphate is a potent and selective inhibitor of acid sphingomyelinase</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1298</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1515%2FBC.2003.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=14515991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BD3svos1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1293-1298&author=M.+Kolzerauthor=C.+Arenzauthor=K.+Ferlinzauthor=N.+Werthauthor=H.+Schulzeauthor=R.+Klingensteinauthor=K.+Sandhoff&title=Phosphatidylinositol-3%2C5-bisphosphate+is+a+potent+and+selective+inhibitor+of+acid+sphingomyelinase&doi=10.1515%2FBC.2003.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase</span></div><div class="casAuthors">Kolzer Melanie; Arenz Christoph; Ferlinz Klaus; Werth Norbert; Schulze Heike; Klingenstein Ralf; Sandhoff Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Biological chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1293-8</span>
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    </div><div class="casAbstract">Acid sphingomyelinase (A-SMase, EC 3.1.4.12) catalyzes the lysosomal degradation of sphingomyelin to phosphorylcholine and ceramide.  Inherited deficiencies of acid sphingomyelinase activity result in various clinical forms of Niemann-Pick disease, which are characterised by massive lysosomal accumulation of sphingomyelin.  Sphingomyelin hydrolysis by both, acid sphingomyelinase and membrane-associated neutral sphingomyelinase, plays also an important role in cellular signaling systems regulating proliferation, apoptosis and differentiation.  Here, we present a potent and selective novel inhibitor of A-SMase, L-alpha-phosphatidyl-D-myo-inositol-3,5-bisphosphate (PtdIns3,5P2), a naturally occurring substance detected in mammalian, plant and yeast cells.  The inhibition constant Ki for the new A-SMase inhibitor PtdIns3,5P2 is 0.53 microM as determined in a micellar assay system with radiolabeled sphingomyelin as substrate and recombinant human A-SMase purified from insect cells.  Even at concentrations of up to 50 microM, PtdIns3,5P2 neither decreased plasma membrane-associated, magnesium-dependent neutral sphingomyelinase activity, nor was it an inhibitor of the lysosomal hydrolases beta-hexosaminidase A and acid ceramidase.  Other phosphoinositides tested had no or a much weaker effect on acid sphingomyelinase.  Different inositol-bisphosphates were studied to elucidate structure-activity relationships for A-SMase inhibition.  Our investigations provide an insight into the structural features required for selective, efficient inhibition of acid sphingomyelinase and may also be used as starting point for the development of new potent A-SMase inhibitors optimised for diverse applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwhFJPqfNjdOxsqfvU0ziafW6udTcc2ea58d0j4VsO9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svos1Kqtw%253D%253D&md5=efd5efbb83d9bfa9098c5fd327d8f676</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.144%26sid%3Dliteratum%253Aachs%26aulast%3DKolzer%26aufirst%3DM.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DFerlinz%26aufirst%3DK.%26aulast%3DWerth%26aufirst%3DN.%26aulast%3DSchulze%26aufirst%3DH.%26aulast%3DKlingenstein%26aufirst%3DR.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DPhosphatidylinositol-3%252C5-bisphosphate%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520acid%2520sphingomyelinase%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1293%26epage%3D1298%26doi%3D10.1515%2FBC.2003.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Potent inhibition of acid sphingomyelinase by phosphoinositide analogues</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2367</span>– <span class="NLM_lpage">2374</span>, <span class="refDoi"> DOI: 10.1002/cbic.200900281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fcbic.200900281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19688786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2367-2374&author=A.+G.+Rothauthor=S.+Redmerauthor=C.+Arenz&title=Potent+inhibition+of+acid+sphingomyelinase+by+phosphoinositide+analogues&doi=10.1002%2Fcbic.200900281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibition of Acid Sphingomyelinase by Phosphoinositide Analogues</span></div><div class="casAuthors">Roth, Anke Gundula; Redmer, Susanne; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2367-2374</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The different mammalian sphingomyelinases are involved in cell regulation, apoptosis and inflammatory events.  Recent reports suggest pharmacol. potential esp. for inhibitors of the acid sphingomyelinase.  Phosphatidyl inositol-3,5bisphosphate (PtdIns3,5P2) is the most potent selective acid sphingomyelinase inhibitor known to date.  In the present study, we synthesized analogs of PtdIns3,5P2 for initial structure-activity-relationship (SAR) studies.  We identified an inhibitor that is easy to synthesize, that has superior chem. and biophys. properties when compared to PtdIns3,5P2 and that should be stable against virtually all phospholipases.  Last but not least, the new inhibitor partially protected cells from dexamethasone-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqtHO3lVUPLVg90H21EOLACvtfcHk0ljptOeuAiqzyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjs7rK&md5=2bdfa6dd555adce810ff4ec478049c48</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900281%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DRedmer%26aufirst%3DS.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DPotent%2520inhibition%2520of%2520acid%2520sphingomyelinase%2520by%2520phosphoinositide%2520analogues%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2367%26epage%3D2374%26doi%3D10.1002%2Fcbic.200900281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibition of acid sphingomyelinase by bisphosphonates</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7560</span>– <span class="NLM_lpage">7563</span>, <span class="refDoi"> DOI: 10.1002/anie.200903288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200903288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Sru7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7560-7563&author=A.+G.+Rothauthor=D.+Drescherauthor=Y.+Yangauthor=S.+Redmerauthor=S.+Uhligauthor=C.+Arenz&title=Potent+and+selective+inhibition+of+acid+sphingomyelinase+by+bisphosphonates&doi=10.1002%2Fanie.200903288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibition of Acid Sphingomyelinase by Bisphosphonates</span></div><div class="casAuthors">Roth, Anke G.; Drescher, Daniela; Yang, Yang; Redmer, Susanne; Uhlig, Stefan; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7560-7563, S7560/1-S7560/8</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">More than mending bones: A simple geminal aminobisphosphonate (see picture) is the most potent selective inhibitor of the acid sphingomyelinase known to date. It can be synthesized in a one-step procedure and inhibits cell death in vitro. Since the acid sphingomyelinase is a putative drug target for inflammatory lung diseases, bisphosphonates may find application in the treatment of pulmonary diseases.  The synthesis of bisphosphonates and their inhibition of acid sphingomyelinase are discussed.  One simple bisphosphonate, compd. 7c, was found to be a potent acid sphingomyelinase inhibitor.  Compd. 7c was shown to inhibit dexamethasone-induced apoptosis and reduce PAF-induced pulmonary edema, which suggests it could be useful for the treatment of lung disorders and other inflammatory ailments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGVWeCRzR5rVg90H21EOLACvtfcHk0ljptOeuAiqzyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Sru7vM&md5=2ac7875b0e3686fffe8ce669bd89b02c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903288%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DDrescher%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRedmer%26aufirst%3DS.%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DPotent%2520and%2520selective%2520inhibition%2520of%2520acid%2520sphingomyelinase%2520by%2520bisphosphonates%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D7560%26epage%3D7563%26doi%3D10.1002%2Fanie.200903288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J.-S.</span>; <span class="NLM_string-name">Jin, H. K.</span>; <span class="NLM_string-name">Park, M. H.</span></span> <span> </span><span class="NLM_article-title">2-Amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol Derivative of Novel Compound for Directly Inhibiting ASM Activity, and Use Thereof</span>. PCT Int. Appl. <span class="NLM_patent">WO 2019/212196</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.-S.+Bae&author=H.+K.+Jin&author=M.+H.+Park&title=2-Amino-2-%281%2C2%2C3-triazole-4-yl%29propane-1%2C3-diol+Derivative+of+Novel+Compound+for+Directly+Inhibiting+ASM+Activity%2C+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.-S.%26atitle%3D2-Amino-2-%25281%252C2%252C3-triazole-4-yl%2529propane-1%252C3-diol%2520Derivative%2520of%2520Novel%2520Compound%2520for%2520Directly%2520Inhibiting%2520ASM%2520Activity%252C%2520and%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of n-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ejmech.2018.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29649738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Kgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=389-400&author=K.+Yangauthor=K.+Nongauthor=Q.+Guauthor=J.+Dongauthor=J.+Wang&title=Discovery+of+n-hydroxy-3-alkoxybenzamides+as+direct+acid+sphingomyelinase+inhibitors+using+a+ligand-based+pharmacophore+model&doi=10.1016%2Fj.ejmech.2018.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model</span></div><div class="casAuthors">Yang, Kan; Nong, Keyi; Gu, Qinlan; Dong, Jibin; Wang, Jinxin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">389-400</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASM) has been shown to be involved in many physiol. processes, emerging to be a promising drug target.  In this study, we constructed a ligand-based pharmacophore model of ASM inhibitors and applied this model to optimize the lead compd. α-mangostin, a known inhibitor of ASM.  23 Compds. were designed and evaluated in vitro for ASM inhibition, of these, 10 compds. were found to be more potent than α-mangostin.  This high hit ratio confirmed that the presented model is very effective and practical.  The most potent hit, 1c, was found to selectively and competitively inhibit the enzyme and inhibit the generation of ceramide in a dose-dependent manner.  Furthermore, I showed favorable anti-apoptosis and anti-inflammatory activity.  Interactions with key residues and the Zn2+ cofactor of I were found by docking simulation.  These results provide promising leads and important guidance for further development of efficient ASM inhibitors and drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg1Vwn1QZzrVg90H21EOLACvtfcHk0ljmYt93JAvZbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Kgsbo%253D&md5=4f5e67c39cf4fa35d7b17811ed80e289</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%26aulast%3DNong%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520n-hydroxy-3-alkoxybenzamides%2520as%2520direct%2520acid%2520sphingomyelinase%2520inhibitors%2520using%2520a%2520ligand-based%2520pharmacophore%2520model%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D389%26epage%3D400%26doi%3D10.1016%2Fj.ejmech.2018.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, and direct acid sphingomyelinase inhibitors with antidepressant activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=961-974&author=K.+Yangauthor=J.+Yuauthor=K.+Nongauthor=Y.+Wangauthor=A.+Niuauthor=W.+Chenauthor=J.+Dongauthor=J.+Wang&title=Discovery+of+potent%2C+selective%2C+and+direct+acid+sphingomyelinase+inhibitors+with+antidepressant+activity&doi=10.1021%2Facs.jmedchem.9b00739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity</span></div><div class="casAuthors">Yang, Kan; Yu, Jinying; Nong, Keyi; Wang, Youzhi; Niu, Ao; Chen, Wenlu; Dong, Jibin; Wang, Jinxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent studies on sphingolipids suggest that acid sphingomyelinase (ASM), which plays a central role in the pathogenesis of major depression, is emerging to be a novel target for developing antidepressants.  Herein we first described the design, synthesis, and biol. evaluation of hydroxamic acid-based direct inhibitors of ASM with the effort of validating their antidepressant effects in vivo.  As a result, a series of novel ASM inhibitors were developed using a structure-based approach.  Our studies demonstrated that the administration of 21b improved depression-like behaviors of rats.  Importantly, this pos. result was relevant to the inhibition of ASM and the increasing neurogenesis in hippocampus.  To the best of our knowledge, this is the first time that direct inhibitors of ASM were developed to support the possibility of ASM as a potential therapeutic target for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaRf8-JMXEB7Vg90H21EOLACvtfcHk0ljmYt93JAvZbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFaku7w%253D&md5=0ac57f01159135c8f07db40ae09c0234</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00739%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNong%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520and%2520direct%2520acid%2520sphingomyelinase%2520inhibitors%2520with%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D961%26epage%3D974%26doi%3D10.1021%2Facs.jmedchem.9b00739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumbansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, W.</span></span> <span> </span><span class="NLM_article-title">Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3638</span>– <span class="NLM_lpage">3643</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.95.7.3638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9520418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXitlKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3638-3643&author=S.+Tomiukauthor=K.+Hofmannauthor=M.+Nixauthor=M.+Zumbansenauthor=W.+Stoffel&title=Cloned+mammalian+neutral+sphingomyelinase%3A+Functions+in+sphingolipid+signaling%3F&doi=10.1073%2Fpnas.95.7.3638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?</span></div><div class="casAuthors">Tomiuk, Stefan; Hofmann, Kay; Nix, Michael; Zumbansen, Markus; Stoffel, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3638-3643</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sphingomyelin is an abundant constituent of the plasma membranes of mammalian cells.  Ceramide, its primary catabolic intermediate, is released by either acid sphingomyelinase or neutral sphingomyelinase (nSMase) and has emerged as a potential lipid signaling mol.  NSMase is regarded as a key enzyme in the regulated activation of the "sphingomyelin cycle" and cell signaling.  The authors report the cloning, identification, and functional characterization of murine and human nSMase, a ubiquitously expressed integral membrane protein, which displays all established properties of the Mg2+-dependent nSMase of the plasma membrane.  Stably nSMase-overexpressing U937 and human embryonic kidney cell lines have been generated for the study of the role of nSMase in signal transduction pathways.  Their stimulation by tumor necrosis factor α leads only to a moderately elevated ceramide concn.  Activation of Jun kinase and NFκB and poly(ADP-ribose) polymerase cleavage are identical in mock-and nSMase-transfected cells.  Tumor necrosis factor α triggers the ERK1 pathway in none of the cell lines.  The cloned nSMase will facilitate further controlled expts. aiming at the definition of a possible role of ceramide as signal transduction mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGranQXUyC1yqLVg90H21EOLACvtfcHk0ljmYt93JAvZbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlKjsbg%253D&md5=1995f8a2b4ed689e9d3e162342bb1009</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3638%26sid%3Dliteratum%253Aachs%26aulast%3DTomiuk%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DNix%26aufirst%3DM.%26aulast%3DZumbansen%26aufirst%3DM.%26aulast%3DStoffel%26aufirst%3DW.%26atitle%3DCloned%2520mammalian%2520neutral%2520sphingomyelinase%253A%2520Functions%2520in%2520sphingolipid%2520signaling%253F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3638%26epage%3D3643%26doi%3D10.1073%2Fpnas.95.7.3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of the mammalian brain-specific, mg2+-dependent neutral sphingomyelinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">5895</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.11.5895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.97.11.5895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10823942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFaktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5895-5900&author=K.+Hofmannauthor=S.+Tomiukauthor=G.+Wolffauthor=W.+Stoffel&title=Cloning+and+characterization+of+the+mammalian+brain-specific%2C+mg2%2B-dependent+neutral+sphingomyelinase&doi=10.1073%2Fpnas.97.11.5895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase</span></div><div class="casAuthors">Hofmann, Kay; Tomiuk, Stefan; Wolff, Gabriela; Stoffel, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5895-5900</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The enzymic breakdown of sphingomyelin by sphingomyelinases is considered the major source of the second messenger ceramide.  Studies on the contribution of the various described acidic and neutral sphingomyelinases to the signaling pool of ceramide have been hampered by the lack of mol. data on the neutral sphingomyelinases (nSMases).  We recently identified a mammalian nSMase, an integral membrane protein with remote similarity to bacterial sphingomyelinases.  However, its ubiquitous expression pattern is in contrast to previous findings that sphingomyelinase activity is found mainly in brain tissues.  By using an improved database search method, combined with phylogenetic anal., we identified a second mammalian nSMase (nSMase2) with predominant expression in the brain.  The sphingomyelinase activity of nSMase2 has a neutral pH optimum, depends on Mg2+ ions, and is activated by unsatd. fatty acids and phosphatidylserine.  Immunofluorescence reveals a neuron-specific punctate perinuclear staining, which colocalizes with a Golgi marker in a no. of cell lines.  The likely identity of nSMase2 with cca1, a rat protein involved in contact inhibition of 3Y1 fibroblasts, suggests a role for this enzyme in cell cycle arrest.  Both mammalian nSMases are members of a superfamily of Mg2+-dependent phosphohydrolases, which also contains nucleases, inositol phosphatases, and bacterial toxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri8YSeb_HvprVg90H21EOLACvtfcHk0ljmYt93JAvZbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFaktbk%253D&md5=8d654f410cafbdb041ad3554d58c8fd6</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.11.5895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.11.5895%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DTomiuk%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DG.%26aulast%3DStoffel%26aufirst%3DW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520mammalian%2520brain-specific%252C%2520mg2%252B-dependent%2520neutral%2520sphingomyelinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5895%26epage%3D5900%26doi%3D10.1073%2Fpnas.97.11.5895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krut, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashkar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdanpanah, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronke, M.</span></span> <span> </span><span class="NLM_article-title">Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a c-tail-anchored protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">13784</span>– <span class="NLM_lpage">13793</span>, <span class="refDoi"> DOI: 10.1074/jbc.M511306200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M511306200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16517606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1ymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13784-13793&author=O.+Krutauthor=K.+Wiegmannauthor=H.+Kashkarauthor=B.+Yazdanpanahauthor=M.+Kronke&title=Novel+tumor+necrosis+factor-responsive+mammalian+neutral+sphingomyelinase-3+is+a+c-tail-anchored+protein&doi=10.1074%2Fjbc.M511306200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein</span></div><div class="casAuthors">Krut, Oleg; Wiegmann, Katja; Kashkar, Hamid; Yazdanpanah, Benjamin; Kroenke, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">13784-13793</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Two genes encoding neutral sphingomyelinases-1 and -2 (sphingomyelin phosphodiesterases-2 and -3) have been recently identified that hydrolyze sphingomyelin to phosphorylcholine and ceramide.  Data bank searches using a peptide sequence derived from a previously purified bovine neutral sphingomyelinase (nSMase) allowed us to identify a cDNA encoding a novel human sphingomyelinase, nSMase3, that shows only a little homol. to nSMase1 and -2.  The nSMase3 form was biochem. characterized by overexpression in a yeast strain, JK9-3dΔIsc1p, lacking endogenous SMase activity.  Similar to nSMase2, nSMase3 is Mg2+-dependent and shows optimal activity at pH 7, which is enhanced in the presence of phosphatidylserine and inhibited by scyphostatin.  NSMase3 is ubiquitously expressed as a 4.6-kb mRNA species.  NSMase3 lacks an N-terminal signal peptide, yet contains a 23-amino-acid transmembrane domain close to the C terminus, which is indicative for the family of C-tail-anchored integral membrane proteins.  Cellular localization studies with hemagglutinin-tagged nSMase3 demonstrated colocalization with markers of the endoplasmic reticulum as well as with Golgi markers.  Tumor necrosis factor stimulates rapid activation of nSMase3 in MCF7 cells with peak activity at 1.5 min, which was impaired by expression of dominant neg. FAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRowycGxPrcLVg90H21EOLACvtfcHk0ljiDRETfQVZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1ymuro%253D&md5=f184626d70d9e378f96da814616e0bab</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511306200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511306200%26sid%3Dliteratum%253Aachs%26aulast%3DKrut%26aufirst%3DO.%26aulast%3DWiegmann%26aufirst%3DK.%26aulast%3DKashkar%26aufirst%3DH.%26aulast%3DYazdanpanah%26aufirst%3DB.%26aulast%3DKronke%26aufirst%3DM.%26atitle%3DNovel%2520tumor%2520necrosis%2520factor-responsive%2520mammalian%2520neutral%2520sphingomyelinase-3%2520is%2520a%2520c-tail-anchored%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13784%26epage%3D13793%26doi%3D10.1074%2Fjbc.M511306200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopalan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (ma-nsmase), the mammalian sphingomyelin phosphodiesterase 5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">17993</span>– <span class="NLM_lpage">18002</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.102988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M110.102988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20378533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslSmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17993-18002&author=B.+X.+Wuauthor=V.+Rajagopalanauthor=P.+L.+Roddyauthor=C.+J.+Clarkeauthor=Y.+A.+Hannun&title=Identification+and+characterization+of+murine+mitochondria-associated+neutral+sphingomyelinase+%28ma-nsmase%29%2C+the+mammalian+sphingomyelin+phosphodiesterase+5&doi=10.1074%2Fjbc.M110.102988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Murine Mitochondria-associated Neutral Sphingomyelinase (MA-nSMase), the Mammalian Sphingomyelin Phosphodiesterase 5</span></div><div class="casAuthors">Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">17993-18002</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingolipids play important roles in regulating cellular responses.  Although mitochondria contain sphingolipids, direct regulation of their levels in mitochondria or mitochondria-assocd. membranes is mostly unclear.  Neutral SMase (N-SMase) isoforms, which catalyze hydrolysis of sphingomyelin (SM) to ceramide and phosphocholine, have been found in the mitochondria of yeast and zebrafish, yet their existence in mammalian mitochondria remains unknown.  Here, we have identified and cloned a cDNA based on nSMase homologous sequences.  This cDNA encodes a novel protein of 483 amino acids that displays significant homol. to nSMase2 and possesses the same catalytic core residues as members of the extended N-SMase family.  A transiently expressed V5-tagged protein co-localized with both mitochondria and endoplasmic reticulum markers in MCF-7 and HEK293 cells; accordingly, the enzyme is referred to as mitochondria-assocd. nSMase (MA-nSMase).  MA-nSMase was highly expressed in testis, pancreas, epididymis, and brain.  MA-nSMase had an abs. requirement for cations such as Mg2+ and Mn2+ and activation by the anionic phospholipids, esp. phosphatidylserine and the mitochondrial cardiolipin.  Importantly, overexpression of MA-nSMase in HEK293 cells significantly increased in vitro N-SMase activity and also modulated the levels of SM and ceramide, indicating that the identified cDNA encodes a functional SMase.  Thus, these studies identify and characterize, for the first time, a mammalian MA-nSMase.  The characterization of MA-nSMase described here will contribute to our understanding of pathways regulated by sphingolipid metabolites, particularly with ref. to the mitochondria and assocd. organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KSf5S1g4obVg90H21EOLACvtfcHk0ljiDRETfQVZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslSmtr8%253D&md5=281e883461b5332155b423e34176bba3</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.102988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.102988%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DRajagopalan%26aufirst%3DV.%26aulast%3DRoddy%26aufirst%3DP.%2BL.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520murine%2520mitochondria-associated%2520neutral%2520sphingomyelinase%2520%2528ma-nsmase%2529%252C%2520the%2520mammalian%2520sphingomyelin%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17993%26epage%3D18002%26doi%3D10.1074%2Fjbc.M110.102988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snook, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matmati, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchesini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The extended family of neutral sphingomyelinases</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">11247</span>– <span class="NLM_lpage">11256</span>, <span class="refDoi"> DOI: 10.1021/bi061307z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi061307z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=11247-11256&author=C.+J.+Clarkeauthor=C.+F.+Snookauthor=M.+Taniauthor=N.+Matmatiauthor=N.+Marchesiniauthor=Y.+A.+Hannun&title=The+extended+family+of+neutral+sphingomyelinases&doi=10.1021%2Fbi061307z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The extended family of neutral sphingomyelinases</span></div><div class="casAuthors">Clarke, Christopher J.; Snook, Christopher F.; Tani, Motohiro; Matmati, Nabil; Marchesini, Norma; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11247-11256</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The neutral sphingomyelinases (N-SMases) are considered major candidates for mediating the stress-induced prodn. of ceramide, and N-SMase activity has been identified, characterized, and cloned from bacteria, yeast, and mammalian cells.  Although the level of identity between these enzymes is low, a no. of key residues thought to be involved in metal binding and catalysis are conserved.  This has led to the suggestion of a common catalytic mechanism, and thus, these enzymes are considered to form an extended family of N-SMases.  Despite considerable research into N-SMase activity in cell culture and various tissues, the lack, until recently, of the mol. identification of specific N-SMase enzymes had precluded specific insights into the regulation, physiol., and pathol. roles of these proteins.  Here, the authors summarize, for the 1st time, current knowledge of the N-SMase family, focusing on cloned members from bacteria, yeast, and mammalian cells.  The authors also briefly consider the major future directions for N-SMase research which promises highly significant and specific insight into sphingolipid-mediated functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE2InB-BZkqbVg90H21EOLACvtfcHk0ljiDRETfQVZTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVaht70%253D&md5=60d576631630dab3e4c48c224489d087</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbi061307z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061307z%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DSnook%26aufirst%3DC.%2BF.%26aulast%3DTani%26aufirst%3DM.%26aulast%3DMatmati%26aufirst%3DN.%26aulast%3DMarchesini%26aufirst%3DN.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520extended%2520family%2520of%2520neutral%2520sphingomyelinases%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D11247%26epage%3D11256%26doi%3D10.1021%2Fbi061307z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses</span>. <i>NeuroMol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1007/s12017-010-8120-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12017-010-8120-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20552297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVegurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=320-330&author=B.+X.+Wuauthor=C.+J.+Clarkeauthor=Y.+A.+Hannun&title=Mammalian+neutral+sphingomyelinases%3A+Regulation+and+roles+in+cell+signaling+responses&doi=10.1007%2Fs12017-010-8120-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses</span></div><div class="casAuthors">Wu, Bill X.; Clarke, Christopher J.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ceramide, a bioactive lipid, has been extensively studied and identified as an essential bioactive mol. in mediating cellular signaling pathways.  Sphingomyelinase (SMase; EC 3.1.4.12) catalyzes the cleavage of the phosphodiester bond in sphingomyelin (SM) to form ceramide and phosphocholine.  In mammals, 3 Mg2+-dependent neutral SMases termed nSMase1, nSMase2, and nSMase3 have been identified.  Among the 3 enzymes, nSMase2 is the most studied and has been implicated in multiple physiol. responses including cell growth arrest, apoptosis, development and inflammation.  Here, the authors summarize recent findings for the cloned nSMases and discuss insights into their roles in the regulation of ceramide metab. and the cellular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkPT177CCAL7Vg90H21EOLACvtfcHk0lh_lh2MFsnj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVegurjL&md5=ca774d00ab7254f9203680d0102f4be3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs12017-010-8120-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-010-8120-z%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DMammalian%2520neutral%2520sphingomyelinases%253A%2520Regulation%2520and%2520roles%2520in%2520cell%2520signaling%2520responses%26jtitle%3DNeuroMol.%2520Med.%26date%3D2010%26volume%3D12%26spage%3D320%26epage%3D330%26doi%3D10.1007%2Fs12017-010-8120-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhogue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamseddine, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guja, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkal, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Structure of human nsmase2 reveals an interdomain allosteric activation mechanism for ceramide generation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5549</span>– <span class="NLM_lpage">E5558</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705134114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.1705134114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28652336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5549-E5558&author=M.+V.+Airolaauthor=P.+Shanbhogueauthor=A.+A.+Shamseddineauthor=K.+E.+Gujaauthor=C.+E.+Senkalauthor=R.+Mainiauthor=N.+Bartkeauthor=B.+X.+Wuauthor=L.+M.+Obeidauthor=M.+Garcia-Diazauthor=Y.+A.+Hannun&title=Structure+of+human+nsmase2+reveals+an+interdomain+allosteric+activation+mechanism+for+ceramide+generation&doi=10.1073%2Fpnas.1705134114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation</span></div><div class="casAuthors">Airola, Michael V.; Shanbhogue, Prajna; Shamseddine, Achraf A.; Guja, Kip E.; Senkal, Can E.; Maini, Rohan; Bartke, Nana; Wu, Bill X.; Obeid, Lina M.; Garcia-Diaz, Miguel; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">E5549-E5558</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2, product of the SMPD3 gene) is a key enzyme for ceramide generation that is involved in regulating cellular stress responses and exosome-mediated intercellular communication.  NSMase2 is activated by diverse stimuli, including the anionic phospholipid phosphatidylserine.  Phosphatidylserine binds to an integral-membrane N-terminal domain (NTD); however, how the NTD activates the C-terminal catalytic domain is unclear.  Here, we identify the complete catalytic (CAT) domain of nSMase2, which was misannotated because of a large insertion.  We find the sol. catalytic domain interacts directly with the membrane-assocd. NTD, which serves as both a membrane anchor and an allosteric activator.  The juxtamembrane (JX) region, which links the NTD and the catalytic domain, is necessary and sufficient for activation.  Furthermore, we provide a mechanistic basis for this phenomenon using the crystal structure of the human nSMase2 catalytic domain detd. at 1.85-Å resoln.  The structure reveals a DNase-I-type fold with a hydrophobic track leading to the active site that is blocked by an evolutionarily conserved motif which we term the "DK switch.".  Structural anal. of nSMase2 and the extended N-SMase family shows that the DK switch can adopt different conformations to reposition a universally conserved Asp (D) residue involved in catalysis.  Mutation of this Asp residue in nSMase2 disrupts catalysis, allosteric activation, stimulation by phosphatidylserine, and pharmacol. inhibition by the lipid-competitive inhibitor GW4869.  Taken together, these results demonstrate that the DK switch regulates ceramide generation by nSMase2 and is governed by an allosteric interdomain interaction at the membrane interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhgaERXSsTLVg90H21EOLACvtfcHk0lh_lh2MFsnj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsrnL&md5=3e3b01cd7d5910f27316563650eb5fc2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705134114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705134114%26sid%3Dliteratum%253Aachs%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DShanbhogue%26aufirst%3DP.%26aulast%3DShamseddine%26aufirst%3DA.%2BA.%26aulast%3DGuja%26aufirst%3DK.%2BE.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DBartke%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DGarcia-Diaz%26aufirst%3DM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DStructure%2520of%2520human%2520nsmase2%2520reveals%2520an%2520interdomain%2520allosteric%2520activation%2520mechanism%2520for%2520ceramide%2520generation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE5549%26epage%3DE5558%26doi%3D10.1073%2Fpnas.1705134114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhogue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">7488</span>– <span class="NLM_lpage">7502</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.007288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.RA118.007288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30890560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=7488-7502&author=P.+Shanbhogueauthor=R.+M.+Hoffmannauthor=M.+V.+Airolaauthor=R.+Mainiauthor=D.+J.+Hamelinauthor=M.+Garcia-Diazauthor=J.+E.+Burkeauthor=Y.+A.+Hannun&title=The+juxtamembrane+linker+in+neutral+sphingomyelinase-2+functions+as+an+intramolecular+allosteric+switch+that+activates+the+enzyme&doi=10.1074%2Fjbc.RA118.007288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme</span></div><div class="casAuthors">Shanbhogue, Prajna; Hoffmann, Reece M.; Airola, Michael V.; Maini, Rohan; Hamelin, David J.; Garcia-Diaz, Miguel; Burke, John E.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7488-7503</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2) produces the bioactive lipid ceramide and has important roles in neurodegeneration, cancer, and exosome formation.  Although nSMase2 has low basal activity, it is fully activated by phosphatidylserine (PS).  Previous work showed that interdomain interactions within nSMase2 are needed for PS activation.  Here, we use multiple approaches, including small angle X-ray scattering, hydrogen-deuterium exchange-MS, CD and thermal shift assays, and membrane yeast two-hybrid assays, to define the mechanism mediating this interdomain interactions within nSMase2.  In contrast to what we previously assumed, we demonstrate that PS binding at the N-terminal and juxtamembrane regions of nSMase2 rather acts as a conformational switch leading to interdomain interactions that are crit. to enzyme activation.  Our work assigns a unique function for a class of linkers of lipid-activated, membrane-assocd. proteins.  It indicates that the linker actively participates in the activation mechanism via intramol. interactions, unlike the canonical linkers that typically aid protein dimerization or localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTN0n-i4dFrVg90H21EOLACvtfcHk0lh_lh2MFsnj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWiu7nE&md5=8780d6bdb95b8cc657a5bf12997f2957</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.007288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.007288%26sid%3Dliteratum%253Aachs%26aulast%3DShanbhogue%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DR.%2BM.%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DHamelin%26aufirst%3DD.%2BJ.%26aulast%3DGarcia-Diaz%26aufirst%3DM.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520juxtamembrane%2520linker%2520in%2520neutral%2520sphingomyelinase-2%2520functions%2520as%2520an%2520intramolecular%2520allosteric%2520switch%2520that%2520activates%2520the%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D7488%26epage%3D7502%26doi%3D10.1074%2Fjbc.RA118.007288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, trichopeziza mollissima: Taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10587877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=525-530&author=F.+Naraauthor=M.+Tanakaauthor=T.+Hosoyaauthor=K.+Suzuki-Konagaiauthor=T.+Ogita&title=Scyphostatin%2C+a+neutral+sphingomyelinase+inhibitor+from+a+discomycete%2C+trichopeziza+mollissima%3A+Taxonomy+of+the+producing+organism%2C+fermentation%2C+isolation%2C+and+physico-chemical+properties&doi=10.7164%2Fantibiotics.52.525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties</span></div><div class="casAuthors">Nara, Futoshi; Tanaka, Masahiro; Hosoya, Tsuyoshi; Suzuki-Konagai, Keiko; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-530</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">We performed expts. to screen for neutral sphingomyelinase inhibitors using rat brain microsomes as an enzyme source.  Among more than 10,000 microbial exts. tested, a mycelial ext. of Trichopeziza mollissima SANK 13892 exhibited potent inhibitory activity.  The active compd., scyphostatin (I), was purified by a series of chromatogs.  I inhibited the enzyme with an IC50 value of 1.0 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB9zc76Lzl37Vg90H21EOLACvtfcHk0lh_lh2MFsnj-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitb4%253D&md5=389dcf1cb5d14bf143ade732534bd75d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.525%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DF.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DScyphostatin%252C%2520a%2520neutral%2520sphingomyelinase%2520inhibitor%2520from%2520a%2520discomycete%252C%2520trichopeziza%2520mollissima%253A%2520Taxonomy%2520of%2520the%2520producing%2520organism%252C%2520fermentation%252C%2520isolation%252C%2520and%2520physico-chemical%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D525%26epage%3D530%26doi%3D10.7164%2Fantibiotics.52.525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">7871</span>– <span class="NLM_lpage">7872</span>, <span class="refDoi"> DOI: 10.1021/ja9713385</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9713385" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1yktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7871-7872&author=M.+Tanakaauthor=F.+Naraauthor=K.+Suzuki-Konagaiauthor=T.+Hosoyaauthor=T.+Ogita&title=Structural+elucidation+of+scyphostatin%2C+an+inhibitor+of+membrane-bound+neutral+sphingomyelinase&doi=10.1021%2Fja9713385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Elucidation of Scyphostatin, an Inhibitor of Membrane-Bound Neutral Sphingomyelinase</span></div><div class="casAuthors">Tanaka, Masahiro; Nara, Futoshi; Suzuki-Konagai, Keiko; Hosoya, Tsuyoshi; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7871-7872</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structural elucidation and abs. ring stereochem. of scyphostatin (I), a structure composed of a fatty acid and an amino acid substituted by a highly oxygenated cyclohexenone moiety is described.  I exhibited potent inhibitory activity (IC50 = 1.0 mM) to neutral sphingomyelinase and is the first inhibitor of the enzyme from either natural sources or synthetic origin except for ganglioside GM3 (IC50 = 45 mM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGYwj-rUedrVg90H21EOLACvtfcHk0lh_iJl5Uv-V6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1yktLo%253D&md5=538801be2db56e68aa3a9326df8feea8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fja9713385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9713385%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DStructural%2520elucidation%2520of%2520scyphostatin%252C%2520an%2520inhibitor%2520of%2520membrane-bound%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7871%26epage%3D7872%26doi%3D10.1021%2Fja9713385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span> <span> </span><span class="NLM_article-title">Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">12550</span>– <span class="NLM_lpage">12556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2945240-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=3040755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFSnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=12550-12556&author=P.+Ghoshauthor=S.+Chatterjee&title=Effects+of+gentamicin+on+sphingomyelinase+activity+in+cultured+human+renal+proximal+tubular+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells</span></div><div class="casAuthors">Ghosh, Pradeep; Chatterjee, Subroto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">12550-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">In order to delineate the biochem. mechanisms responsible for the accumulation of sphingomyelin in proximal tubular cells (PT) incubated with gentamicin, studies on the activity of sphingomyelinase were pursued.  Characterization studies on sphingomyelinase revealed that this enzyme has a bimodal pH optima in PT cells.  Optimum activity was obsd. at pH 5.6 (designated as acid sphingomyelinase, A-SMase) and at pH 7.4 (designated as neutral sphingomyelinase, N-SMase).  The activity of both the enzymes increased proportionately in control cells as a function of days of incubation.  The activity of ASMase was 16% lower in cells incubated with gentamicin as compared to control.  The most striking observation was a gradual decline in the activity of N-SMase in cells incubated with gentamicin.  Thus, following 21 days of incubation of cells with 0.3 mM gentamicin, the N-SMase was 2.7-fold lower than control cells.  It appears that gentamicin exerts a competitive inhibition of the A-SMase in PT cells.  In contrast, gentamicin exerts a noncompetitive inhibition of the N-SMase in PT cells.  Thus gentamicin-mediated decrease in sphingomyelinase activity may be responsible for the storage of sphingomyelin in cultured human PT cells.  Furthermore N-SMase may play a role in gentamicin-induced nephrotoxicity in cultured human PT cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCnsG-gpTr1rVg90H21EOLACvtfcHk0lh_iJl5Uv-V6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFSnsb8%253D&md5=5de9a075aa155142d6f36c9b8d11db6d</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2945240-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252945240-4%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DP.%26aulast%3DChatterjee%26aufirst%3DS.%26atitle%3DEffects%2520of%2520gentamicin%2520on%2520sphingomyelinase%2520activity%2520in%2520cultured%2520human%2520renal%2520proximal%2520tubular%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D12550%26epage%3D12556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lister, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford-Redick, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, C. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of the neutral ph-optimum sphingomyelinase from rat brain: Inhibition by copper ii and ganglioside gm3</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>1165</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(93)90142-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2893%2990142-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8418889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3sXhtF2nurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1165&publication_year=1993&pages=314-320&author=M.+D.+Listerauthor=C.+L.+Crawford-Redickauthor=C.+R.+Loomis&title=Characterization+of+the+neutral+ph-optimum+sphingomyelinase+from+rat+brain%3A+Inhibition+by+copper+ii+and+ganglioside+gm3&doi=10.1016%2F0005-2760%2893%2990142-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3</span></div><div class="casAuthors">Lister, Mark D.; Crawford-Redick, Catherine L.; Loomis, Carson R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">1165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-20</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A neutral pH-optimum sphingomyelinase (N-SMase), solubilized from rat brain membranes, was characterized with respect to metal and membrane lipid effects.  Chromatofocusing chromatog., which separates proteins according to pI, showed 2 N-SMase activities.  One eluted at pH 4.7 and the other required 0.4M NaCl before elution.  Kinetically, the 2 prepns. appeared similar.  The N-SMase eluting at pH 4.7 was most extensively studied here.  Of the phospholipids studied, only phosphatidylserine showed any influence on N-SMase and that was to increase its activity by as much as 50%.  Neither serine nor phosphatidic acid had any effect.  Of the cations tested, none was able to replace Mg2+ as a required activator.  However, it was found that several metals were inhibitory, with Cu2+ being most effective (IC50 = 5 μM).  Gangliosides, particularly the monosialoganglioside, GM3 (IC50 = ∼50 μM), inhibited N-SMase.  Other glycolipids showed little effect on activity, even the immediate precursor to GM3, lactosylceramide.  The ganglioside sugar, N-acetylneuraminic acid, also had no effect on N-SMase activity.  None of these inhibitors affected the acidic pH optimum sphingomyelinase.  Other sphingolipid compds., such as ceramide, the enzymic product, and sphingosylphosphorylcholine (lysosphingomyelin), showed no capacity to inhibit N-Smase, implying that the enzyme may have a selective substrate-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95chNt8PoKbVg90H21EOLACvtfcHk0lh_iJl5Uv-V6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtF2nurg%253D&md5=29b2319f54d574a160d7a025e30d236c</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2893%2990142-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252893%252990142-V%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DM.%2BD.%26aulast%3DCrawford-Redick%26aufirst%3DC.%2BL.%26aulast%3DLoomis%26aufirst%3DC.%2BR.%26atitle%3DCharacterization%2520of%2520the%2520neutral%2520ph-optimum%2520sphingomyelinase%2520from%2520rat%2520brain%253A%2520Inhibition%2520by%2520copper%2520ii%2520and%2520ganglioside%2520gm3%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1993%26volume%3D1165%26spage%3D314%26epage%3D320%26doi%3D10.1016%2F0005-2760%2893%2990142-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda-Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi-Yoshioka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, trichopeziza mollissima</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10470676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=531-535&author=F.+Naraauthor=M.+Tanakaauthor=S.+Masuda-Inoueauthor=Y.+Yamasatoauthor=H.+Doi-Yoshiokaauthor=K.+Suzuki-Konagaiauthor=S.+Kumakuraauthor=T.+Ogita&title=Biological+activities+of+scyphostatin%2C+a+neutral+sphingomyelinase+inhibitor+from+a+discomycete%2C+trichopeziza+mollissima&doi=10.7164%2Fantibiotics.52.531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima</span></div><div class="casAuthors">Nara, Futoshi; Tanaka, Masahiro; Masuda-Inoue, Seiko; Yamasato, Yoko; Doi-Yoshioka, Hiromi; Suzuki-Konagai, Keiko; Kumakura, Seiichiro; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-535</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Scyphostatin is a specific inhibitor for mammalian neutral magnesium-dependent sphingomyelinase with a fifty percent inhibition concn. (IC50) value of 1.0 μM.  When used to inhibit lysosomal acid sphingomyelinase, an approx. 50-fold greater concn. is required.  In human peripheral monocytes, the compd. inhibits bacterial lipopolysaccharide (LPS)-induced prostaglandin E2 prodn. and LPS-induced interleukin-1β prodn. with IC50 values of 0.8 μM and 0.1 μM, resp.  In rat, p.o. administration of the compd. has also been shown to inhibit carrageenin-induced paw edema.  Thus, it is hoped that utility of scyphostatin as a pharmacol. tool will contribute to our understanding of the role of ceramide in the cellular inflammation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorgn3mBcPSbVg90H21EOLACvtfcHk0libJcfAVzD72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitb8%253D&md5=51bcb255040c4ba2025af950f456b9fa</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.531%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DF.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMasuda-Inoue%26aufirst%3DS.%26aulast%3DYamasato%26aufirst%3DY.%26aulast%3DDoi-Yoshioka%26aufirst%3DH.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DBiological%2520activities%2520of%2520scyphostatin%252C%2520a%2520neutral%2520sphingomyelinase%2520inhibitor%2520from%2520a%2520discomycete%252C%2520trichopeziza%2520mollissima%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D531%26epage%3D535%26doi%3D10.7164%2Fantibiotics.52.531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1440</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(20000417)39:8<1440::AID-ANIE1440>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=1440-1442&author=C.+Arenzauthor=A.+Giannis&title=Synthesis+of+the+first+selective+irreversible+inhibitor+of+neutral+sphingomyelinase&doi=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1440-1442</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The epoxide I was prepd. from D-serine by reaction with decanoyl chloride and 5-amino-2-hydroxybenzyl alc., followed by epoxide ring formation.  I inhibited neutral sphingomyelinase, an effect that was inhibited by increased concns. of sphingomyelin, indicating that the compd. binds to the active site of the enzyme.  I does not inhibit acid sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdM4stC4pm7Vg90H21EOLACvtfcHk0libJcfAVzD72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFSqsrk%253D&md5=05f474fcb171fd95525bbbbdc4ae75a9</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252820000417%252939%253A8%253C1440%253A%253AAID-ANIE1440%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520the%2520first%2520selective%2520irreversible%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D1440%26epage%3D1442%26doi%3D10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wascholowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(01)00165-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0968-0896%2801%2900165-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11597471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2901-2904&author=C.+Arenzauthor=M.+Gartnerauthor=V.+Wascholowskiauthor=A.+Giannis&title=Synthesis+and+biochemical+investigation+of+scyphostatin+analogues+as+inhibitors+of+neutral+sphingomyelinase&doi=10.1016%2FS0968-0896%2801%2900165-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Gartner, Michael; Wascholowski, Veit; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The sphingolipid ceramide is considered to be an important intracellular mediator.  However, many aspects of its action and the role of several different ceramide generating sphingomyelinases are still unclear.  Recently, the synthesis of the first selective irreversible inhibitor of the neutral sphingomyelinase (N-SMase), as well as the identification of Manumycin A and some of its analogs as irreversible inhibitors of N-SMase were reported.  For the development of pharmacol. interesting competitive inhibitors of N-SMase, structure-activity studies are essential.  Herein the synthesis and enzymic investigation of two scyphostatin analogs revealing the importance of the primary hydroxy group in N-[(1R)-1-(hydroxymethyl)-2-oxo-2-[(8-oxo-1-oxaspiro[2.5]octa-4,6-dien-5-yl)amino]ethyl]decanamide for N-SMase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreluVKWEKi4LVg90H21EOLACvtfcHk0libJcfAVzD72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGktbk%253D&md5=b6a1c74fff9b7d347bc72683a18b8138</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900165-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900165-1%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGartner%26aufirst%3DM.%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biochemical%2520investigation%2520of%2520scyphostatin%2520analogues%2520as%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D2901%26epage%3D2904%26doi%3D10.1016%2FS0968-0896%2801%2900165-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thutewohl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenbach, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Manumycin a and its analogues are irreversible inhibitors of neutral sphingomyelinase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20010202)2:2<141::AID-CBIC141>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11828438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=141-143&author=C.+Arenzauthor=M.+Thutewohlauthor=O.+Blockauthor=H.+Waldmannauthor=H.+J.+Altenbachauthor=A.+Giannis&title=Manumycin+a+and+its+analogues+are+irreversible+inhibitors+of+neutral+sphingomyelinase&doi=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Thutewohl, Michael; Block, Oliver; Waldmann, Herbert; Altenbach, Hans-Josef; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-143</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Using a raw microsome prepn., rat brain Mg+2-dependent neutral sphingomyelinase was inhibited by manumycin A, whereas lysosomal acid sphingomyelinase was not inhibited.  Four analogs of manumycin A were also tested and 2 of them inhibited the neutral sphingomyelinase.  The active compds. were also shown to be inhibitors of Ras farnesyltransferase (which is inhibited by manumycin A).  The relation of these results to the anti-inflammatory activity of manumycin A and the role of neutral sphingomyelinase in signal transduction are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPS9sStQGXLVg90H21EOLACvtfcHk0lgHOvICw04aLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVSqsbc%253D&md5=151df29021aaaaa73dfbb32bb8d6addf</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820010202%25292%253A2%253C141%253A%253AAID-CBIC141%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DThutewohl%26aufirst%3DM.%26aulast%3DBlock%26aufirst%3DO.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DAltenbach%26aufirst%3DH.%2BJ.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DManumycin%2520a%2520and%2520its%2520analogues%2520are%2520irreversible%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DChemBioChem%26date%3D2001%26volume%3D2%26spage%3D141%26epage%3D143%26doi%3D10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span> <span> </span><span class="NLM_article-title">Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by penicillium sp. Fo-7436</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10470682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=572-574&author=R.+Uchidaauthor=H.+Tomodaauthor=Y.+Dongauthor=S.+Omura&title=Alutenusin%2C+a+specific+neutral+sphingomyelinase+inhibitor%2C+produced+by+penicillium+sp.+Fo-7436&doi=10.7164%2Fantibiotics.52.572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by Penicillium sp. FO-7436</span></div><div class="casAuthors">Uchida, Ryuji; Tomoda, Hiroshi; Dong, Yuesheng; Omura, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-574</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The fermn., isolation, and sphingomyelinase-inhibiting activity of alutenusin (I) of Penicillium FO-7436 are described.  I is a specific inhibitor of neutral sphingomyelinase (Ki = 20 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLr8aQNOH0rVg90H21EOLACvtfcHk0lgHOvICw04aLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitbk%253D&md5=ed7fcf0c05400125d3fcea96955486ab</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.572%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DR.%26aulast%3DTomoda%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DOmura%26aufirst%3DS.%26atitle%3DAlutenusin%252C%2520a%2520specific%2520neutral%2520sphingomyelinase%2520inhibitor%252C%2520produced%2520by%2520penicillium%2520sp.%2520Fo-7436%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D572%26epage%3D574%26doi%3D10.7164%2Fantibiotics.52.572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">F-11334s, new inhibitors of membrane-bound neutral sphingomyelinase</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10726931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXmtl2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=827-830&author=M.+Tanakaauthor=F.+Naraauthor=Y.+Yamasatoauthor=Y.+Onoauthor=T.+Ogita&title=F-11334s%2C+new+inhibitors+of+membrane-bound+neutral+sphingomyelinase&doi=10.7164%2Fantibiotics.52.827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">F-11334s, new inhibitors of membrane-bound neutral sphingomyelinase</span></div><div class="casAuthors">Tanaka, Masahiro; Nara, Futoshi; Yamasato, Yoko; Ono, Yasunori; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The fermn., isolation, and structural properties of F-11334A1-3 and F-11334B1-2, inhibitors of sphingomyelinase derived from rat brain and produced by Acremonium murorum, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKdfwCLe30LVg90H21EOLACvtfcHk0lgHOvICw04aLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtl2mu7g%253D&md5=6779425b1b06dfb101331c245814dca6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.827%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DYamasato%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DF-11334s%252C%2520new%2520inhibitors%2520of%2520membrane-bound%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D827%26epage%3D830%26doi%3D10.7164%2Fantibiotics.52.827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span>; <span class="NLM_string-name">Nara, F.</span>; <span class="NLM_string-name">Hosoya, T.</span></span> <span> </span><span class="NLM_article-title">New Compound F-11263</span>. Jpn. Pat. Appl. <span class="NLM_patent">JPH0853387</span>, <span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=Y.+Ogura&author=F.+Nara&author=T.+Hosoya&title=New+Compound+F-11263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DY.%26atitle%3DNew%2520Compound%2520F-11263%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forthoffer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: Purification and inhibition by ubiquinol</span>. <i>J. Bioenerg. Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1023/A:1010704715979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1023%2FA%3A1010704715979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11456220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1WgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=143-153&author=S.+F.+Martinauthor=F.+Navarroauthor=N.+Forthofferauthor=P.+Navasauthor=J.+M.+Villalba&title=Neutral+magnesium-dependent+sphingomyelinase+from+liver+plasma+membrane%3A+Purification+and+inhibition+by+ubiquinol&doi=10.1023%2FA%3A1010704715979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol</span></div><div class="casAuthors">Martin, Sergio F.; Navarro, Francisco; Forthoffer, Nathalie; Navas, Placido; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioenergetics and Biomembranes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-153</span>CODEN:
                <span class="NLM_cas:coden">JBBID4</span>;
        ISSN:<span class="NLM_cas:issn">0145-479X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Plasma membranes isolated from pig liver contained almost no acid sphingomyelinase, but significant Mg2+-dependent neutral sphingomyelinase (n-SMase) that was activated by phosphatidylserine (PS).  Here, the purifn. to apparent homogeneity of n-SMase of ∼87 kDa from liver plasma membranes is reported.  The purified enzyme strictly required Mg2+ and had a neutral optimal pH.  In contrast with n-SMase purified from other sources (such as brain), the enzyme purified from liver plasma membrane was not inhibited by glutathione, and strikingly, it was not activated by PS.  Liver n-SMase was inhibited by several lipophilic antioxidants in a dose-dependent manner.  Ubiquinol-10 was a more effective inhibitor than α-tocopherol, α-tocopherylquinone, α-tocopherylquinone, or ubiquinone-10, and the inhibition was noncompetitive.  Differential inhibition of n-SMase by antioxidants did not correlate with different levels of protection against lipid peroxidn.  Purified n-SMase was not inhibited significantly by ubiquinone-10 and ubiquinol-10, but ubiquinol-0 and ubiquinone-0 inhibited the enzyme by 30 and 60%, resp.  These results demonstrate a direct inhibitory effect of ubiquinol on plasma membrane n-SMase and support the participation of this mol. in the regulation of ceramide-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJU_M6LzBs7Vg90H21EOLACvtfcHk0lhcL-IFQ3xJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1WgtLs%253D&md5=5fb02cf1b81edbd9018350819684fb21</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010704715979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010704715979%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DNavarro%26aufirst%3DF.%26aulast%3DForthoffer%26aufirst%3DN.%26aulast%3DNavas%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DNeutral%2520magnesium-dependent%2520sphingomyelinase%2520from%2520liver%2520plasma%2520membrane%253A%2520Purification%2520and%2520inhibition%2520by%2520ubiquinol%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2001%26volume%3D33%26spage%3D143%26epage%3D153%26doi%3D10.1023%2FA%3A1010704715979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Diaz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: Specific inhibition of the mg(2+)-dependent enzyme and role of isoprenoid chain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)02222-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0006-291X%2802%2902222-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12270134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=581-586&author=S.+F.+Martinauthor=C.+Gomez-Diazauthor=P.+Navasauthor=J.+M.+Villalba&title=Ubiquinol+inhibition+of+neutral+sphingomyelinase+in+liver+plasma+membrane%3A+Specific+inhibition+of+the+mg%282%2B%29-dependent+enzyme+and+role+of+isoprenoid+chain&doi=10.1016%2FS0006-291X%2802%2902222-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg2+-dependent enzyme and role of isoprenoid chain</span></div><div class="casAuthors">Martin, Sergio F.; Gomez-Diaz, Consuelo; Navas, Placido; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-586</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">In this work, the specificity of ubiquinol as inhibitor of the neutral sphingomyelinases present at the plasma membrane (Mg2+-dependent and -independent) and structural requirements for such inhibition have been studied.  Our results have shown that ubiquinol specifically inhibits Mg2+-dependent neutral sphingomyelinase activity in isolated liver plasma membranes, but no significant participation of the Mg2+-independent enzyme was obsd.  Both the redn. state of the (hydro)quinone ring and the length of the hydrophobic side chain were important determinants in neutral sphingomyelinase inhibition.  Ubiquinols inhibited the nSMase more efficiently than ubiquinones, and hydrophobic homologs with six or nine isoprene units were the most effective inhibitors.  Inhibition of nSMase by ubiquinols displayed similarities with inhibition by manumycin and the hydroquinones F11334's, suggesting that these compds. could act as structural analogs of ubiquinol.  Beyond its participation in mitochondrial energy metab., and as antioxidant, this novel role for ubiquinol as a neutral sphingomyelinase inhibitor should be considered an important factor to regulate lipid signaling at the plasma membrane that could be related to its beneficial effects on cells, tissues, and organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI25yEG4S6f7Vg90H21EOLACvtfcHk0lhcL-IFQ3xJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVymsbw%253D&md5=442d79bb67d2f309227ab58d81f573ce</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902222-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902222-2%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DGomez-Diaz%26aufirst%3DC.%26aulast%3DNavas%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DUbiquinol%2520inhibition%2520of%2520neutral%2520sphingomyelinase%2520in%2520liver%2520plasma%2520membrane%253A%2520Specific%2520inhibition%2520of%2520the%2520mg%25282%252B%2529-dependent%2520enzyme%2520and%2520role%2520of%2520isoprenoid%2520chain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D297%26spage%3D581%26epage%3D586%26doi%3D10.1016%2FS0006-291X%2802%2902222-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lister, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span> <span> </span><span class="NLM_article-title">Interaction of sphingomyelinase with sphingomyelin analogs modified at the c-1 and c-3 positions of the sphingosine backbone</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1256</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(94)00249-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2894%2900249-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=7742352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2MXkvFGmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1256&publication_year=1995&pages=25-30&author=M.+D.+Listerauthor=Z.+S.+Ruanauthor=R.+Bittman&title=Interaction+of+sphingomyelinase+with+sphingomyelin+analogs+modified+at+the+c-1+and+c-3+positions+of+the+sphingosine+backbone&doi=10.1016%2F0005-2760%2894%2900249-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone</span></div><div class="casAuthors">Lister, Mark D.; Ruan, Zhong-shi; Bittman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, analogs differing at the C-1 or C-3 position of the sphingosine backbone of sphingomyelin were examd. in neutral pH-optimum sphingomyelinase assays.  Two analogs modified at the C-1 position, ceramide-1-phosphate and ceramide-1-phosphoethanol-N,N-dimethylamine, could act as modest substrates but showed no ability to inhibit the reaction when egg sphingomyelin was used as the substrate.  Four analogs of sphingomyelin differing at the C-3 position were used in which the hydroxyl group was replaced by a hydrogen atom (to give a deoxy-sphingomyelin analog), or with a O-Me, O-Et or O-tetrahydropyranyl group.  The deoxy analog showed no ability to compete with substrate of sphingomyelinase nor could it be hydrolyzed by the enzyme, suggesting that the hydroxyl group is a required substituent for the substrate.  The 3-O-Me and 3-O-ethyl-sphingomyelin analogs were inhibitors, with IC50 values of 50 μM and 140 μM, resp., at std. assay conditions.  However, when the rat brain acidic pH-optimum sphingomyelinase was used, no inhibition by the 3-O-Me analog could be detected.  The size of the alkyl group on the ether moiety was important, as shown by the inability of 3-O-tetrahydropyranyl-sphingomyelin to compete with substrate of neutral pH-optimum sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEt__iSUlvz7Vg90H21EOLACvtfcHk0lhcL-IFQ3xJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvFGmsro%253D&md5=bed9d02a8780602fad990f492546ce40</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2894%2900249-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252894%252900249-X%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DM.%2BD.%26aulast%3DRuan%26aufirst%3DZ.%2BS.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DInteraction%2520of%2520sphingomyelinase%2520with%2520sphingomyelin%2520analogs%2520modified%2520at%2520the%2520c-1%2520and%2520c-3%2520positions%2520of%2520the%2520sphingosine%2520backbone%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1256%26spage%3D25%26epage%3D30%26doi%3D10.1016%2F0005-2760%2894%2900249-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokomatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takechi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeno, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)00179-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2801%2900179-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11392536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1277-1280&author=T.+Yokomatsuauthor=H.+Takechiauthor=T.+Akiyamaauthor=S.+Shibuyaauthor=T.+Kominatoauthor=S.+Soedaauthor=H.+Shimeno&title=Synthesis+and+evaluation+of+a+difluoromethylene+analogue+of+sphingomyelin+as+an+inhibitor+of+sphingomyelinase&doi=10.1016%2FS0960-894X%2801%2900179-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase</span></div><div class="casAuthors">Yokomatsu, T.; Takechi, H.; Akiyama, T.; Shibuya, S.; Kominato, T.; Soeda, S.; Shimeno, H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1277-1280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A sphingomyelin analog I, in which the long alkenyl chain and the phosphodiester moiety of sphingomyelin were replaced by a Ph and an isosteric difluoromethylenephosphonic acid resp., was prepd. to evaluate its inhibitory potency to sphingomyelinase.  I non-competitively inhibited the neutral sphingomyelinase in bovine brain microsomes with an IC50 of 400 μM.  The compd. also possessed the ability to suppress tumor necrosis factor α-induced apoptosis of PC-12 neurons at a low concn. of 0.1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdma6VFUUPELVg90H21EOLACvtfcHk0lhcL-IFQ3xJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlSrsLo%253D&md5=41bd960b4e5b22a2e82d27d339397cf1</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900179-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900179-2%26sid%3Dliteratum%253Aachs%26aulast%3DYokomatsu%26aufirst%3DT.%26aulast%3DTakechi%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DShibuya%26aufirst%3DS.%26aulast%3DKominato%26aufirst%3DT.%26aulast%3DSoeda%26aufirst%3DS.%26aulast%3DShimeno%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520difluoromethylene%2520analogue%2520of%2520sphingomyelin%2520as%2520an%2520inhibitor%2520of%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1277%26epage%3D1280%26doi%3D10.1016%2FS0960-894X%2801%2900179-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokomatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeno, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00888-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2802%2900888-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12482429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=229-236&author=T.+Yokomatsuauthor=T.+Muranoauthor=T.+Akiyamaauthor=J.+Koizumiauthor=S.+Shibuyaauthor=Y.+Tsujiauthor=S.+Soedaauthor=H.+Shimeno&title=Synthesis+of+non-competitive+inhibitors+of+sphingomyelinases+with+significant+activity&doi=10.1016%2FS0960-894X%2802%2900888-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of non-competitive inhibitors of Sphingomyelinases with significant activity</span></div><div class="casAuthors">Yokomatsu, Tsutomu; Murano, Tetsuo; Akiyama, Takeshi; Koizumi, Junichi; Shibuya, Shiroshi; Tsuji, Yoshiaki; Soeda, Shinji; Shimeno, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-236</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of short-chain analogs of N-palmitoylsphingosine-1-phosphate, modified by replacement of the phosphate and the long alkenyl side chain with hydrolytically stable difluoromethylene phosphonate and Ph, resp., (e.g. I) were prepd. to study the structure-activity relationship for inhibition of sphingomyelinase.  The study revealed that inhibition is highly dependent upon the stereochem. of the asym. centers of the acylamino moiety, and resulted in identification of a non-competitive inhibitor with the same level of inhibitory activity of scyphostatin, the most potent of the few known small mol. inhibitors of sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7rtSpxpbyM7Vg90H21EOLACvtfcHk0lg17bBiWSaNxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVels70%253D&md5=02a994fba5496c09c58c9822764b480d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900888-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900888-0%26sid%3Dliteratum%253Aachs%26aulast%3DYokomatsu%26aufirst%3DT.%26aulast%3DMurano%26aufirst%3DT.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DShibuya%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DY.%26aulast%3DSoeda%26aufirst%3DS.%26aulast%3DShimeno%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520non-competitive%2520inhibitors%2520of%2520sphingomyelinases%2520with%2520significant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D229%26epage%3D236%26doi%3D10.1016%2FS0960-894X%2802%2900888-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, T.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelin analogues as inhibitors of sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1963</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00360-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2803%2900360-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12781174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1963-1966&author=M.+Taguchiauthor=K.+Sugimotoauthor=K.+Godaauthor=T.+Akamaauthor=K.+Yamamotoauthor=T.+Suzukiauthor=Y.+Tomishimaauthor=M.+Nishiguchiauthor=K.+Araiauthor=K.+Takahashiauthor=T.+Kobori&title=Sphingomyelin+analogues+as+inhibitors+of+sphingomyelinase&doi=10.1016%2FS0960-894X%2803%2900360-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin analogues as inhibitors of sphingomyelinase</span></div><div class="casAuthors">Taguchi, Minoru; Sugimoto, Kikuo; Goda, Ken-Ichi; Akama, Tomoko; Yamamoto, Kyoko; Suzuki, Taizo; Tomishima, Yasumitsu; Nishiguchi, Mariko; Arai, Koshi; Takahashi, Kenzo; Kobori, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1963-1966</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">To search for neutral sphingomyelinase inhibitors hydrolytically stable analogs of sphingomyelin were designed and synthesized.  The novel compds. in which the phosphodiester moiety of sphingomyelin was replaced with the carbamate moiety showed inhibitory activity with an IC50 value of μM on neutral sphingomyelinase in rat brain microsomes.  Compd. I showed a selective neutral sphingomyelinase inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTEKiRH1pEArVg90H21EOLACvtfcHk0lg17bBiWSaNxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVGqsLY%253D&md5=0b70d076ecd7987ca7c99b925207824b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900360-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900360-3%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DGoda%26aufirst%3DK.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DNishiguchi%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKobori%26aufirst%3DT.%26atitle%3DSphingomyelin%2520analogues%2520as%2520inhibitors%2520of%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1963%26epage%3D1966%26doi%3D10.1016%2FS0960-894X%2803%2900360-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of a neutral form of sphingomyelinase by alkylthioureido-l,3-propandiols, ky353x series</span>. <i>J. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1CgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=169-173&author=S.+M.+Jungauthor=E.+M.+Jeongauthor=D.+H.+Joauthor=M.+R.+Chinauthor=H.+J.+Junauthor=Y.+H.+Kimauthor=H.+J.+Jeonauthor=D.+H.+Leeauthor=M.+J.+Parkauthor=M.+J.+Ohauthor=C.+B.+Yimauthor=D.+K.+Kim&title=Inhibition+of+a+neutral+form+of+sphingomyelinase+by+alkylthioureido-l%2C3-propandiols%2C+ky353x+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of a neutral form of sphingomyelinase by alkylthioureido-1,3-propandiols, KY353X series</span></div><div class="casAuthors">Jung, Sang Mi; Jeong, Eui Man; Jo, Dong Hwawn; Chin, Mi Reyoung; Jun, Hyung Jin; Kim, Yong Hyun; Jeon, Hyung Jun; Lee, Dong Hun; Park, Mi Ja; Oh, Mi Jung; Yim, Chul Bu; Kim, Dae Kyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-173</span>CODEN:
                <span class="NLM_cas:coden">JOAPA6</span>;
        ISSN:<span class="NLM_cas:issn">1225-6110</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Alkylthioureido-1,3-propandiols (KY353X series) were synthesized and evaluated as inhibitors for neutral sphingomyelinase (N-SMase).  To examine whether KY353X series inhibit N-SMase, we purified the N-SMase from bovine brain.  The N-SMase was partially purified by sequential chromatogs. of DEAE-Cellulose anionic exchange and phenyl-5PW hydrophobic HPLC.  These sequential procedures for N-SMase resulted in a 67-fold purifn. and excluded other isoforms of SMase.  Based on in vitro assay, KY353X series inhibited N-SMase activity in time, concn.-dependent manners and completely inactivated N-SMase at 50 μM.  In particular, KY3535 and KY3536 inhibited more effectively than the others.  To further det. the inhibitory pattern, a Dixon plot was constructed, to showing that the inhibition by KY3535 and KY3536 were competitive.  The inhibition const. (Ki) of KY3535 and KY3536 was 1.7 μM and 2.5 μM in 100 mM Tris-HCl buffer, pH 7.0, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUIhL47nbE27Vg90H21EOLACvtfcHk0lg17bBiWSaNxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1CgtbY%253D&md5=7fba2349be938feb0bd57911e8e1a17d</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DJeong%26aufirst%3DE.%2BM.%26aulast%3DJo%26aufirst%3DD.%2BH.%26aulast%3DChin%26aufirst%3DM.%2BR.%26aulast%3DJun%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DJeon%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DOh%26aufirst%3DM.%2BJ.%26aulast%3DYim%26aufirst%3DC.%2BB.%26aulast%3DKim%26aufirst%3DD.%2BK.%26atitle%3DInhibition%2520of%2520a%2520neutral%2520form%2520of%2520sphingomyelinase%2520by%2520alkylthioureido-l%252C3-propandiols%252C%2520ky353x%2520series%26jtitle%3DJ.%2520Appl.%2520Pharmacol.%26date%3D2003%26volume%3D11%26spage%3D169%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wascholowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Sphingolactones: Selective and irreversible inhibitors of neutral sphingomyelinase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1002/anie.200501983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200501983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=827-830&author=V.+Wascholowskiauthor=A.+Giannis&title=Sphingolactones%3A+Selective+and+irreversible+inhibitors+of+neutral+sphingomyelinase&doi=10.1002%2Fanie.200501983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Wascholowski, Veit; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ceramide analogs, sphingolactones I [R = CH:CHCH:CHMe, (CH2)4Me] and II [R = CH:CHCH:CHMe, CH:CH(CH2)2Me, (CH2)4Me, Ph], without reactive epoxy groups, act as potent inhibitors of the neutral sphingomyelinase (N-SMase).  Thus, sphingolactones are useful chem. tools for exploring the biol. significance of ceramide and N-SMase in, for example, apoptosis and inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCS47EKlOx7Vg90H21EOLACvtfcHk0lgeu-Xb6Rf_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtLg%253D&md5=bee557db1ba93a02c97b366d879bb7ff</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1002%2Fanie.200501983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200501983%26sid%3Dliteratum%253Aachs%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSphingolactones%253A%2520Selective%2520and%2520irreversible%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D827%26epage%3D830%26doi%3D10.1002%2Fanie.200501983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, G.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication</span>. <i>Drugs Exp Clin Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10894556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=57-65&author=E.+Amtmannauthor=M.+Zollerauthor=G.+Schilling&title=Neutral+sphingomyelinase-inhibiting+guanidines+prevent+herpes+simplex+virus-1+replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication</span></div><div class="casAuthors">Amtmann, E.; Zoller, M.; Schilling, G.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint Inc.</span>)
        </div><div class="casAbstract">We synthesized a series of new guanidinium derivs. and studied the inhibitory activity on both neutral sphingomyelinase and herpes simplex virus-1 (HSV-1) replication.  The lipophilic quality of the mols. was found to be correlated with the inhibitory potential of the compds.  Undecylidene-aminoguanidine was superior to derivs. with 10, 8 or 6 carbon atoms whereas propylidene-aminoguanidine was completely inactive.  Decylidene-aminoguanidine was the most active deriv., with 10 carbon atoms.  Various cyclic satd. isomers were inferior to the linear mol.  Arom. cyclic residues were superior to satd. cyclic residues.  The most active compd. was a deriv. contg. 11 carbon atoms, undecylidene-aminoguanidine (C11AG), which inhibited the replication of HSV-1 by 50% at a concn. of 2.6 μM while cytotoxic adverse effects were only obsd. at a concn. of 31 μM.  Expression of immediate early gene ICP-4 and concomitantly of HSV-1 specific DNA replication was found to be a target of C11AG.  This result suggests that C11AG interferes with cellular signal transduction mechanisms that regulate expression of HSV-1 immediate early genes.  C11AG was shown to inhibit neutral sphingomyelinase without affecting phospholipase A2, phosphatidylcholine-specific phospholipase C and phospholipase D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ4rbNLlizJbVg90H21EOLACvtfcHk0lgeu-Xb6Rf_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGgsb0%253D&md5=f01ce26d71bd8024108f6ded995c4bb1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DZoller%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DG.%26atitle%3DNeutral%2520sphingomyelinase-inhibiting%2520guanidines%2520prevent%2520herpes%2520simplex%2520virus-1%2520replication%26jtitle%3DDrugs%2520Exp%2520Clin%2520Res.%26date%3D2000%26volume%3D26%26spage%3D57%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baader, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase inhibitor c11ag prevents lipopolysaccharide-induced macrophage activation</span>. <i>Drugs Exp. Clin. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12866359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=5-13&author=E.+Amtmannauthor=W.+Baaderauthor=M.+Zoller&title=Neutral+sphingomyelinase+inhibitor+c11ag+prevents+lipopolysaccharide-induced+macrophage+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide-induced macrophage activation</span></div><div class="casAuthors">Amtmann, E.; Baader, W.; Zoeller, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-13</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint Inc.</span>)
        </div><div class="casAbstract">Stimulation of macrophages by lipopolysaccharide (LPS) leads to the synthesis of proinflammatory cytokines and nitric oxide (NO) and, as a consequence, to endotoxic shock.  We provide evidence that LPS stimulates the activity of a membrane-assocd. neutral sphingomyelinase (nSMase) and that this activity is mandatory for the liberation of nuclear factor-.vkappa.B (NF.vkappa.B) and the induction of inducible NO-synthase (iNOS).  With the aid of a newly developed, selective inhibitor of nSMase, C11AG, we could distinguish between nSMase-dependent and -independent LPS-induced signals.  C11AG blocked LPS-stimulated sphingomyelin degrdn. and NF.vkappa.B activation without interfering with p42 tyrosine phosphorylation.  Concomitantly, the expression of iNOS was found to be reduced both in mononuclear cells and in murine endotoxemia.  Therefore, specific inhibitors of nSMase may define a new class of antiinflammatory substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFyb-NDgBO_rVg90H21EOLACvtfcHk0lgeu-Xb6Rf_pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVOis7Y%253D&md5=640a2be268599ac994d79fc2ef08e099</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DBaader%26aufirst%3DW.%26aulast%3DZoller%26aufirst%3DM.%26atitle%3DNeutral%2520sphingomyelinase%2520inhibitor%2520c11ag%2520prevents%2520lipopolysaccharide-induced%2520macrophage%2520activation%26jtitle%3DDrugs%2520Exp.%2520Clin.%2520Res.%26date%3D2003%26volume%3D29%26spage%3D5%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collenburg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyersdorf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saied, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Flegler, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Schaulies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avota, E.</span></span> <span> </span><span class="NLM_article-title">The activity of the neutral sphingomyelinase is important in T cell recruitment and directional migration</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1007</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.01007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3389%2Ffimmu.2017.01007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28871263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWntLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1007&author=L.+Collenburgauthor=N.+Beyersdorfauthor=T.+Wieseauthor=C.+Arenzauthor=E.+M.+Saiedauthor=K.+A.+Becker-Fleglerauthor=S.+Schneider-Schauliesauthor=E.+Avota&title=The+activity+of+the+neutral+sphingomyelinase+is+important+in+T+cell+recruitment+and+directional+migration&doi=10.3389%2Ffimmu.2017.01007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The activity of the neutral sphingomyelinase is important in t cell recruitment and directional migration</span></div><div class="casAuthors">Collenburg, Lena; Beyersdorf, Niklas; Wiese, Teresa; Arenz, Christoph; Saied, Essa M.; Becker-Flegler, Katrin Anne; Schneider-Schaulies, Sibylle; Avota, Elita</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1007/1-1007/12</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Breakdown of sphingomyelin as catalyzed by the activity of sphingomyelinases pro - foundly affects biophys. properties of cellular membranes which is particularly important with regard to compartmentalization of surface receptors and their signaling relay.  As it is activated both upon TCR ligation and co-stimulation in a spatiotemporally controlled manner, the neutral sphingomyelinase (NSM) has proven to be important in T cell activation, where it appears to play a particularly important role in cytoskeletal reorganization and cell polarization.  Because these are important parameters in directional T cell migration and motility in tissues, we analyzed the role of the NSM in these processes.  Pharmacol. inhibition of NSM interfered with early lymph node homing of T cells in vivo indicating that the enzyme impacts on endothelial adhesion, transendothelial migration, sensing of chemokine gradients or, at a cellular level, acquisition of a polarized phenotype.  NSM inhibition reduced adhesion of T cells to TNF-α /IFN-γ activated, but not resting endothelial cells, most likely via inhibiting high-affinity LFA-1 clustering.  NSM activity proved to be highly important in directional T cell motility in response to SDF1-α, indicating that their ability to sense and translate chemokine gradients might be NSM dependent.  In fact, pharmacol. or genetic NSM ablation interfered with T cell polarization both at an overall morphol. level and redistribution of CXCR4 and pERM proteins on endothelial cells or fibronectin, as well as with F-actin polymn. in response to SDF1-α stimulation, indicating that efficient directional perception and signaling relay depend on NSM activity.  Altogether, these data support a central role of the NSM in T cell recruitment and migration both under homeostatic and inflamed conditions by regulating polarized redistribution of receptors and their coupling to the cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUR7BQTf6LTrVg90H21EOLACvtfcHk0lhwc8YkvmAmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWntLvP&md5=5dba3deccc65f44864a745ab0a3b7901</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.01007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.01007%26sid%3Dliteratum%253Aachs%26aulast%3DCollenburg%26aufirst%3DL.%26aulast%3DBeyersdorf%26aufirst%3DN.%26aulast%3DWiese%26aufirst%3DT.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DSaied%26aufirst%3DE.%2BM.%26aulast%3DBecker-Flegler%26aufirst%3DK.%2BA.%26aulast%3DSchneider-Schaulies%26aufirst%3DS.%26aulast%3DAvota%26aufirst%3DE.%26atitle%3DThe%2520activity%2520of%2520the%2520neutral%2520sphingomyelinase%2520is%2520important%2520in%2520T%2520cell%2520recruitment%2520and%2520directional%2520migration%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1007%26doi%3D10.3389%2Ffimmu.2017.01007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wachter, M. P.</span>; <span class="NLM_string-name">Lalan, P.</span></span> <span> </span><span class="NLM_article-title">Substituted Amino Acids as Neutral Sphingomyelinase Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2001/056560</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+P.+Wachter&author=P.+Lalan&title=Substituted+Amino+Acids+as+Neutral+Sphingomyelinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWachter%26aufirst%3DM.%2BP.%26atitle%3DSubstituted%2520Amino%2520Acids%2520as%2520Neutral%2520Sphingomyelinase%2520Inhibitors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luberto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassler, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen-Martin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor necrosis factor-induced cell death in mcf7 by a novel inhibitor of neutral sphingomyelinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">41128</span>– <span class="NLM_lpage">41139</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206747200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M206747200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12154098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFymsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=41128-41139&author=C.+Lubertoauthor=D.+F.+Hasslerauthor=P.+Signorelliauthor=Y.+Okamotoauthor=H.+Sawaiauthor=E.+Borosauthor=D.+J.+Hazen-Martinauthor=L.+M.+Obeidauthor=Y.+A.+Hannunauthor=G.+K.+Smith&title=Inhibition+of+tumor+necrosis+factor-induced+cell+death+in+mcf7+by+a+novel+inhibitor+of+neutral+sphingomyelinase&doi=10.1074%2Fjbc.M206747200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Tumor Necrosis Factor-Induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase</span></div><div class="casAuthors">Luberto, Chiara; Hassler, Daniel F.; Signorelli, Paola; Okamoto, Yasuo; Sawai, Hirofumi; Boros, Eric; Hazen-Martin, Debra J.; Obeid, Lina M.; Hannun, Yusuf A.; Smith, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">41128-41139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A high throughput screen for neutral, magnesium-dependent sphingomyelinase (SMase) was performed.  One inhibitor discovered in the screen, GW4869, functioned as a noncompetitive inhibitor of the enzyme in vitro with an IC50 of 1 μM.  It did not inhibit acid SMase at up to at least 150 μM.  The compd. was then evaluated for its ability to inhibit tumor necrosis factor (TNF)-induced activation of neutral SMase (N-SMase) in MCF7 cells.  GW4869 (10 μM) partially inhibited TNF-induced sphingomyelin (SM) hydrolysis, and 20 μM of the compd. was protected completely from the loss of SM.  The addn. of 10-20 μM GW4869 completely inhibited the initial accumulation of ceramide, whereas this effect was partially lost at later time points (24 h).  These data therefore support the inhibitory action of GW4869 on N-SMase not only in vitro but also in a cellular model.  The addn. of GW4869 at both 10 and 20 μM did not modify cellular glutathione levels in response to TNF, suggesting that the action of GW4869 occurred downstream of the drop in glutathione, which was shown previously to occur upstream of the activation of N-SMase.  Further, whereas TNF treatment also caused a 75% increase of de novo synthesized ceramide after 20 h of incubation, GW4869, at either 10 or 20 μM, had no effect on this pathway of ceramide generation.  In addn., GW4869 did not significantly impair TNF-induced NF-κB translocation to nuclei.  Therefore, GW4869 does not interfere with other key TNF-mediated signaling effects.  GW4869 was able, in a dose-dependent manner, to significantly protect from cell death as measured by nuclear condensation, caspase activation, PARP degrdn., and trypan blue uptake.  These protective effects were accompanied by significant inhibition of cytochrome c release from mitochondria and caspase 9 activation, therefore localizing N-SMase activation upstream of mitochondrial dysfunction.  In conclusion, our results indicate that N-SMase activation is a necessary step for the full development of the cytotoxic program induced by TNF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM6H3u0rsMErVg90H21EOLACvtfcHk0lhwc8YkvmAmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFymsL8%253D&md5=dcab096a8b7ba127e498c6d0bc985f4b</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206747200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206747200%26sid%3Dliteratum%253Aachs%26aulast%3DLuberto%26aufirst%3DC.%26aulast%3DHassler%26aufirst%3DD.%2BF.%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DHazen-Martin%26aufirst%3DD.%2BJ.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26atitle%3DInhibition%2520of%2520tumor%2520necrosis%2520factor-induced%2520cell%2520death%2520in%2520mcf7%2520by%2520a%2520novel%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D41128%26epage%3D41139%26doi%3D10.1074%2Fjbc.M206747200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamiya-Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, K.</span></span> <span> </span><span class="NLM_article-title">Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a135659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1093%2Foxfordjournals.jbchem.a135659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=3017927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL28XksFKrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1986&pages=1803-1806&author=K.+Tamiya-Koizumiauthor=K.+Kojima&title=Activation+of+magnesium-dependent%2C+neutral+sphingomyelinase+by+phosphatidylserine&doi=10.1093%2Foxfordjournals.jbchem.a135659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine</span></div><div class="casAuthors">Tamiya-Koizumi, Keiko; Kojima, Kiyohide</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1803-6</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">The plasma membrane isolated from rat ascites hepatoma, AH 7974 cells was treated with 1% Triton X-100, which resulted in a >80% redn. in the phospholipid content of the plasma membrane.  The delipidized plasma membrane showed only 18% of the activity of the Mg2+-dependent, neutral sphingomyelinase in the untreated plasma membrane.  On the addn. of acidic phospholipids, esp. phosphatidylserine, however, the enzyme activity in the delipidized membrane was markedly restored (≤77% of that in the untreated membrane).  Considering the phospholipid compn. of the AH 7974 plasma membrane, phosphatidylserine may be a natural activator of neutral sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGory5Dsk4v04rVg90H21EOLACvtfcHk0lhwc8YkvmAmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFKrtbw%253D&md5=d022cf97bcbb14d0f6e5ac0436e8da66</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a135659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a135659%26sid%3Dliteratum%253Aachs%26aulast%3DTamiya-Koizumi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DK.%26atitle%3DActivation%2520of%2520magnesium-dependent%252C%2520neutral%2520sphingomyelinase%2520by%2520phosphatidylserine%26jtitle%3DJ.%2520Biochem.%26date%3D1986%26volume%3D99%26spage%3D1803%26epage%3D1806%26doi%3D10.1093%2Foxfordjournals.jbchem.a135659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieberich, E.</span></span> <span> </span><span class="NLM_article-title">Exosome reduction in vivo is associated with lower amyloid plaque load in the 5xfad mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1792</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.neurobiolaging.2014.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24650793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1792-1800&author=M.+B.+Dinkinsauthor=S.+Dasguptaauthor=G.+Wangauthor=G.+Zhuauthor=E.+Bieberich&title=Exosome+reduction+in+vivo+is+associated+with+lower+amyloid+plaque+load+in+the+5xfad+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2014.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Dinkins, Michael B.; Dasgupta, Somsankar; Wang, Guanghu; Zhu, Gu; Bieberich, Erhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1792-1800</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 in vitro and in vivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia in vitro.  Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869.  Using the 5XFAD mouse, we show that i.p. injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load.  Redn. of total Aβ1-42 as well as no. of plaques in brain sections was significantly greater (40% redn.) in male than female mice.  Our results suggest that GW4869 reduces amyloid plaque formation in vivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLIu4kNCudmrVg90H21EOLACvtfcHk0lhwc8YkvmAmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFWms74%253D&md5=fad449ab8ae238c05722159ca0d1771d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DDinkins%26aufirst%3DM.%2BB.%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DBieberich%26aufirst%3DE.%26atitle%3DExosome%2520reduction%2520in%2520vivo%2520is%2520associated%2520with%2520lower%2520amyloid%2520plaque%2520load%2520in%2520the%25205xfad%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D1792%26epage%3D1800%26doi%3D10.1016%2Fj.neurobiolaging.2014.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medalla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luebke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolozin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, T.</span></span> <span> </span><span class="NLM_article-title">Depletion of microglia and inhibition of exosome synthesis halt tau propagation</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.1038/nn.4132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fnn.4132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26436904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=1584-1593&author=H.+Asaiauthor=S.+Ikezuauthor=S.+Tsunodaauthor=M.+Medallaauthor=J.+Luebkeauthor=T.+Haydarauthor=B.+Wolozinauthor=O.+Butovskyauthor=S.+Kuglerauthor=T.+Ikezu&title=Depletion+of+microglia+and+inhibition+of+exosome+synthesis+halt+tau+propagation&doi=10.1038%2Fnn.4132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of microglia and inhibition of exosome synthesis halt tau propagation</span></div><div class="casAuthors">Asai, Hirohide; Ikezu, Seiko; Tsunoda, Satoshi; Medalla, Maria; Luebke, Jennifer; Haydar, Tarik; Wolozin, Benjamin; Butovsky, Oleg; Kugler, Sebastian; Ikezu, Tsuneya</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1584-1593</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of pathol. tau protein is a major hallmark of Alzheimer's disease.  Tau protein spreads from the entorhinal cortex to the hippocampal region early in the disease.  Microglia, the primary phagocytes in the brain, are pos. correlated with tau pathol., but their involvement in tau propagation is unknown.  We developed an adeno-assocd. virus-based model exhibiting rapid tau propagation from the entorhinal cortex to the dentate gyrus in 4 wk.  We found that depleting microglia dramatically suppressed the propagation of tau and reduced excitability in the dentate gyrus in this mouse model.  Moreover, we demonstrate that microglia spread tau via exosome secretion, and inhibiting exosome synthesis significantly reduced tau propagation in vitro and in vivo.  These data suggest that microglia and exosomes contribute to the progression of tauopathy and that the exosome secretion pathway may be a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqToyvNuy7O_LVg90H21EOLACvtfcHk0lgEca6mNQeBYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wls7bJ&md5=f7812e38de725ea70862ec6dfea32ca2</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fnn.4132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4132%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DH.%26aulast%3DIkezu%26aufirst%3DS.%26aulast%3DTsunoda%26aufirst%3DS.%26aulast%3DMedalla%26aufirst%3DM.%26aulast%3DLuebke%26aufirst%3DJ.%26aulast%3DHaydar%26aufirst%3DT.%26aulast%3DWolozin%26aufirst%3DB.%26aulast%3DButovsky%26aufirst%3DO.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DIkezu%26aufirst%3DT.%26atitle%3DDepletion%2520of%2520microglia%2520and%2520inhibition%2520of%2520exosome%2520synthesis%2520halt%2520tau%2520propagation%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D1584%26epage%3D1593%26doi%3D10.1038%2Fnn.4132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoica, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loane, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abulwerdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faden, A. I.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase inhibition alleviates lps-induced microglia activation and neuroinflammation after experimental traumatic brain injury</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1124/jpet.118.253955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fjpet.118.253955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30563941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2019&pages=338-352&author=A.+Kumarauthor=R.+J.+Henryauthor=B.+A.+Stoicaauthor=D.+J.+Loaneauthor=G.+Abulwerdiauthor=S.+A.+Bhatauthor=A.+I.+Faden&title=Neutral+sphingomyelinase+inhibition+alleviates+lps-induced+microglia+activation+and+neuroinflammation+after+experimental+traumatic+brain+injury&doi=10.1124%2Fjpet.118.253955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase inhibition alleviates LPS-induced microglia activation and neuroinflammation after experimental traumatic brain injury</span></div><div class="casAuthors">Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-352</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuroinflammation is one of the key secondary injury mechanisms triggered by traumatic brain injury (TBI).  Microglial activation, a hallmark of brain neuroinflammation, plays a crit. role in regulating immune responses after TBI and contributes to progressive neurodegeneration and neurol. deficits following brain trauma.  Here we evaluated the role of neutral sphingomyelinase (nSMase) in microglial activation by examg. the effects of the nSMase inhibitors altenusin and GW4869 in vitro (using BV2 microglia cells and primary microglia), as well as in a controlled cortical injury (CCI) model in adult male C57BL/6 mice.  Pretreatment of altenusin or GW4869 prior to lipopolysaccharide (LPS) stimulation for 4 or 24 h, significantly downregulated gene expression of the pro-inflammatory mediators TNF-α, IL-1β, IL-6, iNOS, and CCL2 in microglia and reduced the release of nitric oxide and TNF-α.  These nSMase inhibitors also attenuated the release of microparticles and phosphorylation of p38MAPK and ERK1/2.  In addn., altenusin pretreatment also reduced the gene expression of multiple inflammatory markers assocd. with microglial activation after exptl. TBI, including TNF-α, IL-1β, IL-6, iNOS, CCL2, CD68, NOX2, and p22phox.  Overall, our data demonstrate that nSMase inhibitors attenuate multiple inflammatory pathways assocd. with microglial activation in vitro and after exptl. TBI.  Thus, nSMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNXZPfzc0WRLVg90H21EOLACvtfcHk0lgEca6mNQeBYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFWgs7g%253D&md5=725fc7ab7274233ab50716e77a6d10ee</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1124%2Fjpet.118.253955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.118.253955%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DR.%2BJ.%26aulast%3DStoica%26aufirst%3DB.%2BA.%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DAbulwerdi%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DS.%2BA.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DNeutral%2520sphingomyelinase%2520inhibition%2520alleviates%2520lps-induced%2520microglia%2520activation%2520and%2520neuroinflammation%2520after%2520experimental%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D368%26spage%3D338%26epage%3D352%26doi%3D10.1124%2Fjpet.118.253955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuro, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casquilho, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardim-Neto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncally-Carvalho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atella, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zin, W. A.</span></span> <span> </span><span class="NLM_article-title">The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2018.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.pupt.2018.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29702255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=100-110&author=R.+T.+Okuroauthor=M.+N.+Machadoauthor=N.+V.+Casquilhoauthor=A.+Jardim-Netoauthor=A.+Roncally-Carvalhoauthor=G.+C.+Atellaauthor=W.+A.+Zin&title=The+role+of+sphingolipid+metabolism+disruption+on+lipopolysaccharide-induced+lung+injury+in+mice&doi=10.1016%2Fj.pupt.2018.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice</span></div><div class="casAuthors">Okuro, Renata Tiemi; Machado, Mariana Nascimento; Casquilho, Natalia Vasconcelos; Jardim-Neto, Alcendino; Roncally-Carvalho, Alysson; Atella, Georgia Correa; Zin, Walter Araujo</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-110</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This study assessed pulmonary outcomes generated by inhibiting key enzymes of sphingolipid metab. pathways related to ceramide synthesis in a murine model of lung injury induced by lipopolysaccharide (LPS).  C57BL/6 male adult mice received LPS intratracheally and the expressions of acid sphingomyelinase (ASM), neutral sphingomyelinase (NSM), serine palmitoyl transferase (SPT) and dihydroceramide synthase (DS) were assessed at 2, 4, 6, 12 and 24 h after LPS instillation in lung homogenate (n = 30).  The pharmacol. inhibition of ASM, NSM, SPT and DS were assayed in other mice groups by three different doses of desipramine, GW4869, myriocin and fumonisin, resp. (n = 90).  Their most EDs were administered i.p. 1 or 2 h before LPS to different animal groups (n = 120).  Mice underwent detn. of pulmonary mechanics, lung histopathol. aspects and apoptosis.  The expression levels of the enzymes reached their peak at 2-4 h after LPS administration.  ASM inhibition attenuated alveolar collapse and GW4869 decreased lung elastance, proinflammatory cytokines' levels and was more effective to improve alveolar collapse than desipramine.  On the other hand, SPT blockage aggravated lung lesion and no effects it was obsd. with fumonisin.  Moreover, simultaneous administration of inhibitors (desipramine + GW4869, myriocin + fumonisin and all inhibitors together) resulted in no changes.  Blockage of sphingomyelinases and the de novo pathways improved and aggravated lung injury, resp., putatively suggesting specific targets to therapeutic strategies in LPS-induced lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVCwlpRfSUkLVg90H21EOLACvtfcHk0lgEca6mNQeBYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyksLY%253D&md5=eee19551299c73b99e3a572ab3f9d7c1</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2018.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2018.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DOkuro%26aufirst%3DR.%2BT.%26aulast%3DMachado%26aufirst%3DM.%2BN.%26aulast%3DCasquilho%26aufirst%3DN.%2BV.%26aulast%3DJardim-Neto%26aufirst%3DA.%26aulast%3DRoncally-Carvalho%26aufirst%3DA.%26aulast%3DAtella%26aufirst%3DG.%2BC.%26aulast%3DZin%26aufirst%3DW.%2BA.%26atitle%3DThe%2520role%2520of%2520sphingolipid%2520metabolism%2520disruption%2520on%2520lipopolysaccharide-induced%2520lung%2520injury%2520in%2520mice%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D50%26spage%3D100%26epage%3D110%26doi%3D10.1016%2Fj.pupt.2018.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lallemand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouahi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiader, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazide, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoffre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alayrac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recazens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvayre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negre-Salvayre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auge, N.</span></span> <span> </span><span class="NLM_article-title">Nsmase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by gw4869 reduces inflammation and atherosclerosis in apoe(−/−) mice</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.118.311208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1161%2FATVBAHA.118.311208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29794115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Srt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1479-1492&author=T.+Lallemandauthor=M.+Rouahiauthor=A.+Swiaderauthor=M.+H.+Grazideauthor=N.+Geoffreauthor=P.+Alayracauthor=E.+Recazensauthor=A.+Costeauthor=R.+Salvayreauthor=A.+Negre-Salvayreauthor=N.+Auge&title=Nsmase2+%28type+2-neutral+sphingomyelinase%29+deficiency+or+inhibition+by+gw4869+reduces+inflammation+and+atherosclerosis+in+apoe%28%E2%88%92%2F%E2%88%92%29+mice&doi=10.1161%2FATVBAHA.118.311208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice</span></div><div class="casAuthors">Lallemand, Tom; Rouahi, Myriam; Swiader, Audrey; Grazide, Marie-Helene; Geoffre, Nancy; Alayrac, Paul; Recazens, Emeline; Coste, Agnes; Salvayre, Robert; Negre-Salvayre, Anne; Auge, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1479-1492</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Atherosclerosis is a chronic multifactorial and inflammatory disease of large and medium arteries and the leading cause of cardiovascular diseases worldwide.  The aim of this study was to investigate whether and how the nSMase2 (type 2-neutral sphingomyelinase), a key enzyme of sphingolipid metab., may contribute to the development of atherosclerotic lesions.  APPROACH AND RESULTS-: The role of nSMase2 in atherosclerosis was investigated in Apoe;Smpd3 mice, mutant for nSMase2, and in Apoe;Smpd3 mice i.p. injected with GW4869, a pharmacol. nSMase2 inhibitor.  The defect or inhibition of nSMase2 resulted in a redn. of atherosclerotic lesions and a decrease in macrophage infiltration and lipid deposition, although cholesterolemia remained unchanged.  NSMase2 inhibition decreased the inflammatory response of murine endothelial cells to oxLDL (oxidized low-d. lipoprotein), as assessed by the significant redn. of MCP-1 (monocyte chemoattractant protein 1), ICAM-1 (intercellular adhesion mol.-1), and VCAM-1 (vascular cell adhesion mol.-1) mRNA expressions and macrophage recruitment.  Likewise, in RAW264.7 or in macrophages isolated from Apoe/Smpd3 or Apoe/Smpd3 mice stimulated by lipopolysaccharides, nSMase2 inhibition resulted in a decrease in the expression of inflammatory mols.  Mechanistically, the anti-inflammatory response resulting from nSMase2 inhibition involves Nrf2 (nuclear factor [erythroid-derived 2]-like 2 or NF-E2-related factor-2) activation in both endothelial cells and macrophages, as assessed by the lack of protective effect of GW4869 in endothelial cells silenced for Nrf2 by small interfering RNAs, and in lipopolysaccharide-stimulated macrophages issued from Nrf2-KO mice.  CONCLUSIONS-: The genetic deficiency or inhibition of nSMase2 strongly decreases the development of atherosclerotic lesions in Apoe mice, by reducing inflammatory responses through a mechanism involving the Nrf2 pathway.  Inhibitors of nSMase2 may, therefore, constitute a novel approach to slow down atherosclerosis progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTrIQAiPGDVrVg90H21EOLACvtfcHk0livd0PA02savQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Srt7jN&md5=544cca02f689f9161e7b09eadf8ee43d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.118.311208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.118.311208%26sid%3Dliteratum%253Aachs%26aulast%3DLallemand%26aufirst%3DT.%26aulast%3DRouahi%26aufirst%3DM.%26aulast%3DSwiader%26aufirst%3DA.%26aulast%3DGrazide%26aufirst%3DM.%2BH.%26aulast%3DGeoffre%26aufirst%3DN.%26aulast%3DAlayrac%26aufirst%3DP.%26aulast%3DRecazens%26aufirst%3DE.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DNegre-Salvayre%26aufirst%3DA.%26aulast%3DAuge%26aufirst%3DN.%26atitle%3DNsmase2%2520%2528type%25202-neutral%2520sphingomyelinase%2529%2520deficiency%2520or%2520inhibition%2520by%2520gw4869%2520reduces%2520inflammation%2520and%2520atherosclerosis%2520in%2520apoe%2528%25E2%2588%2592%252F%25E2%2588%2592%2529%2520mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3D1479%26epage%3D1492%26doi%3D10.1161%2FATVBAHA.118.311208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coblentz, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christou, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L. F.</span></span> <span> </span><span class="NLM_article-title">Small-hairpin rna and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction</span>. <i>Am. J. Physiol Lung Cell Mol. Physiol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">L679</span>– <span class="NLM_lpage">L690</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00516.2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1152%2Fajplung.00516.2018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30702345" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2019&pages=L679-L690&author=P.+D.+Coblentzauthor=B.+Ahnauthor=L.+F.+Haywardauthor=J.+K.+Yooauthor=D.+D.+Christouauthor=L.+F.+Ferreira&title=Small-hairpin+rna+and+pharmacological+targeting+of+neutral+sphingomyelinase+prevent+diaphragm+weakness+in+rats+with+heart+failure+and+reduced+ejection+fraction&doi=10.1152%2Fajplung.00516.2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00516.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00516.2018%26sid%3Dliteratum%253Aachs%26aulast%3DCoblentz%26aufirst%3DP.%2BD.%26aulast%3DAhn%26aufirst%3DB.%26aulast%3DHayward%26aufirst%3DL.%2BF.%26aulast%3DYoo%26aufirst%3DJ.%2BK.%26aulast%3DChristou%26aufirst%3DD.%2BD.%26aulast%3DFerreira%26aufirst%3DL.%2BF.%26atitle%3DSmall-hairpin%2520rna%2520and%2520pharmacological%2520targeting%2520of%2520neutral%2520sphingomyelinase%2520prevent%2520diaphragm%2520weakness%2520in%2520rats%2520with%2520heart%2520failure%2520and%2520reduced%2520ejection%2520fraction%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2019%26volume%3D316%26spage%3DL679%26epage%3DL690%26doi%3D10.1152%2Fajplung.00516.2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Drug-resistant endothelial cells facilitate progression, emt and chemoresistance in nasopharyngeal carcinoma via exosomes</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">109385</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2019.109385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.cellsig.2019.109385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31394194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2rtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=109385&author=L.+Huangauthor=C.+Huauthor=H.+Chaoauthor=Y.+Zhangauthor=Y.+Liauthor=J.+Houauthor=Z.+Xuauthor=H.+Luauthor=H.+Liauthor=H.+Chen&title=Drug-resistant+endothelial+cells+facilitate+progression%2C+emt+and+chemoresistance+in+nasopharyngeal+carcinoma+via+exosomes&doi=10.1016%2Fj.cellsig.2019.109385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-resistant endothelial cells facilitate progression, EMT and chemoresistance in nasopharyngeal carcinoma via exosomes</span></div><div class="casAuthors">Huang, Limin; Hu, Chaoquan; Chao, Hui; Zhang, Yu; Li, Yong; Hou, Jing; Xu, Zhong; Lu, He; Li, Hong; Chen, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109385</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent antitumor drug development has included investigation of a wide variety of anti-angiogenesis therapies.  Because cancer cells in tumors require new blood vessels to grow and spread, they stimulate capillary proliferation from existing vessels as well as new vessel formation from endothelial precursor cells.  Our previous findings suggested that drug resistance in mouse endothelial cells supported tumor growth, but the relationship between endothelial cells (ECs) and nasopharyngeal carcinoma (NPC) cells remained unclear.  Exosomes are small membrane vesicles that are released by several cell types, including human microvascular ECs (HMECs).  Exosomes carrying membrane and cytoplasmic constituents have been described as participants in a novel mechanism of cell-to-cell communication.  In the present study, we investigated the mechanisms underlying the interactions between HMECs and NPC cells.  We found that drug-resistant HMECs secreted small heterogeneous 40-100 nm vesicles, defined as exosomes.  Co-incubation of NPC cells with doxorubicin-resistant (R-DOX) HMEC-derived exosomes resulted in promotion of their proliferation, migration, and chemoresistance, as well as changes in the expression of epithelial-mesenchymal transition (EMT) markers.  These effects were significantly inhibited by treatment with GW4869 (an exosome inhibitor).  We also found that GW4869 inhibited the stimulation of drug-resistant HMECs on NPC progression by modulating EMT in vivo.  These data suggest that exosomes participate in a novel mechanism by which drug-resistant ECs enhance NPC progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6nJ-GSU8C7Vg90H21EOLACvtfcHk0livd0PA02savQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2rtrvL&md5=e7dee5b7167fe0777fd5547ce0a02788</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2019.109385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2019.109385%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DDrug-resistant%2520endothelial%2520cells%2520facilitate%2520progression%252C%2520emt%2520and%2520chemoresistance%2520in%2520nasopharyngeal%2520carcinoma%2520via%2520exosomes%26jtitle%3DCell.%2520Signalling%26date%3D2019%26volume%3D63%26spage%3D109385%26doi%3D10.1016%2Fj.cellsig.2019.109385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the erk pathway</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31934075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslags7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=2485-2495&author=B.+Wangauthor=Y.+Wangauthor=Z.+Yanauthor=Y.+Sunauthor=C.+Su&title=Colorectal+cancer+cell-derived+exosomes+promote+proliferation+and+decrease+apoptosis+by+activating+the+erk+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the ERK pathway</span></div><div class="casAuthors">Wang, Baochen; Wang, Yong; Yan, Zhanfu; Sun, Yueming; Su, Chuan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2485-2495</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Exosomes are small microvesicles released by various cells that play important roles in cell-cell communi- cation.  Numerous studies show that colorectal cancer (CRC) cell-derived exosomes are involved in the progression of CRC.  However, the specific ways and mechanisms of action have not yet been fully clarified.  In the present study, we found that, compared to normal colon epithelial cell (NCM460) derived exosomes, CRC cell-Lovo derived exo- somes (Lovo-exo) could be more easily taken up by Lovo cells, most likely because of their cell tropism.  In addn., Lovo-exo promoted Lovo cell proliferation and inhibited apoptosis, which is assocd. with an increased activation of the extracellular signal-regulated protein kinase (ERK).  Lovo-exo also dramatically increased Lovo tumor cell growth in vivo.  Moreover, the intratumoral injection of GW4869 (an exosomes inhibitor) suppressed tumor growth.  These results indicate that CRC cell Lovo-derived exosomes may be a messenger for the proliferation requirements of the originating cancer cells, and targeting tumor-derived exosomes may be very promising for tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYH_n4uSJJArVg90H21EOLACvtfcHk0ljBQwCyawgKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslags7k%253D&md5=8820f9e21b9b37deb0b2c8c6300fdb26</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DC.%26atitle%3DColorectal%2520cancer%2520cell-derived%2520exosomes%2520promote%2520proliferation%2520and%2520decrease%2520apoptosis%2520by%2520activating%2520the%2520erk%2520pathway%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2019%26volume%3D12%26spage%3D2485%26epage%3D2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delaet, N.</span>; <span class="NLM_string-name">Ohmawari, N.</span>; <span class="NLM_string-name">Nakai, H.</span></span> <span> </span><span class="NLM_article-title">4H-1,2,4-Triazole-3(2H)-thione Deratives as Sphingomyelinase Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2002/066447</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=N.+Delaet&author=N.+Ohmawari&author=H.+Nakai&title=4H-1%2C2%2C4-Triazole-3%282H%29-thione+Deratives+as+Sphingomyelinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDelaet%26aufirst%3DN.%26atitle%3D4H-1%252C2%252C4-Triazole-3%25282H%2529-thione%2520Deratives%2520as%2520Sphingomyelinase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heltweg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatbonton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posakony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goehle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollipara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedalov, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4368</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1158%2F0008-5472.CAN-05-3617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16618762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4368-4377&author=B.+Heltwegauthor=T.+Gatbontonauthor=A.+D.+Schulerauthor=J.+Posakonyauthor=H.+Liauthor=S.+Goehleauthor=R.+Kolliparaauthor=R.+A.+Depinhoauthor=Y.+Guauthor=J.+A.+Simonauthor=A.+Bedalov&title=Antitumor+activity+of+a+small-molecule+inhibitor+of+human+silent+information+regulator+2+enzymes&doi=10.1158%2F0008-5472.CAN-05-3617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes</span></div><div class="casAuthors">Heltweg, Birgit; Gatbonton, Tonibelle; Schuler, Aaron D.; Posakony, Jeff; Li, Hongzhe; Goehle, Sondra; Kollipara, Ramya; DePinho, Ronald A.; Gu, Yansong; Simon, Julian A.; Bedalov, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4368-4377</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT1 and other NAD-dependent deacetylases have been implicated in control of cellular responses to stress and in tumorigenesis through deacetylation of important regulatory proteins, including p53 and the BCL6 oncoprotein.  Hereby, we describe the identification of a compd. we named cambinol that inhibits NAD-dependent deacetylase activity of human SIRT1 and SIRT2.  Consistent with the role of SIRT1 in promoting cell survival during stress, inhibition of SIRT1 activity with cambinol during genotoxic stress leads to hyperacetylation of key stress response proteins and promotes cell cycle arrest.  Treatment of BCL6-expressing Burkitt lymphoma cells with cambinol as a single agent induced apoptosis, which was accompanied by hyperacetylation of BCL6 and p53.  Because acetylation inactivates BCL6 and has the opposite effect on the function of p53 and other checkpoint pathways, the antitumor activity of cambinol in Burkitt lymphoma cells may be accomplished through a combined effect of BCL6 inactivation and checkpoint activation.  Cambinol was well tolerated in mice and inhibited growth of Burkitt lymphoma xenografts.  Inhibitors of NAD-dependent deacetylases may constitute novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGDg0dxQdUrVg90H21EOLACvtfcHk0ljBQwCyawgKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSltbY%253D&md5=8f82a191cde3db6024b1672047af77ae</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3617%26sid%3Dliteratum%253Aachs%26aulast%3DHeltweg%26aufirst%3DB.%26aulast%3DGatbonton%26aufirst%3DT.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGoehle%26aufirst%3DS.%26aulast%3DKollipara%26aufirst%3DR.%26aulast%3DDepinho%26aufirst%3DR.%2BA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DBedalov%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520human%2520silent%2520information%2520regulator%25202%2520enzymes%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4368%26epage%3D4377%26doi%3D10.1158%2F0008-5472.CAN-05-3617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Figuera-Losada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorskind, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandaru, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span> <span> </span><span class="NLM_article-title">Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0124481</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0124481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0124481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26010541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslymtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=M.+Figuera-Losadaauthor=M.+Stathisauthor=J.+M.+Dorskindauthor=A.+G.+Thomasauthor=V.+V.+Bandaruauthor=S.+W.+Yooauthor=N.+J.+Westwoodauthor=G.+W.+Rogersauthor=J.+C.+McArthurauthor=N.+J.+Haugheyauthor=B.+S.+Slusherauthor=C.+Rojas&title=Cambinol%2C+a+novel+inhibitor+of+neutral+sphingomyelinase+2+shows+neuroprotective+properties&doi=10.1371%2Fjournal.pone.0124481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties</span></div><div class="casAuthors">Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; Westwood, Nicholas J.; Rogers, Graeme W.; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0124481/1-e0124481/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Ceramide is a bioactive lipid that plays an important role in stress responses leading to apoptosis, cell growth arrest and differentiation.  Ceramide prodn. is due in part to sphingomyelin hydrolysis by sphingomyelinases.  In brain, neutral sphingomyelinase 2 (nSMase2) is expressed in neurons and increases in its activity and expression have been assocd. with pro-inflammatory conditions obsd. in Alzheimer's disease, multiple sclerosis and human immunodeficiency virus (HIV-1) patients.  Increased nSMase2 activity translates into higher ceramide levels and neuronal cell death, which can be prevented by chem. or genetic inhibition of nSMase2 activity or expression.  However, to date, there are no sol., specific and potent small mol. inhibitor tool compds. for in vivo studies or as a starting point for medicinal chem. optimization.  Moreover, the majority of the known inhibitors were identified using bacterial, bovine or rat nSMase2.  In an attempt to identify new inhibitor scaffolds, two activity assays were optimized as screening platform using the recombinant human enzyme.  First, active hits were identified using a fluorescence-based high throughput compatible assay.  Then, hits were confirmed using a 14C sphingomyelin-based direct activity assay.  Pharmacol. active compds. and approved drugs were screened using this strategy which led to the identification of cambinol as a novel uncompetitive nSMase2 inhibitor (Ki = 7 μM).  The inhibitory activity of cambinol for nSMase2 was approx. 10-fold more potent than for its previously known target, silence information regulator 1 and 2 (SIRT1/2).  Cambinol decreased tumor necrosis factor-α or interleukin-1 β-induced increases of ceramide and cell death in primary neurons.  A preliminary study of cambinol structure and activity allowed the identification of the main structural features required for nSMase2 inhibition.  Cambinol and its analogs may be useful as nSMase2 inhibitor tool compds. to prevent ceramide-dependent neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEaQLieBrPbVg90H21EOLACvtfcHk0ljBQwCyawgKnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslymtLvL&md5=ab65b22b0759cd933ca4eb267d08df11</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0124481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0124481%26sid%3Dliteratum%253Aachs%26aulast%3DFiguera-Losada%26aufirst%3DM.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDorskind%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DBandaru%26aufirst%3DV.%2BV.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DG.%2BW.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DRojas%26aufirst%3DC.%26atitle%3DCambinol%252C%2520a%2520novel%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%25202%2520shows%2520neuroprotective%2520properties%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0124481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilousova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gylys, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Suppression of tau propagation using an inhibitor that targets the dk-switch of nsmase2</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>499</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.03.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.03.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29604274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Khtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2018&pages=751-757&author=T.+Bilousovaauthor=C.+Eliasauthor=E.+Miyoshiauthor=M.+P.+Alamauthor=C.+Zhuauthor=J.+Campagnaauthor=K.+Vadivelauthor=B.+Jagodzinskaauthor=K.+H.+Gylysauthor=V.+John&title=Suppression+of+tau+propagation+using+an+inhibitor+that+targets+the+dk-switch+of+nsmase2&doi=10.1016%2Fj.bbrc.2018.03.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2</span></div><div class="casAuthors">Bilousova, Tina; Elias, Chris; Miyoshi, Emily; Alam, Mohammad Parvez; Zhu, Chunni; Campagna, Jesus; Vadivel, Kanagasabai; Jagodzinska, Barbara; Gylys, Karen Hoppens; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">499</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">751-757</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting of mol. pathways involved in the cell-to-cell propagation of pathol. tau species is a novel approach for development of disease-modifying therapies that could block tau pathol. and attenuate cognitive decline in patients with Alzheimer's disease and other tauopathies.  We discovered cambinol through a screening effort and show that it is an inhibitor of cell-to-cell tau propagation.  Our in vitro data demonstrate that cambinol inhibits neutral sphingomyelinase 2 (nSMase2) enzyme activity in dose response fashion, and suppresses extracellular vesicle (EV) prodn. while reducing tau seed propagation.  Our in vivo testing with cambinol shows that it can reduce the nSMase2 activity in the brain after oral administration.  Our mol. docking and simulation anal. reveals that cambinol can target the DK-switch in the nSMase2 active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4cxKo7bvNZrVg90H21EOLACvtfcHk0ljWSZO-E6mmSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Khtrs%253D&md5=02e0f6a69946d64e818368ad6aef4b3d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.03.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.03.209%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%26aulast%3DElias%26aufirst%3DC.%26aulast%3DMiyoshi%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DM.%2BP.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DCampagna%26aufirst%3DJ.%26aulast%3DVadivel%26aufirst%3DK.%26aulast%3DJagodzinska%26aufirst%3DB.%26aulast%3DGylys%26aufirst%3DK.%2BH.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DSuppression%2520of%2520tau%2520propagation%2520using%2520an%2520inhibitor%2520that%2520targets%2520the%2520dk-switch%2520of%2520nsmase2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D499%26spage%3D751%26epage%3D757%26doi%3D10.1016%2Fj.bbrc.2018.03.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhuri, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadiano, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Dptip, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">17715</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36144-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs41598-018-36144-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30531925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1emur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=17715&author=C.+Rojasauthor=E.+Barnaevaauthor=A.+G.+Thomasauthor=X.+Huauthor=N.+Southallauthor=J.+Maruganauthor=A.+D.+Chaudhuriauthor=S.+W.+Yooauthor=N.+Hinauthor=O.+Stepanekauthor=Y.+Wuauthor=S.+C.+Zimmermannauthor=A.+G.+Gadianoauthor=T.+Tsukamotoauthor=R.+Raisauthor=N.+Haugheyauthor=M.+Ferrerauthor=B.+S.+Slusher&title=Dptip%2C+a+newly+identified+potent+brain+penetrant+neutral+sphingomyelinase+2+inhibitor%2C+regulates+astrocyte-peripheral+immune+communication+following+brain+inflammation&doi=10.1038%2Fs41598-018-36144-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation</span></div><div class="casAuthors">Rojas, Camilo; Barnaeva, Elena; Thomas, Ajit G.; Hu, Xin; Southall, Noel; Marugan, Juan; Datta Chaudhuri, Amrita; Yoo, Seung-Wan; Hin, Niyada; Stepanek, Ondrej; Wu, Ying; Zimmermann, Sarah C.; Gadiano, Alexandra G.; Tsukamoto, Takashi; Rais, Rana; Haughey, Norman; Ferrer, Marc; Slusher, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17715</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Brain injury and inflammation induces a local release of extracellular vesicles (EVs) from astrocytes carrying proteins, RNAs, and microRNAs into the circulation.  When these vesicles reach the liver, they stimulate the secretion of cytokines that mobilize peripheral immune cell infiltration into the brain, which can cause secondary tissue damage and impair recovery.  Recent studies suggest that suppression of EV biosynthesis through neutral sphingomyelinase 2 (nSMase2) inhibition may represent a new therapeutic strategy.  Unfortunately, currently available nSMase2 inhibitors exhibit low potency (IC50 ≥ 1μM), poor soly. and/or limited brain penetration.  Through a high throughput screening campaign of >365,000 compds. against human nSMase2 we identified 2,6-dimethoxy-4-(5-phenyl-4-thiophen-2-yl-1H-imidazol-2-yl)-phenol (DPTIP), a potent (IC50 30 nM), selective, metabolically stable, and brain penetrable (AUCbrain/AUCplasma = 0.26) nSMase2 inhibitor.  DPTIP dose-dependently inhibited EV release in primary astrocyte cultures.  In a mouse model of brain injury conducted in GFAP-GFP mice, DPTIP potently (10 mg/kg IP) inhibited IL-1β-induced astrocyte-derived EV release (51 ± 13%; p < 0.001).  This inhibition led to a redn. of cytokine upregulation in liver and attenuation of the infiltration of immune cells into the brain (80 ± 23%; p < 0.01).  A structurally similar but inactive analog had no effect in-vitro or in-vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcwxWnEMWvfLVg90H21EOLACvtfcHk0ljWSZO-E6mmSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1emur4%253D&md5=52549589a81f6d99bb183a6412ca7f79</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36144-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36144-2%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DMarugan%26aufirst%3DJ.%26aulast%3DChaudhuri%26aufirst%3DA.%2BD.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DStepanek%26aufirst%3DO.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DGadiano%26aufirst%3DA.%2BG.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DHaughey%26aufirst%3DN.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDptip%252C%2520a%2520newly%2520identified%2520potent%2520brain%2520penetrant%2520neutral%2520sphingomyelinase%25202%2520inhibitor%252C%2520regulates%2520astrocyte-peripheral%2520immune%2520communication%2520following%2520brain%2520inflammation%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D17715%26doi%3D10.1038%2Fs41598-018-36144-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase 2 inhibitors based on the 4-(1h-imidazol-2-yl)-2,6-dialkoxyphenol scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ejmech.2019.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30921693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2019&pages=276-289&author=O.+Stepanekauthor=N.+Hinauthor=A.+G.+Thomasauthor=R.+P.+Dashauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Neutral+sphingomyelinase+2+inhibitors+based+on+the+4-%281h-imidazol-2-yl%29-2%2C6-dialkoxyphenol+scaffold&doi=10.1016%2Fj.ejmech.2019.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold</span></div><div class="casAuthors">Stepanek, Ondrej; Hin, Niyada; Thomas, Ajit G.; Dash, Ranjeet P.; Alt, Jesse; Rais, Rana; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276-289</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2), a key enzyme in ceramide biosynthesis, is a new therapeutic target for the treatment of neurol. disorders and cancer.  Using 2,6-dimethoxy-4-[4-phenyl-5-(2-thienyl)-1H-imidazol-2-yl]phenol (DPTIP), our initial hit compd. (IC50 = 30 nM) from nSMase2 screening efforts, as a mol. template, a series of 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol derivs. were designed, synthesized, and evaluated.  Systematic examn. of various regions of DPTIP identified the key pharmacophore required for potent nSMase2 inhibition as well as a no. of compds. with the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold with similar or higher inhibitory potency against nSMase2 as compared to DPTIP.  Among them, 4-(4,5-diisopropyl-1H-imidazol-2-yl)-2,6-dimethoxyphenol was found to be metabolically stable against P 450 metab. in liver microsomes and displayed higher plasma exposure following oral administration as compared to DPTIP.  Anal. of plasma samples identified an O-glucuronide as the major metabolite.  Blockade of the phase II metab. should further facilitate our efforts to identify potent nSMase2 inhibitors with desirable ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mrCU1mbcCLVg90H21EOLACvtfcHk0ljWSZO-E6mmSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGktrc%253D&md5=8890e746b19a9a84515821574017875a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DStepanek%26aufirst%3DO.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DNeutral%2520sphingomyelinase%25202%2520inhibitors%2520based%2520on%2520the%25204-%25281h-imidazol-2-yl%2529-2%252C6-dialkoxyphenol%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D170%26spage%3D276%26epage%3D289%26doi%3D10.1016%2Fj.ejmech.2019.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta
Chaudhuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B.</span></span> <span> </span><span class="NLM_article-title">A novel and potent brain penetrant inhibitor of extracellular vesicle release</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1111/bph.14789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fbph.14789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31273753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslShs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=3857-3870&author=C.+Rojasauthor=M.+Salaauthor=A.+G.+Thomasauthor=A.+Datta%0AChaudhuriauthor=S.+W.+Yooauthor=Z.+Liauthor=R.+P.+Dashauthor=R.+Raisauthor=N.+J.+Haugheyauthor=R.+Nenckaauthor=B.+Slusher&title=A+novel+and+potent+brain+penetrant+inhibitor+of+extracellular+vesicle+release&doi=10.1111%2Fbph.14789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and potent brain penetrant inhibitor of extracellular vesicle release</span></div><div class="casAuthors">Rojas, Camilo; Sala, Michal; Thomas, Ajit G.; Datta Chaudhuri, Amrita; Yoo, Seung-Wan; Li, Zhigang; Dash, Ranjeet P.; Rais, Rana; Haughey, Norman J.; Nencka, Radim; Slusher, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3857-3870</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Unfortunately, known inhibitors exhibit μM potency, poor physicochem. properties, and/or limited brain penetration.  Here, we sought to identify a drug-like inhibitor of nSMase2.  Exptl. Approach : We conducted a human nSMase2 high throughput screen (>365,000 compds.).  Selected hits were optimized focusing on potency, selectivity, metabolic stability, pharmacokinetics, and ability to inhibit EV release in vitro and in vivo.  Key Results : We identified phenyl(R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl)pyrrolidin-3-yl)-carbamate (PDDC), a potent (pIC50 = 6.57) and selective non-competitive inhibitor of nSMase2.  PDDC was metabolically stable, with excellent oral bioavailability (%F = 88) and brain penetration (AUCbrain/AUCplasma = 0.60).  PDDC dose-dependently (pEC50 = 5.5) inhibited release of astrocyte-derived extracellular vesicles (ADEV).  In an in vivo inflammatory brain injury model, PDDC robustly inhibited ADEV release and the assocd. peripheral immunol. response.  A closely related inactive PDDC analog was ineffective.  Conclusion and Implications : PDDC is a structurally novel, potent, orally available, and brain penetrant inhibitor of nSMase2.  PDDC inhibited release of ADEVs in tissue culture and in vivo.  PDDC is actively being tested in animal models of neurol. disease and, along with closely related analogs, is being considered for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoFvk19ATqi7Vg90H21EOLACvtfcHk0lgsdaPazxXyfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslShs7%252FN&md5=3fcb236d4398167f42f7fb350cdb758a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fbph.14789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14789%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSala%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDatta%2BChaudhuri%26aufirst%3DA.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26aulast%3DNencka%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%26atitle%3DA%2520novel%2520and%2520potent%2520brain%2520penetrant%2520inhibitor%2520of%2520extracellular%2520vesicle%2520release%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D3857%26epage%3D3870%26doi%3D10.1111%2Fbph.14789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollinger, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeravalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrebabecky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochazkova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesuta, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donoghue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencka, R.</span></span> <span> </span><span class="NLM_article-title">Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6028</span>– <span class="NLM_lpage">6056</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00278</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00278" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnt12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6028-6056&author=M.+Salaauthor=K.+R.+Hollingerauthor=A.+G.+Thomasauthor=R.+P.+Dashauthor=C.+Tallonauthor=V.+Veeravalliauthor=L.+Lovellauthor=M.+Koglerauthor=H.+Hrebabeckyauthor=E.+Prochazkovaauthor=O.+Nesutaauthor=A.+Donoghueauthor=J.+Lamauthor=R.+Raisauthor=C.+Rojasauthor=B.+S.+Slusherauthor=R.+Nencka&title=Novel+human+neutral+sphingomyelinase+2+inhibitors+as+potential+therapeutics+for+alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.0c00278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease</span></div><div class="casAuthors">Sala, Michal; Hollinger, Kristen R.; Thomas, Ajit G.; Dash, Ranjeet P.; Tallon, Carolyn; Veeravalli, Vijayabhaskar; Lovell, Lyndah; Kogler, Martin; Hrebabecky, Hubert; Prochazkova, Eliska; Nesuta, Ondrej; Donoghue, Amanda; Lam, Jenny; Rais, Rana; Rojas, Camilo; Slusher, Barbara S.; Nencka, Radim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6028-6056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2) catalyzes the cleavage of sphingomyelin to phosphorylcholine and ceramide, an essential step in the formation and release of exosomes from cells that is crit. for intracellular communication.  Chronic increase of brain nSMase2 activity and related exosome release has been implicated in various pathol. processes, including the progression of Alzheimer's disease (AD), making nSMase2 a viable therapeutic target.  Recently, we identified phenyl(R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b] pyridazin-8-yl) pyrrolidin-3-yl)-carbamate 1 (PDDC)(I), the first nSMase2 inhibitor which possesses both favorable pharmacodynamics and pharmacokinetic (PK) parameters, including substantial oral bioavailability, brain penetration and significant inhibition of exosome release from the brain in vivo.  Herein we demonstrate efficacy of 1 (PDDC) in a mouse model of AD and detail extensive structure-activity relationship (SAR) studies with 70 analogs, unveiling several that exert similar or higher activity against nSMase2 with favorable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi-0Z_uFZAgLVg90H21EOLACvtfcHk0lgsdaPazxXyfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnt12ru7k%253D&md5=ae913fb6068ef7d230f0ef4a49d25975</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00278%26sid%3Dliteratum%253Aachs%26aulast%3DSala%26aufirst%3DM.%26aulast%3DHollinger%26aufirst%3DK.%2BR.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DTallon%26aufirst%3DC.%26aulast%3DVeeravalli%26aufirst%3DV.%26aulast%3DLovell%26aufirst%3DL.%26aulast%3DKogler%26aufirst%3DM.%26aulast%3DHrebabecky%26aufirst%3DH.%26aulast%3DProchazkova%26aufirst%3DE.%26aulast%3DNesuta%26aufirst%3DO.%26aulast%3DDonoghue%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DNencka%26aufirst%3DR.%26atitle%3DNovel%2520human%2520neutral%2520sphingomyelinase%25202%2520inhibitors%2520as%2520potential%2520therapeutics%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6028%26epage%3D6056%26doi%3D10.1021%2Facs.jmedchem.0c00278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilousova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gylys, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Dual neutral sphingomyelinase-2/acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1021/acschembio.0c00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1erurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1671-1684&author=T.+Bilousovaauthor=B.+J.+Simmonsauthor=R.+R.+Knappauthor=C.+J.+Eliasauthor=J.+Campagnaauthor=M.+Melnikauthor=S.+Chandraauthor=S.+Fochtauthor=C.+Zhuauthor=K.+Vadivelauthor=B.+Jagodzinskaauthor=W.+Cohnauthor=P.+Spilmanauthor=K.+H.+Gylysauthor=N.+K.+Gargauthor=V.+John&title=Dual+neutral+sphingomyelinase-2%2Facetylcholinesterase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschembio.0c00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Bilousova, Tina; Simmons, Bryan J.; Knapp, Rachel R.; Elias, Chris J.; Campagna, Jesus; Melnik, Mikhail; Chandra, Sujyoti; Focht, Samantha; Zhu, Chunni; Vadivel, Kanagasabai; Jagodzinska, Barbara; Cohn, Whitaker; Spilman, Patricia; Gylys, Karen H.; Garg, Neil K.; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1684</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a novel class of compds. that function as dual inhibitors of the enzymes neutral sphingomyelinase-2 (nSMase2) and acetylcholinesterase (AChE).  Inhibition of these enzymes provides a unique strategy to suppress the propagation of tau pathol. in the treatment of Alzheimer's disease (AD).  We describe the key SAR elements that affect relative nSMase2 and/or AChE inhibitor effects and potency, in addn. to the identification of two analogs that suppress the release of tau-bearing exosomes in vitro and in vivo.  Identification of these novel dual nSMase2/AChE inhibitors represents a new therapeutic approach to AD and has the potential to lead to the development of truly disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLUqqhHNAtLVg90H21EOLACvtfcHk0lgsdaPazxXyfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1erurw%253D&md5=028a09760c6d27501798ea788a3f1cb4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00311%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%26aulast%3DSimmons%26aufirst%3DB.%2BJ.%26aulast%3DKnapp%26aufirst%3DR.%2BR.%26aulast%3DElias%26aufirst%3DC.%2BJ.%26aulast%3DCampagna%26aufirst%3DJ.%26aulast%3DMelnik%26aufirst%3DM.%26aulast%3DChandra%26aufirst%3DS.%26aulast%3DFocht%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DVadivel%26aufirst%3DK.%26aulast%3DJagodzinska%26aufirst%3DB.%26aulast%3DCohn%26aufirst%3DW.%26aulast%3DSpilman%26aufirst%3DP.%26aulast%3DGylys%26aufirst%3DK.%2BH.%26aulast%3DGarg%26aufirst%3DN.%2BK.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DDual%2520neutral%2520sphingomyelinase-2%252Facetylcholinesterase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D1671%26epage%3D1684%26doi%3D10.1021%2Facschembio.0c00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzostowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrisey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soncrant, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapoport, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radunz, H.-E.</span></span> <span> </span><span class="NLM_article-title">Physovenines: Efficient synthesis of (−)- and (+)-physovenine and synthesis of carbarnate analogues of (−)-physovenine. Anticholinesterase activity and analgesic properties of optically active physovenines</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1002/hlca.19910740409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fhlca.19910740409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2nu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1991&pages=761-766&author=Q.-s.+Yuauthor=C.+Liuauthor=M.+Brzostowskaauthor=L.+Chriseyauthor=A.+Brossiauthor=N.+H.+Greigauthor=J.+R.+Atackauthor=T.+T.+Soncrantauthor=S.+I.+Rapoportauthor=H.-E.+Radunz&title=Physovenines%3A+Efficient+synthesis+of+%28%E2%88%92%29-+and+%28%2B%29-physovenine+and+synthesis+of+carbarnate+analogues+of+%28%E2%88%92%29-physovenine.+Anticholinesterase+activity+and+analgesic+properties+of+optically+active+physovenines&doi=10.1002%2Fhlca.19910740409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Physovenines:  efficient synthesis of (-)- and (+)-physovenine and synthesis of carbamate analogs of (-)-physovenine.  Anticholinesterase activity and analgesic properties of optically active physovenines</span></div><div class="casAuthors">Yu, Qiansheng; Liu, Chi; Brzostowska, Margareth; Chrisev, Linda; Brossi, Arnold; Greig, Nigel H.; Atack, John R.; Soncrant, Timothy T.; Rapoport, Stanley I.; Radunz, Hans Eckart</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-6</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    </div><div class="casAbstract">Column chromatog. of easy available (±)-physovenine (I) on cellulose triacetate afforded (-)- and (+)-I.  Alkaloids (-)- and (+)-I required for pharmacol. testing were prepd. from eserolines (-)- and (+)-II by an improved procedure.  Natural (-)-I was equally potent in inhibiting AChE and BChE in vitro as natural physostigmine, and twice as potent as the unnatural antipode (+)-I against AChE and 14 times as potent against BChE.  Several carbamate analogs of (-)-I were at least as potent as the former compd. in these assays.  None of the compds. tested did bind to different opiate receptor or serotonin receptor prepns.  Most of the compds. tested had considerable analgesic activity in the Writhing test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgplVeSBPrdbVg90H21EOLACvtfcHk0lgj4PN0_yebWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2nu78%253D&md5=9ae3c827f4e2a339a25aea506129206f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19910740409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19910740409%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.-s.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBrzostowska%26aufirst%3DM.%26aulast%3DChrisey%26aufirst%3DL.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DSoncrant%26aufirst%3DT.%2BT.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26aulast%3DRadunz%26aufirst%3DH.-E.%26atitle%3DPhysovenines%253A%2520Efficient%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-%2520and%2520%2528%252B%2529-physovenine%2520and%2520synthesis%2520of%2520carbarnate%2520analogues%2520of%2520%2528%25E2%2588%2592%2529-physovenine.%2520Anticholinesterase%2520activity%2520and%2520analgesic%2520properties%2520of%2520optically%2520active%2520physovenines%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1991%26volume%3D74%26spage%3D761%26epage%3D766%26doi%3D10.1002%2Fhlca.19910740409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmae, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seike, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Role of sphingomyelinase in infectious diseases caused by bacillus cereus</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e38054</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0038054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0038054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22701599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=M.+Odaauthor=M.+Hashimotoauthor=M.+Takahashiauthor=Y.+Ohmaeauthor=S.+Seikeauthor=R.+Katoauthor=A.+Fujitaauthor=H.+Tsugeauthor=M.+Nagahamaauthor=S.+Ochiauthor=T.+Sasaharaauthor=S.+Hayashiauthor=Y.+Hiraiauthor=J.+Sakurai&title=Role+of+sphingomyelinase+in+infectious+diseases+caused+by+bacillus+cereus&doi=10.1371%2Fjournal.pone.0038054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sphingomyelinase in infectious diseases caused by Bacillus cereus</span></div><div class="casAuthors">Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Tsuge, Hideaki; Nagahama, Masahiro; Ochi, Sadayuki; Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e38054</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Bacillus cereus (B. cereus) is a pathogen in opportunistic infections.  Here we show that Bacillus cereus sphingomyelinase (Bc-SMase) is a virulence factor for septicemia.  Clin. isolates produced large amts. of Bc-SMase, grew in vivo, and caused death among mice, but ATCC strains isolated from soil did not.  A transformant of the ATCC strain carrying a recombinant plasmid contg. the Bc-SMase gene grew in vivo, but that with the gene for E53A, which has little enzymic activity, did not.  Administration of an anti-Bc-SMase antibody and immunization against Bc-SMase prevented death caused by the clin. isolates, showing that Bc-SMase plays an important role in the diseases caused by B. cereus.  Treatment of mouse macrophages with Bc-SMase resulted in a redn. in the generation of H2O2 and phagocytosis of macrophages induced by peptidoglycan (PGN), but no effect on the release of TNF-α and little release of LDH under our exptl. conditions.  Confocal laser microscopy showed that the treatment of mouse macrophages with Bc-SMase resulted in the formation of ceramide-rich domains.  A photobleaching anal. suggested that the cells treated with Bc-SMase exhibited a redn. in membrane fluidity.  The results suggest that Bc-SMase is essential for the hydrolysis of SM in membranes, leading to a redn. in phagocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRnXEvq3_LPrVg90H21EOLACvtfcHk0lgj4PN0_yebWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1KntLo%253D&md5=92cce9addf638d6559971d05e1b3567b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0038054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0038054%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DOhmae%26aufirst%3DY.%26aulast%3DSeike%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DA.%26aulast%3DTsuge%26aufirst%3DH.%26aulast%3DNagahama%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DS.%26aulast%3DSasahara%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DRole%2520of%2520sphingomyelinase%2520in%2520infectious%2520diseases%2520caused%2520by%2520bacillus%2520cereus%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0038054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Openshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Race, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monzo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Boland, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, M. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of smcl, a bacterial neutral sphingomyelinase c from listeria</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">35011</span>– <span class="NLM_lpage">35017</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506800200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M506800200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16093240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyks7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35011-35017&author=A.+E.+Openshawauthor=P.+R.+Raceauthor=H.+J.+Monzoauthor=J.+A.+Vazquez-Bolandauthor=M.+J.+Banfield&title=Crystal+structure+of+smcl%2C+a+bacterial+neutral+sphingomyelinase+c+from+listeria&doi=10.1074%2Fjbc.M506800200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria</span></div><div class="casAuthors">Openshaw, Amy E. A.; Race, Paul R.; Monzo, Hector J.; Vazquez-Boland, Jose-Antonio; Banfield, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">35011-35017</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingomyelinases C are enzymes that catalyze the hydrolysis of sphingomyelin in biol. membranes to ceramide and phosphorylcholine.  Various pathogenic bacteria produce secreted neutral sphingomyelinases C that act as membrane-damaging virulence factors.  Mammalian neutral sphingomyelinases C, which display sequence homol. to the bacterial enzymes, are involved in sphingolipid metab. and signaling.  Here, the authors describe the 1st crystal structure to be detd. for a member of the neutral sphingomyelinase C family, SmcL, from the intracellular bacterial pathogen, L. ivanovii.  The structure was refined to 1.9-Å resoln. with phases derived by single isomorphous replacement with anomalous scattering techniques from a single Ir deriv.  SmcL adopted a DNase I-like fold, and was the 1st member of this protein superfamily to have its structure detd. that acts as a phospholipase.  The structure revealed several unique features that adapted the protein to its phospholipid substrate.  These included large hydrophobic β-hairpin and hydrophobic loops surrounding the active site that may bind and penetrate the lipid bilayer to position sphingomyelin in a catalytically competent position.  The structure also provided insight into the proposed general base/acid catalytic mechanism, in which His-325 and His-185 play key roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMqZSElUwawLVg90H21EOLACvtfcHk0lgj4PN0_yebWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyks7rF&md5=7478eaa4cb09c3bca31f70cfaf5462ad</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506800200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506800200%26sid%3Dliteratum%253Aachs%26aulast%3DOpenshaw%26aufirst%3DA.%2BE.%26aulast%3DRace%26aufirst%3DP.%2BR.%26aulast%3DMonzo%26aufirst%3DH.%2BJ.%26aulast%3DVazquez-Boland%26aufirst%3DJ.%2BA.%26aulast%3DBanfield%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520smcl%252C%2520a%2520bacterial%2520neutral%2520sphingomyelinase%2520c%2520from%2520listeria%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D35011%26epage%3D35017%26doi%3D10.1074%2Fjbc.M506800200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ago, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katunuma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from bacillus cereus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">16157</span>– <span class="NLM_lpage">16167</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601089200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M601089200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16595670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1Crsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=16157-16167&author=H.+Agoauthor=M.+Odaauthor=M.+Takahashiauthor=H.+Tsugeauthor=S.+Ochiauthor=N.+Katunumaauthor=M.+Miyanoauthor=J.+Sakurai&title=Structural+basis+of+the+sphingomyelin+phosphodiesterase+activity+in+neutral+sphingomyelinase+from+bacillus+cereus&doi=10.1074%2Fjbc.M601089200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Sphingomyelin Phosphodiesterase Activity in Neutral Sphingomyelinase from Bacillus cereus</span></div><div class="casAuthors">Ago, Hideo; Oda, Masataka; Takahashi, Masaya; Tsuge, Hideaki; Ochi, Sadayuki; Katunuma, Nobuhiko; Miyano, Masashi; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16157-16167</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingomyelinase (SMase) from Bacillus cereus (Bc-SMase) hydrolyzes sphingomyelin to phosphocholine and ceramide in a divalent metal ion-dependent manner.  Bc-SMase is a homolog of mammalian neutral SMase (nSMase) and mimics the actions of the endogenous mammalian nSMase in causing differentiation, development, aging, and apoptosis.  Thus Bc-SMase may be a good model for the poorly characterized mammalian nSMase.  The metal ion activation of sphingomyelinase activity of Bc-SMase was in the order Co2+ ≥ Mn2+ ≥ Mg2+ » Ca2+ ≥ Sr2+.  The first crystal structures of Bc-SMase bound to Co2+, Mg2+, or Ca2+ were detd.  The water-bridged double divalent metal ions at the center of the cleft in both the Co2+- and Mg2+-bound forms were concluded to be the catalytic architecture required for sphingomyelinase activity.  In contrast, the architecture of Ca2+ binding at the site showed only one binding site.  A further single metal-binding site exists at one side edge of the cleft.  Based on the highly conserved nature of the residues of the binding sites, the crystal structure of Bc-SMase with bound Mg2+ or Co2+ may provide a common structural framework applicable to phosphohydrolases belonging to the DNase I-like folding superfamily.  In addn., the structural features and site-directed mutagenesis suggest that the specific β-hairpin with the arom. amino acid residues participates in binding to the membrane-bound sphingomyelin substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquLksjEE9SFLVg90H21EOLACvtfcHk0lhrrWDtERDFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1Crsro%253D&md5=16514a75f68870bdf751007ca19848f6</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601089200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601089200%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsuge%26aufirst%3DH.%26aulast%3DOchi%26aufirst%3DS.%26aulast%3DKatunuma%26aufirst%3DN.%26aulast%3DMiyano%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520the%2520sphingomyelin%2520phosphodiesterase%2520activity%2520in%2520neutral%2520sphingomyelinase%2520from%2520bacillus%2520cereus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D16157%26epage%3D16167%26doi%3D10.1074%2Fjbc.M601089200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengistu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohach, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlievert, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, C. A.</span></span> <span> </span><span class="NLM_article-title">Structure and biological activities of beta toxin from staphylococcus aureus</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">8719</span>– <span class="NLM_lpage">8726</span>, <span class="refDoi"> DOI: 10.1128/JB.00741-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1128%2FJB.00741-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17873030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWitbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2007&pages=8719-8726&author=M.+Husebyauthor=K.+Shiauthor=C.+K.+Brownauthor=J.+Digreauthor=F.+Mengistuauthor=K.+S.+Seoauthor=G.+A.+Bohachauthor=P.+M.+Schlievertauthor=D.+H.+Ohlendorfauthor=C.+A.+Earhart&title=Structure+and+biological+activities+of+beta+toxin+from+staphylococcus+aureus&doi=10.1128%2FJB.00741-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and biological activities of beta toxin from Staphylococcus aureus</span></div><div class="casAuthors">Huseby, Medora; Shi, Ke; Brown, C. Kent; Digre, Jeff; Mengistu, Fikre; Seo, Keun Seok; Bohach, Gregory A.; Schlievert, Patrick M.; Ohlendorf, Douglas H.; Earhart, Cathleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8719-8726</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Beta toxin is a neutral sphingomyelinase secreted by certain strains of Staphylococcus aureus.  This virulence factor lyses erythrocytes to evade the host immune system as well as scavenge nutrients.  The structure of beta toxin was detd. at 2.4-Å resoln. using crystals that were merohedrally twinned.  This structure is similar to that of the sphingomyelinases of Listeria ivanovii and Bacillus cereus.  Beta toxin belongs to the DNase I folding superfamily; in addn. to sphingomyelinases, the proteins most structurally related to beta toxin include human endonuclease HAP1, Escherichia coli endonuclease III, bovine pancreatic DNase I, and the endonuclease domain of TRAS1 from Bombyx mori.  The authors' biol. assays demonstrated for the first time that beta toxin kills proliferating human lymphocytes.  Structure-directed active site mutations show that biol. activities, including hemolysis and lymphotoxicity, are due to the sphingomyelinase activity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3isnbmrnoM7Vg90H21EOLACvtfcHk0lhrrWDtERDFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWitbjN&md5=faf12957045fe21f667ecf14524472d5</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1128%2FJB.00741-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00741-07%26sid%3Dliteratum%253Aachs%26aulast%3DHuseby%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DC.%2BK.%26aulast%3DDigre%26aufirst%3DJ.%26aulast%3DMengistu%26aufirst%3DF.%26aulast%3DSeo%26aufirst%3DK.%2BS.%26aulast%3DBohach%26aufirst%3DG.%2BA.%26aulast%3DSchlievert%26aufirst%3DP.%2BM.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DEarhart%26aufirst%3DC.%2BA.%26atitle%3DStructure%2520and%2520biological%2520activities%2520of%2520beta%2520toxin%2520from%2520staphylococcus%2520aureus%26jtitle%3DJ.%2520Bacteriol.%26date%3D2007%26volume%3D189%26spage%3D8719%26epage%3D8726%26doi%3D10.1128%2FJB.00741-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, C. A.</span></span> <span> </span><span class="NLM_article-title">Structure of a mutant beta toxin from staphylococcus aureus reveals domain swapping and conformational flexibility</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1107/S1744309111005239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1107%2FS1744309111005239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21505235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=438-441&author=A.+C.+Kruseauthor=M.+J.+Husebyauthor=K.+Shiauthor=J.+Digreauthor=D.+H.+Ohlendorfauthor=C.+A.+Earhart&title=Structure+of+a+mutant+beta+toxin+from+staphylococcus+aureus+reveals+domain+swapping+and+conformational+flexibility&doi=10.1107%2FS1744309111005239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a mutant β toxin from Staphylococcus aureus reveals domain swapping and conformational flexibility</span></div><div class="casAuthors">Kruse, Andrew C.; Huseby, Medora J.; Shi, Ke; Digre, Jeff; Ohlendorf, Douglas H.; Earhart, Cathleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-441</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The 3.35 Å resoln. crystal structure of a mutant form of the staphylococcal sphingomyelinase β toxin in which a conserved hydrophobic β-hairpin has been deleted is reported.  It is shown that this mutation induces domain swapping of a C-terminal β-strand, leading to the formation of dimers linked by a conformationally flexible hinge region.  Eight dimers are seen in the asym. unit, exhibiting a broad spectrum of conformations trapped in place by intermol. contacts within the crystal lattice.  Furthermore, the 16 monomers within each asym. unit exhibit a remarkable heterogeneity in thermal factors, which can be accounted for by the varying degrees to which each monomer interacts with other mols. in the crystal.  This structure provides a unique example of the challenges assocd. with crystallog. study of flexible proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp764HdSWclybVg90H21EOLACvtfcHk0lhrrWDtERDFRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGksr8%253D&md5=42fcc73cafed05f0c8ba0e926331b047</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1107%2FS1744309111005239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309111005239%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHuseby%26aufirst%3DM.%2BJ.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DDigre%26aufirst%3DJ.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DEarhart%26aufirst%3DC.%2BA.%26atitle%3DStructure%2520of%2520a%2520mutant%2520beta%2520toxin%2520from%2520staphylococcus%2520aureus%2520reveals%2520domain%2520swapping%2520and%2520conformational%2520flexibility%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2011%26volume%3D67%26spage%3D438%26epage%3D441%26doi%3D10.1107%2FS1744309111005239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Stereocontrolled synthesis of a sphingomyelin methylene analogue as a sphingomyelinase inhibitor</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2629</span>, <span class="refDoi"> DOI: 10.1021/ol006147c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006147c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlagsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=2627-2629&author=T.+Hakogiauthor=Y.+Mondenauthor=S.+Iwamaauthor=S.+Katsumura&title=Stereocontrolled+synthesis+of+a+sphingomyelin+methylene+analogue+as+a+sphingomyelinase+inhibitor&doi=10.1021%2Fol006147c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Stereocontrolled Synthesis of a Sphingomyelin Methylene Analogue as a Sphingomyelinase Inhibitor</span></div><div class="casAuthors">Hakogi, Toshikazu; Monden, Yoshiko; Iwama, Seiji; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2627-2629</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient synthesis of a sphingomyelin methylene analog I, which was designed as a sphingomyelinase inhibitor, was stereoselectively achieved.  The Hofmann rearrangement of the α-hydroxyethyl-β-hydroxy amide II followed by the intramol. oxazolidinone ring formation was one of the key steps.  I showed moderate inhibitory activity toward sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4khR0nI8GO7Vg90H21EOLACvtfcHk0lhrnMMPX12M5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlagsL8%253D&md5=8b2520f1b3680d319fcdb239f730e680</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fol006147c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006147c%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DMonden%26aufirst%3DY.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520a%2520sphingomyelin%2520methylene%2520analogue%2520as%2520a%2520sphingomyelinase%2520inhibitor%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D2627%26epage%3D2629%26doi%3D10.1021%2Fol006147c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin carbon analogues as sphingomyelinase inhibitors</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">4839</span>– <span class="NLM_lpage">4846</span>, <span class="refDoi"> DOI: 10.1021/jo025529o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025529o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=4839-4846&author=T.+Hakogiauthor=Y.+Mondenauthor=M.+Taichiauthor=S.+Iwamaauthor=S.+Fujiiauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+carbon+analogues+as+sphingomyelinase+inhibitors&doi=10.1021%2Fjo025529o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Sphingomyelin Carbon Analogues as Sphingomyelinase Inhibitors</span></div><div class="casAuthors">Hakogi, Toshikazu; Monden, Yoshiko; Taichi, Misako; Iwama, Seiji; Fujii, Shinobu; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4839-4846</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The highly efficient and stereocontrolled syntheses of sphingomyelin carbon analogs I (X = CH2, CH2CH2) were achieved by effectively utilizing Hofmann rearrangement of an enantiomerically pure β-hydroxyamide, which was prepd. by an asym. hydrogenation of a α-acyl-γ-butyrolactone and ring opening with NH3.  An intermediary isocyanate was selectively trapped with the vicinal hydroxy group in an intramol. fashion to produce an oxazolidinone deriv., intermediate.  In the synthesis of a quite polar compd. such as I, a convenient one-pot procedure of the introduction of a benzyloxycarbonyl group into the hydroxy group resulting from the oxazolidinone ring opening is another key point, because, in addn. to the efficiency, this protecting group was easily removable by a simple procedure and workup at the final step.  Both synthesized compds. I (X = CH2, CH2CH2) showed moderate inhibitory activity toward sphingomyelinase from B. cereus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSEvsBfde8LVg90H21EOLACvtfcHk0lhrnMMPX12M5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKjtLg%253D&md5=8549bc8784a801b1fac2d562feba48dc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjo025529o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025529o%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DMonden%26aufirst%3DY.%26aulast%3DTaichi%26aufirst%3DM.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520carbon%2520analogues%2520as%2520sphingomyelinase%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D4839%26epage%3D4846%26doi%3D10.1021%2Fjo025529o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2804</span>, <span class="refDoi"> DOI: 10.1021/ol034771u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol034771u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltF2rurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2801-2804&author=T.+Hakogiauthor=M.+Taichiauthor=S.+Katsumura&title=Synthesis+of+a+nitrogen+analogue+of+sphingomyelin+as+a+sphingomyelinase+inhibitor&doi=10.1021%2Fol034771u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Nitrogen Analogue of Sphingomyelin as a Sphingomyelinase Inhibitor</span></div><div class="casAuthors">Hakogi, Toshikazu; Taichi, Misako; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2801-2804</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingomyelin nitrogen analog I was designed and synthesized as a sphingomyelinase inhibitor.  The synthesis was established by continuous Hofmann rearrangement and Curtius rearrangement as key steps in constructing the 3-hydroxy-1,2-diamine structure in the backbone of I.  This analog showed moderate inhibitory activity toward sphingomyelinase isolated from B. cereus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh3Jq5mhvGwLVg90H21EOLACvtfcHk0lhrnMMPX12M5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltF2rurg%253D&md5=65e99d208f1458243deeae1085d931e7</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fol034771u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol034771u%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DTaichi%26aufirst%3DM.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520nitrogen%2520analogue%2520of%2520sphingomyelin%2520as%2520a%2520sphingomyelinase%2520inhibitor%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2801%26epage%3D2804%26doi%3D10.1021%2Fol034771u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin difluoromethylene analogue</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2630</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.tetlet.2006.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitlarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=2627-2630&author=T.+Hakogiauthor=T.+Yamamotoauthor=S.+Fujiiauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+difluoromethylene+analogue&doi=10.1016%2Fj.tetlet.2006.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sphingomyelin difluoromethylene analog</span></div><div class="casAuthors">Hakogi, Toshikazu; Yamamoto, Tetsuya; Fujii, Shinobu; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2627-2630</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a new sphingomyelinase inhibitor, a novel sphingomyelin CF2 analog was designed and synthesized.  One key step of this synthesis is the very mild hydrolysis of the oxazolidinone ring of methylphosphonate I, a suitable intermediate for the introduction of a di-Et difluoro-methylphosphonate group, by utilizing the characteristic electron withdrawing nature of the group at the oxazolidinone ring in an alc. solvent to produce the corresponding carbonate attaching at the secondary hydroxy group.  The synthesized CF2 analog inactivated toward B. cereus sphingomyelinase with nearly the same attitude as the nitrogen analog that we previously reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXswOb8tpvRrVg90H21EOLACvtfcHk0ljpr_w8-Xv-Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitlarsbo%253D&md5=a50d891bb2c469fbfb8e2fadf044ee0a</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520difluoromethylene%2520analogue%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D2627%26epage%3D2630%26doi%3D10.1016%2Fj.tetlet.2006.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2144</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmcl.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15808485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVKgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2141-2144&author=T.+Hakogiauthor=S.+Fujiiauthor=M.+Moritaauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+sulfur+analogue+and+its+behavior+toward+sphingomyelinase&doi=10.1016%2Fj.bmcl.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase</span></div><div class="casAuthors">Hakogi, Toshikazu; Fujii, Shinobu; Morita, Michio; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2141-2144</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The sulfur analog of sphingomyelin was designed and stereoselectively synthesized from S-benzyl-N-Boc-cysteine.  The introduction of the phosphoryl choline moiety was successfully achieved by our own method using 2-bromoethyl di-Me phosphite and carbon tetrabromide followed by a trimethylamine treatment.  The synthesized compd. proved to be a useful substrate for monitoring the enzyme activity of sphingomyelinase by detecting the liberated thiol group with a thiol-sensitive reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj_NTCRC4o9LVg90H21EOLACvtfcHk0ljpr_w8-Xv-Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVKgtb0%253D&md5=553bfebe30cc909ebe340ab29b6f3c0c</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520sulfur%2520analogue%2520and%2520its%2520behavior%2520toward%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2141%26epage%3D2144%26doi%3D10.1016%2Fj.bmcl.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabiku, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3868</span>– <span class="NLM_lpage">3871</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmcl.2010.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20627555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVWju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3868-3871&author=H.+Imagawaauthor=M.+Odaauthor=T.+Takemotoauthor=R.+Yamauchiauthor=T.+Yoshikawaauthor=H.+Yamamotoauthor=M.+Nishizawaauthor=H.+Takahashiauthor=M.+Hashimotoauthor=K.+Yabikuauthor=M.+Nagahamaauthor=J.+Sakurai&title=Synthesis+and+evaluation+of+novel+phosphate+ester+analogs+as+neutral+sphingomyelinase+inhibitors&doi=10.1016%2Fj.bmcl.2010.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors</span></div><div class="casAuthors">Imagawa, Hiroshi; Oda, Masataka; Takemoto, Takayuki; Yamauchi, Rieko; Yoshikawa, Tomomi; Yamamoto, Hirofumi; Nishizawa, Mugio; Takahashi, Hironobu; Hashimoto, Manabu; Yabiku, Kenta; Nagahama, Masahiro; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3868-3871</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel sphingomyelin inhibitor RY221B-a I, which contains a bipyridyl moiety as a metal coordination site was designed based upon the mechanism of phosphate ester hydrolysis.  I was synthesized from N-Boc-sphingosine in three steps via selective etherification using stannyl acetal.  Synthesized I exhibited relatively-strong inhibitory activity against Bacillus subtillis sphingomyelinase (IC50 = 1.2 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-r0iFo4PgrVg90H21EOLACvtfcHk0ljpr_w8-Xv-Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVWju7Y%253D&md5=cba3b6b3c9a5195eead28f3dffd3a6be</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DImagawa%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DR.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DYabiku%26aufirst%3DK.%26aulast%3DNagahama%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520phosphate%2520ester%2520analogs%2520as%2520neutral%2520sphingomyelinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3868%26epage%3D3871%26doi%3D10.1016%2Fj.bmcl.2010.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabiku, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitor of bacterial sphingomyelinase, smy-540, developed based on three-dimensional structure analysis</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.3109/14756366.2013.777717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3109%2F14756366.2013.777717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=23488740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=303-310&author=M.+Odaauthor=H.+Imagawaauthor=R.+Katoauthor=K.+Yabikuauthor=T.+Yoshikawaauthor=T.+Takemotoauthor=H.+Takahashiauthor=H.+Yamamotoauthor=M.+Nishizawaauthor=J.+Sakuraiauthor=M.+Nagahama&title=Novel+inhibitor+of+bacterial+sphingomyelinase%2C+smy-540%2C+developed+based+on+three-dimensional+structure+analysis&doi=10.3109%2F14756366.2013.777717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis</span></div><div class="casAuthors">Oda, Masataka; Imagawa, Hiroshi; Kato, Ryoko; Yabiku, Kenta; Yoshikawa, Tomomi; Takemoto, Takayuki; Takahashi, Hironobu; Yamamoto, Hirofumi; Nishizawa, Mugio; Sakurai, Jun; Nagahama, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-310</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Context: Bacterial sphingomyelinase (SMase) is thought to play a crucial role in bacterial evasion of the immune response during the early stages of infections.  Objective: The objective of this study was to predict the chem. structure required for competitive SMase inhibition, then synthesize and test the effect of potential inhibitors on the hydrolysis of sphingomyelin (SM) and protection against infection by Bacillus cereus.  Materials and methods: We synthesized 10 potential SMase inhibitors, derivs. of RY221B-a analogs, based on predictions from three-dimensional structural anal.  We then tested the effect of these compds. on the inhibition of SM hydrolysis and protection of mice inoculated with B. cereus.  Results: One compd., SMY-540, displayed a strong inhibitory effect (IC50 = 0.8 μM) upon SMase and prevented mortality in mice.  Conclusion: SMY-540 is an effective inhibitor of Bc-SMase and has potential for use in the development of drugs to treat infectious diseases caused by bacteria that produce SMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfa2DgvHxPnbVg90H21EOLACvtfcHk0ljjr6F1ofv8Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ns7o%253D&md5=0339eb5ce17bc430701cb93ae0440c13</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.3109%2F14756366.2013.777717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2013.777717%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DM.%26aulast%3DImagawa%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DYabiku%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26aulast%3DNagahama%26aufirst%3DM.%26atitle%3DNovel%2520inhibitor%2520of%2520bacterial%2520sphingomyelinase%252C%2520smy-540%252C%2520developed%2520based%2520on%2520three-dimensional%2520structure%2520analysis%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2014%26volume%3D29%26spage%3D303%26epage%3D310%26doi%3D10.3109%2F14756366.2013.777717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waggoner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Munoz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">16506</span>– <span class="NLM_lpage">16509</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.28.16506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.271.28.16506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8663293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1equrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=16506-16509&author=D.+W.+Waggonerauthor=A.+Gomez-Munozauthor=J.+Dewaldauthor=D.+N.+Brindley&title=Phosphatidate+phosphohydrolase+catalyzes+the+hydrolysis+of+ceramide+1-phosphate%2C+lysophosphatidate%2C+and+sphingosine+1-phosphate&doi=10.1074%2Fjbc.271.28.16506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate</span></div><div class="casAuthors">Waggoner, David W.; Gomez-Munoz, Antonio; Dewald, Jay; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">16506-16509</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A Mg2+-independent phosphatidate phosphohydrolase was purified from rat liver plasma membranes in two distinct forms, an anionic protein and a cationic protein.  Both forms of the enzyme dephosphorylated phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.  When assayed at a const. molar ratio of lipid to Triton X-100 of 1:500, the apparent Km values of the anionic phosphohydrolase for the lipid substrates was 3.5, 1.9, 0.4, and 4.0 μM, resp.  The relative catalytic efficiency of the enzyme for phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate was 0.16, 0.14, 0.48, and 0.04 L (min·mg)-1, resp.  The hydrolysis of phosphatidate was inhibited competitively by ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.  The Ki(app) values were 5.5, 5.9, and 4.0 μM, resp.  The hydrolysis of phosphatidate by the phosphohydrolase conformed to a surface diln. kinetic model.  It is concluded that the enzyme is a lipid phosphomonoesterase that could modify the balance of phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate relative to diacylglycerol, ceramide, monoacylglycerol, and sphingosine, resp.  The enzyme could thus play an important role in regulating cell activation and signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBipUSDoi3mLVg90H21EOLACvtfcHk0ljjr6F1ofv8Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1equrs%253D&md5=3f980775e8126636a0b53e260e73309b</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.28.16506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.28.16506%26sid%3Dliteratum%253Aachs%26aulast%3DWaggoner%26aufirst%3DD.%2BW.%26aulast%3DGomez-Munoz%26aufirst%3DA.%26aulast%3DDewald%26aufirst%3DJ.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DPhosphatidate%2520phosphohydrolase%2520catalyzes%2520the%2520hydrolysis%2520of%2520ceramide%25201-phosphate%252C%2520lysophosphatidate%252C%2520and%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D16506%26epage%3D16509%26doi%3D10.1074%2Fjbc.271.28.16506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shinghal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajjalieh, S. M.</span></span> <span> </span><span class="NLM_article-title">Ceramide 1-phosphate phosphatase activity in brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2279</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1993.tb07470.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1471-4159.1993.tb07470.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8245978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXivVSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1993&pages=2279-2285&author=R.+Shinghalauthor=R.+H.+Schellerauthor=S.+M.+Bajjalieh&title=Ceramide+1-phosphate+phosphatase+activity+in+brain&doi=10.1111%2Fj.1471-4159.1993.tb07470.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide 1-phosphate phosphatase activity in brain</span></div><div class="casAuthors">Shinghal, Rajesh; Scheller, Richard H.; Bajjalieh, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2279-85</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Recent studies have implicated sphingolipids in a variety of intracellular signaling systems.  The finding that a calcium-stimulated ceramide kinase copurifies with neurotransmitter-contg. vesicles suggests that ceramide, or one of its metabolites, has a role in neurotransmitter release.  As a step toward understanding the role of ceramide kinase in vesicle functioning, this study sought to det. the metabolic fate of the product, ceramide 1-phosphate.  The authors report that ceramide 1-phosphate is not deacylated by brain ceramidases to produce sphingosine 1-phosphate.  It is however, the substrate for a phosphatase activity that the authors name ceramide 1-phosphate phosphatase (CCPase).  Subcellular fractionation studies suggest that CPPase is found in the synaptic terminal and is assocd. with both synaptic vesicle and plasma membranes.  Divalent cations, most notably calcium, inhibit CPPase activity although not at concns. that activate ceramide kinase.  The existence of both ceramide kinase and CPPase activities at the synapse suggests that ceramide 1-phosphate prodn. regulates some aspect of synaptic vesicle functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAAw2sXaq4LLVg90H21EOLACvtfcHk0ljjr6F1ofv8Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivVSjsQ%253D%253D&md5=b433c45f7ce5f820c6ea7fb30cb1b7db</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1993.tb07470.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1993.tb07470.x%26sid%3Dliteratum%253Aachs%26aulast%3DShinghal%26aufirst%3DR.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DBajjalieh%26aufirst%3DS.%2BM.%26atitle%3DCeramide%25201-phosphate%2520phosphatase%2520activity%2520in%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1993%26volume%3D61%26spage%3D2279%26epage%3D2285%26doi%3D10.1111%2Fj.1471-4159.1993.tb07470.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">22150</span>– <span class="NLM_lpage">22155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2820%2980660-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8408075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXjt1Gh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=22150-22155&author=O.+Boudkerauthor=A.+H.+Futerman&title=Detection+and+characterization+of+ceramide-1-phosphate+phosphatase+activity+in+rat+liver+plasma+membrane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane</span></div><div class="casAuthors">Boudker, Olga; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22150-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A Ca2+-dependent ceramide (Cer) kinase was recently detected in human leukemia (HL-60) cells where it may function in terminating the regulatory effects of Cer, and in synaptic vesicles.  Here, it is demonstrated that the addn. of both Cer-1-phosphate (Cer-1-P) and a short-acyl chain analog of Cer-1-P, N-hexanoylsphingosine-1-phosphate (C6-Cer-1-P), to cultured cells and a variety of subcellular fractions resulted in rapid degrdn. to Cer and C6-Cer, resp.  The ceramide 1-phosphatase activity was enriched in a rat liver plasma membrane fraction and appeared to be distinct from the phosphatase that hydrolyzes phosphatidic acid (PA), phosphatidate phosphatase, as shown by the difference in sensitivity of Cer-1-P and PA hydrolysis to propranolol, detergent, and heat treatment.  Moreover, the Km of C6-Cer-1-P hydrolysis was 10-fold lower than the Km of PA hydrolysis in plasma membrane.  PA was a noncompetitive inhibitor of C6-Cer-1-P hydrolysis, with a Ki 1-1.5-fold higher than the Km of C6-Cer-1-P hydrolysis.  In contrast, C6-Cer-1-P did not inhibit PA hydrolysis.  Finally, the synthesis of a novel analog of Cer-1-P, C6-Cer-cyclic 1,3-phosphate, is described, which is not hydrolyzed in vitro and in vivo and is internalized in cultured cells by endocytosis.  These results were discussed in relation to the possible roles of Cer-1-P in regulating intracellular levels of Cer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMIghVYmGRrVg90H21EOLACvtfcHk0ljjr6F1ofv8Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjt1Gh&md5=daca544d3af06216d06b9ae4b411b190</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2820%2980660-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252820%252980660-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoudker%26aufirst%3DO.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DDetection%2520and%2520characterization%2520of%2520ceramide-1-phosphate%2520phosphatase%2520activity%2520in%2520rat%2520liver%2520plasma%2520membrane%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D22150%26epage%3D22155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stirnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmatoug, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serratrice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froissart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serratrice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billette
de Villemeur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. G.</span></span> <span> </span><span class="NLM_article-title">A review of gaucher disease pathophysiology, clinical presentation and treatments</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.3390/ijms18020441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3390%2Fijms18020441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVSju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=441&author=J.+Stirnemannauthor=N.+Belmatougauthor=F.+Camouauthor=C.+Serratriceauthor=R.+Froissartauthor=C.+Caillaudauthor=T.+Levadeauthor=L.+Astudilloauthor=J.+Serratriceauthor=A.+Brassierauthor=C.+Roseauthor=T.+Billette%0Ade+Villemeurauthor=M.+G.+Berger&title=A+review+of+gaucher+disease+pathophysiology%2C+clinical+presentation+and+treatments&doi=10.3390%2Fijms18020441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A review of gaucher disease pathophysiology, clinical presentation and treatments</span></div><div class="casAuthors">Stirnemann, Jerome; Belmatoug, Nadia; Camou, Fabrice; Serratrice, Christine; Froissart, Roseline; Caillaud, Catherine; Levade, Thierry; Astudillo, Leonardo; Serratrice, Jacques; Brassier, Anais; Rose, Christian; Billette de Villemeur, Thierry; Berger, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441/1-441/30</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder.  It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages.  In the general population, its incidence is approx. 1/40,000 to 1/60,000 births, rising to 1/800 in Ashkenazi Jews.  The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions assocd. with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.  Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whereas types 2 and 3 are also assocd. with neurol. impairment, either severe in type 2 or variable in type 3.  A diagnosis of GD can be confirmed by demonstrating the deficiency of acid glucocerebrosidase activity in leukocytes.  Mutations in the GBA1 gene should be identified as they may be of prognostic value in some cases.  Patients with type-1 GD-but also carriers of GBA1 mutation-have been found to be predisposed to developing Parkinson's disease, and the risk of neoplasia assocd. with the disease is still subject to discussion.  Disease-specific treatment consists of i.v. enzyme replacement therapy (ERT) using one of the currently available mols. (imiglucerase, velaglucerase, or taliglucerase).  Orally administered inhibitors of glucosylceramide biosynthesis can also be used (miglustat or eliglustat).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpeVOOYHDqyLVg90H21EOLACvtfcHk0ljyvVN6-PC44w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVSju70%253D&md5=38a4c125a4007d25177135c8996f7abe</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.3390%2Fijms18020441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18020441%26sid%3Dliteratum%253Aachs%26aulast%3DStirnemann%26aufirst%3DJ.%26aulast%3DBelmatoug%26aufirst%3DN.%26aulast%3DCamou%26aufirst%3DF.%26aulast%3DSerratrice%26aufirst%3DC.%26aulast%3DFroissart%26aufirst%3DR.%26aulast%3DCaillaud%26aufirst%3DC.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DAstudillo%26aufirst%3DL.%26aulast%3DSerratrice%26aufirst%3DJ.%26aulast%3DBrassier%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DBillette%2Bde%2BVillemeur%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DM.%2BG.%26atitle%3DA%2520review%2520of%2520gaucher%2520disease%2520pathophysiology%252C%2520clinical%2520presentation%2520and%2520treatments%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D441%26doi%3D10.3390%2Fijms18020441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span> <span> </span><span class="NLM_article-title">Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe’s disease</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1006</span>, <span class="refDoi"> DOI: 10.1002/jnr.23873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fjnr.23873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27638584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWltr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=990-1006&author=J.+S.+Wonauthor=A.+K.+Singhauthor=I.+Singh&title=Biochemical%2C+cell+biological%2C+pathological%2C+and+therapeutic+aspects+of+Krabbe%E2%80%99s+disease&doi=10.1002%2Fjnr.23873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease</span></div><div class="casAuthors">Won, Je-Seong; Singh, Avtar K.; Singh, Inderjit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-1006</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Krabbe's disease (KD; also called globoid cell leukodystrophy) is a genetic disorder involving demyelination of the central (CNS) and peripheral (PNS) nervous systems.  The disease may be subdivided into three types, an infantile form, which is the most common and severe; a juvenile form; and a rare adult form.  KD is an autosomal recessive disorder caused by a deficiency of galactocerebrosidase activity in lysosomes, leading to accumulation of galactoceramide and neurotoxic galactosylsphingosine (psychosine [PSY]) in macrophages (globoid cells) as well as neural cells, esp. in oligodendrocytes and Schwann cells.  This ultimately results in damage to myelin in both CNS and PNS with assocd. morbidity and mortality.  Accumulation of PSY, a lysolipid with detergent-like properties, over a threshold level could trigger membrane destabilization, leading to cell lysis.  Moreover, subthreshold concns. of PSY trigger cell signaling pathways that induce oxidative stress, mitochondrial dysfunction, apoptosis, inflammation, endothelial/vascular dysfunctions, and neuronal and axonal damage.  From the time the "psychosine hypothesis" was proposed, considerable efforts have been made in search of an effective therapy for lowering PSY load with pharmacol., gene, and stem cell approaches to attenuate PSY-induced neurotoxicity.  This Review focuses on the recent advances and prospective research for understanding disease mechanisms and therapeutic approaches for KD. © 2016 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyiXLjIgjfi7Vg90H21EOLACvtfcHk0ljyvVN6-PC44w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWltr3I&md5=4f5306516d90cf3abf8a9023172ac8dc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23873%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DJ.%2BS.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DI.%26atitle%3DBiochemical%252C%2520cell%2520biological%252C%2520pathological%252C%2520and%2520therapeutic%2520aspects%2520of%2520Krabbe%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2016%26volume%3D94%26spage%3D990%26epage%3D1006%26doi%3D10.1002%2Fjnr.23873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropak, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhaber, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahuran, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of ambroxol as an enzyme enhancement agent for gaucher disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23502</span>– <span class="NLM_lpage">23516</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.012393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M109.012393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19578116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23502-23516&author=G.+H.+Maegawaauthor=M.+B.+Tropakauthor=J.+D.+Buttnerauthor=B.+A.+Rigatauthor=M.+Fullerauthor=D.+Panditauthor=L.+Tangauthor=G.+J.+Kornhaberauthor=Y.+Hamuroauthor=J.+T.+Clarkeauthor=D.+J.+Mahuran&title=Identification+and+characterization+of+ambroxol+as+an+enzyme+enhancement+agent+for+gaucher+disease&doi=10.1074%2Fjbc.M109.012393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease</span></div><div class="casAuthors">Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Fuller, Maria; Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo; Clarke, Joe T. R.; Mahuran, Don J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23502-23516</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase).  The identification of small mols. acting as agents for enzyme enhancement therapy is an attractive approach for treating different forms of GD.  A thermal denaturation assay utilizing wild type GCase was developed to screen a library of 1,040 Food and Drug Administration-approved drugs.  Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase.  Its inhibitory activity was maximal at neutral pH, found in the endoplasmic reticulum, and undetectable at the acidic pH of lysosomes.  The pH dependence of ABX to bind and stabilize the enzyme was confirmed by monitoring the rate of hydrogen/deuterium exchange at increasing guanidine hydrochloride concns.  ABX treatment significantly increased N370S and F213I mutant GCase activity and protein levels in GD fibroblasts.  These increases were primarily confined to the lysosome-enriched fraction of treated cells, a finding confirmed by confocal immunofluorescence microscopy.  Addnl., enhancement of GCase activity and a redn. in glucosylceramide storage was verified in ABX-treated GD lymphoblasts (N370S/N370S).  Hydrogen/deuterium exchange mass spectrometry revealed that upon binding of ABX, amino acid segments 243-249, 310-312, and 386-400 near the active site of GCase are stabilized.  Consistent with its mixed-type inhibition of GCase, modeling studies indicated that ABX interacts with both active and non-active site residues.  Thus, ABX has the biochem. characteristics of a safe and effective enzyme enhancement therapy agent for the treatment of patients with the most common GD genotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Zxl1_6m-5rVg90H21EOLACvtfcHk0ljyvVN6-PC44w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt77J&md5=251abe854d7aed644de329e595e7294a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.012393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.012393%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DFuller%26aufirst%3DM.%26aulast%3DPandit%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520ambroxol%2520as%2520an%2520enzyme%2520enhancement%2520agent%2520for%2520gaucher%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23502%26epage%3D23516%26doi%3D10.1074%2Fjbc.M109.012393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybczynski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological chaperones as therapeutics for lysosomal storage diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1021/jm301557k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301557k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2705-2725&author=R.+E.+Boydauthor=G.+Leeauthor=P.+Rybczynskiauthor=E.+R.+Benjaminauthor=R.+Khannaauthor=B.+A.+Wustmanauthor=K.+J.+Valenzano&title=Pharmacological+chaperones+as+therapeutics+for+lysosomal+storage+diseases&doi=10.1021%2Fjm301557k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases</span></div><div class="casAuthors">Boyd, Robert E.; Lee, Gary; Rybczynski, Philip; Benjamin, Elfrida R.; Khanna, Richie; Wustman, Brandon A.; Valenzano, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2705-2725</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lysosomal enzymes are responsible for the degrdn. of a wide variety of glycolipids, oligosaccharides, proteins, and glycoproteins.  Inherited mutations in the genes that encode these proteins can lead to reduced stability of newly synthesized lysosomal enzymes.  While often catalytically competent, the mutated enzymes are unable to efficiently pass the quality control mechanisms of the endoplasmic reticulum, resulting in reduced lysosomal trafficking, substrate accumulation, and cellular dysfunction.  Pharmacol. chaperones (PCs) are small mols. that bind and stabilize mutant lysosomal enzymes, thereby allowing proper cellular translocation.  Such compds. have been shown to increase enzyme activity and reduce substrate burden in a no. of preclin. models and clin. studies.  In this Perspective, we review several of the lysosomal diseases for which PCs have been studied and the SAR of the various classes of mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5XMGP8Eg5B7Vg90H21EOLACvtfcHk0lg-wuuiFvyWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtLc%253D&md5=09294f7cc13deaddf5069adecf71f8b8</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm301557k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301557k%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRybczynski%26aufirst%3DP.%26aulast%3DBenjamin%26aufirst%3DE.%2BR.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWustman%26aufirst%3DB.%2BA.%26aulast%3DValenzano%26aufirst%3DK.%2BJ.%26atitle%3DPharmacological%2520chaperones%2520as%2520therapeutics%2520for%2520lysosomal%2520storage%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2705%26epage%3D2725%26doi%3D10.1021%2Fjm301557k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances and novel treatments for sphingolipidoses</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1687</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.4155%2Ffmc-2017-0065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28857617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BC1cbjt12nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1687-1700&author=C.+Arenz&title=Recent+advances+and+novel+treatments+for+sphingolipidoses&doi=10.4155%2Ffmc-2017-0065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances and novel treatments for sphingolipidoses</span></div><div class="casAuthors">Arenz Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1687-1700</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingolipidoses are genetically inherited diseases in which genetic mutations lead to functional deficiencies in the enzymes needed for lysosomal degradation of sphingolipid substrates.  As a consequence, nondegradable lipids enrich in the lysosomes and lead to fatal pathological phenotypes in affected individuals.  In this review, different drug-based treatment strategies including enzyme replacement therapy and substrate reduction therapy are discussed.  A special focus is on the concept of pharmacological chaperones, one of which recently acquired clinical approval within the EU.  On the basis of the different limitations for each approach, possible future directions of research are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU_JNgrtbOLH6oPH0mYWL1fW6udTcc2ebwVmsFzVXz9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbjt12nsQ%253D%253D&md5=4af9941c6d9f7fdcc6e7f6740922687f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0065%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520and%2520novel%2520treatments%2520for%2520sphingolipidoses%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1687%26epage%3D1700%26doi%3D10.4155%2Ffmc-2017-0065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chew, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seow, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span> <span> </span><span class="NLM_article-title">Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.04.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29654754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvFemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2018&pages=596-601&author=W.+S.+Chewauthor=W.+L.+Seowauthor=J.+R.+Chongauthor=M.+K.+P.+Laiauthor=F.+Tortaauthor=M.+R.+Wenkauthor=D.+R.+Herr&title=Sphingolipidomics+analysis+of+large+clinical+cohorts.+Part+1%3A+Technical+notes+and+practical+considerations&doi=10.1016%2Fj.bbrc.2018.04.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations</span></div><div class="casAuthors">Chew, Wee Siong; Seow, Wei Lun; Chong, Joyce R.; Lai, Mitchell K. P.; Torta, Federico; Wenk, Markus R.; Herr, Deron R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lipids comprise an exceptionally diverse class of bioactive macromols.  While quant. abundant lipid species serve fundamental roles in cell structure and energy metab., thousands of structurally-distinct, quant. minor species may serve as important regulators of cellular processes.  Historically, a complete understanding of the biol. roles of these lipids has been limited by a lack of sensitive, discriminating anal. techniques.  The class of sphingolipids alone, for example, is known to consist of over 600 different confirmed species, but is likely to include tens of thousands of metabolites with potential biol. significance.  Advances in mass spectrometry (MS) have improved the throughput and discrimination of lipid anal., allowing for the detn. of detailed lipid profiles in large cohorts of clin. samples.  Databases emerging from these studies will provide a rich resource for the identification of novel biomarkers and for the discovery of potential drug targets, analogous to that of existing genomics databases.  In this , we will provide an overview of the field of sphingolipidomics, and will discuss some of the challenges and considerations facing the generation of robust lipidomics databases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj8LdDhANPjrVg90H21EOLACvtfcHk0lg-wuuiFvyWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvFemsrg%253D&md5=5b20d8cb615fdc2bef9ac77f63ceae05</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DChew%26aufirst%3DW.%2BS.%26aulast%3DSeow%26aufirst%3DW.%2BL.%26aulast%3DChong%26aufirst%3DJ.%2BR.%26aulast%3DLai%26aufirst%3DM.%2BK.%2BP.%26aulast%3DTorta%26aufirst%3DF.%26aulast%3DWenk%26aufirst%3DM.%2BR.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26atitle%3DSphingolipidomics%2520analysis%2520of%2520large%2520clinical%2520cohorts.%2520Part%25201%253A%2520Technical%2520notes%2520and%2520practical%2520considerations%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D504%26spage%3D596%26epage%3D601%26doi%3D10.1016%2Fj.bbrc.2018.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chong, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hind, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span> <span> </span><span class="NLM_article-title">Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.04.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29654757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvFenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2018&pages=602-607&author=J.+R.+Chongauthor=P.+Xiangauthor=W.+Wangauthor=T.+Hindauthor=W.+S.+Chewauthor=W.+Y.+Ongauthor=M.+K.+P.+Laiauthor=D.+R.+Herr&title=Sphingolipidomics+analysis+of+large+clinical+cohorts.+Part+2%3A+Potential+impact+and+applications&doi=10.1016%2Fj.bbrc.2018.04.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications</span></div><div class="casAuthors">Chong, Joyce R.; Xiang, Ping; Wang, Wei; Hind, Tatsuma; Chew, Wee Siong; Ong, Wei-Yi; Lai, Mitchell K. P.; Herr, Deron R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has been known for decades that the regulation of sphingolipids (SLs) is essential for the proper function of many cellular processes.  However, a complete understanding of these processes has been complicated by the structural diversity of these lipids.  A well-characterized metabolic pathway is responsible for homeostatic maintenance of hundreds of distinct SL species.  This pathway is perturbed in a no. of pathol. processes, resulting in derangement of the "sphingolipidome.".  Recently, advances in mass spectrometry (MS) techniques have made it possible to characterize the sphingolipidome in large-scale clin. studies, allowing for the identification of specific SL mols. that mediate pathol. processes and/or may serve as biomarkers.  This manuscript provides an overview of the functions of SLs, and reviews previous studies that have used MS techniques to identify changes to the sphingolipidome in non-metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGgZAzrcuIhLVg90H21EOLACvtfcHk0lg-wuuiFvyWeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvFenurY%253D&md5=fdf7cef204b623153112545a4d195a65</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DJ.%2BR.%26aulast%3DXiang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHind%26aufirst%3DT.%26aulast%3DChew%26aufirst%3DW.%2BS.%26aulast%3DOng%26aufirst%3DW.%2BY.%26aulast%3DLai%26aufirst%3DM.%2BK.%2BP.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26atitle%3DSphingolipidomics%2520analysis%2520of%2520large%2520clinical%2520cohorts.%2520Part%25202%253A%2520Potential%2520impact%2520and%2520applications%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D504%26spage%3D602%26epage%3D607%26doi%3D10.1016%2Fj.bbrc.2018.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matanes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twal, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammad, S. M.</span></span> <span> </span><span class="NLM_article-title">Sphingolipids as biomarkers of disease</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1159</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/978-3-030-21162-2_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-3-030-21162-2_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31502202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsVGmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1159&publication_year=2019&pages=109-138&author=F.+Matanesauthor=W.+O.+Twalauthor=S.+M.+Hammad&title=Sphingolipids+as+biomarkers+of+disease&doi=10.1007%2F978-3-030-21162-2_7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids as Biomarkers of Disease</span></div><div class="casAuthors">Matanes, Faris; Twal, Waleed O.; Hammad, Samar M.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1159</span>
        (<span class="NLM_cas:issue">Bioactive Ceramides in Health and Disease</span>),
    <span class="NLM_cas:pages">109-138</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Despite the advancements in modern medicine, there are still difficulties in diagnosing common illnesses.  The invasiveness and price of the tests used to follow up certain diseases can be a barrier to proper patient follow-up.  Sphingolipids are a diverse category of lipids.  They are structural mols. in cell membranes and signaling mols. involved in the regulation of crucial cell functions, including cell growth, differentiation, proliferation and apoptosis.  Recent research has shown that abnormal sphingolipid metab. is assocd. with genetic and metabolic disease processes.  Given their crucial role to maintain homeostasis within the body, sphingolipids have been investigated as potential biomarkers to predict disease in the population.  Here we discuss how sphingolipids levels are altered in different diseases, thus illustrating their possible use as diagnostic and prognostic biomarkers for disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1BnvX8uGvLbVg90H21EOLACvtfcHk0ljgsEAjtZWflg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVGmsr0%253D&md5=3d40f5c6c13e4056451131d9980e9d4b</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1007%2F978-3-030-21162-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-030-21162-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DMatanes%26aufirst%3DF.%26aulast%3DTwal%26aufirst%3DW.%2BO.%26aulast%3DHammad%26aufirst%3DS.%2BM.%26atitle%3DSphingolipids%2520as%2520biomarkers%2520of%2520disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2019%26volume%3D1159%26spage%3D109%26epage%3D138%26doi%3D10.1007%2F978-3-030-21162-2_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alec  Millner</span>, <span class="hlFld-ContribAuthor ">G. Ekin  Atilla-Gokcumen</span>. </span><span class="cited-content_cbyCitation_article-title">Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>65 </em>, 49-56. <a href="https://doi.org/10.1016/j.cbpa.2021.05.001" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DSolving%252Bthe%252Benigma%25253A%252BMass%252Bspectrometry%252Band%252Bsmall%252Bmolecule%252Bprobes%252Bto%252Bstudy%252Bsphingolipid%252Bfunction%26aulast%3DMillner%26aufirst%3DAlec%26date%3D2021%26volume%3D65%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Pritts</span>. </span><span class="cited-content_cbyCitation_article-title">Trauma, Metabolomics, Outcomes, and Secrets of the Sphinx. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American College of Surgeons</span><span> <strong>2021,</strong> <em>232 </em>
                                    (5)
                                     , 797-798. <a href="https://doi.org/10.1016/j.jamcollsurg.2021.02.002" title="DOI URL">https://doi.org/10.1016/j.jamcollsurg.2021.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jamcollsurg.2021.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jamcollsurg.2021.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520College%2520of%2520Surgeons%26atitle%3DTrauma%25252C%252BMetabolomics%25252C%252BOutcomes%25252C%252Band%252BSecrets%252Bof%252Bthe%252BSphinx%26aulast%3DPritts%26aufirst%3DTimothy%2BA.%26date%3D2021%26volume%3D232%26issue%3D5%26spage%3D797%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolyn  Tallon</span>, <span class="hlFld-ContribAuthor ">Kristen R.  Hollinger</span>, <span class="hlFld-ContribAuthor ">Arindom  Pal</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Bell</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Takashi  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Witwer</span>, <span class="hlFld-ContribAuthor ">Norman J.  Haughey</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>. </span><span class="cited-content_cbyCitation_article-title">Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1016/j.drudis.2021.03.025" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DNipping%252Bdisease%252Bin%252Bthe%252Bbud%25253A%252BnSMase2%252Binhibitors%252Bas%252Btherapeutics%252Bin%252Bextracellular%252Bvesicle-mediated%252Bdiseases%26aulast%3DTallon%26aufirst%3DCarolyn%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0039.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Ceramide biosynthesis pathways (adapted from ref <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a>). Various biosynthetic routes to ceramide are depicted for Cer(d18:1/18:1(9Z)). De novo pathway, salvage pathway, and sphingomyelin hydrolysis are highlighted in purple, orange, and cyan, respectively. Other sources of ceramide include glucocerebrosidase (gray), galactocerebrosidase (green), and ceramide-1-phosphate phosphatase (beige).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of ceramide-based DES1 inhibitors GT11 (<b>1</b>), XM462 (<b>2</b>), and compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of retinoid-based DES1 inhibitors <b>4</b>–<b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of SKI II (<b>8</b>) and its derivatives <b>9</b> and <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of DES1 inhibitors <b>11</b>–<b>14</b> containing a 6-acylamino-3-pyridinol or 4-acylaminophenol scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Acyl-CoA substrate preference of CerS isoforms.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of fumonisin B1 (<b>15</b>) and aminopentol (<b>16</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of FTY720 (<b>17</b>) and its derivatives <b>18</b>–<b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of CerS inhibitors <b>25</b>–<b>29</b> derived from FTY720 (<b>17</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structures of (A) the closed form (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>) and (B) the open form (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FIB">5FIB</a>) of murine aSMase.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The saposin domain is shown in blue, and the active site zinc ions are shown as gray spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of representative functional inhibitors of aSMase (FIASMAs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Structures of xanthone-based aSMase inhibitors <b>35</b>–<b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of γ-pyrone-based aSMase inhibitors <b>40</b> and <b>41</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structures of catechin-based secretory SMase inhibitors <b>42</b> and <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Structures of inositol-4,5-bisphosphate-based aSMase inhibitors <b>44</b>–<b>49</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of bisphosphonate-based aSMase inhibitors <b>50</b>–<b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Crystal structure of the murine aSMase active site in complex with compound <b>51</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9">5FI9</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Key residues are shown as a green stick model, zinc ions are shown as gray spheres, and compound <b>51</b> is shown as a cyan stick model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of serinol-based aSMase inhibitors <b>54</b>–<b>57</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of hydroxamate-based aSMase inhibitors <b>58</b> and <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Crystal structure of human nSMase2 CAT (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG">5UVG</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> (A) Ca<sup>2+</sup> shown as a gray sphere occupies the position of the primary Mg<sup>2+</sup> ion required for the Mg<sup>2+</sup>-dependent activity of nSMase2. DK switch is shown in blue, and the conserved Asp430 is shown as a purple stick model. (B) Close-up view of the substrate binding site. DK switch shown in blue obstructs the entrance to the hydrophobic track stretching from the active site (painted in yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of scyphostatin <b>60</b> and its derivatives <b>61</b>–<b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structure of alutenusin (<b>67</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Structures of benzoquinol- and benzoquinone-based nSMase inhibitors <b>68</b>–<b>73</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of phosphonate-based nSMase inhibitors <b>74</b> and <b>75</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of carbamate-based nSMase inhibitors <b>76</b>–<b>79</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structures of thiourea-based nSMase inhibitors <b>80</b> and <b>81</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of γ-lactone-based nSMase inhibitors <b>82</b> and <b>83</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Structures of aminoguanidine-based nSMase inhibitors <b>84</b>–<b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Structures of α-amino acid-based nSMase inhibitors <b>87</b> and <b>88</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Structures of GW4869 (<b>89</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Structures of nSMase inhibitors <b>90</b>–<b>94</b> containing a 1,2,4-triazole-3-thione or pyrimidine-2-thione ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Structures of nSMase inhibitors <b>95</b>–<b>99</b> based on the 4-(1<i>H</i>-imidazol-2-yl)-2,6-dialkoxyphenol scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0033.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. Structures of nSMase inhibitors <b>100</b>–<b>103</b> containing an imidazo[1,2-<i>b</i>]pyridazine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0034.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. Structures of phensvenine-based nSMase inhibitors <b>104</b>–<b>106</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0035.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. (A) Overall structure of SmcL (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZWX">1ZWX</a>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> The hydrophobic β-hairpin and the hydrophobic loop are shown in green and red, respectively. Phosphate ion shown as an orange/red stick model is likely located in the position occupied by the phosphate moiety of sphingomyelin in the enzyme–substrate complex. DK switch shown in blue forms a short α-helix and directs the conserved Asp160 residue shown as a purple stick model into the active site. (B) Schematic diagram of SmcL-catalyzed hydrolysis of sphingomyelin into ceramide on the outer leaflet of the plasma membrane (adapted from ref <a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0036.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. Structures of phosphorus-based SMaseC inhibitors <b>107</b>–<b>111</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0037.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. Structures of SMaseC inhibitors <b>112</b>–<b>115</b> containing a bipyridyl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig38" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/medium/jm0c01664_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0038.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. Structure of a pH-dependent glucocerebrosidase inhibitor, ambroxol <b>116</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01664/20210107/images/large/jm0c01664_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01664&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 163 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fahy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramaniam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raetz, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spener, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Meer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanNieuwenhze, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witztum, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span> <span> </span><span class="NLM_article-title">A comprehensive classification system for lipids</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1194/jlr.E400004-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.E400004-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15722563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFaqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=839-861&author=E.+Fahyauthor=S.+Subramaniamauthor=H.+A.+Brownauthor=C.+K.+Glassauthor=A.+H.+Merrillauthor=R.+C.+Murphyauthor=C.+R.+Raetzauthor=D.+W.+Russellauthor=Y.+Seyamaauthor=W.+Shawauthor=T.+Shimizuauthor=F.+Spenerauthor=G.+van+Meerauthor=M.+S.+VanNieuwenhzeauthor=S.+H.+Whiteauthor=J.+L.+Witztumauthor=E.+A.+Dennis&title=A+comprehensive+classification+system+for+lipids&doi=10.1194%2Fjlr.E400004-JLR200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive classification system for lipids</span></div><div class="casAuthors">Fahy, Eoin; Subramaniam, Shankar; Brown, H. Alex; Glass, Christopher K.; Merrill, Alfred H., Jr.; Murphy, Robert C.; Raetz, Christian R. H.; Russell, David W.; Seyama, Yousuke; Shaw, Walter; Shimizu, Takao; Spener, Friedrich; van Meer, Gerrit; VanNieuwenhze, Michael S.; White, Stephen H.; Witztum, Joseph L.; Dennis, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">839-861</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Lipids are produced, transported, and recognized by the concerted actions of numerous enzymes, binding proteins, and receptors.  A comprehensive anal. of lipid mols., "lipidomics," in the context of genomics and proteomics is crucial to understanding cellular physiol. and pathol.; consequently, lipid biol. has become a major research target of the postgenomic revolution and systems biol.  To facilitate international communication about lipids, a comprehensive classification of lipids with a common platform that is compatible with informatics requirements has been developed to deal with the massive amts. of data that will be generated by the lipid community.  As an initial step in this development, the authors divide lipids into 8 categories (fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides) contg. distinct classes and subclasses of mols., devise a common manner of representing the chem. structures of individual lipids and their derivs., and provide a 12 digit identifier for each unique lipid mol.  The lipid classification scheme is chem. based and driven by the distinct hydrophobic and hydrophilic elements that compose the lipid.  This structured vocabulary will facilitate the systematization of lipid biol. and enable the cataloging of lipids and their properties in a way that is compatible with other macromol. databases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmvzCdGOvWmLVg90H21EOLACvtfcHk0lhwwYZImGeIqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFaqtLY%253D&md5=1ca24f3b244e28edc6509cd08057072f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1194%2Fjlr.E400004-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.E400004-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DE.%26aulast%3DSubramaniam%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DH.%2BA.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26aulast%3DRaetz%26aufirst%3DC.%2BR.%26aulast%3DRussell%26aufirst%3DD.%2BW.%26aulast%3DSeyama%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DW.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSpener%26aufirst%3DF.%26aulast%3Dvan%2BMeer%26aufirst%3DG.%26aulast%3DVanNieuwenhze%26aufirst%3DM.%2BS.%26aulast%3DWhite%26aufirst%3DS.%2BH.%26aulast%3DWitztum%26aufirst%3DJ.%2BL.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26atitle%3DA%2520comprehensive%2520classification%2520system%2520for%2520lipids%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2005%26volume%3D46%26spage%3D839%26epage%3D861%26doi%3D10.1194%2Fjlr.E400004-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wattenberg, B. W.</span></span> <span> </span><span class="NLM_article-title">The long and the short of ceramides</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">9922</span>– <span class="NLM_lpage">9923</span>, <span class="refDoi"> DOI: 10.1074/jbc.H118.003522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.H118.003522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29934368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFynurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2018&pages=9922-9923&author=B.+W.+Wattenberg&title=The+long+and+the+short+of+ceramides&doi=10.1074%2Fjbc.H118.003522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The long and the short of ceramides</span></div><div class="casAuthors">Wattenberg, Binks W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">9922-9923</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A brief review with refs. and commentary on recent research by Tidhar et al. (ibid. 2018, 293, 9912-9921).  The sphingolipid ceramide is not only a precursor of more complex sphingolipids, but also a potent signaling mol.  Specific ceramide species have distinct cellular functions, and each ceramide synthase therefore has particular roles in cells and organisms.  Tidhar and colleagues, utilizing two ceramide synthases differing widely in fatty acid specificity, have identified a short amino acid sequence that is crit. for this specificity.  This work represents a crucial first step in the understanding of both the enzymol. and the biol. driving the diverse functions of ceramide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbP5ndY1ilrVg90H21EOLACvtfcHk0lhwwYZImGeIqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFynurfL&md5=c19b5a7b4eccf6565d37dbd201c83ef7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.H118.003522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.H118.003522%26sid%3Dliteratum%253Aachs%26aulast%3DWattenberg%26aufirst%3DB.%2BW.%26atitle%3DThe%2520long%2520and%2520the%2520short%2520of%2520ceramides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2018%26volume%3D293%26spage%3D9922%26epage%3D9923%26doi%3D10.1074%2Fjbc.H118.003522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gault, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">An overview of sphingolipid metabolism: From synthesis to breakdown</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>688</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-6741-1_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-1-4419-6741-1_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20919643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=2010&pages=1-23&author=C.+R.+Gaultauthor=L.+M.+Obeidauthor=Y.+A.+Hannun&title=An+overview+of+sphingolipid+metabolism%3A+From+synthesis+to+breakdown&doi=10.1007%2F978-1-4419-6741-1_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of sphingolipid metabolism: from synthesis to breakdown</span></div><div class="casAuthors">Gault, Christopher R.; Obeid, Lina M.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">688</span>
        (<span class="NLM_cas:issue">Sphingolipids as Signaling and Regulatory Molecules</span>),
    <span class="NLM_cas:pages">1-23</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Sphingolipids constitute a class of lipids defined by their eighteen carbon amino-alc. backbones which are synthesized in the ER from nonsphingolipid precursors.  Modification of this basic structure is what gives rise to the vast family of sphingolipids that play significant roles in membrane biol. and provide many bioactive metabolites that regulate cell function.  Despite the diversity of structure and function of sphingolipids, their creation and destruction are governed by common synthetic and catabolic pathways.  In this regard, sphingolipid metab. can be imagined as an array of interconnected networks that diverge from a single common entry point and converge into a single common breakdown pathway.  In their simplest forms, sphingosine, phytosphingosine and dihydrosphingosine serve as the backbones upon which further complexity is achieved.  For example, phosphorylation of the C1 hydroxyl group yields the final breakdown products and/or the important signaling mols. sphingosine-1-phosphate, phytosphingosine-1-phosphate and dihydrosphingosine-1-phosphate, resp.  On the other hand, acylation of sphingosine, phytosphingosine, or dihydrosphingosine with one of several possible acyl CoA mols. through the action of distinct ceramide synthases produces the mols. defined as ceramide, phytoceramide, or dihydroceramide.  Ceramide, due to the differing acyl CoAs that can be used to produce it, is tech. a class of mols. rather than a single mol. and therefore may have different biol. functions depending on the acyl chain it is composed of.  At the apex of complexity is the group of lipids known as glycosphingolipids (GSL) which contain dozens of different sphingolipid species differing by both the order and type of sugar residues attached to their headgroups.  Since these mols. are produced from ceramide precursors, they too may have differences in their acyl chain compn., revealing an addnl. layer of variation.  The glycosphingolipids are divided broadly into two categories: glucosphingolipids and galactosphingolipids.  The glucosphingolipids depend initially on the enzyme glucosylceramide synthase (GCS) which attaches glucose as the first residue to the C1 hydroxyl position.  Galactosphingolipids, on the other hand, are generated from galactosylceramide synthase (GalCerS), an evolutionarily dissimilar enzyme from GCS.  Glycosphingolipids are further divided based upon further modification by various glycosyltransferases which increases the potential variation in lipid species by several fold.  Far more abundant are the sphingomyelin species which are produced in parallel with glycosphingolipids, however they are defined by a phosphocholine headgroup rather than the addn. of sugar residues.  Although sphingomyelin species all share a common headgroup, they too are produced from a variety of ceramide species and therefore can have differing acyl chains attached to their C-2 amino groups.  Whether or not the differing acyl chain lengths in SMs dictate unique functions or important biophys. distinctions has not yet been established.  Understanding the function of all the existing glycosphingolipids and sphingomyelin species will be a major undertaking in the future since the tools to study and measure these species are only beginning to be developed (see Fig 1 for an illustrated depiction of the various sphingolipid structures).  The simple sphingolipids serve both as the precursors and the breakdown products of the more complex ones.  Importantly, in recent decades, these simple sphingolipids have gained attention for having significant signaling and regulatory roles within cells.  In addn., many tools have emerged to measure the levels of simple sphingolipids and therefore have become the focus of even more intense study in recent years.  With this thought in mind, this chapter will pay tribute to the complex sphingolipids, but focus on the regulation of simple sphingolipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-glJUw4HtHrVg90H21EOLACvtfcHk0lhwwYZImGeIqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtg%253D%253D&md5=512ae1d4d9d2f9f2f231e0e189a2b3a0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6741-1_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-6741-1_1%26sid%3Dliteratum%253Aachs%26aulast%3DGault%26aufirst%3DC.%2BR.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DAn%2520overview%2520of%2520sphingolipid%2520metabolism%253A%2520From%2520synthesis%2520to%2520breakdown%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2010%26volume%3D688%26spage%3D1%26epage%3D23%26doi%3D10.1007%2F978-1-4419-6741-1_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiban, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidhar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases: Roles in cell physiology and signaling</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>688</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1007/978-1-4419-6741-1_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-1-4419-6741-1_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20919646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=688&publication_year=2010&pages=60-71&author=J.+Stibanauthor=R.+Tidharauthor=A.+H.+Futerman&title=Ceramide+synthases%3A+Roles+in+cell+physiology+and+signaling&doi=10.1007%2F978-1-4419-6741-1_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases: roles in cell physiology and signaling</span></div><div class="casAuthors">Stiban, Johnny; Tidhar, Rotem; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">688</span>
        (<span class="NLM_cas:issue">Sphingolipids as Signaling and Regulatory Molecules</span>),
    <span class="NLM_cas:pages">60-71</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ceramide synthases (CerS) are integral membrane proteins of the endoplasmic reticulum.  Six mammalian CerS have been described, with each utilizing fatty acyl CoAs of relatively defined chain lengths for N-acylation of the sphingoid long chain base.  In this chapter, we review the main functional features of the CerS proteins, discuss their fatty acid specificity, kinetics, tissue distribution and mode of inhibition, as well as possible posttranslational modifications.  We then address the reason that mammals contain six distinct CerS, whereas most other enzymes in the sphingolipid biosynthetic pathway only occur in one or two isoforms.  Finally, we discuss the putative roles of CerS and the ceramide derived from the CerS, in signaling pathways and in development of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQW55vCLljy7Vg90H21EOLACvtfcHk0lggR4jNoXR4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFGhtQ%253D%253D&md5=1c06bdac2417d993aeaaab15efabe5e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-6741-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4419-6741-1_4%26sid%3Dliteratum%253Aachs%26aulast%3DStiban%26aufirst%3DJ.%26aulast%3DTidhar%26aufirst%3DR.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthases%253A%2520Roles%2520in%2520cell%2520physiology%2520and%2520signaling%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2010%26volume%3D688%26spage%3D60%26epage%3D71%26doi%3D10.1007%2F978-1-4419-6741-1_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnick, R. N.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthesis and metabolism as a target for cancer therapy</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2003.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.canlet.2003.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15013522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=169-180&author=C.+P.+Reynoldsauthor=B.+J.+Maurerauthor=R.+N.+Kolesnick&title=Ceramide+synthesis+and+metabolism+as+a+target+for+cancer+therapy&doi=10.1016%2Fj.canlet.2003.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthesis and metabolism as a target for cancer therapy</span></div><div class="casAuthors">Reynolds, C. Patrick; Maurer, Barry J.; Kolesnick, Richard N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-180</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sphingolipids, which include ceramides and sphingosine, are essential structural components of cell membranes that also have messenger functions that regulate the proliferation, survival, and death of cells.  Exogenous application of ceramide is cytotoxic, and exposure of cells to radiation or chemotherapy is assocd. with increased ceramide levels due to enhanced de novo synthesis, catabolism of sphingomyelin, or both.  Ceramide can be metabolized to less toxic forms by glycosylation, acylation, or by catabolism to sphingosine, which is then phosphorylated to the anti-apoptotic sphingosine 1-phosphate.  Glucosylceramide synthase overexpression has been shown to enhance resistance to doxorubicin, suggesting that inhibition of ceramide metab. or catabolism might enhance cancer chemotherapy.  Several anticancer agents, including the cytotoxic retinoid, fenretinide (4-HPR), have been shown to act, at least in part, by increasing tumor cell ceramide via de novo synthesis.  Combinations of 4-HPR and modulators of ceramide action and/or metab. demonstrated increased anti-tumor activity in pre-clin. models with minimal toxicity for non-malignant cells, and were effective in a p53-independent manner against tumor cell lines resistant to std. cytotoxic agents.  Phase I trials of ceramide metab. inhibitors in combination with 4-HPR and with other cytotoxic agents are in development.  Thus, pharmacol. manipulation of sphingolipid metab. to enhance tumor cell ceramide is being realized and offers a novel approach to cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzYTneIHg6rVg90H21EOLACvtfcHk0lggR4jNoXR4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu7c%253D&md5=417e52b2c2723e022ca5fc8478f349bc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BP.%26aulast%3DMaurer%26aufirst%3DB.%2BJ.%26aulast%3DKolesnick%26aufirst%3DR.%2BN.%26atitle%3DCeramide%2520synthesis%2520and%2520metabolism%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D169%26epage%3D180%26doi%3D10.1016%2Fj.canlet.2003.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Sphingolipids and their metabolism in physiology and disease</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/nrm.2017.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fnrm.2017.107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29165427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKqt7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=175-191&author=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Sphingolipids+and+their+metabolism+in+physiology+and+disease&doi=10.1038%2Fnrm.2017.107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids and their metabolism in physiology and disease</span></div><div class="casAuthors">Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-191</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many functions, which rivals, if not exceeds, that of the genome or proteome.  These results highlight crit. roles for bioactive sphingolipids in most, if not all, major cell biol. responses, including all major cell signalling pathways, and they link sphingolipid metab. to key human diseases.  Nevertheless, the fairly nascent field of bioactive sphingolipids still faces challenges in its biochem. and mol. underpinnings, including defining the mol. mechanisms of pathway and enzyme regulation, the study of lipid-protein interactions and the development of cellular probes, suitable biomarkers and therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9A-uh9uFPrVg90H21EOLACvtfcHk0lggR4jNoXR4Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKqt7fE&md5=81409d71ab1c29c9dea5f060105032be</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.107%26sid%3Dliteratum%253Aachs%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DSphingolipids%2520and%2520their%2520metabolism%2520in%2520physiology%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D19%26spage%3D175%26epage%3D191%26doi%3D10.1038%2Fnrm.2017.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Cuenca, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbarroja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal-Puig, A.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1851</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2014.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbalip.2014.09.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslags7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1851&publication_year=2015&pages=40-50&author=S.+Rodriguez-Cuencaauthor=N.+Barbarrojaauthor=A.+Vidal-Puig&title=Dihydroceramide+desaturase+1%2C+the+gatekeeper+of+ceramide+induced+lipotoxicity&doi=10.1016%2Fj.bbalip.2014.09.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity</span></div><div class="casAuthors">Rodriguez-Cuenca, S.; Barbarroja, N.; Vidal-Puig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1851</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  The pathogenic relevance of sphingolipid metab. is increasingly being recognized.  Here we elaborate on a new player within the sphingolipid field: the degs1 enzyme, a recently discovered enzyme that catalyzes the final step in the de novo biosynthesis of ceramides controlling the step from dihydroceramides to ceramides.  Here, we describe its function and dysregulation by factors such as oxidative stress, hypoxia and inflammation and provide evidence indicating that dihydroceramides constitute a biol. active mol. from the sphingolipid family with certain differential characteristics with respect to its delta-4 unsatd. counterparts, the ceramides.  Finally we present pathophysiol. scenarios characterised by specific increases in dihydroceramide that challenge the concept that "all ceramides species are the same".  This article is part of a Special Issue entitled Linking transcription to physiol. in lipodomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTKHI742MCMbVg90H21EOLACvtfcHk0lhY7k4Yo9lq9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslags7zL&md5=c11c540ed2c8b854bdba4c41645435ec</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2014.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2014.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Cuenca%26aufirst%3DS.%26aulast%3DBarbarroja%26aufirst%3DN.%26aulast%3DVidal-Puig%26aufirst%3DA.%26atitle%3DDihydroceramide%2520desaturase%25201%252C%2520the%2520gatekeeper%2520of%2520ceramide%2520induced%2520lipotoxicity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2015%26volume%3D1851%26spage%3D40%26epage%3D50%26doi%3D10.1016%2Fj.bbalip.2014.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Olaya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliostro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidoni, R.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2011.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.plipres.2011.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22200621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFCktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=82-94&author=G.+Fabriasauthor=J.+Munoz-Olayaauthor=F.+Cingolaniauthor=P.+Signorelliauthor=J.+Casasauthor=V.+Gagliostroauthor=R.+Ghidoni&title=Dihydroceramide+desaturase+and+dihydrosphingolipids%3A+Debutant+players+in+the+sphingolipid+arena&doi=10.1016%2Fj.plipres.2011.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena</span></div><div class="casAuthors">Fabrias, Gemma; Munoz-Olaya, Jose; Cingolani, Francesca; Signorelli, Paola; Casas, Josefina; Gagliostro, Vincenzo; Ghidoni, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">82-94</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are a wide family of lipids that share common sphingoid backbones, including (2S,3R)-2-amino-4-octadecane-1,3-diol (dihydrosphingosine) and (2S,3R,4E)-2-amino-4-octadecene-1,3-diol (sphingosine).  The metab. and biol. functions of sphingolipids derived from sphingosine have been the subject of many reviews.  In contrast, dihydrosphingolipids have received poor attention, mainly due to their supposed lack of biol. activity.  However, the reported biol. effects of active site directed dihydroceramide desaturase inhibitors and the involvement of dihydrosphingolipids in the response of cells to known therapeutic agents support that dihydrosphingolipids are not inert but are in fact biol. active and underscore the importance of elucidating further the metabolic pathways and cell signaling networks involved in the biol. activities of dihydrosphingolipids.  Dihydroceramide desaturase is the enzyme involved in the conversion of dihydroceramide into ceramide and it is crucial in the regulation of the balance between sphingolipids and dihydrosphingolipids.  Furthermore, given the enzyme requirement for O2 and the NAD(P)H cofactor, the cellular redox balance and dihydroceramide desaturase activity may reciprocally influence each other.  In this review both dihydroceramide desaturase and the biol. functions of dihydrosphingolipids are addressed and perspectives on this field are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPYnW2t819bVg90H21EOLACvtfcHk0lhY7k4Yo9lq9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFCktro%253D&md5=6c9bbd0a1bcca73de0ca72ffe3859749</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2011.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2011.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DMunoz-Olaya%26aufirst%3DJ.%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DGagliostro%26aufirst%3DV.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DDihydroceramide%2520desaturase%2520and%2520dihydrosphingolipids%253A%2520Debutant%2520players%2520in%2520the%2520sphingolipid%2520arena%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2012%26volume%3D51%26spage%3D82%26epage%3D94%26doi%3D10.1016%2Fj.plipres.2011.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases as potential targets for therapeutic intervention in human diseases</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1841</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2013.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbalip.2013.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24021978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFelu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1841&publication_year=2014&pages=671-681&author=J.+W.+Parkauthor=W.+J.+Parkauthor=A.+H.+Futerman&title=Ceramide+synthases+as+potential+targets+for+therapeutic+intervention+in+human+diseases&doi=10.1016%2Fj.bbalip.2013.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases as potential targets for therapeutic intervention in human diseases</span></div><div class="casAuthors">Park, Joo-Won; Park, Woo-Jae; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1841</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">671-681</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Ceramide is located at a key hub in the sphingolipid metabolic pathway and also acts as an important cellular signaling mol.  Ceramide contains one acyl chain which is attached to a sphingoid long chain base via an amide bond, with the acyl chain varying in length and degree of satn.  The identification of a family of six mammalian ceramide synthases (CerS) that synthesize ceramide with distinct acyl chains, has led to significant advances in our understanding of ceramide biol., including further delineation of the role of ceramide in various pathophysiologies in both mice and humans.  Since ceramides, and the complex sphingolipids generated from ceramide, are implicated in disease, the CerS might potentially be novel targets for therapeutic intervention in the diseases in which the ceramide acyl chain length is altered.  This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9INu_SVNk4bVg90H21EOLACvtfcHk0lhY7k4Yo9lq9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFelu7nF&md5=bf04d53475052497d59daeaf6456b71e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2013.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DW.%2BJ.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthases%2520as%2520potential%2520targets%2520for%2520therapeutic%2520intervention%2520in%2520human%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2014%26volume%3D1841%26spage%3D671%26epage%3D681%26doi%3D10.1016%2Fj.bbalip.2013.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases in biomedical research</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26248326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=25-32&author=F.+Cingolaniauthor=A.+H.+Futermanauthor=J.+Casas&title=Ceramide+synthases+in+biomedical+research&doi=10.1016%2Fj.chemphyslip.2015.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases in biomedical research</span></div><div class="casAuthors">Cingolani, Francesca; Futerman, Anthony H.; Casas, Josefina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipid metab. consists of multiple metabolic pathways that converge upon ceramide, one of the key mols. among sphingolipids (SLs).  In mammals, ceramide synthesis occurs via N-acylation of sphingoid backbones, dihydrosphingosine (dhSo) or sphingosine (So).  The reaction is catalyzed by ceramide synthases (CerS), a family of enzymes with six different isoforms, with each showing specificity towards a restricted group of acyl-CoAs, thus producing ceramides (Cer) and dihydroceramides (dhCer) with different fatty acid chain lengths.  A large body of evidence documents the role of both So and dhSo as bioactive mols., as well as the involvement of dhCer and Cer in physiol. and pathol. processes.  In particular, the fatty acid compn. of Cer has different effects in cell biol. and in the onset and progression of different diseases.  Therefore, modulation of CerS activity represents an attractive target in biomedical research and in finding new treatment modalities.  In this review, functional, structural and biochem. features of CerS and examine CerS inhibitors that are currently available are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzE6aQ4E0Av7Vg90H21EOLACvtfcHk0lhY7k4Yo9lq9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCis7%252FM&md5=edabfc593072a31c147a42e7727b022b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26aulast%3DCasas%26aufirst%3DJ.%26atitle%3DCeramide%2520synthases%2520in%2520biomedical%2520research%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D25%26epage%3D32%26doi%3D10.1016%2Fj.chemphyslip.2015.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassbender, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span> <span> </span><span class="NLM_article-title">A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1111/jnc.13145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fjnc.13145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25925550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVClurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2015&pages=183-192&author=E.+Gulbinsauthor=S.+Walterauthor=K.+A.+Beckerauthor=R.+Halmerauthor=Y.+Liuauthor=M.+Reichelauthor=M.+J.+Edwardsauthor=C.+P.+Mullerauthor=K.+Fassbenderauthor=J.+Kornhuber&title=A+central+role+for+the+acid+sphingomyelinase%2Fceramide+system+in+neurogenesis+and+major+depression&doi=10.1111%2Fjnc.13145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression</span></div><div class="casAuthors">Gulbins, Erich; Walter, Silke; Becker, Katrin Anne; Halmer, Ramona; Liu, Yang; Reichel, Martin; Edwards, Michael J.; Mueller, Christian P.; Fassbender, Klaus; Kornhuber, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-192</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Major depressive disorder is a severe and chronic illness with high lifetime prevalence and a high incidence of suicide as the cause of death for patients with this diagnosis.  Major depressive disorder is often treated with anti-depressants.  Although these drugs have been used for many years, their exact mode of action is still unknown.  It has been suggested that many anti-depressants act by increasing the concns. of serotonergic transmitters in the synaptic space.  However, recent studies have examd. the effects of anti-depressants on neurogenesis in the hippocampus, the restoration of hippocampal neuronal networks that may be affected by major depression, and the regulation of the hypothalamic-pituitary-adrenal axis by immature neurons in the hippocampus.  Here, we present and discuss a novel hypothesis suggesting that these events are regulated by the concns. of sphingolipids, in particular ceramide, in the hippocampus.  These concepts suggest that the acid sphingomyelinase/ceramide system plays a central role in the pathogenesis of major depression and may be a novel target for anti-depressants.  Major depressive disorder is a severe and chronic illness with high lifetime prevalence and high incidence of suicide.  Major depression is caused in part by an imbalance between factors that pos. and neg. control neurogenesis.  Anti-depressants inhibit the acid sphingomyelinase/ceramide system and thereby reduce the sum of neg. factors restoring neurogenesis, neuronal survival, and improved mood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SAzDGaleDrVg90H21EOLACvtfcHk0lgGfWD6Rsvmjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVClurk%253D&md5=0a65fa53a7d0435413525f2d3b1fe385</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13145%26sid%3Dliteratum%253Aachs%26aulast%3DGulbins%26aufirst%3DE.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DK.%2BA.%26aulast%3DHalmer%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DM.%2BJ.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DFassbender%26aufirst%3DK.%26aulast%3DKornhuber%26aufirst%3DJ.%26atitle%3DA%2520central%2520role%2520for%2520the%2520acid%2520sphingomyelinase%252Fceramide%2520system%2520in%2520neurogenesis%2520and%2520major%2520depression%26jtitle%3DJ.%2520Neurochem.%26date%3D2015%26volume%3D134%26spage%3D183%26epage%3D192%26doi%3D10.1111%2Fjnc.13145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J. S.</span></span> <span> </span><span class="NLM_article-title">Potential therapeutic target for aging and age-related neurodegenerative diseases: The role of acid sphingomyelinase</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1038/s12276-020-0399-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs12276-020-0399-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=32203096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltFSjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2020&pages=380-389&author=M.+H.+Parkauthor=H.+K.+Jinauthor=J.+S.+Bae&title=Potential+therapeutic+target+for+aging+and+age-related+neurodegenerative+diseases%3A+The+role+of+acid+sphingomyelinase&doi=10.1038%2Fs12276-020-0399-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase</span></div><div class="casAuthors">Park, Min Hee; Jin, Hee Kyung; Bae, Jae-sung</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & Molecular Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-389</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">2092-6413</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Aging, which is assocd. with age-related changes in physiol. processes, is the most significant risk factor for the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.  Accumulating evidence has indicated that sphingolipids are significant regulators that are assocd. with pathogenesis in aging and several age-related neurodegenerative diseases.  In particular, abnormal levels of acid sphingomyelinase (ASM), one of the significant sphingolipid-metabolizing enzymes, have been found in the blood and some tissues under various neuropathol. conditions.  Moreover, recent studies have reported the importance of ASM as a crit. mediator that contributes to pathologies in aging and age-related neurodegenerative diseases.  In this review, we describe the pathophysiol. processes that are regulated by ASM, focusing on the age-related neurodegenerative environment.  Furthermore, we discuss novel insights into how new therapeutics targeting ASM may potentially lead to effective strategies to combat aging and age-related neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg2mYJ_v9RRrVg90H21EOLACvtfcHk0lgGfWD6Rsvmjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltFSjsbY%253D&md5=936db712241902b938c08be197aa1674</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs12276-020-0399-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs12276-020-0399-8%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DM.%2BH.%26aulast%3DJin%26aufirst%3DH.%2BK.%26aulast%3DBae%26aufirst%3DJ.%2BS.%26atitle%3DPotential%2520therapeutic%2520target%2520for%2520aging%2520and%2520age-related%2520neurodegenerative%2520diseases%253A%2520The%2520role%2520of%2520acid%2520sphingomyelinase%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2020%26volume%3D52%26spage%3D380%26epage%3D389%26doi%3D10.1038%2Fs12276-020-0399-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhle, C.</span></span> <span> </span><span class="NLM_article-title">Secretory sphingomyelinase in health and disease</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>396</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1515%2Fhsz-2015-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25803076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotFWltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2015&pages=707-736&author=J.+Kornhuberauthor=C.+Rheinauthor=C.+P.+Mullerauthor=C.+Muhle&title=Secretory+sphingomyelinase+in+health+and+disease&doi=10.1515%2Fhsz-2015-0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Secretory sphingomyelinase in health and disease</span></div><div class="casAuthors">Kornhuber, Johannes; Rhein, Cosima; Mueller, Christian P.; Muehle, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">707-736</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Acid sphingomyelinase (ASM), a key enzyme in sphingolipid metab., hydrolyzes sphingomyelin to ceramide and phosphorylcholine.  In mammals, the expression of a single gene, SMPD1, results in two forms of the enzyme that differ in several characteristics.  Lysosomal ASM (L-ASM) is located within the lysosome, requires no addnl. Zn2+ ions for activation and is glycosylated mainly with high-mannose oligosaccharides.  By contrast, the secretory ASM (S-ASM) is located extracellularly, requires Zn2+ ions for activation, has a complex glycosylation pattern and has a longer in vivo half-life.  In this review, we summarize current knowledge regarding the physiol. and pathophysiol. of S-ASM, including its sources and distribution, mol. and cellular mechanisms of generation and regulation and relevant in vitro and in vivo studies.  Polymorphisms or mutations of SMPD1 lead to decreased S-ASM activity, as detected in patients with Niemann-Pick disease B. Thus, lower serum/plasma activities of S-ASM are trait markers.  No genetic causes of increased S-ASM activity have been identified.  Instead, elevated activity is the result of enhanced release (e.g., induced by lipopolysaccharide and cytokine stimulation) or increased enzyme activation (e.g., induced by oxidative stress).  Increased S-ASM activity in serum or plasma is a state marker of a wide range of diseases.  In particular, high S-ASM activity occurs in inflammation of the endothelium and liver.  Several studies have demonstrated a correlation between S-ASM activity and mortality induced by severe inflammatory diseases.  Serial measurements of S-ASM reveal prolonged activation and, therefore, the measurement of this enzyme may also provide information on past inflammatory processes.  Thus, S-ASM may be both a promising clin. chem. marker and a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKjnkkVp2Ie7Vg90H21EOLACvtfcHk0lgGfWD6Rsvmjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotFWltbY%253D&md5=6ea99e68268b51b1296ac0ced8ce228e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0109%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DRhein%26aufirst%3DC.%26aulast%3DMuller%26aufirst%3DC.%2BP.%26aulast%3DMuhle%26aufirst%3DC.%26atitle%3DSecretory%2520sphingomyelinase%2520in%2520health%2520and%2520disease%26jtitle%3DBiol.%2520Chem.%26date%3D2015%26volume%3D396%26spage%3D707%26epage%3D736%26doi%3D10.1515%2Fhsz-2015-0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The neutral sphingomyelinase family: Identifying biochemical connections</span>. <i>Adv. Enzyme Regul.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.advenzreg.2010.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.advenzreg.2010.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21035485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1OjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=51-58&author=C.+J.+Clarkeauthor=B.+X.+Wuauthor=Y.+A.+Hannun&title=The+neutral+sphingomyelinase+family%3A+Identifying+biochemical+connections&doi=10.1016%2Fj.advenzreg.2010.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The neutral sphingomyelinase family: Identifying biochemical connections</span></div><div class="casAuthors">Clarke, Christopher J.; Wu, Bill X.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzyme Regulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">AEZRA2</span>;
        ISSN:<span class="NLM_cas:issn">0065-2571</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Neutral sphingomyelinases (N-SMases) are considered to be key mediators of stress-induced ceramide prodn.  The extended family of N-SMases is a subset of the DNase I superfamily and comprises members from bacteria, yeast, and mammals.  In recent years, the identification and cloning of mammalian N-SMase family members has led to significant advances in understanding their physiol. roles and regulation.  However, there is still limited information on their regulation at the biochem. and mol. level.  Here, the authors summarize current knowledge about the biochem. regulation of eukaryotic N-SMases and identify the major areas where knowledge is lacking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5mouhaPiOrVg90H21EOLACvtfcHk0lifYjwzdwjbxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1OjsLY%253D&md5=4022f5a93bcc3435fe79d7fe275ea899</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.advenzreg.2010.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.advenzreg.2010.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520neutral%2520sphingomyelinase%2520family%253A%2520Identifying%2520biochemical%2520connections%26jtitle%3DAdv.%2520Enzyme%2520Regul.%26date%3D2011%26volume%3D51%26spage%3D51%26epage%3D58%26doi%3D10.1016%2Fj.advenzreg.2010.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamseddine, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.jbior.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=25465297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGit7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2015&pages=24-41&author=A.+A.+Shamseddineauthor=M.+V.+Airolaauthor=Y.+A.+Hannun&title=Roles+and+regulation+of+neutral+sphingomyelinase-2+in+cellular+and+pathological+processes&doi=10.1016%2Fj.jbior.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes</span></div><div class="casAuthors">Shamseddine, Achraf A.; Airola, Michael V.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Our understanding of the functions of ceramide signaling has advanced tremendously over the past decade.  In this review, we focus on the roles and regulation of neutral sphingomyelinase 2 (nSMase2), an enzyme that generates the bioactive lipid ceramide through the hydrolysis of the membrane lipid sphingomyelin.  A large body of work has now implicated nSMase2 in a diverse set of cellular functions, physiol. processes, and disease pathologies.  We discuss different aspects of this enzyme's regulation from transcriptional, post-translational, and biochem.  Furthermore, we highlight nSMase2 involvement in cellular processes including inflammatory signaling, exosome generation, cell growth, and apoptosis, which in turn play important roles in pathologies such as cancer metastasis, Alzheimer's disease, and other organ systems disorders.  Lastly, we examine avenues where targeted nSMase2-inhibition may be clin. beneficial in disease scenarios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEdx4XHmhwrVg90H21EOLACvtfcHk0lifYjwzdwjbxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGit7rM&md5=cb69e74eebfb7a4fb6f6c3cda13195b9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DShamseddine%26aufirst%3DA.%2BA.%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DRoles%2520and%2520regulation%2520of%2520neutral%2520sphingomyelinase-2%2520in%2520cellular%2520and%2520pathological%2520processes%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2015%26volume%3D57%26spage%3D24%26epage%3D41%26doi%3D10.1016%2Fj.jbior.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monturiol-Gross, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naylor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alape-Giron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flieger, A.</span></span> <span> </span><span class="NLM_article-title">Bacterial sphingomyelinases and phospholipases as virulence factors</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00082-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1128%2FMMBR.00082-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27307578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Kqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=597-628&author=M.+Flores-Diazauthor=L.+Monturiol-Grossauthor=C.+Naylorauthor=A.+Alape-Gironauthor=A.+Flieger&title=Bacterial+sphingomyelinases+and+phospholipases+as+virulence+factors&doi=10.1128%2FMMBR.00082-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial sphingomyelinases and phospholipases as virulence factors</span></div><div class="casAuthors">Flores-Diaz, Marietta; Monturiol-Gross, Laura; Naylor, Claire; Alape-Giron, Alberto; Flieger, Antje</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">597-628</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Bacterial sphingomyelinases and phospholipases are a heterogeneous group of esterases which are usually surface assocd. or secreted by a wide variety of Gram-pos. and Gram-neg. bacteria.  These enzymes hydrolyze sphingomyelin and glycerophospholipids, resp., generating products identical to the ones produced by eukaryotic enzymes which play crucial roles in distinct physiol. processes, including membrane dynamics, cellular signaling, migration, growth, and death.  Several bacterial sphingomyelinases and phospholipases are essential for virulence of extracellular, facultative, or obligate intracellular pathogens, as these enzymes contribute to phagosomal escape or phagosomal maturation avoidance, favoring tissue colonization, infection establishment and progression, or immune response evasion.  This work presents a classification proposal for bacterial sphingomyelinases and phospholipases that considers not only their enzymic activities but also their structural aspects.  An overview of the main physiopathol. activities is provided for each enzyme type, as are examples in which inactivation of a sphingomyelinase- or a phospholipase-encoding gene impairs the virulence of a pathogen.  The identification of sphingomyelinases and phospholipases important for bacterial pathogenesis and the development of inhibitors for these enzymes could generate candidate vaccines and therapeutic agents, which will diminish the impacts of the assocd. human and animal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9SXAh1gTjk7Vg90H21EOLACvtfcHk0lifYjwzdwjbxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Kqtr0%253D&md5=fd357e334eb85c92dffc048522500394</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00082-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00082-15%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Diaz%26aufirst%3DM.%26aulast%3DMonturiol-Gross%26aufirst%3DL.%26aulast%3DNaylor%26aufirst%3DC.%26aulast%3DAlape-Giron%26aufirst%3DA.%26aulast%3DFlieger%26aufirst%3DA.%26atitle%3DBacterial%2520sphingomyelinases%2520and%2520phospholipases%2520as%2520virulence%2520factors%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2016%26volume%3D80%26spage%3D597%26epage%3D628%26doi%3D10.1128%2FMMBR.00082-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of sphingolipid metabolism enzymes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1758</i></span>,  <span class="NLM_fpage">1957</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2006.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbamem.2006.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17049336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12kt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=1957-1977&author=A.+Delgadoauthor=J.+Casasauthor=A.+Llebariaauthor=J.+L.+Abadauthor=G.+Fabrias&title=Inhibitors+of+sphingolipid+metabolism+enzymes&doi=10.1016%2Fj.bbamem.2006.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of sphingolipid metabolism enzymes</span></div><div class="casAuthors">Delgado, Antonio; Casas, Josefina; Llebaria, Amadeu; Abad, Jose Luis; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1758</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1957-1977</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are a family of lipids that play essential roles both as structural cell membrane components and in cell signaling.  The cellular contents of the various sphingolipid species are controlled by enzymes involved in their metabolic pathways.  In this context, the discovery of small chem. entities able to modify these enzyme activities in a potent and selective way should offer new pharmacol. tools and therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGkDZBpzjGhbVg90H21EOLACvtfcHk0lifYjwzdwjbxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12kt7zO&md5=2c784651c0fb01c8f19d5d177a02823a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520sphingolipid%2520metabolism%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2006%26volume%3D1758%26spage%3D1957%26epage%3D1977%26doi%3D10.1016%2Fj.bbamem.2006.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of acid sphingomyelinase</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1159/000315100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000315100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20501999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=1-8&author=C.+Arenz&title=Small+molecule+inhibitors+of+acid+sphingomyelinase&doi=10.1159%2F000315100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Acid Sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Despite of the importance of the acid sphingomyelinase for sphingomyelin homeostasis and sphingolipid signaling, potent and selective inhibitors for this enzyme are rare.  An increasing set of data on the inhibition of acid sphingomyelinase in different disease models using indirect inhibitors has been generated and strongly implies acid sphingomyelinase as an emerging drug target.  Very recently, some new and promising inhibitors from different substance classes have been developed.  In this review, previous and current developments in the field are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt0JWqu52OurVg90H21EOLACvtfcHk0lgpxDRj_bopBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsr8%253D&md5=fab358f1d275fe86618fbc76a23fc8c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1159%2F000315100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315100%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520acid%2520sphingomyelinase%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D1%26epage%3D8%26doi%3D10.1159%2F000315100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhabak, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Novel drugs targeting sphingolipid metabolism</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1007/978-3-7091-1368-4_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-3-7091-1368-4_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2013&pages=187-196&author=K.+P.+Bhabakauthor=C.+Arenz&title=Novel+drugs+targeting+sphingolipid+metabolism&doi=10.1007%2F978-3-7091-1368-4_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel drugs targeting sphingolipid metabolism</span></div><div class="casAuthors">Bhabak, Krishna P.; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">Sphingolipids: Basic Science and Drug Development</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  While the evidence for an involvement of sphingolipids (SLs) in a variety of diseases is rapidly increasing, the development of sphingolipid-related drugs is still in its infancy.  In fact, the recently FDA-approved fingolimod or FTY-720 (see chapter by J. Pfeilschifter for more information) is the first drug on the market to interfere with sphingolipid signaling.  The reasons for this lagging are manifold and within this chapter we try to name some of them.  Ceramide is in the center of sphingolipid metab.  We describe the most important and most recent inhibitors for enzymes controlling cellular ceramide levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorRSYJ5zERArVg90H21EOLACvtfcHk0lgpxDRj_bopBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2htL7K&md5=2b2704689d2ed3555c83d36dc7faa504</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1368-4_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-1368-4_10%26sid%3Dliteratum%253Aachs%26aulast%3DBhabak%26aufirst%3DK.%2BP.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DNovel%2520drugs%2520targeting%2520sphingolipid%2520metabolism%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2013%26volume%3D215%26spage%3D187%26epage%3D196%26doi%3D10.1007%2F978-3-7091-1368-4_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luberto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26200918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=45-59&author=M.+Adadaauthor=C.+Lubertoauthor=D.+Canals&title=Inhibitors+of+the+sphingomyelin+cycle%3A+Sphingomyelin+synthases+and+sphingomyelinases&doi=10.1016%2Fj.chemphyslip.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases</span></div><div class="casAuthors">Adada, Mohamad; Luberto, Chiara; Canals, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-59</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Sphingolipids are a class of bioactive lipids, which are key modulators of an increasing no. of physiol. and pathophysiol. processes that include cell cycle, apoptosis, angiogenesis, stress and inflammatory responses.  Sphingomyelin is an important structural component of biol. membranes, and one of the end-points in the synthesis of sphingolipids.  Mainly synthesized in the Golgi app., sphingomyelin is transported to all other biol. membranes.  Upon stimulation, sphingomyelin can be hydrolyzed to ceramide by 5 different sphingomyelinases.  The diversity and cellular topol. of ceramide allow it to exert multiple biologies.  Furthermore, ceramide can be metabolized to many other bioactive sphingolipids.  Ceramide, coming from sphingomyelin or other complex sphingolipids, can be hydrolyzed to sphingosine, which can easily change cellular localization.  In turn, sphingosine can be recycled to ceramide and to sphingomyelin in the endoplasmic reticulum, completing the sphingomyelin cycle.  Our understanding of the roles of various sphingolipids in the regulation of different cellular processes has come from studying the enzymes that regulate these sphingolipids, and their manipulation.  The use of pharmacol. inhibitors has been crit. for their study, as well as being promising bullets for disease treatment.  Some of these diseases involving the sphingomyelin cycle include cancer, inflammation, atherosclerosis, diabetes and some rare diseases such as Niemann-Pick disease.  This review will focus on the enzymes involved in the sphingomyelin cycle, their history, and their involvement in pathophysiol. processes.  Finally, it will describe in details all the small mols. that are being used to inhibit these enzymes and their use in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjd9O5ncoqb7Vg90H21EOLACvtfcHk0lgpxDRj_bopBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsr3O&md5=031be24b5bc303721852894ba81b6bc7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DAdada%26aufirst%3DM.%26aulast%3DLuberto%26aufirst%3DC.%26aulast%3DCanals%26aufirst%3DD.%26atitle%3DInhibitors%2520of%2520the%2520sphingomyelin%2520cycle%253A%2520Sphingomyelin%2520synthases%2520and%2520sphingomyelinases%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D45%26epage%3D59%26doi%3D10.1016%2Fj.chemphyslip.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casasampere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology</span>. <i>Chem. Phys. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.chemphyslip.2015.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.chemphyslip.2015.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26248324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=33-44&author=M.+Casasampereauthor=Y.+F.+Ordonezauthor=A.+Pouauthor=J.+Casas&title=Inhibitors+of+dihydroceramide+desaturase+1%3A+Therapeutic+agents+and+pharmacological+tools+to+decipher+the+role+of+dihydroceramides+in+cell+biology&doi=10.1016%2Fj.chemphyslip.2015.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology</span></div><div class="casAuthors">Casasampere, Mireia; Ordonez, Yadira F.; Pou, Ana; Casas, Josefina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-44</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Dihydroceramide desaturase (Des1) is the last enzyme in the de novo synthesis of ceramides (Cer).  It catalyzes the insertion of a double bond into dihydroceramides (dhCer) to convert them to Cer, both of which are further metabolized to more complex (dihydro) sphingolipids.  For many years dhCer have received poor attention, mainly due to their supposed lack of biol. activity.  It was not until about ten years ago that the concept that dhCer might have regulatory roles in biol. emerged for the first time.  Since then, multiple publications have established that dhCer are implicated in a wide spectrum of biol. processes.  Physiol. and pathophysiol. functions of dhCer have been recently reviewed.  In this review we will focus on the biochem. features of Des1 and on its inhibition by different compds. with presumably different modes of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrccXfvOQjNArVg90H21EOLACvtfcHk0lgpxDRj_bopBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVajs7jM&md5=86eb5e2a77b2a53336b0fbec272e13dd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chemphyslip.2015.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chemphyslip.2015.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DCasasampere%26aufirst%3DM.%26aulast%3DOrdonez%26aufirst%3DY.%2BF.%26aulast%3DPou%26aufirst%3DA.%26aulast%3DCasas%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520dihydroceramide%2520desaturase%25201%253A%2520Therapeutic%2520agents%2520and%2520pharmacological%2520tools%2520to%2520decipher%2520the%2520role%2520of%2520dihydroceramides%2520in%2520cell%2520biology%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2016%26volume%3D197%26spage%3D33%26epage%3D44%26doi%3D10.1016%2Fj.chemphyslip.2015.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsai, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haag, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korenke, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanisch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suriyanarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knopp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbracht, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornemann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurth, I.</span></span> <span> </span><span class="NLM_article-title">Degs1-associated aberrant sphingolipid metabolism impairs nervous system function in humans</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1229</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1172/JCI124159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1172%2FJCI124159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30620338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BB3cnptFersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=1229-1239&author=G.+Karsaiauthor=F.+Kraftauthor=N.+Haagauthor=G.+C.+Korenkeauthor=B.+Hanischauthor=A.+Othmanauthor=S.+Suriyanarayananauthor=R.+Steinerauthor=C.+Knoppauthor=M.+Mullauthor=M.+Bergmannauthor=J.+M.+Schroderauthor=J.+Weisauthor=M.+Elbrachtauthor=M.+Begemannauthor=T.+Hornemannauthor=I.+Kurth&title=Degs1-associated+aberrant+sphingolipid+metabolism+impairs+nervous+system+function+in+humans&doi=10.1172%2FJCI124159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans</span></div><div class="casAuthors">Karsai Gergely; Othman Alaa; Suriyanarayanan Saranya; Steiner Regula; Hornemann Thorsten; Karsai Gergely; Othman Alaa; Suriyanarayanan Saranya; Steiner Regula; Hornemann Thorsten; Kraft Florian; Haag Natja; Hanisch Benjamin; Knopp Cordula; Elbracht Miriam; Begemann Matthias; Kurth Ingo; Korenke G Christoph; Mull Michael; Bergmann Markus; Schroder J Michael; Weis Joachim</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1229-1239</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Sphingolipids are important components of cellular membranes and functionally associated with fundamental processes such as cell differentiation, neuronal signaling, and myelin sheath formation.  Defects in the synthesis or degradation of sphingolipids leads to various neurological pathologies; however, the entire spectrum of sphingolipid metabolism disorders remains elusive.  METHODS:  A combined approach of genomics and lipidomics was applied to identify and characterize a human sphingolipid metabolism disorder.  RESULTS:  By whole-exome sequencing in a patient with a multisystem neurological disorder of both the central and peripheral nervous systems, we identified a homozygous p.Ala280Val variant in DEGS1, which catalyzes the last step in the ceramide synthesis pathway.  The blood sphingolipid profile in the patient showed a significant increase in dihydro sphingolipid species that was further recapitulated in patient-derived fibroblasts, in CRISPR/Cas9-derived DEGS1-knockout cells, and by pharmacological inhibition of DEGS1.  The enzymatic activity in patient fibroblasts was reduced by 80% compared with wild-type cells, which was in line with a reduced expression of mutant DEGS1 protein.  Moreover, an atypical and potentially neurotoxic sphingosine isomer was identified in patient plasma and in cells expressing mutant DEGS1.  CONCLUSION:  We report DEGS1 dysfunction as the cause of a sphingolipid disorder with hypomyelination and degeneration of both the central and peripheral nervous systems.  TRIAL REGISTRATION:  Not applicable.  FUNDING:  Seventh Framework Program of the European Commission, Swiss National Foundation, Rare Disease Initiative Zurich.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBHJFurk9wJGyYR5VtavbzfW6udTcc2eaTovtW_qN2v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnptFersA%253D%253D&md5=dae3c2a4d6f1705470b3047eb0454118</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1172%2FJCI124159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI124159%26sid%3Dliteratum%253Aachs%26aulast%3DKarsai%26aufirst%3DG.%26aulast%3DKraft%26aufirst%3DF.%26aulast%3DHaag%26aufirst%3DN.%26aulast%3DKorenke%26aufirst%3DG.%2BC.%26aulast%3DHanisch%26aufirst%3DB.%26aulast%3DOthman%26aufirst%3DA.%26aulast%3DSuriyanarayanan%26aufirst%3DS.%26aulast%3DSteiner%26aufirst%3DR.%26aulast%3DKnopp%26aufirst%3DC.%26aulast%3DMull%26aufirst%3DM.%26aulast%3DBergmann%26aufirst%3DM.%26aulast%3DSchroder%26aufirst%3DJ.%2BM.%26aulast%3DWeis%26aufirst%3DJ.%26aulast%3DElbracht%26aufirst%3DM.%26aulast%3DBegemann%26aufirst%3DM.%26aulast%3DHornemann%26aufirst%3DT.%26aulast%3DKurth%26aufirst%3DI.%26atitle%3DDegs1-associated%2520aberrant%2520sphingolipid%2520metabolism%2520impairs%2520nervous%2520system%2520function%2520in%2520humans%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D1229%26epage%3D1239%26doi%3D10.1172%2FJCI124159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Breen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudz, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Buren, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Separovic, D.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=23267130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=77-84&author=P.+Breenauthor=N.+Josephauthor=K.+Thompsonauthor=J.+M.+Kravekaauthor=T.+I.+Gudzauthor=L.+Liauthor=M.+Rahmaniyanauthor=J.+Bielawskiauthor=J.+S.+Pierceauthor=W.+van+Burenauthor=G.+Bhattiauthor=D.+Separovic&title=Dihydroceramide+desaturase+knockdown+impacts+sphingolipids+and+apoptosis+after+photodamage+in+human+head+and+neck+squamous+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells</span></div><div class="casAuthors">Breen, Paul; Joseph, Nicholas; Thompson, Kyle; Kraveka, Jacqueline M.; Gudz, Tatyana I.; Li, Li; Rahmaniyan, Mehrdad; Bielawski, Jacek; Pierce, Jason S.; Van Buren, Eric; Bhatti, Gaurav; Separovic, Duska</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Dihydroceramide desaturase 1 (DES) is the enzyme responsible for converting dihydroceramide into ceramide in the de novo sphingolipid biosynthesis pathway.  Dihydroceramide can inhibit ceramide channel formation to interfere with apoptosis.  We have shown that following ceramide synthase knockdown, photodynamic therapy (PDT), a cancer treatment modality, is assocd. with decreased levels of ceramides and dihydroceramides in cells that are resistant to apoptosis.  Aim: Here we investigated the effect of DES knockdown on the sphingolipid profile and apoptosis in human head and neck squamous carcinoma cells after PDT with the silicon phthalocyanine Pc 4.  Materials and Methods: Following siRNA transfection and PDT treatment, quant. real-time polymerase chain reaction for quantification of DES mRNA, immunoblotting for protein expression, mass spectrometry for sphingolipid anal., spectrofluorometry for caspase 3-like (DEVDase) activity, flow cytometry for apoptosis detection, and trypan blue assay for cell viability evaluation, were performed.  Results: Down-regulation of DES led to a substantial increase in levels of dihydroceramides without affecting ceramide levels.  PDT-induced accumulation of individual dihydroceramides and global ceramides was increased by DES knockdown.  Concomitantly, mitochondrial depolarization, DEVDase activation, late-apoptosis and cell death were attenuated by DES knockdown.  Early apoptosis, however, was enhanced.  Conclusion: Our findings support the following: (i) dihydroceramide reduces pro-apoptotic effects of ceramide; (ii) cells adapt to DES knockdown to become more sensitive to ceramide and early-apoptosis; (iii) DES is a potential mol. target for regulating apoptotic resistance to PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzL-HvZqc6wbVg90H21EOLACvtfcHk0lghbtfs64Zewg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFSjs70%253D&md5=e0a825a2750a2794b561c7a8aab6d5da</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBreen%26aufirst%3DP.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DGudz%26aufirst%3DT.%2BI.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DJ.%2BS.%26aulast%3Dvan%2BBuren%26aufirst%3DW.%26aulast%3DBhatti%26aufirst%3DG.%26aulast%3DSeparovic%26aufirst%3DD.%26atitle%3DDihydroceramide%2520desaturase%2520knockdown%2520impacts%2520sphingolipids%2520and%2520apoptosis%2520after%2520photodamage%2520in%2520human%2520head%2520and%2520neck%2520squamous%2520carcinoma%2520cells%26jtitle%3DAnticancer%2520Res.%26date%3D2013%26volume%3D33%26spage%3D77%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez-Gutierrez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benito-Cuesta, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandosell, F.</span></span> <span> </span><span class="NLM_article-title">Dihydroceramide desaturase 1 inhibitors reduce amyloid-beta levels in primary neurons from an Alzheimer’s disease transgenic model</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">49</span>, <span class="refDoi"> DOI: 10.1007/s11095-017-2312-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs11095-017-2312-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29411122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BC1MvosVSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2018&pages=49&author=L.+Ordonez-Gutierrezauthor=I.+Benito-Cuestaauthor=J.+L.+Abadauthor=J.+Casasauthor=G.+Fabriasauthor=F.+Wandosell&title=Dihydroceramide+desaturase+1+inhibitors+reduce+amyloid-beta+levels+in+primary+neurons+from+an+Alzheimer%E2%80%99s+disease+transgenic+model&doi=10.1007%2Fs11095-017-2312-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model</span></div><div class="casAuthors">Ordonez-Gutierrez Lara; Benito-Cuesta Irene; Wandosell Francisco; Ordonez-Gutierrez Lara; Wandosell Francisco; Abad Jose Luis; Casas Josefina; Fabrias Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The induction of autophagy has recently been explored as a promising therapeutic strategy to combat Alzheimer's disease.  Among many other factors, there is evidence that ceramides/dihydroceramides act as mediators of autophagy, although the exact mechanisms underlying such effects are poorly understood.  Here, we describe how two dihydroceramide desaturase inhibitors (XM461 and XM462) trigger autophagy and reduce amyloid secretion by neurons.  METHODS:  Neurons isolated from wild-type and APP/PS1 transgenic mice were exposed to the two dihydroceramide desaturase inhibitors to assess their effect on these cell's protein and lipid profiles.  RESULTS:  Both dihydroceramide desaturase inhibitors increased the autophagic vesicles in wild-type neurons, reflected as an increase in LC3-II, and this was correlated with the accumulation of dihydroceramides and dihydrosphingomyelins.  Exposing APP/PS1 transgenic neurons to these inhibitors also produced a 50% reduction in amyloid secretion and/or production.  The lipidomic defects triggered by these dihydroceramide desaturase inhibitors were correlated with a loss of S6K activity, witnessed by the changes in S6 phosphorylation, which strongly suggested a reduction of mTORC1 activity.  CONCLUSIONS:  The data obtained strongly suggest that dihydroceramide desaturase 1 activity may modulate autophagy and mTORC1 activity in neurons, inhibiting amyloid secretion and S6K activity.  As such, it is tantalizing to propose that dihydroceramide desaturase 1 may be an important therapeutic target to combat amyloidosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvOg7QsHOnSyO2kE7krGOBfW6udTcc2eaTovtW_qN2v7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvosVSktA%253D%253D&md5=a44eaee90592293c72828628954ac4ae</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1007%2Fs11095-017-2312-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-017-2312-2%26sid%3Dliteratum%253Aachs%26aulast%3DOrdonez-Gutierrez%26aufirst%3DL.%26aulast%3DBenito-Cuesta%26aufirst%3DI.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DWandosell%26aufirst%3DF.%26atitle%3DDihydroceramide%2520desaturase%25201%2520inhibitors%2520reduce%2520amyloid-beta%2520levels%2520in%2520primary%2520neurons%2520from%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520transgenic%2520model%26jtitle%3DPharm.%2520Res.%26date%3D2018%26volume%3D35%26spage%3D49%26doi%3D10.1007%2Fs11095-017-2312-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaurasia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippetts, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayoral Monibas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maschek, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaddai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddique, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previs, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, S. A.</span></span> <span> </span><span class="NLM_article-title">Targeting a ceramide double bond improves insulin resistance and hepatic steatosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">392</span>, <span class="refDoi"> DOI: 10.1126/science.aav3722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1126%2Fscience.aav3722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31273070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOhsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2019&pages=386-392&author=B.+Chaurasiaauthor=T.+S.+Tippettsauthor=R.+Mayoral+Monibasauthor=J.+Liuauthor=Y.+Liauthor=L.+Wangauthor=J.+L.+Wilkersonauthor=C.+R.+Sweeneyauthor=R.+F.+Pereiraauthor=D.+H.+Sumidaauthor=J.+A.+Maschekauthor=J.+E.+Coxauthor=V.+Kaddaiauthor=G.+I.+Lancasterauthor=M.+M.+Siddiqueauthor=A.+Possauthor=M.+Pearsonauthor=S.+Satapatiauthor=H.+Zhouauthor=D.+G.+McLarenauthor=S.+F.+Previsauthor=Y.+Chenauthor=Y.+Qianauthor=A.+Petrovauthor=M.+Wuauthor=X.+Shenauthor=J.+Yaoauthor=C.+N.+Nunesauthor=A.+D.+Howardauthor=L.+Wangauthor=M.+D.+Erionauthor=J.+Rutterauthor=W.+L.+Hollandauthor=D.+E.+Kelleyauthor=S.+A.+Summers&title=Targeting+a+ceramide+double+bond+improves+insulin+resistance+and+hepatic+steatosis&doi=10.1126%2Fscience.aav3722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a ceramide double bond improves insulin resistance and hepatic steatosis</span></div><div class="casAuthors">Chaurasia, Bhagirath; Tippetts, Trevor S.; Mayoral Monibas, Rafael; Liu, Jinqi; Li, Ying; Wang, Liping; Wilkerson, Joseph L.; Sweeney, C. Rufus; Pereira, Renato Felipe; Sumida, Doris Hissako; Maschek, J. Alan; Cox, James E.; Kaddai, Vincent; Lancaster, Graeme Iain; Siddique, Monowarul Mobin; Poss, Annelise; Pearson, Mackenzie; Satapati, Santhosh; Zhou, Heather; McLaren, David G.; Previs, Stephen F.; Chen, Ying; Qian, Ying; Petrov, Aleksandr; Wu, Margaret; Shen, Xiaolan; Yao, Jun; Nunes, Christian N.; Howard, Andrew D.; Wang, Liangsu; Erion, Mark D.; Rutter, Jared; Holland, William L.; Kelley, David E.; Summers, Scott A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6451</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Excess calorie intake can ultimately lead to a metabolic syndrome that interferes with fat or lipid metab.  There are many different types of lipids, and it has been widely debated which are the true culprits underlying metabolic disorders.  Chaurasia et al. report that ceramides are the major contributor to insulin resistance and fatty liver disease (see the Perspective by Kusminski and Scherer).  This appears to be caused by the enzyme dihydroceramide desaturase 1 (DES1), which is normally involved in ceramide prodn. by inserting a double bond into the backbone of the mol.  In mice fed a high-fat diet, deletion of DES1 improved glucose and lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8xoYIoe7g07Vg90H21EOLACvtfcHk0li55FFGx55PTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOhsLnE&md5=fa1ffeaff6c37554fb9e1550c32d6218</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.aav3722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aav3722%26sid%3Dliteratum%253Aachs%26aulast%3DChaurasia%26aufirst%3DB.%26aulast%3DTippetts%26aufirst%3DT.%2BS.%26aulast%3DMayoral%2BMonibas%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DSweeney%26aufirst%3DC.%2BR.%26aulast%3DPereira%26aufirst%3DR.%2BF.%26aulast%3DSumida%26aufirst%3DD.%2BH.%26aulast%3DMaschek%26aufirst%3DJ.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BE.%26aulast%3DKaddai%26aufirst%3DV.%26aulast%3DLancaster%26aufirst%3DG.%2BI.%26aulast%3DSiddique%26aufirst%3DM.%2BM.%26aulast%3DPoss%26aufirst%3DA.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DSatapati%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DPrevis%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DC.%2BN.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DRutter%26aufirst%3DJ.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DSummers%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520a%2520ceramide%2520double%2520bond%2520improves%2520insulin%2520resistance%2520and%2520hepatic%2520steatosis%26jtitle%3DScience%26date%3D2019%26volume%3D365%26spage%3D386%26epage%3D392%26doi%3D10.1126%2Fscience.aav3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1960</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1002/1521-3773(20010518)40:10<1960::AID-ANIE1960>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1960-1962&author=G.+Triolaauthor=G.+Fabriasauthor=A.+Llebaria&title=Synthesis+of+a+cyclopropene+analogue+of+ceramide%2C+a+potent+inhibitor+of+dihydroceramide+desaturase&doi=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Llebaria, Amadeu</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1960-1962</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">A review, with 23 refs., describes the synthesis of cyclopropene ceramide analog erythro-1, and inhibition expts. that show that erythro-1 is a potent inhibitor of dihydroceramide desaturase.  The introduction of a cyclopropene unit to replace the double bond in the ceramide structure has resulted in the first potent inhibitor of dihydroceramide desaturase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8eFQcfKc3e7Vg90H21EOLACvtfcHk0li55FFGx55PTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFyqtbk%253D&md5=074d121dda360e732c35714558a52ac1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820010518%252940%253A10%253C1960%253A%253AAID-ANIE1960%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DLlebaria%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520a%2520cyclopropene%2520analogue%2520of%2520ceramide%252C%2520a%2520potent%2520inhibitor%2520of%2520dihydroceramide%2520desaturase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2001%26volume%3D40%26spage%3D1960%26epage%3D1962%26doi%3D10.1002%2F1521-3773%2820010518%2940%3A10%3C1960%3A%3AAID-ANIE1960%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenstone, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogerty, A. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the desaturation of stearic to oleic acid by cyclopropene fatty acids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1245</span>, <span class="refDoi"> DOI: 10.1038/2141244a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2F2141244a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=6066117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaF2sXksVWntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1967&pages=1244-1245&author=A.+R.+Johnsonauthor=J.+A.+Pearsonauthor=F.+S.+Shenstoneauthor=A.+C.+Fogerty&title=Inhibition+of+the+desaturation+of+stearic+to+oleic+acid+by+cyclopropene+fatty+acids&doi=10.1038%2F2141244a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the desaturation of stearic to oleic acid by cyclopropene fatty acids</span></div><div class="casAuthors">Johnson, Alan Rhodes; Pearson, Judith A.; Shenstone, F. S.; Fogerty, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">5094</span>),
    <span class="NLM_cas:pages">1244-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">During the incubation of liver prepns. malvalic acid (2.5 and 10 micromoles) and sterculic acid (2.4 and 9.6 micromoles) inhibited the desatn. of stearic acid (I) to oleic acid (II), being most pronounced in the esterified fatty acids and being dependent upon the concn. of the cyclopropene fatty acid.  Methyl sterculate fed to hens at 2.8 and 13.9 mg./kg./day for 3 months reduced the conversion of I to II in liver prepns. from these hens to 12 and 3%, resp., compared with 68% conversion in a control prepn., and reduced the amt. of II in the egg yolk to 48.3 and 30.5% of the total fatty acids compared with 51.8% in the controls.  The high I:II ratio in egg yolk and the consequent hardening of the yolk in methyl sterculate-fed hens can be attributed to inhibition of the hepatic desaturase system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomBNbLHSHyU7Vg90H21EOLACvtfcHk0lg1okyU3w31jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXksVWntLY%253D&md5=d77bb312ed8715aa1e2d15d22f7d01f6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F2141244a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F2141244a0%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DPearson%26aufirst%3DJ.%2BA.%26aulast%3DShenstone%26aufirst%3DF.%2BS.%26aulast%3DFogerty%26aufirst%3DA.%2BC.%26atitle%3DInhibition%2520of%2520the%2520desaturation%2520of%2520stearic%2520to%2520oleic%2520acid%2520by%2520cyclopropene%2520fatty%2520acids%26jtitle%3DNature%26date%3D1967%26volume%3D214%26spage%3D1244%26epage%3D1245%26doi%3D10.1038%2F2141244a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">9924</span>– <span class="NLM_lpage">9932</span>, <span class="refDoi"> DOI: 10.1021/jo030141u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo030141u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=9924-9932&author=G.+Triolaauthor=G.+Fabriasauthor=J.+Casasauthor=A.+Llebaria&title=Synthesis+of+cyclopropene+analogues+of+ceramide+and+their+effect+on+dihydroceramide+desaturase&doi=10.1021%2Fjo030141u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclopropene Analogues of Ceramide and Their Effect on Dihydroceramide Desaturase</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Casas, Josefina; Llebaria, Amadeu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9924-9932</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of several analogs of the N-[(1S,2R)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide (GT11), the first reported inhibitor of dihydroceramide desaturase, as well as their effects on this enzyme, are described.  Modifications of the parent structure include variations on the cyclopropene ring, the N-acyl chain length, the configuration of the stereocenters, and the hydroxyl group at C1.  The key intermediates for the synthesis are the products resulting from the addn. of suitable organolithium compds. to either Garner's aldehyde or its enantiomer.  The final products are obtained by TMSTf-induced cleavage of the protecting groups and N-acylation, both under specific conditions.  An alternative method for N-Boc deprotection is also reported that allows us to obtain the cyclopropene analog of sphingosine, which can be transformed into GT11 upon acylation.  The procedure consists of the conversion of the Garner aldehyde addn. products into the bicyclic dihydrooxazolo[3,4,0]oxazol-3-ones by transesterification in basic medium of the tert-Bu group with the hydroxyl function at C3.  Mild cleavage of the N,O-isopropylidene cyclic acetal affords the oxazolidin-2-one, which gives the sphingosine analog upon sapon.  Furthermore, the oxazolidin-2-one compd. is also the key intermediate in the synthesis of the terminal deoxy, methoxy, and fluoro derivs.  Detn. of dihydroceramide desaturase activity in vitro showed that GT11 was a competitive inhibitor (Ki = 6 μM) and that its analogs with N-hexanoyl and N-decanoyl moieties inhibited the enzyme with similar potencies (IC50 = 13 and 31 μM, resp.).  No decrease in dihydroceramide desaturase activity was obsd. with any of the other compds. tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCMQkmCf6D7Vg90H21EOLACvtfcHk0lg1okyU3w31jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFOkurk%253D&md5=c728d11084c5ec16999d51c9e1f6f0d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo030141u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo030141u%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520cyclopropene%2520analogues%2520of%2520ceramide%2520and%2520their%2520effect%2520on%2520dihydroceramide%2520desaturase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D9924%26epage%3D9932%26doi%3D10.1021%2Fjo030141u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragusin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederhausen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broere, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Echten-Deckert, G.</span></span> <span> </span><span class="NLM_article-title">Specificity of the dihydroceramide desaturase inhibitor n-[(1r,2s)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanami de (gt11) in primary cultured cerebellar neurons</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1678</span>, <span class="refDoi"> DOI: 10.1124/mol.104.003681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fmol.104.003681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15371559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1671-1678&author=G.+Triolaauthor=G.+Fabriasauthor=M.+Dragusinauthor=L.+Niederhausenauthor=R.+Broereauthor=A.+Llebariaauthor=G.+van+Echten-Deckert&title=Specificity+of+the+dihydroceramide+desaturase+inhibitor+n-%5B%281r%2C2s%29-2-hydroxy-1-hydroxymethyl-2-%282-tridecyl-1-cyclopropenyl%29ethyl%5Doctanami+de+%28gt11%29+in+primary+cultured+cerebellar+neurons&doi=10.1124%2Fmol.104.003681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity of the dihydroceramide desaturase inhibitor N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl] octanamide (GT11) in primary cultured cerebellar neurons</span></div><div class="casAuthors">Triola, Gemma; Fabrias, Gemma; Dragusin, Mihaela; Niederhausen, Lars; Broere, Roland; Llebaria, Amadeu; van Echten-Deckert, Gerhild</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1678</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydroceramide deaturase catalyzes the conversion of the innocuous precursor dihydroceramide into a highly bioactive product ceramide.  We studied the effect of GT11, the first inhibitor of this enzyme, in primary cultured cerebellar neurons.  Although deaturase was efficiently inhibited (IC50 of 23 nM), the compd. lost its specificity at higher concns.  From 5 μM upward, GT11 also decreased de novo sphingolipid biosynthesis.  Studies with two differentially labeled radioactive analogs of GT11 support that the inhibitor itself and not a downstream metabolic product, interferes with sphingolipid biosynthesis.  It is interesting that serine palmitoyltransferase activity decreased in the presence of high concns. of GT11 in intact cells, but not when added directly into cell homogenates.  However, suppression of enzyme transcription could not be detected.  But at high concns. GT11 provoked an accumulation of sphingosine-1-phosphate and esp. of dihydrosphingosine-1-phosphate, suggesting a decreased activity of sphingosine-1-phosphate lyase.  Enzyme activity measurements indeed supported this assumption.  Thus, at higher concns., GT11 interferes with lyase activity, inducing an accumulation of sphingoid base phosphates that, in turn, down-regulate serine palmitoyltransferase activity.  At low concns., however, GT11 is the first specific inhibitor of dihydroceramide deaturase described so far.  Considering the proapoptotic and proinflammatory effect of ceramide, GT11 could also turn out to be a novel cell-protective agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6eiC3ZeIUKbVg90H21EOLACvtfcHk0lg1okyU3w31jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jL&md5=5ec69cb057f96da478cf1c3a7d0a6b44</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.003681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.003681%26sid%3Dliteratum%253Aachs%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DDragusin%26aufirst%3DM.%26aulast%3DNiederhausen%26aufirst%3DL.%26aulast%3DBroere%26aufirst%3DR.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3Dvan%2BEchten-Deckert%26aufirst%3DG.%26atitle%3DSpecificity%2520of%2520the%2520dihydroceramide%2520desaturase%2520inhibitor%2520n-%255B%25281r%252C2s%2529-2-hydroxy-1-hydroxymethyl-2-%25282-tridecyl-1-cyclopropenyl%2529ethyl%255Doctanami%2520de%2520%2528gt11%2529%2520in%2520primary%2520cultured%2520cerebellar%2520neurons%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1671%26epage%3D1678%26doi%3D10.1124%2Fmol.104.003681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ordonez, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span> <span> </span><span class="NLM_article-title">From the configurational preference of dihydroceramide desaturase-1 towards delta(6)-unsaturated substrates to the discovery of a new inhibitor</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4394</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1039/C6CC08268H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2FC6CC08268H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28379228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1enu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=4394-4397&author=A.+Pouauthor=J.+L.+Abadauthor=Y.+F.+Ordonezauthor=M.+Garridoauthor=J.+Casasauthor=G.+Fabriasauthor=A.+Delgado&title=From+the+configurational+preference+of+dihydroceramide+desaturase-1+towards+delta%286%29-unsaturated+substrates+to+the+discovery+of+a+new+inhibitor&doi=10.1039%2FC6CC08268H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">From the configurational preference of dihydroceramide desaturase-1 towards Δ6-unsaturated substrates to the discovery of a new inhibitor</span></div><div class="casAuthors">Pou, Ana; Abad, Jose-Luis; Ordonez, Yadira F.; Garrido, Maria; Casas, Josefina; Fabrias, Gemma; Delgado, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4394-4397</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dihydroceramide desaturase 1 (Des1) catalyzes the last step of ceramide synthesis de novo, thus regulating the physiol. relevant balance between dihydrosphingolipids and sphingolipids.  Here we report on the configurational preference of Des1 towards isomeric Δ6-unsatd. dihydroceramide analogs and the discovery of a potent Des1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroJVfgy1KwErVg90H21EOLACvtfcHk0liSkDOCZvB9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1enu7s%253D&md5=c0047f508f55ee177b0d4e92de4ce12e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC6CC08268H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC08268H%26sid%3Dliteratum%253Aachs%26aulast%3DPou%26aufirst%3DA.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DOrdonez%26aufirst%3DY.%2BF.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DA.%26atitle%3DFrom%2520the%2520configurational%2520preference%2520of%2520dihydroceramide%2520desaturase-1%2520towards%2520delta%25286%2529-unsaturated%2520substrates%2520to%2520the%2520discovery%2520of%2520a%2520new%2520inhibitor%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D4394%26epage%3D4397%26doi%3D10.1039%2FC6CC08268H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Olaya, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matabosch, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egido-Gabas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fcmdc.200700325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=18236489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVWmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=946-953&author=J.+M.+Munoz-Olayaauthor=X.+Mataboschauthor=C.+Bediaauthor=M.+Egido-Gabasauthor=J.+Casasauthor=A.+Llebariaauthor=A.+Delgadoauthor=G.+Fabrias&title=Synthesis+and+biological+activity+of+a+novel+inhibitor+of+dihydroceramide+desaturase&doi=10.1002%2Fcmdc.200700325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase</span></div><div class="casAuthors">Munoz-Olaya, Jose M.; Matabosch, Xavier; Bedia, Carmen; Egido-Gabas, Meritxell; Casas, Josefina; Llebaria, Amadeu; Delgado, Antonio; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">946-953</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel mechanism-based dihydroceramide desaturase inhibitor (XM462) in which the substrate C5 methylene group is replaced by a sulfur atom is reported.  Dihydroceramide desaturase inhibition occurred both in vitro and in cultured cells with IC50 values of 8.2 and 0.78 μM, at a substrate concn. of 10 μM.  In vitro expts. showed that XM462 produced a mixed-type inhibition (Ki = 2 μM, α = 0.83).  LC-MS analyses showed that accumulation of endogenous dihydroceramides occurred in cells upon treatment with XM462 in serum-free medium, whereas ceramides built up in controls.  In addn., XM462 was found to be metabolised to its 1-glucosyl and 1-phosphocholine derivs., and to the products of N-deacylation and reacylation with palmitoyl and stearoyl groups.  In Jurkat A3 cells cultured in serum-free medium, viability, as the percentage of trypan blue unstained cells in total cells, was reduced upon XM462 treatment (5 μM, 24 h), but not in controls.  The interest of this compd. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo98D7t9TGb7Vg90H21EOLACvtfcHk0liSkDOCZvB9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVWmtL8%253D&md5=4cbc9db99062a5146e255ddf3daedf35</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700325%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Olaya%26aufirst%3DJ.%2BM.%26aulast%3DMatabosch%26aufirst%3DX.%26aulast%3DBedia%26aufirst%3DC.%26aulast%3DEgido-Gabas%26aufirst%3DM.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520inhibitor%2520of%2520dihydroceramide%2520desaturase%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D946%26epage%3D953%26doi%3D10.1002%2Fcmdc.200700325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buist, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallmann, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymerson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seigel, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, P.</span></span> <span> </span><span class="NLM_article-title">Use of sulfur as an oxidant detector</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)80115-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0040-4039%2800%2980115-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVens7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1988&pages=435-438&author=P.+H.+Buistauthor=H.+G.+Dallmannauthor=R.+R.+Rymersonauthor=P.+M.+Seigelauthor=P.+Skala&title=Use+of+sulfur+as+an+oxidant+detector&doi=10.1016%2FS0040-4039%2800%2980115-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Use of sulfur as an oxidant detector</span></div><div class="casAuthors">Buist, Peter H.; Dallmann, H. Garry; Rymerson, Robert R.; Seigel, Peter M.; Skala, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-8</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    </div><div class="casAbstract">The oxidn. of a no. of Me thiastearates has been examd. as a function of sulfur position using the yeast, Saccharomyces cerevisiae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqBUsRmHzz0LVg90H21EOLACvtfcHk0liSkDOCZvB9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVens7w%253D&md5=3a3533c4db1d4d6943d206008cab7d85</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2980115-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252980115-X%26sid%3Dliteratum%253Aachs%26aulast%3DBuist%26aufirst%3DP.%2BH.%26aulast%3DDallmann%26aufirst%3DH.%2BG.%26aulast%3DRymerson%26aufirst%3DR.%2BR.%26aulast%3DSeigel%26aufirst%3DP.%2BM.%26aulast%3DSkala%26aufirst%3DP.%26atitle%3DUse%2520of%2520sulfur%2520as%2520an%2520oxidant%2520detector%26jtitle%3DTetrahedron%2520Lett.%26date%3D1988%26volume%3D29%26spage%3D435%26epage%3D438%26doi%3D10.1016%2FS0040-4039%2800%2980115-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hovik, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spydevold, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, J.</span></span> <span> </span><span class="NLM_article-title">Thia fatty acids as substrates and inhibitors of stearoyl-coa desaturase</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1349</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/S0005-2760(97)00135-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0005-2760%2897%2900135-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9434139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1349&publication_year=1997&pages=251-256&author=K.+E.+Hovikauthor=O.+S.+Spydevoldauthor=J.+Bremer&title=Thia+fatty+acids+as+substrates+and+inhibitors+of+stearoyl-coa+desaturase&doi=10.1016%2FS0005-2760%2897%2900135-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Thia fatty acids as inhibitors and substrates of Δ9 desaturation of stearic acid</span></div><div class="casAuthors">Hovik, Kjerstin E.; Spydevold, Oystein S.; Bremer, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-256</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thia fatty acids are fatty acid analogs, where sulfur atoms substitute methylene groups in the carbon chain.  In 7800 C1 Morris hepatoma cells and in hepatocytes 9-thia and 10-thia stearic acid are strong inhibitors of Δ9 desaturase, while 3,9-dithia stearic acid and 3,10-dithia stearic acid are much weaker inhibitors.  No effect on the Δ9 desaturase can be obsd. with 3-thia stearic acid.  In microsomes, an equimolar concn. of 9-thia stearoyl-CoA inhibits the Δ9 desatn. of [1-14C]stearoyl-CoA approx. 75, while 3,9-dithia stearoyl-CoA and 3,10-dithia stearoyl-CoA again are weak inhibitors. 3-Thia stearoyl-CoA has no effect on the desatn. of [1-14C]stearoyl-CoA. [2-14C]3-Thia stearoyl-CoA is Δ9 desatd. to [2-14C]thia oleic acid.  This desatn. is inhibited by unlabeled stearoyl-CoA, which therefore is the preferred substrate.  These results show that a sulfur atom in the 3 position reduces the affinity of the CoA ester for the enzyme, but permits desatn.  A sulfur in the 9 or 10 position does not affect binding to the enzyme.  The 9-thia and 10-thia stearoyl-CoA, which cannot be desatd., therefore are strong inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosH_UDeCVc_rVg90H21EOLACvtfcHk0liSkDOCZvB9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGjtLs%253D&md5=bd0dee3cdb118617e698e6ed71aa6e90</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0005-2760%2897%2900135-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2760%252897%252900135-5%26sid%3Dliteratum%253Aachs%26aulast%3DHovik%26aufirst%3DK.%2BE.%26aulast%3DSpydevold%26aufirst%3DO.%2BS.%26aulast%3DBremer%26aufirst%3DJ.%26atitle%3DThia%2520fatty%2520acids%2520as%2520substrates%2520and%2520inhibitors%2520of%2520stearoyl-coa%2520desaturase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1997%26volume%3D1349%26spage%3D251%26epage%3D256%26doi%3D10.1016%2FS0005-2760%2897%2900135-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llebaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Analogs of the dihydroceramide desaturase inhibitor gt11 modified at the amide function: Synthesis and biological activities</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">3707</span>– <span class="NLM_lpage">3712</span>, <span class="refDoi"> DOI: 10.1039/b510198k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2Fb510198k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16211106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOiur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3707-3712&author=C.+Bediaauthor=G.+Triolaauthor=J.+Casasauthor=A.+Llebariaauthor=G.+Fabrias&title=Analogs+of+the+dihydroceramide+desaturase+inhibitor+gt11+modified+at+the+amide+function%3A+Synthesis+and+biological+activities&doi=10.1039%2Fb510198k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Analogs of the dihydro-ceramide desaturase inhibitor GT11 modified at the amide function: synthesis and biological activities</span></div><div class="casAuthors">Bedia, Carmen; Triola, Gemma; Casas, Josefina; Llebaria, Amadeu; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3707-3712</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Dihydro-ceramide desaturase is the last enzyme in the biosynthesis of ceramide de novo.  The cyclopropene-contg. sphingolipid GT11 I is a competitive inhibitor of dihydro-ceramide desaturase.  The biol. effects of chem. modification of the GT11 amide linkage are reported in this article.  Either N-Me substitution or replacement of the amide α-carbonyl methylene by oxygen result in inactive compds.  In contrast, both urea and thiourea analogs of GT11, as well as three α-keto-amides, did inhibit the desatn. of N-octanoyl-sphinganine to N-octanoyl-sphingosine, although with significantly lower potency than GT11.  Furthermore, the α-keto-amides inhibit the acidic ceramidase with similar potencies (IC50 52-83 μM).  Inhibition of the neutral/alk. ceramidase by these compds. requires around 20-fold higher concns.  Structure-activity relationships and the biol. interest of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMMlfjxVHbFrVg90H21EOLACvtfcHk0lgHHvgYH4_7cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOiur%252FI&md5=847ac0c814d5b2bffef9db92d8444ee8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fb510198k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb510198k%26sid%3Dliteratum%253Aachs%26aulast%3DBedia%26aufirst%3DC.%26aulast%3DTriola%26aufirst%3DG.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DLlebaria%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DAnalogs%2520of%2520the%2520dihydroceramide%2520desaturase%2520inhibitor%2520gt11%2520modified%2520at%2520the%2520amide%2520function%253A%2520Synthesis%2520and%2520biological%2520activities%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D3707%26epage%3D3712%26doi%3D10.1039%2Fb510198k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simbari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">3-deoxy-3,4-dehydro analogs of xm462. Preparation and activity on sphingolipid metabolism and cell fate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3173</span>– <span class="NLM_lpage">3179</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmc.2012.03.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22537678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3173-3179&author=L.+Camachoauthor=F.+Simbariauthor=M.+Garridoauthor=J.+L.+Abadauthor=J.+Casasauthor=A.+Delgadoauthor=G.+Fabrias&title=3-deoxy-3%2C4-dehydro+analogs+of+xm462.+Preparation+and+activity+on+sphingolipid+metabolism+and+cell+fate&doi=10.1016%2Fj.bmc.2012.03.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate</span></div><div class="casAuthors">Camacho, Luz; Simbari, Fabio; Garrido, Maria; Abad, Jose Luis; Casas, Josefina; Delgado, Antonio; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3173-3179</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three analogs of the dihydroceramide deaturase inhibitor XM462 are reported.  The compds. inhibit both dihydroceramide deaturase and acid ceramidase, but with different potencies depending on the N-acyl moiety.  Other enzymes of sphingolipid metab., such as neutral ceramidase, acid sphingomyelinase, acid glucosylceramide hydrolase, sphingomyelin synthase and glucosylceramide synthase, are not affected.  The effect on the sphingolipidome of the two best inhibitors, namely (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)octanamide (RBM2-1B) and (R,E)-N-(1-hydroxy-4-(tridecylthio)but-3-en-2-yl)pivalamide (RBM2-1D), is in accordance with the results obtained in the enzyme assays.  These two compds. reduce cell viability in A549 and HCT116 cell lines with similar potencies and both induced apoptotic cell death to similar levels than C8-Cer in HCT116 cells.  The possible therapeutic implications of the activities of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwahFbtXayrVg90H21EOLACvtfcHk0lgHHvgYH4_7cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWqtbk%253D&md5=b6d0f5f9b140e173d5903934c7c4ac33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.073%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%26aufirst%3DL.%26aulast%3DSimbari%26aufirst%3DF.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DAbad%26aufirst%3DJ.%2BL.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DDelgado%26aufirst%3DA.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3D3-deoxy-3%252C4-dehydro%2520analogs%2520of%2520xm462.%2520Preparation%2520and%2520activity%2520on%2520sphingolipid%2520metabolism%2520and%2520cell%2520fate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3173%26epage%3D3179%26doi%3D10.1016%2Fj.bmc.2012.03.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becci, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gander, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sporn, M. B.</span></span> <span> </span><span class="NLM_article-title">N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1346</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=421218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE1MXktlaku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1979&pages=1339-1346&author=R.+C.+Moonauthor=H.+J.+Thompsonauthor=P.+J.+Becciauthor=C.+J.+Grubbsauthor=R.+J.+Ganderauthor=D.+L.+Newtonauthor=J.+M.+Smithauthor=S.+L.+Phillipsauthor=W.+R.+Hendersonauthor=L.+T.+Mullenauthor=C.+C.+Brownauthor=M.+B.+Sporn&title=N-%284-hydroxyphenyl%29retinamide%2C+a+new+retinoid+for+prevention+of+breast+cancer+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat</span></div><div class="casAuthors">Moon, Richard C.; Thompson, Henry J.; Becci, Peter J.; Grubbs, Clinton J.; Gander, Robert J.; Newton, Dianne L.; Smith, Joseph M.; Phillips, Sandra L.; Henderson, William R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1339-46</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The synthesis of a new retinoid N-(4-hydroxyphenyl)-all-trans-retinamide (I)  [65646-68-6] is described.  I was more potent that retinyl acetate in reversing keratinization caused by retinoid deficiency in tracheal organ culture.  I was markedly less toxic than retinyl acetate when fed orally to rats over 2-wk or 6-mo periods.  I was an effective agent for inhibition of the development of breast cancer induced in rats by N-nitroso-N-methylurea, although it was not as potent as retinyl acetate in this regard.  However, the lesser toxicity of I makes it a superior agent for prevention of breast cancer.  High-pressure liq. chromatog. analyses of liver and breast exts. from rats treated for 6 mo with retinoids show the pharmacokinetic basis for the superiority of I; this retinoid and its metabolites were found in high concns. in breast tissue, without any measurable accumulation in the liver or evident liver toxicity.  In contrast, chronic feeding of retinyl acetate caused marked deposition of retinyl esters in the liver and severe hepatotoxicity.  Whole mounts of rat mammary glands, made after chronic feeding of I showed that it had a marked antiproliferative effect on mammary epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos8Iznf_bvpLVg90H21EOLACvtfcHk0lgHHvgYH4_7cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXktlaku7c%253D&md5=3e4d0463a75c7f17f2ce0927e2f2d668</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DR.%2BC.%26aulast%3DThompson%26aufirst%3DH.%2BJ.%26aulast%3DBecci%26aufirst%3DP.%2BJ.%26aulast%3DGrubbs%26aufirst%3DC.%2BJ.%26aulast%3DGander%26aufirst%3DR.%2BJ.%26aulast%3DNewton%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DPhillips%26aufirst%3DS.%2BL.%26aulast%3DHenderson%26aufirst%3DW.%2BR.%26aulast%3DMullen%26aufirst%3DL.%2BT.%26aulast%3DBrown%26aufirst%3DC.%2BC.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DN-%25284-hydroxyphenyl%2529retinamide%252C%2520a%2520new%2520retinoid%2520for%2520prevention%2520of%2520breast%2520cancer%2520in%2520the%2520rat%26jtitle%3DCancer%2520Res.%26date%3D1979%26volume%3D39%26spage%3D1339%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szulc, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogretmen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bielawska, A.</span></span> <span> </span><span class="NLM_article-title">Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">16718</span>– <span class="NLM_lpage">16728</span>, <span class="refDoi"> DOI: 10.1074/jbc.M700647200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M700647200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17283068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1agsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=16718-16728&author=J.+M.+Kravekaauthor=L.+Liauthor=Z.+M.+Szulcauthor=J.+Bielawskiauthor=B.+Ogretmenauthor=Y.+A.+Hannunauthor=L.+M.+Obeidauthor=A.+Bielawska&title=Involvement+of+dihydroceramide+desaturase+in+cell+cycle+progression+in+human+neuroblastoma+cells&doi=10.1074%2Fjbc.M700647200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of Dihydroceramide Desaturase in Cell Cycle Progression in Human Neuroblastoma Cells</span></div><div class="casAuthors">Kraveka, Jacqueline M.; Li, Li; Szulc, Zdzislaw M.; Bielawski, Jacek; Ogretmen, Besim; Hannun, Yusuf A.; Obeid, Lina M.; Bielawska, Alicja</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16718-16728</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The role of dihydroceramide desaturase as a key enzyme in the de novo pathway of ceramide generation was investigated in human neuroblastoma cells (SMS-KCNR).  A novel assay using water-sol. analogs of dihydroceramide, dihydroceramidoids (D-erythro-dhCCPS analogs), was used to measure desaturase activity in situ.  Conversion of D-erythro-2-N-[12'-(1''-pyridinium)-dodecanoyl]-4,5-dihydrosphingosine bromide (C12-dhCCPS) to its 4,5-desatd. counterpart, D-erythro-2-N-[12'-(1''-pyridinium)dodecanoyl]sphingosine bromide (C12-CCPS), was detd. by liq. chromatog./mass spectrometry anal.  The validity of the assay was confirmed using C8-cyclopropenylceramide, a competitive inhibitor of dihydroceramide desaturase.  A human homolog (DEGS-1) of the Drosophila melanogaster des-1 gene was recently identified and reported to have desaturase activity.  Transfection of SMS-KCNR cells with small interfering RNA to DEGS-1 significantly blocked the conversion of C12-dhCCPS to C12-CCPS.  The assocd. accumulation of endogenous dihydroceramides confirmed DEGS-1 as the main active dihydroceramide desaturase in these cells.  The partial loss of DEGS-1 inhibited cell growth, with cell cycle arrest at G0/G1.  This was accompanied by a significant decrease in the amt. of phosphorylated retinoblastoma protein.  This hypophosphorylation was inhibited by tautomycin and not by okadaic acid, suggesting the involvement of protein phosphatase 1.  Addnl., we found that treatment of SMS-KCNR cells with fenretinide inhibited desaturase activity in a dose-dependent manner.  An increase in dihydroceramides (but not ceramides) paralleled this process as measured by liq. chromatog./mass spectrometry.  There were no effects on the mRNA or protein levels of DEGS-1, suggesting that fenretinide acts at the post-translational level as an inhibitor of this enzyme.  Tautomycin was also able to block the hypophosphorylation of the retinoblastoma protein obsd. upon fenretinide treatment.  These findings suggest a novel biol. function for dihydroceramides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpESfa0p4qfN7Vg90H21EOLACvtfcHk0lgIg2ZcJadUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1agsr8%253D&md5=56f06a2c01172fcd71b0f2d78beeb053</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M700647200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M700647200%26sid%3Dliteratum%253Aachs%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSzulc%26aufirst%3DZ.%2BM.%26aulast%3DBielawski%26aufirst%3DJ.%26aulast%3DOgretmen%26aufirst%3DB.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DBielawska%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520dihydroceramide%2520desaturase%2520in%2520cell%2520cycle%2520progression%2520in%2520human%2520neuroblastoma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D16718%26epage%3D16728%26doi%3D10.1074%2Fjbc.M700647200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahmaniyan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curley, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraveka, J. M.</span></span> <span> </span><span class="NLM_article-title">Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">24754</span>– <span class="NLM_lpage">24764</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.250779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M111.250779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21543327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFGmsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=24754-24764&author=M.+Rahmaniyanauthor=R.+W.+Curleyauthor=L.+M.+Obeidauthor=Y.+A.+Hannunauthor=J.+M.+Kraveka&title=Identification+of+dihydroceramide+desaturase+as+a+direct+in+vitro+target+for+fenretinide&doi=10.1074%2Fjbc.M111.250779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide</span></div><div class="casAuthors">Rahmaniyan, Mehrdad; Curley, Robert W., Jr.; Obeid, Lina M.; Hannun, Yusuf A.; Kraveka, Jacqueline M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">24754-24764</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide.  We previously demonstrated that fenretinide (4-HPR) inhibited DES activity in SMS-KCNR neuroblastoma cells.  In this study, we investigated whether 4-HPR acted directly on the enzyme in vitro.  N-C8:0-D-erythro-dihydroceramide (C8-dhCer) was used as a substrate to study the conversion of dihydroceramide into ceramide in vitro using rat liver microsomes, and the formation of tritiated water after the addn. of the tritiated substrate was detected and used to measure DES activity.  NADH served as a cofactor.  The apparent Km for C8-dhCer and NADH were 1.92 ± 0.36 μM and 43.4 ± 6.47 μM, resp.; and the Vmax was 3.16 ± 0.24 and 4.11 ± 0.18 nmol/min/g protein.  Next, the effects of 4-HPR and its metabolites on DES activity were investigated. 4-HPR was found to inhibit DES in a dose-dependent manner.  At 20 min, the inhibition was competitive; however, longer incubation times demonstrated the inhibition to be irreversible.  Among the major metabolites of 4-HPR, 4-oxo-N-(4-hydroxyphenyl)retinamide (4-oxo-4-HPR) showed the highest inhibitory effect with substrate concn. of 0.5 μM, with an IC50 of 1.68 μM as compared with an IC50 of 2.32 μM for 4-HPR.  N-(4-Methoxyphenyl)retinamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl)retinamide (4-oxo-4-MPR) had minimal effects on DES activity.  A known competitive inhibitor of DES, C8-cyclopropenylceramide was used as a pos. control.  These studies define for the first time a direct in vitro target for 4-HPR and suggest that inhibitors of DES may be used as therapeutic interventions to regulate ceramide desatn. and consequent function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIlNxfyqhQbVg90H21EOLACvtfcHk0lgIg2ZcJadUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFGmsLw%253D&md5=e9cddef915d8b9e976ca654317631256</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.250779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.250779%26sid%3Dliteratum%253Aachs%26aulast%3DRahmaniyan%26aufirst%3DM.%26aulast%3DCurley%26aufirst%3DR.%2BW.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DKraveka%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520dihydroceramide%2520desaturase%2520as%2520a%2520direct%2520in%2520vitro%2520target%2520for%2520fenretinide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D24754%26epage%3D24764%26doi%3D10.1074%2Fjbc.M111.250779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">French, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of sphingosine kinase inhibitors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">603</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.101345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fjpet.106.101345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16632640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=596-603&author=K.+J.+Frenchauthor=J.+J.+Upsonauthor=S.+N.+Kellerauthor=Y.+Zhuangauthor=J.+K.+Yunauthor=C.+D.+Smith&title=Antitumor+activity+of+sphingosine+kinase+inhibitors&doi=10.1124%2Fjpet.106.101345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor activity of sphingosine kinase inhibitors</span></div><div class="casAuthors">French, Kevin J.; Upson, John J.; Keller, Staci N.; Zhuang, Yan; Yun, Jong K.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine kinase (SK) is an oncogenic sphingolipid-metabolizing enzyme that catalyzes the formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) at the expense of proapoptotic ceramide.  Thus, SK is an attractive target for cancer therapy because blockage of S1P formation leads to inhibition of proliferation, as well as the induction of apoptosis in cancer cells.  We have recently identified novel SK inhibitors with nanomolar to low micromolar potencies toward recombinant human SK.  This study describes the continuing anal. of these inhibitors through in vitro and in vivo expts.  All three structurally diverse SK inhibitors tested showed antitumor activity in mice without exhibiting toxicity.  Blood and tumor inhibitor concns. exceeded in vitro potency levels.  Cell signaling analyses in vitro revealed mixed inhibition of mitogen-activated protein kinase kinase and Akt phosphorylation by the SK inhibitors.  Importantly, 4-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-phenol (SKI-II) is orally bioavailable, detected in the blood for at least 8 h, and showed a significant inhibition of tumor growth in mice.  These compds. are the first examples of nonlipid selective inhibitors of SK with in vivo antitumor activity and provide leads for further development of inhibitors of this important mol. target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOz-4ODWl8HbVg90H21EOLACvtfcHk0lgIg2ZcJadUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOlsLs%253D&md5=625e4f9f3c438f2ee00f9039ffb76690</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.101345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.101345%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DK.%2BJ.%26aulast%3DUpson%26aufirst%3DJ.%2BJ.%26aulast%3DKeller%26aufirst%3DS.%2BN.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DYun%26aufirst%3DJ.%2BK.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DAntitumor%2520activity%2520of%2520sphingosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D596%26epage%3D603%26doi%3D10.1124%2Fjpet.106.101345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span> <span> </span><span class="NLM_article-title">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e44543</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0044543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0044543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22970244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlOltLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=P.+Gaoauthor=Y.+K.+Petersonauthor=R.+A.+Smithauthor=C.+D.+Smith&title=Characterization+of+isoenzyme-selective+inhibitors+of+human+sphingosine+kinases&doi=10.1371%2Fjournal.pone.0044543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of isoenzyme-selective inhibitors of human sphingosine kinases</span></div><div class="casAuthors">Gao, Peng; Peterson, Yuri K.; Smith, Ryan A.; Smith, Charles D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e44543</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Sphingosine kinases (SKs) are promising new therapeutic targets for cancer because they regulate the balance between pro-apoptotic ceramides and mitogenic sphingosine-1-phosphate.  The functions of the two SK isoenzymes, SK1 and SK2, are not redundant, with genetic ablation of SK2 having more pronounced anticancer effects than removal of SK1.  Although several small mol. inhibitors of SKs have been described in the literature, detailed characterization of their mol. and cellular pharmacol., particularly their activities against human SK1 and SK2, have not been completed.  Computational modeling of the putative active sites of SK1 and SK2 suggests structural differences that might allow isoenzyme-selective inhibitors.  Therefore, we characterized several SK-inhibitory compds. which revealed differential inhibitory effects on SK1 and SK2 as follows: SKI-II and ABC294735 are SK1/2-dual inhibitors; CB5468139 is a SK1-selective inhibitor; and ABC294640 is a SK2-selective inhibitor.  We examd. the effects of the SK inhibitors on several biochem. and phenotypic processes in A498 kidney adenocarcinoma cells.  The SK2-selective inhibitor ABC294640 demonstrated the most pronounced effects on SK1 and SK2 mRNA expression, decrease of S1P levels, elevation of ceramide levels, cell cycle arrest, and inhibition of proliferation, migration and invasion.  ABC294640 also down-regulated the expression or activation of several signaling proteins, including STAT3, AKT, ERK, p21, p53 and FAK.  These effects were equiv. or superior to responses to the SK1/2-dual inhibitors.  Overall, these results suggest that inhibition of SK2 results in stronger anticancer effects than does inhibition of SK1 or both SK1 and SK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7FPd4N4yAUbVg90H21EOLACvtfcHk0lgIg2ZcJadUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlOltLjF&md5=d0eeac2da418c330f5e63fc866a77003</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044543%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DP.%26aulast%3DPeterson%26aufirst%3DY.%2BK.%26aulast%3DSmith%26aufirst%3DR.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26atitle%3DCharacterization%2520of%2520isoenzyme-selective%2520inhibitors%2520of%2520human%2520sphingosine%2520kinases%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0044543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cingolani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casasampere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanllehi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bujons, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrias, G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor ski ii</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1720</span>, <span class="refDoi"> DOI: 10.1194/jlr.M049759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.M049759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24875537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1agsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1711-1720&author=F.+Cingolaniauthor=M.+Casasampereauthor=P.+Sanllehiauthor=J.+Casasauthor=J.+Bujonsauthor=G.+Fabrias&title=Inhibition+of+dihydroceramide+desaturase+activity+by+the+sphingosine+kinase+inhibitor+ski+ii&doi=10.1194%2Fjlr.M049759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II</span></div><div class="casAuthors">Cingolani, Francesca; Casasampere, Mireia; Sanllehi, Pol; Casas, Josefina; Bujons, Jordi; Fabrias, Gemma</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1711-1720</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Sphingosine kinase inhibitor (SKI) II has been reported as a dual inhibitor of sphingosine kinases (SKs) 1 and 2 and has been extensively used to prove the involvement of SKs and sphingosine-1-phosphate (S1P) in cellular processes.  Dihydroceramide desaturase (Des1), the last enzyme in the de novo synthesis of ceramide (Cer), regulates the balance between dihydroceramides (dhCers) and Cers.  Both SKs and Des1 have interest as therapeutic targets.  Here we show that SKI II is a noncompetitive inhibitor (Ki = 0.3 μM) of Des1 activity with effect also in intact cells without modifying Des1 protein levels.  Mol. modeling studies support that the SKI II-induced decrease in Des1 activity could result from inhibition of NADH-cytochrome b5 reductase.  SKI II, but not the SK1-specific inhibitor PF-543, provoked a remarkable accumulation of dhCers and their metabolites, while both SKI II and PF-543 reduced S1P to almost undetectable levels.  SKI II, but not PF543, reduced cell proliferation with accumulation of cells in the G0/G1 phase.  SKI II, but not PF543, induced autophagy.  These overall findings should be taken into account when using SKI II as a pharmacol. tool, as some of the effects attributed to decreased S1P may actually be caused by augmented dhCers and/or their metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNQtrJS2ry7Vg90H21EOLACvtfcHk0lj_VRkzhYl7IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1agsrnE&md5=b0c80a9893c7616875c436364d56a108</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M049759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M049759%26sid%3Dliteratum%253Aachs%26aulast%3DCingolani%26aufirst%3DF.%26aulast%3DCasasampere%26aufirst%3DM.%26aulast%3DSanllehi%26aufirst%3DP.%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DBujons%26aufirst%3DJ.%26aulast%3DFabrias%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520dihydroceramide%2520desaturase%2520activity%2520by%2520the%2520sphingosine%2520kinase%2520inhibitor%2520ski%2520ii%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1711%26epage%3D1720%26doi%3D10.1194%2Fjlr.M049759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aurelio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scullino, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebello, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creek, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flynn, B. L.</span></span> <span> </span><span class="NLM_article-title">From sphingosine kinase to dihydroceramide desaturase: A structure-activity relationship (sar) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl)thiazol-2-yl)amino)phenol (ski-ii)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">984</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01439</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01439" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlCltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=965-984&author=L.+Aurelioauthor=C.+V.+Scullinoauthor=M.+R.+Pitmanauthor=A.+Sextonauthor=V.+Oliverauthor=L.+Daviesauthor=R.+J.+Rebelloauthor=L.+Furicauthor=D.+J.+Creekauthor=S.+M.+Pitsonauthor=B.+L.+Flynn&title=From+sphingosine+kinase+to+dihydroceramide+desaturase%3A+A+structure-activity+relationship+%28sar%29+study+of+the+enzyme+inhibitory+and+anticancer+activity+of+4-%28%284-%284-chlorophenyl%29thiazol-2-yl%29amino%29phenol+%28ski-ii%29&doi=10.1021%2Facs.jmedchem.5b01439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)</span></div><div class="casAuthors">Aurelio, Luigi; Scullino, Carmen V.; Pitman, Melissa R.; Sexton, Anna; Oliver, Victoria; Davies, Lorena; Rebello, Richard J.; Furic, Luc; Creek, Darren J.; Pitson, Stuart M.; Flynn, Bernard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">965-984</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sphingosine kinase (SK) inhibitor, SKI-II, has been employed extensively in biol. investigations of the role of SK1 and SK2 in disease and has demonstrated impressive anticancer activity in vitro and in vivo.  However, interpretations of results using this pharmacol. agent are complicated by several factors: poor SK1/2 selectivity, addnl. activity as an inducer of SK1-degrdn., and off-target effects, including its recently identified capacity to inhibit dihydroceramide desaturase-1 (Des1).  In this study, we have delineated the structure-activity relationship (SAR) for these different targets and correlated them to that required for anticancer activity and detd. that Des1 inhibition is primarily responsible for the antiproliferative effects of SKI-II and its analogs.  In the course of these efforts, a series of novel SK1, SK2, and Des1 inhibitors have been generated, including compds. with significantly greater anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5l2c1kugWFLVg90H21EOLACvtfcHk0lj_VRkzhYl7IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlCltw%253D%253D&md5=53212d9b590fac3eff62b4fbff069f4e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01439%26sid%3Dliteratum%253Aachs%26aulast%3DAurelio%26aufirst%3DL.%26aulast%3DScullino%26aufirst%3DC.%2BV.%26aulast%3DPitman%26aufirst%3DM.%2BR.%26aulast%3DSexton%26aufirst%3DA.%26aulast%3DOliver%26aufirst%3DV.%26aulast%3DDavies%26aufirst%3DL.%26aulast%3DRebello%26aufirst%3DR.%2BJ.%26aulast%3DFuric%26aufirst%3DL.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DPitson%26aufirst%3DS.%2BM.%26aulast%3DFlynn%26aufirst%3DB.%2BL.%26atitle%3DFrom%2520sphingosine%2520kinase%2520to%2520dihydroceramide%2520desaturase%253A%2520A%2520structure-activity%2520relationship%2520%2528sar%2529%2520study%2520of%2520the%2520enzyme%2520inhibitory%2520and%2520anticancer%2520activity%2520of%25204-%2528%25284-%25284-chlorophenyl%2529thiazol-2-yl%2529amino%2529phenol%2520%2528ski-ii%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D965%26epage%3D984%26doi%3D10.1021%2Facs.jmedchem.5b01439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span>; <span class="NLM_string-name">Mccall, J. M.</span>; <span class="NLM_string-name">Blitzer, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Dihydroceramide Desaturase for Treating Disease</span>. PCT Int. Appl. <span class="NLM_patent">WO 2018112077</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=D.+L.+Romero&author=J.+M.+Mccall&author=J.+Blitzer&title=Inhibitors+of+Dihydroceramide+Desaturase+for+Treating+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DD.%2BL.%26atitle%3DInhibitors%2520of%2520Dihydroceramide%2520Desaturase%2520for%2520Treating%2520Disease%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases at the centre of sphingolipid metabolism and biology</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1042/BJ20111626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1042%2FBJ20111626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22248339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=789-802&author=T.+D.+Mullenauthor=Y.+A.+Hannunauthor=L.+M.+Obeid&title=Ceramide+synthases+at+the+centre+of+sphingolipid+metabolism+and+biology&doi=10.1042%2FBJ20111626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases at the center of sphingolipid metabolism and biology</span></div><div class="casAuthors">Mullen, Thomas D.; Hannun, Yusuf A.; Obeid, Lina M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-802</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingolipid metab. in metazoan cells consists of a complex interconnected web of numerous enzymes, metabolites, and modes of regulation.  At the center of sphingolipid metab. reside ceramide synthases (CerSs), a group of enzymes that catalyze the formation of ceramides from sphingoid base and acyl-CoA substrates.  From a metabolic perspective, these enzymes occupy a unique niche in that they simultaneously regulate de novo sphingolipid synthesis and the recycling of free sphingosine produced from the degrdn. of pre-formed sphingolipids (salvage pathway).  Six mammalian CerSs (CerS1-CerS6) have been identified.  Unique characteristics have been described for each of these enzymes, but perhaps the most notable is the ability of individual CerS isoforms to produce ceramides with characteristic acyl-chain distributions.  Through this control of acyl-chain length and perhaps in a compartment-specific manner, CerSs appear to regulate multiple aspects of sphingolipid-mediated cell and organismal biol.  Here, the authors discuss the function of CerSs as crit. regulators of sphingolipid metab., highlight their unique characteristics, and explore the emerging roles of CerSs in regulating programmed cell death, cancer, and many other aspects of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGragKGT5uAgn7Vg90H21EOLACvtfcHk0lj_VRkzhYl7IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFKktw%253D%253D&md5=56ec959e19c18947244ec20afeeb0b4c</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1042%2FBJ20111626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111626%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DT.%2BD.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26atitle%3DCeramide%2520synthases%2520at%2520the%2520centre%2520of%2520sphingolipid%2520metabolism%2520and%2520biology%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26spage%3D789%26epage%3D802%26doi%3D10.1042%2FBJ20111626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Mammalian ceramide synthases</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1002/iub.319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fiub.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20222015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=347-356&author=M.+Levyauthor=A.+H.+Futerman&title=Mammalian+ceramide+synthases&doi=10.1002%2Fiub.319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian ceramide synthases</span></div><div class="casAuthors">Levy, Michal; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Inc.</span>)
        </div><div class="casAbstract">A review.  In mammals, ceramide, a key intermediate in sphingolipid metab. and an important signaling mol., is synthesized by a family of 6 ceramide synthases (CerSs), each of which synthesizes ceramides with distinct acyl chain lengths.  There are a no. of common biochem. features between the CerSs, such as their catalytic mechanism, and their structure and intracellular localization.  Different CerSs also display marked differences in their biol. properties, with each of them playing distinct roles in processes as diverse as cancer and tumor suppression, in response to chemotherapeutic drugs, in apoptosis, and in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB06J4X10_O7Vg90H21EOLACvtfcHk0lgUPEcaT4zntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFegtbw%253D&md5=1796685b5383eed06d1e51949aa22950</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fiub.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.319%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DMammalian%2520ceramide%2520synthases%26jtitle%3DIUBMB%2520Life%26date%3D2010%26volume%3D62%26spage%3D347%26epage%3D356%26doi%3D10.1002%2Fiub.319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Car, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zendzian-Piotrowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiedorowicz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawicka, D.</span></span> <span> </span><span class="NLM_article-title">Ceramide profiles in the brain of rats with diabetes induced by streptozotocin</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">1943</span>– <span class="NLM_lpage">1952</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08575.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1742-4658.2012.08575.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22429392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1eqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=1943-1952&author=H.+Carauthor=M.+Zendzian-Piotrowskaauthor=S.+Prokopiukauthor=A.+Fiedorowiczauthor=A.+Sadowskaauthor=K.+Kurekauthor=D.+Sawicka&title=Ceramide+profiles+in+the+brain+of+rats+with+diabetes+induced+by+streptozotocin&doi=10.1111%2Fj.1742-4658.2012.08575.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide profiles in the brain of rats with diabetes induced by streptozotocin</span></div><div class="casAuthors">Car, Halina; Zendzian-Piotrowska, Malgorzata; Prokopiuk, Slawomir; Fiedorowicz, Anna; Sadowska, Anna; Kurek, Krzysztof; Sawicka, Diana</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1943-1952</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diabetes is assocd. with disturbances of brain activity and cognitive impairment.  We hypothesize that ceramides may constitute an important contribution to diabetes-linked neuro-dysfunction.  In our study we used rats injected with streptozotocin (STZ) as a model of severe hyperglycemia.  Using the gas-liq. chromatog. technique we found a significant increase of ceramide content in brains and a decrease in plasma of diabetic rats.  The inhibitor of serine palmitoyltransferase, myriocin, reduced ceramide generation in hyperglycemic brains, although injected alone it exerted a paradoxical effect of ceramide upregulation.  Myriocin had no impact on ceramide concn. in the plasma of either control or diabetic rats.  The level of ceramide satd. fatty acids was elevated whereas the level of ceramide poly-unsatd. fatty acids was downregulated in brains of all exptl. groups.  The concn. of ceramide mono-unsatd. fatty acids remained unchanged.  The pattern of individual ceramide species was altered depending on treatment.  We noted an STZ-evoked increase of brain ceramide C16:0, C18:0 and C20:0 and a strong decline in ceramide C18:2 fatty acid levels.  Some changes of brain ceramide pattern were modified by myriocin.  We found a decreased amt. of total ceramide-ω-6 fatty acids in STZ-treated rat brains and no changes in ceramide-ω-3 concn.  We conclude that ceramides may be important mediators of diabetes-accompanied brain dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9DrBq0XVqrVg90H21EOLACvtfcHk0lgUPEcaT4zntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1eqtbo%253D&md5=95ccd80497b5d390ab35496a08bd73ac</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08575.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08575.x%26sid%3Dliteratum%253Aachs%26aulast%3DCar%26aufirst%3DH.%26aulast%3DZendzian-Piotrowska%26aufirst%3DM.%26aulast%3DProkopiuk%26aufirst%3DS.%26aulast%3DFiedorowicz%26aufirst%3DA.%26aulast%3DSadowska%26aufirst%3DA.%26aulast%3DKurek%26aufirst%3DK.%26aulast%3DSawicka%26aufirst%3DD.%26atitle%3DCeramide%2520profiles%2520in%2520the%2520brain%2520of%2520rats%2520with%2520diabetes%2520induced%2520by%2520streptozotocin%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D1943%26epage%3D1952%26doi%3D10.1111%2Fj.1742-4658.2012.08575.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brachtendorf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Hindi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosch, S.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthases in cancer therapy and chemoresistance</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">160</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2019.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.plipres.2019.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30953657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFOjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2019&pages=160-185&author=S.+Brachtendorfauthor=K.+El-Hindiauthor=S.+Grosch&title=Ceramide+synthases+in+cancer+therapy+and+chemoresistance&doi=10.1016%2Fj.plipres.2019.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide synthases in cancer therapy and chemoresistance</span></div><div class="casAuthors">Brachtendorf, Sebastian; El-Hindi, Khadija; Groesch, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160-185</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug resistance is one major reason for failure of cancer therapy.  In the past 10 years, evidence emerged showing that ceramides of specific chain length, generated by six different ceramide synthases (CerS), are deregulated in different cancer types thereby influencing chemosensitivity.  In this review we sum up the cellular mechanisms regulated by CerS and the resp. ceramides of specific chain length contributing to chemoresistance and how we can interfere with these mechanisms to overcome drug resistance by targeting CerS.  We compile an overview of the different cellular effects influenced by CerS in dependency of the used drug and cancer type.  Finally, the potential of CerS as new drug targets in chemotherapy or as biomarkers for the prediction of therapeutic response rates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQgt5Cm1eB87Vg90H21EOLACvtfcHk0lgUPEcaT4zntg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFOjsL0%253D&md5=28dfbbdcf07bf6271a39f7cce94418ad</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2019.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2019.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DBrachtendorf%26aufirst%3DS.%26aulast%3DEl-Hindi%26aufirst%3DK.%26aulast%3DGrosch%26aufirst%3DS.%26atitle%3DCeramide%2520synthases%2520in%2520cancer%2520therapy%2520and%2520chemoresistance%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2019%26volume%3D74%26spage%3D160%26epage%3D185%26doi%3D10.1016%2Fj.plipres.2019.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norred, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with fusarium moniliforme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">14486</span>– <span class="NLM_lpage">14490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2998712-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1860857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlt12luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=14486-14490&author=E.+Wangauthor=W.+P.+Norredauthor=C.+W.+Baconauthor=R.+T.+Rileyauthor=A.+H.+Merrill&title=Inhibition+of+sphingolipid+biosynthesis+by+fumonisins.+Implications+for+diseases+associated+with+fusarium+moniliforme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of sphingolipid biosynthesis by fumonisins.  Implications for diseases associated with Fusarium moniliforme</span></div><div class="casAuthors">Wang, Elaine; Norred, William P.; Bacon, Charles W.; Riley, Ronald T.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">14486-90</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Incubation of rat hepatocytes with fumonisins inhibited incorporation of [14C]serine into the sphingosine moiety of cellular sphingolipids with an IC50 of 0.1 μM for fumonisin B1 (I).  In contrast, I increased the amt. of the biosynthetic intermediate sphinganine, which suggests that fumonisins inhibit the conversion of [14C]sphinganine to N-acyl-[14C]sphinganines, a step that is thought to precede introduction of the 4,5-trans double bond of sphingosine (1986).  In agreement with this mechanism, I inhibited the activity of sphingosine N-acyltransferase (ceramide synthase) in rat liver microsomes with 50% inhibition at approx. 0.1 μM and reduced the conversion of [3H]sphingosine to [3H]ceramide by intact hepatocytes.  As far as the authors are aware, this is the 1st discovery of a naturally occurring inhibitor of this step of sphingolipid metab.  These findings suggest that disruption of the de novo pathway of sphingolipid biosynthesis may be a crit. event in the diseases that have been assocd. with consumption of fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriD3wO0JGdirVg90H21EOLACvtfcHk0lhoxoQghkZVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlt12luro%253D&md5=cc1b3ed76f6c11b4be62b94aebfdbdfd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2998712-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252998712-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DE.%26aulast%3DNorred%26aufirst%3DW.%2BP.%26aulast%3DBacon%26aufirst%3DC.%2BW.%26aulast%3DRiley%26aufirst%3DR.%2BT.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520sphingolipid%2520biosynthesis%2520by%2520fumonisins.%2520Implications%2520for%2520diseases%2520associated%2520with%2520fusarium%2520moniliforme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D14486%26epage%3D14490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. T.</span></span> <span> </span><span class="NLM_article-title">Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins</span>. <i>Environ. Health Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">Suppl. 2</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1289/ehp.01109s2283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1289%2Fehp.01109s2283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11359697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVOgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2001&pages=283-289&issue=Suppl.+2&author=A.+H.+Merrillauthor=M.+C.+Sullardsauthor=E.+Wangauthor=K.+A.+Vossauthor=R.+T.+Riley&title=Sphingolipid+metabolism%3A+Roles+in+signal+transduction+and+disruption+by+fumonisins&doi=10.1289%2Fehp.01109s2283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins</span></div><div class="casAuthors">Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine; Voss, Kenneth A.; Riley, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Environmental Health Perspectives Supplements</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">EHPSEO</span>;
        ISSN:<span class="NLM_cas:issn">1078-0475</span>.
    
            (<span class="NLM_cas:orgname">National Institute of Environmental Health Sciences</span>)
        </div><div class="casAbstract">A review and discussion with 59 refs.  Sphingolipids have important roles in membrane and lipoprotein structure and in cell regulation as second messengers for growth factors, differentiation factors, cytokines, and a growing list of agonists.  Bioactive sphingolipids are formed both by the turnover of complex sphingolipids and as intermediates of sphingolipid biosynthesis.  Usually, the amts. are highly regulated; however, by inhibiting ceramide synthase, fumonisins block the biosynthesis of complex sphingolipids and cause sphinganine (and sometimes sphingosine) to accumulate.  Where the mechanism has been studied most thoroughly, the accumulation of sphingoid bases is a primary cause of the toxicity of fumonisin B (FB).  Nonetheless, the full effects of fumonisins probably involve many biochem. events.  The elevations in sphingoid bases also affect the amts. of other lipids, including the 1-phosphates and N-acetyl derivs. of sphinganine.  Furthermore, the aminopentol backbone of FB1 (AP1) is both an inhibitor and a substrate for ceramide synthase, and the resultant N-palmitoyl-AP1 (PAP1) is an even more potent inhibitor of ceramide synthase (presumably as a product analog).  PAP1 is 10 times more toxic than FB1 or AP1 for HT-29 cells in culture, and hence may play a role in the toxicity of nixtamalized fumonisins.  All these processes - the effects of fumonisins on sphingolipid metab., the pathways altered by perturbation of sphingolipid metab., and the complex cellular behaviors regulated by sphingolipids - must be borne in mind when evaluating the pathol. effects of fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUIifa-AOFYbVg90H21EOLACvtfcHk0lhoxoQghkZVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVOgt70%253D&md5=ca4e749da342361f74b36648fe05e288</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1289%2Fehp.01109s2283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.01109s2283%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DVoss%26aufirst%3DK.%2BA.%26aulast%3DRiley%26aufirst%3DR.%2BT.%26atitle%3DSphingolipid%2520metabolism%253A%2520Roles%2520in%2520signal%2520transduction%2520and%2520disruption%2520by%2520fumonisins%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2001%26volume%3D109%26issue%3DSuppl.%25202%26spage%3D283%26epage%3D289%26doi%3D10.1289%2Fehp.01109s2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Echten, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Fumonisin b1 inhibits sphingosine (sphinganine) n-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">27299</span>– <span class="NLM_lpage">27306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2819%2974249-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8262970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXis1enurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=27299-27306&author=A.+H.+Merrillauthor=G.+van+Echtenauthor=E.+Wangauthor=K.+Sandhoff&title=Fumonisin+b1+inhibits+sphingosine+%28sphinganine%29+n-acyltransferase+and+de+novo+sphingolipid+biosynthesis+in+cultured+neurons+in+situ"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ</span></div><div class="casAuthors">Merrill, Alfred H., Jr.; van Echten, Gerhild; Wang, Elaine; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">27299-306</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The current study utilized mouse cerebellar neurons in culture to evaluate the distribution of newly synthesized ceramides among different complex sphingolipids.  Fumonisin B1 inhibited ceramide synthase in mouse brain microsomes with a competitive-like kinetic behavior with respect to both sphinganine and stearoyl-CoA.  Fumonisin B1 inhibited sphingolipid biosynthesis in cultured cerebellar neurons in situ as reflected by accumulation of free sphinganine, a redn. in the mass of total sphingolipids, redns. in the incorporation of [14C]serine into glucosylceramide, lactosylceramide, sphingomyelin, and gangliosides (GM1, GD3, GD1a, GD1b, GT1b, and GQ1b), and inhibition of the incorporation of [14C]galactose and [3H]sphinganine into complex sphingolipids.  Dose-response studies revealed that the labeling of sphingomyelin (IC50 of 0.7 μM) was more sensitive to inhibition by fumonisin B1 than was glycolipid formation (IC50 of ∼7 μM) in these cells.  A similar effect was seen when β-fluoroalanine was added to inhibit the activity of serine palmitoyltransferase, the first enzyme of the pathway.  The inhibition of complex sphingolipid synthesis was reversible, and nearly normal labeling profiles were obtained 48 h after removing the mycotoxin.  These studies establish that fumonisin B1 inhibits de novo sphingolipid biosynthesis by neuronal cells and, moreover, that limiting ceramide synthesis differentially affects the formation of sphingomyelin vs. glycosphingolipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouHI-ry4l6y7Vg90H21EOLACvtfcHk0lhoxoQghkZVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1enurk%253D&md5=69e734d2e3b09551ae3cf78b22f7a606</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2819%2974249-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252819%252974249-5%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26aulast%3Dvan%2BEchten%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DFumonisin%2520b1%2520inhibits%2520sphingosine%2520%2528sphinganine%2529%2520n-acyltransferase%2520and%2520de%2520novo%2520sphingolipid%2520biosynthesis%2520in%2520cultured%2520neurons%2520in%2520situ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D27299%26epage%3D27306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humpf, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelz, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesper, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vales, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of n-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, ap1, and a new category of ceramide synthase inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span>,  <span class="NLM_fpage">19060</span>– <span class="NLM_lpage">19064</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.30.19060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.273.30.19060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9668088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=19060-19064&author=H.+U.+Humpfauthor=E.+M.+Schmelzauthor=F.+I.+Meredithauthor=H.+Vesperauthor=T.+R.+Valesauthor=E.+Wangauthor=D.+S.+Menaldinoauthor=D.+C.+Liottaauthor=A.+H.+Merrill&title=Acylation+of+naturally+occurring+and+synthetic+1-deoxysphinganines+by+ceramide+synthase.+Formation+of+n-palmitoyl-aminopentol+produces+a+toxic+metabolite+of+hydrolyzed+fumonisin%2C+ap1%2C+and+a+new+category+of+ceramide+synthase+inhibitor&doi=10.1074%2Fjbc.273.30.19060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase</span></div><div class="casAuthors">Humpf, Hans-Ulrich; Schmelz, Eva-Maria; Meredith, Filmore I.; Vesper, Hubert; Vales, Teresa R.; Wang, Elaine; Menaldino, David S.; Liotta, Dennis C.; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">19060-19064</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fumonisin B1 (FB1) is the predominant member of a family of mycotoxins produced by Fusarium moniliforme (Sheldon) and related fungi.  Certain foods also contain the aminopentol backbone (AP1) that is formed upon base hydrolysis of the ester-linked tricarballylic acids of FB1.  Both FB1 and, to a lesser extent, AP1 inhibit ceramide synthase due to structural similarities between fumonisins (as 1-deoxy-analogs of sphinganine) and sphingoid bases.  To explore these structure-function relationships further, erythro- and threo-2-amino, 3-hydroxy-(and 3,5-dihydroxy-) octadecanes were prepd. by highly stereoselective syntheses.  All of these analogs inhibit the acylation of sphingoid bases by ceramide synthase, and are themselves acylated with Vmax/Km of 40-125 for the erythro-isomers (compared with approx. 250 for D-erythro-sphinganine) and 4-6 for the threo-isomers.  Ceramide synthase also acylates AP1 (but not FB1, under the conditions tested) to N-palmitoyl-AP1 (PAP1) with a Vmax/Km of approx. 1.  The toxicity of the PAP1 was evaluated using HT29 cells, a human colonic cell line.  PAP1 was at least 10 times more toxic than FB1 or AP1 and caused sphinganine accumulation as an inhibitor of ceramide synthase.  These studies demonstrate that: the 1-hydroxyl group is not required for sphingoid bases to be acylated; both erythro- and threo-isomers are acylated with the highest apparent Vmax/Km for the erythro-analogs; and AP1 is acylated to PAP1, a new category of ceramide synthase inhibitor as well as a toxic metabolite that may play a role in the diseases caused by fumonisins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6kGeiahYbB7Vg90H21EOLACvtfcHk0lhoxoQghkZVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGrtLw%253D&md5=76349ef60303310823373e34e7fb268c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.30.19060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.30.19060%26sid%3Dliteratum%253Aachs%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DSchmelz%26aufirst%3DE.%2BM.%26aulast%3DMeredith%26aufirst%3DF.%2BI.%26aulast%3DVesper%26aufirst%3DH.%26aulast%3DVales%26aufirst%3DT.%2BR.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DAcylation%2520of%2520naturally%2520occurring%2520and%2520synthetic%25201-deoxysphinganines%2520by%2520ceramide%2520synthase.%2520Formation%2520of%2520n-palmitoyl-aminopentol%2520produces%2520a%2520toxic%2520metabolite%2520of%2520hydrolyzed%2520fumonisin%252C%2520ap1%252C%2520and%2520a%2520new%2520category%2520of%2520ceramide%2520synthase%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D19060%26epage%3D19064%26doi%3D10.1074%2Fjbc.273.30.19060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seiferlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpf, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullards, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegood, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merrill, A. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Hydrolyzed fumonisins hfb1 and hfb2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic n-acyl-metabolites</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1120</span>– <span class="NLM_lpage">1130</span>, <span class="refDoi"> DOI: 10.1002/mnfr.200700118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fmnfr.200700118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17729221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOnu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=1120-1130&author=M.+Seiferleinauthor=H.+U.+Humpfauthor=K.+A.+Vossauthor=M.+C.+Sullardsauthor=J.+C.+Allegoodauthor=E.+Wangauthor=A.+H.+Merrill&title=Hydrolyzed+fumonisins+hfb1+and+hfb2+are+acylated+in+vitro+and+in+vivo+by+ceramide+synthase+to+form+cytotoxic+n-acyl-metabolites&doi=10.1002%2Fmnfr.200700118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites</span></div><div class="casAuthors">Seiferlein, Michaela; Humpf, Hans-Ulrich; Voss, Kenneth A.; Sullards, M. Cameron; Allegood, Jeremy C.; Wang, Elaine; Merrill, Alfred H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Nutrition & Food Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1120-1130</span>CODEN:
                <span class="NLM_cas:coden">MNFRCV</span>;
        ISSN:<span class="NLM_cas:issn">1613-4125</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Fumonisins B1 and B2 (FB1 and FB2) are the most abundant members of the fumonisins - mycotoxins that are produced by Fusarium verticillioides and are natural inhibitors of ceramide synthase.  Their hydrolyzed forms, HFB1 and HFB2 (also called AP1 and AP2) are found in some foods, and they are not only inhibitors of ceramide synthase but also undergo acylation by this enzyme.  This study characterized the conversion of HFB1 and HFB2 by ceramide synthase to their resp. N-acylated metabolites using rat liver microsomes and palmitoyl-CoA or nervonoyl-CoA as cosubstrates, and examd. animals that had been dosed with hydrolyzed fumonisins to ascertain if acylation occurs in vivo.  Using an HPLC-MS/MS method that allowed the sensitive and selective detection of the acylation products, both HFB1 and HFB2 were found to be metabolized in vitro to nervonoyl- or palmitoyl-HFB1 and -HFB2 (i.e. C24:1-HFB1/2 and C16-HFB1/2, resp.).  The apparent vmax was considerably higher for formation of C24:1HFB1 (157 pmol/min/mg protein) than for formation of C16HFB1 (8.7 pmol/min/mg protein).  The acylation products also inhibited ceramide synthase and significantly reduced the no. of viable cells in an in vitro [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)] assay using a human colonic cell line (HT29).  Furthermore, HPLC-MS/MS anal. of tissues from rats given i.p. doses of HFB1 confirmed that formation of N-acyl-HFB1 occurs in vivo to produce metabolites with fatty acids of various chain lengths.  The contribution of acylated HFB1 and HFB2 metabolites to fumonisin toxicity in vivo warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaapec0eBA5rVg90H21EOLACvtfcHk0lhOFQiDEG_6Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOnu73L&md5=ea6b2934a8e0b9dc9d6f97294a233f5e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.200700118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.200700118%26sid%3Dliteratum%253Aachs%26aulast%3DSeiferlein%26aufirst%3DM.%26aulast%3DHumpf%26aufirst%3DH.%2BU.%26aulast%3DVoss%26aufirst%3DK.%2BA.%26aulast%3DSullards%26aufirst%3DM.%2BC.%26aulast%3DAllegood%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DMerrill%26aufirst%3DA.%2BH.%26atitle%3DHydrolyzed%2520fumonisins%2520hfb1%2520and%2520hfb2%2520are%2520acylated%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520ceramide%2520synthase%2520to%2520form%2520cytotoxic%2520n-acyl-metabolites%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2007%26volume%3D51%26spage%3D1120%26epage%3D1130%26doi%3D10.1002%2Fmnfr.200700118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of fumonisin b1-induced toxicities and its applications in the mechanism-based interventions</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2019.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.toxicon.2019.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31173793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFOru7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2019&pages=1-5&author=X.+Liuauthor=L.+Fanauthor=S.+Yinauthor=H.+Chenauthor=H.+Hu&title=Molecular+mechanisms+of+fumonisin+b1-induced+toxicities+and+its+applications+in+the+mechanism-based+interventions&doi=10.1016%2Fj.toxicon.2019.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of fumonisin B1-induced toxicities and its applications in the mechanism-based interventions</span></div><div class="casAuthors">Liu, Xiaoyi; Fan, Lihong; Yin, Shutao; Chen, Hui; Hu, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Fumonisin B1 (FB1), the most toxic member of fumonisins, is one of the most common mycotoxins contaminating feed and food.  It has been shown to produce pleiotropic toxicities in animals including neurotoxicity, hepatotoxicity and nephrotoxicity, and with highly potential impact on human health.  Proposed mechanisms include disruption of sphingolipid metab., induction of oxidative stress, activation of endoplasmic reticulum (ER) stress and MAPKs, modulation of autophagy and alteration of DNA methylation.  These mechanistic findings provide the theor. basis for effectively managing FB1-induced adverse health effects.  In this review, we will summarize the present understanding of the mol. basis underlying FB1-mediated toxicities, discuss the feasibility of developing mechanism-based approach to prevent FB1-induced toxicities, and suggest the issues that need to be addressed in the future in the field of FB1 toxicity-related studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXzP9N8LZflrVg90H21EOLACvtfcHk0lhOFQiDEG_6Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFOru7bE&md5=e197f334b855b06b4102341641cbbaaf</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2019.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2019.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DH.%26atitle%3DMolecular%2520mechanisms%2520of%2520fumonisin%2520b1-induced%2520toxicities%2520and%2520its%2520applications%2520in%2520the%2520mechanism-based%2520interventions%26jtitle%3DToxicon%26date%3D2019%26volume%3D167%26spage%3D1%26epage%3D5%26doi%3D10.1016%2Fj.toxicon.2019.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorshkova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skobeleva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudek, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzapoiazova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, V.</span></span> <span> </span><span class="NLM_article-title">Fty720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5477</span>, <span class="refDoi"> DOI: 10.1074/jbc.M805186200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M805186200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19119142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFSntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=5467-5477&author=E.+V.+Berdyshevauthor=I.+Gorshkovaauthor=A.+Skobelevaauthor=R.+Bittmanauthor=X.+Luauthor=S.+M.+Dudekauthor=T.+Mirzapoiazovaauthor=J.+G.+Garciaauthor=V.+Natarajan&title=Fty720+inhibits+ceramide+synthases+and+up-regulates+dihydrosphingosine+1-phosphate+formation+in+human+lung+endothelial+cells&doi=10.1074%2Fjbc.M805186200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells</span></div><div class="casAuthors">Berdyshev, Evgeny V.; Gorshkova, Irina; Skobeleva, Anastasia; Bittman, Robert; Lu, Xuequan; Dudek, Steven M.; Mirzapoiazova, Tamara; Garcia, Joe G. N.; Natarajan, Viswanathan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5467-5477</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Novel immunomodulatory mol. FTY720 is a synthetic analog of myriocin, but unlike myriocin FTY720 does not inhibit serine palmitoyltransferase.  Although many of the effects of FTY720 are ascribed to its phosphorylation and subsequent sphingosine 1-phosphate (S1P)-like action through S1P1,3-5 receptors, studies on modulation of intracellular balance of signaling sphingolipids by FTY720 are limited.  In this study, we used stable isotope pulse labeling of human pulmonary artery endothelial cells with L-[U-13C, 15N]serine as well as in vitro enzymic assays and liq. chromatog.-tandem mass spectrometry methodol. to characterize FTY720 interference with sphingolipid de novo biosynthesis.  In human pulmonary artery endothelial cells, FTY720 inhibited ceramide synthases, resulting in decreased cellular levels of dihydroceramides, ceramides, sphingosine, and S1P but increased levels of dihydrosphingosine and dihydrosphingosine 1-phosphate (DHS1P).  The FTY720-induced modulation of sphingolipid de novo biosynthesis was similar to that of fumonisin B1, a classical inhibitor of ceramide synthases, but differed in the efficiency to inhibit biosynthesis of short-chain vs. long-chain ceramides.  In vitro kinetic studies revealed that FTY720 is a competitive inhibitor of ceramide synthase 2 toward dihydrosphingosine with an apparent Ki of 2.15 μM.  FTY720-induced up-regulation of DHS1P level was mediated by sphingosine kinase (SphK) 1, but not SphK2, as confirmed by expts. using SphK1/2 silencing with small interfering RNA.  Our data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids.  These findings open a novel direction for therapeutic applications of FTY720 that focuses on inhibition of ceramide biosynthesis, ceramide-dependent signaling, and the up-regulation of DHS1P generation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbph9U9yevJ7Vg90H21EOLACvtfcHk0lhOFQiDEG_6Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFSntb0%253D&md5=49f070c74097290e88bf6691d731f921</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M805186200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M805186200%26sid%3Dliteratum%253Aachs%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DGorshkova%26aufirst%3DI.%26aulast%3DSkobeleva%26aufirst%3DA.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDudek%26aufirst%3DS.%2BM.%26aulast%3DMirzapoiazova%26aufirst%3DT.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DFty720%2520inhibits%2520ceramide%2520synthases%2520and%2520up-regulates%2520dihydrosphingosine%25201-phosphate%2520formation%2520in%2520human%2520lung%2520endothelial%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D5467%26epage%3D5477%26doi%3D10.1074%2Fjbc.M805186200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laviad, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Ceramide synthesis is modulated by the sphingosine analog fty720 via a mixture of uncompetitive and noncompetitive inhibition in an acyl-coa chain length-dependent manner</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">16090</span>– <span class="NLM_lpage">16098</span>, <span class="refDoi"> DOI: 10.1074/jbc.M807438200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M807438200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19357080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16090-16098&author=S.+Lahiriauthor=H.+Parkauthor=E.+L.+Laviadauthor=X.+Luauthor=R.+Bittmanauthor=A.+H.+Futerman&title=Ceramide+synthesis+is+modulated+by+the+sphingosine+analog+fty720+via+a+mixture+of+uncompetitive+and+noncompetitive+inhibition+in+an+acyl-coa+chain+length-dependent+manner&doi=10.1074%2Fjbc.M807438200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-dependent Manner</span></div><div class="casAuthors">Lahiri, Sujoy; Park, Hyejung; Laviad, Elad L.; Lu, Xuequan; Bittman, Robert; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16090-16098</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">FTY720, a sphingosine analog, is in clin. trials as an immunomodulator.  The biol. effects of FTY720 are believed to occur after its metab. to FTY720 phosphate.  However, very little is known about whether FTY720 can interact with and modulate the activity of other enzymes of sphingolipid metab.  We examd. the ability of FTY720 to modulate de novo ceramide synthesis.  In mammals, ceramide is synthesized by a family of six ceramide synthases, each of which utilizes a restricted subset of acyl-CoAs.  We show that FTY720 inhibits ceramide synthase activity in vitro by noncompetitive inhibition toward acyl-CoA and uncompetitive inhibition toward sphinganine; surprisingly, the efficacy of inhibition depends on the acyl-CoA chain length.  In cultured cells, FTY720 has a more complex effect, with ceramide synthesis inhibited at high (500 nM to 5 μM) but not low (<200 nM) sphinganine concns., consistent with FTY720 acting as an uncompetitive inhibitor toward sphinganine.  Finally, electrospray ionization-tandem mass spectrometry demonstrated, unexpectedly, elevated levels of ceramide, sphingomyelin, and hexosylceramides after incubation with FTY720.  Our data suggest a novel mechanism by which FTY720 might mediate some of its biol. effects, which may be of mechanistic significance for understanding its mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmh_8JR-P59bVg90H21EOLACvtfcHk0liiyqsqwADkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjsLc%253D&md5=d99d9cd44e82a228b028f501d15aa1c0</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M807438200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M807438200%26sid%3Dliteratum%253Aachs%26aulast%3DLahiri%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLaviad%26aufirst%3DE.%2BL.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DCeramide%2520synthesis%2520is%2520modulated%2520by%2520the%2520sphingosine%2520analog%2520fty720%2520via%2520a%2520mixture%2520of%2520uncompetitive%2520and%2520noncompetitive%2520inhibition%2520in%2520an%2520acyl-coa%2520chain%2520length-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D16090%26epage%3D16098%26doi%3D10.1074%2Fjbc.M807438200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span> <span> </span><span class="NLM_article-title">A fluorescent assay for ceramide synthase activity</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1701</span>– <span class="NLM_lpage">1707</span>, <span class="refDoi"> DOI: 10.1194/jlr.D025627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1194%2Fjlr.D025627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22661289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1701-1707&author=H.+J.+Kimauthor=Q.+Qiaoauthor=H.+D.+Toopauthor=J.+C.+Morrisauthor=A.+S.+Don&title=A+fluorescent+assay+for+ceramide+synthase+activity&doi=10.1194%2Fjlr.D025627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescent assay for ceramide synthase activity</span></div><div class="casAuthors">Kim, Hyun Joon; Qiao, Qiao; Toop, Hamish D.; Morris, Jonathan C.; Don, Anthony S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1701-1707</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">The sphingolipids are a diverse family of lipids with important roles in membrane compartmentalization, intracellular signaling, and cell-cell recognition.  The central sphingolipid metabolite is ceramide, formed by the transfer of a variable length fatty acid from CoA to a sphingoid base, generally sphingosine or dihydrosphingosine (sphinganine) in mammals.  This reaction is catalyzed by a family of 6 ceramide synthases (CerS1-6).  CerS activity is usually assayed using either radioactive substrates or LC-MS/MS.  Here, the authors describe a CerS assay with fluorescent, NBD-labeled sphinganine as substrate.  The assay is readily able to detect endogenous CerS activity when using amts. of cell or tissue homogenate protein that are lower than those reported for the radioactive assay, and the Km was essentially the same for NBD-sphinganine and unlabeled sphinganine, indicating that NBD-sphinganine is a good substrate for these enzymes.  Using this assay, the authors confirmed that the new clin. immunosuppressant, FTY 720, was a competitive inhibitor of CerS activity, and showed that inhibition required the compd.'s lipid tail and amine headgroup.  In summary, the authors describe a fluorescent assay for CerS activity that circumvents the need to use radioactive substrates, while being more accessible and inexpensive than LC-MS based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_c-FbSPLksbVg90H21EOLACvtfcHk0liiyqsqwADkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSqtLnF&md5=9817ad606b3839b0d039982e4d418e1c</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1194%2Fjlr.D025627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.D025627%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DQiao%26aufirst%3DQ.%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDon%26aufirst%3DA.%2BS.%26atitle%3DA%2520fluorescent%2520assay%2520for%2520ceramide%2520synthase%2520activity%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2012%26volume%3D53%26spage%3D1701%26epage%3D1707%26doi%3D10.1194%2Fjlr.D025627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prieschl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumruker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, K. R.</span></span> <span> </span><span class="NLM_article-title">The immune modulator fty720 targets sphingosine 1-phosphate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">21453</span>– <span class="NLM_lpage">21457</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200176200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+fty720+targets+sphingosine+1-phosphate+receptors&doi=10.1074%2Fjbc.C200176200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0liiyqsqwADkLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520fty720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457%26doi%3D10.1074%2Fjbc.C200176200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of analogs of aal(s) for use as ceramide synthase 1 inhibitors</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">11593</span>– <span class="NLM_lpage">11596</span>, <span class="refDoi"> DOI: 10.1039/C5OB01931A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1039%2FC5OB01931A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26535908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCms73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=11593-11596&author=H.+D.+Toopauthor=A.+S.+Donauthor=J.+C.+Morris&title=Synthesis+and+biological+evaluation+of+analogs+of+aal%28s%29+for+use+as+ceramide+synthase+1+inhibitors&doi=10.1039%2FC5OB01931A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of analogs of AAL(S) for use as ceramide synthase 1 inhibitors</span></div><div class="casAuthors">Toop, Hamish D.; Don, Anthony S.; Morris, Jonathan C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">11593-11596</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A convergent synthesis to access hydrophobic tail analogs and head group modifications of AAL(S) I is described.  The analogs synthesized were evaluated for their ability to inhibit ceramide synthase 1 and for their cytotoxicity in K562 cells.  Our results have identified inhibitors which are non-cytotoxic yet maintain CerS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBaCpRopafurVg90H21EOLACvtfcHk0ljF8NxSw5ONmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCms73O&md5=b202a76af3e1c25480596d1457238aad</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2FC5OB01931A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01931A%26sid%3Dliteratum%253Aachs%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DDon%26aufirst%3DA.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520analogs%2520of%2520aal%2528s%2529%2520for%2520use%2520as%2520ceramide%2520synthase%25201%2520inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D11593%26epage%3D11596%26doi%3D10.1039%2FC5OB01931A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiffmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birod, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiros, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zivkovic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of specific ceramide synthases</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2011.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.biochi.2011.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21945810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFGjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2012&pages=558-565&author=S.+Schiffmannauthor=D.+Hartmannauthor=S.+Fuchsauthor=K.+Birodauthor=N.+Ferreirosauthor=Y.+Schreiberauthor=A.+Zivkovicauthor=G.+Geisslingerauthor=S.+Groschauthor=H.+Stark&title=Inhibitors+of+specific+ceramide+synthases&doi=10.1016%2Fj.biochi.2011.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of specific ceramide synthases</span></div><div class="casAuthors">Schiffmann, Susanne; Hartmann, Daniela; Fuchs, Sina; Birod, Kerstin; Ferreiros, Nerea; Schreiber, Yannick; Zivkovic, Aleksandra; Geisslinger, Gerd; Groesch, Sabine; Stark, Holger</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">558-565</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Ceramide synthases (CerSs) are key enzymes in the biosynthesis of ceramides and display a group of at least six different isoenzymes (CerS1-6).  Ceramides itself are bioactive mols.  Ceramides with different N-acyl side chains (C14:0-Cer - C26:0-Cer) possess distinct roles in cell signaling.  Therefore, the selective inhibition of specific CerSs which are responsible for the formation of a specific ceramide holds promise for a no. of new clin. treatment strategies, e.g., cancer.  Here, we identified four of hitherto unknown functional inhibitors of CerSs derived from the FTY720 (Fingolimod) lead structure and showed their inhibitory effectiveness by two in vitro CerS activity assays.  Addnl., we tested the substances in two cell lines (HCT-116 and HeLa) with different ceramide patterns.  In summary, the in vitro activity assays revealed out that ST1058 and ST1074 preferentially inhibit CerS2 and CerS4, while ST1072 inhibits most potently CerS4 and CerS6.  Importantly, ST1060 inhibits predominately CerS2.  First structure-activity relationships and the potential biol. impact of these compds. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIGghUZw85hLVg90H21EOLACvtfcHk0ljF8NxSw5ONmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFGjtA%253D%253D&md5=af3943b0158723198aee511587440c2e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2011.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2011.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffmann%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DBirod%26aufirst%3DK.%26aulast%3DFerreiros%26aufirst%3DN.%26aulast%3DSchreiber%26aufirst%3DY.%26aulast%3DZivkovic%26aufirst%3DA.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DGrosch%26aufirst%3DS.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520specific%2520ceramide%2520synthases%26jtitle%3DBiochimie%26date%3D2012%26volume%3D94%26spage%3D558%26epage%3D565%26doi%3D10.1016%2Fj.biochi.2011.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toop, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiveash, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindaraju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwen, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couttas, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoehn, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz-Peiffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, A. S.</span></span> <span> </span><span class="NLM_article-title">A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3165</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05613-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs41467-018-05613-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30131496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BB3c3gsVOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3165&author=N.+Turnerauthor=X.+Y.+Limauthor=H.+D.+Toopauthor=B.+Osborneauthor=A.+E.+Brandonauthor=E.+N.+Taylorauthor=C.+E.+Fiveashauthor=H.+Govindarajuauthor=J.+D.+Teoauthor=H.+P.+McEwenauthor=T.+A.+Couttasauthor=S.+M.+Butlerauthor=A.+Dasauthor=G.+M.+Kowalskiauthor=C.+R.+Bruceauthor=K.+L.+Hoehnauthor=T.+Fathauthor=C.+Schmitz-Peifferauthor=G.+J.+Cooneyauthor=M.+K.+Montgomeryauthor=J.+C.+Morrisauthor=A.+S.+Don&title=A+selective+inhibitor+of+ceramide+synthase+1+reveals+a+novel+role+in+fat+metabolism&doi=10.1038%2Fs41467-018-05613-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism</span></div><div class="casAuthors">Turner Nigel; Osborne Brenna; Fiveash Corrine E; Govindaraju Hemna; Das Abhirup; Fath Thomas; Montgomery Magdalene K; Lim Xin Ying; Lim Xin Ying; Teo Jonathan D; McEwen Holly P; Couttas Timothy A; Don Anthony S; Toop Hamish D; Taylor Elysha N; Butler Stephen M; Morris Jonathan C; Brandon Amanda E; Cooney Gregory J; Kowalski Greg M; Bruce Clinton R; Hoehn Kyle L; Fath Thomas; Schmitz-Peiffer Carsten; Don Anthony S</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3165</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology.  Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue.  C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans.  We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency.  Lipidomic profiling shows that P053 is highly selective for CerS1.  Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance.  Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR03VZRArx4bCCEBeYuoi7AfW6udTcc2eZYMvg3Id4SHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3gsVOitQ%253D%253D&md5=63ddf6f40e9a100f077917167d27517f</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05613-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05613-7%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DN.%26aulast%3DLim%26aufirst%3DX.%2BY.%26aulast%3DToop%26aufirst%3DH.%2BD.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DBrandon%26aufirst%3DA.%2BE.%26aulast%3DTaylor%26aufirst%3DE.%2BN.%26aulast%3DFiveash%26aufirst%3DC.%2BE.%26aulast%3DGovindaraju%26aufirst%3DH.%26aulast%3DTeo%26aufirst%3DJ.%2BD.%26aulast%3DMcEwen%26aufirst%3DH.%2BP.%26aulast%3DCouttas%26aufirst%3DT.%2BA.%26aulast%3DButler%26aufirst%3DS.%2BM.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DKowalski%26aufirst%3DG.%2BM.%26aulast%3DBruce%26aufirst%3DC.%2BR.%26aulast%3DHoehn%26aufirst%3DK.%2BL.%26aulast%3DFath%26aufirst%3DT.%26aulast%3DSchmitz-Peiffer%26aufirst%3DC.%26aulast%3DCooney%26aufirst%3DG.%2BJ.%26aulast%3DMontgomery%26aufirst%3DM.%2BK.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DDon%26aufirst%3DA.%2BS.%26atitle%3DA%2520selective%2520inhibitor%2520of%2520ceramide%2520synthase%25201%2520reveals%2520a%2520novel%2520role%2520in%2520fat%2520metabolism%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3165%26doi%3D10.1038%2Fs41467-018-05613-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanani, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, B.</span></span> <span> </span><span class="NLM_article-title">The many faces (and phases) of ceramide and sphingomyelin i - single lipids</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1007/s12551-017-0297-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12551-017-0297-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28815463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGktLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=589-600&author=M.+L.+Fananiauthor=B.+Maggio&title=The+many+faces+%28and+phases%29+of+ceramide+and+sphingomyelin+i+-+single+lipids&doi=10.1007%2Fs12551-017-0297-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces (and phases) of ceramide and sphingomyelin I - single lipids</span></div><div class="casAuthors">Fanani, Maria Laura; Maggio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">589-600</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ceramides, the simplest kind of two-chained sphingolipids, contain a single hydroxyl group in position 1 of the sphingoid base.  Sphingomyelins further contain a phosphocholine group at the OH of position 1 of ceramide.  Ceramides and sphingomyelins show a variety of species depending on the fatty acyl chain length, hydroxylation, and unsatn.  Because of the relatively high transition temp. of sphingomyelin compared to lecithin and, particularly, of ceramides with 16:0-18:0 satd. chains, a widespread idea on their functional importance refers to formation of rather solid domains enriched in sphingomyelin and ceramide.  Frequently, and esp. in the cell biol. field, these are generally (and erroneously) assumed to occur irresp. on the type of N-acyl chain in these lipids.  This is because most studies indicating such condensed ordered domains employed sphingolipids with acyl chains with 16 carbons while scarce attention has been focused on the influence of the N-acyl chain on their surface properties.  However, abundant evidence has shown that variations of the N-acyl chain length in ceramides and sphingomyelins markedly affect their phase state, interfacial elasticity, surface topog., electrostatics and miscibility and that, even the usually conceived "condensed" sphingolipids and many of their mixts., may exhibit liq.-like expanded states.  This review is a summarized overview of our work and of related others on some facts regarding membranes composed of single mol. species of ceramide and sphingomyelin.  A second part is dedicated to discuss the miscibility properties between species of sphingolipids that differ in N-acyl and oligosaccharide chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6x7s45I54GrVg90H21EOLACvtfcHk0lgDq2RNx-7DbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGktLfN&md5=84be6833a8b26a97c1d44f38b532e185</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs12551-017-0297-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-017-0297-z%26sid%3Dliteratum%253Aachs%26aulast%3DFanani%26aufirst%3DM.%2BL.%26aulast%3DMaggio%26aufirst%3DB.%26atitle%3DThe%2520many%2520faces%2520%2528and%2520phases%2529%2520of%2520ceramide%2520and%2520sphingomyelin%2520i%2520-%2520single%2520lipids%26jtitle%3DBiophys.%2520Rev.%26date%3D2017%26volume%3D9%26spage%3D589%26epage%3D600%26doi%3D10.1007%2Fs12551-017-0297-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fanani, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, B.</span></span> <span> </span><span class="NLM_article-title">The many faces (and phases) of ceramide and sphingomyelin ii - binary mixtures</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1007/s12551-017-0298-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12551-017-0298-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28823080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKnu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=601-616&author=M.+L.+Fananiauthor=B.+Maggio&title=The+many+faces+%28and+phases%29+of+ceramide+and+sphingomyelin+ii+-+binary+mixtures&doi=10.1007%2Fs12551-017-0298-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces (and phases) of ceramide and sphingomyelin II - binary mixtures</span></div><div class="casAuthors">Fanani, Maria Laura; Maggio, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">601-616</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A rather widespread idea on the functional importance of sphingolipids in cell membranes refers to the occurrence of ordered domains enriched in sphingomyelin and ceramide that are largely assumed to exist irresp. of the type of N-acyl chain in the sphingolipid.  Ceramides and sphingomyelins are the simplest kind of two-chained sphingolipids and show a variety of species, depending on the fatty acyl chain length, hydroxylation, and unsatn.  Abundant evidences have shown that variations of the N-acyl chain length in ceramides and sphingomyelins markedly affect their phase state, interfacial elasticity, surface topog., electrostatics, and miscibility, and that even the usually conceived "condensed" sphingolipids and many of their mixts. may exhibit liq.-like expanded states.  Their lateral miscibility properties are subtlety regulated by those chem. differences.  Even between ceramides with different acyl chain length, their partial miscibility is responsible for a rich two-dimensional structural variety that impacts on the membrane properties at the mesoscale level.  In this review, we will discuss the miscibility properties of ceramide, sphingomyelin, and glycosphingolipids that differ in their N-acyl or oligosaccharide chains.  This work is a second part that accompanies a previous overview of the properties of membranes formed by pure ceramides or sphingomyelins, which is also included in this Special Issue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojAAaFL6j0n7Vg90H21EOLACvtfcHk0lgDq2RNx-7DbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKnu73K&md5=adf7ac565f4ed4e7c490e9d3e19a9bc2</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs12551-017-0298-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-017-0298-y%26sid%3Dliteratum%253Aachs%26aulast%3DFanani%26aufirst%3DM.%2BL.%26aulast%3DMaggio%26aufirst%3DB.%26atitle%3DThe%2520many%2520faces%2520%2528and%2520phases%2529%2520of%2520ceramide%2520and%2520sphingomyelin%2520ii%2520-%2520binary%2520mixtures%26jtitle%3DBiophys.%2520Rev.%26date%3D2017%26volume%3D9%26spage%3D601%26epage%3D616%26doi%3D10.1007%2Fs12551-017-0298-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Meer, G.</span></span> <span> </span><span class="NLM_article-title">Lipid traffic in animal cells</span>. <i>Annu. Rev. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1146/annurev.cb.05.110189.001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1146%2Fannurev.cb.05.110189.001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2688705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3cXjtlOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1989&pages=247-275&author=G.+van%0AMeer&title=Lipid+traffic+in+animal+cells&doi=10.1146%2Fannurev.cb.05.110189.001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid traffic in animal cells</span></div><div class="casAuthors">Van Meer, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell Biology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-75</span>CODEN:
                <span class="NLM_cas:coden">ARCBE2</span>;
        ISSN:<span class="NLM_cas:issn">0743-4634</span>.
    </div><div class="casAbstract">A review, with ∼130 refs., of lipid traffic in animal cells, sites of lipid sorting events for generating the distribution in different organelles, and mechanisms of lipid sorting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeLUW76FBt4rVg90H21EOLACvtfcHk0lgDq2RNx-7DbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtlOhuw%253D%253D&md5=da040ac35b58f53164f9ce140b4c5f6b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cb.05.110189.001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cb.05.110189.001335%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeer%26aufirst%3DG.%26atitle%3DLipid%2520traffic%2520in%2520animal%2520cells%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Biol.%26date%3D1989%26volume%3D5%26spage%3D247%26epage%3D275%26doi%3D10.1146%2Fannurev.cb.05.110189.001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goni, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, A.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelinases: Enzymology and membrane activity</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>531</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(02)03482-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0014-5793%2802%2903482-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12401200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVOjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=531&publication_year=2002&pages=38-46&author=F.+M.+Goniauthor=A.+Alonso&title=Sphingomyelinases%3A+Enzymology+and+membrane+activity&doi=10.1016%2FS0014-5793%2802%2903482-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelinases: enzymology and membrane activity</span></div><div class="casAuthors">Goni, Felix M.; Alonso, Alicia</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">531</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-46</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review and discussion with 112 refs., of sphingomyelinase properties, catalytic mechanism, and membrane interactions.  Six types of sphingomyelinases are considered, namely acidic, secretory, Mg2+-dependent neutral, Mg2+-independent neutral, alk., and bacterial enzymes with both phospholipase C and sphingomyelinase activity.  Sphingomyelinase assay methods and specific inhibitors are also reviewed.  Kinetic and mechanistic studies are summarized, and a kinetic model and a general-base catalytic mechanism are proposed.  Sphingomyelinase-membrane interactions are considered from the point of view of the influence of lipids on enzyme activity.  Moreover, the effects of sphingomyelinase activity on membrane architecture (increased membrane permeability, membrane aggregation, and fusion) are described.  Finally, a no. of open questions on the above topics are enunciated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB1kb-CrYn6rVg90H21EOLACvtfcHk0lgDq2RNx-7DbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVOjtLo%253D&md5=0486ffeff663dd86a0001893a1454608</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2802%2903482-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252802%252903482-8%26sid%3Dliteratum%253Aachs%26aulast%3DGoni%26aufirst%3DF.%2BM.%26aulast%3DAlonso%26aufirst%3DA.%26atitle%3DSphingomyelinases%253A%2520Enzymology%2520and%2520membrane%2520activity%26jtitle%3DFEBS%2520Lett.%26date%3D2002%26volume%3D531%26spage%3D38%26epage%3D46%26doi%3D10.1016%2FS0014-5793%2802%2903482-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuchman, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desnick, R. J.</span></span> <span> </span><span class="NLM_article-title">Types a and b niemann-pick disease</span>. <i>Mol. Genet. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.ymgme.2016.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ymgme.2016.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28164782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1ersbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2017&pages=27-33&author=E.+H.+Schuchmanauthor=R.+J.+Desnick&title=Types+a+and+b+niemann-pick+disease&doi=10.1016%2Fj.ymgme.2016.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Types A and B Niemann-Pick disease</span></div><div class="casAuthors">Schuchman, Edward H.; Desnick, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-33</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The eponym Niemann-Pick disease (NPD) refers to a group of patients who present with varying degrees of lipid storage and foam cell infiltration in tissues, as well as overlapping clin. features including hepatosplenomegaly, pulmonary insufficiency and/or central nervous system (CNS) involvement.  Due to the pioneering work of Roscoe Brady and co-workers, we now know that there are two distinct metabolic abnormalities that account for NPD.  The first is due to the deficient activity of the enzyme acid sphingomyelinase (ASM; "types A & B" NPD), and the second is due to defective function in cholesterol transport ("type C" NPD).  Herein only types A and B NPD will be discussed.  Type A NPD patients exhibit hepatosplenomegaly in infancy and profound CNS involvement.  They rarely survive beyond 2-3 years of age.  Type B patients also have hepatosplenomegaly and pathol. alterations of their lungs, but there are usually no CNS signs.  The age of onset and rate of disease progression varies greatly among type B patients, and they frequently live into adulthood.  Intermediate patients also have been reported with mild to moderate neurol. findings.  All patients with types A and B NPD have mutations in the gene encoding ASM (SMPD1), and thus the disease is more accurately referred to as ASM deficiency (ASMD).  Herein we will review the clin., pathol., biochem., and genetic findings in types A and B NPD, and emphasize the seminal contributions of Dr. Brady to this disease.  We will also discuss the current status of therapy for this disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUy0fwGlQM7Vg90H21EOLACvtfcHk0lh69drpuHdjlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1ersbY%253D&md5=444d00f998e4c82d08a243514a41ac56</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2016.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DSchuchman%26aufirst%3DE.%2BH.%26aulast%3DDesnick%26aufirst%3DR.%2BJ.%26atitle%3DTypes%2520a%2520and%2520b%2520niemann-pick%2520disease%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2017%26volume%3D120%26spage%3D27%26epage%3D33%26doi%3D10.1016%2Fj.ymgme.2016.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of mammalian acid sphingomyelinase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12196</span>, <span class="refDoi"> DOI: 10.1038/ncomms12196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fncomms12196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27435900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksVelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12196&author=A.+Gorelikauthor=K.+Illesauthor=L.+X.+Heinzauthor=G.+Superti-Furgaauthor=B.+Nagar&title=Crystal+structure+of+mammalian+acid+sphingomyelinase&doi=10.1038%2Fncomms12196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of mammalian acid sphingomyelinase</span></div><div class="casAuthors">Gorelik, Alexei; Illes, Katalin; Heinz, Leonhard X.; Superti-Furga, Giulio; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12196</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASMase, ASM, SMPD1) converts sphingomyelin into ceramide, modulating membrane properties and signal transduction.  Inactivating mutations in ASMase cause Niemann-Pick disease, and its inhibition is also beneficial in models of depression and cancer.  To gain a better understanding of this crit. therapeutic target, we detd. crystal structures of mammalian ASMase in various conformations.  The catalytic domain adopts a calcineurin-like fold with two zinc ions and a hydrophobic track leading to the active site.  Strikingly, the membrane interacting saposin domain assumes either a closed globular conformation independent from the catalytic domain, or an open conformation, which establishes an interface with the catalytic domain essential for activity.  Structural mapping of Niemann-Pick mutations reveals that most of them likely destabilize the protein's fold.  This study sheds light on the mol. mechanism of ASMase function, and provides a platform for the rational development of ASMase inhibitors and therapeutic use of recombinant ASMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGridMh3_0b9ArVg90H21EOLACvtfcHk0lh69drpuHdjlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksVelt70%253D&md5=5f2284adc9619117853e2b0c2a06c635</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fncomms12196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12196%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DHeinz%26aufirst%3DL.%2BX.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520of%2520mammalian%2520acid%2520sphingomyelinase%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12196%26doi%3D10.1038%2Fncomms12196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prive, G. G.</span></span> <span> </span><span class="NLM_article-title">Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">3026</span>– <span class="NLM_lpage">3042</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2016.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.jmb.2016.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27349982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyntLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2016&pages=3026-3042&author=Z.+J.+Xiongauthor=J.+Huangauthor=G.+Podaauthor=R.+Pomesauthor=G.+G.+Prive&title=Structure+of+human+acid+sphingomyelinase+reveals+the+role+of+the+saposin+domain+in+activating+substrate+hydrolysis&doi=10.1016%2Fj.jmb.2016.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis</span></div><div class="casAuthors">Xiong, Zi-Jian; Huang, Jingjing; Poda, Gennady; Pomes, Regis; Prive, Gilbert G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3026-3042</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (I) is a lysosomal phosphodiesterase that catalyzes the hydrolysis of sphingomyelin to produce ceramide and phosphocholine.  While other lysosomal sphingolipid hydrolases require a saposin activator protein for full activity, the I polypeptide incorporates a built-in N-terminal saposin domain and does not require an external activator protein.  Here, the authors report the crystal structure of human I and describe the organization of the 3 main regions of the enzyme: the N-terminal saposin domain, the proline-rich connector, and the catalytic domain.  The saposin domain was tightly assocd. along an edge of the large, bowl-shaped catalytic domain and adopted an open form that exposed a hydrophobic concave surface ∼30 Å from the catalytic center.  The calcd. electrostatic potential of the enzyme was electropos. at the acidic pH of the lysosome, consistent with the strict requirement for the presence of acidic lipids in target membranes.  Mol. docking studies indicated that sphingomyelin binds with the ceramide-phosphate group positioned at the binuclear Zn center and mol. dynamics simulations indicated that the intrinsic flexibility of the saposin domain was important for monomer-dimer exchange and for membrane interactions.  Overall, I uses a combination of electrostatic and hydrophobic interactions to cause local disruptions of target bilayers in order to bring the lipid headgroup to the catalytic center in a membrane-bound reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoll53c_B4LEbVg90H21EOLACvtfcHk0lh69drpuHdjlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyntLbF&md5=852a00d567e604849f7ca517f261ea97</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2016.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2016.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DZ.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DPoda%26aufirst%3DG.%26aulast%3DPomes%26aufirst%3DR.%26aulast%3DPrive%26aufirst%3DG.%2BG.%26atitle%3DStructure%2520of%2520human%2520acid%2520sphingomyelinase%2520reveals%2520the%2520role%2520of%2520the%2520saposin%2520domain%2520in%2520activating%2520substrate%2520hydrolysis%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D428%26spage%3D3026%26epage%3D3042%26doi%3D10.1016%2Fj.jmb.2016.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metcalf, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R. R.</span></span> <span> </span><span class="NLM_article-title">Human acid sphingomyelinase structures provide insight to molecular basis of niemann-pick disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13082</span>, <span class="refDoi"> DOI: 10.1038/ncomms13082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fncomms13082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27725636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GnurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13082&author=Y.+F.+Zhouauthor=M.+C.+Metcalfauthor=S.+C.+Garmanauthor=T.+Edmundsauthor=H.+Qiuauthor=R.+R.+Wei&title=Human+acid+sphingomyelinase+structures+provide+insight+to+molecular+basis+of+niemann-pick+disease&doi=10.1038%2Fncomms13082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease</span></div><div class="casAuthors">Zhou, Yan-Feng; Metcalf, Matthew C.; Garman, Scott C.; Edmunds, Tim; Qiu, Huawei; Wei, Ronnie R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13082</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and phosphocholine, essential components of myelin in neurons.  Genetic alterations in ASM lead to ASM deficiency (ASMD) and have been linked to Niemann-Pick disease types A and B.  Olipudase alfa, a recombinant form of human ASM, is being developed as enzyme replacement therapy to treat the non-neurol. manifestations of ASMD.  Here we present the human ASM holoenzyme and product bound structures encompassing all of the functional domains.  The catalytic domain has a metallophosphatase fold, and two zinc ions and one reaction product phosphocholine are identified in a histidine-rich active site.  The structures reveal the underlying catalytic mechanism, in which two zinc ions activate a water mol. for nucleophilic attack of the phosphodiester bond.  Docking of sphingomyelin provides a model that allows insight into the selectivity of the enzyme and how the ASM domains collaborate to complete hydrolysis.  Mapping of known mutations provides a basic understanding on correlations between enzyme dysfunction and phenotypes obsd. in ASMD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0JJXSvWY4rVg90H21EOLACvtfcHk0lhiHUJ_Ua3Hyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GnurjP&md5=4128c3df4585ba86a2eee9adf2a602d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fncomms13082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13082%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BF.%26aulast%3DMetcalf%26aufirst%3DM.%2BC.%26aulast%3DGarman%26aufirst%3DS.%2BC.%26aulast%3DEdmunds%26aufirst%3DT.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DR.%2BR.%26atitle%3DHuman%2520acid%2520sphingomyelinase%2520structures%2520provide%2520insight%2520to%2520molecular%2520basis%2520of%2520niemann-pick%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13082%26doi%3D10.1038%2Fncomms13082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span> <span> </span><span class="NLM_article-title">Changes in brain hydrolytic enzyme activities in rats treated with cholesterol biosynthesis inhibitor, ay9944</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(75)90685-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0006-8993%2875%2990685-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=48406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE2MXlt1KqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1975&pages=97-114&author=M.+Igarashiauthor=K.+Suzukiauthor=S.+M.+Chenauthor=K.+Suzuki&title=Changes+in+brain+hydrolytic+enzyme+activities+in+rats+treated+with+cholesterol+biosynthesis+inhibitor%2C+ay9944&doi=10.1016%2F0006-8993%2875%2990685-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in brain hydrolytic enzyme activities in rats treated with the cholesterol biosynthesis inhibitor, AY9944</span></div><div class="casAuthors">Igarashi, Masahiro; Suzuki, Kinuko; Chen, Shih M.; Suzuki, Kunihiko</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-114</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">In 5-day-old rats, AY9944 (I) [366-93-8] (30 mg/kg, for 30 days, i.p.) increased the activities of 13 brain hydrolytic enzymes reaching a peak in 15-25 day-old rats and corresponding to the max. appearance of neuronal inclusions and degenerating oligodendroglia.  Despite the continued administration of I and a high tissue concn. of 7-dehydrocholesterol [434-16-2] most enzyme activities declined after 25 days to steady levels somewhat higher than the controls.  In 5-, 15-, 25-, and 35-day-old rats which received injections for 10 days, enzyme activities reached a peak at the end of the injections and then rapidly returned to normal within 10 days thereafter, corresponding to the appearance and disappearance of the abnormal inclusions.  However 7-dehydrocholesterol continued to increase for 10 days after drug administration was discontinued.  I had no direct effect on any of the enzymes in vitro.  Apparently, lysosomal activation occurred concomitantly with the formation of I-induced abnormal neuronal inclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU-gx72Lj7_7Vg90H21EOLACvtfcHk0lhiHUJ_Ua3Hyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXlt1KqsLw%253D&md5=4fb403e7a542e9df2ea87a7f7fc4b5b2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2875%2990685-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252875%252990685-X%26sid%3Dliteratum%253Aachs%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%2BM.%26aulast%3DSuzuki%26aufirst%3DK.%26atitle%3DChanges%2520in%2520brain%2520hydrolytic%2520enzyme%2520activities%2520in%2520rats%2520treated%2520with%2520cholesterol%2520biosynthesis%2520inhibitor%252C%2520ay9944%26jtitle%3DBrain%2520Res.%26date%3D1975%26volume%3D90%26spage%3D97%26epage%3D114%26doi%3D10.1016%2F0006-8993%2875%2990685-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, M.</span></span> <span> </span><span class="NLM_article-title">Niemann-pick disease-like inclusions caused by a hypocholesteremic agent</span>. <i>Invest. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=62729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADyaE2s%252FltVygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1976&pages=1022-1027&author=M.+Sakuragawa&title=Niemann-pick+disease-like+inclusions+caused+by+a+hypocholesteremic+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Niemann-Pick disease-like inclusions caused by a hypocholesteremic agent</span></div><div class="casAuthors">Sakuragawa M</div><div class="citationInfo"><span class="NLM_cas:title">Investigative ophthalmology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1022-7</span>
        ISSN:<span class="NLM_cas:issn">0020-9988</span>.
    </div><div class="casAbstract">AY9944, an inhibitor of cholesterol biosynthesis, was injected into albino rats and the ocular tissue was studied by light and electron microscopy.  Abundant lamellar inclusion bodies accumulated in various cells of the eye, especially in the ganglion cells of the retina and glial cells of the optic nerve.  Prolonged administration of this drug resulted in degeneration of retinal ganglion cells and oligodendroglial cells of the optic nerve.  Micro-organelles of the inclusion body-laden cells were otherwise normal in their appearance.  The electron microscopic appearance of these inclusion bodies and their distribution in the ocular tissues closely resembled those of Niemann-Pick diseasees.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_s-GqsofmyDAyhZbj3lKdfW6udTcc2eadgNZlb5tWRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2s%252FltVygtA%253D%253D&md5=9fd6d4719692781a78d401bde0456b80</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakuragawa%26aufirst%3DM.%26atitle%3DNiemann-pick%2520disease-like%2520inclusions%2520caused%2520by%2520a%2520hypocholesteremic%2520agent%26jtitle%3DInvest.%2520Ophthalmol.%26date%3D1976%26volume%3D15%26spage%3D1022%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentchev, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barranger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. O.</span></span> <span> </span><span class="NLM_article-title">Niemann-pick disease experimental model: Sphingomyelinase reduction induced by ay-9944</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1126/science.66749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1126%2Fscience.66749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=66749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaE2sXhs1yqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=1977&pages=317-319&author=N.+Sakuragawaauthor=M.+Sakuragawauthor=T.+Kuwabaraauthor=P.+G.+Pentchevauthor=J.+A.+Barrangerauthor=R.+O.+Brady&title=Niemann-pick+disease+experimental+model%3A+Sphingomyelinase+reduction+induced+by+ay-9944&doi=10.1126%2Fscience.66749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Niemann-pick disease experimental model:  sphingomyelinase reduction induced by AY-9944</span></div><div class="casAuthors">Sakuragawa, Norio; Sakuragawa, Machiko; Kuwabara, Toichiro; Pentchev, Peter G.; Barranger, John A.; Brady, Roscoe O.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">4287</span>),
    <span class="NLM_cas:pages">317-19</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Organs of rats treated with the drug AY-9944 (trans-1,4-bis(2-chlorobenzylaminomethyl)cyclohexane dihydrochloride), causing symptoms similar to those in Niemann-Pick disease, for 5 days showed a redn. in sphingomyelinase activity.  This redn. may be due to impaired enzyme synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlu-9NFLoDRbVg90H21EOLACvtfcHk0lhiHUJ_Ua3Hyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhs1yqtb4%253D&md5=9fee57b589110d543b8ce7ad8cef7910</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.66749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.66749%26sid%3Dliteratum%253Aachs%26aulast%3DSakuragawa%26aufirst%3DN.%26aulast%3DSakuragaw%26aufirst%3DM.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DPentchev%26aufirst%3DP.%2BG.%26aulast%3DBarranger%26aufirst%3DJ.%2BA.%26aulast%3DBrady%26aufirst%3DR.%2BO.%26atitle%3DNiemann-pick%2520disease%2520experimental%2520model%253A%2520Sphingomyelinase%2520reduction%2520induced%2520by%2520ay-9944%26jtitle%3DScience%26date%3D1977%26volume%3D196%26spage%3D317%26epage%3D319%26doi%3D10.1126%2Fscience.66749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albouz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauw, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berwald-Netter, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourdon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, N.</span></span> <span> </span><span class="NLM_article-title">Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures</span>. <i>Biomedicine</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000155973" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=6285997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL38XksV2gsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1981&pages=218-220&author=S.+Albouzauthor=J.+J.+Hauwauthor=Y.+Berwald-Netterauthor=J.+M.+Boutryauthor=R.+Bourdonauthor=N.+Baumann&title=Tricyclic+antidepressants+induce+sphingomyelinase+deficiency+in+fibroblast+and+neuroblastoma+cell+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures</span></div><div class="casAuthors">Albouz, S.; Hauw, J. J.; Berwald-Netter, Y.; Boutry, J. M.; Bourdon, R.; Baumann, N.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine Express</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">218-20</span>CODEN:
                <span class="NLM_cas:coden">BMEXBH</span>;
        ISSN:<span class="NLM_cas:issn">0300-0885</span>.
    </div><div class="casAbstract">Tricyclic antidepressants (imipramine (I)  [50-49-7] and desipramine  [50-47-5]) gave rise to an important decrease of sphingomyelinase  [9031-54-3] activity in murine neuroblastoma and human fibroblast cell cultures.  It occurred within 1 to 2 h at a final concn. of 1 or 2 × 10-5 M in cell culture medium.  Other lysosomal enzymes such as acid lipase, arylsulfatases A and B and hexosaminidases were not modified.  Low level of sphingomyelinase activity may be related to the amphiphilic characteristics of the drugs; iminodibenzyl  [494-19-9] which has the same tricyclic core but is devoid of the side chain necessary for amphiphilic properties had no effect.  As iminodibenzyl has no therapeutic action, amphiphilicity may be requisite to antidepressant properties of tricyclic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDg6WWOf2N7Vg90H21EOLACvtfcHk0lj_HncO9IY75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XksV2gsLk%253D&md5=7adddf6acea3f0042968fb7e0535f4f2</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1159%2F000155973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000155973%26sid%3Dliteratum%253Aachs%26aulast%3DAlbouz%26aufirst%3DS.%26aulast%3DHauw%26aufirst%3DJ.%2BJ.%26aulast%3DBerwald-Netter%26aufirst%3DY.%26aulast%3DBoutry%26aufirst%3DJ.%2BM.%26aulast%3DBourdon%26aufirst%3DR.%26aulast%3DBaumann%26aufirst%3DN.%26atitle%3DTricyclic%2520antidepressants%2520induce%2520sphingomyelinase%2520deficiency%2520in%2520fibroblast%2520and%2520neuroblastoma%2520cell%2520cultures%26jtitle%3DBiomedicine%26date%3D1981%26volume%3D35%26spage%3D218%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuragawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoyoshi, E.</span></span> <span> </span><span class="NLM_article-title">Reduction of acid sphingomyelinase activity in human fibroblasts induced by ay-9944 and other cationic amphiphilic drugs</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a135438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1093%2Foxfordjournals.jbchem.a135438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2419314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL28XmtFylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1985&pages=1669-1679&author=Y.+Yoshidaauthor=K.+Arimotoauthor=M.+Satoauthor=N.+Sakuragawaauthor=M.+Arimaauthor=E.+Satoyoshi&title=Reduction+of+acid+sphingomyelinase+activity+in+human+fibroblasts+induced+by+ay-9944+and+other+cationic+amphiphilic+drugs&doi=10.1093%2Foxfordjournals.jbchem.a135438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs</span></div><div class="casAuthors">Yoshida, Yutaka; Arimoto, Kiyoshi; Sato, Mitsuru; Sakuragawa, Norio; Arima, Masataka; Satoyoshi, Eijiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-79</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">AY-9944 (I)  [366-93-8], a cationic amphiphilic drug, caused a rapid, irreversible and concn.-dependent redn. of acid sphingomyelinase(EC 3.1.4.12)  [9031-54-3] activity in normal human fibroblasts without changing the activities of other lysosomal hydrolases tested.  Examns. of activities against synthetic substrates and of the pH dependency of sphingomyelinase in the drug-treated cells also suggested that the redn. of activity was specific to acid sphingomyelinase.  Such a specific redn. was also found with 12 other cationic amphiphilic drugs, most of which are inducers of exptl. phospholipidosis in animals and/or cultured cells.  These results strongly suggest that acid sphingomyelinase is involved in the process of drug-induced lipidosis.  The redn. of acid sphingomyelinase seemed not to be due to direct inhibition by these drugs, a specific loss of the enzyme into the culture medium, the presence of inhibitor in the drug-treated cells, or impaired synthesis of the enzyme.  There was no indication that changes in the catalytic properties of the enzyme or changes in its requirement for detergents for activity occurred in the cell.  AY-9944 and other cationic amphiphilic drugs may cause redn. of acid sphingomyelinase activity by inducing an increased rate of degrdn. of the enzyme or by causing an irreversible inactivation via some undetected factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFaESClCA37Vg90H21EOLACvtfcHk0lj_HncO9IY75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmtFylsg%253D%253D&md5=3b1553ca4af524b30386b8df3058b383</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a135438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a135438%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DArimoto%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSakuragawa%26aufirst%3DN.%26aulast%3DArima%26aufirst%3DM.%26aulast%3DSatoyoshi%26aufirst%3DE.%26atitle%3DReduction%2520of%2520acid%2520sphingomyelinase%2520activity%2520in%2520human%2520fibroblasts%2520induced%2520by%2520ay-9944%2520and%2520other%2520cationic%2520amphiphilic%2520drugs%26jtitle%3DJ.%2520Biochem.%26date%3D1985%26volume%3D98%26spage%3D1669%26epage%3D1679%26doi%3D10.1093%2Foxfordjournals.jbchem.a135438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albouz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutry, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spezzatti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castagna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, N.</span></span> <span> </span><span class="NLM_article-title">Calmodulin antagonist w-7 inhibits lysosomal sphingomyelinase activity in c6 glioma cells</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1645</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1989.tb09221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1471-4159.1989.tb09221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2540282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Ggtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1989&pages=1645-1647&author=M.+Massonauthor=S.+Albouzauthor=J.+M.+Boutryauthor=B.+Spezzattiauthor=M.+Castagnaauthor=N.+Baumann&title=Calmodulin+antagonist+w-7+inhibits+lysosomal+sphingomyelinase+activity+in+c6+glioma+cells&doi=10.1111%2Fj.1471-4159.1989.tb09221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Calmodulin antagonist W-7 inhibits lysosomal sphingomyelinase activity in C6 glioma cells</span></div><div class="casAuthors">Masson, Martial; Albouz, Samia; Boutry, Jeanne Marie; Spezzatti, Bettina; Castagna, Monique; Baumann, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1645-7</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) is known to be a potent calmodulin antagonist and inhibitor of calmodulin-dependent protein kinases.  W-7 and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) are inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.  In C6 glioma cells, W-7 and not H-7 inhibited concn.-dependently acid sphingomyelinase, a result indicating the modulation of this lysosomal enzyme by a calmodulin-dependent system.  Other lysosomal enzymes, such as β-glucosidase, α-galactosidase, and arylsulfatase A, were unaffected by W-7 and H-7, a finding indicating a selective effect of W-7 on sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo25n7icNK5eLVg90H21EOLACvtfcHk0lj_HncO9IY75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Ggtbk%253D&md5=51d17ba23978b7f029131927d30c75ba</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1989.tb09221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1989.tb09221.x%26sid%3Dliteratum%253Aachs%26aulast%3DMasson%26aufirst%3DM.%26aulast%3DAlbouz%26aufirst%3DS.%26aulast%3DBoutry%26aufirst%3DJ.%2BM.%26aulast%3DSpezzatti%26aufirst%3DB.%26aulast%3DCastagna%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DN.%26atitle%3DCalmodulin%2520antagonist%2520w-7%2520inhibits%2520lysosomal%2520sphingomyelinase%2520activity%2520in%2520c6%2520glioma%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1989%26volume%3D52%26spage%3D1645%26epage%3D1647%26doi%3D10.1111%2Fj.1471-4159.1989.tb09221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaffrezou, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gau, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurent, G.</span></span> <span> </span><span class="NLM_article-title">Reversal of multidrug resistance by calcium channel blocker sr33557 without photoaffinity labeling of p-glycoprotein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">19858</span>– <span class="NLM_lpage">19864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2955070-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1918089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlvFOrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=19858-19864&author=J.+P.+Jaffrezouauthor=J.+M.+Herbertauthor=T.+Levadeauthor=M.+N.+Gauauthor=P.+Chatelainauthor=G.+Laurent&title=Reversal+of+multidrug+resistance+by+calcium+channel+blocker+sr33557+without+photoaffinity+labeling+of+p-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein</span></div><div class="casAuthors">Jaffrezou, Jean Pierre; Herbert, Jean Marc; Levade, Thierry; Gau, Marie Noelle; Chatelain, Pierre; Laurent, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">19858</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The altered pharmacol. of drugs in multidrug-resistant cells (decreased accumulation and retention) appears to be mediated by a high mol. wt. integral membrane protein, called P-glycoprotein (P-gp).  Agents known to reverse this pleiotropic drug resistance (chemosensitizers) have been shown to interact with P-gp; and as such, the inhibition of photoaffinity labeling by P-gp probes (such as [3H]azidonine) has been proposed as a basis for mass screening of chemosensitizers.  In this study, direct evidence is provided that a novel calcium channel blocker SR33557 (I), which was 4.5 times more potent in sensitizing P388/ADR cells to doxorubicin as compared to verapamil while inducing a similar increase in uptake and decrease in efflux of [14C]doxorubicin, did not compete for the [3H]azidonine-binding site on P-gp, whereas verapamil did.  Moreover, SR33557, which is inherently photoactivable, did not photolabel P-gp, but a 65-kDa protein did appear to be an acceptor; and this binding was displaced by diltiazem and nifedipine, but not by verapamil.  Finally, the implication for the participation of a sphingomyelin/sphingosine cycle (as a potential lipid second messenger system) in the chemosensitization of P388/ADR cells was investigated.  SR33557 (30 μM) induced a 72% inhibition in acid lysosomal sphingomyelinase activity, a 5-fold increase in sphingosine levels, and a 75% inhibition in intracellular protein kinase C activity.  Although no direct link is established between these observations and P-gp activity, further studies on a possible sphingosine-mediated regulation of P-gp may yield information on the involvement of this second messenger system in the action of SR33557.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSPeBr0m_ybVg90H21EOLACvtfcHk0lj_HncO9IY75w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlvFOrtbk%253D&md5=d3f93d3a455f364a59585e4195de8dc6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2955070-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252955070-5%26sid%3Dliteratum%253Aachs%26aulast%3DJaffrezou%26aufirst%3DJ.%2BP.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DGau%26aufirst%3DM.%2BN.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DLaurent%26aufirst%3DG.%26atitle%3DReversal%2520of%2520multidrug%2520resistance%2520by%2520calcium%2520channel%2520blocker%2520sr33557%2520without%2520photoaffinity%2520labeling%2520of%2520p-glycoprotein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D19858%26epage%3D19864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terfloth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltfang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span> <span> </span><span class="NLM_article-title">Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1021/jm070524a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070524a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlejsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=219-237&author=J.+Kornhuberauthor=P.+Tripalauthor=M.+Reichelauthor=L.+Terflothauthor=S.+Bleichauthor=J.+Wiltfangauthor=E.+Gulbins&title=Identification+of+new+functional+inhibitors+of+acid+sphingomyelinase+using+a+structure-property-activity+relation+model&doi=10.1021%2Fjm070524a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure-Property-Activity Relation Model</span></div><div class="casAuthors">Kornhuber, Johannes; Tripal, Philipp; Reichel, Martin; Terfloth, Lothar; Bleich, Stefan; Wiltfang, Jens; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-237</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Some org. weak bases induce a detachment from inner lysosomal membranes and subsequent inactivation of acid sphingomyelinase (ASM) and thus work as functional ASM inhibitors.  The aim of the present investigation was to develop a structure-property-activity relation (SPAR) model in order to specify the structural and physicochem. characteristics of probes capable of functionally inhibiting ASM.  High pKa and high log P values are necessary but not sufficient preconditions for functional inhibition of ASM.  The exptl. data supported the requirement of an addnl. factor, which is necessary for functional inhibition of ASM.  This factor k is related to the steric hindrance of the most basic nitrogen atom and presumably modulates the free presentation of a protonated nitrogen atom at the inner lysosomal surface.  During the course of the study, the authors characterized 26 new functional ASM inhibitors, including doxepine 63, fluoxetine 104, maprotiline 109, nortriptyline 114, paroxetine 118, sertraline 124, suloctidil 125, and terfenadine 127.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3zAdkl_bqSbVg90H21EOLACvtfcHk0lhlTpIygZEjEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlejsbnP&md5=93b672e37d8574bf09ee8dadb865039a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm070524a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070524a%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DTerfloth%26aufirst%3DL.%26aulast%3DBleich%26aufirst%3DS.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520new%2520functional%2520inhibitors%2520of%2520acid%2520sphingomyelinase%2520using%2520a%2520structure-property-activity%2520relation%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D219%26epage%3D237%26doi%3D10.1021%2Fjm070524a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>559</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00033-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0014-5793%2804%2900033-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=14960314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252Fnt1SksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=559&publication_year=2004&pages=96-98&author=M.+Kolzerauthor=N.+Werthauthor=K.+Sandhoff&title=Interactions+of+acid+sphingomyelinase+and+lipid+bilayers+in+the+presence+of+the+tricyclic+antidepressant+desipramine&doi=10.1016%2FS0014-5793%2804%2900033-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine</span></div><div class="casAuthors">Kolzer Melanie; Werth Norbert; Sandhoff Konrad</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">559</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">96-8</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The tricyclic antidepressant desipramine causes a decrease in cellular acid sphingomyelinase (A-SMase, EC 3.1.4.12) activity when added to culture medium of human fibroblasts.  This effect can be prevented by incubation of the cells with the protease inhibitor leupeptin, which suggests that desipramine induces proteolytic degradation of the lysosomal enzyme.  By using surface plasmon resonance (SPR, Biacore) we were able to monitor the interactions of A-SMase and substrate-containing lipid bilayers immobilized on the surface of a Pioneer trade mark L1 sensor chip.  SPR binding curves show that the enzyme hardly dissociates from the lipid surface at acidic pH values.  On the other hand, a drop in binding signals (resonance units, RU) of approximately 50% occurred after injection of 20 mM desipramine.  Our findings indicate that desipramine interferes with the binding of A-SMase to the lipid bilayers and thereby displaces the enzyme from its membrane-bound substrate.  The application of control substances suggests a key role for the cationic moiety of desipramine.  We hypothesize that the displacement of the glycoprotein A-SMase from the inner membranes of late endosomes and lysosomes by desipramine renders it susceptible to proteolytic cleavage by lysosomal proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSvh2pXInD65agfuraLLzSfW6udTcc2ebyWyiscR879rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252Fnt1SksQ%253D%253D&md5=e327b94a0fc7ad8edf303c99dc2d245b</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900033-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900033-X%26sid%3Dliteratum%253Aachs%26aulast%3DKolzer%26aufirst%3DM.%26aulast%3DWerth%26aufirst%3DN.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DInteractions%2520of%2520acid%2520sphingomyelinase%2520and%2520lipid%2520bilayers%2520in%2520the%2520presence%2520of%2520the%2520tricyclic%2520antidepressant%2520desipramine%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D559%26spage%3D96%26epage%3D98%26doi%3D10.1016%2FS0014-5793%2804%2900033-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kornhuber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muehlbacher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groemer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span> <span> </span><span class="NLM_article-title">Functional inhibitors of acid sphingomyelinase (fiasmas): A novel pharmacological group of drugs with broad clinical applications</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1159/000315101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000315101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20502000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=9-20&author=J.+Kornhuberauthor=P.+Tripalauthor=M.+Reichelauthor=C.+Muhleauthor=C.+Rheinauthor=M.+Muehlbacherauthor=T.+W.+Groemerauthor=E.+Gulbins&title=Functional+inhibitors+of+acid+sphingomyelinase+%28fiasmas%29%3A+A+novel+pharmacological+group+of+drugs+with+broad+clinical+applications&doi=10.1159%2F000315101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications</span></div><div class="casAuthors">Kornhuber, Johannes; Tripal, Philipp; Reichel, Martin; Muehle, Christiane; Rhein, Cosima; Muehlbacher, Markus; Groemer, Teja W.; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-20</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Acid sphingomyelinase (ASM) is an important lipid-metabolizing enzyme cleaving sphingomyelin to ceramide, mainly within lysosomes.  Acid ceramidase (AC) further degrades ceramide to sphingosine which can then be phosphorylated to sphingosine-1-phosphate.  Ceramide and its metabolite sphingosine-1-phosphate have been shown to antagonistically regulate apoptosis, cellular differentiation, proliferation and cell migration.  Inhibitors of ASM or AC therefore hold promise for a no. of new clin. therapies, e.g. for Alzheimer's disease and major depression on the one hand and cancer on the other.  Inhibitors of ASM have been known for a long time.  Cationic amphiphilic substances induce the detachment of ASM protein from inner lysosomal membranes with its consecutive inactivation, thereby working as functional inhibitors of ASM.  We recently exptl. identified a large no. of hitherto unknown functional inhibitors of ASM and detd. specific physicochem. properties of such cationic amphiphilic substances that functionally inhibit ASM.  We propose the acronym "FIASMA" (Functional Inhibitor of Acid SphingoMyelinAse) for members of this large group of compds. with a broad range of new clin. indications.  FIASMAs differ markedly with respect to mol. structure and current clin. indication.  Most of the available FIASMAs are licensed for medical use in humans, are minimally toxic and may therefore be applied for disease states assocd. with increased activity of ASM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLKnWFqe8RjbVg90H21EOLACvtfcHk0lhlTpIygZEjEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOmsrw%253D&md5=5d2be89bb837b472ea4c9182b85ddc3c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1159%2F000315101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315101%26sid%3Dliteratum%253Aachs%26aulast%3DKornhuber%26aufirst%3DJ.%26aulast%3DTripal%26aufirst%3DP.%26aulast%3DReichel%26aufirst%3DM.%26aulast%3DMuhle%26aufirst%3DC.%26aulast%3DRhein%26aufirst%3DC.%26aulast%3DMuehlbacher%26aufirst%3DM.%26aulast%3DGroemer%26aufirst%3DT.%2BW.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DFunctional%2520inhibitors%2520of%2520acid%2520sphingomyelinase%2520%2528fiasmas%2529%253A%2520A%2520novel%2520pharmacological%2520group%2520of%2520drugs%2520with%2520broad%2520clinical%2520applications%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D9%26epage%3D20%26doi%3D10.1159%2F000315101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Icheva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deppisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graepler-Mainka, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riethmueller, J.</span></span> <span> </span><span class="NLM_article-title">Long-term pulmonal therapy of cystic fibrosis-patients with amitriptyline</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1159/000445648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1159%2F000445648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27395380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ynur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=565-572&author=C.+Adamsauthor=V.+Ichevaauthor=C.+Deppischauthor=J.+Lauerauthor=G.+Herrmannauthor=U.+Graepler-Mainkaauthor=S.+Heyderauthor=E.+Gulbinsauthor=J.+Riethmueller&title=Long-term+pulmonal+therapy+of+cystic+fibrosis-patients+with+amitriptyline&doi=10.1159%2F000445648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline</span></div><div class="casAuthors">Adams, Constantin; Icheva, Vanya; Deppisch, Caroline; Lauer, Josefine; Herrmann, Gloria; Graepler-Mainka, Ute; Heyder, Susanne; Gulbins, Erich; Riethmueller, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">565-572</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Several recent clin. studies revealed an accumulation of ceramide in bronchial epithelial cells of patients with cystic fibrosis (CF).  Degrdn. of ceramide concns. in lungs of CF patients employing the functional acid sphingomyelinase inhibitor amitriptyline revealed a benefit in lung function, wt. and exacerbation rates.  Methods: To test for a beneficial effect of amitriptyline in vivo, we performed two phase II randomized, double-blind, placebo-controlled studies.  CF patients were treated with 25 mg amitriptyline twice daily, i.e. a total dose of 50 mg/d.  After those two studies part of the patients used amitriptyline in an off-lable-use for routine treatment.  These patients were obsd. after one, two and three years after continuous use of amitriptyline and were matched with those patients who were not treated.  These patients were used as a control group.  Results: After one year of treatment, forced expiratory vol. in 1 s predicted (FEV1) increased significantly by 7.6±7.0%, p=<0.001, and wt. increased by 2.1±2.3kg, p=<0.001 in the amitriptyline population (n=20), whereas FEV1 decreased significantly in the control group by 1.8±3.3%, p=0.010, and wt. increased by 1.1±2.7kg, p=0.010 (n=14).  After two years of treatment, FEV1 increased significantly by 5.6±10.3%, p=0.009, and wt. increased by 3.6±2.9kg, p=<0.001 in the amitriptyline population (n=12).  In contrast, FEV1 decreased in the control group by 2.1±3.7%, p=0.051 and wt. increased by only 0.4±2.9kg, p=0.31 (n=10).  After three years of treatment, FEV1 increased significantly by 7.7±8%, p=0.050, and wt. increased by 7.3±3.8kg, p=0.016, in the amitriptyline population (n=5), whereas FEV1 decreased in the control group by 1.0±1.3%, p=0.075 and wt. increased by 0.4±1.5kg, p=0.29 (n=5).  Conclusion: Amitriptyline significantly increases FEV1, reduces ceramide in lung cells and increases wt. of CF patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj_G6lhBCRt7Vg90H21EOLACvtfcHk0lg4X0KJuNrOAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ynur7O&md5=8a016e35665ad4de3cefef1d16b6135a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1159%2F000445648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000445648%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DC.%26aulast%3DIcheva%26aufirst%3DV.%26aulast%3DDeppisch%26aufirst%3DC.%26aulast%3DLauer%26aufirst%3DJ.%26aulast%3DHerrmann%26aufirst%3DG.%26aulast%3DGraepler-Mainka%26aufirst%3DU.%26aulast%3DHeyder%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26aulast%3DRiethmueller%26aufirst%3DJ.%26atitle%3DLong-term%2520pulmonal%2520therapy%2520of%2520cystic%2520fibrosis-patients%2520with%2520amitriptyline%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2016%26volume%3D39%26spage%3D565%26epage%3D572%26doi%3D10.1159%2F000445648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umezawa, K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acidic sphingomyelinase by xanthone compounds isolated from garcinia speciosa</span>. <i>J. Enzyme Inhib.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1080/14756360009030346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1080%2F14756360009030346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10938539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1ygs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=129-138&author=C.+Okudairaauthor=Y.+Ikedaauthor=S.+Kondoauthor=S.+Furuyaauthor=Y.+Hirabayashiauthor=T.+Koyanoauthor=Y.+Saitoauthor=K.+Umezawa&title=Inhibition+of+acidic+sphingomyelinase+by+xanthone+compounds+isolated+from+garcinia+speciosa&doi=10.1080%2F14756360009030346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acidic sphingomyelinase by xanthone compounds isolated from Garcinia speciosa</span></div><div class="casAuthors">Okudaira, Chiyono; Ikeda, Yoko; Kondo, Shinichi; Furuya, Shigeki; Hirabayashi, Yoshio; Koyano, Takashi; Saito, Yoshio; Umezawa, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">Sphingomyelinase is considered to be involved in the regulation of apoptosis and cell growth.  In the course of our screening for acidic sphingomyelinase inhibitors we isolated three xanthone compds., α-mangostin, cowanin, and cowanol, from the bark of Garcinia speciosa.  These compds. competitively inhibited bovine brain-derived acidic sphingomyelinase with IC50 values of 14.1, 19.2, and 10.9 μM, resp. and inhibited the acidic sphingomyelinase more effectively than the neutral sphingomyelinase of bovine brain.  α-Mangostin inhibited the acidic sphingomyelinase in the most selective manner.  α-Mangostin was chem. modified and its structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqEPtlHF_D7Vg90H21EOLACvtfcHk0lg4X0KJuNrOAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1ygs7Y%253D&md5=7b550de425e3085911abca36aa50418e</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1080%2F14756360009030346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360009030346%26sid%3Dliteratum%253Aachs%26aulast%3DOkudaira%26aufirst%3DC.%26aulast%3DIkeda%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DFuruya%26aufirst%3DS.%26aulast%3DHirabayashi%26aufirst%3DY.%26aulast%3DKoyano%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DUmezawa%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520acidic%2520sphingomyelinase%2520by%2520xanthone%2520compounds%2520isolated%2520from%2520garcinia%2520speciosa%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D2000%26volume%3D15%26spage%3D129%26epage%3D138%26doi%3D10.1080%2F14756360009030346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wetzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chammaa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperl, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yektaoglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyrones</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3666</span>– <span class="NLM_lpage">3670</span>, <span class="refDoi"> DOI: 10.1002/anie.200906555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200906555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFWisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3666-3670&author=S.+Wetzelauthor=W.+Wilkauthor=S.+Chammaaauthor=B.+Sperlauthor=A.+G.+Rothauthor=A.+Yektaogluauthor=S.+Rennerauthor=T.+Bergauthor=C.+Arenzauthor=A.+Giannisauthor=T.+I.+Opreaauthor=D.+Rauhauthor=M.+Kaiserauthor=H.+Waldmann&title=A+scaffold-tree-merging+strategy+for+prospective+bioactivity+annotation+of+gamma-pyrones&doi=10.1002%2Fanie.200906555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A Scaffold-Tree-Merging Strategy for Prospective Bioactivity Annotation of γ-Pyrones</span></div><div class="casAuthors">Wetzel, Stefan; Wilk, Wolfram; Chammaa, Samy; Sperl, Bianca; Roth, Anke G.; Yektaoglu, Aybike; Renner, Steffen; Berg, Thorsten; Arenz, Christoph; Giannis, Athanassios; Oprea, Tudor I.; Rauh, Daniel; Kaiser, Markus; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3666-3670, S3666/1-S3666/115</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Natural products (NPs) can be regarded as biol. relevant compd. classes selected during evolution and endowed with structural parameters required for binding to proteins.  They are a rich source of small-mol. modulators of protein function.  However, their use is often hampered by their limited accessibility and a lack of knowledge about their biol. targets.  Synthetically accessible NP-inspired and NP-derived compd. collections may offer an attractive possibility to overcome these limitations if their bioactivity could be annotated prospectively.  Cheminformatic methods can provide crucial clues and crit. insight to guide compd.-development programs.  Accordingly, several chemoinformatic approaches have been described for the anal. of NP structure and properties in the context of bioactive-compd. development and to chart NP chem. space.  We recently introduced a hierarchical, chem.-based classification and arrangement of natural products in a natural product scaffold tree to inspire the synthesis of NP-derived compd. collections.  Brachiation along lines of biol. relevance, i.e., movement along the branches of the NP tree from complex to simpler structures, enables the identification of structurally simpler scaffolds with retained, yet varying bioactivity.  In the light of these findings, we hypothesized that the correlation of NP scaffolds not annotated for bioactivity with scaffolds of related yet non-natural small mols. with known bioactivity and targets could identify potential proteins targeted by natural product inspired and derived compd. collections.  We envisaged that merging of trees not annotated for bioactivity (e.g. the NP scaffold tree) with trees annotated for bioactivity would generate novel merged trees from which bioactivity could be assigned prospectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZAsXs8diPP7Vg90H21EOLACvtfcHk0lg4X0KJuNrOAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFWisrc%253D&md5=dc65ee32bbfa712223b6c670fd84a09d</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906555%26sid%3Dliteratum%253Aachs%26aulast%3DWetzel%26aufirst%3DS.%26aulast%3DWilk%26aufirst%3DW.%26aulast%3DChammaa%26aufirst%3DS.%26aulast%3DSperl%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DYektaoglu%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DS.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGiannis%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DA%2520scaffold-tree-merging%2520strategy%2520for%2520prospective%2520bioactivity%2520annotation%2520of%2520gamma-pyrones%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D3666%26epage%3D3670%26doi%3D10.1002%2Fanie.200906555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuzaki, H.</span></span> <span> </span><span class="NLM_article-title">Strong inhibition of secretory sphingomyelinase by catechins, particularly by (−)-epicatechin 3-o-gallate and (−)-3′-o-methylepigallocatechin 3-o-gallate</span>. <i>J. Nutr. Sci. Vitaminol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.3177/jnsv.62.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3177%2Fjnsv.62.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27264097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWhsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=123-129&author=K.+Kobayashiauthor=Y.+Ishizakiauthor=S.+Kojoauthor=H.+Kikuzaki&title=Strong+inhibition+of+secretory+sphingomyelinase+by+catechins%2C+particularly+by+%28%E2%88%92%29-epicatechin+3-o-gallate+and+%28%E2%88%92%29-3%E2%80%B2-o-methylepigallocatechin+3-o-gallate&doi=10.3177%2Fjnsv.62.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Strong inhibition of secretory sphingomyelinase by catechins, particularly by (-)-epicatechin 3-O-gallate and (-)-3'-O-methylepigallocatechin 3-O-Gallate</span></div><div class="casAuthors">Kobayashi, Keiko; Ishizaki, Yuki; Kojo, Shosuke; Kikuzaki, Hiroe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutritional Science and Vitaminology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-129</span>CODEN:
                <span class="NLM_cas:coden">JNSVA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-4800</span>.
    
            (<span class="NLM_cas:orgname">Center for Academic Publications Japan</span>)
        </div><div class="casAbstract">Sphingomyelinases (SMases) are key enzymes involved in many diseases which are caused by oxidative stress, such as atherosclerosis, diabetes mellitus, nonalcoholic fatty liver disease, and Alzheimer's disease.  SMases hydrolyze sphingomyelin to generate ceramide, a well-known pro-apoptotic lipid.  SMases are classified into five types based on pH optimum, subcellular localization, and cation dependence.  Previously, we demonstrated that elevation of secretory sphingomyelinase (sSMase) activity increased the plasma ceramide concn. under oxidative stress induced by diabetes and atherosclerosis in murine models.  These results suggest that sSMase inhibitors can prevent the progress of these diseases.  The present study demonstrated that sSMase activity was activated by oxidn. and inhibited by redn.  Furthermore, we examd. whether catechins inhibited the sSMase activity in a physiol. plasma concn.  Among catechins, (-)-epicatechin 3-O-gallate (ECg) exhibited strong inhibitory effect on sSMase (IC50=25.7 μM).  This effect was attenuated by methylation at the 3''- or 4''-position.  On the other hand, (-)-epigallocatechin 3-O-gallate (EGCg) and (-)-catechin 3-O-gallate (Cg) exhibited weaker inhibitory activity than ECg, and (-)-epicatechin and (-)-epigallocatechin did not affect sSMase activity.  Addnl., one synthetic catechin, (-)-3'-O-methylepigallocatechin 3-O-gallate (EGCg-3'-O-Me), showed the strongest inhibitory effect (IC50=1.7 μm) on sSMase.  This phenomenon was not obsd. for (-)-4'-O-methylepigallocatechin 3-O-gallate.  These results suggest that the redn. potential, the presence of the galloyl residue at the C-3 position, and the steric requirement to interact with sSMase protein are important for effective inhibition of sSMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp41MMdqZIgFbVg90H21EOLACvtfcHk0ljb5qG_dod41A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWhsL3O&md5=9d8ae02b23f399641f9657d23d1c0fb8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.3177%2Fjnsv.62.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3177%252Fjnsv.62.123%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DIshizaki%26aufirst%3DY.%26aulast%3DKojo%26aufirst%3DS.%26aulast%3DKikuzaki%26aufirst%3DH.%26atitle%3DStrong%2520inhibition%2520of%2520secretory%2520sphingomyelinase%2520by%2520catechins%252C%2520particularly%2520by%2520%2528%25E2%2588%2592%2529-epicatechin%25203-o-gallate%2520and%2520%2528%25E2%2588%2592%2529-3%25E2%2580%25B2-o-methylepigallocatechin%25203-o-gallate%26jtitle%3DJ.%2520Nutr.%2520Sci.%2520Vitaminol.%26date%3D2016%26volume%3D62%26spage%3D123%26epage%3D129%26doi%3D10.3177%2Fjnsv.62.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quintern, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrkorn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schram, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Acid sphingomyelinase from human urine: Purification and characterization</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>922</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(87)90055-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2887%2990055-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=2825797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL1cXht1OhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=922&publication_year=1987&pages=323-336&author=L.+E.+Quinternauthor=G.+Weitzauthor=H.+Nehrkornauthor=J.+M.+Tagerauthor=A.+W.+Schramauthor=K.+Sandhoff&title=Acid+sphingomyelinase+from+human+urine%3A+Purification+and+characterization&doi=10.1016%2F0005-2760%2887%2990055-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Acid sphingomyelinase from human urine:  purification and characterization</span></div><div class="casAuthors">Quintern, Lothar E.; Weitz, Gaby; Nehrkorn, Heidi; Tager, Joseph M.; Schram, Andre W.; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">922</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-36</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    </div><div class="casAbstract">Acid sphingomyelinase (EC 3.1.4.12) (I) was purified from human urine in the presence of 0.1% Nonidet P-40.  I activity could be enriched 23,000-fold by sequential chromatog. on octyl-Sepharose, concanavalin A-Sepharose, Blue Sepharose and DEAE-cellulose.  The last purifn. step yielded an enzyme prepn. with a specific activity of ∼2.5 mmol sphingomyelin (SM) cleaved/h/mg protein and with a yield of ∼3%.  Purified I appeared to be homogeneous in SDS-PAGE with a mol. wt. of 70,000.  In the presence of 0.08% Na taurodeoxycholate, the I prepn. showed phosphodiesterase activity toward SM, phosphatidylcholine (PC), and phosphatidylglycerol (PG).  These activities copurified during the entire purifn. procedure, indicating that I hydrolyzes not only SM, but also possesses a phospholipase C activity in hydrolyzing PC and PG.  The addn. of 100 μM tripalmitoylglycerol to the assay system (which contains 100 μM SM) instead of detergent, stimulated the reaction ∼20-fold compared to an assay which did not contain detergents, thus offering a very sensitive and efficient system for the assay of I in a system free of detergents.  SM degrdn. was strongly inhibited by phosphatidylinositol 4',5'-bisphosphate, adenosine 3',5'-diphosphate and adenine-9β-D-arabinofuranoside 5'-monophosphate (50% inhibition at inhibitor concns. of 1-5 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3L30YWQA9-rVg90H21EOLACvtfcHk0ljb5qG_dod41A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXht1OhtLc%253D&md5=0506a42a176fc98245cfd8258ea5df09</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2887%2990055-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252887%252990055-5%26sid%3Dliteratum%253Aachs%26aulast%3DQuintern%26aufirst%3DL.%2BE.%26aulast%3DWeitz%26aufirst%3DG.%26aulast%3DNehrkorn%26aufirst%3DH.%26aulast%3DTager%26aufirst%3DJ.%2BM.%26aulast%3DSchram%26aufirst%3DA.%2BW.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DAcid%2520sphingomyelinase%2520from%2520human%2520urine%253A%2520Purification%2520and%2520characterization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1987%26volume%3D922%26spage%3D323%26epage%3D336%26doi%3D10.1016%2F0005-2760%2887%2990055-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlinz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werth, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klingenstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol-3,5-bisphosphate is a potent and selective inhibitor of acid sphingomyelinase</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1298</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1515%2FBC.2003.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=14515991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BD3svos1Kqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1293-1298&author=M.+Kolzerauthor=C.+Arenzauthor=K.+Ferlinzauthor=N.+Werthauthor=H.+Schulzeauthor=R.+Klingensteinauthor=K.+Sandhoff&title=Phosphatidylinositol-3%2C5-bisphosphate+is+a+potent+and+selective+inhibitor+of+acid+sphingomyelinase&doi=10.1515%2FBC.2003.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase</span></div><div class="casAuthors">Kolzer Melanie; Arenz Christoph; Ferlinz Klaus; Werth Norbert; Schulze Heike; Klingenstein Ralf; Sandhoff Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Biological chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1293-8</span>
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    </div><div class="casAbstract">Acid sphingomyelinase (A-SMase, EC 3.1.4.12) catalyzes the lysosomal degradation of sphingomyelin to phosphorylcholine and ceramide.  Inherited deficiencies of acid sphingomyelinase activity result in various clinical forms of Niemann-Pick disease, which are characterised by massive lysosomal accumulation of sphingomyelin.  Sphingomyelin hydrolysis by both, acid sphingomyelinase and membrane-associated neutral sphingomyelinase, plays also an important role in cellular signaling systems regulating proliferation, apoptosis and differentiation.  Here, we present a potent and selective novel inhibitor of A-SMase, L-alpha-phosphatidyl-D-myo-inositol-3,5-bisphosphate (PtdIns3,5P2), a naturally occurring substance detected in mammalian, plant and yeast cells.  The inhibition constant Ki for the new A-SMase inhibitor PtdIns3,5P2 is 0.53 microM as determined in a micellar assay system with radiolabeled sphingomyelin as substrate and recombinant human A-SMase purified from insect cells.  Even at concentrations of up to 50 microM, PtdIns3,5P2 neither decreased plasma membrane-associated, magnesium-dependent neutral sphingomyelinase activity, nor was it an inhibitor of the lysosomal hydrolases beta-hexosaminidase A and acid ceramidase.  Other phosphoinositides tested had no or a much weaker effect on acid sphingomyelinase.  Different inositol-bisphosphates were studied to elucidate structure-activity relationships for A-SMase inhibition.  Our investigations provide an insight into the structural features required for selective, efficient inhibition of acid sphingomyelinase and may also be used as starting point for the development of new potent A-SMase inhibitors optimised for diverse applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwhFJPqfNjdOxsqfvU0ziafW6udTcc2eYZLq01pF2oeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svos1Kqtw%253D%253D&md5=efd5efbb83d9bfa9098c5fd327d8f676</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.144%26sid%3Dliteratum%253Aachs%26aulast%3DKolzer%26aufirst%3DM.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DFerlinz%26aufirst%3DK.%26aulast%3DWerth%26aufirst%3DN.%26aulast%3DSchulze%26aufirst%3DH.%26aulast%3DKlingenstein%26aufirst%3DR.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DPhosphatidylinositol-3%252C5-bisphosphate%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520acid%2520sphingomyelinase%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1293%26epage%3D1298%26doi%3D10.1515%2FBC.2003.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Potent inhibition of acid sphingomyelinase by phosphoinositide analogues</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2367</span>– <span class="NLM_lpage">2374</span>, <span class="refDoi"> DOI: 10.1002/cbic.200900281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fcbic.200900281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19688786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGjs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2367-2374&author=A.+G.+Rothauthor=S.+Redmerauthor=C.+Arenz&title=Potent+inhibition+of+acid+sphingomyelinase+by+phosphoinositide+analogues&doi=10.1002%2Fcbic.200900281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Inhibition of Acid Sphingomyelinase by Phosphoinositide Analogues</span></div><div class="casAuthors">Roth, Anke Gundula; Redmer, Susanne; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2367-2374</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The different mammalian sphingomyelinases are involved in cell regulation, apoptosis and inflammatory events.  Recent reports suggest pharmacol. potential esp. for inhibitors of the acid sphingomyelinase.  Phosphatidyl inositol-3,5bisphosphate (PtdIns3,5P2) is the most potent selective acid sphingomyelinase inhibitor known to date.  In the present study, we synthesized analogs of PtdIns3,5P2 for initial structure-activity-relationship (SAR) studies.  We identified an inhibitor that is easy to synthesize, that has superior chem. and biophys. properties when compared to PtdIns3,5P2 and that should be stable against virtually all phospholipases.  Last but not least, the new inhibitor partially protected cells from dexamethasone-induced cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqtHO3lVUPLVg90H21EOLACvtfcHk0ljVBOTyja26yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGjs7rK&md5=2bdfa6dd555adce810ff4ec478049c48</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900281%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DRedmer%26aufirst%3DS.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DPotent%2520inhibition%2520of%2520acid%2520sphingomyelinase%2520by%2520phosphoinositide%2520analogues%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2367%26epage%3D2374%26doi%3D10.1002%2Fcbic.200900281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drescher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhlig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Potent and selective inhibition of acid sphingomyelinase by bisphosphonates</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7560</span>– <span class="NLM_lpage">7563</span>, <span class="refDoi"> DOI: 10.1002/anie.200903288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200903288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Sru7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7560-7563&author=A.+G.+Rothauthor=D.+Drescherauthor=Y.+Yangauthor=S.+Redmerauthor=S.+Uhligauthor=C.+Arenz&title=Potent+and+selective+inhibition+of+acid+sphingomyelinase+by+bisphosphonates&doi=10.1002%2Fanie.200903288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Inhibition of Acid Sphingomyelinase by Bisphosphonates</span></div><div class="casAuthors">Roth, Anke G.; Drescher, Daniela; Yang, Yang; Redmer, Susanne; Uhlig, Stefan; Arenz, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7560-7563, S7560/1-S7560/8</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">More than mending bones: A simple geminal aminobisphosphonate (see picture) is the most potent selective inhibitor of the acid sphingomyelinase known to date. It can be synthesized in a one-step procedure and inhibits cell death in vitro. Since the acid sphingomyelinase is a putative drug target for inflammatory lung diseases, bisphosphonates may find application in the treatment of pulmonary diseases.  The synthesis of bisphosphonates and their inhibition of acid sphingomyelinase are discussed.  One simple bisphosphonate, compd. 7c, was found to be a potent acid sphingomyelinase inhibitor.  Compd. 7c was shown to inhibit dexamethasone-induced apoptosis and reduce PAF-induced pulmonary edema, which suggests it could be useful for the treatment of lung disorders and other inflammatory ailments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGVWeCRzR5rVg90H21EOLACvtfcHk0ljVBOTyja26yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Sru7vM&md5=2ac7875b0e3686fffe8ce669bd89b02c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fanie.200903288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200903288%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DDrescher%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRedmer%26aufirst%3DS.%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DPotent%2520and%2520selective%2520inhibition%2520of%2520acid%2520sphingomyelinase%2520by%2520bisphosphonates%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26spage%3D7560%26epage%3D7563%26doi%3D10.1002%2Fanie.200903288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bae, J.-S.</span>; <span class="NLM_string-name">Jin, H. K.</span>; <span class="NLM_string-name">Park, M. H.</span></span> <span> </span><span class="NLM_article-title">2-Amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol Derivative of Novel Compound for Directly Inhibiting ASM Activity, and Use Thereof</span>. PCT Int. Appl. <span class="NLM_patent">WO 2019/212196</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.-S.+Bae&author=H.+K.+Jin&author=M.+H.+Park&title=2-Amino-2-%281%2C2%2C3-triazole-4-yl%29propane-1%2C3-diol+Derivative+of+Novel+Compound+for+Directly+Inhibiting+ASM+Activity%2C+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBae%26aufirst%3DJ.-S.%26atitle%3D2-Amino-2-%25281%252C2%252C3-triazole-4-yl%2529propane-1%252C3-diol%2520Derivative%2520of%2520Novel%2520Compound%2520for%2520Directly%2520Inhibiting%2520ASM%2520Activity%252C%2520and%2520Use%2520Thereof%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of n-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ejmech.2018.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29649738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Kgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=389-400&author=K.+Yangauthor=K.+Nongauthor=Q.+Guauthor=J.+Dongauthor=J.+Wang&title=Discovery+of+n-hydroxy-3-alkoxybenzamides+as+direct+acid+sphingomyelinase+inhibitors+using+a+ligand-based+pharmacophore+model&doi=10.1016%2Fj.ejmech.2018.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model</span></div><div class="casAuthors">Yang, Kan; Nong, Keyi; Gu, Qinlan; Dong, Jibin; Wang, Jinxin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">389-400</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Acid sphingomyelinase (ASM) has been shown to be involved in many physiol. processes, emerging to be a promising drug target.  In this study, we constructed a ligand-based pharmacophore model of ASM inhibitors and applied this model to optimize the lead compd. α-mangostin, a known inhibitor of ASM.  23 Compds. were designed and evaluated in vitro for ASM inhibition, of these, 10 compds. were found to be more potent than α-mangostin.  This high hit ratio confirmed that the presented model is very effective and practical.  The most potent hit, 1c, was found to selectively and competitively inhibit the enzyme and inhibit the generation of ceramide in a dose-dependent manner.  Furthermore, I showed favorable anti-apoptosis and anti-inflammatory activity.  Interactions with key residues and the Zn2+ cofactor of I were found by docking simulation.  These results provide promising leads and important guidance for further development of efficient ASM inhibitors and drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVg1Vwn1QZzrVg90H21EOLACvtfcHk0ljVBOTyja26yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Kgsbo%253D&md5=4f5e67c39cf4fa35d7b17811ed80e289</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%26aulast%3DNong%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520n-hydroxy-3-alkoxybenzamides%2520as%2520direct%2520acid%2520sphingomyelinase%2520inhibitors%2520using%2520a%2520ligand-based%2520pharmacophore%2520model%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D389%26epage%3D400%26doi%3D10.1016%2Fj.ejmech.2018.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, and direct acid sphingomyelinase inhibitors with antidepressant activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00739</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00739" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=961-974&author=K.+Yangauthor=J.+Yuauthor=K.+Nongauthor=Y.+Wangauthor=A.+Niuauthor=W.+Chenauthor=J.+Dongauthor=J.+Wang&title=Discovery+of+potent%2C+selective%2C+and+direct+acid+sphingomyelinase+inhibitors+with+antidepressant+activity&doi=10.1021%2Facs.jmedchem.9b00739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity</span></div><div class="casAuthors">Yang, Kan; Yu, Jinying; Nong, Keyi; Wang, Youzhi; Niu, Ao; Chen, Wenlu; Dong, Jibin; Wang, Jinxin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-974</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent studies on sphingolipids suggest that acid sphingomyelinase (ASM), which plays a central role in the pathogenesis of major depression, is emerging to be a novel target for developing antidepressants.  Herein we first described the design, synthesis, and biol. evaluation of hydroxamic acid-based direct inhibitors of ASM with the effort of validating their antidepressant effects in vivo.  As a result, a series of novel ASM inhibitors were developed using a structure-based approach.  Our studies demonstrated that the administration of 21b improved depression-like behaviors of rats.  Importantly, this pos. result was relevant to the inhibition of ASM and the increasing neurogenesis in hippocampus.  To the best of our knowledge, this is the first time that direct inhibitors of ASM were developed to support the possibility of ASM as a potential therapeutic target for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaRf8-JMXEB7Vg90H21EOLACvtfcHk0ljVBOTyja26yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFaku7w%253D&md5=0ac57f01159135c8f07db40ae09c0234</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00739%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNong%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520and%2520direct%2520acid%2520sphingomyelinase%2520inhibitors%2520with%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D961%26epage%3D974%26doi%3D10.1021%2Facs.jmedchem.9b00739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumbansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, W.</span></span> <span> </span><span class="NLM_article-title">Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3638</span>– <span class="NLM_lpage">3643</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.95.7.3638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=9520418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1cXitlKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3638-3643&author=S.+Tomiukauthor=K.+Hofmannauthor=M.+Nixauthor=M.+Zumbansenauthor=W.+Stoffel&title=Cloned+mammalian+neutral+sphingomyelinase%3A+Functions+in+sphingolipid+signaling%3F&doi=10.1073%2Fpnas.95.7.3638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?</span></div><div class="casAuthors">Tomiuk, Stefan; Hofmann, Kay; Nix, Michael; Zumbansen, Markus; Stoffel, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3638-3643</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Sphingomyelin is an abundant constituent of the plasma membranes of mammalian cells.  Ceramide, its primary catabolic intermediate, is released by either acid sphingomyelinase or neutral sphingomyelinase (nSMase) and has emerged as a potential lipid signaling mol.  NSMase is regarded as a key enzyme in the regulated activation of the "sphingomyelin cycle" and cell signaling.  The authors report the cloning, identification, and functional characterization of murine and human nSMase, a ubiquitously expressed integral membrane protein, which displays all established properties of the Mg2+-dependent nSMase of the plasma membrane.  Stably nSMase-overexpressing U937 and human embryonic kidney cell lines have been generated for the study of the role of nSMase in signal transduction pathways.  Their stimulation by tumor necrosis factor α leads only to a moderately elevated ceramide concn.  Activation of Jun kinase and NFκB and poly(ADP-ribose) polymerase cleavage are identical in mock-and nSMase-transfected cells.  Tumor necrosis factor α triggers the ERK1 pathway in none of the cell lines.  The cloned nSMase will facilitate further controlled expts. aiming at the definition of a possible role of ceramide as signal transduction mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGranQXUyC1yqLVg90H21EOLACvtfcHk0lip4nfbrjD6Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlKjsbg%253D&md5=1995f8a2b4ed689e9d3e162342bb1009</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3638%26sid%3Dliteratum%253Aachs%26aulast%3DTomiuk%26aufirst%3DS.%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DNix%26aufirst%3DM.%26aulast%3DZumbansen%26aufirst%3DM.%26aulast%3DStoffel%26aufirst%3DW.%26atitle%3DCloned%2520mammalian%2520neutral%2520sphingomyelinase%253A%2520Functions%2520in%2520sphingolipid%2520signaling%253F%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3638%26epage%3D3643%26doi%3D10.1073%2Fpnas.95.7.3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomiuk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, W.</span></span> <span> </span><span class="NLM_article-title">Cloning and characterization of the mammalian brain-specific, mg2+-dependent neutral sphingomyelinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">5895</span>– <span class="NLM_lpage">5900</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.11.5895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.97.11.5895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10823942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFaktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5895-5900&author=K.+Hofmannauthor=S.+Tomiukauthor=G.+Wolffauthor=W.+Stoffel&title=Cloning+and+characterization+of+the+mammalian+brain-specific%2C+mg2%2B-dependent+neutral+sphingomyelinase&doi=10.1073%2Fpnas.97.11.5895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase</span></div><div class="casAuthors">Hofmann, Kay; Tomiuk, Stefan; Wolff, Gabriela; Stoffel, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5895-5900</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The enzymic breakdown of sphingomyelin by sphingomyelinases is considered the major source of the second messenger ceramide.  Studies on the contribution of the various described acidic and neutral sphingomyelinases to the signaling pool of ceramide have been hampered by the lack of mol. data on the neutral sphingomyelinases (nSMases).  We recently identified a mammalian nSMase, an integral membrane protein with remote similarity to bacterial sphingomyelinases.  However, its ubiquitous expression pattern is in contrast to previous findings that sphingomyelinase activity is found mainly in brain tissues.  By using an improved database search method, combined with phylogenetic anal., we identified a second mammalian nSMase (nSMase2) with predominant expression in the brain.  The sphingomyelinase activity of nSMase2 has a neutral pH optimum, depends on Mg2+ ions, and is activated by unsatd. fatty acids and phosphatidylserine.  Immunofluorescence reveals a neuron-specific punctate perinuclear staining, which colocalizes with a Golgi marker in a no. of cell lines.  The likely identity of nSMase2 with cca1, a rat protein involved in contact inhibition of 3Y1 fibroblasts, suggests a role for this enzyme in cell cycle arrest.  Both mammalian nSMases are members of a superfamily of Mg2+-dependent phosphohydrolases, which also contains nucleases, inositol phosphatases, and bacterial toxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri8YSeb_HvprVg90H21EOLACvtfcHk0lip4nfbrjD6Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFaktbk%253D&md5=8d654f410cafbdb041ad3554d58c8fd6</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.11.5895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.11.5895%26sid%3Dliteratum%253Aachs%26aulast%3DHofmann%26aufirst%3DK.%26aulast%3DTomiuk%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DG.%26aulast%3DStoffel%26aufirst%3DW.%26atitle%3DCloning%2520and%2520characterization%2520of%2520the%2520mammalian%2520brain-specific%252C%2520mg2%252B-dependent%2520neutral%2520sphingomyelinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5895%26epage%3D5900%26doi%3D10.1073%2Fpnas.97.11.5895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krut, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashkar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdanpanah, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronke, M.</span></span> <span> </span><span class="NLM_article-title">Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a c-tail-anchored protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">13784</span>– <span class="NLM_lpage">13793</span>, <span class="refDoi"> DOI: 10.1074/jbc.M511306200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M511306200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16517606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1ymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=13784-13793&author=O.+Krutauthor=K.+Wiegmannauthor=H.+Kashkarauthor=B.+Yazdanpanahauthor=M.+Kronke&title=Novel+tumor+necrosis+factor-responsive+mammalian+neutral+sphingomyelinase-3+is+a+c-tail-anchored+protein&doi=10.1074%2Fjbc.M511306200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein</span></div><div class="casAuthors">Krut, Oleg; Wiegmann, Katja; Kashkar, Hamid; Yazdanpanah, Benjamin; Kroenke, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">13784-13793</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Two genes encoding neutral sphingomyelinases-1 and -2 (sphingomyelin phosphodiesterases-2 and -3) have been recently identified that hydrolyze sphingomyelin to phosphorylcholine and ceramide.  Data bank searches using a peptide sequence derived from a previously purified bovine neutral sphingomyelinase (nSMase) allowed us to identify a cDNA encoding a novel human sphingomyelinase, nSMase3, that shows only a little homol. to nSMase1 and -2.  The nSMase3 form was biochem. characterized by overexpression in a yeast strain, JK9-3dΔIsc1p, lacking endogenous SMase activity.  Similar to nSMase2, nSMase3 is Mg2+-dependent and shows optimal activity at pH 7, which is enhanced in the presence of phosphatidylserine and inhibited by scyphostatin.  NSMase3 is ubiquitously expressed as a 4.6-kb mRNA species.  NSMase3 lacks an N-terminal signal peptide, yet contains a 23-amino-acid transmembrane domain close to the C terminus, which is indicative for the family of C-tail-anchored integral membrane proteins.  Cellular localization studies with hemagglutinin-tagged nSMase3 demonstrated colocalization with markers of the endoplasmic reticulum as well as with Golgi markers.  Tumor necrosis factor stimulates rapid activation of nSMase3 in MCF7 cells with peak activity at 1.5 min, which was impaired by expression of dominant neg. FAN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRowycGxPrcLVg90H21EOLACvtfcHk0lip4nfbrjD6Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1ymuro%253D&md5=f184626d70d9e378f96da814616e0bab</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M511306200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M511306200%26sid%3Dliteratum%253Aachs%26aulast%3DKrut%26aufirst%3DO.%26aulast%3DWiegmann%26aufirst%3DK.%26aulast%3DKashkar%26aufirst%3DH.%26aulast%3DYazdanpanah%26aufirst%3DB.%26aulast%3DKronke%26aufirst%3DM.%26atitle%3DNovel%2520tumor%2520necrosis%2520factor-responsive%2520mammalian%2520neutral%2520sphingomyelinase-3%2520is%2520a%2520c-tail-anchored%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D13784%26epage%3D13793%26doi%3D10.1074%2Fjbc.M511306200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajagopalan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (ma-nsmase), the mammalian sphingomyelin phosphodiesterase 5</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">17993</span>– <span class="NLM_lpage">18002</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.102988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M110.102988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20378533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslSmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17993-18002&author=B.+X.+Wuauthor=V.+Rajagopalanauthor=P.+L.+Roddyauthor=C.+J.+Clarkeauthor=Y.+A.+Hannun&title=Identification+and+characterization+of+murine+mitochondria-associated+neutral+sphingomyelinase+%28ma-nsmase%29%2C+the+mammalian+sphingomyelin+phosphodiesterase+5&doi=10.1074%2Fjbc.M110.102988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Murine Mitochondria-associated Neutral Sphingomyelinase (MA-nSMase), the Mammalian Sphingomyelin Phosphodiesterase 5</span></div><div class="casAuthors">Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">17993-18002</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingolipids play important roles in regulating cellular responses.  Although mitochondria contain sphingolipids, direct regulation of their levels in mitochondria or mitochondria-assocd. membranes is mostly unclear.  Neutral SMase (N-SMase) isoforms, which catalyze hydrolysis of sphingomyelin (SM) to ceramide and phosphocholine, have been found in the mitochondria of yeast and zebrafish, yet their existence in mammalian mitochondria remains unknown.  Here, we have identified and cloned a cDNA based on nSMase homologous sequences.  This cDNA encodes a novel protein of 483 amino acids that displays significant homol. to nSMase2 and possesses the same catalytic core residues as members of the extended N-SMase family.  A transiently expressed V5-tagged protein co-localized with both mitochondria and endoplasmic reticulum markers in MCF-7 and HEK293 cells; accordingly, the enzyme is referred to as mitochondria-assocd. nSMase (MA-nSMase).  MA-nSMase was highly expressed in testis, pancreas, epididymis, and brain.  MA-nSMase had an abs. requirement for cations such as Mg2+ and Mn2+ and activation by the anionic phospholipids, esp. phosphatidylserine and the mitochondrial cardiolipin.  Importantly, overexpression of MA-nSMase in HEK293 cells significantly increased in vitro N-SMase activity and also modulated the levels of SM and ceramide, indicating that the identified cDNA encodes a functional SMase.  Thus, these studies identify and characterize, for the first time, a mammalian MA-nSMase.  The characterization of MA-nSMase described here will contribute to our understanding of pathways regulated by sphingolipid metabolites, particularly with ref. to the mitochondria and assocd. organelles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KSf5S1g4obVg90H21EOLACvtfcHk0lhs89S4SaUgoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslSmtr8%253D&md5=281e883461b5332155b423e34176bba3</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.102988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.102988%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DRajagopalan%26aufirst%3DV.%26aulast%3DRoddy%26aufirst%3DP.%2BL.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520murine%2520mitochondria-associated%2520neutral%2520sphingomyelinase%2520%2528ma-nsmase%2529%252C%2520the%2520mammalian%2520sphingomyelin%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17993%26epage%3D18002%26doi%3D10.1074%2Fjbc.M110.102988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snook, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matmati, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchesini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The extended family of neutral sphingomyelinases</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">11247</span>– <span class="NLM_lpage">11256</span>, <span class="refDoi"> DOI: 10.1021/bi061307z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi061307z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=11247-11256&author=C.+J.+Clarkeauthor=C.+F.+Snookauthor=M.+Taniauthor=N.+Matmatiauthor=N.+Marchesiniauthor=Y.+A.+Hannun&title=The+extended+family+of+neutral+sphingomyelinases&doi=10.1021%2Fbi061307z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The extended family of neutral sphingomyelinases</span></div><div class="casAuthors">Clarke, Christopher J.; Snook, Christopher F.; Tani, Motohiro; Matmati, Nabil; Marchesini, Norma; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11247-11256</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The neutral sphingomyelinases (N-SMases) are considered major candidates for mediating the stress-induced prodn. of ceramide, and N-SMase activity has been identified, characterized, and cloned from bacteria, yeast, and mammalian cells.  Although the level of identity between these enzymes is low, a no. of key residues thought to be involved in metal binding and catalysis are conserved.  This has led to the suggestion of a common catalytic mechanism, and thus, these enzymes are considered to form an extended family of N-SMases.  Despite considerable research into N-SMase activity in cell culture and various tissues, the lack, until recently, of the mol. identification of specific N-SMase enzymes had precluded specific insights into the regulation, physiol., and pathol. roles of these proteins.  Here, the authors summarize, for the 1st time, current knowledge of the N-SMase family, focusing on cloned members from bacteria, yeast, and mammalian cells.  The authors also briefly consider the major future directions for N-SMase research which promises highly significant and specific insight into sphingolipid-mediated functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE2InB-BZkqbVg90H21EOLACvtfcHk0lhs89S4SaUgoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVaht70%253D&md5=60d576631630dab3e4c48c224489d087</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fbi061307z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061307z%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DSnook%26aufirst%3DC.%2BF.%26aulast%3DTani%26aufirst%3DM.%26aulast%3DMatmati%26aufirst%3DN.%26aulast%3DMarchesini%26aufirst%3DN.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520extended%2520family%2520of%2520neutral%2520sphingomyelinases%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D11247%26epage%3D11256%26doi%3D10.1021%2Fbi061307z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses</span>. <i>NeuroMol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1007/s12017-010-8120-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2Fs12017-010-8120-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20552297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVegurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=320-330&author=B.+X.+Wuauthor=C.+J.+Clarkeauthor=Y.+A.+Hannun&title=Mammalian+neutral+sphingomyelinases%3A+Regulation+and+roles+in+cell+signaling+responses&doi=10.1007%2Fs12017-010-8120-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses</span></div><div class="casAuthors">Wu, Bill X.; Clarke, Christopher J.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ceramide, a bioactive lipid, has been extensively studied and identified as an essential bioactive mol. in mediating cellular signaling pathways.  Sphingomyelinase (SMase; EC 3.1.4.12) catalyzes the cleavage of the phosphodiester bond in sphingomyelin (SM) to form ceramide and phosphocholine.  In mammals, 3 Mg2+-dependent neutral SMases termed nSMase1, nSMase2, and nSMase3 have been identified.  Among the 3 enzymes, nSMase2 is the most studied and has been implicated in multiple physiol. responses including cell growth arrest, apoptosis, development and inflammation.  Here, the authors summarize recent findings for the cloned nSMases and discuss insights into their roles in the regulation of ceramide metab. and the cellular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkPT177CCAL7Vg90H21EOLACvtfcHk0lhs89S4SaUgoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVegurjL&md5=ca774d00ab7254f9203680d0102f4be3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs12017-010-8120-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-010-8120-z%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DClarke%26aufirst%3DC.%2BJ.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DMammalian%2520neutral%2520sphingomyelinases%253A%2520Regulation%2520and%2520roles%2520in%2520cell%2520signaling%2520responses%26jtitle%3DNeuroMol.%2520Med.%26date%3D2010%26volume%3D12%26spage%3D320%26epage%3D330%26doi%3D10.1007%2Fs12017-010-8120-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhogue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamseddine, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guja, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkal, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartke, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">Structure of human nsmase2 reveals an interdomain allosteric activation mechanism for ceramide generation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E5549</span>– <span class="NLM_lpage">E5558</span>, <span class="refDoi"> DOI: 10.1073/pnas.1705134114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1073%2Fpnas.1705134114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28652336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E5549-E5558&author=M.+V.+Airolaauthor=P.+Shanbhogueauthor=A.+A.+Shamseddineauthor=K.+E.+Gujaauthor=C.+E.+Senkalauthor=R.+Mainiauthor=N.+Bartkeauthor=B.+X.+Wuauthor=L.+M.+Obeidauthor=M.+Garcia-Diazauthor=Y.+A.+Hannun&title=Structure+of+human+nsmase2+reveals+an+interdomain+allosteric+activation+mechanism+for+ceramide+generation&doi=10.1073%2Fpnas.1705134114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation</span></div><div class="casAuthors">Airola, Michael V.; Shanbhogue, Prajna; Shamseddine, Achraf A.; Guja, Kip E.; Senkal, Can E.; Maini, Rohan; Bartke, Nana; Wu, Bill X.; Obeid, Lina M.; Garcia-Diaz, Miguel; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">E5549-E5558</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2, product of the SMPD3 gene) is a key enzyme for ceramide generation that is involved in regulating cellular stress responses and exosome-mediated intercellular communication.  NSMase2 is activated by diverse stimuli, including the anionic phospholipid phosphatidylserine.  Phosphatidylserine binds to an integral-membrane N-terminal domain (NTD); however, how the NTD activates the C-terminal catalytic domain is unclear.  Here, we identify the complete catalytic (CAT) domain of nSMase2, which was misannotated because of a large insertion.  We find the sol. catalytic domain interacts directly with the membrane-assocd. NTD, which serves as both a membrane anchor and an allosteric activator.  The juxtamembrane (JX) region, which links the NTD and the catalytic domain, is necessary and sufficient for activation.  Furthermore, we provide a mechanistic basis for this phenomenon using the crystal structure of the human nSMase2 catalytic domain detd. at 1.85-Å resoln.  The structure reveals a DNase-I-type fold with a hydrophobic track leading to the active site that is blocked by an evolutionarily conserved motif which we term the "DK switch.".  Structural anal. of nSMase2 and the extended N-SMase family shows that the DK switch can adopt different conformations to reposition a universally conserved Asp (D) residue involved in catalysis.  Mutation of this Asp residue in nSMase2 disrupts catalysis, allosteric activation, stimulation by phosphatidylserine, and pharmacol. inhibition by the lipid-competitive inhibitor GW4869.  Taken together, these results demonstrate that the DK switch regulates ceramide generation by nSMase2 and is governed by an allosteric interdomain interaction at the membrane interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhgaERXSsTLVg90H21EOLACvtfcHk0liFYvfoo_6eDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKhsrnL&md5=3e3b01cd7d5910f27316563650eb5fc2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1705134114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1705134114%26sid%3Dliteratum%253Aachs%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DShanbhogue%26aufirst%3DP.%26aulast%3DShamseddine%26aufirst%3DA.%2BA.%26aulast%3DGuja%26aufirst%3DK.%2BE.%26aulast%3DSenkal%26aufirst%3DC.%2BE.%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DBartke%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DGarcia-Diaz%26aufirst%3DM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DStructure%2520of%2520human%2520nsmase2%2520reveals%2520an%2520interdomain%2520allosteric%2520activation%2520mechanism%2520for%2520ceramide%2520generation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3DE5549%26epage%3DE5558%26doi%3D10.1073%2Fpnas.1705134114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shanbhogue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airola, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Diaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span> <span> </span><span class="NLM_article-title">The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">7488</span>– <span class="NLM_lpage">7502</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA118.007288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.RA118.007288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30890560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWiu7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=7488-7502&author=P.+Shanbhogueauthor=R.+M.+Hoffmannauthor=M.+V.+Airolaauthor=R.+Mainiauthor=D.+J.+Hamelinauthor=M.+Garcia-Diazauthor=J.+E.+Burkeauthor=Y.+A.+Hannun&title=The+juxtamembrane+linker+in+neutral+sphingomyelinase-2+functions+as+an+intramolecular+allosteric+switch+that+activates+the+enzyme&doi=10.1074%2Fjbc.RA118.007288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme</span></div><div class="casAuthors">Shanbhogue, Prajna; Hoffmann, Reece M.; Airola, Michael V.; Maini, Rohan; Hamelin, David J.; Garcia-Diaz, Miguel; Burke, John E.; Hannun, Yusuf A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7488-7503</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2) produces the bioactive lipid ceramide and has important roles in neurodegeneration, cancer, and exosome formation.  Although nSMase2 has low basal activity, it is fully activated by phosphatidylserine (PS).  Previous work showed that interdomain interactions within nSMase2 are needed for PS activation.  Here, we use multiple approaches, including small angle X-ray scattering, hydrogen-deuterium exchange-MS, CD and thermal shift assays, and membrane yeast two-hybrid assays, to define the mechanism mediating this interdomain interactions within nSMase2.  In contrast to what we previously assumed, we demonstrate that PS binding at the N-terminal and juxtamembrane regions of nSMase2 rather acts as a conformational switch leading to interdomain interactions that are crit. to enzyme activation.  Our work assigns a unique function for a class of linkers of lipid-activated, membrane-assocd. proteins.  It indicates that the linker actively participates in the activation mechanism via intramol. interactions, unlike the canonical linkers that typically aid protein dimerization or localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCTN0n-i4dFrVg90H21EOLACvtfcHk0liFYvfoo_6eDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWiu7nE&md5=8780d6bdb95b8cc657a5bf12997f2957</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA118.007288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA118.007288%26sid%3Dliteratum%253Aachs%26aulast%3DShanbhogue%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DR.%2BM.%26aulast%3DAirola%26aufirst%3DM.%2BV.%26aulast%3DMaini%26aufirst%3DR.%26aulast%3DHamelin%26aufirst%3DD.%2BJ.%26aulast%3DGarcia-Diaz%26aufirst%3DM.%26aulast%3DBurke%26aufirst%3DJ.%2BE.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26atitle%3DThe%2520juxtamembrane%2520linker%2520in%2520neutral%2520sphingomyelinase-2%2520functions%2520as%2520an%2520intramolecular%2520allosteric%2520switch%2520that%2520activates%2520the%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D7488%26epage%3D7502%26doi%3D10.1074%2Fjbc.RA118.007288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, trichopeziza mollissima: Taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10587877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=525-530&author=F.+Naraauthor=M.+Tanakaauthor=T.+Hosoyaauthor=K.+Suzuki-Konagaiauthor=T.+Ogita&title=Scyphostatin%2C+a+neutral+sphingomyelinase+inhibitor+from+a+discomycete%2C+trichopeziza+mollissima%3A+Taxonomy+of+the+producing+organism%2C+fermentation%2C+isolation%2C+and+physico-chemical+properties&doi=10.7164%2Fantibiotics.52.525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties</span></div><div class="casAuthors">Nara, Futoshi; Tanaka, Masahiro; Hosoya, Tsuyoshi; Suzuki-Konagai, Keiko; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-530</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">We performed expts. to screen for neutral sphingomyelinase inhibitors using rat brain microsomes as an enzyme source.  Among more than 10,000 microbial exts. tested, a mycelial ext. of Trichopeziza mollissima SANK 13892 exhibited potent inhibitory activity.  The active compd., scyphostatin (I), was purified by a series of chromatogs.  I inhibited the enzyme with an IC50 value of 1.0 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB9zc76Lzl37Vg90H21EOLACvtfcHk0liFYvfoo_6eDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitb4%253D&md5=389dcf1cb5d14bf143ade732534bd75d</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.525%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DF.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DScyphostatin%252C%2520a%2520neutral%2520sphingomyelinase%2520inhibitor%2520from%2520a%2520discomycete%252C%2520trichopeziza%2520mollissima%253A%2520Taxonomy%2520of%2520the%2520producing%2520organism%252C%2520fermentation%252C%2520isolation%252C%2520and%2520physico-chemical%2520properties%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D525%26epage%3D530%26doi%3D10.7164%2Fantibiotics.52.525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">7871</span>– <span class="NLM_lpage">7872</span>, <span class="refDoi"> DOI: 10.1021/ja9713385</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9713385" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2sXlt1yktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7871-7872&author=M.+Tanakaauthor=F.+Naraauthor=K.+Suzuki-Konagaiauthor=T.+Hosoyaauthor=T.+Ogita&title=Structural+elucidation+of+scyphostatin%2C+an+inhibitor+of+membrane-bound+neutral+sphingomyelinase&doi=10.1021%2Fja9713385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Elucidation of Scyphostatin, an Inhibitor of Membrane-Bound Neutral Sphingomyelinase</span></div><div class="casAuthors">Tanaka, Masahiro; Nara, Futoshi; Suzuki-Konagai, Keiko; Hosoya, Tsuyoshi; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">7871-7872</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structural elucidation and abs. ring stereochem. of scyphostatin (I), a structure composed of a fatty acid and an amino acid substituted by a highly oxygenated cyclohexenone moiety is described.  I exhibited potent inhibitory activity (IC50 = 1.0 mM) to neutral sphingomyelinase and is the first inhibitor of the enzyme from either natural sources or synthetic origin except for ganglioside GM3 (IC50 = 45 mM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGYwj-rUedrVg90H21EOLACvtfcHk0liFYvfoo_6eDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt1yktLo%253D&md5=538801be2db56e68aa3a9326df8feea8</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fja9713385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9713385%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DStructural%2520elucidation%2520of%2520scyphostatin%252C%2520an%2520inhibitor%2520of%2520membrane-bound%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7871%26epage%3D7872%26doi%3D10.1021%2Fja9713385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span> <span> </span><span class="NLM_article-title">Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">12550</span>– <span class="NLM_lpage">12556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2818%2945240-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=3040755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFSnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=12550-12556&author=P.+Ghoshauthor=S.+Chatterjee&title=Effects+of+gentamicin+on+sphingomyelinase+activity+in+cultured+human+renal+proximal+tubular+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells</span></div><div class="casAuthors">Ghosh, Pradeep; Chatterjee, Subroto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">12550-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">In order to delineate the biochem. mechanisms responsible for the accumulation of sphingomyelin in proximal tubular cells (PT) incubated with gentamicin, studies on the activity of sphingomyelinase were pursued.  Characterization studies on sphingomyelinase revealed that this enzyme has a bimodal pH optima in PT cells.  Optimum activity was obsd. at pH 5.6 (designated as acid sphingomyelinase, A-SMase) and at pH 7.4 (designated as neutral sphingomyelinase, N-SMase).  The activity of both the enzymes increased proportionately in control cells as a function of days of incubation.  The activity of ASMase was 16% lower in cells incubated with gentamicin as compared to control.  The most striking observation was a gradual decline in the activity of N-SMase in cells incubated with gentamicin.  Thus, following 21 days of incubation of cells with 0.3 mM gentamicin, the N-SMase was 2.7-fold lower than control cells.  It appears that gentamicin exerts a competitive inhibition of the A-SMase in PT cells.  In contrast, gentamicin exerts a noncompetitive inhibition of the N-SMase in PT cells.  Thus gentamicin-mediated decrease in sphingomyelinase activity may be responsible for the storage of sphingomyelin in cultured human PT cells.  Furthermore N-SMase may play a role in gentamicin-induced nephrotoxicity in cultured human PT cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCnsG-gpTr1rVg90H21EOLACvtfcHk0ljBNwWJlsQpXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFSnsb8%253D&md5=5de9a075aa155142d6f36c9b8d11db6d</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2945240-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252945240-4%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DP.%26aulast%3DChatterjee%26aufirst%3DS.%26atitle%3DEffects%2520of%2520gentamicin%2520on%2520sphingomyelinase%2520activity%2520in%2520cultured%2520human%2520renal%2520proximal%2520tubular%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D12550%26epage%3D12556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lister, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford-Redick, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, C. R.</span></span> <span> </span><span class="NLM_article-title">Characterization of the neutral ph-optimum sphingomyelinase from rat brain: Inhibition by copper ii and ganglioside gm3</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>1165</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(93)90142-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2893%2990142-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8418889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3sXhtF2nurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1165&publication_year=1993&pages=314-320&author=M.+D.+Listerauthor=C.+L.+Crawford-Redickauthor=C.+R.+Loomis&title=Characterization+of+the+neutral+ph-optimum+sphingomyelinase+from+rat+brain%3A+Inhibition+by+copper+ii+and+ganglioside+gm3&doi=10.1016%2F0005-2760%2893%2990142-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3</span></div><div class="casAuthors">Lister, Mark D.; Crawford-Redick, Catherine L.; Loomis, Carson R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">1165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-20</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0005-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A neutral pH-optimum sphingomyelinase (N-SMase), solubilized from rat brain membranes, was characterized with respect to metal and membrane lipid effects.  Chromatofocusing chromatog., which separates proteins according to pI, showed 2 N-SMase activities.  One eluted at pH 4.7 and the other required 0.4M NaCl before elution.  Kinetically, the 2 prepns. appeared similar.  The N-SMase eluting at pH 4.7 was most extensively studied here.  Of the phospholipids studied, only phosphatidylserine showed any influence on N-SMase and that was to increase its activity by as much as 50%.  Neither serine nor phosphatidic acid had any effect.  Of the cations tested, none was able to replace Mg2+ as a required activator.  However, it was found that several metals were inhibitory, with Cu2+ being most effective (IC50 = 5 μM).  Gangliosides, particularly the monosialoganglioside, GM3 (IC50 = ∼50 μM), inhibited N-SMase.  Other glycolipids showed little effect on activity, even the immediate precursor to GM3, lactosylceramide.  The ganglioside sugar, N-acetylneuraminic acid, also had no effect on N-SMase activity.  None of these inhibitors affected the acidic pH optimum sphingomyelinase.  Other sphingolipid compds., such as ceramide, the enzymic product, and sphingosylphosphorylcholine (lysosphingomyelin), showed no capacity to inhibit N-Smase, implying that the enzyme may have a selective substrate-binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq95chNt8PoKbVg90H21EOLACvtfcHk0ljBNwWJlsQpXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtF2nurg%253D&md5=29b2319f54d574a160d7a025e30d236c</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2893%2990142-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252893%252990142-V%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DM.%2BD.%26aulast%3DCrawford-Redick%26aufirst%3DC.%2BL.%26aulast%3DLoomis%26aufirst%3DC.%2BR.%26atitle%3DCharacterization%2520of%2520the%2520neutral%2520ph-optimum%2520sphingomyelinase%2520from%2520rat%2520brain%253A%2520Inhibition%2520by%2520copper%2520ii%2520and%2520ganglioside%2520gm3%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1993%26volume%3D1165%26spage%3D314%26epage%3D320%26doi%3D10.1016%2F0005-2760%2893%2990142-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda-Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi-Yoshioka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki-Konagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumakura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, trichopeziza mollissima</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10470676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=531-535&author=F.+Naraauthor=M.+Tanakaauthor=S.+Masuda-Inoueauthor=Y.+Yamasatoauthor=H.+Doi-Yoshiokaauthor=K.+Suzuki-Konagaiauthor=S.+Kumakuraauthor=T.+Ogita&title=Biological+activities+of+scyphostatin%2C+a+neutral+sphingomyelinase+inhibitor+from+a+discomycete%2C+trichopeziza+mollissima&doi=10.7164%2Fantibiotics.52.531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima</span></div><div class="casAuthors">Nara, Futoshi; Tanaka, Masahiro; Masuda-Inoue, Seiko; Yamasato, Yoko; Doi-Yoshioka, Hiromi; Suzuki-Konagai, Keiko; Kumakura, Seiichiro; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-535</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">Scyphostatin is a specific inhibitor for mammalian neutral magnesium-dependent sphingomyelinase with a fifty percent inhibition concn. (IC50) value of 1.0 μM.  When used to inhibit lysosomal acid sphingomyelinase, an approx. 50-fold greater concn. is required.  In human peripheral monocytes, the compd. inhibits bacterial lipopolysaccharide (LPS)-induced prostaglandin E2 prodn. and LPS-induced interleukin-1β prodn. with IC50 values of 0.8 μM and 0.1 μM, resp.  In rat, p.o. administration of the compd. has also been shown to inhibit carrageenin-induced paw edema.  Thus, it is hoped that utility of scyphostatin as a pharmacol. tool will contribute to our understanding of the role of ceramide in the cellular inflammation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorgn3mBcPSbVg90H21EOLACvtfcHk0ljBNwWJlsQpXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitb8%253D&md5=51bcb255040c4ba2025af950f456b9fa</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.531%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DF.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DMasuda-Inoue%26aufirst%3DS.%26aulast%3DYamasato%26aufirst%3DY.%26aulast%3DDoi-Yoshioka%26aufirst%3DH.%26aulast%3DSuzuki-Konagai%26aufirst%3DK.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DBiological%2520activities%2520of%2520scyphostatin%252C%2520a%2520neutral%2520sphingomyelinase%2520inhibitor%2520from%2520a%2520discomycete%252C%2520trichopeziza%2520mollissima%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D531%26epage%3D535%26doi%3D10.7164%2Fantibiotics.52.531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1440</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(20000417)39:8<1440::AID-ANIE1440>3.0.CO;2-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtFSqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=1440-1442&author=C.+Arenzauthor=A.+Giannis&title=Synthesis+of+the+first+selective+irreversible+inhibitor+of+neutral+sphingomyelinase&doi=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of the first selective irreversible inhibitor of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1440-1442</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The epoxide I was prepd. from D-serine by reaction with decanoyl chloride and 5-amino-2-hydroxybenzyl alc., followed by epoxide ring formation.  I inhibited neutral sphingomyelinase, an effect that was inhibited by increased concns. of sphingomyelin, indicating that the compd. binds to the active site of the enzyme.  I does not inhibit acid sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdM4stC4pm7Vg90H21EOLACvtfcHk0lhBaHMj4jsdRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtFSqsrk%253D&md5=05f474fcb171fd95525bbbbdc4ae75a9</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252820000417%252939%253A8%253C1440%253A%253AAID-ANIE1440%253E3.0.CO%253B2-R%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520the%2520first%2520selective%2520irreversible%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2000%26volume%3D39%26spage%3D1440%26epage%3D1442%26doi%3D10.1002%2F%28SICI%291521-3773%2820000417%2939%3A8%3C1440%3A%3AAID-ANIE1440%3E3.0.CO%3B2-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wascholowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(01)00165-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0968-0896%2801%2900165-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11597471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=2901-2904&author=C.+Arenzauthor=M.+Gartnerauthor=V.+Wascholowskiauthor=A.+Giannis&title=Synthesis+and+biochemical+investigation+of+scyphostatin+analogues+as+inhibitors+of+neutral+sphingomyelinase&doi=10.1016%2FS0968-0896%2801%2900165-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Gartner, Michael; Wascholowski, Veit; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The sphingolipid ceramide is considered to be an important intracellular mediator.  However, many aspects of its action and the role of several different ceramide generating sphingomyelinases are still unclear.  Recently, the synthesis of the first selective irreversible inhibitor of the neutral sphingomyelinase (N-SMase), as well as the identification of Manumycin A and some of its analogs as irreversible inhibitors of N-SMase were reported.  For the development of pharmacol. interesting competitive inhibitors of N-SMase, structure-activity studies are essential.  Herein the synthesis and enzymic investigation of two scyphostatin analogs revealing the importance of the primary hydroxy group in N-[(1R)-1-(hydroxymethyl)-2-oxo-2-[(8-oxo-1-oxaspiro[2.5]octa-4,6-dien-5-yl)amino]ethyl]decanamide for N-SMase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreluVKWEKi4LVg90H21EOLACvtfcHk0lhBaHMj4jsdRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGktbk%253D&md5=b6a1c74fff9b7d347bc72683a18b8138</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2801%2900165-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252801%252900165-1%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DGartner%26aufirst%3DM.%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biochemical%2520investigation%2520of%2520scyphostatin%2520analogues%2520as%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D2901%26epage%3D2904%26doi%3D10.1016%2FS0968-0896%2801%2900165-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thutewohl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altenbach, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Manumycin a and its analogues are irreversible inhibitors of neutral sphingomyelinase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20010202)2:2<141::AID-CBIC141>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11828438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=141-143&author=C.+Arenzauthor=M.+Thutewohlauthor=O.+Blockauthor=H.+Waldmannauthor=H.+J.+Altenbachauthor=A.+Giannis&title=Manumycin+a+and+its+analogues+are+irreversible+inhibitors+of+neutral+sphingomyelinase&doi=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Arenz, Christoph; Thutewohl, Michael; Block, Oliver; Waldmann, Herbert; Altenbach, Hans-Josef; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-143</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">Using a raw microsome prepn., rat brain Mg+2-dependent neutral sphingomyelinase was inhibited by manumycin A, whereas lysosomal acid sphingomyelinase was not inhibited.  Four analogs of manumycin A were also tested and 2 of them inhibited the neutral sphingomyelinase.  The active compds. were also shown to be inhibitors of Ras farnesyltransferase (which is inhibited by manumycin A).  The relation of these results to the anti-inflammatory activity of manumycin A and the role of neutral sphingomyelinase in signal transduction are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPS9sStQGXLVg90H21EOLACvtfcHk0lhBaHMj4jsdRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVSqsbc%253D&md5=151df29021aaaaa73dfbb32bb8d6addf</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820010202%25292%253A2%253C141%253A%253AAID-CBIC141%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DThutewohl%26aufirst%3DM.%26aulast%3DBlock%26aufirst%3DO.%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DAltenbach%26aufirst%3DH.%2BJ.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DManumycin%2520a%2520and%2520its%2520analogues%2520are%2520irreversible%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DChemBioChem%26date%3D2001%26volume%3D2%26spage%3D141%26epage%3D143%26doi%3D10.1002%2F1439-7633%2820010202%292%3A2%3C141%3A%3AAID-CBIC141%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omura, S.</span></span> <span> </span><span class="NLM_article-title">Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by penicillium sp. Fo-7436</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10470682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXktFKitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=572-574&author=R.+Uchidaauthor=H.+Tomodaauthor=Y.+Dongauthor=S.+Omura&title=Alutenusin%2C+a+specific+neutral+sphingomyelinase+inhibitor%2C+produced+by+penicillium+sp.+Fo-7436&doi=10.7164%2Fantibiotics.52.572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Alutenusin, a specific neutral sphingomyelinase inhibitor, produced by Penicillium sp. FO-7436</span></div><div class="casAuthors">Uchida, Ryuji; Tomoda, Hiroshi; Dong, Yuesheng; Omura, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-574</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The fermn., isolation, and sphingomyelinase-inhibiting activity of alutenusin (I) of Penicillium FO-7436 are described.  I is a specific inhibitor of neutral sphingomyelinase (Ki = 20 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLr8aQNOH0rVg90H21EOLACvtfcHk0ljxqNlBWYy7Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFKitbk%253D&md5=ed7fcf0c05400125d3fcea96955486ab</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.572%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DR.%26aulast%3DTomoda%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DOmura%26aufirst%3DS.%26atitle%3DAlutenusin%252C%2520a%2520specific%2520neutral%2520sphingomyelinase%2520inhibitor%252C%2520produced%2520by%2520penicillium%2520sp.%2520Fo-7436%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D572%26epage%3D574%26doi%3D10.7164%2Fantibiotics.52.572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogita, T.</span></span> <span> </span><span class="NLM_article-title">F-11334s, new inhibitors of membrane-bound neutral sphingomyelinase</span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.52.827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.7164%2Fantibiotics.52.827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10726931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK1MXmtl2mu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=827-830&author=M.+Tanakaauthor=F.+Naraauthor=Y.+Yamasatoauthor=Y.+Onoauthor=T.+Ogita&title=F-11334s%2C+new+inhibitors+of+membrane-bound+neutral+sphingomyelinase&doi=10.7164%2Fantibiotics.52.827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">F-11334s, new inhibitors of membrane-bound neutral sphingomyelinase</span></div><div class="casAuthors">Tanaka, Masahiro; Nara, Futoshi; Yamasato, Yoko; Ono, Yasunori; Ogita, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antibiotics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">JANTAJ</span>;
        ISSN:<span class="NLM_cas:issn">0021-8820</span>.
    
            (<span class="NLM_cas:orgname">Japan Antibiotics Research Association</span>)
        </div><div class="casAbstract">The fermn., isolation, and structural properties of F-11334A1-3 and F-11334B1-2, inhibitors of sphingomyelinase derived from rat brain and produced by Acremonium murorum, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKdfwCLe30LVg90H21EOLACvtfcHk0ljxqNlBWYy7Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtl2mu7g%253D&md5=6779425b1b06dfb101331c245814dca6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.52.827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.52.827%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DYamasato%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DOgita%26aufirst%3DT.%26atitle%3DF-11334s%252C%2520new%2520inhibitors%2520of%2520membrane-bound%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Antibiot.%26date%3D1999%26volume%3D52%26spage%3D827%26epage%3D830%26doi%3D10.7164%2Fantibiotics.52.827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span>; <span class="NLM_string-name">Nara, F.</span>; <span class="NLM_string-name">Hosoya, T.</span></span> <span> </span><span class="NLM_article-title">New Compound F-11263</span>. Jpn. Pat. Appl. <span class="NLM_patent">JPH0853387</span>, <span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=Y.+Ogura&author=F.+Nara&author=T.+Hosoya&title=New+Compound+F-11263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DY.%26atitle%3DNew%2520Compound%2520F-11263%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forthoffer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: Purification and inhibition by ubiquinol</span>. <i>J. Bioenerg. Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1023/A:1010704715979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1023%2FA%3A1010704715979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11456220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1WgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=143-153&author=S.+F.+Martinauthor=F.+Navarroauthor=N.+Forthofferauthor=P.+Navasauthor=J.+M.+Villalba&title=Neutral+magnesium-dependent+sphingomyelinase+from+liver+plasma+membrane%3A+Purification+and+inhibition+by+ubiquinol&doi=10.1023%2FA%3A1010704715979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol</span></div><div class="casAuthors">Martin, Sergio F.; Navarro, Francisco; Forthoffer, Nathalie; Navas, Placido; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bioenergetics and Biomembranes</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">143-153</span>CODEN:
                <span class="NLM_cas:coden">JBBID4</span>;
        ISSN:<span class="NLM_cas:issn">0145-479X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Plasma membranes isolated from pig liver contained almost no acid sphingomyelinase, but significant Mg2+-dependent neutral sphingomyelinase (n-SMase) that was activated by phosphatidylserine (PS).  Here, the purifn. to apparent homogeneity of n-SMase of ∼87 kDa from liver plasma membranes is reported.  The purified enzyme strictly required Mg2+ and had a neutral optimal pH.  In contrast with n-SMase purified from other sources (such as brain), the enzyme purified from liver plasma membrane was not inhibited by glutathione, and strikingly, it was not activated by PS.  Liver n-SMase was inhibited by several lipophilic antioxidants in a dose-dependent manner.  Ubiquinol-10 was a more effective inhibitor than α-tocopherol, α-tocopherylquinone, α-tocopherylquinone, or ubiquinone-10, and the inhibition was noncompetitive.  Differential inhibition of n-SMase by antioxidants did not correlate with different levels of protection against lipid peroxidn.  Purified n-SMase was not inhibited significantly by ubiquinone-10 and ubiquinol-10, but ubiquinol-0 and ubiquinone-0 inhibited the enzyme by 30 and 60%, resp.  These results demonstrate a direct inhibitory effect of ubiquinol on plasma membrane n-SMase and support the participation of this mol. in the regulation of ceramide-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJU_M6LzBs7Vg90H21EOLACvtfcHk0ljxqNlBWYy7Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1WgtLs%253D&md5=5fb02cf1b81edbd9018350819684fb21</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010704715979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010704715979%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DNavarro%26aufirst%3DF.%26aulast%3DForthoffer%26aufirst%3DN.%26aulast%3DNavas%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DNeutral%2520magnesium-dependent%2520sphingomyelinase%2520from%2520liver%2520plasma%2520membrane%253A%2520Purification%2520and%2520inhibition%2520by%2520ubiquinol%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2001%26volume%3D33%26spage%3D143%26epage%3D153%26doi%3D10.1023%2FA%3A1010704715979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Diaz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: Specific inhibition of the mg(2+)-dependent enzyme and role of isoprenoid chain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)02222-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0006-291X%2802%2902222-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12270134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XntVymsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=581-586&author=S.+F.+Martinauthor=C.+Gomez-Diazauthor=P.+Navasauthor=J.+M.+Villalba&title=Ubiquinol+inhibition+of+neutral+sphingomyelinase+in+liver+plasma+membrane%3A+Specific+inhibition+of+the+mg%282%2B%29-dependent+enzyme+and+role+of+isoprenoid+chain&doi=10.1016%2FS0006-291X%2802%2902222-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquinol inhibition of neutral sphingomyelinase in liver plasma membrane: specific inhibition of the Mg2+-dependent enzyme and role of isoprenoid chain</span></div><div class="casAuthors">Martin, Sergio F.; Gomez-Diaz, Consuelo; Navas, Placido; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-586</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">In this work, the specificity of ubiquinol as inhibitor of the neutral sphingomyelinases present at the plasma membrane (Mg2+-dependent and -independent) and structural requirements for such inhibition have been studied.  Our results have shown that ubiquinol specifically inhibits Mg2+-dependent neutral sphingomyelinase activity in isolated liver plasma membranes, but no significant participation of the Mg2+-independent enzyme was obsd.  Both the redn. state of the (hydro)quinone ring and the length of the hydrophobic side chain were important determinants in neutral sphingomyelinase inhibition.  Ubiquinols inhibited the nSMase more efficiently than ubiquinones, and hydrophobic homologs with six or nine isoprene units were the most effective inhibitors.  Inhibition of nSMase by ubiquinols displayed similarities with inhibition by manumycin and the hydroquinones F11334's, suggesting that these compds. could act as structural analogs of ubiquinol.  Beyond its participation in mitochondrial energy metab., and as antioxidant, this novel role for ubiquinol as a neutral sphingomyelinase inhibitor should be considered an important factor to regulate lipid signaling at the plasma membrane that could be related to its beneficial effects on cells, tissues, and organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI25yEG4S6f7Vg90H21EOLACvtfcHk0li6FbL5dxP7kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntVymsbw%253D&md5=442d79bb67d2f309227ab58d81f573ce</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902222-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902222-2%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BF.%26aulast%3DGomez-Diaz%26aufirst%3DC.%26aulast%3DNavas%26aufirst%3DP.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DUbiquinol%2520inhibition%2520of%2520neutral%2520sphingomyelinase%2520in%2520liver%2520plasma%2520membrane%253A%2520Specific%2520inhibition%2520of%2520the%2520mg%25282%252B%2529-dependent%2520enzyme%2520and%2520role%2520of%2520isoprenoid%2520chain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D297%26spage%3D581%26epage%3D586%26doi%3D10.1016%2FS0006-291X%2802%2902222-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lister, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittman, R.</span></span> <span> </span><span class="NLM_article-title">Interaction of sphingomyelinase with sphingomyelin analogs modified at the c-1 and c-3 positions of the sphingosine backbone</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1256</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(94)00249-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2F0005-2760%2894%2900249-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=7742352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2MXkvFGmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1256&publication_year=1995&pages=25-30&author=M.+D.+Listerauthor=Z.+S.+Ruanauthor=R.+Bittman&title=Interaction+of+sphingomyelinase+with+sphingomyelin+analogs+modified+at+the+c-1+and+c-3+positions+of+the+sphingosine+backbone&doi=10.1016%2F0005-2760%2894%2900249-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone</span></div><div class="casAuthors">Lister, Mark D.; Ruan, Zhong-shi; Bittman, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1256</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, analogs differing at the C-1 or C-3 position of the sphingosine backbone of sphingomyelin were examd. in neutral pH-optimum sphingomyelinase assays.  Two analogs modified at the C-1 position, ceramide-1-phosphate and ceramide-1-phosphoethanol-N,N-dimethylamine, could act as modest substrates but showed no ability to inhibit the reaction when egg sphingomyelin was used as the substrate.  Four analogs of sphingomyelin differing at the C-3 position were used in which the hydroxyl group was replaced by a hydrogen atom (to give a deoxy-sphingomyelin analog), or with a O-Me, O-Et or O-tetrahydropyranyl group.  The deoxy analog showed no ability to compete with substrate of sphingomyelinase nor could it be hydrolyzed by the enzyme, suggesting that the hydroxyl group is a required substituent for the substrate.  The 3-O-Me and 3-O-ethyl-sphingomyelin analogs were inhibitors, with IC50 values of 50 μM and 140 μM, resp., at std. assay conditions.  However, when the rat brain acidic pH-optimum sphingomyelinase was used, no inhibition by the 3-O-Me analog could be detected.  The size of the alkyl group on the ether moiety was important, as shown by the inability of 3-O-tetrahydropyranyl-sphingomyelin to compete with substrate of neutral pH-optimum sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEt__iSUlvz7Vg90H21EOLACvtfcHk0li6FbL5dxP7kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvFGmsro%253D&md5=bed9d02a8780602fad990f492546ce40</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2894%2900249-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252894%252900249-X%26sid%3Dliteratum%253Aachs%26aulast%3DLister%26aufirst%3DM.%2BD.%26aulast%3DRuan%26aufirst%3DZ.%2BS.%26aulast%3DBittman%26aufirst%3DR.%26atitle%3DInteraction%2520of%2520sphingomyelinase%2520with%2520sphingomyelin%2520analogs%2520modified%2520at%2520the%2520c-1%2520and%2520c-3%2520positions%2520of%2520the%2520sphingosine%2520backbone%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1256%26spage%3D25%26epage%3D30%26doi%3D10.1016%2F0005-2760%2894%2900249-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokomatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takechi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kominato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeno, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1280</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)00179-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2801%2900179-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=11392536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1277-1280&author=T.+Yokomatsuauthor=H.+Takechiauthor=T.+Akiyamaauthor=S.+Shibuyaauthor=T.+Kominatoauthor=S.+Soedaauthor=H.+Shimeno&title=Synthesis+and+evaluation+of+a+difluoromethylene+analogue+of+sphingomyelin+as+an+inhibitor+of+sphingomyelinase&doi=10.1016%2FS0960-894X%2801%2900179-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase</span></div><div class="casAuthors">Yokomatsu, T.; Takechi, H.; Akiyama, T.; Shibuya, S.; Kominato, T.; Soeda, S.; Shimeno, H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1277-1280</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A sphingomyelin analog I, in which the long alkenyl chain and the phosphodiester moiety of sphingomyelin were replaced by a Ph and an isosteric difluoromethylenephosphonic acid resp., was prepd. to evaluate its inhibitory potency to sphingomyelinase.  I non-competitively inhibited the neutral sphingomyelinase in bovine brain microsomes with an IC50 of 400 μM.  The compd. also possessed the ability to suppress tumor necrosis factor α-induced apoptosis of PC-12 neurons at a low concn. of 0.1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdma6VFUUPELVg90H21EOLACvtfcHk0li6FbL5dxP7kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlSrsLo%253D&md5=41bd960b4e5b22a2e82d27d339397cf1</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900179-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900179-2%26sid%3Dliteratum%253Aachs%26aulast%3DYokomatsu%26aufirst%3DT.%26aulast%3DTakechi%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DShibuya%26aufirst%3DS.%26aulast%3DKominato%26aufirst%3DT.%26aulast%3DSoeda%26aufirst%3DS.%26aulast%3DShimeno%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520difluoromethylene%2520analogue%2520of%2520sphingomyelin%2520as%2520an%2520inhibitor%2520of%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1277%26epage%3D1280%26doi%3D10.1016%2FS0960-894X%2801%2900179-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yokomatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koizumi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeno, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00888-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2802%2900888-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12482429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVels70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=229-236&author=T.+Yokomatsuauthor=T.+Muranoauthor=T.+Akiyamaauthor=J.+Koizumiauthor=S.+Shibuyaauthor=Y.+Tsujiauthor=S.+Soedaauthor=H.+Shimeno&title=Synthesis+of+non-competitive+inhibitors+of+sphingomyelinases+with+significant+activity&doi=10.1016%2FS0960-894X%2802%2900888-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of non-competitive inhibitors of Sphingomyelinases with significant activity</span></div><div class="casAuthors">Yokomatsu, Tsutomu; Murano, Tetsuo; Akiyama, Takeshi; Koizumi, Junichi; Shibuya, Shiroshi; Tsuji, Yoshiaki; Soeda, Shinji; Shimeno, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-236</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of short-chain analogs of N-palmitoylsphingosine-1-phosphate, modified by replacement of the phosphate and the long alkenyl side chain with hydrolytically stable difluoromethylene phosphonate and Ph, resp., (e.g. I) were prepd. to study the structure-activity relationship for inhibition of sphingomyelinase.  The study revealed that inhibition is highly dependent upon the stereochem. of the asym. centers of the acylamino moiety, and resulted in identification of a non-competitive inhibitor with the same level of inhibitory activity of scyphostatin, the most potent of the few known small mol. inhibitors of sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7rtSpxpbyM7Vg90H21EOLACvtfcHk0li6FbL5dxP7kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVels70%253D&md5=02a994fba5496c09c58c9822764b480d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900888-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900888-0%26sid%3Dliteratum%253Aachs%26aulast%3DYokomatsu%26aufirst%3DT.%26aulast%3DMurano%26aufirst%3DT.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DKoizumi%26aufirst%3DJ.%26aulast%3DShibuya%26aufirst%3DS.%26aulast%3DTsuji%26aufirst%3DY.%26aulast%3DSoeda%26aufirst%3DS.%26aulast%3DShimeno%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520non-competitive%2520inhibitors%2520of%2520sphingomyelinases%2520with%2520significant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D229%26epage%3D236%26doi%3D10.1016%2FS0960-894X%2802%2900888-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomishima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobori, T.</span></span> <span> </span><span class="NLM_article-title">Sphingomyelin analogues as inhibitors of sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1963</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00360-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0960-894X%2803%2900360-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12781174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVGqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1963-1966&author=M.+Taguchiauthor=K.+Sugimotoauthor=K.+Godaauthor=T.+Akamaauthor=K.+Yamamotoauthor=T.+Suzukiauthor=Y.+Tomishimaauthor=M.+Nishiguchiauthor=K.+Araiauthor=K.+Takahashiauthor=T.+Kobori&title=Sphingomyelin+analogues+as+inhibitors+of+sphingomyelinase&doi=10.1016%2FS0960-894X%2803%2900360-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin analogues as inhibitors of sphingomyelinase</span></div><div class="casAuthors">Taguchi, Minoru; Sugimoto, Kikuo; Goda, Ken-Ichi; Akama, Tomoko; Yamamoto, Kyoko; Suzuki, Taizo; Tomishima, Yasumitsu; Nishiguchi, Mariko; Arai, Koshi; Takahashi, Kenzo; Kobori, Takeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1963-1966</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">To search for neutral sphingomyelinase inhibitors hydrolytically stable analogs of sphingomyelin were designed and synthesized.  The novel compds. in which the phosphodiester moiety of sphingomyelin was replaced with the carbamate moiety showed inhibitory activity with an IC50 value of μM on neutral sphingomyelinase in rat brain microsomes.  Compd. I showed a selective neutral sphingomyelinase inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTEKiRH1pEArVg90H21EOLACvtfcHk0lix3NDqA9492Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVGqsLY%253D&md5=0b70d076ecd7987ca7c99b925207824b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900360-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900360-3%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DGoda%26aufirst%3DK.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DNishiguchi%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DKobori%26aufirst%3DT.%26atitle%3DSphingomyelin%2520analogues%2520as%2520inhibitors%2520of%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1963%26epage%3D1966%26doi%3D10.1016%2FS0960-894X%2803%2900360-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of a neutral form of sphingomyelinase by alkylthioureido-l,3-propandiols, ky353x series</span>. <i>J. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1CgtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=169-173&author=S.+M.+Jungauthor=E.+M.+Jeongauthor=D.+H.+Joauthor=M.+R.+Chinauthor=H.+J.+Junauthor=Y.+H.+Kimauthor=H.+J.+Jeonauthor=D.+H.+Leeauthor=M.+J.+Parkauthor=M.+J.+Ohauthor=C.+B.+Yimauthor=D.+K.+Kim&title=Inhibition+of+a+neutral+form+of+sphingomyelinase+by+alkylthioureido-l%2C3-propandiols%2C+ky353x+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of a neutral form of sphingomyelinase by alkylthioureido-1,3-propandiols, KY353X series</span></div><div class="casAuthors">Jung, Sang Mi; Jeong, Eui Man; Jo, Dong Hwawn; Chin, Mi Reyoung; Jun, Hyung Jin; Kim, Yong Hyun; Jeon, Hyung Jun; Lee, Dong Hun; Park, Mi Ja; Oh, Mi Jung; Yim, Chul Bu; Kim, Dae Kyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-173</span>CODEN:
                <span class="NLM_cas:coden">JOAPA6</span>;
        ISSN:<span class="NLM_cas:issn">1225-6110</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Applied Pharmacology</span>)
        </div><div class="casAbstract">Alkylthioureido-1,3-propandiols (KY353X series) were synthesized and evaluated as inhibitors for neutral sphingomyelinase (N-SMase).  To examine whether KY353X series inhibit N-SMase, we purified the N-SMase from bovine brain.  The N-SMase was partially purified by sequential chromatogs. of DEAE-Cellulose anionic exchange and phenyl-5PW hydrophobic HPLC.  These sequential procedures for N-SMase resulted in a 67-fold purifn. and excluded other isoforms of SMase.  Based on in vitro assay, KY353X series inhibited N-SMase activity in time, concn.-dependent manners and completely inactivated N-SMase at 50 μM.  In particular, KY3535 and KY3536 inhibited more effectively than the others.  To further det. the inhibitory pattern, a Dixon plot was constructed, to showing that the inhibition by KY3535 and KY3536 were competitive.  The inhibition const. (Ki) of KY3535 and KY3536 was 1.7 μM and 2.5 μM in 100 mM Tris-HCl buffer, pH 7.0, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUIhL47nbE27Vg90H21EOLACvtfcHk0lix3NDqA9492Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1CgtbY%253D&md5=7fba2349be938feb0bd57911e8e1a17d</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DJeong%26aufirst%3DE.%2BM.%26aulast%3DJo%26aufirst%3DD.%2BH.%26aulast%3DChin%26aufirst%3DM.%2BR.%26aulast%3DJun%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DJeon%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DOh%26aufirst%3DM.%2BJ.%26aulast%3DYim%26aufirst%3DC.%2BB.%26aulast%3DKim%26aufirst%3DD.%2BK.%26atitle%3DInhibition%2520of%2520a%2520neutral%2520form%2520of%2520sphingomyelinase%2520by%2520alkylthioureido-l%252C3-propandiols%252C%2520ky353x%2520series%26jtitle%3DJ.%2520Appl.%2520Pharmacol.%26date%3D2003%26volume%3D11%26spage%3D169%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wascholowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannis, A.</span></span> <span> </span><span class="NLM_article-title">Sphingolactones: Selective and irreversible inhibitors of neutral sphingomyelinase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1002/anie.200501983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fanie.200501983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=827-830&author=V.+Wascholowskiauthor=A.+Giannis&title=Sphingolactones%3A+Selective+and+irreversible+inhibitors+of+neutral+sphingomyelinase&doi=10.1002%2Fanie.200501983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase</span></div><div class="casAuthors">Wascholowski, Veit; Giannis, Athanassios</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">827-830</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ceramide analogs, sphingolactones I [R = CH:CHCH:CHMe, (CH2)4Me] and II [R = CH:CHCH:CHMe, CH:CH(CH2)2Me, (CH2)4Me, Ph], without reactive epoxy groups, act as potent inhibitors of the neutral sphingomyelinase (N-SMase).  Thus, sphingolactones are useful chem. tools for exploring the biol. significance of ceramide and N-SMase in, for example, apoptosis and inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbCS47EKlOx7Vg90H21EOLACvtfcHk0lix3NDqA9492Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtLg%253D&md5=bee557db1ba93a02c97b366d879bb7ff</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1002%2Fanie.200501983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200501983%26sid%3Dliteratum%253Aachs%26aulast%3DWascholowski%26aufirst%3DV.%26aulast%3DGiannis%26aufirst%3DA.%26atitle%3DSphingolactones%253A%2520Selective%2520and%2520irreversible%2520inhibitors%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D827%26epage%3D830%26doi%3D10.1002%2Fanie.200501983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, G.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication</span>. <i>Drugs Exp Clin Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10894556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=57-65&author=E.+Amtmannauthor=M.+Zollerauthor=G.+Schilling&title=Neutral+sphingomyelinase-inhibiting+guanidines+prevent+herpes+simplex+virus-1+replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication</span></div><div class="casAuthors">Amtmann, E.; Zoller, M.; Schilling, G.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint Inc.</span>)
        </div><div class="casAbstract">We synthesized a series of new guanidinium derivs. and studied the inhibitory activity on both neutral sphingomyelinase and herpes simplex virus-1 (HSV-1) replication.  The lipophilic quality of the mols. was found to be correlated with the inhibitory potential of the compds.  Undecylidene-aminoguanidine was superior to derivs. with 10, 8 or 6 carbon atoms whereas propylidene-aminoguanidine was completely inactive.  Decylidene-aminoguanidine was the most active deriv., with 10 carbon atoms.  Various cyclic satd. isomers were inferior to the linear mol.  Arom. cyclic residues were superior to satd. cyclic residues.  The most active compd. was a deriv. contg. 11 carbon atoms, undecylidene-aminoguanidine (C11AG), which inhibited the replication of HSV-1 by 50% at a concn. of 2.6 μM while cytotoxic adverse effects were only obsd. at a concn. of 31 μM.  Expression of immediate early gene ICP-4 and concomitantly of HSV-1 specific DNA replication was found to be a target of C11AG.  This result suggests that C11AG interferes with cellular signal transduction mechanisms that regulate expression of HSV-1 immediate early genes.  C11AG was shown to inhibit neutral sphingomyelinase without affecting phospholipase A2, phosphatidylcholine-specific phospholipase C and phospholipase D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ4rbNLlizJbVg90H21EOLACvtfcHk0lhq4aJhf3pszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGgsb0%253D&md5=f01ce26d71bd8024108f6ded995c4bb1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DZoller%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DG.%26atitle%3DNeutral%2520sphingomyelinase-inhibiting%2520guanidines%2520prevent%2520herpes%2520simplex%2520virus-1%2520replication%26jtitle%3DDrugs%2520Exp%2520Clin%2520Res.%26date%3D2000%26volume%3D26%26spage%3D57%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baader, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase inhibitor c11ag prevents lipopolysaccharide-induced macrophage activation</span>. <i>Drugs Exp. Clin. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12866359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtVOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2003&pages=5-13&author=E.+Amtmannauthor=W.+Baaderauthor=M.+Zoller&title=Neutral+sphingomyelinase+inhibitor+c11ag+prevents+lipopolysaccharide-induced+macrophage+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide-induced macrophage activation</span></div><div class="casAuthors">Amtmann, E.; Baader, W.; Zoeller, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-13</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint Inc.</span>)
        </div><div class="casAbstract">Stimulation of macrophages by lipopolysaccharide (LPS) leads to the synthesis of proinflammatory cytokines and nitric oxide (NO) and, as a consequence, to endotoxic shock.  We provide evidence that LPS stimulates the activity of a membrane-assocd. neutral sphingomyelinase (nSMase) and that this activity is mandatory for the liberation of nuclear factor-.vkappa.B (NF.vkappa.B) and the induction of inducible NO-synthase (iNOS).  With the aid of a newly developed, selective inhibitor of nSMase, C11AG, we could distinguish between nSMase-dependent and -independent LPS-induced signals.  C11AG blocked LPS-stimulated sphingomyelin degrdn. and NF.vkappa.B activation without interfering with p42 tyrosine phosphorylation.  Concomitantly, the expression of iNOS was found to be reduced both in mononuclear cells and in murine endotoxemia.  Therefore, specific inhibitors of nSMase may define a new class of antiinflammatory substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFyb-NDgBO_rVg90H21EOLACvtfcHk0lhq4aJhf3pszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtVOis7Y%253D&md5=640a2be268599ac994d79fc2ef08e099</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmtmann%26aufirst%3DE.%26aulast%3DBaader%26aufirst%3DW.%26aulast%3DZoller%26aufirst%3DM.%26atitle%3DNeutral%2520sphingomyelinase%2520inhibitor%2520c11ag%2520prevents%2520lipopolysaccharide-induced%2520macrophage%2520activation%26jtitle%3DDrugs%2520Exp.%2520Clin.%2520Res.%26date%3D2003%26volume%3D29%26spage%3D5%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collenburg, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyersdorf, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saied, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Flegler, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Schaulies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avota, E.</span></span> <span> </span><span class="NLM_article-title">The activity of the neutral sphingomyelinase is important in T cell recruitment and directional migration</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1007</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.01007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3389%2Ffimmu.2017.01007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28871263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWntLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1007&author=L.+Collenburgauthor=N.+Beyersdorfauthor=T.+Wieseauthor=C.+Arenzauthor=E.+M.+Saiedauthor=K.+A.+Becker-Fleglerauthor=S.+Schneider-Schauliesauthor=E.+Avota&title=The+activity+of+the+neutral+sphingomyelinase+is+important+in+T+cell+recruitment+and+directional+migration&doi=10.3389%2Ffimmu.2017.01007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The activity of the neutral sphingomyelinase is important in t cell recruitment and directional migration</span></div><div class="casAuthors">Collenburg, Lena; Beyersdorf, Niklas; Wiese, Teresa; Arenz, Christoph; Saied, Essa M.; Becker-Flegler, Katrin Anne; Schneider-Schaulies, Sibylle; Avota, Elita</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1007/1-1007/12</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Breakdown of sphingomyelin as catalyzed by the activity of sphingomyelinases pro - foundly affects biophys. properties of cellular membranes which is particularly important with regard to compartmentalization of surface receptors and their signaling relay.  As it is activated both upon TCR ligation and co-stimulation in a spatiotemporally controlled manner, the neutral sphingomyelinase (NSM) has proven to be important in T cell activation, where it appears to play a particularly important role in cytoskeletal reorganization and cell polarization.  Because these are important parameters in directional T cell migration and motility in tissues, we analyzed the role of the NSM in these processes.  Pharmacol. inhibition of NSM interfered with early lymph node homing of T cells in vivo indicating that the enzyme impacts on endothelial adhesion, transendothelial migration, sensing of chemokine gradients or, at a cellular level, acquisition of a polarized phenotype.  NSM inhibition reduced adhesion of T cells to TNF-α /IFN-γ activated, but not resting endothelial cells, most likely via inhibiting high-affinity LFA-1 clustering.  NSM activity proved to be highly important in directional T cell motility in response to SDF1-α, indicating that their ability to sense and translate chemokine gradients might be NSM dependent.  In fact, pharmacol. or genetic NSM ablation interfered with T cell polarization both at an overall morphol. level and redistribution of CXCR4 and pERM proteins on endothelial cells or fibronectin, as well as with F-actin polymn. in response to SDF1-α stimulation, indicating that efficient directional perception and signaling relay depend on NSM activity.  Altogether, these data support a central role of the NSM in T cell recruitment and migration both under homeostatic and inflamed conditions by regulating polarized redistribution of receptors and their coupling to the cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUR7BQTf6LTrVg90H21EOLACvtfcHk0lhq4aJhf3pszw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWntLvP&md5=5dba3deccc65f44864a745ab0a3b7901</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.01007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.01007%26sid%3Dliteratum%253Aachs%26aulast%3DCollenburg%26aufirst%3DL.%26aulast%3DBeyersdorf%26aufirst%3DN.%26aulast%3DWiese%26aufirst%3DT.%26aulast%3DArenz%26aufirst%3DC.%26aulast%3DSaied%26aufirst%3DE.%2BM.%26aulast%3DBecker-Flegler%26aufirst%3DK.%2BA.%26aulast%3DSchneider-Schaulies%26aufirst%3DS.%26aulast%3DAvota%26aufirst%3DE.%26atitle%3DThe%2520activity%2520of%2520the%2520neutral%2520sphingomyelinase%2520is%2520important%2520in%2520T%2520cell%2520recruitment%2520and%2520directional%2520migration%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D1007%26doi%3D10.3389%2Ffimmu.2017.01007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wachter, M. P.</span>; <span class="NLM_string-name">Lalan, P.</span></span> <span> </span><span class="NLM_article-title">Substituted Amino Acids as Neutral Sphingomyelinase Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2001/056560</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+P.+Wachter&author=P.+Lalan&title=Substituted+Amino+Acids+as+Neutral+Sphingomyelinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWachter%26aufirst%3DM.%2BP.%26atitle%3DSubstituted%2520Amino%2520Acids%2520as%2520Neutral%2520Sphingomyelinase%2520Inhibitors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luberto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassler, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazen-Martin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannun, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor necrosis factor-induced cell death in mcf7 by a novel inhibitor of neutral sphingomyelinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">41128</span>– <span class="NLM_lpage">41139</span>, <span class="refDoi"> DOI: 10.1074/jbc.M206747200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M206747200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=12154098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFymsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=41128-41139&author=C.+Lubertoauthor=D.+F.+Hasslerauthor=P.+Signorelliauthor=Y.+Okamotoauthor=H.+Sawaiauthor=E.+Borosauthor=D.+J.+Hazen-Martinauthor=L.+M.+Obeidauthor=Y.+A.+Hannunauthor=G.+K.+Smith&title=Inhibition+of+tumor+necrosis+factor-induced+cell+death+in+mcf7+by+a+novel+inhibitor+of+neutral+sphingomyelinase&doi=10.1074%2Fjbc.M206747200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Tumor Necrosis Factor-Induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase</span></div><div class="casAuthors">Luberto, Chiara; Hassler, Daniel F.; Signorelli, Paola; Okamoto, Yasuo; Sawai, Hirofumi; Boros, Eric; Hazen-Martin, Debra J.; Obeid, Lina M.; Hannun, Yusuf A.; Smith, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">41128-41139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A high throughput screen for neutral, magnesium-dependent sphingomyelinase (SMase) was performed.  One inhibitor discovered in the screen, GW4869, functioned as a noncompetitive inhibitor of the enzyme in vitro with an IC50 of 1 μM.  It did not inhibit acid SMase at up to at least 150 μM.  The compd. was then evaluated for its ability to inhibit tumor necrosis factor (TNF)-induced activation of neutral SMase (N-SMase) in MCF7 cells.  GW4869 (10 μM) partially inhibited TNF-induced sphingomyelin (SM) hydrolysis, and 20 μM of the compd. was protected completely from the loss of SM.  The addn. of 10-20 μM GW4869 completely inhibited the initial accumulation of ceramide, whereas this effect was partially lost at later time points (24 h).  These data therefore support the inhibitory action of GW4869 on N-SMase not only in vitro but also in a cellular model.  The addn. of GW4869 at both 10 and 20 μM did not modify cellular glutathione levels in response to TNF, suggesting that the action of GW4869 occurred downstream of the drop in glutathione, which was shown previously to occur upstream of the activation of N-SMase.  Further, whereas TNF treatment also caused a 75% increase of de novo synthesized ceramide after 20 h of incubation, GW4869, at either 10 or 20 μM, had no effect on this pathway of ceramide generation.  In addn., GW4869 did not significantly impair TNF-induced NF-κB translocation to nuclei.  Therefore, GW4869 does not interfere with other key TNF-mediated signaling effects.  GW4869 was able, in a dose-dependent manner, to significantly protect from cell death as measured by nuclear condensation, caspase activation, PARP degrdn., and trypan blue uptake.  These protective effects were accompanied by significant inhibition of cytochrome c release from mitochondria and caspase 9 activation, therefore localizing N-SMase activation upstream of mitochondrial dysfunction.  In conclusion, our results indicate that N-SMase activation is a necessary step for the full development of the cytotoxic program induced by TNF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM6H3u0rsMErVg90H21EOLACvtfcHk0li1e3UaeL8zgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFymsL8%253D&md5=dcab096a8b7ba127e498c6d0bc985f4b</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M206747200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M206747200%26sid%3Dliteratum%253Aachs%26aulast%3DLuberto%26aufirst%3DC.%26aulast%3DHassler%26aufirst%3DD.%2BF.%26aulast%3DSignorelli%26aufirst%3DP.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DSawai%26aufirst%3DH.%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DHazen-Martin%26aufirst%3DD.%2BJ.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DHannun%26aufirst%3DY.%2BA.%26aulast%3DSmith%26aufirst%3DG.%2BK.%26atitle%3DInhibition%2520of%2520tumor%2520necrosis%2520factor-induced%2520cell%2520death%2520in%2520mcf7%2520by%2520a%2520novel%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D41128%26epage%3D41139%26doi%3D10.1074%2Fjbc.M206747200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamiya-Koizumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, K.</span></span> <span> </span><span class="NLM_article-title">Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1803</span>– <span class="NLM_lpage">1806</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.jbchem.a135659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1093%2Foxfordjournals.jbchem.a135659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=3017927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaL28XksFKrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1986&pages=1803-1806&author=K.+Tamiya-Koizumiauthor=K.+Kojima&title=Activation+of+magnesium-dependent%2C+neutral+sphingomyelinase+by+phosphatidylserine&doi=10.1093%2Foxfordjournals.jbchem.a135659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine</span></div><div class="casAuthors">Tamiya-Koizumi, Keiko; Kojima, Kiyohide</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry </span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1803-6</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    </div><div class="casAbstract">The plasma membrane isolated from rat ascites hepatoma, AH 7974 cells was treated with 1% Triton X-100, which resulted in a >80% redn. in the phospholipid content of the plasma membrane.  The delipidized plasma membrane showed only 18% of the activity of the Mg2+-dependent, neutral sphingomyelinase in the untreated plasma membrane.  On the addn. of acidic phospholipids, esp. phosphatidylserine, however, the enzyme activity in the delipidized membrane was markedly restored (≤77% of that in the untreated membrane).  Considering the phospholipid compn. of the AH 7974 plasma membrane, phosphatidylserine may be a natural activator of neutral sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGory5Dsk4v04rVg90H21EOLACvtfcHk0li1e3UaeL8zgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XksFKrtbw%253D&md5=d022cf97bcbb14d0f6e5ac0436e8da66</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a135659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a135659%26sid%3Dliteratum%253Aachs%26aulast%3DTamiya-Koizumi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DK.%26atitle%3DActivation%2520of%2520magnesium-dependent%252C%2520neutral%2520sphingomyelinase%2520by%2520phosphatidylserine%26jtitle%3DJ.%2520Biochem.%26date%3D1986%26volume%3D99%26spage%3D1803%26epage%3D1806%26doi%3D10.1093%2Foxfordjournals.jbchem.a135659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkins, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieberich, E.</span></span> <span> </span><span class="NLM_article-title">Exosome reduction in vivo is associated with lower amyloid plaque load in the 5xfad mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1792</span>– <span class="NLM_lpage">1800</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.neurobiolaging.2014.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=24650793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1792-1800&author=M.+B.+Dinkinsauthor=S.+Dasguptaauthor=G.+Wangauthor=G.+Zhuauthor=E.+Bieberich&title=Exosome+reduction+in+vivo+is+associated+with+lower+amyloid+plaque+load+in+the+5xfad+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2014.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Dinkins, Michael B.; Dasgupta, Somsankar; Wang, Guanghu; Zhu, Gu; Bieberich, Erhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1792-1800</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 in vitro and in vivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia in vitro.  Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869.  Using the 5XFAD mouse, we show that i.p. injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load.  Redn. of total Aβ1-42 as well as no. of plaques in brain sections was significantly greater (40% redn.) in male than female mice.  Our results suggest that GW4869 reduces amyloid plaque formation in vivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLIu4kNCudmrVg90H21EOLACvtfcHk0li1e3UaeL8zgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFWms74%253D&md5=fad449ab8ae238c05722159ca0d1771d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DDinkins%26aufirst%3DM.%2BB.%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DBieberich%26aufirst%3DE.%26atitle%3DExosome%2520reduction%2520in%2520vivo%2520is%2520associated%2520with%2520lower%2520amyloid%2520plaque%2520load%2520in%2520the%25205xfad%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D1792%26epage%3D1800%26doi%3D10.1016%2Fj.neurobiolaging.2014.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medalla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luebke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haydar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolozin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikezu, T.</span></span> <span> </span><span class="NLM_article-title">Depletion of microglia and inhibition of exosome synthesis halt tau propagation</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.1038/nn.4132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fnn.4132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26436904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=1584-1593&author=H.+Asaiauthor=S.+Ikezuauthor=S.+Tsunodaauthor=M.+Medallaauthor=J.+Luebkeauthor=T.+Haydarauthor=B.+Wolozinauthor=O.+Butovskyauthor=S.+Kuglerauthor=T.+Ikezu&title=Depletion+of+microglia+and+inhibition+of+exosome+synthesis+halt+tau+propagation&doi=10.1038%2Fnn.4132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of microglia and inhibition of exosome synthesis halt tau propagation</span></div><div class="casAuthors">Asai, Hirohide; Ikezu, Seiko; Tsunoda, Satoshi; Medalla, Maria; Luebke, Jennifer; Haydar, Tarik; Wolozin, Benjamin; Butovsky, Oleg; Kugler, Sebastian; Ikezu, Tsuneya</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1584-1593</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of pathol. tau protein is a major hallmark of Alzheimer's disease.  Tau protein spreads from the entorhinal cortex to the hippocampal region early in the disease.  Microglia, the primary phagocytes in the brain, are pos. correlated with tau pathol., but their involvement in tau propagation is unknown.  We developed an adeno-assocd. virus-based model exhibiting rapid tau propagation from the entorhinal cortex to the dentate gyrus in 4 wk.  We found that depleting microglia dramatically suppressed the propagation of tau and reduced excitability in the dentate gyrus in this mouse model.  Moreover, we demonstrate that microglia spread tau via exosome secretion, and inhibiting exosome synthesis significantly reduced tau propagation in vitro and in vivo.  These data suggest that microglia and exosomes contribute to the progression of tauopathy and that the exosome secretion pathway may be a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqToyvNuy7O_LVg90H21EOLACvtfcHk0lhX8_tTohiThg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wls7bJ&md5=f7812e38de725ea70862ec6dfea32ca2</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fnn.4132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4132%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DH.%26aulast%3DIkezu%26aufirst%3DS.%26aulast%3DTsunoda%26aufirst%3DS.%26aulast%3DMedalla%26aufirst%3DM.%26aulast%3DLuebke%26aufirst%3DJ.%26aulast%3DHaydar%26aufirst%3DT.%26aulast%3DWolozin%26aufirst%3DB.%26aulast%3DButovsky%26aufirst%3DO.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DIkezu%26aufirst%3DT.%26atitle%3DDepletion%2520of%2520microglia%2520and%2520inhibition%2520of%2520exosome%2520synthesis%2520halt%2520tau%2520propagation%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D1584%26epage%3D1593%26doi%3D10.1038%2Fnn.4132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoica, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loane, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abulwerdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faden, A. I.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase inhibition alleviates lps-induced microglia activation and neuroinflammation after experimental traumatic brain injury</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1124/jpet.118.253955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1124%2Fjpet.118.253955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30563941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2019&pages=338-352&author=A.+Kumarauthor=R.+J.+Henryauthor=B.+A.+Stoicaauthor=D.+J.+Loaneauthor=G.+Abulwerdiauthor=S.+A.+Bhatauthor=A.+I.+Faden&title=Neutral+sphingomyelinase+inhibition+alleviates+lps-induced+microglia+activation+and+neuroinflammation+after+experimental+traumatic+brain+injury&doi=10.1124%2Fjpet.118.253955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase inhibition alleviates LPS-induced microglia activation and neuroinflammation after experimental traumatic brain injury</span></div><div class="casAuthors">Kumar, Asit; Henry, Rebecca J.; Stoica, Bogdan A.; Loane, David J.; Abulwerdi, Gelareh; Bhat, Shahnawaz A.; Faden, Alan I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">338-352</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuroinflammation is one of the key secondary injury mechanisms triggered by traumatic brain injury (TBI).  Microglial activation, a hallmark of brain neuroinflammation, plays a crit. role in regulating immune responses after TBI and contributes to progressive neurodegeneration and neurol. deficits following brain trauma.  Here we evaluated the role of neutral sphingomyelinase (nSMase) in microglial activation by examg. the effects of the nSMase inhibitors altenusin and GW4869 in vitro (using BV2 microglia cells and primary microglia), as well as in a controlled cortical injury (CCI) model in adult male C57BL/6 mice.  Pretreatment of altenusin or GW4869 prior to lipopolysaccharide (LPS) stimulation for 4 or 24 h, significantly downregulated gene expression of the pro-inflammatory mediators TNF-α, IL-1β, IL-6, iNOS, and CCL2 in microglia and reduced the release of nitric oxide and TNF-α.  These nSMase inhibitors also attenuated the release of microparticles and phosphorylation of p38MAPK and ERK1/2.  In addn., altenusin pretreatment also reduced the gene expression of multiple inflammatory markers assocd. with microglial activation after exptl. TBI, including TNF-α, IL-1β, IL-6, iNOS, CCL2, CD68, NOX2, and p22phox.  Overall, our data demonstrate that nSMase inhibitors attenuate multiple inflammatory pathways assocd. with microglial activation in vitro and after exptl. TBI.  Thus, nSMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNXZPfzc0WRLVg90H21EOLACvtfcHk0lhX8_tTohiThg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFWgs7g%253D&md5=725fc7ab7274233ab50716e77a6d10ee</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1124%2Fjpet.118.253955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.118.253955%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DHenry%26aufirst%3DR.%2BJ.%26aulast%3DStoica%26aufirst%3DB.%2BA.%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DAbulwerdi%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DS.%2BA.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DNeutral%2520sphingomyelinase%2520inhibition%2520alleviates%2520lps-induced%2520microglia%2520activation%2520and%2520neuroinflammation%2520after%2520experimental%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D368%26spage%3D338%26epage%3D352%26doi%3D10.1124%2Fjpet.118.253955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okuro, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casquilho, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardim-Neto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncally-Carvalho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atella, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zin, W. A.</span></span> <span> </span><span class="NLM_article-title">The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2018.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.pupt.2018.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29702255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=100-110&author=R.+T.+Okuroauthor=M.+N.+Machadoauthor=N.+V.+Casquilhoauthor=A.+Jardim-Netoauthor=A.+Roncally-Carvalhoauthor=G.+C.+Atellaauthor=W.+A.+Zin&title=The+role+of+sphingolipid+metabolism+disruption+on+lipopolysaccharide-induced+lung+injury+in+mice&doi=10.1016%2Fj.pupt.2018.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice</span></div><div class="casAuthors">Okuro, Renata Tiemi; Machado, Mariana Nascimento; Casquilho, Natalia Vasconcelos; Jardim-Neto, Alcendino; Roncally-Carvalho, Alysson; Atella, Georgia Correa; Zin, Walter Araujo</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100-110</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">This study assessed pulmonary outcomes generated by inhibiting key enzymes of sphingolipid metab. pathways related to ceramide synthesis in a murine model of lung injury induced by lipopolysaccharide (LPS).  C57BL/6 male adult mice received LPS intratracheally and the expressions of acid sphingomyelinase (ASM), neutral sphingomyelinase (NSM), serine palmitoyl transferase (SPT) and dihydroceramide synthase (DS) were assessed at 2, 4, 6, 12 and 24 h after LPS instillation in lung homogenate (n = 30).  The pharmacol. inhibition of ASM, NSM, SPT and DS were assayed in other mice groups by three different doses of desipramine, GW4869, myriocin and fumonisin, resp. (n = 90).  Their most EDs were administered i.p. 1 or 2 h before LPS to different animal groups (n = 120).  Mice underwent detn. of pulmonary mechanics, lung histopathol. aspects and apoptosis.  The expression levels of the enzymes reached their peak at 2-4 h after LPS administration.  ASM inhibition attenuated alveolar collapse and GW4869 decreased lung elastance, proinflammatory cytokines' levels and was more effective to improve alveolar collapse than desipramine.  On the other hand, SPT blockage aggravated lung lesion and no effects it was obsd. with fumonisin.  Moreover, simultaneous administration of inhibitors (desipramine + GW4869, myriocin + fumonisin and all inhibitors together) resulted in no changes.  Blockage of sphingomyelinases and the de novo pathways improved and aggravated lung injury, resp., putatively suggesting specific targets to therapeutic strategies in LPS-induced lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVCwlpRfSUkLVg90H21EOLACvtfcHk0lhX8_tTohiThg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyksLY%253D&md5=eee19551299c73b99e3a572ab3f9d7c1</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2018.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2018.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DOkuro%26aufirst%3DR.%2BT.%26aulast%3DMachado%26aufirst%3DM.%2BN.%26aulast%3DCasquilho%26aufirst%3DN.%2BV.%26aulast%3DJardim-Neto%26aufirst%3DA.%26aulast%3DRoncally-Carvalho%26aufirst%3DA.%26aulast%3DAtella%26aufirst%3DG.%2BC.%26aulast%3DZin%26aufirst%3DW.%2BA.%26atitle%3DThe%2520role%2520of%2520sphingolipid%2520metabolism%2520disruption%2520on%2520lipopolysaccharide-induced%2520lung%2520injury%2520in%2520mice%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2018%26volume%3D50%26spage%3D100%26epage%3D110%26doi%3D10.1016%2Fj.pupt.2018.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lallemand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouahi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiader, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grazide, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoffre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alayrac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recazens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvayre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negre-Salvayre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auge, N.</span></span> <span> </span><span class="NLM_article-title">Nsmase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by gw4869 reduces inflammation and atherosclerosis in apoe(−/−) mice</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.118.311208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1161%2FATVBAHA.118.311208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29794115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Srt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1479-1492&author=T.+Lallemandauthor=M.+Rouahiauthor=A.+Swiaderauthor=M.+H.+Grazideauthor=N.+Geoffreauthor=P.+Alayracauthor=E.+Recazensauthor=A.+Costeauthor=R.+Salvayreauthor=A.+Negre-Salvayreauthor=N.+Auge&title=Nsmase2+%28type+2-neutral+sphingomyelinase%29+deficiency+or+inhibition+by+gw4869+reduces+inflammation+and+atherosclerosis+in+apoe%28%E2%88%92%2F%E2%88%92%29+mice&doi=10.1161%2FATVBAHA.118.311208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice</span></div><div class="casAuthors">Lallemand, Tom; Rouahi, Myriam; Swiader, Audrey; Grazide, Marie-Helene; Geoffre, Nancy; Alayrac, Paul; Recazens, Emeline; Coste, Agnes; Salvayre, Robert; Negre-Salvayre, Anne; Auge, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1479-1492</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Atherosclerosis is a chronic multifactorial and inflammatory disease of large and medium arteries and the leading cause of cardiovascular diseases worldwide.  The aim of this study was to investigate whether and how the nSMase2 (type 2-neutral sphingomyelinase), a key enzyme of sphingolipid metab., may contribute to the development of atherosclerotic lesions.  APPROACH AND RESULTS-: The role of nSMase2 in atherosclerosis was investigated in Apoe;Smpd3 mice, mutant for nSMase2, and in Apoe;Smpd3 mice i.p. injected with GW4869, a pharmacol. nSMase2 inhibitor.  The defect or inhibition of nSMase2 resulted in a redn. of atherosclerotic lesions and a decrease in macrophage infiltration and lipid deposition, although cholesterolemia remained unchanged.  NSMase2 inhibition decreased the inflammatory response of murine endothelial cells to oxLDL (oxidized low-d. lipoprotein), as assessed by the significant redn. of MCP-1 (monocyte chemoattractant protein 1), ICAM-1 (intercellular adhesion mol.-1), and VCAM-1 (vascular cell adhesion mol.-1) mRNA expressions and macrophage recruitment.  Likewise, in RAW264.7 or in macrophages isolated from Apoe/Smpd3 or Apoe/Smpd3 mice stimulated by lipopolysaccharides, nSMase2 inhibition resulted in a decrease in the expression of inflammatory mols.  Mechanistically, the anti-inflammatory response resulting from nSMase2 inhibition involves Nrf2 (nuclear factor [erythroid-derived 2]-like 2 or NF-E2-related factor-2) activation in both endothelial cells and macrophages, as assessed by the lack of protective effect of GW4869 in endothelial cells silenced for Nrf2 by small interfering RNAs, and in lipopolysaccharide-stimulated macrophages issued from Nrf2-KO mice.  CONCLUSIONS-: The genetic deficiency or inhibition of nSMase2 strongly decreases the development of atherosclerotic lesions in Apoe mice, by reducing inflammatory responses through a mechanism involving the Nrf2 pathway.  Inhibitors of nSMase2 may, therefore, constitute a novel approach to slow down atherosclerosis progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTrIQAiPGDVrVg90H21EOLACvtfcHk0ljOI4wdEvekwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Srt7jN&md5=544cca02f689f9161e7b09eadf8ee43d</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.118.311208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.118.311208%26sid%3Dliteratum%253Aachs%26aulast%3DLallemand%26aufirst%3DT.%26aulast%3DRouahi%26aufirst%3DM.%26aulast%3DSwiader%26aufirst%3DA.%26aulast%3DGrazide%26aufirst%3DM.%2BH.%26aulast%3DGeoffre%26aufirst%3DN.%26aulast%3DAlayrac%26aufirst%3DP.%26aulast%3DRecazens%26aufirst%3DE.%26aulast%3DCoste%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DNegre-Salvayre%26aufirst%3DA.%26aulast%3DAuge%26aufirst%3DN.%26atitle%3DNsmase2%2520%2528type%25202-neutral%2520sphingomyelinase%2529%2520deficiency%2520or%2520inhibition%2520by%2520gw4869%2520reduces%2520inflammation%2520and%2520atherosclerosis%2520in%2520apoe%2528%25E2%2588%2592%252F%25E2%2588%2592%2529%2520mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3D1479%26epage%3D1492%26doi%3D10.1161%2FATVBAHA.118.311208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coblentz, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christou, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L. F.</span></span> <span> </span><span class="NLM_article-title">Small-hairpin rna and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction</span>. <i>Am. J. Physiol Lung Cell Mol. Physiol</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">L679</span>– <span class="NLM_lpage">L690</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00516.2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1152%2Fajplung.00516.2018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30702345" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2019&pages=L679-L690&author=P.+D.+Coblentzauthor=B.+Ahnauthor=L.+F.+Haywardauthor=J.+K.+Yooauthor=D.+D.+Christouauthor=L.+F.+Ferreira&title=Small-hairpin+rna+and+pharmacological+targeting+of+neutral+sphingomyelinase+prevent+diaphragm+weakness+in+rats+with+heart+failure+and+reduced+ejection+fraction&doi=10.1152%2Fajplung.00516.2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00516.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00516.2018%26sid%3Dliteratum%253Aachs%26aulast%3DCoblentz%26aufirst%3DP.%2BD.%26aulast%3DAhn%26aufirst%3DB.%26aulast%3DHayward%26aufirst%3DL.%2BF.%26aulast%3DYoo%26aufirst%3DJ.%2BK.%26aulast%3DChristou%26aufirst%3DD.%2BD.%26aulast%3DFerreira%26aufirst%3DL.%2BF.%26atitle%3DSmall-hairpin%2520rna%2520and%2520pharmacological%2520targeting%2520of%2520neutral%2520sphingomyelinase%2520prevent%2520diaphragm%2520weakness%2520in%2520rats%2520with%2520heart%2520failure%2520and%2520reduced%2520ejection%2520fraction%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2019%26volume%3D316%26spage%3DL679%26epage%3DL690%26doi%3D10.1152%2Fajplung.00516.2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Drug-resistant endothelial cells facilitate progression, emt and chemoresistance in nasopharyngeal carcinoma via exosomes</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">109385</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2019.109385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.cellsig.2019.109385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31394194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2rtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=109385&author=L.+Huangauthor=C.+Huauthor=H.+Chaoauthor=Y.+Zhangauthor=Y.+Liauthor=J.+Houauthor=Z.+Xuauthor=H.+Luauthor=H.+Liauthor=H.+Chen&title=Drug-resistant+endothelial+cells+facilitate+progression%2C+emt+and+chemoresistance+in+nasopharyngeal+carcinoma+via+exosomes&doi=10.1016%2Fj.cellsig.2019.109385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-resistant endothelial cells facilitate progression, EMT and chemoresistance in nasopharyngeal carcinoma via exosomes</span></div><div class="casAuthors">Huang, Limin; Hu, Chaoquan; Chao, Hui; Zhang, Yu; Li, Yong; Hou, Jing; Xu, Zhong; Lu, He; Li, Hong; Chen, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109385</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent antitumor drug development has included investigation of a wide variety of anti-angiogenesis therapies.  Because cancer cells in tumors require new blood vessels to grow and spread, they stimulate capillary proliferation from existing vessels as well as new vessel formation from endothelial precursor cells.  Our previous findings suggested that drug resistance in mouse endothelial cells supported tumor growth, but the relationship between endothelial cells (ECs) and nasopharyngeal carcinoma (NPC) cells remained unclear.  Exosomes are small membrane vesicles that are released by several cell types, including human microvascular ECs (HMECs).  Exosomes carrying membrane and cytoplasmic constituents have been described as participants in a novel mechanism of cell-to-cell communication.  In the present study, we investigated the mechanisms underlying the interactions between HMECs and NPC cells.  We found that drug-resistant HMECs secreted small heterogeneous 40-100 nm vesicles, defined as exosomes.  Co-incubation of NPC cells with doxorubicin-resistant (R-DOX) HMEC-derived exosomes resulted in promotion of their proliferation, migration, and chemoresistance, as well as changes in the expression of epithelial-mesenchymal transition (EMT) markers.  These effects were significantly inhibited by treatment with GW4869 (an exosome inhibitor).  We also found that GW4869 inhibited the stimulation of drug-resistant HMECs on NPC progression by modulating EMT in vivo.  These data suggest that exosomes participate in a novel mechanism by which drug-resistant ECs enhance NPC progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC6nJ-GSU8C7Vg90H21EOLACvtfcHk0ljOI4wdEvekwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2rtrvL&md5=e7dee5b7167fe0777fd5547ce0a02788</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2019.109385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2019.109385%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DDrug-resistant%2520endothelial%2520cells%2520facilitate%2520progression%252C%2520emt%2520and%2520chemoresistance%2520in%2520nasopharyngeal%2520carcinoma%2520via%2520exosomes%26jtitle%3DCell.%2520Signalling%26date%3D2019%26volume%3D63%26spage%3D109385%26doi%3D10.1016%2Fj.cellsig.2019.109385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span> <span> </span><span class="NLM_article-title">Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the erk pathway</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2485</span>– <span class="NLM_lpage">2495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31934075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslags7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=2485-2495&author=B.+Wangauthor=Y.+Wangauthor=Z.+Yanauthor=Y.+Sunauthor=C.+Su&title=Colorectal+cancer+cell-derived+exosomes+promote+proliferation+and+decrease+apoptosis+by+activating+the+erk+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Colorectal cancer cell-derived exosomes promote proliferation and decrease apoptosis by activating the ERK pathway</span></div><div class="casAuthors">Wang, Baochen; Wang, Yong; Yan, Zhanfu; Sun, Yueming; Su, Chuan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2485-2495</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">Exosomes are small microvesicles released by various cells that play important roles in cell-cell communi- cation.  Numerous studies show that colorectal cancer (CRC) cell-derived exosomes are involved in the progression of CRC.  However, the specific ways and mechanisms of action have not yet been fully clarified.  In the present study, we found that, compared to normal colon epithelial cell (NCM460) derived exosomes, CRC cell-Lovo derived exo- somes (Lovo-exo) could be more easily taken up by Lovo cells, most likely because of their cell tropism.  In addn., Lovo-exo promoted Lovo cell proliferation and inhibited apoptosis, which is assocd. with an increased activation of the extracellular signal-regulated protein kinase (ERK).  Lovo-exo also dramatically increased Lovo tumor cell growth in vivo.  Moreover, the intratumoral injection of GW4869 (an exosomes inhibitor) suppressed tumor growth.  These results indicate that CRC cell Lovo-derived exosomes may be a messenger for the proliferation requirements of the originating cancer cells, and targeting tumor-derived exosomes may be very promising for tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYH_n4uSJJArVg90H21EOLACvtfcHk0lgBRac2UBzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslags7k%253D&md5=8820f9e21b9b37deb0b2c8c6300fdb26</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DC.%26atitle%3DColorectal%2520cancer%2520cell-derived%2520exosomes%2520promote%2520proliferation%2520and%2520decrease%2520apoptosis%2520by%2520activating%2520the%2520erk%2520pathway%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2019%26volume%3D12%26spage%3D2485%26epage%3D2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Delaet, N.</span>; <span class="NLM_string-name">Ohmawari, N.</span>; <span class="NLM_string-name">Nakai, H.</span></span> <span> </span><span class="NLM_article-title">4H-1,2,4-Triazole-3(2H)-thione Deratives as Sphingomyelinase Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2002/066447</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=N.+Delaet&author=N.+Ohmawari&author=H.+Nakai&title=4H-1%2C2%2C4-Triazole-3%282H%29-thione+Deratives+as+Sphingomyelinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDelaet%26aufirst%3DN.%26atitle%3D4H-1%252C2%252C4-Triazole-3%25282H%2529-thione%2520Deratives%2520as%2520Sphingomyelinase%2520Inhibitors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heltweg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatbonton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posakony, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goehle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollipara, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depinho, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedalov, A.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">4368</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1158%2F0008-5472.CAN-05-3617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16618762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFSltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4368-4377&author=B.+Heltwegauthor=T.+Gatbontonauthor=A.+D.+Schulerauthor=J.+Posakonyauthor=H.+Liauthor=S.+Goehleauthor=R.+Kolliparaauthor=R.+A.+Depinhoauthor=Y.+Guauthor=J.+A.+Simonauthor=A.+Bedalov&title=Antitumor+activity+of+a+small-molecule+inhibitor+of+human+silent+information+regulator+2+enzymes&doi=10.1158%2F0008-5472.CAN-05-3617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes</span></div><div class="casAuthors">Heltweg, Birgit; Gatbonton, Tonibelle; Schuler, Aaron D.; Posakony, Jeff; Li, Hongzhe; Goehle, Sondra; Kollipara, Ramya; DePinho, Ronald A.; Gu, Yansong; Simon, Julian A.; Bedalov, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4368-4377</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">SIRT1 and other NAD-dependent deacetylases have been implicated in control of cellular responses to stress and in tumorigenesis through deacetylation of important regulatory proteins, including p53 and the BCL6 oncoprotein.  Hereby, we describe the identification of a compd. we named cambinol that inhibits NAD-dependent deacetylase activity of human SIRT1 and SIRT2.  Consistent with the role of SIRT1 in promoting cell survival during stress, inhibition of SIRT1 activity with cambinol during genotoxic stress leads to hyperacetylation of key stress response proteins and promotes cell cycle arrest.  Treatment of BCL6-expressing Burkitt lymphoma cells with cambinol as a single agent induced apoptosis, which was accompanied by hyperacetylation of BCL6 and p53.  Because acetylation inactivates BCL6 and has the opposite effect on the function of p53 and other checkpoint pathways, the antitumor activity of cambinol in Burkitt lymphoma cells may be accomplished through a combined effect of BCL6 inactivation and checkpoint activation.  Cambinol was well tolerated in mice and inhibited growth of Burkitt lymphoma xenografts.  Inhibitors of NAD-dependent deacetylases may constitute novel anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTGDg0dxQdUrVg90H21EOLACvtfcHk0lgBRac2UBzN9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFSltbY%253D&md5=8f82a191cde3db6024b1672047af77ae</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3617%26sid%3Dliteratum%253Aachs%26aulast%3DHeltweg%26aufirst%3DB.%26aulast%3DGatbonton%26aufirst%3DT.%26aulast%3DSchuler%26aufirst%3DA.%2BD.%26aulast%3DPosakony%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGoehle%26aufirst%3DS.%26aulast%3DKollipara%26aufirst%3DR.%26aulast%3DDepinho%26aufirst%3DR.%2BA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSimon%26aufirst%3DJ.%2BA.%26aulast%3DBedalov%26aufirst%3DA.%26atitle%3DAntitumor%2520activity%2520of%2520a%2520small-molecule%2520inhibitor%2520of%2520human%2520silent%2520information%2520regulator%25202%2520enzymes%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4368%26epage%3D4377%26doi%3D10.1158%2F0008-5472.CAN-05-3617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Figuera-Losada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stathis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorskind, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandaru, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span> <span> </span><span class="NLM_article-title">Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0124481</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0124481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0124481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=26010541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslymtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=M.+Figuera-Losadaauthor=M.+Stathisauthor=J.+M.+Dorskindauthor=A.+G.+Thomasauthor=V.+V.+Bandaruauthor=S.+W.+Yooauthor=N.+J.+Westwoodauthor=G.+W.+Rogersauthor=J.+C.+McArthurauthor=N.+J.+Haugheyauthor=B.+S.+Slusherauthor=C.+Rojas&title=Cambinol%2C+a+novel+inhibitor+of+neutral+sphingomyelinase+2+shows+neuroprotective+properties&doi=10.1371%2Fjournal.pone.0124481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties</span></div><div class="casAuthors">Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; Westwood, Nicholas J.; Rogers, Graeme W.; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0124481/1-e0124481/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Ceramide is a bioactive lipid that plays an important role in stress responses leading to apoptosis, cell growth arrest and differentiation.  Ceramide prodn. is due in part to sphingomyelin hydrolysis by sphingomyelinases.  In brain, neutral sphingomyelinase 2 (nSMase2) is expressed in neurons and increases in its activity and expression have been assocd. with pro-inflammatory conditions obsd. in Alzheimer's disease, multiple sclerosis and human immunodeficiency virus (HIV-1) patients.  Increased nSMase2 activity translates into higher ceramide levels and neuronal cell death, which can be prevented by chem. or genetic inhibition of nSMase2 activity or expression.  However, to date, there are no sol., specific and potent small mol. inhibitor tool compds. for in vivo studies or as a starting point for medicinal chem. optimization.  Moreover, the majority of the known inhibitors were identified using bacterial, bovine or rat nSMase2.  In an attempt to identify new inhibitor scaffolds, two activity assays were optimized as screening platform using the recombinant human enzyme.  First, active hits were identified using a fluorescence-based high throughput compatible assay.  Then, hits were confirmed using a 14C sphingomyelin-based direct activity assay.  Pharmacol. active compds. and approved drugs were screened using this strategy which led to the identification of cambinol as a novel uncompetitive nSMase2 inhibitor (Ki = 7 μM).  The inhibitory activity of cambinol for nSMase2 was approx. 10-fold more potent than for its previously known target, silence information regulator 1 and 2 (SIRT1/2).  Cambinol decreased tumor necrosis factor-α or interleukin-1 β-induced increases of ceramide and cell death in primary neurons.  A preliminary study of cambinol structure and activity allowed the identification of the main structural features required for nSMase2 inhibition.  Cambinol and its analogs may be useful as nSMase2 inhibitor tool compds. to prevent ceramide-dependent neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTEaQLieBrPbVg90H21EOLACvtfcHk0lhyx7FZ4c1g6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslymtLvL&md5=ab65b22b0759cd933ca4eb267d08df11</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0124481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0124481%26sid%3Dliteratum%253Aachs%26aulast%3DFiguera-Losada%26aufirst%3DM.%26aulast%3DStathis%26aufirst%3DM.%26aulast%3DDorskind%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DBandaru%26aufirst%3DV.%2BV.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DWestwood%26aufirst%3DN.%2BJ.%26aulast%3DRogers%26aufirst%3DG.%2BW.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DRojas%26aufirst%3DC.%26atitle%3DCambinol%252C%2520a%2520novel%2520inhibitor%2520of%2520neutral%2520sphingomyelinase%25202%2520shows%2520neuroprotective%2520properties%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0124481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilousova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gylys, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Suppression of tau propagation using an inhibitor that targets the dk-switch of nsmase2</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>499</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.03.209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.03.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29604274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1Khtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2018&pages=751-757&author=T.+Bilousovaauthor=C.+Eliasauthor=E.+Miyoshiauthor=M.+P.+Alamauthor=C.+Zhuauthor=J.+Campagnaauthor=K.+Vadivelauthor=B.+Jagodzinskaauthor=K.+H.+Gylysauthor=V.+John&title=Suppression+of+tau+propagation+using+an+inhibitor+that+targets+the+dk-switch+of+nsmase2&doi=10.1016%2Fj.bbrc.2018.03.209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of tau propagation using an inhibitor that targets the DK-switch of nSMase2</span></div><div class="casAuthors">Bilousova, Tina; Elias, Chris; Miyoshi, Emily; Alam, Mohammad Parvez; Zhu, Chunni; Campagna, Jesus; Vadivel, Kanagasabai; Jagodzinska, Barbara; Gylys, Karen Hoppens; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">499</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">751-757</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting of mol. pathways involved in the cell-to-cell propagation of pathol. tau species is a novel approach for development of disease-modifying therapies that could block tau pathol. and attenuate cognitive decline in patients with Alzheimer's disease and other tauopathies.  We discovered cambinol through a screening effort and show that it is an inhibitor of cell-to-cell tau propagation.  Our in vitro data demonstrate that cambinol inhibits neutral sphingomyelinase 2 (nSMase2) enzyme activity in dose response fashion, and suppresses extracellular vesicle (EV) prodn. while reducing tau seed propagation.  Our in vivo testing with cambinol shows that it can reduce the nSMase2 activity in the brain after oral administration.  Our mol. docking and simulation anal. reveals that cambinol can target the DK-switch in the nSMase2 active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4cxKo7bvNZrVg90H21EOLACvtfcHk0lhyx7FZ4c1g6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1Khtrs%253D&md5=02e0f6a69946d64e818368ad6aef4b3d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.03.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.03.209%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%26aulast%3DElias%26aufirst%3DC.%26aulast%3DMiyoshi%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DM.%2BP.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DCampagna%26aufirst%3DJ.%26aulast%3DVadivel%26aufirst%3DK.%26aulast%3DJagodzinska%26aufirst%3DB.%26aulast%3DGylys%26aufirst%3DK.%2BH.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DSuppression%2520of%2520tau%2520propagation%2520using%2520an%2520inhibitor%2520that%2520targets%2520the%2520dk-switch%2520of%2520nsmase2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D499%26spage%3D751%26epage%3D757%26doi%3D10.1016%2Fj.bbrc.2018.03.209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhuri, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadiano, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Dptip, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">17715</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-36144-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1038%2Fs41598-018-36144-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30531925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1emur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=17715&author=C.+Rojasauthor=E.+Barnaevaauthor=A.+G.+Thomasauthor=X.+Huauthor=N.+Southallauthor=J.+Maruganauthor=A.+D.+Chaudhuriauthor=S.+W.+Yooauthor=N.+Hinauthor=O.+Stepanekauthor=Y.+Wuauthor=S.+C.+Zimmermannauthor=A.+G.+Gadianoauthor=T.+Tsukamotoauthor=R.+Raisauthor=N.+Haugheyauthor=M.+Ferrerauthor=B.+S.+Slusher&title=Dptip%2C+a+newly+identified+potent+brain+penetrant+neutral+sphingomyelinase+2+inhibitor%2C+regulates+astrocyte-peripheral+immune+communication+following+brain+inflammation&doi=10.1038%2Fs41598-018-36144-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation</span></div><div class="casAuthors">Rojas, Camilo; Barnaeva, Elena; Thomas, Ajit G.; Hu, Xin; Southall, Noel; Marugan, Juan; Datta Chaudhuri, Amrita; Yoo, Seung-Wan; Hin, Niyada; Stepanek, Ondrej; Wu, Ying; Zimmermann, Sarah C.; Gadiano, Alexandra G.; Tsukamoto, Takashi; Rais, Rana; Haughey, Norman; Ferrer, Marc; Slusher, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17715</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Brain injury and inflammation induces a local release of extracellular vesicles (EVs) from astrocytes carrying proteins, RNAs, and microRNAs into the circulation.  When these vesicles reach the liver, they stimulate the secretion of cytokines that mobilize peripheral immune cell infiltration into the brain, which can cause secondary tissue damage and impair recovery.  Recent studies suggest that suppression of EV biosynthesis through neutral sphingomyelinase 2 (nSMase2) inhibition may represent a new therapeutic strategy.  Unfortunately, currently available nSMase2 inhibitors exhibit low potency (IC50 ≥ 1μM), poor soly. and/or limited brain penetration.  Through a high throughput screening campaign of >365,000 compds. against human nSMase2 we identified 2,6-dimethoxy-4-(5-phenyl-4-thiophen-2-yl-1H-imidazol-2-yl)-phenol (DPTIP), a potent (IC50 30 nM), selective, metabolically stable, and brain penetrable (AUCbrain/AUCplasma = 0.26) nSMase2 inhibitor.  DPTIP dose-dependently inhibited EV release in primary astrocyte cultures.  In a mouse model of brain injury conducted in GFAP-GFP mice, DPTIP potently (10 mg/kg IP) inhibited IL-1β-induced astrocyte-derived EV release (51 ± 13%; p < 0.001).  This inhibition led to a redn. of cytokine upregulation in liver and attenuation of the infiltration of immune cells into the brain (80 ± 23%; p < 0.01).  A structurally similar but inactive analog had no effect in-vitro or in-vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcwxWnEMWvfLVg90H21EOLACvtfcHk0lhyx7FZ4c1g6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1emur4%253D&md5=52549589a81f6d99bb183a6412ca7f79</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-36144-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-36144-2%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DMarugan%26aufirst%3DJ.%26aulast%3DChaudhuri%26aufirst%3DA.%2BD.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DStepanek%26aufirst%3DO.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DGadiano%26aufirst%3DA.%2BG.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DHaughey%26aufirst%3DN.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDptip%252C%2520a%2520newly%2520identified%2520potent%2520brain%2520penetrant%2520neutral%2520sphingomyelinase%25202%2520inhibitor%252C%2520regulates%2520astrocyte-peripheral%2520immune%2520communication%2520following%2520brain%2520inflammation%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D17715%26doi%3D10.1038%2Fs41598-018-36144-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Neutral sphingomyelinase 2 inhibitors based on the 4-(1h-imidazol-2-yl)-2,6-dialkoxyphenol scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.ejmech.2019.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=30921693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2019&pages=276-289&author=O.+Stepanekauthor=N.+Hinauthor=A.+G.+Thomasauthor=R.+P.+Dashauthor=J.+Altauthor=R.+Raisauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Neutral+sphingomyelinase+2+inhibitors+based+on+the+4-%281h-imidazol-2-yl%29-2%2C6-dialkoxyphenol+scaffold&doi=10.1016%2Fj.ejmech.2019.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold</span></div><div class="casAuthors">Stepanek, Ondrej; Hin, Niyada; Thomas, Ajit G.; Dash, Ranjeet P.; Alt, Jesse; Rais, Rana; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276-289</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2), a key enzyme in ceramide biosynthesis, is a new therapeutic target for the treatment of neurol. disorders and cancer.  Using 2,6-dimethoxy-4-[4-phenyl-5-(2-thienyl)-1H-imidazol-2-yl]phenol (DPTIP), our initial hit compd. (IC50 = 30 nM) from nSMase2 screening efforts, as a mol. template, a series of 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol derivs. were designed, synthesized, and evaluated.  Systematic examn. of various regions of DPTIP identified the key pharmacophore required for potent nSMase2 inhibition as well as a no. of compds. with the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold with similar or higher inhibitory potency against nSMase2 as compared to DPTIP.  Among them, 4-(4,5-diisopropyl-1H-imidazol-2-yl)-2,6-dimethoxyphenol was found to be metabolically stable against P 450 metab. in liver microsomes and displayed higher plasma exposure following oral administration as compared to DPTIP.  Anal. of plasma samples identified an O-glucuronide as the major metabolite.  Blockade of the phase II metab. should further facilitate our efforts to identify potent nSMase2 inhibitors with desirable ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mrCU1mbcCLVg90H21EOLACvtfcHk0lgLDKC8fs1_cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGktrc%253D&md5=8890e746b19a9a84515821574017875a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DStepanek%26aufirst%3DO.%26aulast%3DHin%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DNeutral%2520sphingomyelinase%25202%2520inhibitors%2520based%2520on%2520the%25204-%25281h-imidazol-2-yl%2529-2%252C6-dialkoxyphenol%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D170%26spage%3D276%26epage%3D289%26doi%3D10.1016%2Fj.ejmech.2019.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta
Chaudhuri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haughey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B.</span></span> <span> </span><span class="NLM_article-title">A novel and potent brain penetrant inhibitor of extracellular vesicle release</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">3857</span>– <span class="NLM_lpage">3870</span>, <span class="refDoi"> DOI: 10.1111/bph.14789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fbph.14789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31273753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslShs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=3857-3870&author=C.+Rojasauthor=M.+Salaauthor=A.+G.+Thomasauthor=A.+Datta%0AChaudhuriauthor=S.+W.+Yooauthor=Z.+Liauthor=R.+P.+Dashauthor=R.+Raisauthor=N.+J.+Haugheyauthor=R.+Nenckaauthor=B.+Slusher&title=A+novel+and+potent+brain+penetrant+inhibitor+of+extracellular+vesicle+release&doi=10.1111%2Fbph.14789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and potent brain penetrant inhibitor of extracellular vesicle release</span></div><div class="casAuthors">Rojas, Camilo; Sala, Michal; Thomas, Ajit G.; Datta Chaudhuri, Amrita; Yoo, Seung-Wan; Li, Zhigang; Dash, Ranjeet P.; Rais, Rana; Haughey, Norman J.; Nencka, Radim; Slusher, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3857-3870</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Unfortunately, known inhibitors exhibit μM potency, poor physicochem. properties, and/or limited brain penetration.  Here, we sought to identify a drug-like inhibitor of nSMase2.  Exptl. Approach : We conducted a human nSMase2 high throughput screen (>365,000 compds.).  Selected hits were optimized focusing on potency, selectivity, metabolic stability, pharmacokinetics, and ability to inhibit EV release in vitro and in vivo.  Key Results : We identified phenyl(R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl)pyrrolidin-3-yl)-carbamate (PDDC), a potent (pIC50 = 6.57) and selective non-competitive inhibitor of nSMase2.  PDDC was metabolically stable, with excellent oral bioavailability (%F = 88) and brain penetration (AUCbrain/AUCplasma = 0.60).  PDDC dose-dependently (pEC50 = 5.5) inhibited release of astrocyte-derived extracellular vesicles (ADEV).  In an in vivo inflammatory brain injury model, PDDC robustly inhibited ADEV release and the assocd. peripheral immunol. response.  A closely related inactive PDDC analog was ineffective.  Conclusion and Implications : PDDC is a structurally novel, potent, orally available, and brain penetrant inhibitor of nSMase2.  PDDC inhibited release of ADEVs in tissue culture and in vivo.  PDDC is actively being tested in animal models of neurol. disease and, along with closely related analogs, is being considered for clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoFvk19ATqi7Vg90H21EOLACvtfcHk0lgLDKC8fs1_cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslShs7%252FN&md5=3fcb236d4398167f42f7fb350cdb758a</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fbph.14789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14789%26sid%3Dliteratum%253Aachs%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSala%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDatta%2BChaudhuri%26aufirst%3DA.%26aulast%3DYoo%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DHaughey%26aufirst%3DN.%2BJ.%26aulast%3DNencka%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%26atitle%3DA%2520novel%2520and%2520potent%2520brain%2520penetrant%2520inhibitor%2520of%2520extracellular%2520vesicle%2520release%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26spage%3D3857%26epage%3D3870%26doi%3D10.1111%2Fbph.14789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollinger, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dash, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeravalli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kogler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrebabecky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prochazkova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesuta, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donoghue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencka, R.</span></span> <span> </span><span class="NLM_article-title">Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6028</span>– <span class="NLM_lpage">6056</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00278</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00278" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnt12ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6028-6056&author=M.+Salaauthor=K.+R.+Hollingerauthor=A.+G.+Thomasauthor=R.+P.+Dashauthor=C.+Tallonauthor=V.+Veeravalliauthor=L.+Lovellauthor=M.+Koglerauthor=H.+Hrebabeckyauthor=E.+Prochazkovaauthor=O.+Nesutaauthor=A.+Donoghueauthor=J.+Lamauthor=R.+Raisauthor=C.+Rojasauthor=B.+S.+Slusherauthor=R.+Nencka&title=Novel+human+neutral+sphingomyelinase+2+inhibitors+as+potential+therapeutics+for+alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.0c00278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease</span></div><div class="casAuthors">Sala, Michal; Hollinger, Kristen R.; Thomas, Ajit G.; Dash, Ranjeet P.; Tallon, Carolyn; Veeravalli, Vijayabhaskar; Lovell, Lyndah; Kogler, Martin; Hrebabecky, Hubert; Prochazkova, Eliska; Nesuta, Ondrej; Donoghue, Amanda; Lam, Jenny; Rais, Rana; Rojas, Camilo; Slusher, Barbara S.; Nencka, Radim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6028-6056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neutral sphingomyelinase 2 (nSMase2) catalyzes the cleavage of sphingomyelin to phosphorylcholine and ceramide, an essential step in the formation and release of exosomes from cells that is crit. for intracellular communication.  Chronic increase of brain nSMase2 activity and related exosome release has been implicated in various pathol. processes, including the progression of Alzheimer's disease (AD), making nSMase2 a viable therapeutic target.  Recently, we identified phenyl(R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b] pyridazin-8-yl) pyrrolidin-3-yl)-carbamate 1 (PDDC)(I), the first nSMase2 inhibitor which possesses both favorable pharmacodynamics and pharmacokinetic (PK) parameters, including substantial oral bioavailability, brain penetration and significant inhibition of exosome release from the brain in vivo.  Herein we demonstrate efficacy of 1 (PDDC) in a mouse model of AD and detail extensive structure-activity relationship (SAR) studies with 70 analogs, unveiling several that exert similar or higher activity against nSMase2 with favorable pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi-0Z_uFZAgLVg90H21EOLACvtfcHk0lgLDKC8fs1_cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnt12ru7k%253D&md5=ae913fb6068ef7d230f0ef4a49d25975</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00278%26sid%3Dliteratum%253Aachs%26aulast%3DSala%26aufirst%3DM.%26aulast%3DHollinger%26aufirst%3DK.%2BR.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DDash%26aufirst%3DR.%2BP.%26aulast%3DTallon%26aufirst%3DC.%26aulast%3DVeeravalli%26aufirst%3DV.%26aulast%3DLovell%26aufirst%3DL.%26aulast%3DKogler%26aufirst%3DM.%26aulast%3DHrebabecky%26aufirst%3DH.%26aulast%3DProchazkova%26aufirst%3DE.%26aulast%3DNesuta%26aufirst%3DO.%26aulast%3DDonoghue%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DNencka%26aufirst%3DR.%26atitle%3DNovel%2520human%2520neutral%2520sphingomyelinase%25202%2520inhibitors%2520as%2520potential%2520therapeutics%2520for%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6028%26epage%3D6056%26doi%3D10.1021%2Facs.jmedchem.0c00278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilousova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spilman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gylys, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, V.</span></span> <span> </span><span class="NLM_article-title">Dual neutral sphingomyelinase-2/acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1671</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1021/acschembio.0c00311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.0c00311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1erurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=1671-1684&author=T.+Bilousovaauthor=B.+J.+Simmonsauthor=R.+R.+Knappauthor=C.+J.+Eliasauthor=J.+Campagnaauthor=M.+Melnikauthor=S.+Chandraauthor=S.+Fochtauthor=C.+Zhuauthor=K.+Vadivelauthor=B.+Jagodzinskaauthor=W.+Cohnauthor=P.+Spilmanauthor=K.+H.+Gylysauthor=N.+K.+Gargauthor=V.+John&title=Dual+neutral+sphingomyelinase-2%2Facetylcholinesterase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschembio.0c00311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Bilousova, Tina; Simmons, Bryan J.; Knapp, Rachel R.; Elias, Chris J.; Campagna, Jesus; Melnik, Mikhail; Chandra, Sujyoti; Focht, Samantha; Zhu, Chunni; Vadivel, Kanagasabai; Jagodzinska, Barbara; Cohn, Whitaker; Spilman, Patricia; Gylys, Karen H.; Garg, Neil K.; John, Varghese</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1671-1684</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of a novel class of compds. that function as dual inhibitors of the enzymes neutral sphingomyelinase-2 (nSMase2) and acetylcholinesterase (AChE).  Inhibition of these enzymes provides a unique strategy to suppress the propagation of tau pathol. in the treatment of Alzheimer's disease (AD).  We describe the key SAR elements that affect relative nSMase2 and/or AChE inhibitor effects and potency, in addn. to the identification of two analogs that suppress the release of tau-bearing exosomes in vitro and in vivo.  Identification of these novel dual nSMase2/AChE inhibitors represents a new therapeutic approach to AD and has the potential to lead to the development of truly disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTLUqqhHNAtLVg90H21EOLACvtfcHk0lgjpRSWBcJ-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1erurw%253D&md5=028a09760c6d27501798ea788a3f1cb4</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Facschembio.0c00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.0c00311%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%26aulast%3DSimmons%26aufirst%3DB.%2BJ.%26aulast%3DKnapp%26aufirst%3DR.%2BR.%26aulast%3DElias%26aufirst%3DC.%2BJ.%26aulast%3DCampagna%26aufirst%3DJ.%26aulast%3DMelnik%26aufirst%3DM.%26aulast%3DChandra%26aufirst%3DS.%26aulast%3DFocht%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DVadivel%26aufirst%3DK.%26aulast%3DJagodzinska%26aufirst%3DB.%26aulast%3DCohn%26aufirst%3DW.%26aulast%3DSpilman%26aufirst%3DP.%26aulast%3DGylys%26aufirst%3DK.%2BH.%26aulast%3DGarg%26aufirst%3DN.%2BK.%26aulast%3DJohn%26aufirst%3DV.%26atitle%3DDual%2520neutral%2520sphingomyelinase-2%252Facetylcholinesterase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2020%26volume%3D15%26spage%3D1671%26epage%3D1684%26doi%3D10.1021%2Facschembio.0c00311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzostowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrisey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greig, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soncrant, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapoport, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radunz, H.-E.</span></span> <span> </span><span class="NLM_article-title">Physovenines: Efficient synthesis of (−)- and (+)-physovenine and synthesis of carbarnate analogues of (−)-physovenine. Anticholinesterase activity and analgesic properties of optically active physovenines</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1002/hlca.19910740409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fhlca.19910740409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK3MXlsF2nu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1991&pages=761-766&author=Q.-s.+Yuauthor=C.+Liuauthor=M.+Brzostowskaauthor=L.+Chriseyauthor=A.+Brossiauthor=N.+H.+Greigauthor=J.+R.+Atackauthor=T.+T.+Soncrantauthor=S.+I.+Rapoportauthor=H.-E.+Radunz&title=Physovenines%3A+Efficient+synthesis+of+%28%E2%88%92%29-+and+%28%2B%29-physovenine+and+synthesis+of+carbarnate+analogues+of+%28%E2%88%92%29-physovenine.+Anticholinesterase+activity+and+analgesic+properties+of+optically+active+physovenines&doi=10.1002%2Fhlca.19910740409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Physovenines:  efficient synthesis of (-)- and (+)-physovenine and synthesis of carbamate analogs of (-)-physovenine.  Anticholinesterase activity and analgesic properties of optically active physovenines</span></div><div class="casAuthors">Yu, Qiansheng; Liu, Chi; Brzostowska, Margareth; Chrisev, Linda; Brossi, Arnold; Greig, Nigel H.; Atack, John R.; Soncrant, Timothy T.; Rapoport, Stanley I.; Radunz, Hans Eckart</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-6</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    </div><div class="casAbstract">Column chromatog. of easy available (±)-physovenine (I) on cellulose triacetate afforded (-)- and (+)-I.  Alkaloids (-)- and (+)-I required for pharmacol. testing were prepd. from eserolines (-)- and (+)-II by an improved procedure.  Natural (-)-I was equally potent in inhibiting AChE and BChE in vitro as natural physostigmine, and twice as potent as the unnatural antipode (+)-I against AChE and 14 times as potent against BChE.  Several carbamate analogs of (-)-I were at least as potent as the former compd. in these assays.  None of the compds. tested did bind to different opiate receptor or serotonin receptor prepns.  Most of the compds. tested had considerable analgesic activity in the Writhing test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgplVeSBPrdbVg90H21EOLACvtfcHk0lgjpRSWBcJ-UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsF2nu78%253D&md5=9ae3c827f4e2a339a25aea506129206f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19910740409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19910740409%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DQ.-s.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBrzostowska%26aufirst%3DM.%26aulast%3DChrisey%26aufirst%3DL.%26aulast%3DBrossi%26aufirst%3DA.%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DSoncrant%26aufirst%3DT.%2BT.%26aulast%3DRapoport%26aufirst%3DS.%2BI.%26aulast%3DRadunz%26aufirst%3DH.-E.%26atitle%3DPhysovenines%253A%2520Efficient%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-%2520and%2520%2528%252B%2529-physovenine%2520and%2520synthesis%2520of%2520carbarnate%2520analogues%2520of%2520%2528%25E2%2588%2592%2529-physovenine.%2520Anticholinesterase%2520activity%2520and%2520analgesic%2520properties%2520of%2520optically%2520active%2520physovenines%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1991%26volume%3D74%26spage%3D761%26epage%3D766%26doi%3D10.1002%2Fhlca.19910740409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmae, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seike, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Role of sphingomyelinase in infectious diseases caused by bacillus cereus</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e38054</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0038054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1371%2Fjournal.pone.0038054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=22701599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=M.+Odaauthor=M.+Hashimotoauthor=M.+Takahashiauthor=Y.+Ohmaeauthor=S.+Seikeauthor=R.+Katoauthor=A.+Fujitaauthor=H.+Tsugeauthor=M.+Nagahamaauthor=S.+Ochiauthor=T.+Sasaharaauthor=S.+Hayashiauthor=Y.+Hiraiauthor=J.+Sakurai&title=Role+of+sphingomyelinase+in+infectious+diseases+caused+by+bacillus+cereus&doi=10.1371%2Fjournal.pone.0038054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sphingomyelinase in infectious diseases caused by Bacillus cereus</span></div><div class="casAuthors">Oda, Masataka; Hashimoto, Manabu; Takahashi, Masaya; Ohmae, Yuka; Seike, Soshi; Kato, Ryoko; Fujita, Aoi; Tsuge, Hideaki; Nagahama, Masahiro; Ochi, Sadayuki; Sasahara, Teppei; Hayashi, Shunji; Hirai, Yoshikazu; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e38054</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Bacillus cereus (B. cereus) is a pathogen in opportunistic infections.  Here we show that Bacillus cereus sphingomyelinase (Bc-SMase) is a virulence factor for septicemia.  Clin. isolates produced large amts. of Bc-SMase, grew in vivo, and caused death among mice, but ATCC strains isolated from soil did not.  A transformant of the ATCC strain carrying a recombinant plasmid contg. the Bc-SMase gene grew in vivo, but that with the gene for E53A, which has little enzymic activity, did not.  Administration of an anti-Bc-SMase antibody and immunization against Bc-SMase prevented death caused by the clin. isolates, showing that Bc-SMase plays an important role in the diseases caused by B. cereus.  Treatment of mouse macrophages with Bc-SMase resulted in a redn. in the generation of H2O2 and phagocytosis of macrophages induced by peptidoglycan (PGN), but no effect on the release of TNF-α and little release of LDH under our exptl. conditions.  Confocal laser microscopy showed that the treatment of mouse macrophages with Bc-SMase resulted in the formation of ceramide-rich domains.  A photobleaching anal. suggested that the cells treated with Bc-SMase exhibited a redn. in membrane fluidity.  The results suggest that Bc-SMase is essential for the hydrolysis of SM in membranes, leading to a redn. in phagocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRnXEvq3_LPrVg90H21EOLACvtfcHk0liGUSaDaRE3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1KntLo%253D&md5=92cce9addf638d6559971d05e1b3567b</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0038054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0038054%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DOhmae%26aufirst%3DY.%26aulast%3DSeike%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DA.%26aulast%3DTsuge%26aufirst%3DH.%26aulast%3DNagahama%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DS.%26aulast%3DSasahara%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DHirai%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DRole%2520of%2520sphingomyelinase%2520in%2520infectious%2520diseases%2520caused%2520by%2520bacillus%2520cereus%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0038054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Openshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Race, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monzo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Boland, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, M. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of smcl, a bacterial neutral sphingomyelinase c from listeria</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">35011</span>– <span class="NLM_lpage">35017</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506800200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M506800200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16093240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVyks7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=35011-35017&author=A.+E.+Openshawauthor=P.+R.+Raceauthor=H.+J.+Monzoauthor=J.+A.+Vazquez-Bolandauthor=M.+J.+Banfield&title=Crystal+structure+of+smcl%2C+a+bacterial+neutral+sphingomyelinase+c+from+listeria&doi=10.1074%2Fjbc.M506800200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria</span></div><div class="casAuthors">Openshaw, Amy E. A.; Race, Paul R.; Monzo, Hector J.; Vazquez-Boland, Jose-Antonio; Banfield, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">35011-35017</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingomyelinases C are enzymes that catalyze the hydrolysis of sphingomyelin in biol. membranes to ceramide and phosphorylcholine.  Various pathogenic bacteria produce secreted neutral sphingomyelinases C that act as membrane-damaging virulence factors.  Mammalian neutral sphingomyelinases C, which display sequence homol. to the bacterial enzymes, are involved in sphingolipid metab. and signaling.  Here, the authors describe the 1st crystal structure to be detd. for a member of the neutral sphingomyelinase C family, SmcL, from the intracellular bacterial pathogen, L. ivanovii.  The structure was refined to 1.9-Å resoln. with phases derived by single isomorphous replacement with anomalous scattering techniques from a single Ir deriv.  SmcL adopted a DNase I-like fold, and was the 1st member of this protein superfamily to have its structure detd. that acts as a phospholipase.  The structure revealed several unique features that adapted the protein to its phospholipid substrate.  These included large hydrophobic β-hairpin and hydrophobic loops surrounding the active site that may bind and penetrate the lipid bilayer to position sphingomyelin in a catalytically competent position.  The structure also provided insight into the proposed general base/acid catalytic mechanism, in which His-325 and His-185 play key roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMqZSElUwawLVg90H21EOLACvtfcHk0liGUSaDaRE3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVyks7rF&md5=7478eaa4cb09c3bca31f70cfaf5462ad</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506800200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506800200%26sid%3Dliteratum%253Aachs%26aulast%3DOpenshaw%26aufirst%3DA.%2BE.%26aulast%3DRace%26aufirst%3DP.%2BR.%26aulast%3DMonzo%26aufirst%3DH.%2BJ.%26aulast%3DVazquez-Boland%26aufirst%3DJ.%2BA.%26aulast%3DBanfield%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520smcl%252C%2520a%2520bacterial%2520neutral%2520sphingomyelinase%2520c%2520from%2520listeria%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D35011%26epage%3D35017%26doi%3D10.1074%2Fjbc.M506800200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ago, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katunuma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from bacillus cereus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">16157</span>– <span class="NLM_lpage">16167</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601089200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M601089200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=16595670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1Crsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=16157-16167&author=H.+Agoauthor=M.+Odaauthor=M.+Takahashiauthor=H.+Tsugeauthor=S.+Ochiauthor=N.+Katunumaauthor=M.+Miyanoauthor=J.+Sakurai&title=Structural+basis+of+the+sphingomyelin+phosphodiesterase+activity+in+neutral+sphingomyelinase+from+bacillus+cereus&doi=10.1074%2Fjbc.M601089200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of the Sphingomyelin Phosphodiesterase Activity in Neutral Sphingomyelinase from Bacillus cereus</span></div><div class="casAuthors">Ago, Hideo; Oda, Masataka; Takahashi, Masaya; Tsuge, Hideaki; Ochi, Sadayuki; Katunuma, Nobuhiko; Miyano, Masashi; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">16157-16167</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingomyelinase (SMase) from Bacillus cereus (Bc-SMase) hydrolyzes sphingomyelin to phosphocholine and ceramide in a divalent metal ion-dependent manner.  Bc-SMase is a homolog of mammalian neutral SMase (nSMase) and mimics the actions of the endogenous mammalian nSMase in causing differentiation, development, aging, and apoptosis.  Thus Bc-SMase may be a good model for the poorly characterized mammalian nSMase.  The metal ion activation of sphingomyelinase activity of Bc-SMase was in the order Co2+ ≥ Mn2+ ≥ Mg2+ » Ca2+ ≥ Sr2+.  The first crystal structures of Bc-SMase bound to Co2+, Mg2+, or Ca2+ were detd.  The water-bridged double divalent metal ions at the center of the cleft in both the Co2+- and Mg2+-bound forms were concluded to be the catalytic architecture required for sphingomyelinase activity.  In contrast, the architecture of Ca2+ binding at the site showed only one binding site.  A further single metal-binding site exists at one side edge of the cleft.  Based on the highly conserved nature of the residues of the binding sites, the crystal structure of Bc-SMase with bound Mg2+ or Co2+ may provide a common structural framework applicable to phosphohydrolases belonging to the DNase I-like folding superfamily.  In addn., the structural features and site-directed mutagenesis suggest that the specific β-hairpin with the arom. amino acid residues participates in binding to the membrane-bound sphingomyelin substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquLksjEE9SFLVg90H21EOLACvtfcHk0liGUSaDaRE3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1Crsro%253D&md5=16514a75f68870bdf751007ca19848f6</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601089200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601089200%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsuge%26aufirst%3DH.%26aulast%3DOchi%26aufirst%3DS.%26aulast%3DKatunuma%26aufirst%3DN.%26aulast%3DMiyano%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520the%2520sphingomyelin%2520phosphodiesterase%2520activity%2520in%2520neutral%2520sphingomyelinase%2520from%2520bacillus%2520cereus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D16157%26epage%3D16167%26doi%3D10.1074%2Fjbc.M601089200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengistu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohach, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlievert, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, C. A.</span></span> <span> </span><span class="NLM_article-title">Structure and biological activities of beta toxin from staphylococcus aureus</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">8719</span>– <span class="NLM_lpage">8726</span>, <span class="refDoi"> DOI: 10.1128/JB.00741-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1128%2FJB.00741-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=17873030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWitbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2007&pages=8719-8726&author=M.+Husebyauthor=K.+Shiauthor=C.+K.+Brownauthor=J.+Digreauthor=F.+Mengistuauthor=K.+S.+Seoauthor=G.+A.+Bohachauthor=P.+M.+Schlievertauthor=D.+H.+Ohlendorfauthor=C.+A.+Earhart&title=Structure+and+biological+activities+of+beta+toxin+from+staphylococcus+aureus&doi=10.1128%2FJB.00741-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and biological activities of beta toxin from Staphylococcus aureus</span></div><div class="casAuthors">Huseby, Medora; Shi, Ke; Brown, C. Kent; Digre, Jeff; Mengistu, Fikre; Seo, Keun Seok; Bohach, Gregory A.; Schlievert, Patrick M.; Ohlendorf, Douglas H.; Earhart, Cathleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8719-8726</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Beta toxin is a neutral sphingomyelinase secreted by certain strains of Staphylococcus aureus.  This virulence factor lyses erythrocytes to evade the host immune system as well as scavenge nutrients.  The structure of beta toxin was detd. at 2.4-Å resoln. using crystals that were merohedrally twinned.  This structure is similar to that of the sphingomyelinases of Listeria ivanovii and Bacillus cereus.  Beta toxin belongs to the DNase I folding superfamily; in addn. to sphingomyelinases, the proteins most structurally related to beta toxin include human endonuclease HAP1, Escherichia coli endonuclease III, bovine pancreatic DNase I, and the endonuclease domain of TRAS1 from Bombyx mori.  The authors' biol. assays demonstrated for the first time that beta toxin kills proliferating human lymphocytes.  Structure-directed active site mutations show that biol. activities, including hemolysis and lymphotoxicity, are due to the sphingomyelinase activity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3isnbmrnoM7Vg90H21EOLACvtfcHk0liGUSaDaRE3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWitbjN&md5=faf12957045fe21f667ecf14524472d5</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1128%2FJB.00741-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00741-07%26sid%3Dliteratum%253Aachs%26aulast%3DHuseby%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DC.%2BK.%26aulast%3DDigre%26aufirst%3DJ.%26aulast%3DMengistu%26aufirst%3DF.%26aulast%3DSeo%26aufirst%3DK.%2BS.%26aulast%3DBohach%26aufirst%3DG.%2BA.%26aulast%3DSchlievert%26aufirst%3DP.%2BM.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DEarhart%26aufirst%3DC.%2BA.%26atitle%3DStructure%2520and%2520biological%2520activities%2520of%2520beta%2520toxin%2520from%2520staphylococcus%2520aureus%26jtitle%3DJ.%2520Bacteriol.%26date%3D2007%26volume%3D189%26spage%3D8719%26epage%3D8726%26doi%3D10.1128%2FJB.00741-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huseby, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earhart, C. A.</span></span> <span> </span><span class="NLM_article-title">Structure of a mutant beta toxin from staphylococcus aureus reveals domain swapping and conformational flexibility</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1107/S1744309111005239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1107%2FS1744309111005239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=21505235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=438-441&author=A.+C.+Kruseauthor=M.+J.+Husebyauthor=K.+Shiauthor=J.+Digreauthor=D.+H.+Ohlendorfauthor=C.+A.+Earhart&title=Structure+of+a+mutant+beta+toxin+from+staphylococcus+aureus+reveals+domain+swapping+and+conformational+flexibility&doi=10.1107%2FS1744309111005239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a mutant β toxin from Staphylococcus aureus reveals domain swapping and conformational flexibility</span></div><div class="casAuthors">Kruse, Andrew C.; Huseby, Medora J.; Shi, Ke; Digre, Jeff; Ohlendorf, Douglas H.; Earhart, Cathleen A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-441</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The 3.35 Å resoln. crystal structure of a mutant form of the staphylococcal sphingomyelinase β toxin in which a conserved hydrophobic β-hairpin has been deleted is reported.  It is shown that this mutation induces domain swapping of a C-terminal β-strand, leading to the formation of dimers linked by a conformationally flexible hinge region.  Eight dimers are seen in the asym. unit, exhibiting a broad spectrum of conformations trapped in place by intermol. contacts within the crystal lattice.  Furthermore, the 16 monomers within each asym. unit exhibit a remarkable heterogeneity in thermal factors, which can be accounted for by the varying degrees to which each monomer interacts with other mols. in the crystal.  This structure provides a unique example of the challenges assocd. with crystallog. study of flexible proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp764HdSWclybVg90H21EOLACvtfcHk0lgfAPyW5ncF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGksr8%253D&md5=42fcc73cafed05f0c8ba0e926331b047</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1107%2FS1744309111005239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309111005239%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DHuseby%26aufirst%3DM.%2BJ.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DDigre%26aufirst%3DJ.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DEarhart%26aufirst%3DC.%2BA.%26atitle%3DStructure%2520of%2520a%2520mutant%2520beta%2520toxin%2520from%2520staphylococcus%2520aureus%2520reveals%2520domain%2520swapping%2520and%2520conformational%2520flexibility%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2011%26volume%3D67%26spage%3D438%26epage%3D441%26doi%3D10.1107%2FS1744309111005239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Stereocontrolled synthesis of a sphingomyelin methylene analogue as a sphingomyelinase inhibitor</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2629</span>, <span class="refDoi"> DOI: 10.1021/ol006147c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol006147c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlagsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=2627-2629&author=T.+Hakogiauthor=Y.+Mondenauthor=S.+Iwamaauthor=S.+Katsumura&title=Stereocontrolled+synthesis+of+a+sphingomyelin+methylene+analogue+as+a+sphingomyelinase+inhibitor&doi=10.1021%2Fol006147c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Stereocontrolled Synthesis of a Sphingomyelin Methylene Analogue as a Sphingomyelinase Inhibitor</span></div><div class="casAuthors">Hakogi, Toshikazu; Monden, Yoshiko; Iwama, Seiji; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2627-2629</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efficient synthesis of a sphingomyelin methylene analog I, which was designed as a sphingomyelinase inhibitor, was stereoselectively achieved.  The Hofmann rearrangement of the α-hydroxyethyl-β-hydroxy amide II followed by the intramol. oxazolidinone ring formation was one of the key steps.  I showed moderate inhibitory activity toward sphingomyelinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4khR0nI8GO7Vg90H21EOLACvtfcHk0lgfAPyW5ncF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlagsL8%253D&md5=8b2520f1b3680d319fcdb239f730e680</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fol006147c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006147c%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DMonden%26aufirst%3DY.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520a%2520sphingomyelin%2520methylene%2520analogue%2520as%2520a%2520sphingomyelinase%2520inhibitor%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D2627%26epage%3D2629%26doi%3D10.1021%2Fol006147c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monden, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin carbon analogues as sphingomyelinase inhibitors</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">4839</span>– <span class="NLM_lpage">4846</span>, <span class="refDoi"> DOI: 10.1021/jo025529o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo025529o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVKjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=4839-4846&author=T.+Hakogiauthor=Y.+Mondenauthor=M.+Taichiauthor=S.+Iwamaauthor=S.+Fujiiauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+carbon+analogues+as+sphingomyelinase+inhibitors&doi=10.1021%2Fjo025529o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Sphingomyelin Carbon Analogues as Sphingomyelinase Inhibitors</span></div><div class="casAuthors">Hakogi, Toshikazu; Monden, Yoshiko; Taichi, Misako; Iwama, Seiji; Fujii, Shinobu; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4839-4846</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The highly efficient and stereocontrolled syntheses of sphingomyelin carbon analogs I (X = CH2, CH2CH2) were achieved by effectively utilizing Hofmann rearrangement of an enantiomerically pure β-hydroxyamide, which was prepd. by an asym. hydrogenation of a α-acyl-γ-butyrolactone and ring opening with NH3.  An intermediary isocyanate was selectively trapped with the vicinal hydroxy group in an intramol. fashion to produce an oxazolidinone deriv., intermediate.  In the synthesis of a quite polar compd. such as I, a convenient one-pot procedure of the introduction of a benzyloxycarbonyl group into the hydroxy group resulting from the oxazolidinone ring opening is another key point, because, in addn. to the efficiency, this protecting group was easily removable by a simple procedure and workup at the final step.  Both synthesized compds. I (X = CH2, CH2CH2) showed moderate inhibitory activity toward sphingomyelinase from B. cereus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSEvsBfde8LVg90H21EOLACvtfcHk0lgfAPyW5ncF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVKjtLg%253D&md5=8549bc8784a801b1fac2d562feba48dc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjo025529o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025529o%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DMonden%26aufirst%3DY.%26aulast%3DTaichi%26aufirst%3DM.%26aulast%3DIwama%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520carbon%2520analogues%2520as%2520sphingomyelinase%2520inhibitors%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D4839%26epage%3D4846%26doi%3D10.1021%2Fjo025529o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taichi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2801</span>– <span class="NLM_lpage">2804</span>, <span class="refDoi"> DOI: 10.1021/ol034771u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol034771u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltF2rurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2801-2804&author=T.+Hakogiauthor=M.+Taichiauthor=S.+Katsumura&title=Synthesis+of+a+nitrogen+analogue+of+sphingomyelin+as+a+sphingomyelinase+inhibitor&doi=10.1021%2Fol034771u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Nitrogen Analogue of Sphingomyelin as a Sphingomyelinase Inhibitor</span></div><div class="casAuthors">Hakogi, Toshikazu; Taichi, Misako; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2801-2804</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sphingomyelin nitrogen analog I was designed and synthesized as a sphingomyelinase inhibitor.  The synthesis was established by continuous Hofmann rearrangement and Curtius rearrangement as key steps in constructing the 3-hydroxy-1,2-diamine structure in the backbone of I.  This analog showed moderate inhibitory activity toward sphingomyelinase isolated from B. cereus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh3Jq5mhvGwLVg90H21EOLACvtfcHk0lhJnq475RNWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltF2rurg%253D&md5=65e99d208f1458243deeae1085d931e7</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fol034771u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol034771u%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DTaichi%26aufirst%3DM.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520nitrogen%2520analogue%2520of%2520sphingomyelin%2520as%2520a%2520sphingomyelinase%2520inhibitor%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2801%26epage%3D2804%26doi%3D10.1021%2Fol034771u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin difluoromethylene analogue</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2627</span>– <span class="NLM_lpage">2630</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2006.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.tetlet.2006.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitlarsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=2627-2630&author=T.+Hakogiauthor=T.+Yamamotoauthor=S.+Fujiiauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+difluoromethylene+analogue&doi=10.1016%2Fj.tetlet.2006.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sphingomyelin difluoromethylene analog</span></div><div class="casAuthors">Hakogi, Toshikazu; Yamamoto, Tetsuya; Fujii, Shinobu; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2627-2630</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As a new sphingomyelinase inhibitor, a novel sphingomyelin CF2 analog was designed and synthesized.  One key step of this synthesis is the very mild hydrolysis of the oxazolidinone ring of methylphosphonate I, a suitable intermediate for the introduction of a di-Et difluoro-methylphosphonate group, by utilizing the characteristic electron withdrawing nature of the group at the oxazolidinone ring in an alc. solvent to produce the corresponding carbonate attaching at the secondary hydroxy group.  The synthesized CF2 analog inactivated toward B. cereus sphingomyelinase with nearly the same attitude as the nitrogen analog that we previously reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXswOb8tpvRrVg90H21EOLACvtfcHk0lhJnq475RNWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitlarsbo%253D&md5=a50d891bb2c469fbfb8e2fadf044ee0a</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2006.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2006.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520difluoromethylene%2520analogue%26jtitle%3DTetrahedron%2520Lett.%26date%3D2006%26volume%3D47%26spage%3D2627%26epage%3D2630%26doi%3D10.1016%2Fj.tetlet.2006.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakogi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumura, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2141</span>– <span class="NLM_lpage">2144</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmcl.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=15808485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVKgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2141-2144&author=T.+Hakogiauthor=S.+Fujiiauthor=M.+Moritaauthor=K.+Ikedaauthor=S.+Katsumura&title=Synthesis+of+sphingomyelin+sulfur+analogue+and+its+behavior+toward+sphingomyelinase&doi=10.1016%2Fj.bmcl.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase</span></div><div class="casAuthors">Hakogi, Toshikazu; Fujii, Shinobu; Morita, Michio; Ikeda, Kiyoshi; Katsumura, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2141-2144</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The sulfur analog of sphingomyelin was designed and stereoselectively synthesized from S-benzyl-N-Boc-cysteine.  The introduction of the phosphoryl choline moiety was successfully achieved by our own method using 2-bromoethyl di-Me phosphite and carbon tetrabromide followed by a trimethylamine treatment.  The synthesized compd. proved to be a useful substrate for monitoring the enzyme activity of sphingomyelinase by detecting the liberated thiol group with a thiol-sensitive reagent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj_NTCRC4o9LVg90H21EOLACvtfcHk0lhJnq475RNWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVKgtb0%253D&md5=553bfebe30cc909ebe340ab29b6f3c0c</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHakogi%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKatsumura%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520sphingomyelin%2520sulfur%2520analogue%2520and%2520its%2520behavior%2520toward%2520sphingomyelinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2141%26epage%3D2144%26doi%3D10.1016%2Fj.bmcl.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabiku, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3868</span>– <span class="NLM_lpage">3871</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bmcl.2010.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=20627555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVWju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3868-3871&author=H.+Imagawaauthor=M.+Odaauthor=T.+Takemotoauthor=R.+Yamauchiauthor=T.+Yoshikawaauthor=H.+Yamamotoauthor=M.+Nishizawaauthor=H.+Takahashiauthor=M.+Hashimotoauthor=K.+Yabikuauthor=M.+Nagahamaauthor=J.+Sakurai&title=Synthesis+and+evaluation+of+novel+phosphate+ester+analogs+as+neutral+sphingomyelinase+inhibitors&doi=10.1016%2Fj.bmcl.2010.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors</span></div><div class="casAuthors">Imagawa, Hiroshi; Oda, Masataka; Takemoto, Takayuki; Yamauchi, Rieko; Yoshikawa, Tomomi; Yamamoto, Hirofumi; Nishizawa, Mugio; Takahashi, Hironobu; Hashimoto, Manabu; Yabiku, Kenta; Nagahama, Masahiro; Sakurai, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3868-3871</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel sphingomyelin inhibitor RY221B-a I, which contains a bipyridyl moiety as a metal coordination site was designed based upon the mechanism of phosphate ester hydrolysis.  I was synthesized from N-Boc-sphingosine in three steps via selective etherification using stannyl acetal.  Synthesized I exhibited relatively-strong inhibitory activity against Bacillus subtillis sphingomyelinase (IC50 = 1.2 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs-r0iFo4PgrVg90H21EOLACvtfcHk0liEPLVipX3LVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVWju7Y%253D&md5=cba3b6b3c9a5195eead28f3dffd3a6be</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DImagawa%26aufirst%3DH.%26aulast%3DOda%26aufirst%3DM.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DYamauchi%26aufirst%3DR.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DYabiku%26aufirst%3DK.%26aulast%3DNagahama%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520phosphate%2520ester%2520analogs%2520as%2520neutral%2520sphingomyelinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3868%26epage%3D3871%26doi%3D10.1016%2Fj.bmcl.2010.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabiku, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takemoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahama, M.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitor of bacterial sphingomyelinase, smy-540, developed based on three-dimensional structure analysis</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.3109/14756366.2013.777717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3109%2F14756366.2013.777717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=23488740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=303-310&author=M.+Odaauthor=H.+Imagawaauthor=R.+Katoauthor=K.+Yabikuauthor=T.+Yoshikawaauthor=T.+Takemotoauthor=H.+Takahashiauthor=H.+Yamamotoauthor=M.+Nishizawaauthor=J.+Sakuraiauthor=M.+Nagahama&title=Novel+inhibitor+of+bacterial+sphingomyelinase%2C+smy-540%2C+developed+based+on+three-dimensional+structure+analysis&doi=10.3109%2F14756366.2013.777717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis</span></div><div class="casAuthors">Oda, Masataka; Imagawa, Hiroshi; Kato, Ryoko; Yabiku, Kenta; Yoshikawa, Tomomi; Takemoto, Takayuki; Takahashi, Hironobu; Yamamoto, Hirofumi; Nishizawa, Mugio; Sakurai, Jun; Nagahama, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-310</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Context: Bacterial sphingomyelinase (SMase) is thought to play a crucial role in bacterial evasion of the immune response during the early stages of infections.  Objective: The objective of this study was to predict the chem. structure required for competitive SMase inhibition, then synthesize and test the effect of potential inhibitors on the hydrolysis of sphingomyelin (SM) and protection against infection by Bacillus cereus.  Materials and methods: We synthesized 10 potential SMase inhibitors, derivs. of RY221B-a analogs, based on predictions from three-dimensional structural anal.  We then tested the effect of these compds. on the inhibition of SM hydrolysis and protection of mice inoculated with B. cereus.  Results: One compd., SMY-540, displayed a strong inhibitory effect (IC50 = 0.8 μM) upon SMase and prevented mortality in mice.  Conclusion: SMY-540 is an effective inhibitor of Bc-SMase and has potential for use in the development of drugs to treat infectious diseases caused by bacteria that produce SMase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfa2DgvHxPnbVg90H21EOLACvtfcHk0liEPLVipX3LVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ns7o%253D&md5=0339eb5ce17bc430701cb93ae0440c13</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.3109%2F14756366.2013.777717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2013.777717%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DM.%26aulast%3DImagawa%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DR.%26aulast%3DYabiku%26aufirst%3DK.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DJ.%26aulast%3DNagahama%26aufirst%3DM.%26atitle%3DNovel%2520inhibitor%2520of%2520bacterial%2520sphingomyelinase%252C%2520smy-540%252C%2520developed%2520based%2520on%2520three-dimensional%2520structure%2520analysis%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2014%26volume%3D29%26spage%3D303%26epage%3D310%26doi%3D10.3109%2F14756366.2013.777717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waggoner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Munoz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">16506</span>– <span class="NLM_lpage">16509</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.28.16506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.271.28.16506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8663293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1equrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=16506-16509&author=D.+W.+Waggonerauthor=A.+Gomez-Munozauthor=J.+Dewaldauthor=D.+N.+Brindley&title=Phosphatidate+phosphohydrolase+catalyzes+the+hydrolysis+of+ceramide+1-phosphate%2C+lysophosphatidate%2C+and+sphingosine+1-phosphate&doi=10.1074%2Fjbc.271.28.16506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate</span></div><div class="casAuthors">Waggoner, David W.; Gomez-Munoz, Antonio; Dewald, Jay; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">16506-16509</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A Mg2+-independent phosphatidate phosphohydrolase was purified from rat liver plasma membranes in two distinct forms, an anionic protein and a cationic protein.  Both forms of the enzyme dephosphorylated phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.  When assayed at a const. molar ratio of lipid to Triton X-100 of 1:500, the apparent Km values of the anionic phosphohydrolase for the lipid substrates was 3.5, 1.9, 0.4, and 4.0 μM, resp.  The relative catalytic efficiency of the enzyme for phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate was 0.16, 0.14, 0.48, and 0.04 L (min·mg)-1, resp.  The hydrolysis of phosphatidate was inhibited competitively by ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.  The Ki(app) values were 5.5, 5.9, and 4.0 μM, resp.  The hydrolysis of phosphatidate by the phosphohydrolase conformed to a surface diln. kinetic model.  It is concluded that the enzyme is a lipid phosphomonoesterase that could modify the balance of phosphatidate, ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate relative to diacylglycerol, ceramide, monoacylglycerol, and sphingosine, resp.  The enzyme could thus play an important role in regulating cell activation and signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBipUSDoi3mLVg90H21EOLACvtfcHk0liEPLVipX3LVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1equrs%253D&md5=3f980775e8126636a0b53e260e73309b</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.28.16506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.28.16506%26sid%3Dliteratum%253Aachs%26aulast%3DWaggoner%26aufirst%3DD.%2BW.%26aulast%3DGomez-Munoz%26aufirst%3DA.%26aulast%3DDewald%26aufirst%3DJ.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DPhosphatidate%2520phosphohydrolase%2520catalyzes%2520the%2520hydrolysis%2520of%2520ceramide%25201-phosphate%252C%2520lysophosphatidate%252C%2520and%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D16506%26epage%3D16509%26doi%3D10.1074%2Fjbc.271.28.16506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shinghal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajjalieh, S. M.</span></span> <span> </span><span class="NLM_article-title">Ceramide 1-phosphate phosphatase activity in brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2279</span>– <span class="NLM_lpage">2285</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1993.tb07470.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1111%2Fj.1471-4159.1993.tb07470.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8245978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXivVSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1993&pages=2279-2285&author=R.+Shinghalauthor=R.+H.+Schellerauthor=S.+M.+Bajjalieh&title=Ceramide+1-phosphate+phosphatase+activity+in+brain&doi=10.1111%2Fj.1471-4159.1993.tb07470.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide 1-phosphate phosphatase activity in brain</span></div><div class="casAuthors">Shinghal, Rajesh; Scheller, Richard H.; Bajjalieh, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2279-85</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Recent studies have implicated sphingolipids in a variety of intracellular signaling systems.  The finding that a calcium-stimulated ceramide kinase copurifies with neurotransmitter-contg. vesicles suggests that ceramide, or one of its metabolites, has a role in neurotransmitter release.  As a step toward understanding the role of ceramide kinase in vesicle functioning, this study sought to det. the metabolic fate of the product, ceramide 1-phosphate.  The authors report that ceramide 1-phosphate is not deacylated by brain ceramidases to produce sphingosine 1-phosphate.  It is however, the substrate for a phosphatase activity that the authors name ceramide 1-phosphate phosphatase (CCPase).  Subcellular fractionation studies suggest that CPPase is found in the synaptic terminal and is assocd. with both synaptic vesicle and plasma membranes.  Divalent cations, most notably calcium, inhibit CPPase activity although not at concns. that activate ceramide kinase.  The existence of both ceramide kinase and CPPase activities at the synapse suggests that ceramide 1-phosphate prodn. regulates some aspect of synaptic vesicle functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAAw2sXaq4LLVg90H21EOLACvtfcHk0lg7yTWpkE7yPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivVSjsQ%253D%253D&md5=b433c45f7ce5f820c6ea7fb30cb1b7db</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1993.tb07470.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1993.tb07470.x%26sid%3Dliteratum%253Aachs%26aulast%3DShinghal%26aufirst%3DR.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DBajjalieh%26aufirst%3DS.%2BM.%26atitle%3DCeramide%25201-phosphate%2520phosphatase%2520activity%2520in%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1993%26volume%3D61%26spage%3D2279%26epage%3D2285%26doi%3D10.1111%2Fj.1471-4159.1993.tb07470.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boudker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futerman, A. H.</span></span> <span> </span><span class="NLM_article-title">Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">22150</span>– <span class="NLM_lpage">22155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2FS0021-9258%2820%2980660-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=8408075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADyaK2cXjt1Gh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1993&pages=22150-22155&author=O.+Boudkerauthor=A.+H.+Futerman&title=Detection+and+characterization+of+ceramide-1-phosphate+phosphatase+activity+in+rat+liver+plasma+membrane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane</span></div><div class="casAuthors">Boudker, Olga; Futerman, Anthony H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">22150-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A Ca2+-dependent ceramide (Cer) kinase was recently detected in human leukemia (HL-60) cells where it may function in terminating the regulatory effects of Cer, and in synaptic vesicles.  Here, it is demonstrated that the addn. of both Cer-1-phosphate (Cer-1-P) and a short-acyl chain analog of Cer-1-P, N-hexanoylsphingosine-1-phosphate (C6-Cer-1-P), to cultured cells and a variety of subcellular fractions resulted in rapid degrdn. to Cer and C6-Cer, resp.  The ceramide 1-phosphatase activity was enriched in a rat liver plasma membrane fraction and appeared to be distinct from the phosphatase that hydrolyzes phosphatidic acid (PA), phosphatidate phosphatase, as shown by the difference in sensitivity of Cer-1-P and PA hydrolysis to propranolol, detergent, and heat treatment.  Moreover, the Km of C6-Cer-1-P hydrolysis was 10-fold lower than the Km of PA hydrolysis in plasma membrane.  PA was a noncompetitive inhibitor of C6-Cer-1-P hydrolysis, with a Ki 1-1.5-fold higher than the Km of C6-Cer-1-P hydrolysis.  In contrast, C6-Cer-1-P did not inhibit PA hydrolysis.  Finally, the synthesis of a novel analog of Cer-1-P, C6-Cer-cyclic 1,3-phosphate, is described, which is not hydrolyzed in vitro and in vivo and is internalized in cultured cells by endocytosis.  These results were discussed in relation to the possible roles of Cer-1-P in regulating intracellular levels of Cer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzMIghVYmGRrVg90H21EOLACvtfcHk0lg7yTWpkE7yPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjt1Gh&md5=daca544d3af06216d06b9ae4b411b190</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2820%2980660-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252820%252980660-7%26sid%3Dliteratum%253Aachs%26aulast%3DBoudker%26aufirst%3DO.%26aulast%3DFuterman%26aufirst%3DA.%2BH.%26atitle%3DDetection%2520and%2520characterization%2520of%2520ceramide-1-phosphate%2520phosphatase%2520activity%2520in%2520rat%2520liver%2520plasma%2520membrane%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1993%26volume%3D268%26spage%3D22150%26epage%3D22155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stirnemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmatoug, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serratrice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froissart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levade, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serratrice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billette
de Villemeur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. G.</span></span> <span> </span><span class="NLM_article-title">A review of gaucher disease pathophysiology, clinical presentation and treatments</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.3390/ijms18020441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.3390%2Fijms18020441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVSju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=441&author=J.+Stirnemannauthor=N.+Belmatougauthor=F.+Camouauthor=C.+Serratriceauthor=R.+Froissartauthor=C.+Caillaudauthor=T.+Levadeauthor=L.+Astudilloauthor=J.+Serratriceauthor=A.+Brassierauthor=C.+Roseauthor=T.+Billette%0Ade+Villemeurauthor=M.+G.+Berger&title=A+review+of+gaucher+disease+pathophysiology%2C+clinical+presentation+and+treatments&doi=10.3390%2Fijms18020441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">A review of gaucher disease pathophysiology, clinical presentation and treatments</span></div><div class="casAuthors">Stirnemann, Jerome; Belmatoug, Nadia; Camou, Fabrice; Serratrice, Christine; Froissart, Roseline; Caillaud, Catherine; Levade, Thierry; Astudillo, Leonardo; Serratrice, Jacques; Brassier, Anais; Rose, Christian; Billette de Villemeur, Thierry; Berger, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441/1-441/30</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder.  It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages.  In the general population, its incidence is approx. 1/40,000 to 1/60,000 births, rising to 1/800 in Ashkenazi Jews.  The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions assocd. with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.  Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whereas types 2 and 3 are also assocd. with neurol. impairment, either severe in type 2 or variable in type 3.  A diagnosis of GD can be confirmed by demonstrating the deficiency of acid glucocerebrosidase activity in leukocytes.  Mutations in the GBA1 gene should be identified as they may be of prognostic value in some cases.  Patients with type-1 GD-but also carriers of GBA1 mutation-have been found to be predisposed to developing Parkinson's disease, and the risk of neoplasia assocd. with the disease is still subject to discussion.  Disease-specific treatment consists of i.v. enzyme replacement therapy (ERT) using one of the currently available mols. (imiglucerase, velaglucerase, or taliglucerase).  Orally administered inhibitors of glucosylceramide biosynthesis can also be used (miglustat or eliglustat).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpeVOOYHDqyLVg90H21EOLACvtfcHk0lg7yTWpkE7yPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVSju70%253D&md5=38a4c125a4007d25177135c8996f7abe</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.3390%2Fijms18020441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18020441%26sid%3Dliteratum%253Aachs%26aulast%3DStirnemann%26aufirst%3DJ.%26aulast%3DBelmatoug%26aufirst%3DN.%26aulast%3DCamou%26aufirst%3DF.%26aulast%3DSerratrice%26aufirst%3DC.%26aulast%3DFroissart%26aufirst%3DR.%26aulast%3DCaillaud%26aufirst%3DC.%26aulast%3DLevade%26aufirst%3DT.%26aulast%3DAstudillo%26aufirst%3DL.%26aulast%3DSerratrice%26aufirst%3DJ.%26aulast%3DBrassier%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DBillette%2Bde%2BVillemeur%26aufirst%3DT.%26aulast%3DBerger%26aufirst%3DM.%2BG.%26atitle%3DA%2520review%2520of%2520gaucher%2520disease%2520pathophysiology%252C%2520clinical%2520presentation%2520and%2520treatments%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D441%26doi%3D10.3390%2Fijms18020441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span> <span> </span><span class="NLM_article-title">Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe’s disease</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1006</span>, <span class="refDoi"> DOI: 10.1002/jnr.23873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1002%2Fjnr.23873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=27638584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWltr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=990-1006&author=J.+S.+Wonauthor=A.+K.+Singhauthor=I.+Singh&title=Biochemical%2C+cell+biological%2C+pathological%2C+and+therapeutic+aspects+of+Krabbe%E2%80%99s+disease&doi=10.1002%2Fjnr.23873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease</span></div><div class="casAuthors">Won, Je-Seong; Singh, Avtar K.; Singh, Inderjit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">990-1006</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Krabbe's disease (KD; also called globoid cell leukodystrophy) is a genetic disorder involving demyelination of the central (CNS) and peripheral (PNS) nervous systems.  The disease may be subdivided into three types, an infantile form, which is the most common and severe; a juvenile form; and a rare adult form.  KD is an autosomal recessive disorder caused by a deficiency of galactocerebrosidase activity in lysosomes, leading to accumulation of galactoceramide and neurotoxic galactosylsphingosine (psychosine [PSY]) in macrophages (globoid cells) as well as neural cells, esp. in oligodendrocytes and Schwann cells.  This ultimately results in damage to myelin in both CNS and PNS with assocd. morbidity and mortality.  Accumulation of PSY, a lysolipid with detergent-like properties, over a threshold level could trigger membrane destabilization, leading to cell lysis.  Moreover, subthreshold concns. of PSY trigger cell signaling pathways that induce oxidative stress, mitochondrial dysfunction, apoptosis, inflammation, endothelial/vascular dysfunctions, and neuronal and axonal damage.  From the time the "psychosine hypothesis" was proposed, considerable efforts have been made in search of an effective therapy for lowering PSY load with pharmacol., gene, and stem cell approaches to attenuate PSY-induced neurotoxicity.  This Review focuses on the recent advances and prospective research for understanding disease mechanisms and therapeutic approaches for KD. © 2016 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyiXLjIgjfi7Vg90H21EOLACvtfcHk0lg7yTWpkE7yPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWltr3I&md5=4f5306516d90cf3abf8a9023172ac8dc</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23873%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DJ.%2BS.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSingh%26aufirst%3DI.%26atitle%3DBiochemical%252C%2520cell%2520biological%252C%2520pathological%252C%2520and%2520therapeutic%2520aspects%2520of%2520Krabbe%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2016%26volume%3D94%26spage%3D990%26epage%3D1006%26doi%3D10.1002%2Fjnr.23873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maegawa, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropak, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buttner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornhaber, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamuro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahuran, D. J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of ambroxol as an enzyme enhancement agent for gaucher disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23502</span>– <span class="NLM_lpage">23516</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.012393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1074%2Fjbc.M109.012393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=19578116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23502-23516&author=G.+H.+Maegawaauthor=M.+B.+Tropakauthor=J.+D.+Buttnerauthor=B.+A.+Rigatauthor=M.+Fullerauthor=D.+Panditauthor=L.+Tangauthor=G.+J.+Kornhaberauthor=Y.+Hamuroauthor=J.+T.+Clarkeauthor=D.+J.+Mahuran&title=Identification+and+characterization+of+ambroxol+as+an+enzyme+enhancement+agent+for+gaucher+disease&doi=10.1074%2Fjbc.M109.012393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease</span></div><div class="casAuthors">Maegawa, Gustavo H. B.; Tropak, Michael B.; Buttner, Justin D.; Rigat, Brigitte A.; Fuller, Maria; Pandit, Deepangi; Tang, Liangiie; Kornhaber, Gregory J.; Hamuro, Yoshitomo; Clarke, Joe T. R.; Mahuran, Don J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23502-23516</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase).  The identification of small mols. acting as agents for enzyme enhancement therapy is an attractive approach for treating different forms of GD.  A thermal denaturation assay utilizing wild type GCase was developed to screen a library of 1,040 Food and Drug Administration-approved drugs.  Ambroxol (ABX), a drug used to treat airway mucus hypersecretion and hyaline membrane disease in newborns, was identified and found to be a pH-dependent, mixed-type inhibitor of GCase.  Its inhibitory activity was maximal at neutral pH, found in the endoplasmic reticulum, and undetectable at the acidic pH of lysosomes.  The pH dependence of ABX to bind and stabilize the enzyme was confirmed by monitoring the rate of hydrogen/deuterium exchange at increasing guanidine hydrochloride concns.  ABX treatment significantly increased N370S and F213I mutant GCase activity and protein levels in GD fibroblasts.  These increases were primarily confined to the lysosome-enriched fraction of treated cells, a finding confirmed by confocal immunofluorescence microscopy.  Addnl., enhancement of GCase activity and a redn. in glucosylceramide storage was verified in ABX-treated GD lymphoblasts (N370S/N370S).  Hydrogen/deuterium exchange mass spectrometry revealed that upon binding of ABX, amino acid segments 243-249, 310-312, and 386-400 near the active site of GCase are stabilized.  Consistent with its mixed-type inhibition of GCase, modeling studies indicated that ABX interacts with both active and non-active site residues.  Thus, ABX has the biochem. characteristics of a safe and effective enzyme enhancement therapy agent for the treatment of patients with the most common GD genotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Zxl1_6m-5rVg90H21EOLACvtfcHk0lgnRXKydGdHxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt77J&md5=251abe854d7aed644de329e595e7294a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.012393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.012393%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DFuller%26aufirst%3DM.%26aulast%3DPandit%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520ambroxol%2520as%2520an%2520enzyme%2520enhancement%2520agent%2520for%2520gaucher%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23502%26epage%3D23516%26doi%3D10.1074%2Fjbc.M109.012393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybczynski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wustman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological chaperones as therapeutics for lysosomal storage diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2705</span>– <span class="NLM_lpage">2725</span>, <span class="refDoi"> DOI: 10.1021/jm301557k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301557k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2705-2725&author=R.+E.+Boydauthor=G.+Leeauthor=P.+Rybczynskiauthor=E.+R.+Benjaminauthor=R.+Khannaauthor=B.+A.+Wustmanauthor=K.+J.+Valenzano&title=Pharmacological+chaperones+as+therapeutics+for+lysosomal+storage+diseases&doi=10.1021%2Fjm301557k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases</span></div><div class="casAuthors">Boyd, Robert E.; Lee, Gary; Rybczynski, Philip; Benjamin, Elfrida R.; Khanna, Richie; Wustman, Brandon A.; Valenzano, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2705-2725</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Lysosomal enzymes are responsible for the degrdn. of a wide variety of glycolipids, oligosaccharides, proteins, and glycoproteins.  Inherited mutations in the genes that encode these proteins can lead to reduced stability of newly synthesized lysosomal enzymes.  While often catalytically competent, the mutated enzymes are unable to efficiently pass the quality control mechanisms of the endoplasmic reticulum, resulting in reduced lysosomal trafficking, substrate accumulation, and cellular dysfunction.  Pharmacol. chaperones (PCs) are small mols. that bind and stabilize mutant lysosomal enzymes, thereby allowing proper cellular translocation.  Such compds. have been shown to increase enzyme activity and reduce substrate burden in a no. of preclin. models and clin. studies.  In this Perspective, we review several of the lysosomal diseases for which PCs have been studied and the SAR of the various classes of mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5XMGP8Eg5B7Vg90H21EOLACvtfcHk0lgnRXKydGdHxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtLc%253D&md5=09294f7cc13deaddf5069adecf71f8b8</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm301557k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301557k%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRybczynski%26aufirst%3DP.%26aulast%3DBenjamin%26aufirst%3DE.%2BR.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWustman%26aufirst%3DB.%2BA.%26aulast%3DValenzano%26aufirst%3DK.%2BJ.%26atitle%3DPharmacological%2520chaperones%2520as%2520therapeutics%2520for%2520lysosomal%2520storage%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2705%26epage%3D2725%26doi%3D10.1021%2Fjm301557k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arenz, C.</span></span> <span> </span><span class="NLM_article-title">Recent advances and novel treatments for sphingolipidoses</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1687</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.4155%2Ffmc-2017-0065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=28857617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A280%3ADC%252BC1cbjt12nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1687-1700&author=C.+Arenz&title=Recent+advances+and+novel+treatments+for+sphingolipidoses&doi=10.4155%2Ffmc-2017-0065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances and novel treatments for sphingolipidoses</span></div><div class="casAuthors">Arenz Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Future medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1687-1700</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Sphingolipidoses are genetically inherited diseases in which genetic mutations lead to functional deficiencies in the enzymes needed for lysosomal degradation of sphingolipid substrates.  As a consequence, nondegradable lipids enrich in the lysosomes and lead to fatal pathological phenotypes in affected individuals.  In this review, different drug-based treatment strategies including enzyme replacement therapy and substrate reduction therapy are discussed.  A special focus is on the concept of pharmacological chaperones, one of which recently acquired clinical approval within the EU.  On the basis of the different limitations for each approach, possible future directions of research are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU_JNgrtbOLH6oPH0mYWL1fW6udTcc2ebK_qf0-Zh317ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbjt12nsQ%253D%253D&md5=4af9941c6d9f7fdcc6e7f6740922687f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0065%26sid%3Dliteratum%253Aachs%26aulast%3DArenz%26aufirst%3DC.%26atitle%3DRecent%2520advances%2520and%2520novel%2520treatments%2520for%2520sphingolipidoses%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1687%26epage%3D1700%26doi%3D10.4155%2Ffmc-2017-0065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chew, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seow, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenk, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span> <span> </span><span class="NLM_article-title">Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.04.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.04.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29654754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvFemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2018&pages=596-601&author=W.+S.+Chewauthor=W.+L.+Seowauthor=J.+R.+Chongauthor=M.+K.+P.+Laiauthor=F.+Tortaauthor=M.+R.+Wenkauthor=D.+R.+Herr&title=Sphingolipidomics+analysis+of+large+clinical+cohorts.+Part+1%3A+Technical+notes+and+practical+considerations&doi=10.1016%2Fj.bbrc.2018.04.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipidomics analysis of large clinical cohorts. Part 1: Technical notes and practical considerations</span></div><div class="casAuthors">Chew, Wee Siong; Seow, Wei Lun; Chong, Joyce R.; Lai, Mitchell K. P.; Torta, Federico; Wenk, Markus R.; Herr, Deron R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Lipids comprise an exceptionally diverse class of bioactive macromols.  While quant. abundant lipid species serve fundamental roles in cell structure and energy metab., thousands of structurally-distinct, quant. minor species may serve as important regulators of cellular processes.  Historically, a complete understanding of the biol. roles of these lipids has been limited by a lack of sensitive, discriminating anal. techniques.  The class of sphingolipids alone, for example, is known to consist of over 600 different confirmed species, but is likely to include tens of thousands of metabolites with potential biol. significance.  Advances in mass spectrometry (MS) have improved the throughput and discrimination of lipid anal., allowing for the detn. of detailed lipid profiles in large cohorts of clin. samples.  Databases emerging from these studies will provide a rich resource for the identification of novel biomarkers and for the discovery of potential drug targets, analogous to that of existing genomics databases.  In this , we will provide an overview of the field of sphingolipidomics, and will discuss some of the challenges and considerations facing the generation of robust lipidomics databases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj8LdDhANPjrVg90H21EOLACvtfcHk0lh-BU7dzEx8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvFemsrg%253D&md5=5b20d8cb615fdc2bef9ac77f63ceae05</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.04.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.04.076%26sid%3Dliteratum%253Aachs%26aulast%3DChew%26aufirst%3DW.%2BS.%26aulast%3DSeow%26aufirst%3DW.%2BL.%26aulast%3DChong%26aufirst%3DJ.%2BR.%26aulast%3DLai%26aufirst%3DM.%2BK.%2BP.%26aulast%3DTorta%26aufirst%3DF.%26aulast%3DWenk%26aufirst%3DM.%2BR.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26atitle%3DSphingolipidomics%2520analysis%2520of%2520large%2520clinical%2520cohorts.%2520Part%25201%253A%2520Technical%2520notes%2520and%2520practical%2520considerations%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D504%26spage%3D596%26epage%3D601%26doi%3D10.1016%2Fj.bbrc.2018.04.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chong, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hind, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chew, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, D. R.</span></span> <span> </span><span class="NLM_article-title">Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>504</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.04.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1016%2Fj.bbrc.2018.04.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=29654757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnvFenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2018&pages=602-607&author=J.+R.+Chongauthor=P.+Xiangauthor=W.+Wangauthor=T.+Hindauthor=W.+S.+Chewauthor=W.+Y.+Ongauthor=M.+K.+P.+Laiauthor=D.+R.+Herr&title=Sphingolipidomics+analysis+of+large+clinical+cohorts.+Part+2%3A+Potential+impact+and+applications&doi=10.1016%2Fj.bbrc.2018.04.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications</span></div><div class="casAuthors">Chong, Joyce R.; Xiang, Ping; Wang, Wei; Hind, Tatsuma; Chew, Wee Siong; Ong, Wei-Yi; Lai, Mitchell K. P.; Herr, Deron R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">602-607</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">It has been known for decades that the regulation of sphingolipids (SLs) is essential for the proper function of many cellular processes.  However, a complete understanding of these processes has been complicated by the structural diversity of these lipids.  A well-characterized metabolic pathway is responsible for homeostatic maintenance of hundreds of distinct SL species.  This pathway is perturbed in a no. of pathol. processes, resulting in derangement of the "sphingolipidome.".  Recently, advances in mass spectrometry (MS) techniques have made it possible to characterize the sphingolipidome in large-scale clin. studies, allowing for the identification of specific SL mols. that mediate pathol. processes and/or may serve as biomarkers.  This manuscript provides an overview of the functions of SLs, and reviews previous studies that have used MS techniques to identify changes to the sphingolipidome in non-metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGgZAzrcuIhLVg90H21EOLACvtfcHk0lh-BU7dzEx8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnvFenurY%253D&md5=fdf7cef204b623153112545a4d195a65</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.04.075%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DJ.%2BR.%26aulast%3DXiang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHind%26aufirst%3DT.%26aulast%3DChew%26aufirst%3DW.%2BS.%26aulast%3DOng%26aufirst%3DW.%2BY.%26aulast%3DLai%26aufirst%3DM.%2BK.%2BP.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26atitle%3DSphingolipidomics%2520analysis%2520of%2520large%2520clinical%2520cohorts.%2520Part%25202%253A%2520Potential%2520impact%2520and%2520applications%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D504%26spage%3D602%26epage%3D607%26doi%3D10.1016%2Fj.bbrc.2018.04.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matanes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twal, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammad, S. M.</span></span> <span> </span><span class="NLM_article-title">Sphingolipids as biomarkers of disease</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1159</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/978-3-030-21162-2_7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=10.1007%2F978-3-030-21162-2_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=31502202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsVGmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1159&publication_year=2019&pages=109-138&author=F.+Matanesauthor=W.+O.+Twalauthor=S.+M.+Hammad&title=Sphingolipids+as+biomarkers+of+disease&doi=10.1007%2F978-3-030-21162-2_7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids as Biomarkers of Disease</span></div><div class="casAuthors">Matanes, Faris; Twal, Waleed O.; Hammad, Samar M.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1159</span>
        (<span class="NLM_cas:issue">Bioactive Ceramides in Health and Disease</span>),
    <span class="NLM_cas:pages">109-138</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">2214-8019</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Despite the advancements in modern medicine, there are still difficulties in diagnosing common illnesses.  The invasiveness and price of the tests used to follow up certain diseases can be a barrier to proper patient follow-up.  Sphingolipids are a diverse category of lipids.  They are structural mols. in cell membranes and signaling mols. involved in the regulation of crucial cell functions, including cell growth, differentiation, proliferation and apoptosis.  Recent research has shown that abnormal sphingolipid metab. is assocd. with genetic and metabolic disease processes.  Given their crucial role to maintain homeostasis within the body, sphingolipids have been investigated as potential biomarkers to predict disease in the population.  Here we discuss how sphingolipids levels are altered in different diseases, thus illustrating their possible use as diagnostic and prognostic biomarkers for disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1BnvX8uGvLbVg90H21EOLACvtfcHk0lh-BU7dzEx8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVGmsr0%253D&md5=3d40f5c6c13e4056451131d9980e9d4b</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1007%2F978-3-030-21162-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-030-21162-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DMatanes%26aufirst%3DF.%26aulast%3DTwal%26aufirst%3DW.%2BO.%26aulast%3DHammad%26aufirst%3DS.%2BM.%26atitle%3DSphingolipids%2520as%2520biomarkers%2520of%2520disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2019%26volume%3D1159%26spage%3D109%26epage%3D138%26doi%3D10.1007%2F978-3-030-21162-2_7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FI9','PDB','5FI9'); return false;">PDB: 5FI9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FIB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FIB','PDB','5FIB'); return false;">PDB: 5FIB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UVG','PDB','5UVG'); return false;">PDB: 5UVG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZWX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1ZWX','PDB','1ZWX'); return false;">PDB: 1ZWX</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01664&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01664%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01664" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ab0a482e3d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
